block_id,drug_drug1_id,drug_drug2_id,cell_line_id,conc_r_unit,conc_c_unit,synergy_zip,synergy_loewe,synergy_hsa,synergy_bliss,ic50_drug1,ic50_drug2,ri_drug1,ri_drug2,css_drug1,css_drug2,css_ri,S_sum,quality,S_mean,S_max,dname_drug1,chembl_id_drug1,inchikey_drug1,smiles_drug1,molecular_formula_drug1,drugbank_id_drug1,kegg_id_drug1,cmaps_name_drug1,dname_drug2,chembl_id_drug2,inchikey_drug2,smiles_drug2,molecular_formula_drug2,drugbank_id_drug2,kegg_id_drug2,cmaps_name_drug2,cell_line_name,cell_disease_id,tumor_location_cosmic,tumor_location_cellosaurus
4641,1,2,4,uM,uM,-1.83228783414542,-26.97861655761,-8.16607289305839,-4.94496001409903,10.0,0.147261962652638,4.246,-3.729,-3.261,37.649,17.194,16.677,,16.935499999999998,12.948,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,Veliparib,CHEMBL506871,JNAHVYVRKWKWKQ-CYBMUJFWSA-N,CC1(CCCN1)C2=NC3=C(C=CC=C3N2)C(=O)N,C13H16N4O,DB07232,D09692,veliparib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
4645,1,3,4,uM,uM,2.61237915690029,-2.54258302407204,5.44388997832592,2.0585506720643,10.0,0.275256624434363,4.246,22.135,59.882,60.151,60.0165,33.6355,,46.826,37.8815,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,MK-1775,CHEMBL1976040,BKWJAKQVGHWELA-UHFFFAOYSA-N,CC(C)(C1=NC(=CC=C1)N2C3=NC(=NC=C3C(=O)N2CC=C)NC4=CC=C(C=C4)N5CCN(CC5)C)O,C27H32N8O2,DB11740,,MK-1775,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
4649,1,4,4,uM,uM,3.86612449954102,0.871119387171716,6.24448631841223,2.77848284295951,10.0,0.0464858993314337,4.246,38.393,54.41,67.967,61.1885,18.5495,,39.869,22.7955,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,915019-65-7,CHEMBL1879463,JOGKUKXHTYWRGZ-UHFFFAOYSA-N,CC(C)(C#N)C1=CC=C(C=C1)N2C3=C4C=C(C=CC4=NC=C3N(C2=O)C)C5=CC6=CC=CC=C6N=C5,C30H23N5O,DB11651,D10552,NVP-BEZ235,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
4653,1,5,4,uM,uM,0.589177241838738,-16.4822043900083,-4.21431480358832,-4.7248689738407,10.0,0.0077324775308884,4.246,36.901,59.939,67.395,63.667,22.52,,43.0935,26.766,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
4657,1,8,4,uM,uM,-0.756503961557655,-5.74964305981024,0.124409915825921,-3.22984572556144,10.0,3.0,4.246,15.013,60.383,52.88,56.6315,37.3725,,47.002,41.6185,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
4661,1,10,4,uM,uM,1.40501470983126,-10.8700652156672,3.27859519641168,2.52881128273338,10.0,0.0110887210319778,4.246,31.661,65.682,63.965,64.8235,28.9165,,46.86999999999999,33.162499999999994,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,Dinaciclib,CHEMBL2103840,PIMQWRZWLQKKBJ-SFHVURJKSA-N,CCC1=C2N=C(C=C(N2N=C1)NCC3=C[N+](=CC=C3)[O-])N4CCCCC4CCO,C21H28N6O2,DB12021,D09604,dinaciclib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
4665,1,12,4,uM,uM,3.65809619196657,3.16572159840613,10.0867863639676,6.98061986698772,10.0,5.0,4.246,8.723,48.945,56.992,52.9685,39.9995,,46.484,44.2455,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,Erlotinib,CHEMBL553,AAKJLRGGTJKAMG-UHFFFAOYSA-N,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,C22H23N3O4,DB00530,D07907,erlotinib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
4669,1,36,4,uM,uM,6.76473382664265,4.10972379719577,9.09372220961757,5.68024970642813,10.0,0.524844391102545,4.246,24.423,63.851,57.771,60.811,32.142,,46.4765,36.388000000000005,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,geldanamycin,CHEMBL278315,QTQAWLPCGQOSGP-KSRBKZBZSA-N,CC1CC(C(C(C=C(C(C(C=CC=C(C(=O)NC2=CC(=O)C(=C(C1)C2=O)OC)C)OC)OC(=O)N)C)C)O)OC,C29H40N2O9,DB02424,C11222,geldanamycin,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
4677,1,15,4,uM,uM,-3.44047893328309,-4.17224841455118,0.799958926467557,-1.31143928030365,10.0,5.0,4.246,3.612,18.232,41.542,29.887,22.029,,25.958,25.641,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
4681,1,16,4,uM,uM,-2.24728264372936,-5.9100507562624,-1.72887628676674,-2.31091651106346,10.0,0.124215844359492,4.246,0.494,8.199,44.135,26.167,21.427,,23.797,21.921,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,MK-2206,CHEMBL1079175,ULDXWLCXEDXJGE-UHFFFAOYSA-N,C1CC(C1)(C2=CC=C(C=C2)C3=C(C=C4C(=N3)C=CN5C4=NNC5=O)C6=CC=CC=C6)N,C25H21N5O,,,MK-2206,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
4701,1,26,4,uM,uM,-3.92489597602933,-6.06622372154328,-1.65219290488344,-6.17055180799623,10.0,0.0034098240224188,4.246,52.864,30.143,59.728,44.9355,-12.1745,,16.380499999999998,-7.9285,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,391210-10-9,CHEMBL507361,SUDAHWBOROXANE-SECBINFHSA-N,C1=CC(=C(C=C1I)F)NC2=C(C=CC(=C2F)F)C(=O)NOCC(CO)O,C16H14F3IN2O4,DB07101,,PD-0325901,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
4705,1,29,4,uM,uM,5.16642271519958,-5.00001321494562,7.63204533461755,4.09709469812376,10.0,20.0,4.246,34.547,94.258,64.001,79.1295,40.3365,,59.73299999999999,44.5825,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
4709,1,30,4,uM,uM,5.13645789169074,-0.779692022029178,10.6353084872038,5.86351354735807,10.0,5.0,4.246,38.25,78.32,66.514,72.417,29.921,,51.169,34.167,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
4713,1,31,4,uM,uM,-8.59874940282592,-28.3735097050304,-10.7939531203459,-12.0515997577092,10.0,92.320290932801,4.246,7.632,-2.237,25.221,11.492,-0.385999999999999,,5.553000000000001,3.860000000000001,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
4717,1,35,4,uM,uM,-3.45596119791051,-11.8848118846814,-3.25397883417409,-5.65460696295784,10.0,4.0,4.246,15.401,80.766,61.612,71.189,51.542,,61.3655,55.788,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
4721,2,4,4,uM,uM,10.9607434151771,-35.8208942958764,4.80365646862633,7.0672858282233,0.151859259563708,0.0464858993314337,-3.734,38.393,62.526,39.845,51.1855,16.5265,,33.855999999999995,12.792499999999997,Veliparib,CHEMBL506871,JNAHVYVRKWKWKQ-CYBMUJFWSA-N,CC1(CCCN1)C2=NC3=C(C=CC=C3N2)C(=O)N,C13H16N4O,DB07232,D09692,veliparib,915019-65-7,CHEMBL1879463,JOGKUKXHTYWRGZ-UHFFFAOYSA-N,CC(C)(C#N)C1=CC=C(C=C1)N2C3=C4C=C(C=CC4=NC=C3N(C2=O)C)C5=CC6=CC=CC=C6N=C5,C30H23N5O,DB11651,D10552,NVP-BEZ235,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
4725,2,10,4,uM,uM,6.90846445445616,-54.5071187826163,6.73625671164455,9.11780233387315,0.151859259563708,0.0110887210319778,-3.734,31.661,56.937,32.575,44.756,16.829,,30.7925,13.095,Veliparib,CHEMBL506871,JNAHVYVRKWKWKQ-CYBMUJFWSA-N,CC1(CCCN1)C2=NC3=C(C=CC=C3N2)C(=O)N,C13H16N4O,DB07232,D09692,veliparib,Dinaciclib,CHEMBL2103840,PIMQWRZWLQKKBJ-SFHVURJKSA-N,CCC1=C2N=C(C=C(N2N=C1)NCC3=C[N+](=CC=C3)[O-])N4CCCCC4CCO,C21H28N6O2,DB12021,D09604,dinaciclib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
4729,2,36,4,uM,uM,3.64092285726352,-41.5405934218876,-3.99775153137368,-1.32088079261013,0.151859259563708,0.524844391102545,-3.734,24.423,59.725,18.351,39.038,18.349,,28.6935,14.614999999999998,Veliparib,CHEMBL506871,JNAHVYVRKWKWKQ-CYBMUJFWSA-N,CC1(CCCN1)C2=NC3=C(C=CC=C3N2)C(=O)N,C13H16N4O,DB07232,D09692,veliparib,geldanamycin,CHEMBL278315,QTQAWLPCGQOSGP-KSRBKZBZSA-N,CC1CC(C(C(C=C(C(C(C=CC=C(C(=O)NC2=CC(=O)C(=C(C1)C2=O)OC)C)OC)OC(=O)N)C)C)O)OC,C29H40N2O9,DB02424,C11222,geldanamycin,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
4741,2,28,4,uM,uM,8.21492729552486,-86.467687192237,2.66436271862632,5.9523404676639,0.151859259563708,0.005,-3.734,6.981,62.007,4.039,33.023,29.776,,31.399500000000003,26.042,Veliparib,CHEMBL506871,JNAHVYVRKWKWKQ-CYBMUJFWSA-N,CC1(CCCN1)C2=NC3=C(C=CC=C3N2)C(=O)N,C13H16N4O,DB07232,D09692,veliparib,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
4745,2,29,4,uM,uM,12.12607950607,-6.47925907251066,8.02899846862631,10.249434392708,0.151859259563708,20.0,-3.734,34.547,96.049,45.437,70.743,39.93,,55.3365,36.196,Veliparib,CHEMBL506871,JNAHVYVRKWKWKQ-CYBMUJFWSA-N,CC1(CCCN1)C2=NC3=C(C=CC=C3N2)C(=O)N,C13H16N4O,DB07232,D09692,veliparib,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
4753,3,2,4,uM,uM,8.54307316923715,-42.6365657759816,7.24484263194162,10.0260663344836,0.275182465695595,0.147261962652638,22.134,-3.729,23.132,44.95,34.041,15.636,,24.8385,11.906999999999996,MK-1775,CHEMBL1976040,BKWJAKQVGHWELA-UHFFFAOYSA-N,CC(C)(C1=NC(=CC=C1)N2C3=NC(=NC=C3C(=O)N2CC=C)NC4=CC=C(C=C4)N5CCN(CC5)C)O,C27H32N8O2,DB11740,,MK-1775,Veliparib,CHEMBL506871,JNAHVYVRKWKWKQ-CYBMUJFWSA-N,CC1(CCCN1)C2=NC3=C(C=CC=C3N2)C(=O)N,C13H16N4O,DB07232,D09692,veliparib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
4757,3,4,4,uM,uM,19.9585100642979,18.8541661369597,23.7923723915806,17.8881566195976,0.275182465695595,0.0464858993314337,22.134,38.393,89.592,91.722,90.657,30.13,,60.3935,52.264,MK-1775,CHEMBL1976040,BKWJAKQVGHWELA-UHFFFAOYSA-N,CC(C)(C1=NC(=CC=C1)N2C3=NC(=NC=C3C(=O)N2CC=C)NC4=CC=C(C=C4)N5CCN(CC5)C)O,C27H32N8O2,DB11740,,MK-1775,915019-65-7,CHEMBL1879463,JOGKUKXHTYWRGZ-UHFFFAOYSA-N,CC(C)(C#N)C1=CC=C(C=C1)N2C3=C4C=C(C=CC4=NC=C3N(C2=O)C)C5=CC6=CC=CC=C6N=C5,C30H23N5O,DB11651,D10552,NVP-BEZ235,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
4761,3,5,4,uM,uM,1.97326075173683,-0.692067318542864,2.44876795891169,1.17610213659911,0.275182465695595,0.0077324775308884,22.134,36.901,73.928,66.238,70.083,11.048,,40.5655,33.181999999999995,MK-1775,CHEMBL1976040,BKWJAKQVGHWELA-UHFFFAOYSA-N,CC(C)(C1=NC(=CC=C1)N2C3=NC(=NC=C3C(=O)N2CC=C)NC4=CC=C(C=C4)N5CCN(CC5)C)O,C27H32N8O2,DB11740,,MK-1775,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
4765,3,8,4,uM,uM,19.8121980302863,19.4568339547453,24.2824814956412,19.2872923149087,0.275182465695595,3.0,22.134,15.013,92.686,83.366,88.026,50.879,,69.4525,65.892,MK-1775,CHEMBL1976040,BKWJAKQVGHWELA-UHFFFAOYSA-N,CC(C)(C1=NC(=CC=C1)N2C3=NC(=NC=C3C(=O)N2CC=C)NC4=CC=C(C=C4)N5CCN(CC5)C)O,C27H32N8O2,DB11740,,MK-1775,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
4769,3,10,4,uM,uM,6.46512445651434,0.0988778876990892,6.77426955632538,4.88414247209781,0.275182465695595,0.0110887210319778,22.134,31.661,77.6,74.518,76.059,22.264,,49.1615,44.398,MK-1775,CHEMBL1976040,BKWJAKQVGHWELA-UHFFFAOYSA-N,CC(C)(C1=NC(=CC=C1)N2C3=NC(=NC=C3C(=O)N2CC=C)NC4=CC=C(C=C4)N5CCN(CC5)C)O,C27H32N8O2,DB11740,,MK-1775,Dinaciclib,CHEMBL2103840,PIMQWRZWLQKKBJ-SFHVURJKSA-N,CCC1=C2N=C(C=C(N2N=C1)NCC3=C[N+](=CC=C3)[O-])N4CCCCC4CCO,C21H28N6O2,DB12021,D09604,dinaciclib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
4773,3,12,4,uM,uM,3.41528051403735,1.19278241616613,6.62081778907891,2.57453176262584,0.275182465695595,5.0,22.134,8.723,54.084,52.466,53.275,22.418,,37.8465,31.141,MK-1775,CHEMBL1976040,BKWJAKQVGHWELA-UHFFFAOYSA-N,CC(C)(C1=NC(=CC=C1)N2C3=NC(=NC=C3C(=O)N2CC=C)NC4=CC=C(C=C4)N5CCN(CC5)C)O,C27H32N8O2,DB11740,,MK-1775,Erlotinib,CHEMBL553,AAKJLRGGTJKAMG-UHFFFAOYSA-N,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,C22H23N3O4,DB00530,D07907,erlotinib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
4777,3,36,4,uM,uM,10.9704303305865,11.3529071706713,16.2731852921919,11.0561737393153,0.275182465695595,0.524844391102545,22.134,24.423,68.251,68.124,68.1875,21.6305,,44.909,43.7645,MK-1775,CHEMBL1976040,BKWJAKQVGHWELA-UHFFFAOYSA-N,CC(C)(C1=NC(=CC=C1)N2C3=NC(=NC=C3C(=O)N2CC=C)NC4=CC=C(C=C4)N5CCN(CC5)C)O,C27H32N8O2,DB11740,,MK-1775,geldanamycin,CHEMBL278315,QTQAWLPCGQOSGP-KSRBKZBZSA-N,CC1CC(C(C(C=C(C(C(C=CC=C(C(=O)NC2=CC(=O)C(=C(C1)C2=O)OC)C)OC)OC(=O)N)C)C)O)OC,C29H40N2O9,DB02424,C11222,geldanamycin,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
4781,3,15,4,uM,uM,9.10695294289254,-17.3629816577527,10.2724319329885,8.31931851224231,0.275182465695595,5.0,22.134,3.612,38.488,61.04,49.764,24.018,,36.891000000000005,27.630000000000003,MK-1775,CHEMBL1976040,BKWJAKQVGHWELA-UHFFFAOYSA-N,CC(C)(C1=NC(=CC=C1)N2C3=NC(=NC=C3C(=O)N2CC=C)NC4=CC=C(C=C4)N5CCN(CC5)C)O,C27H32N8O2,DB11740,,MK-1775,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
4785,3,16,4,uM,uM,9.52441238817235,-23.3737513416194,10.4535320076734,9.77271909750021,0.275182465695595,0.124215844359492,22.134,0.494,25.936,64.913,45.4245,22.7965,,34.1105,23.2905,MK-1775,CHEMBL1976040,BKWJAKQVGHWELA-UHFFFAOYSA-N,CC(C)(C1=NC(=CC=C1)N2C3=NC(=NC=C3C(=O)N2CC=C)NC4=CC=C(C=C4)N5CCN(CC5)C)O,C27H32N8O2,DB11740,,MK-1775,MK-2206,CHEMBL1079175,ULDXWLCXEDXJGE-UHFFFAOYSA-N,C1CC(C1)(C2=CC=C(C=C2)C3=C(C=C4C(=N3)C=CN5C4=NNC5=O)C6=CC=CC=C6)N,C25H21N5O,,,MK-2206,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
4809,3,26,4,uM,uM,-1.56926710060146,1.47826421628278,5.31784062787971,-2.34955372176502,0.275182465695595,0.0034098240224188,22.134,52.864,46.974,69.199,58.0865,-16.9115,,20.58750000000001,5.222500000000004,MK-1775,CHEMBL1976040,BKWJAKQVGHWELA-UHFFFAOYSA-N,CC(C)(C1=NC(=CC=C1)N2C3=NC(=NC=C3C(=O)N2CC=C)NC4=CC=C(C=C4)N5CCN(CC5)C)O,C27H32N8O2,DB11740,,MK-1775,391210-10-9,CHEMBL507361,SUDAHWBOROXANE-SECBINFHSA-N,C1=CC(=C(C=C1I)F)NC2=C(C=CC(=C2F)F)C(=O)NOCC(CO)O,C16H14F3IN2O4,DB07101,,PD-0325901,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
4813,3,28,4,uM,uM,1.37335301690726,0.846185593535157,7.6170520390789,3.69631936405283,0.275182465695595,0.005,22.134,6.981,58.145,53.784,55.9645,26.8495,,41.407,33.8305,MK-1775,CHEMBL1976040,BKWJAKQVGHWELA-UHFFFAOYSA-N,CC(C)(C1=NC(=CC=C1)N2C3=NC(=NC=C3C(=O)N2CC=C)NC4=CC=C(C=C4)N5CCN(CC5)C)O,C27H32N8O2,DB11740,,MK-1775,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
4817,3,29,4,uM,uM,4.97189695034057,2.67826329462897,11.4986722665806,5.89577377925136,0.275182465695595,20.0,22.134,34.547,95.87,66.934,81.402,24.721,,53.0615,46.855,MK-1775,CHEMBL1976040,BKWJAKQVGHWELA-UHFFFAOYSA-N,CC(C)(C1=NC(=CC=C1)N2C3=NC(=NC=C3C(=O)N2CC=C)NC4=CC=C(C=C4)N5CCN(CC5)C)O,C27H32N8O2,DB11740,,MK-1775,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
4825,4,10,4,uM,uM,4.77949520951348,0.994144879326683,5.50172240542469,3.05661600950618,0.04648380831425,0.0110887210319778,38.392,31.661,77.606,71.123,74.3645,4.3115,,39.33800000000001,35.972500000000004,915019-65-7,CHEMBL1879463,JOGKUKXHTYWRGZ-UHFFFAOYSA-N,CC(C)(C#N)C1=CC=C(C=C1)N2C3=C4C=C(C=CC4=NC=C3N(C2=O)C)C5=CC6=CC=CC=C6N=C5,C30H23N5O,DB11651,D10552,NVP-BEZ235,Dinaciclib,CHEMBL2103840,PIMQWRZWLQKKBJ-SFHVURJKSA-N,CCC1=C2N=C(C=C(N2N=C1)NCC3=C[N+](=CC=C3)[O-])N4CCCCC4CCO,C21H28N6O2,DB12021,D09604,dinaciclib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
4837,4,28,4,uM,uM,8.66316301873533,7.97297741835103,12.2968389576145,8.76532621881153,0.04648380831425,0.005,38.392,6.981,73.806,59.509,66.6575,21.2845,,43.971,28.2655,915019-65-7,CHEMBL1879463,JOGKUKXHTYWRGZ-UHFFFAOYSA-N,CC(C)(C#N)C1=CC=C(C=C1)N2C3=C4C=C(C=CC4=NC=C3N(C2=O)C)C5=CC6=CC=CC=C6N=C5,C30H23N5O,DB11651,D10552,NVP-BEZ235,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
4841,4,29,4,uM,uM,4.36786687004675,3.3070852893203,9.1346495287912,3.4353009014909,0.04648380831425,20.0,38.392,34.547,96.141,64.945,80.543,7.60400000000001,,44.07350000000001,42.151,915019-65-7,CHEMBL1879463,JOGKUKXHTYWRGZ-UHFFFAOYSA-N,CC(C)(C#N)C1=CC=C(C=C1)N2C3=C4C=C(C=CC4=NC=C3N(C2=O)C)C5=CC6=CC=CC=C6N=C5,C30H23N5O,DB11651,D10552,NVP-BEZ235,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
4845,5,2,4,uM,uM,0.39069401846674,-60.2328798220581,-4.03184394305838,-1.95168789451866,0.0078122487385619,0.147261962652638,37.01,-3.729,35.035,49.956,42.4955,9.2145,,25.855,5.485500000000002,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,Veliparib,CHEMBL506871,JNAHVYVRKWKWKQ-CYBMUJFWSA-N,CC1(CCCN1)C2=NC3=C(C=CC=C3N2)C(=O)N,C13H16N4O,DB07232,D09692,veliparib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
4849,5,4,4,uM,uM,3.7009281455209,2.01964069206005,4.14556758501562,2.03242718126026,0.0078122487385619,0.0464858993314337,37.01,38.393,70.338,84.528,77.433,2.03,,39.73150000000001,39.040000000000006,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,915019-65-7,CHEMBL1879463,JOGKUKXHTYWRGZ-UHFFFAOYSA-N,CC(C)(C#N)C1=CC=C(C=C1)N2C3=C4C=C(C=CC4=NC=C3N(C2=O)C)C5=CC6=CC=CC=C6N=C5,C30H23N5O,DB11651,D10552,NVP-BEZ235,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
4853,5,8,4,uM,uM,-1.89869802311898,-0.203379240301379,3.0073431910512,2.11377515812918,0.0078122487385619,3.0,37.01,15.013,72.499,71.568,72.0335,20.0105,,46.022000000000006,35.023500000000006,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
4857,5,10,4,uM,uM,3.48013063784164,-2.60455719917094,2.34035809727468,2.00891650292957,0.0078122487385619,0.0110887210319778,37.01,31.661,73.421,82.333,77.877,9.20600000000002,,43.5415,40.867,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,Dinaciclib,CHEMBL2103840,PIMQWRZWLQKKBJ-SFHVURJKSA-N,CCC1=C2N=C(C=C(N2N=C1)NCC3=C[N+](=CC=C3)[O-])N4CCCCC4CCO,C21H28N6O2,DB12021,D09604,dinaciclib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
4861,5,36,4,uM,uM,1.93185622991558,-4.3054592328926,2.74195819105121,1.28872380164466,0.0078122487385619,0.524844391102545,37.01,24.423,70.166,76.914,73.54,12.107,,42.82350000000001,36.53000000000001,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,geldanamycin,CHEMBL278315,QTQAWLPCGQOSGP-KSRBKZBZSA-N,CC1CC(C(C(C=C(C(C(C=CC=C(C(=O)NC2=CC(=O)C(=C(C1)C2=O)OC)C)OC)OC(=O)N)C)C)O)OC,C29H40N2O9,DB02424,C11222,geldanamycin,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
4873,5,28,4,uM,uM,1.59043725135584,0.128396915414852,4.66629656605121,4.27180127283996,0.0078122487385619,0.005,37.01,6.981,62.38,71.173,66.7765,22.7855,,44.781,29.7665,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
4877,5,29,4,uM,uM,3.78106126829231,-2.97287904980451,4.10706108501561,2.91307832275316,0.0078122487385619,20.0,37.01,34.547,96.794,69.295,83.0445,11.4875,,47.266000000000005,46.0345,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5045,8,2,4,uM,uM,4.08358087868768,-32.5737742916386,2.37684160694162,5.37669646852929,3.0,0.147261962652638,15.023,-3.729,16.491,52.643,34.567,23.273,,28.92,19.544,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,Veliparib,CHEMBL506871,JNAHVYVRKWKWKQ-CYBMUJFWSA-N,CC1(CCCN1)C2=NC3=C(C=CC=C3N2)C(=O)N,C13H16N4O,DB07232,D09692,veliparib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5049,8,4,4,uM,uM,10.5598424124525,11.5899233759841,14.972194325394,9.78603327811179,3.0,0.0464858993314337,15.023,38.393,75.789,71.938,73.8635,20.4475,,47.1555,35.4705,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,915019-65-7,CHEMBL1879463,JOGKUKXHTYWRGZ-UHFFFAOYSA-N,CC(C)(C#N)C1=CC=C(C=C1)N2C3=C4C=C(C=CC4=NC=C3N(C2=O)C)C5=CC6=CC=CC=C6N=C5,C30H23N5O,DB11651,D10552,NVP-BEZ235,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5053,8,10,4,uM,uM,-0.616756029203345,-4.54911537972945,0.181802446411681,-1.42538445909013,3.0,0.0110887210319778,15.023,31.661,61.114,66.406,63.76,17.076,,40.418,32.099,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,Dinaciclib,CHEMBL2103840,PIMQWRZWLQKKBJ-SFHVURJKSA-N,CCC1=C2N=C(C=C(N2N=C1)NCC3=C[N+](=CC=C3)[O-])N4CCCCC4CCO,C21H28N6O2,DB12021,D09604,dinaciclib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5057,8,36,4,uM,uM,10.5294508288788,10.3573402047012,13.3677175421919,8.83281159041801,3.0,0.524844391102545,15.023,24.423,74.501,67.772,71.1365,31.6905,,51.4135,46.7135,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,geldanamycin,CHEMBL278315,QTQAWLPCGQOSGP-KSRBKZBZSA-N,CC1CC(C(C(C=C(C(C(C=CC=C(C(=O)NC2=CC(=O)C(=C(C1)C2=O)OC)C)OC)OC(=O)N)C)C)O)OC,C29H40N2O9,DB02424,C11222,geldanamycin,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5073,8,28,4,uM,uM,7.92314084420396,7.57985487001271,11.9977594765789,8.21543863360381,3.0,0.005,15.023,6.981,65.364,64.43,64.897,42.893,,53.89500000000001,49.87400000000001,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5077,8,29,4,uM,uM,15.2905220787281,12.5907970543929,19.2660513502934,14.0218146962424,3.0,20.0,15.023,34.547,97.916,76.822,87.369,37.799,,62.584,52.822,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5169,11,2,4,uM,uM,5.2000028325561,-31.5086376318759,4.75607460694162,6.16885033168834,0.0304502425961739,0.147261962652638,63.225,-3.729,67.423,55.012,61.2175,1.7215,,31.4695,-2.0075000000000003,doxorubicin,CHEMBL53463,AOJJSUZBOXZQNB-TZSSRYMLSA-N,CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O,C27H29NO11,DB00997,D03899,doxorubicin,Veliparib,CHEMBL506871,JNAHVYVRKWKWKQ-CYBMUJFWSA-N,CC1(CCCN1)C2=NC3=C(C=CC=C3N2)C(=O)N,C13H16N4O,DB07232,D09692,veliparib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5173,11,3,4,uM,uM,0.0990736530145901,1.49766144514625,6.67302952174798,0.336118843042395,0.0304502425961739,0.275256624434363,63.225,22.135,75.625,60.588,68.1065,-17.2535,,25.4265,4.881499999999996,doxorubicin,CHEMBL53463,AOJJSUZBOXZQNB-TZSSRYMLSA-N,CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O,C27H29NO11,DB00997,D03899,doxorubicin,MK-1775,CHEMBL1976040,BKWJAKQVGHWELA-UHFFFAOYSA-N,CC(C)(C1=NC(=CC=C1)N2C3=NC(=NC=C3C(=O)N2CC=C)NC4=CC=C(C=C4)N5CCN(CC5)C)O,C27H32N8O2,DB11740,,MK-1775,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5177,11,4,4,uM,uM,5.83729768147742,9.81538297122076,13.2863126033103,5.79715049524772,0.0304502425961739,0.0464858993314337,63.225,38.393,86.165,77.444,81.8045,-19.8135,,30.995500000000007,18.579500000000003,doxorubicin,CHEMBL53463,AOJJSUZBOXZQNB-TZSSRYMLSA-N,CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O,C27H29NO11,DB00997,D03899,doxorubicin,915019-65-7,CHEMBL1879463,JOGKUKXHTYWRGZ-UHFFFAOYSA-N,CC(C)(C#N)C1=CC=C(C=C1)N2C3=C4C=C(C=CC4=NC=C3N(C2=O)C)C5=CC6=CC=CC=C6N=C5,C30H23N5O,DB11651,D10552,NVP-BEZ235,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5181,11,5,4,uM,uM,-1.2095833200715,-3.1041289729036,1.2728036554247,-1.15200436437445,0.0304502425961739,0.0077324775308884,63.225,36.901,81.747,67.302,74.5245,-25.6015,,24.4615,11.299500000000002,doxorubicin,CHEMBL53463,AOJJSUZBOXZQNB-TZSSRYMLSA-N,CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O,C27H29NO11,DB00997,D03899,doxorubicin,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5185,11,8,4,uM,uM,-7.96334944807121,-13.883857507301,-10.2623738514363,-15.7473881982461,0.0304502425961739,3.0,63.225,15.013,59.797,42.174,50.9855,-27.2525,,11.866500000000002,-12.2395,doxorubicin,CHEMBL53463,AOJJSUZBOXZQNB-TZSSRYMLSA-N,CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O,C27H29NO11,DB00997,D03899,doxorubicin,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5189,11,10,4,uM,uM,1.06031927168885,-0.57199066344633,4.8769874488624,1.48153579049239,0.0304502425961739,0.0110887210319778,63.225,31.661,81.189,65.822,73.5055,-21.3805,,26.0625,10.280499999999996,doxorubicin,CHEMBL53463,AOJJSUZBOXZQNB-TZSSRYMLSA-N,CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O,C27H29NO11,DB00997,D03899,doxorubicin,Dinaciclib,CHEMBL2103840,PIMQWRZWLQKKBJ-SFHVURJKSA-N,CCC1=C2N=C(C=C(N2N=C1)NCC3=C[N+](=CC=C3)[O-])N4CCCCC4CCO,C21H28N6O2,DB12021,D09604,dinaciclib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5193,11,12,4,uM,uM,-2.93617045906373,-6.64863249167877,-2.60266010143634,-6.41801737207866,0.0304502425961739,5.0,63.225,8.723,52.411,41.857,47.134,-24.814,,11.159999999999997,-16.091,doxorubicin,CHEMBL53463,AOJJSUZBOXZQNB-TZSSRYMLSA-N,CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O,C27H29NO11,DB00997,D03899,doxorubicin,Erlotinib,CHEMBL553,AAKJLRGGTJKAMG-UHFFFAOYSA-N,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,C22H23N3O4,DB00530,D07907,erlotinib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5197,11,36,4,uM,uM,-2.54558497447284,-4.00408540216589,2.79871452174799,-3.14153272185169,0.0304502425961739,0.524844391102545,63.225,24.423,74.041,56.706,65.3735,-22.2745,,21.54950000000001,2.1485000000000056,doxorubicin,CHEMBL53463,AOJJSUZBOXZQNB-TZSSRYMLSA-N,CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O,C27H29NO11,DB00997,D03899,doxorubicin,geldanamycin,CHEMBL278315,QTQAWLPCGQOSGP-KSRBKZBZSA-N,CC1CC(C(C(C=C(C(C(C=CC=C(C(=O)NC2=CC(=O)C(=C(C1)C2=O)OC)C)OC)OC(=O)N)C)C)O)OC,C29H40N2O9,DB02424,C11222,geldanamycin,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5205,11,15,4,uM,uM,-3.31282218900375,-36.9393955835867,-5.65436289305837,-7.03808299670139,0.0304502425961739,5.0,63.225,3.612,59.436,45.97,52.703,-14.134,,19.2845,-10.521999999999998,doxorubicin,CHEMBL53463,AOJJSUZBOXZQNB-TZSSRYMLSA-N,CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O,C27H29NO11,DB00997,D03899,doxorubicin,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5209,11,16,4,uM,uM,7.37590579423998,-22.6042291035759,7.79076210694163,7.30047741748026,0.0304502425961739,0.124215844359492,63.225,0.494,68.491,59.126,63.8085,0.0894999999999939,,31.949,0.5835000000000008,doxorubicin,CHEMBL53463,AOJJSUZBOXZQNB-TZSSRYMLSA-N,CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O,C27H29NO11,DB00997,D03899,doxorubicin,MK-2206,CHEMBL1079175,ULDXWLCXEDXJGE-UHFFFAOYSA-N,C1CC(C1)(C2=CC=C(C=C2)C3=C(C=C4C(=N3)C=CN5C4=NNC5=O)C6=CC=CC=C6)N,C25H21N5O,,,MK-2206,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5229,11,26,4,uM,uM,-4.74896409859118,1.46333239140144,4.963363969695,-4.91345056683912,0.0304502425961739,0.0034098240224188,63.225,52.864,70.659,68.507,69.583,-46.506,,11.5385,6.357999999999997,doxorubicin,CHEMBL53463,AOJJSUZBOXZQNB-TZSSRYMLSA-N,CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O,C27H29NO11,DB00997,D03899,doxorubicin,391210-10-9,CHEMBL507361,SUDAHWBOROXANE-SECBINFHSA-N,C1=CC(=C(C=C1I)F)NC2=C(C=CC(=C2F)F)C(=O)NOCC(CO)O,C16H14F3IN2O4,DB07101,,PD-0325901,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5233,11,29,4,uM,uM,-18.7640853785101,-29.0702860536138,-21.0959131761376,-27.5569199660123,0.0304502425961739,20.0,63.225,34.547,96.683,18.298,57.4905,-40.2815,,8.604500000000002,-5.734500000000004,doxorubicin,CHEMBL53463,AOJJSUZBOXZQNB-TZSSRYMLSA-N,CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O,C27H29NO11,DB00997,D03899,doxorubicin,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5237,11,30,4,uM,uM,-19.81911000053,-32.1285808651023,-24.7450747368673,-34.310616484704,0.0304502425961739,5.0,63.225,38.25,47.218,30.868,39.043,-62.432,,-11.694499999999998,-24.182,doxorubicin,CHEMBL53463,AOJJSUZBOXZQNB-TZSSRYMLSA-N,CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O,C27H29NO11,DB00997,D03899,doxorubicin,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5241,11,31,4,uM,uM,-1.64228712461879,-21.9868980873776,1.89951239856366,-0.707404447769583,0.0304502425961739,92.320290932801,63.225,7.632,65.358,50.221,57.7895,-13.0675,,22.361,-5.435500000000005,doxorubicin,CHEMBL53463,AOJJSUZBOXZQNB-TZSSRYMLSA-N,CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O,C27H29NO11,DB00997,D03899,doxorubicin,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5245,11,35,4,uM,uM,3.32857643768039,1.09055459477984,6.76578023568966,2.54465565591778,0.0304502425961739,4.0,63.225,15.401,97.736,62.953,80.3445,1.71850000000001,,41.0315,17.119499999999995,doxorubicin,CHEMBL53463,AOJJSUZBOXZQNB-TZSSRYMLSA-N,CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O,C27H29NO11,DB00997,D03899,doxorubicin,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5249,12,2,4,uM,uM,-3.91706703827488,-28.2476171473124,-3.41376864305838,-0.156051539136821,5.0,0.147261962652638,8.775,-3.729,3.38,35.353,19.3665,14.3205,,16.8435,10.591499999999998,Erlotinib,CHEMBL553,AAKJLRGGTJKAMG-UHFFFAOYSA-N,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,C22H23N3O4,DB00530,D07907,erlotinib,Veliparib,CHEMBL506871,JNAHVYVRKWKWKQ-CYBMUJFWSA-N,CC1(CCCN1)C2=NC3=C(C=CC=C3N2)C(=O)N,C13H16N4O,DB07232,D09692,veliparib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5253,12,4,4,uM,uM,9.91441340908699,9.24104574881284,12.6708630059122,8.98527077061883,5.0,0.0464858993314337,8.775,38.393,61.485,76.848,69.1665,21.9985,,45.5825,30.7735,Erlotinib,CHEMBL553,AAKJLRGGTJKAMG-UHFFFAOYSA-N,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,C22H23N3O4,DB00530,D07907,erlotinib,915019-65-7,CHEMBL1879463,JOGKUKXHTYWRGZ-UHFFFAOYSA-N,CC(C)(C#N)C1=CC=C(C=C1)N2C3=C4C=C(C=CC4=NC=C3N(C2=O)C)C5=CC6=CC=CC=C6N=C5,C30H23N5O,DB11651,D10552,NVP-BEZ235,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5257,12,5,4,uM,uM,0.463571510388858,-0.644992289219155,2.80952482141169,2.36238777495745,5.0,0.0077324775308884,8.775,36.901,64.35,57.716,61.033,15.357,,38.195,24.132,Erlotinib,CHEMBL553,AAKJLRGGTJKAMG-UHFFFAOYSA-N,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,C22H23N3O4,DB00530,D07907,erlotinib,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5261,12,8,4,uM,uM,-5.04607375304902,-0.281810967006845,3.16655869709881,-0.727061460122928,5.0,3.0,8.775,15.013,58.842,53.715,56.2785,32.4905,,44.3845,41.2655,Erlotinib,CHEMBL553,AAKJLRGGTJKAMG-UHFFFAOYSA-N,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,C22H23N3O4,DB00530,D07907,erlotinib,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5265,12,36,4,uM,uM,10.1421944613471,9.89422052444871,13.6052475065663,9.48707394985299,5.0,0.524844391102545,8.775,24.423,63.707,75.016,69.3615,36.1635,,52.7625,44.938500000000005,Erlotinib,CHEMBL553,AAKJLRGGTJKAMG-UHFFFAOYSA-N,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,C22H23N3O4,DB00530,D07907,erlotinib,geldanamycin,CHEMBL278315,QTQAWLPCGQOSGP-KSRBKZBZSA-N,CC1CC(C(C(C=C(C(C(C=CC=C(C(=O)NC2=CC(=O)C(=C(C1)C2=O)OC)C)OC)OC(=O)N)C)C)O)OC,C29H40N2O9,DB02424,C11222,geldanamycin,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5277,12,26,4,uM,uM,1.12911313474706,3.08605230642785,5.91892022011656,1.31122930953263,5.0,0.0034098240224188,8.775,52.864,42.805,71.068,56.9365,-4.7025,,26.117000000000004,4.072500000000005,Erlotinib,CHEMBL553,AAKJLRGGTJKAMG-UHFFFAOYSA-N,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,C22H23N3O4,DB00530,D07907,erlotinib,391210-10-9,CHEMBL507361,SUDAHWBOROXANE-SECBINFHSA-N,C1=CC(=C(C=C1I)F)NC2=C(C=CC(=C2F)F)C(=O)NOCC(CO)O,C16H14F3IN2O4,DB07101,,PD-0325901,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5281,12,28,4,uM,uM,9.33216471310595,7.41642345052429,12.8716140225156,8.87186631453766,5.0,0.005,8.775,6.981,72.391,57.43,64.9105,49.1545,,57.0325,56.1355,Erlotinib,CHEMBL553,AAKJLRGGTJKAMG-UHFFFAOYSA-N,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,C22H23N3O4,DB00530,D07907,erlotinib,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5285,12,29,4,uM,uM,6.19334177677654,1.62329912286841,9.44983686220386,5.16382615593549,5.0,20.0,8.775,34.547,95.305,65.193,80.249,36.927,,58.588,45.702,Erlotinib,CHEMBL553,AAKJLRGGTJKAMG-UHFFFAOYSA-N,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,C22H23N3O4,DB00530,D07907,erlotinib,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5293,13,2,4,uM,uM,5.61658711814057,-31.0156006891476,2.07815335694163,4.37289894955919,0.779496423521478,0.147261962652638,36.007,-3.729,36.094,55.776,45.935,13.657,,29.796000000000003,9.928000000000004,etoposide,CHEMBL44657,VJJPUSNTGOMMGY-MRVIYFEKSA-N,CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,C29H32O13,DB00773,D00125,etoposide,Veliparib,CHEMBL506871,JNAHVYVRKWKWKQ-CYBMUJFWSA-N,CC1(CCCN1)C2=NC3=C(C=CC=C3N2)C(=O)N,C13H16N4O,DB07232,D09692,veliparib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5297,13,3,4,uM,uM,4.20338323864155,5.57161298086044,10.2751678636594,4.15033082126446,0.779496423521478,0.275256624434363,36.007,22.135,66.314,64.053,65.1835,7.0415,,36.1125,29.1765,etoposide,CHEMBL44657,VJJPUSNTGOMMGY-MRVIYFEKSA-N,CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,C29H32O13,DB00773,D00125,etoposide,MK-1775,CHEMBL1976040,BKWJAKQVGHWELA-UHFFFAOYSA-N,CC(C)(C1=NC(=CC=C1)N2C3=NC(=NC=C3C(=O)N2CC=C)NC4=CC=C(C=C4)N5CCN(CC5)C)O,C27H32N8O2,DB11740,,MK-1775,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5301,13,4,4,uM,uM,5.58325181253965,9.17866494222547,12.3998723514488,5.39994639310722,0.779496423521478,0.0464858993314337,36.007,38.393,69.476,73.357,71.4165,-2.98350000000001,,34.2165,33.0235,etoposide,CHEMBL44657,VJJPUSNTGOMMGY-MRVIYFEKSA-N,CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,C29H32O13,DB00773,D00125,etoposide,915019-65-7,CHEMBL1879463,JOGKUKXHTYWRGZ-UHFFFAOYSA-N,CC(C)(C#N)C1=CC=C(C=C1)N2C3=C4C=C(C=CC4=NC=C3N(C2=O)C)C5=CC6=CC=CC=C6N=C5,C30H23N5O,DB11651,D10552,NVP-BEZ235,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5305,13,5,4,uM,uM,-0.289201818081161,-2.31676941890463,0.78846679382539,-1.14313236725048,0.779496423521478,0.0077324775308884,36.007,36.901,73.772,68.111,70.9415,-1.9665,,34.487500000000004,34.0405,etoposide,CHEMBL44657,VJJPUSNTGOMMGY-MRVIYFEKSA-N,CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,C29H32O13,DB00773,D00125,etoposide,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5309,13,8,4,uM,uM,6.41230495009403,7.72981368735904,11.3470067472747,5.54577456325686,0.779496423521478,3.0,36.007,15.013,74.681,69.756,72.2185,21.1985,,46.70850000000001,36.21150000000001,etoposide,CHEMBL44657,VJJPUSNTGOMMGY-MRVIYFEKSA-N,CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,C29H32O13,DB00773,D00125,etoposide,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5313,13,10,4,uM,uM,-15.9657980291827,-41.1940345435909,-36.2717769561746,-38.8721167884093,0.779496423521478,0.0110887210319778,36.007,31.661,16.01,12.688,14.349,-53.319,,-19.485000000000003,-21.658,etoposide,CHEMBL44657,VJJPUSNTGOMMGY-MRVIYFEKSA-N,CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,C29H32O13,DB00773,D00125,etoposide,Dinaciclib,CHEMBL2103840,PIMQWRZWLQKKBJ-SFHVURJKSA-N,CCC1=C2N=C(C=C(N2N=C1)NCC3=C[N+](=CC=C3)[O-])N4CCCCC4CCO,C21H28N6O2,DB12021,D09604,dinaciclib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5317,13,12,4,uM,uM,6.18026910471251,5.86903763353565,9.56802333424799,5.28125065565814,0.779496423521478,5.0,36.007,8.723,66.04,66.622,66.331,21.601,,43.96600000000001,30.324000000000005,etoposide,CHEMBL44657,VJJPUSNTGOMMGY-MRVIYFEKSA-N,CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,C29H32O13,DB00773,D00125,etoposide,Erlotinib,CHEMBL553,AAKJLRGGTJKAMG-UHFFFAOYSA-N,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,C22H23N3O4,DB00530,D07907,erlotinib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5321,13,36,4,uM,uM,1.84568160802783,3.41661455692926,6.67019862227468,0.91348045248712,0.779496423521478,0.524844391102545,36.007,24.423,64.712,63.48,64.096,3.66600000000001,,33.88100000000001,28.08900000000001,etoposide,CHEMBL44657,VJJPUSNTGOMMGY-MRVIYFEKSA-N,CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,C29H32O13,DB00773,D00125,etoposide,geldanamycin,CHEMBL278315,QTQAWLPCGQOSGP-KSRBKZBZSA-N,CC1CC(C(C(C=C(C(C(C=CC=C(C(=O)NC2=CC(=O)C(=C(C1)C2=O)OC)C)OC)OC(=O)N)C)C)O)OC,C29H40N2O9,DB02424,C11222,geldanamycin,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5325,13,15,4,uM,uM,3.15106334817883,-19.2718717575876,2.23840335694163,-0.0091477253933864,0.779496423521478,5.0,36.007,3.612,47.972,56.371,52.1715,12.5525,,32.362,16.164500000000004,etoposide,CHEMBL44657,VJJPUSNTGOMMGY-MRVIYFEKSA-N,CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,C29H32O13,DB00773,D00125,etoposide,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5329,13,16,4,uM,uM,9.03785682746418,-11.0390157156776,8.79465335694162,7.99829296472788,0.779496423521478,0.124215844359492,36.007,0.494,41.359,61.205,51.282,14.781,,33.031499999999994,15.275,etoposide,CHEMBL44657,VJJPUSNTGOMMGY-MRVIYFEKSA-N,CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,C29H32O13,DB00773,D00125,etoposide,MK-2206,CHEMBL1079175,ULDXWLCXEDXJGE-UHFFFAOYSA-N,C1CC(C1)(C2=CC=C(C=C2)C3=C(C=C4C(=N3)C=CN5C4=NNC5=O)C6=CC=CC=C6)N,C25H21N5O,,,MK-2206,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5349,13,26,4,uM,uM,-3.18311347160106,2.49543364557107,5.13878167093057,-4.00691969491982,0.779496423521478,0.0034098240224188,36.007,52.864,54.238,68.35,61.294,-27.577,,16.8585,8.43,etoposide,CHEMBL44657,VJJPUSNTGOMMGY-MRVIYFEKSA-N,CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,C29H32O13,DB00773,D00125,etoposide,391210-10-9,CHEMBL507361,SUDAHWBOROXANE-SECBINFHSA-N,C1=CC(=C(C=C1I)F)NC2=C(C=CC(=C2F)F)C(=O)NOCC(CO)O,C16H14F3IN2O4,DB07101,,PD-0325901,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5353,13,29,4,uM,uM,-0.66346410239211,-2.84343374336774,4.18444031567989,-2.15645531123287,0.779496423521478,20.0,36.007,34.547,95.412,58.292,76.852,6.298,,41.575,40.845000000000006,etoposide,CHEMBL44657,VJJPUSNTGOMMGY-MRVIYFEKSA-N,CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,C29H32O13,DB00773,D00125,etoposide,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5357,13,30,4,uM,uM,-1.78329767945822,0.0422661389254384,6.25333790752988,-2.78476562414874,0.779496423521478,5.0,36.007,38.25,77.287,64.134,70.7105,-3.54650000000001,,33.581999999999994,32.4605,etoposide,CHEMBL44657,VJJPUSNTGOMMGY-MRVIYFEKSA-N,CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,C29H32O13,DB00773,D00125,etoposide,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5361,13,31,4,uM,uM,-13.7816694587759,-43.1631374593539,-26.5051438268103,-28.8139454851415,0.779496423521478,92.320290932801,36.007,7.632,-1.052,5.113,2.0305,-41.6085,,-19.789,-33.9765,etoposide,CHEMBL44657,VJJPUSNTGOMMGY-MRVIYFEKSA-N,CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,C29H32O13,DB00773,D00125,etoposide,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5365,13,35,4,uM,uM,-19.6404163458359,-42.0567912558771,-37.4810344592876,-41.8846243392484,0.779496423521478,4.0,36.007,15.401,8.234,12.468,10.351,-41.057,,-15.353,-25.656,etoposide,CHEMBL44657,VJJPUSNTGOMMGY-MRVIYFEKSA-N,CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,C29H32O13,DB00773,D00125,etoposide,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5369,36,4,4,uM,uM,4.88497187853728,4.69846659702643,8.08867882209883,2.55827737723481,0.524729309910523,0.0464858993314337,24.424,38.393,63.624,71.784,67.704,4.88700000000001,,36.29549999999999,29.311,geldanamycin,CHEMBL278315,QTQAWLPCGQOSGP-KSRBKZBZSA-N,CC1CC(C(C(C=C(C(C(C=CC=C(C(=O)NC2=CC(=O)C(=C(C1)C2=O)OC)C)OC)OC(=O)N)C)C)O)OC,C29H40N2O9,DB02424,C11222,geldanamycin,915019-65-7,CHEMBL1879463,JOGKUKXHTYWRGZ-UHFFFAOYSA-N,CC(C)(C#N)C1=CC=C(C=C1)N2C3=C4C=C(C=CC4=NC=C3N(C2=O)C)C5=CC6=CC=CC=C6N=C5,C30H23N5O,DB11651,D10552,NVP-BEZ235,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5373,36,10,4,uM,uM,11.129880396263,9.86959906565012,13.8481027938254,12.1914932253133,0.524729309910523,0.0110887210319778,24.424,31.661,78.984,76.15,77.567,21.482,,49.52449999999999,45.90599999999999,geldanamycin,CHEMBL278315,QTQAWLPCGQOSGP-KSRBKZBZSA-N,CC1CC(C(C(C=C(C(C(C=CC=C(C(=O)NC2=CC(=O)C(=C(C1)C2=O)OC)C)OC)OC(=O)N)C)C)O)OC,C29H40N2O9,DB02424,C11222,geldanamycin,Dinaciclib,CHEMBL2103840,PIMQWRZWLQKKBJ-SFHVURJKSA-N,CCC1=C2N=C(C=C(N2N=C1)NCC3=C[N+](=CC=C3)[O-])N4CCCCC4CCO,C21H28N6O2,DB12021,D09604,dinaciclib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5385,36,28,4,uM,uM,2.16776625055198,-0.891630241998043,3.75409785331027,-0.336109218562869,0.524729309910523,0.005,24.424,6.981,54.602,61.145,57.8735,26.4685,,42.171,33.4495,geldanamycin,CHEMBL278315,QTQAWLPCGQOSGP-KSRBKZBZSA-N,CC1CC(C(C(C=C(C(C(C=CC=C(C(=O)NC2=CC(=O)C(=C(C1)C2=O)OC)C)OC)OC(=O)N)C)C)O)OC,C29H40N2O9,DB02424,C11222,geldanamycin,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5389,36,29,4,uM,uM,7.17852431429419,2.87384644993142,9.11166425656632,4.06759690674201,0.524729309910523,20.0,24.424,34.547,97.975,61.941,79.958,20.987,,50.4725,45.411,geldanamycin,CHEMBL278315,QTQAWLPCGQOSGP-KSRBKZBZSA-N,CC1CC(C(C(C=C(C(C(C=CC=C(C(=O)NC2=CC(=O)C(=C(C1)C2=O)OC)C)OC)OC(=O)N)C)C)O)OC,C29H40N2O9,DB02424,C11222,geldanamycin,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5397,14,2,4,uM,uM,-2.70182942206206,-10.0787077603632,-6.79602289305837,-6.58014763249904,0.001029682941134,0.147261962652638,96.646,-3.729,96.106,42.486,69.296,-23.621,,22.83750000000001,-27.349999999999994,gemcitabine,CHEMBL888,SDUQYLNIPVEERB-QPPQHZFASA-N,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F,C9H11F2N3O4,DB00441,D02368,gemcitabine,Veliparib,CHEMBL506871,JNAHVYVRKWKWKQ-CYBMUJFWSA-N,CC1(CCCN1)C2=NC3=C(C=CC=C3N2)C(=O)N,C13H16N4O,DB07232,D09692,veliparib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5401,14,3,4,uM,uM,2.88365676742152,0.890542239636842,4.17322710694162,2.73336904076534,0.001029682941134,0.275256624434363,96.646,22.135,98.731,89.488,94.1095,-24.6715,,34.718999999999994,-2.536500000000004,gemcitabine,CHEMBL888,SDUQYLNIPVEERB-QPPQHZFASA-N,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F,C9H11F2N3O4,DB00441,D02368,gemcitabine,MK-1775,CHEMBL1976040,BKWJAKQVGHWELA-UHFFFAOYSA-N,CC(C)(C1=NC(=CC=C1)N2C3=NC(=NC=C3C(=O)N2CC=C)NC4=CC=C(C=C4)N5CCN(CC5)C)O,C27H32N8O2,DB11740,,MK-1775,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5405,14,4,4,uM,uM,2.63916505565811,1.56154271703095,4.84422710694162,2.58315747107441,0.001029682941134,0.0464858993314337,96.646,38.393,99.411,98.184,98.7975,-36.2415,,31.27800000000001,2.151499999999998,gemcitabine,CHEMBL888,SDUQYLNIPVEERB-QPPQHZFASA-N,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F,C9H11F2N3O4,DB00441,D02368,gemcitabine,915019-65-7,CHEMBL1879463,JOGKUKXHTYWRGZ-UHFFFAOYSA-N,CC(C)(C#N)C1=CC=C(C=C1)N2C3=C4C=C(C=CC4=NC=C3N(C2=O)C)C5=CC6=CC=CC=C6N=C5,C30H23N5O,DB11651,D10552,NVP-BEZ235,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5409,14,5,4,uM,uM,0.0540773709928759,-1.3150615869054,0.66691378780408,-0.469474360571775,0.001029682941134,0.0077324775308884,96.646,36.901,98.632,67.303,82.9675,-50.5795,,16.194000000000003,-13.6785,gemcitabine,CHEMBL888,SDUQYLNIPVEERB-QPPQHZFASA-N,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F,C9H11F2N3O4,DB00441,D02368,gemcitabine,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5413,14,8,4,uM,uM,2.02842173264899,1.06297747344047,2.23972710694163,1.14671944358761,0.001029682941134,3.0,96.646,15.013,98.381,85.556,91.9685,-19.6905,,36.139,-4.677499999999995,gemcitabine,CHEMBL888,SDUQYLNIPVEERB-QPPQHZFASA-N,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F,C9H11F2N3O4,DB00441,D02368,gemcitabine,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5417,14,10,4,uM,uM,-0.235162091989923,-0.855541179124002,0.812018023563666,-0.539185918900436,0.001029682941134,0.0110887210319778,96.646,31.661,97.309,76.55,86.9295,-41.3775,,22.776,-9.716499999999996,gemcitabine,CHEMBL888,SDUQYLNIPVEERB-QPPQHZFASA-N,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F,C9H11F2N3O4,DB00441,D02368,gemcitabine,Dinaciclib,CHEMBL2103840,PIMQWRZWLQKKBJ-SFHVURJKSA-N,CCC1=C2N=C(C=C(N2N=C1)NCC3=C[N+](=CC=C3)[O-])N4CCCCC4CCO,C21H28N6O2,DB12021,D09604,dinaciclib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5421,14,12,4,uM,uM,-2.64533943049639,-6.16757092269688,-4.74739789305837,-5.43131646308946,0.001029682941134,5.0,96.646,8.723,80.2,59.631,69.9155,-35.4535,,17.230999999999995,-26.730500000000006,gemcitabine,CHEMBL888,SDUQYLNIPVEERB-QPPQHZFASA-N,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F,C9H11F2N3O4,DB00441,D02368,gemcitabine,Erlotinib,CHEMBL553,AAKJLRGGTJKAMG-UHFFFAOYSA-N,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,C22H23N3O4,DB00530,D07907,erlotinib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5425,14,36,4,uM,uM,-0.269093921031954,-3.64633276036216,-0.363647893058372,-1.9691380697297,0.001029682941134,0.524844391102545,96.646,24.423,94.047,90.122,92.0845,-28.9845,,31.550000000000004,-4.561499999999995,gemcitabine,CHEMBL888,SDUQYLNIPVEERB-QPPQHZFASA-N,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F,C9H11F2N3O4,DB00441,D02368,gemcitabine,geldanamycin,CHEMBL278315,QTQAWLPCGQOSGP-KSRBKZBZSA-N,CC1CC(C(C(C=C(C(C(C=CC=C(C(=O)NC2=CC(=O)C(=C(C1)C2=O)OC)C)OC)OC(=O)N)C)C)O)OC,C29H40N2O9,DB02424,C11222,geldanamycin,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5429,14,15,4,uM,uM,-4.6890638027174,-13.9081452603632,-10.6254603930584,-10.8368958903442,0.001029682941134,5.0,96.646,3.612,65.223,40.573,52.898,-47.36,,2.769000000000005,-43.748,gemcitabine,CHEMBL888,SDUQYLNIPVEERB-QPPQHZFASA-N,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F,C9H11F2N3O4,DB00441,D02368,gemcitabine,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5433,14,16,4,uM,uM,3.32527850407477,-0.004145260363189,3.27853960694163,3.20362302023095,0.001029682941134,0.124215844359492,96.646,0.494,98.382,88.661,93.5215,-3.6185,,44.9515,-3.1244999999999976,gemcitabine,CHEMBL888,SDUQYLNIPVEERB-QPPQHZFASA-N,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F,C9H11F2N3O4,DB00441,D02368,gemcitabine,MK-2206,CHEMBL1079175,ULDXWLCXEDXJGE-UHFFFAOYSA-N,C1CC(C1)(C2=CC=C(C=C2)C3=C(C=C4C(=N3)C=CN5C4=NNC5=O)C6=CC=CC=C6)N,C25H21N5O,,,MK-2206,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5453,14,26,4,uM,uM,-1.30605782563794,-2.97314721429713,0.30728960694163,-2.64862534526817,0.001029682941134,0.0034098240224188,96.646,52.864,96.208,71.464,83.836,-65.674,,9.081000000000005,-12.810000000000002,gemcitabine,CHEMBL888,SDUQYLNIPVEERB-QPPQHZFASA-N,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F,C9H11F2N3O4,DB00441,D02368,gemcitabine,391210-10-9,CHEMBL507361,SUDAHWBOROXANE-SECBINFHSA-N,C1=CC(=C(C=C1I)F)NC2=C(C=CC(=C2F)F)C(=O)NOCC(CO)O,C16H14F3IN2O4,DB07101,,PD-0325901,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5457,14,29,4,uM,uM,-2.34763400428882,-3.87090546102795,-1.43030135143633,-3.24067848887781,0.001029682941134,20.0,96.646,34.547,97.67,65.303,81.4865,-49.7065,,15.890000000000017,-15.159499999999994,gemcitabine,CHEMBL888,SDUQYLNIPVEERB-QPPQHZFASA-N,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F,C9H11F2N3O4,DB00441,D02368,gemcitabine,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5461,14,30,4,uM,uM,-0.366005009236139,-0.898841057994006,1.63691460694163,-0.684629100231689,0.001029682941134,5.0,96.646,38.25,94.635,86.029,90.332,-44.564,,22.883999999999983,-6.314000000000007,gemcitabine,CHEMBL888,SDUQYLNIPVEERB-QPPQHZFASA-N,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F,C9H11F2N3O4,DB00441,D02368,gemcitabine,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5465,14,31,4,uM,uM,-0.282808795205367,-5.89652026036319,-2.61383539305837,-3.13226145889985,0.001029682941134,92.320290932801,96.646,7.632,92.994,54.343,73.6685,-30.6095,,21.52949999999999,-22.977500000000006,gemcitabine,CHEMBL888,SDUQYLNIPVEERB-QPPQHZFASA-N,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F,C9H11F2N3O4,DB00441,D02368,gemcitabine,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5565,15,2,4,uM,uM,0.464780479425338,1.49110135125184,0.665190606941618,4.22072925289762,5.0,0.147261962652638,3.612,-3.729,0.573,9.377,4.975,5.092,,5.0335,1.3629999999999995,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,Veliparib,CHEMBL506871,JNAHVYVRKWKWKQ-CYBMUJFWSA-N,CC1(CCCN1)C2=NC3=C(C=CC=C3N2)C(=O)N,C13H16N4O,DB07232,D09692,veliparib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5569,15,4,4,uM,uM,9.45608619443727,-16.8873290862576,10.8543333013249,9.0977330098731,5.0,0.0464858993314337,3.612,38.393,52.722,49.806,51.264,9.25899999999999,,30.2615,12.871000000000002,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,915019-65-7,CHEMBL1879463,JOGKUKXHTYWRGZ-UHFFFAOYSA-N,CC(C)(C#N)C1=CC=C(C=C1)N2C3=C4C=C(C=CC4=NC=C3N(C2=O)C)C5=CC6=CC=CC=C6N=C5,C30H23N5O,DB11651,D10552,NVP-BEZ235,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5573,15,5,4,uM,uM,1.73506573651068,-43.3463153420948,-1.37608930358831,-1.30724805462843,5.0,0.0077324775308884,3.612,36.901,64.12,50.331,57.2255,16.7125,,36.969,20.3245,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5577,15,8,4,uM,uM,-1.32972693343561,-18.169527846322,-5.34511069867507,-7.68739074737648,5.0,3.0,3.612,15.013,57.99,20.679,39.3345,20.7095,,30.022,24.3215,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5581,15,10,4,uM,uM,6.50562747963856,-39.4552850245362,7.07644569641168,7.62260421488534,5.0,0.0110887210319778,3.612,31.661,73.356,47.31,60.333,25.06,,42.6965,28.672,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,Dinaciclib,CHEMBL2103840,PIMQWRZWLQKKBJ-SFHVURJKSA-N,CCC1=C2N=C(C=C(N2N=C1)NCC3=C[N+](=CC=C3)[O-])N4CCCCC4CCO,C21H28N6O2,DB12021,D09604,dinaciclib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5585,15,12,4,uM,uM,-3.84166049649006,-8.15682546393505,-0.625513947165858,-3.4903673453833,5.0,5.0,3.612,8.723,34.115,19.201,26.658,14.323,,20.4905,17.935000000000002,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,Erlotinib,CHEMBL553,AAKJLRGGTJKAMG-UHFFFAOYSA-N,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,C22H23N3O4,DB00530,D07907,erlotinib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5589,15,36,4,uM,uM,11.6665807212457,0.156542095255311,15.7587827715612,13.2953487099141,5.0,0.524844391102545,3.612,24.423,58.008,45.092,51.55,23.515,,37.5325,27.127,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,geldanamycin,CHEMBL278315,QTQAWLPCGQOSGP-KSRBKZBZSA-N,CC1CC(C(C(C=C(C(C(C=CC=C(C(=O)NC2=CC(=O)C(=C(C1)C2=O)OC)C)OC)OC(=O)N)C)C)O)OC,C29H40N2O9,DB02424,C11222,geldanamycin,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5593,15,16,4,uM,uM,17.6253152656783,21.5401953759399,19.696590524243,18.8292890538745,5.0,0.124215844359492,3.612,0.494,17.877,30.683,24.28,20.174,,22.227,20.668,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,MK-2206,CHEMBL1079175,ULDXWLCXEDXJGE-UHFFFAOYSA-N,C1CC(C1)(C2=CC=C(C=C2)C3=C(C=C4C(=N3)C=CN5C4=NNC5=O)C6=CC=CC=C6)N,C25H21N5O,,,MK-2206,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5617,15,26,4,uM,uM,8.75735672200411,-12.8468128777037,10.7934764686263,9.00545784553681,5.0,0.0034098240224188,3.612,52.864,50.74,70.245,60.4925,4.01650000000001,,32.2545,7.628500000000002,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,391210-10-9,CHEMBL507361,SUDAHWBOROXANE-SECBINFHSA-N,C1=CC(=C(C=C1I)F)NC2=C(C=CC(=C2F)F)C(=O)NOCC(CO)O,C16H14F3IN2O4,DB07101,,PD-0325901,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5621,15,28,4,uM,uM,8.99377670395181,-62.5018658923224,8.07831274033414,5.15501066537445,5.0,0.005,3.612,6.981,61.511,31.587,46.549,35.956,,41.2525,39.568,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5625,15,29,4,uM,uM,6.24672274223937,4.05337647116171,10.5064359686263,8.33175341950227,5.0,20.0,3.612,34.547,95.748,46.539,71.1435,32.9845,,52.06400000000001,36.596500000000006,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5633,23,2,4,uM,uM,2.95876921781039,-2.14561721733652,-2.10245034780839,1.56183615339601,56.5084941288681,0.147261962652638,0.667,-3.729,0.365,-0.331,0.017,3.079,,1.548,-0.65,metformin,CHEMBL1431,XZWYZXLIPXDOLR-UHFFFAOYSA-N,CN(C)C(=N)N=C(N)N,C4H11N5,DB00331,D04966,metformin,Veliparib,CHEMBL506871,JNAHVYVRKWKWKQ-CYBMUJFWSA-N,CC1(CCCN1)C2=NC3=C(C=CC=C3N2)C(=O)N,C13H16N4O,DB07232,D09692,veliparib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5637,23,3,4,uM,uM,14.1738838076347,-19.6233110830565,17.1389746545424,16.7095790837671,56.5084941288681,0.275256624434363,0.667,22.135,55.608,41.687,48.6475,25.8455,,37.2465,26.5125,metformin,CHEMBL1431,XZWYZXLIPXDOLR-UHFFFAOYSA-N,CN(C)C(=N)N=C(N)N,C4H11N5,DB00331,D04966,metformin,MK-1775,CHEMBL1976040,BKWJAKQVGHWELA-UHFFFAOYSA-N,CC(C)(C1=NC(=CC=C1)N2C3=NC(=NC=C3C(=O)N2CC=C)NC4=CC=C(C=C4)N5CCN(CC5)C)O,C27H32N8O2,DB11740,,MK-1775,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5641,23,4,4,uM,uM,5.16256352700722,-38.0349069826033,3.66771896862633,3.25975847030434,56.5084941288681,0.0464858993314337,0.667,38.393,53.36,44.785,49.0725,10.0125,,29.5425,10.679499999999996,metformin,CHEMBL1431,XZWYZXLIPXDOLR-UHFFFAOYSA-N,CN(C)C(=N)N=C(N)N,C4H11N5,DB00331,D04966,metformin,915019-65-7,CHEMBL1879463,JOGKUKXHTYWRGZ-UHFFFAOYSA-N,CC(C)(C#N)C1=CC=C(C=C1)N2C3=C4C=C(C=CC4=NC=C3N(C2=O)C)C5=CC6=CC=CC=C6N=C5,C30H23N5O,DB11651,D10552,NVP-BEZ235,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5645,23,5,4,uM,uM,0.184185074804248,-9.86681441546992,-3.80719103096332,-3.54994321947708,56.5084941288681,0.0077324775308884,0.667,36.901,42.95,33.236,38.093,0.524999999999999,,19.309,1.1920000000000002,metformin,CHEMBL1431,XZWYZXLIPXDOLR-UHFFFAOYSA-N,CN(C)C(=N)N=C(N)N,C4H11N5,DB00331,D04966,metformin,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5649,23,8,4,uM,uM,-4.38107807939928,-62.2068668896253,-7.53426602988342,-8.06913781999212,56.5084941288681,3.0,0.667,15.013,46.519,11.533,29.026,13.346,,21.186,14.013,metformin,CHEMBL1431,XZWYZXLIPXDOLR-UHFFFAOYSA-N,CN(C)C(=N)N=C(N)N,C4H11N5,DB00331,D04966,metformin,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5653,23,10,4,uM,uM,4.46858898417253,-12.8660642702978,-1.01884353096332,-0.0512732256899645,56.5084941288681,0.0110887210319778,0.667,31.661,57.962,30.039,44.0005,11.6725,,27.8365,12.3395,metformin,CHEMBL1431,XZWYZXLIPXDOLR-UHFFFAOYSA-N,CN(C)C(=N)N=C(N)N,C4H11N5,DB00331,D04966,metformin,Dinaciclib,CHEMBL2103840,PIMQWRZWLQKKBJ-SFHVURJKSA-N,CCC1=C2N=C(C=C(N2N=C1)NCC3=C[N+](=CC=C3)[O-])N4CCCCC4CCO,C21H28N6O2,DB12021,D09604,dinaciclib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5657,23,12,4,uM,uM,-1.5140427088755,-80.7116076151952,2.18509571862633,1.59796552552545,56.5084941288681,5.0,0.667,8.723,24.134,4.488,14.311,4.921,,9.616,5.587999999999999,metformin,CHEMBL1431,XZWYZXLIPXDOLR-UHFFFAOYSA-N,CN(C)C(=N)N=C(N)N,C4H11N5,DB00331,D04966,metformin,Erlotinib,CHEMBL553,AAKJLRGGTJKAMG-UHFFFAOYSA-N,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,C22H23N3O4,DB00530,D07907,erlotinib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5661,23,36,4,uM,uM,1.9941385435999,-47.962118815025,-0.562001531373677,-1.04443807333653,56.5084941288681,0.524844391102545,0.667,24.423,53.441,26.458,39.9495,14.8595,,27.4045,15.526500000000002,metformin,CHEMBL1431,XZWYZXLIPXDOLR-UHFFFAOYSA-N,CN(C)C(=N)N=C(N)N,C4H11N5,DB00331,D04966,metformin,geldanamycin,CHEMBL278315,QTQAWLPCGQOSGP-KSRBKZBZSA-N,CC1CC(C(C(C=C(C(C(C=CC=C(C(=O)NC2=CC(=O)C(=C(C1)C2=O)OC)C)OC)OC(=O)N)C)C)O)OC,C29H40N2O9,DB02424,C11222,geldanamycin,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5669,23,15,4,uM,uM,-1.16428063947751,-1.58105326343126,-4.50275753137367,-5.14356339940876,56.5084941288681,5.0,0.667,3.612,5.851,0.168,3.0095,-1.2695,,0.8700000000000001,-0.6025,metformin,CHEMBL1431,XZWYZXLIPXDOLR-UHFFFAOYSA-N,CN(C)C(=N)N=C(N)N,C4H11N5,DB00331,D04966,metformin,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5673,23,16,4,uM,uM,10.1465094279043,15.0888964015147,14.0376630526831,13.8705336281624,56.5084941288681,0.124215844359492,0.667,0.494,12.516,14.248,13.382,12.221,,12.8015,12.715,metformin,CHEMBL1431,XZWYZXLIPXDOLR-UHFFFAOYSA-N,CN(C)C(=N)N=C(N)N,C4H11N5,DB00331,D04966,metformin,MK-2206,CHEMBL1079175,ULDXWLCXEDXJGE-UHFFFAOYSA-N,C1CC(C1)(C2=CC=C(C=C2)C3=C(C=C4C(=N3)C=CN5C4=NNC5=O)C6=CC=CC=C6)N,C25H21N5O,,,MK-2206,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5693,23,26,4,uM,uM,-0.682717850286968,-27.0470404987233,-2.77083603137369,-3.09985975189144,56.5084941288681,0.0034098240224188,0.667,52.864,30.85,51.748,41.299,-12.232,,14.5335,-11.564999999999998,metformin,CHEMBL1431,XZWYZXLIPXDOLR-UHFFFAOYSA-N,CN(C)C(=N)N=C(N)N,C4H11N5,DB00331,D04966,metformin,391210-10-9,CHEMBL507361,SUDAHWBOROXANE-SECBINFHSA-N,C1=CC(=C(C=C1I)F)NC2=C(C=CC(=C2F)F)C(=O)NOCC(CO)O,C16H14F3IN2O4,DB07101,,PD-0325901,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5697,23,29,4,uM,uM,12.3146232354382,-37.0804165978831,16.9566234686263,16.5564474670914,56.5084941288681,20.0,0.667,34.547,96.634,56.062,76.348,41.134,,58.741,41.801,metformin,CHEMBL1431,XZWYZXLIPXDOLR-UHFFFAOYSA-N,CN(C)C(=N)N=C(N)N,C4H11N5,DB00331,D04966,metformin,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5701,23,30,4,uM,uM,9.8031721299146,-48.7315619731851,10.9890439686263,10.5879535293194,56.5084941288681,5.0,0.667,38.25,71.575,51.86,61.7175,22.8005,,42.259,23.4675,metformin,CHEMBL1431,XZWYZXLIPXDOLR-UHFFFAOYSA-N,CN(C)C(=N)N=C(N)N,C4H11N5,DB00331,D04966,metformin,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5705,23,31,4,uM,uM,-3.82866528481415,-6.33623123443512,-6.15881787226259,-5.91419950762252,56.5084941288681,92.320290932801,0.667,7.632,-5.1,-4.417,-4.7585,-13.0575,,-8.908,-12.3905,metformin,CHEMBL1431,XZWYZXLIPXDOLR-UHFFFAOYSA-N,CN(C)C(=N)N=C(N)N,C4H11N5,DB00331,D04966,metformin,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5709,23,35,4,uM,uM,-1.53388507617087,-72.6369371922369,3.12599071862632,2.6222993364628,56.5084941288681,4.0,0.667,15.401,79.258,17.905,48.5815,32.5135,,40.5475,33.180499999999995,metformin,CHEMBL1431,XZWYZXLIPXDOLR-UHFFFAOYSA-N,CN(C)C(=N)N=C(N)N,C4H11N5,DB00331,D04966,metformin,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5853,16,2,4,uM,uM,6.42454590327053,5.33452051179607,4.06598414444162,7.70757512710485,0.120859097567169,0.147261962652638,0.462,-3.729,5.172,0.067,2.6195,5.8865,,4.253,2.1575,MK-2206,CHEMBL1079175,ULDXWLCXEDXJGE-UHFFFAOYSA-N,C1CC(C1)(C2=CC=C(C=C2)C3=C(C=C4C(=N3)C=CN5C4=NNC5=O)C6=CC=CC=C6)N,C25H21N5O,,,MK-2206,Veliparib,CHEMBL506871,JNAHVYVRKWKWKQ-CYBMUJFWSA-N,CC1(CCCN1)C2=NC3=C(C=CC=C3N2)C(=O)N,C13H16N4O,DB07232,D09692,veliparib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5857,16,4,4,uM,uM,13.7316308034088,-21.9200729765471,12.2760347741446,11.6973424991755,0.120859097567169,0.0464858993314337,0.462,38.393,68.399,47.715,58.057,19.202,,38.6295,19.664,MK-2206,CHEMBL1079175,ULDXWLCXEDXJGE-UHFFFAOYSA-N,C1CC(C1)(C2=CC=C(C=C2)C3=C(C=C4C(=N3)C=CN5C4=NNC5=O)C6=CC=CC=C6)N,C25H21N5O,,,MK-2206,915019-65-7,CHEMBL1879463,JOGKUKXHTYWRGZ-UHFFFAOYSA-N,CC(C)(C#N)C1=CC=C(C=C1)N2C3=C4C=C(C=CC4=NC=C3N(C2=O)C)C5=CC6=CC=CC=C6N=C5,C30H23N5O,DB11651,D10552,NVP-BEZ235,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5861,16,5,4,uM,uM,-0.286987906141569,-43.6766960832032,-0.732130034838314,-0.514202397743811,0.120859097567169,0.0077324775308884,0.462,36.901,59.365,39.954,49.6595,12.2965,,30.978,12.758499999999998,MK-2206,CHEMBL1079175,ULDXWLCXEDXJGE-UHFFFAOYSA-N,C1CC(C1)(C2=CC=C(C=C2)C3=C(C=C4C(=N3)C=CN5C4=NNC5=O)C6=CC=CC=C6)N,C25H21N5O,,,MK-2206,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5865,16,8,4,uM,uM,12.7091231429626,-4.39150073768801,12.5537740952598,11.7567073647801,0.120859097567169,3.0,0.462,15.013,60.775,23.713,42.244,26.769,,34.5065,27.231,MK-2206,CHEMBL1079175,ULDXWLCXEDXJGE-UHFFFAOYSA-N,C1CC(C1)(C2=CC=C(C=C2)C3=C(C=C4C(=N3)C=CN5C4=NNC5=O)C6=CC=CC=C6)N,C25H21N5O,,,MK-2206,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5869,16,10,4,uM,uM,5.0030111462384,-58.2462626421138,1.22959246516168,2.10921474609072,0.120859097567169,0.0110887210319778,0.462,31.661,61.052,28.961,45.0065,12.8835,,28.945,13.3455,MK-2206,CHEMBL1079175,ULDXWLCXEDXJGE-UHFFFAOYSA-N,C1CC(C1)(C2=CC=C(C=C2)C3=C(C=C4C(=N3)C=CN5C4=NNC5=O)C6=CC=CC=C6)N,C25H21N5O,,,MK-2206,Dinaciclib,CHEMBL2103840,PIMQWRZWLQKKBJ-SFHVURJKSA-N,CCC1=C2N=C(C=C(N2N=C1)NCC3=C[N+](=CC=C3)[O-])N4CCCCC4CCO,C21H28N6O2,DB12021,D09604,dinaciclib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5873,16,12,4,uM,uM,-2.6167044664147,-11.9926969915567,-4.02297602974018,-4.89057287289266,0.120859097567169,5.0,0.462,8.723,39.17,5.05,22.11,12.925,,17.5175,13.387,MK-2206,CHEMBL1079175,ULDXWLCXEDXJGE-UHFFFAOYSA-N,C1CC(C1)(C2=CC=C(C=C2)C3=C(C=C4C(=N3)C=CN5C4=NNC5=O)C6=CC=CC=C6)N,C25H21N5O,,,MK-2206,Erlotinib,CHEMBL553,AAKJLRGGTJKAMG-UHFFFAOYSA-N,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,C22H23N3O4,DB00530,D07907,erlotinib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5877,16,36,4,uM,uM,5.65071133026181,-19.7267149682774,3.51583659525981,2.78478570944121,0.120859097567169,0.524844391102545,0.462,24.423,57.971,25.317,41.644,16.759,,29.2015,17.221,MK-2206,CHEMBL1079175,ULDXWLCXEDXJGE-UHFFFAOYSA-N,C1CC(C1)(C2=CC=C(C=C2)C3=C(C=C4C(=N3)C=CN5C4=NNC5=O)C6=CC=CC=C6)N,C25H21N5O,,,MK-2206,geldanamycin,CHEMBL278315,QTQAWLPCGQOSGP-KSRBKZBZSA-N,CC1CC(C(C(C=C(C(C(C=CC=C(C(=O)NC2=CC(=O)C(=C(C1)C2=O)OC)C)OC)OC(=O)N)C)C)O)OC,C29H40N2O9,DB02424,C11222,geldanamycin,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5893,16,26,4,uM,uM,1.87011406944151,-24.4521828596332,-0.947836031373695,-1.58134985688843,0.120859097567169,0.0034098240224188,0.462,52.864,28.904,51.79,40.347,-12.979,,13.684,-12.516999999999996,MK-2206,CHEMBL1079175,ULDXWLCXEDXJGE-UHFFFAOYSA-N,C1CC(C1)(C2=CC=C(C=C2)C3=C(C=C4C(=N3)C=CN5C4=NNC5=O)C6=CC=CC=C6)N,C25H21N5O,,,MK-2206,391210-10-9,CHEMBL507361,SUDAHWBOROXANE-SECBINFHSA-N,C1=CC(=C(C=C1I)F)NC2=C(C=CC(=C2F)F)C(=O)NOCC(CO)O,C16H14F3IN2O4,DB07101,,PD-0325901,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5897,16,28,4,uM,uM,7.99357447402166,-77.9680621922369,10.8991721842015,10.0230273655363,0.120859097567169,0.005,0.462,6.981,57.095,13.106,35.1005,27.6575,,31.379,28.119499999999995,MK-2206,CHEMBL1079175,ULDXWLCXEDXJGE-UHFFFAOYSA-N,C1CC(C1)(C2=CC=C(C=C2)C3=C(C=C4C(=N3)C=CN5C4=NNC5=O)C6=CC=CC=C6)N,C25H21N5O,,,MK-2206,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
5901,16,29,4,uM,uM,11.3375857377286,7.57237680532414,12.8067484686263,12.0362355426506,0.120859097567169,20.0,0.462,34.547,97.169,50.853,74.011,39.002,,56.5065,39.464,MK-2206,CHEMBL1079175,ULDXWLCXEDXJGE-UHFFFAOYSA-N,C1CC(C1)(C2=CC=C(C=C2)C3=C(C=C4C(=N3)C=CN5C4=NNC5=O)C6=CC=CC=C6)N,C25H21N5O,,,MK-2206,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
6429,26,2,4,uM,uM,2.62335006830796,-25.3509881350547,-1.17670039305838,0.648903043582865,0.0034100381244945,0.147261962652638,52.864,-3.729,51.99,33.531,42.7605,-6.3745,,18.193,-10.103499999999997,391210-10-9,CHEMBL507361,SUDAHWBOROXANE-SECBINFHSA-N,C1=CC(=C(C=C1I)F)NC2=C(C=CC(=C2F)F)C(=O)NOCC(CO)O,C16H14F3IN2O4,DB07101,,PD-0325901,Veliparib,CHEMBL506871,JNAHVYVRKWKWKQ-CYBMUJFWSA-N,CC1(CCCN1)C2=NC3=C(C=CC=C3N2)C(=O)N,C13H16N4O,DB07232,D09692,veliparib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
6433,26,4,4,uM,uM,-3.38627143096755,2.05640076229359,4.61835127180943,-4.426816960181,0.0034100381244945,0.0464858993314337,52.864,38.393,66.665,55.996,61.3305,-29.9265,,15.701999999999998,8.466500000000003,391210-10-9,CHEMBL507361,SUDAHWBOROXANE-SECBINFHSA-N,C1=CC(=C(C=C1I)F)NC2=C(C=CC(=C2F)F)C(=O)NOCC(CO)O,C16H14F3IN2O4,DB07101,,PD-0325901,915019-65-7,CHEMBL1879463,JOGKUKXHTYWRGZ-UHFFFAOYSA-N,CC(C)(C#N)C1=CC=C(C=C1)N2C3=C4C=C(C=CC4=NC=C3N(C2=O)C)C5=CC6=CC=CC=C6N=C5,C30H23N5O,DB11651,D10552,NVP-BEZ235,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
6437,26,5,4,uM,uM,-2.15457427548301,-6.56803710870607,-0.321378553588311,-3.24966442438486,0.0034100381244945,0.0077324775308884,52.864,36.901,73.295,53.852,63.5735,-26.1915,,18.691000000000003,10.709500000000006,391210-10-9,CHEMBL507361,SUDAHWBOROXANE-SECBINFHSA-N,C1=CC(=C(C=C1I)F)NC2=C(C=CC(=C2F)F)C(=O)NOCC(CO)O,C16H14F3IN2O4,DB07101,,PD-0325901,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
6441,26,8,4,uM,uM,9.54579685894516,12.4012162116554,15.072460771748,8.46988039469963,0.0034100381244945,3.0,52.864,15.013,79.39,59.087,69.2385,1.36150000000001,,35.300000000000004,16.374500000000005,391210-10-9,CHEMBL507361,SUDAHWBOROXANE-SECBINFHSA-N,C1=CC(=C(C=C1I)F)NC2=C(C=CC(=C2F)F)C(=O)NOCC(CO)O,C16H14F3IN2O4,DB07101,,PD-0325901,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
6445,26,10,4,uM,uM,-0.707878292085023,0.458219762810735,3.99025615542469,0.271720742654475,0.0034100381244945,0.0110887210319778,52.864,31.661,65.599,59.04,62.3195,-22.2055,,20.056999999999995,9.4555,391210-10-9,CHEMBL507361,SUDAHWBOROXANE-SECBINFHSA-N,C1=CC(=C(C=C1I)F)NC2=C(C=CC(=C2F)F)C(=O)NOCC(CO)O,C16H14F3IN2O4,DB07101,,PD-0325901,Dinaciclib,CHEMBL2103840,PIMQWRZWLQKKBJ-SFHVURJKSA-N,CCC1=C2N=C(C=C(N2N=C1)NCC3=C[N+](=CC=C3)[O-])N4CCCCC4CCO,C21H28N6O2,DB12021,D09604,dinaciclib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
6449,26,36,4,uM,uM,-2.36561085249094,1.9220503409118,4.48645054071239,-2.96149437586342,0.0034100381244945,0.524844391102545,52.864,24.423,65.914,49.22,57.567,-19.72,,18.923500000000004,4.703000000000003,391210-10-9,CHEMBL507361,SUDAHWBOROXANE-SECBINFHSA-N,C1=CC(=C(C=C1I)F)NC2=C(C=CC(=C2F)F)C(=O)NOCC(CO)O,C16H14F3IN2O4,DB07101,,PD-0325901,geldanamycin,CHEMBL278315,QTQAWLPCGQOSGP-KSRBKZBZSA-N,CC1CC(C(C(C=C(C(C(C=CC=C(C(=O)NC2=CC(=O)C(=C(C1)C2=O)OC)C)OC)OC(=O)N)C)C)O)OC,C29H40N2O9,DB02424,C11222,geldanamycin,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
6465,26,28,4,uM,uM,-2.29726691649848,-2.49293989408012,1.02452489856366,-3.32159391985749,0.0034100381244945,0.005,52.864,6.981,54.443,34.072,44.2575,-15.5875,,14.335,-8.606499999999997,391210-10-9,CHEMBL507361,SUDAHWBOROXANE-SECBINFHSA-N,C1=CC(=C(C=C1I)F)NC2=C(C=CC(=C2F)F)C(=O)NOCC(CO)O,C16H14F3IN2O4,DB07101,,PD-0325901,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
6469,26,29,4,uM,uM,2.84114834532654,5.08790056209831,9.93220944024714,2.45150966610096,0.0034100381244945,20.0,52.864,34.547,96.865,63.597,80.231,-7.18000000000001,,36.5255,27.367,391210-10-9,CHEMBL507361,SUDAHWBOROXANE-SECBINFHSA-N,C1=CC(=C(C=C1I)F)NC2=C(C=CC(=C2F)F)C(=O)NOCC(CO)O,C16H14F3IN2O4,DB07101,,PD-0325901,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
6477,28,10,4,uM,uM,0.376329109893641,-6.73607509453547,-0.509681678588322,-1.00059786976056,0.005,0.0110887210319778,7.048,31.661,59.028,54.274,56.651,17.942,,37.2965,24.99,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,Dinaciclib,CHEMBL2103840,PIMQWRZWLQKKBJ-SFHVURJKSA-N,CCC1=C2N=C(C=C(N2N=C1)NCC3=C[N+](=CC=C3)[O-])N4CCCCC4CCO,C21H28N6O2,DB12021,D09604,dinaciclib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
6485,28,29,4,uM,uM,13.9667408754931,8.82451745401867,18.9642856122039,14.884025750032,0.005,20.0,7.048,34.547,97.318,83.008,90.163,48.568,,69.3655,55.616,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
6489,29,10,4,uM,uM,7.68851642363936,1.05843089150797,10.0491759188254,8.02691026531838,20.0,0.0110887210319778,34.548,31.661,80.998,97.881,89.4395,23.2305,,56.335,54.89149999999999,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,Dinaciclib,CHEMBL2103840,PIMQWRZWLQKKBJ-SFHVURJKSA-N,CCC1=C2N=C(C=C(N2N=C1)NCC3=C[N+](=CC=C3)[O-])N4CCCCC4CCO,C21H28N6O2,DB12021,D09604,dinaciclib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
6497,30,2,4,uM,uM,9.09312785928755,-19.565805481726,8.24624210694163,10.4717104981543,5.0,0.147261962652638,38.25,-3.729,45.936,74.49,60.213,25.692,,42.9525,21.963,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,Veliparib,CHEMBL506871,JNAHVYVRKWKWKQ-CYBMUJFWSA-N,CC1(CCCN1)C2=NC3=C(C=CC=C3N2)C(=O)N,C13H16N4O,DB07232,D09692,veliparib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
6501,30,3,4,uM,uM,9.34945039297327,9.27051980332065,17.4561773722747,9.36742640235168,5.0,0.275256624434363,38.25,22.135,70.544,84.807,77.6755,17.2905,,47.483,39.4255,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,MK-1775,CHEMBL1976040,BKWJAKQVGHWELA-UHFFFAOYSA-N,CC(C)(C1=NC(=CC=C1)N2C3=NC(=NC=C3C(=O)N2CC=C)NC4=CC=C(C=C4)N5CCN(CC5)C)O,C27H32N8O2,DB11740,,MK-1775,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
6505,30,4,4,uM,uM,4.92837336572649,7.72925546740364,13.1653744102101,4.59276703362616,5.0,0.0464858993314337,38.25,38.393,71.822,84.196,78.009,1.366,,39.6875,39.616,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,915019-65-7,CHEMBL1879463,JOGKUKXHTYWRGZ-UHFFFAOYSA-N,CC(C)(C#N)C1=CC=C(C=C1)N2C3=C4C=C(C=CC4=NC=C3N(C2=O)C)C5=CC6=CC=CC=C6N=C5,C30H23N5O,DB11651,D10552,NVP-BEZ235,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
6509,30,5,4,uM,uM,1.31941163659332,-2.15597795731868,4.55871769641169,2.32320118086803,5.0,0.0077324775308884,38.25,36.901,72.502,85.125,78.8135,3.66249999999999,,41.238,40.563500000000005,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
6513,30,8,4,uM,uM,14.9116145035642,16.3161352759109,22.1011886657124,15.0177488026018,5.0,3.0,38.25,15.013,77.86,85.297,81.5785,28.3155,,54.947,43.328500000000005,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
6517,30,10,4,uM,uM,8.60977660125446,4.2644966787669,12.8401992938254,9.44390710954071,5.0,0.0110887210319778,38.25,31.661,84.989,87.487,86.238,16.327,,51.2825,47.988,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,Dinaciclib,CHEMBL2103840,PIMQWRZWLQKKBJ-SFHVURJKSA-N,CCC1=C2N=C(C=C(N2N=C1)NCC3=C[N+](=CC=C3)[O-])N4CCCCC4CCO,C21H28N6O2,DB12021,D09604,dinaciclib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
6521,30,12,4,uM,uM,9.22949295810151,7.6436842076822,14.3305127356897,8.99663034148176,5.0,5.0,38.25,8.723,64.753,76.612,70.6825,23.7095,,47.196000000000005,32.432500000000005,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,Erlotinib,CHEMBL553,AAKJLRGGTJKAMG-UHFFFAOYSA-N,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,C22H23N3O4,DB00530,D07907,erlotinib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
6525,30,36,4,uM,uM,9.56850503364294,11.5797302762036,16.8113286222747,9.33822954939709,5.0,0.524844391102545,38.25,24.423,74.995,79.848,77.4215,14.7485,,46.085,39.1715,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,geldanamycin,CHEMBL278315,QTQAWLPCGQOSGP-KSRBKZBZSA-N,CC1CC(C(C(C=C(C(C(C=CC=C(C(=O)NC2=CC(=O)C(=C(C1)C2=O)OC)C)OC)OC(=O)N)C)C)O)OC,C29H40N2O9,DB02424,C11222,geldanamycin,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
6529,30,15,4,uM,uM,7.24459391626952,-5.28768359693584,10.2341171069416,8.05441844776828,5.0,5.0,38.25,3.612,57.414,79.455,68.4345,26.5725,,47.5035,30.1845,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
6533,30,16,4,uM,uM,13.2569096305098,1.3819574641876,14.7604296069416,13.9881109296176,5.0,0.124215844359492,38.25,0.494,51.002,82.309,66.6555,27.9115,,47.2835,28.405500000000004,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,MK-2206,CHEMBL1079175,ULDXWLCXEDXJGE-UHFFFAOYSA-N,C1CC(C1)(C2=CC=C(C=C2)C3=C(C=C4C(=N3)C=CN5C4=NNC5=O)C6=CC=CC=C6)N,C25H21N5O,,,MK-2206,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
6557,30,26,4,uM,uM,4.38781750974569,11.3460676430054,16.0252629540806,4.17638591757218,5.0,0.0034098240224188,38.25,52.864,69.502,85.734,77.618,-13.496,,32.06099999999999,24.754,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,391210-10-9,CHEMBL507361,SUDAHWBOROXANE-SECBINFHSA-N,C1=CC(=C(C=C1I)F)NC2=C(C=CC(=C2F)F)C(=O)NOCC(CO)O,C16H14F3IN2O4,DB07101,,PD-0325901,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
6561,30,28,4,uM,uM,8.21469323388128,4.19367006793015,12.8918989856897,7.76489403955139,5.0,0.005,38.25,6.981,75.65,78.078,76.864,31.633,,54.24850000000001,38.614,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
6565,30,29,4,uM,uM,10.8027596495649,5.62508388630156,18.5622687718094,10.4744179059802,5.0,20.0,38.25,34.547,97.018,87.999,92.5085,19.7115,,56.11,54.2585,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
6569,30,31,4,uM,uM,7.01070114398184,-17.0051457078643,10.8826702356897,7.50563798635312,5.0,92.320290932801,38.25,7.632,56.367,77.06,66.7135,20.8315,,43.7725,28.4635,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
6577,31,2,4,uM,uM,18.3152156543707,12.7681636624457,13.0588043319416,16.420836776742,92.0820862226579,0.147261962652638,7.622,-3.729,4.716,49.372,27.044,23.151,,25.0975,19.422,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,Veliparib,CHEMBL506871,JNAHVYVRKWKWKQ-CYBMUJFWSA-N,CC1(CCCN1)C2=NC3=C(C=CC=C3N2)C(=O)N,C13H16N4O,DB07232,D09692,veliparib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
6581,31,3,4,uM,uM,2.92490712428158,-14.9707652376408,4.23143860336756,2.04376392529883,92.0820862226579,0.275256624434363,7.622,22.135,62.368,52.762,57.565,27.808,,42.6865,35.42999999999999,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,MK-1775,CHEMBL1976040,BKWJAKQVGHWELA-UHFFFAOYSA-N,CC(C)(C1=NC(=CC=C1)N2C3=NC(=NC=C3C(=O)N2CC=C)NC4=CC=C(C=C4)N5CCN(CC5)C)O,C27H32N8O2,DB11740,,MK-1775,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
6585,31,4,4,uM,uM,5.79969707288917,-3.97305193738367,7.18818098720387,5.07187365526397,92.0820862226579,0.0464858993314337,7.622,38.393,58.478,53.227,55.8525,9.8375,,32.845,17.4595,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,915019-65-7,CHEMBL1879463,JOGKUKXHTYWRGZ-UHFFFAOYSA-N,CC(C)(C#N)C1=CC=C(C=C1)N2C3=C4C=C(C=CC4=NC=C3N(C2=O)C)C5=CC6=CC=CC=C6N=C5,C30H23N5O,DB11651,D10552,NVP-BEZ235,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
6589,31,5,4,uM,uM,2.76392968622959,-21.9210252491389,1.34325664665262,1.13130770702003,92.0820862226579,0.0077324775308884,7.622,36.901,53.832,73.813,63.8225,19.2995,,41.56099999999999,26.921499999999995,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
6593,31,8,4,uM,uM,-4.71949006071053,-11.7964365426922,4.14790095961756,2.34922285827974,92.0820862226579,3.0,7.622,15.013,53.836,41.147,47.4915,24.8565,,36.17400000000001,32.478500000000004,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
6597,31,10,4,uM,uM,0.859400867978403,-26.2700968767995,2.89701978718511,2.70673740725415,92.0820862226579,0.0110887210319778,7.622,31.661,48.95,39.845,44.3975,5.1145,,24.756,12.7365,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,Dinaciclib,CHEMBL2103840,PIMQWRZWLQKKBJ-SFHVURJKSA-N,CCC1=C2N=C(C=C(N2N=C1)NCC3=C[N+](=CC=C3)[O-])N4CCCCC4CCO,C21H28N6O2,DB12021,D09604,dinaciclib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
6601,31,36,4,uM,uM,2.748520123659,-6.63534392074116,2.86107908461756,0.85465373677596,92.0820862226579,0.524844391102545,7.622,24.423,52.166,36.511,44.3385,12.2935,,28.316000000000003,19.915500000000005,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,geldanamycin,CHEMBL278315,QTQAWLPCGQOSGP-KSRBKZBZSA-N,CC1CC(C(C(C=C(C(C(C=CC=C(C(=O)NC2=CC(=O)C(=C(C1)C2=O)OC)C)OC)OC(=O)N)C)C)O)OC,C29H40N2O9,DB02424,C11222,geldanamycin,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
6605,31,15,4,uM,uM,3.03399986389943,-0.407056907595412,-1.59189857353245,-1.84127092191922,92.0820862226579,5.0,7.622,3.612,24.537,24.528,24.5325,13.2985,,18.9155,16.9105,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
6609,31,16,4,uM,uM,14.5690378691053,17.3028453040127,16.4128288378753,16.593556486346,92.0820862226579,0.124215844359492,7.622,0.494,20.936,29.501,25.2185,17.1025,,21.1605,17.5965,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,MK-2206,CHEMBL1079175,ULDXWLCXEDXJGE-UHFFFAOYSA-N,C1CC(C1)(C2=CC=C(C=C2)C3=C(C=C4C(=N3)C=CN5C4=NNC5=O)C6=CC=CC=C6)N,C25H21N5O,,,MK-2206,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
6629,31,26,4,uM,uM,-1.36511380462,-7.81901044619822,2.64478022011656,-0.43799377331967,92.0820862226579,0.0034098240224188,7.622,52.864,41.505,58.421,49.963,-10.523,,19.72,-2.900999999999996,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,391210-10-9,CHEMBL507361,SUDAHWBOROXANE-SECBINFHSA-N,C1=CC(=C(C=C1I)F)NC2=C(C=CC(=C2F)F)C(=O)NOCC(CO)O,C16H14F3IN2O4,DB07101,,PD-0325901,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
6633,31,28,4,uM,uM,-3.35094874146159,-9.25300719932569,4.05809786396755,2.63766860753671,92.0820862226579,0.005,7.622,6.981,39.879,19.194,29.5365,14.9335,,22.235,21.9145,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
6637,31,29,4,uM,uM,10.5810871965346,-9.69812085572143,14.1953693622039,11.862317103323,92.0820862226579,20.0,7.622,34.547,96.553,54.598,75.5755,33.4065,,54.49100000000001,41.02850000000001,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
6817,35,2,4,uM,uM,3.30902188656003,-40.4578908135813,-1.95349864305838,0.84125501663367,4.0,0.147261962652638,15.385,-3.729,17.664,79.024,48.344,36.688,,42.516000000000005,32.959,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,Veliparib,CHEMBL506871,JNAHVYVRKWKWKQ-CYBMUJFWSA-N,CC1(CCCN1)C2=NC3=C(C=CC=C3N2)C(=O)N,C13H16N4O,DB07232,D09692,veliparib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
6821,35,3,4,uM,uM,9.36236820746185,8.35614236094005,13.3030013514488,9.84294431833882,4.0,0.275256624434363,15.385,22.135,77.419,93.509,85.464,47.944,,66.704,63.32899999999999,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,MK-1775,CHEMBL1976040,BKWJAKQVGHWELA-UHFFFAOYSA-N,CC(C)(C1=NC(=CC=C1)N2C3=NC(=NC=C3C(=O)N2CC=C)NC4=CC=C(C=C4)N5CCN(CC5)C)O,C27H32N8O2,DB11740,,MK-1775,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
6825,35,4,4,uM,uM,4.57436291033292,4.02166109029535,7.33619338965769,3.22472806498092,4.0,0.0464858993314337,15.385,38.393,65.153,95.946,80.5495,26.7715,,53.6605,42.1565,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,915019-65-7,CHEMBL1879463,JOGKUKXHTYWRGZ-UHFFFAOYSA-N,CC(C)(C#N)C1=CC=C(C=C1)N2C3=C4C=C(C=CC4=NC=C3N(C2=O)C)C5=CC6=CC=CC=C6N=C5,C30H23N5O,DB11651,D10552,NVP-BEZ235,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
6829,35,5,4,uM,uM,1.35089833005321,-5.6235452208763,0.0505551688253846,-1.04281523775242,4.0,0.0077324775308884,15.385,36.901,81.886,89.964,85.925,33.639,,59.782,49.024,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
6833,35,8,4,uM,uM,-1.0152978051009,-2.74511830866796,1.99870922644881,-1.32274058979843,4.0,3.0,15.385,15.013,57.504,84.167,70.8355,40.4375,,55.6365,55.4505,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
6837,35,10,4,uM,uM,-1.00798918460239,-11.1521167202732,-4.90493858117461,-5.59572285857058,4.0,0.0110887210319778,15.385,31.661,49.722,85.158,67.44,20.394,,43.917,35.779,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,Dinaciclib,CHEMBL2103840,PIMQWRZWLQKKBJ-SFHVURJKSA-N,CCC1=C2N=C(C=C(N2N=C1)NCC3=C[N+](=CC=C3)[O-])N4CCCCC4CCO,C21H28N6O2,DB12021,D09604,dinaciclib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
6841,35,36,4,uM,uM,-3.92695018766444,-11.7417769263736,-6.67979207906942,-10.2607289480265,4.0,0.524844391102545,15.385,24.423,15.743,81.198,48.4705,8.66249999999999,,28.5665,24.047500000000003,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,geldanamycin,CHEMBL278315,QTQAWLPCGQOSGP-KSRBKZBZSA-N,CC1CC(C(C(C=C(C(C(C=CC=C(C(=O)NC2=CC(=O)C(=C(C1)C2=O)OC)C)OC)OC(=O)N)C)C)O)OC,C29H40N2O9,DB02424,C11222,geldanamycin,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
6845,35,14,4,uM,uM,3.39661538292792,2.62256719673174,4.75115396862632,3.33278269536678,4.0,0.0010366868021421,15.385,96.452,94.259,99.162,96.7105,-15.1265,,40.792,0.2584999999999979,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,gemcitabine,CHEMBL888,SDUQYLNIPVEERB-QPPQHZFASA-N,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F,C9H11F2N3O4,DB00441,D02368,gemcitabine,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
6849,35,15,4,uM,uM,1.93292110069961,-10.2978073047839,6.45458972892521,4.32310054174521,4.0,5.0,15.385,3.612,38.379,78.32,58.3495,39.3525,,48.851,42.9645,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
6853,35,16,4,uM,uM,3.28515684044433,-17.9898992418077,3.22228985390913,2.58186993403651,4.0,0.124215844359492,15.385,0.494,16.535,87.933,52.234,36.355,,44.2945,36.849,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,MK-2206,CHEMBL1079175,ULDXWLCXEDXJGE-UHFFFAOYSA-N,C1CC(C1)(C2=CC=C(C=C2)C3=C(C=C4C(=N3)C=CN5C4=NNC5=O)C6=CC=CC=C6)N,C25H21N5O,,,MK-2206,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
6877,35,26,4,uM,uM,-8.18339278066863,-11.4254059007078,-8.95444244853246,-13.9972191267413,4.0,0.0034098240224188,15.385,52.864,27.347,78.78,53.0635,-15.1855,,18.939,0.1995000000000004,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,391210-10-9,CHEMBL507361,SUDAHWBOROXANE-SECBINFHSA-N,C1=CC(=C(C=C1I)F)NC2=C(C=CC(=C2F)F)C(=O)NOCC(CO)O,C16H14F3IN2O4,DB07101,,PD-0325901,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
6881,35,28,4,uM,uM,3.57241516547874,2.52937457733031,9.16208130814119,6.33542871688476,4.0,0.005,15.385,6.981,57.117,86.366,71.7415,49.3755,,60.5585,56.3565,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
6885,35,29,4,uM,uM,8.3648270987439,3.90630274053106,14.0212688502934,10.335050524656,4.0,20.0,15.385,34.547,96.452,93.568,95.01,45.078,,70.04400000000001,60.46300000000001,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
6889,35,30,4,uM,uM,2.07401309745231,-1.92710049845036,7.12395192646754,2.16388412326407,4.0,5.0,15.385,38.25,78.358,92.45,85.404,31.769,,58.5865,47.154,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
6893,35,31,4,uM,uM,11.4490779862211,-3.64130646572456,11.6756575671541,10.6941293719296,4.0,92.320290932801,15.385,7.632,63.902,84.117,74.0095,50.9925,,62.501000000000005,58.624500000000005,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
25369,1,2,28,uM,uM,7.82924378804153,-9.51500965452422,8.03482935694162,11.1119189669497,3.47704724387218,2.56897684420797,24.19,-4.166,35.525,48.951,42.238,22.214,,32.226,18.048,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,Veliparib,CHEMBL506871,JNAHVYVRKWKWKQ-CYBMUJFWSA-N,CC1(CCCN1)C2=NC3=C(C=CC=C3N2)C(=O)N,C13H16N4O,DB07232,D09692,veliparib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
25373,1,3,28,uM,uM,4.8916550077879,-0.190853357785528,8.5736797804247,5.01459848337896,3.47704724387218,0.272102312999941,24.19,24.091,75.699,61.674,68.6865,20.4055,,44.54599999999999,44.4965,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,MK-1775,CHEMBL1976040,BKWJAKQVGHWELA-UHFFFAOYSA-N,CC(C)(C1=NC(=CC=C1)N2C3=NC(=NC=C3C(=O)N2CC=C)NC4=CC=C(C=C4)N5CCN(CC5)C)O,C27H32N8O2,DB11740,,MK-1775,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
25377,1,4,28,uM,uM,3.18506922397948,6.51056349521914,9.90472520408058,1.84413671462616,3.47704724387218,0.0437439398816446,24.19,35.101,55.301,63.269,59.285,-0.0060000000000002,,29.6395,24.184,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,915019-65-7,CHEMBL1879463,JOGKUKXHTYWRGZ-UHFFFAOYSA-N,CC(C)(C#N)C1=CC=C(C=C1)N2C3=C4C=C(C=CC4=NC=C3N(C2=O)C)C5=CC6=CC=CC=C6N=C5,C30H23N5O,DB11651,D10552,NVP-BEZ235,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
25381,1,5,28,uM,uM,2.11244225223227,-1.46333811548428,3.05847081279643,2.24830115595407,3.47704724387218,0.0036938532405762,24.19,52.363,55.895,71.165,63.53,-13.023,,25.253500000000003,11.167000000000002,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
25385,1,8,28,uM,uM,-0.328968727078836,5.71872460938834,8.31294722529341,-1.32292393866401,3.47704724387218,0.118033389259186,24.19,43.276,50.592,63.161,56.8765,-10.5895,,23.1435,13.600499999999997,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
25389,1,10,28,uM,uM,2.21614297795759,0.513973957472632,4.27441418779642,2.30065196697112,3.47704724387218,0.0075883401911804,24.19,38.464,47.524,66.658,57.091,-5.563,,25.764000000000003,18.627,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,Dinaciclib,CHEMBL2103840,PIMQWRZWLQKKBJ-SFHVURJKSA-N,CCC1=C2N=C(C=C(N2N=C1)NCC3=C[N+](=CC=C3)[O-])N4CCCCC4CCO,C21H28N6O2,DB12021,D09604,dinaciclib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
25393,1,12,28,uM,uM,5.58744424119803,7.53403032545108,11.7186164261594,7.19910915547266,3.47704724387218,5.0,24.19,9.298,65.285,55.48,60.3825,26.8945,,43.6385,36.1925,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,Erlotinib,CHEMBL553,AAKJLRGGTJKAMG-UHFFFAOYSA-N,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,C22H23N3O4,DB00530,D07907,erlotinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
25397,1,36,28,uM,uM,-0.420807347976309,-2.7496388436398,1.96720548579245,-2.09249569585159,3.47704724387218,0.0344118931374301,24.19,79.99,58.427,82.223,70.325,-33.855,,18.235000000000007,-9.664999999999992,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,geldanamycin,CHEMBL278315,QTQAWLPCGQOSGP-KSRBKZBZSA-N,CC1CC(C(C(C=C(C(C(C=CC=C(C(=O)NC2=CC(=O)C(=C(C1)C2=O)OC)C)OC)OC(=O)N)C)C)O)OC,C29H40N2O9,DB02424,C11222,geldanamycin,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
25405,1,15,28,uM,uM,4.27627079425863,4.66261124152207,7.42230557222891,3.06349701257253,3.47704724387218,4.18286321924403,24.19,10.617,83.309,51.295,67.302,32.495,,49.898500000000006,43.11200000000001,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
25409,1,16,28,uM,uM,-2.89951883535563,3.72787798437797,6.45677009502988,-1.13987823123472,3.47704724387218,2.21500559399647,24.19,21.792,51.008,52.074,51.541,5.559,,28.55,27.351,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,MK-2206,CHEMBL1079175,ULDXWLCXEDXJGE-UHFFFAOYSA-N,C1CC(C1)(C2=CC=C(C=C2)C3=C(C=C4C(=N3)C=CN5C4=NNC5=O)C6=CC=CC=C6)N,C25H21N5O,,,MK-2206,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
25429,1,26,28,uM,uM,-4.04710031975906,-7.23776652879041,1.52810875287971,-5.82229960442059,3.47704724387218,0.0047899367025841,24.19,57.817,57.378,68.271,62.8245,-19.1825,,21.821,5.0075,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,391210-10-9,CHEMBL507361,SUDAHWBOROXANE-SECBINFHSA-N,C1=CC(=C(C=C1I)F)NC2=C(C=CC(=C2F)F)C(=O)NOCC(CO)O,C16H14F3IN2O4,DB07101,,PD-0325901,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
25433,1,29,28,uM,uM,-2.69757267710003,-6.01254393933947,1.58940500287972,-3.7480793138298,3.47704724387218,5.63752169768596,24.19,60.964,57.571,73.949,65.76,-19.394,,23.183000000000007,4.796000000000007,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
25437,1,30,28,uM,uM,6.88783438132035,7.89047463564382,14.4813323290806,6.77275284938329,3.47704724387218,2.33877884349832,24.19,32.46,64.127,63.566,63.8465,7.19649999999999,,35.5215,31.3865,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
25441,1,31,28,uM,uM,1.25586922044901,-42.6088358869183,-6.10098314305837,-3.22822350700785,3.47704724387218,28.1110621803845,24.19,-3.896,20.742,31.941,26.3415,6.0475,,16.194499999999998,2.151499999999998,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
25445,1,35,28,uM,uM,0.693674537056084,0.328811178925804,5.75899176658058,0.985559132277237,3.47704724387218,1.76535402335707,24.19,34.787,74.016,60.288,67.152,8.175,,37.6635,32.365,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
25449,2,4,28,uM,uM,12.1426769821402,-24.5787939956561,8.62417171862631,11.3283724928632,2.58856720224054,0.0437439398816446,-4.166,35.101,52.193,47.991,50.092,19.157,,34.6245,14.991,Veliparib,CHEMBL506871,JNAHVYVRKWKWKQ-CYBMUJFWSA-N,CC1(CCCN1)C2=NC3=C(C=CC=C3N2)C(=O)N,C13H16N4O,DB07232,D09692,veliparib,915019-65-7,CHEMBL1879463,JOGKUKXHTYWRGZ-UHFFFAOYSA-N,CC(C)(C#N)C1=CC=C(C=C1)N2C3=C4C=C(C=CC4=NC=C3N(C2=O)C)C5=CC6=CC=CC=C6N=C5,C30H23N5O,DB11651,D10552,NVP-BEZ235,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
25453,2,10,28,uM,uM,5.09569628492691,-46.7719472909053,5.10028961382493,8.33427285207529,2.58856720224054,0.0075883401911804,-4.166,38.464,47.267,41.534,44.4005,10.1025,,27.2515,5.936500000000002,Veliparib,CHEMBL506871,JNAHVYVRKWKWKQ-CYBMUJFWSA-N,CC1(CCCN1)C2=NC3=C(C=CC=C3N2)C(=O)N,C13H16N4O,DB07232,D09692,veliparib,Dinaciclib,CHEMBL2103840,PIMQWRZWLQKKBJ-SFHVURJKSA-N,CCC1=C2N=C(C=C(N2N=C1)NCC3=C[N+](=CC=C3)[O-])N4CCCCC4CCO,C21H28N6O2,DB12021,D09604,dinaciclib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
25457,2,36,28,uM,uM,2.27305484894355,-19.6523575573002,-0.896051031373669,0.201238026269201,2.58856720224054,0.0344118931374301,-4.166,79.99,47.961,74.204,61.0825,-14.7415,,23.170500000000004,-18.90749999999999,Veliparib,CHEMBL506871,JNAHVYVRKWKWKQ-CYBMUJFWSA-N,CC1(CCCN1)C2=NC3=C(C=CC=C3N2)C(=O)N,C13H16N4O,DB07232,D09692,veliparib,geldanamycin,CHEMBL278315,QTQAWLPCGQOSGP-KSRBKZBZSA-N,CC1CC(C(C(C=C(C(C(C=CC=C(C(=O)NC2=CC(=O)C(=C(C1)C2=O)OC)C)OC)OC(=O)N)C)C)O)OC,C29H40N2O9,DB02424,C11222,geldanamycin,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
25473,2,28,28,uM,uM,12.0421674252667,-76.717062192237,8.52124621862632,12.0735996446376,2.58856720224054,0.005,-4.166,10.812,64.615,17.117,40.866,34.22,,37.543,30.054,Veliparib,CHEMBL506871,JNAHVYVRKWKWKQ-CYBMUJFWSA-N,CC1(CCCN1)C2=NC3=C(C=CC=C3N2)C(=O)N,C13H16N4O,DB07232,D09692,veliparib,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
25477,2,29,28,uM,uM,3.03618421469232,-15.0665269282866,1.5396389686263,3.23472483143412,2.58856720224054,5.63752169768596,-4.166,60.964,49.831,59.445,54.638,-2.16,,26.239,-6.3260000000000005,Veliparib,CHEMBL506871,JNAHVYVRKWKWKQ-CYBMUJFWSA-N,CC1(CCCN1)C2=NC3=C(C=CC=C3N2)C(=O)N,C13H16N4O,DB07232,D09692,veliparib,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
25485,3,2,28,uM,uM,2.8359927132304,-63.8084200046827,2.01221960694162,4.97382632406445,0.272005434358038,2.56897684420797,24.097,-4.166,26.509,39.265,32.887,12.956,,22.9215,8.79,MK-1775,CHEMBL1976040,BKWJAKQVGHWELA-UHFFFAOYSA-N,CC(C)(C1=NC(=CC=C1)N2C3=NC(=NC=C3C(=O)N2CC=C)NC4=CC=C(C=C4)N5CCN(CC5)C)O,C27H32N8O2,DB11740,,MK-1775,Veliparib,CHEMBL506871,JNAHVYVRKWKWKQ-CYBMUJFWSA-N,CC1(CCCN1)C2=NC3=C(C=CC=C3N2)C(=O)N,C13H16N4O,DB07232,D09692,veliparib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
25489,3,4,28,uM,uM,14.9949882273097,14.145342580304,19.6595708484163,15.3010252313562,0.272005434358038,0.0437439398816446,24.097,35.101,71.761,81.758,76.7595,17.5615,,47.1605,41.6585,MK-1775,CHEMBL1976040,BKWJAKQVGHWELA-UHFFFAOYSA-N,CC(C)(C1=NC(=CC=C1)N2C3=NC(=NC=C3C(=O)N2CC=C)NC4=CC=C(C=C4)N5CCN(CC5)C)O,C27H32N8O2,DB11740,,MK-1775,915019-65-7,CHEMBL1879463,JOGKUKXHTYWRGZ-UHFFFAOYSA-N,CC(C)(C#N)C1=CC=C(C=C1)N2C3=C4C=C(C=CC4=NC=C3N(C2=O)C)C5=CC6=CC=CC=C6N=C5,C30H23N5O,DB11651,D10552,NVP-BEZ235,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
25493,3,5,28,uM,uM,0.57147842439758,-3.71183252300331,2.89894659968512,2.32536758541668,0.272005434358038,0.0036938532405762,24.097,52.363,47.959,66.356,57.1575,-19.3025,,18.927499999999995,4.794499999999999,MK-1775,CHEMBL1976040,BKWJAKQVGHWELA-UHFFFAOYSA-N,CC(C)(C1=NC(=CC=C1)N2C3=NC(=NC=C3C(=O)N2CC=C)NC4=CC=C(C=C4)N5CCN(CC5)C)O,C27H32N8O2,DB11740,,MK-1775,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
25497,3,8,28,uM,uM,7.70740726172872,7.78567679693604,12.8920296921434,7.87578388438895,0.272005434358038,0.118033389259186,24.097,43.276,62.901,84.281,73.591,6.218,,39.90449999999999,30.31499999999999,MK-1775,CHEMBL1976040,BKWJAKQVGHWELA-UHFFFAOYSA-N,CC(C)(C1=NC(=CC=C1)N2C3=NC(=NC=C3C(=O)N2CC=C)NC4=CC=C(C=C4)N5CCN(CC5)C)O,C27H32N8O2,DB11740,,MK-1775,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
25501,3,10,28,uM,uM,1.79080829627,-3.63877546227599,3.40870057209882,2.53070002709267,0.272005434358038,0.0075883401911804,24.097,38.464,37.752,66.605,52.1785,-10.3825,,20.898,13.7145,MK-1775,CHEMBL1976040,BKWJAKQVGHWELA-UHFFFAOYSA-N,CC(C)(C1=NC(=CC=C1)N2C3=NC(=NC=C3C(=O)N2CC=C)NC4=CC=C(C=C4)N5CCN(CC5)C)O,C27H32N8O2,DB11740,,MK-1775,Dinaciclib,CHEMBL2103840,PIMQWRZWLQKKBJ-SFHVURJKSA-N,CCC1=C2N=C(C=C(N2N=C1)NCC3=C[N+](=CC=C3)[O-])N4CCCCC4CCO,C21H28N6O2,DB12021,D09604,dinaciclib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
25505,3,12,28,uM,uM,0.96564823150045,0.318430597878874,6.43454902554812,3.93441030038377,0.272005434358038,5.0,24.097,9.298,57.592,57.447,57.5195,24.1245,,40.822,33.4225,MK-1775,CHEMBL1976040,BKWJAKQVGHWELA-UHFFFAOYSA-N,CC(C)(C1=NC(=CC=C1)N2C3=NC(=NC=C3C(=O)N2CC=C)NC4=CC=C(C=C4)N5CCN(CC5)C)O,C27H32N8O2,DB11740,,MK-1775,Erlotinib,CHEMBL553,AAKJLRGGTJKAMG-UHFFFAOYSA-N,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,C22H23N3O4,DB00530,D07907,erlotinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
25509,3,36,28,uM,uM,-0.420415625544822,-5.30323135784095,1.65851500287973,-1.81171869509954,0.272005434358038,0.0344118931374301,24.097,79.99,52.462,85.478,68.97,-35.117,,16.926500000000004,-11.019999999999996,MK-1775,CHEMBL1976040,BKWJAKQVGHWELA-UHFFFAOYSA-N,CC(C)(C1=NC(=CC=C1)N2C3=NC(=NC=C3C(=O)N2CC=C)NC4=CC=C(C=C4)N5CCN(CC5)C)O,C27H32N8O2,DB11740,,MK-1775,geldanamycin,CHEMBL278315,QTQAWLPCGQOSGP-KSRBKZBZSA-N,CC1CC(C(C(C=C(C(C(C=CC=C(C(=O)NC2=CC(=O)C(=C(C1)C2=O)OC)C)OC)OC(=O)N)C)C)O)OC,C29H40N2O9,DB02424,C11222,geldanamycin,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
25513,3,15,28,uM,uM,6.62732095701721,5.33208329011414,11.3927162100156,9.00406020270183,0.272005434358038,4.18286321924403,24.097,10.617,72.696,63.575,68.1355,33.4215,,50.7785,44.03849999999999,MK-1775,CHEMBL1976040,BKWJAKQVGHWELA-UHFFFAOYSA-N,CC(C)(C1=NC(=CC=C1)N2C3=NC(=NC=C3C(=O)N2CC=C)NC4=CC=C(C=C4)N5CCN(CC5)C)O,C27H32N8O2,DB11740,,MK-1775,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
25517,3,16,28,uM,uM,3.14780735725231,1.37327549482986,6.94078322341631,2.5993300230538,0.272005434358038,2.21500559399647,24.097,21.792,60.976,67.622,64.299,18.41,,41.3545,40.202000000000005,MK-1775,CHEMBL1976040,BKWJAKQVGHWELA-UHFFFAOYSA-N,CC(C)(C1=NC(=CC=C1)N2C3=NC(=NC=C3C(=O)N2CC=C)NC4=CC=C(C=C4)N5CCN(CC5)C)O,C27H32N8O2,DB11740,,MK-1775,MK-2206,CHEMBL1079175,ULDXWLCXEDXJGE-UHFFFAOYSA-N,C1CC(C1)(C2=CC=C(C=C2)C3=C(C=C4C(=N3)C=CN5C4=NNC5=O)C6=CC=CC=C6)N,C25H21N5O,,,MK-2206,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
25541,3,26,28,uM,uM,0.807932633979352,0.606519556305459,5.4751465671434,0.934866378311127,0.272005434358038,0.0047899367025841,24.097,57.817,61.815,77.472,69.6435,-12.2705,,28.6865,11.826500000000005,MK-1775,CHEMBL1976040,BKWJAKQVGHWELA-UHFFFAOYSA-N,CC(C)(C1=NC(=CC=C1)N2C3=NC(=NC=C3C(=O)N2CC=C)NC4=CC=C(C=C4)N5CCN(CC5)C)O,C27H32N8O2,DB11740,,MK-1775,391210-10-9,CHEMBL507361,SUDAHWBOROXANE-SECBINFHSA-N,C1=CC(=C(C=C1I)F)NC2=C(C=CC(=C2F)F)C(=O)NOCC(CO)O,C16H14F3IN2O4,DB07101,,PD-0325901,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
25545,3,28,28,uM,uM,13.3488391758544,7.53122817522571,16.7193062100156,14.3455616413684,0.272005434358038,0.005,24.097,10.812,87.536,75.18,81.358,46.449,,63.90350000000001,57.261,MK-1775,CHEMBL1976040,BKWJAKQVGHWELA-UHFFFAOYSA-N,CC(C)(C1=NC(=CC=C1)N2C3=NC(=NC=C3C(=O)N2CC=C)NC4=CC=C(C=C4)N5CCN(CC5)C)O,C27H32N8O2,DB11740,,MK-1775,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
25549,3,29,28,uM,uM,0.776989792477674,-5.63309732039429,4.75136222529341,1.54727936820153,0.272005434358038,5.63752169768596,24.097,60.964,62.524,74.022,68.273,-16.788,,25.7425,7.308999999999997,MK-1775,CHEMBL1976040,BKWJAKQVGHWELA-UHFFFAOYSA-N,CC(C)(C1=NC(=CC=C1)N2C3=NC(=NC=C3C(=O)N2CC=C)NC4=CC=C(C=C4)N5CCN(CC5)C)O,C27H32N8O2,DB11740,,MK-1775,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
25557,4,10,28,uM,uM,2.53610852899379,2.50768238752824,5.17829532141169,2.12305141585615,0.0437656966690191,0.0075883401911804,35.101,38.464,65.013,68.424,66.7185,-6.84649999999999,,29.936000000000007,28.254500000000007,915019-65-7,CHEMBL1879463,JOGKUKXHTYWRGZ-UHFFFAOYSA-N,CC(C)(C#N)C1=CC=C(C=C1)N2C3=C4C=C(C=CC4=NC=C3N(C2=O)C)C5=CC6=CC=CC=C6N=C5,C30H23N5O,DB11651,D10552,NVP-BEZ235,Dinaciclib,CHEMBL2103840,PIMQWRZWLQKKBJ-SFHVURJKSA-N,CCC1=C2N=C(C=C(N2N=C1)NCC3=C[N+](=CC=C3)[O-])N4CCCCC4CCO,C21H28N6O2,DB12021,D09604,dinaciclib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
25569,4,28,28,uM,uM,6.67363986536695,9.18308396590496,13.1430008171541,7.88844261407468,0.0437656966690191,0.005,35.101,10.812,71.415,48.889,60.152,14.239,,37.1955,25.051,915019-65-7,CHEMBL1879463,JOGKUKXHTYWRGZ-UHFFFAOYSA-N,CC(C)(C#N)C1=CC=C(C=C1)N2C3=C4C=C(C=CC4=NC=C3N(C2=O)C)C5=CC6=CC=CC=C6N=C5,C30H23N5O,DB11651,D10552,NVP-BEZ235,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
25573,4,29,28,uM,uM,5.57171566427931,8.01451822038283,12.2720276066669,5.47495271197151,0.0437656966690191,5.63752169768596,35.101,60.964,76.061,82.336,79.1985,-16.8665,,31.166,18.2345,915019-65-7,CHEMBL1879463,JOGKUKXHTYWRGZ-UHFFFAOYSA-N,CC(C)(C#N)C1=CC=C(C=C1)N2C3=C4C=C(C=CC4=NC=C3N(C2=O)C)C5=CC6=CC=CC=C6N=C5,C30H23N5O,DB11651,D10552,NVP-BEZ235,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
25577,5,2,28,uM,uM,0.667361609023047,-53.1484019277649,-4.38132394305838,-2.30025327043925,0.0036935825062621,2.56897684420797,52.364,-4.166,45.894,24.827,35.3605,-12.8375,,11.261500000000003,-17.003499999999995,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,Veliparib,CHEMBL506871,JNAHVYVRKWKWKQ-CYBMUJFWSA-N,CC1(CCCN1)C2=NC3=C(C=CC=C3N2)C(=O)N,C13H16N4O,DB07232,D09692,veliparib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
25581,5,4,28,uM,uM,3.41607434124847,1.03836146489893,4.2809035660512,3.34129141437317,0.0036935825062621,0.0437439398816446,52.364,35.101,76.702,72.076,74.389,-13.076,,30.6565,22.025,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,915019-65-7,CHEMBL1879463,JOGKUKXHTYWRGZ-UHFFFAOYSA-N,CC(C)(C#N)C1=CC=C(C=C1)N2C3=C4C=C(C=CC4=NC=C3N(C2=O)C)C5=CC6=CC=CC=C6N=C5,C30H23N5O,DB11651,D10552,NVP-BEZ235,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
25585,5,8,28,uM,uM,2.40423482552116,1.43083465964708,3.7059534410512,2.77114230907315,0.0036935825062621,0.118033389259186,52.364,43.276,69.42,62.338,65.879,-29.761,,18.059000000000005,13.515000000000008,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
25589,5,10,28,uM,uM,1.43456281921374,-3.78037958970082,1.09689674408371,1.28162847646474,0.0036935825062621,0.0075883401911804,52.364,38.464,70.654,66.621,68.6375,-22.1905,,23.2235,16.273500000000006,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,Dinaciclib,CHEMBL2103840,PIMQWRZWLQKKBJ-SFHVURJKSA-N,CCC1=C2N=C(C=C(N2N=C1)NCC3=C[N+](=CC=C3)[O-])N4CCCCC4CCO,C21H28N6O2,DB12021,D09604,dinaciclib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
25593,5,36,28,uM,uM,-1.54564259875018,-7.72809707121139,-3.60805155894878,-4.52295817868735,0.0036935825062621,0.0344118931374301,52.364,79.99,57.609,74.73,66.1695,-66.1845,,-0.0074999999999931,-13.820499999999996,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,geldanamycin,CHEMBL278315,QTQAWLPCGQOSGP-KSRBKZBZSA-N,CC1CC(C(C(C=C(C(C(C=CC=C(C(=O)NC2=CC(=O)C(=C(C1)C2=O)OC)C)OC)OC(=O)N)C)C)O)OC,C29H40N2O9,DB02424,C11222,geldanamycin,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
25609,5,28,28,uM,uM,0.83531572545213,-5.25338812399057,0.787058976676786,0.106913705667568,0.0036935825062621,0.005,52.364,10.812,72.862,41.883,57.3725,-5.80349999999999,,25.784500000000005,5.008500000000005,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
25613,5,29,28,uM,uM,-2.55981695947418,-9.83922479652442,-3.54956491498439,-4.41061653087346,0.0036935825062621,5.63752169768596,52.364,60.964,66.448,65.18,65.814,-47.514,,9.149999999999991,4.849999999999994,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
25781,8,2,28,uM,uM,5.03940824820838,-15.7412220568737,2.79809460694163,5.18998570943989,0.117999491036784,2.56897684420797,43.275,-4.166,44.711,42.068,43.3895,4.2805,,23.835,0.1144999999999996,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,Veliparib,CHEMBL506871,JNAHVYVRKWKWKQ-CYBMUJFWSA-N,CC1(CCCN1)C2=NC3=C(C=CC=C3N2)C(=O)N,C13H16N4O,DB07232,D09692,veliparib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
25785,8,4,28,uM,uM,0.256297326459793,9.95264688251166,11.9106581468094,-0.379099904178318,0.117999491036784,0.0437439398816446,43.275,35.101,67.219,61.884,64.5515,-13.8245,,25.3635,21.27650000000001,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,915019-65-7,CHEMBL1879463,JOGKUKXHTYWRGZ-UHFFFAOYSA-N,CC(C)(C#N)C1=CC=C(C=C1)N2C3=C4C=C(C=CC4=NC=C3N(C2=O)C)C5=CC6=CC=CC=C6N=C5,C30H23N5O,DB11651,D10552,NVP-BEZ235,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
25789,8,10,28,uM,uM,-1.06577298615606,-0.888441656914255,0.912970196411691,-2.91592968373314,0.117999491036784,0.0075883401911804,43.275,38.464,61.248,58.985,60.1165,-21.6225,,19.247,16.841500000000003,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,Dinaciclib,CHEMBL2103840,PIMQWRZWLQKKBJ-SFHVURJKSA-N,CCC1=C2N=C(C=C(N2N=C1)NCC3=C[N+](=CC=C3)[O-])N4CCCCC4CCO,C21H28N6O2,DB12021,D09604,dinaciclib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
25793,8,36,28,uM,uM,1.74776872007133,3.85913418392875,7.09242080830672,0.785306113842144,0.117999491036784,0.0344118931374301,43.275,79.99,75.613,88.858,82.2355,-41.0295,,20.60300000000001,2.245500000000007,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,geldanamycin,CHEMBL278315,QTQAWLPCGQOSGP-KSRBKZBZSA-N,CC1CC(C(C(C=C(C(C(C=CC=C(C(=O)NC2=CC(=O)C(=C(C1)C2=O)OC)C)OC)OC(=O)N)C)C)O)OC,C29H40N2O9,DB02424,C11222,geldanamycin,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
25809,8,28,28,uM,uM,6.65529794841795,9.56255351772396,12.5093246106897,6.62012119006133,0.117999491036784,0.005,43.275,10.812,78.263,50.409,64.336,10.249,,37.2925,21.061,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
25813,8,29,28,uM,uM,4.02486076215998,8.30232538052629,12.3499673496851,4.25927377131822,0.117999491036784,5.63752169768596,43.275,60.964,77.925,79.973,78.949,-25.29,,26.8295,17.985,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
25905,11,2,28,uM,uM,5.47857049355108,-46.1441790675763,0.525552106941632,2.52441924262754,0.0571866653447834,2.56897684420797,51.881,-4.166,58.833,64.956,61.8945,14.1795,,38.037,10.0135,doxorubicin,CHEMBL53463,AOJJSUZBOXZQNB-TZSSRYMLSA-N,CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O,C27H29NO11,DB00997,D03899,doxorubicin,Veliparib,CHEMBL506871,JNAHVYVRKWKWKQ-CYBMUJFWSA-N,CC1(CCCN1)C2=NC3=C(C=CC=C3N2)C(=O)N,C13H16N4O,DB07232,D09692,veliparib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
25909,11,3,28,uM,uM,7.23469021365665,1.96660036374352,9.5730174157124,5.42625987208223,0.0571866653447834,0.272102312999941,51.881,24.091,88.702,82.008,85.355,9.38299999999998,,47.369,33.474000000000004,doxorubicin,CHEMBL53463,AOJJSUZBOXZQNB-TZSSRYMLSA-N,CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O,C27H29NO11,DB00997,D03899,doxorubicin,MK-1775,CHEMBL1976040,BKWJAKQVGHWELA-UHFFFAOYSA-N,CC(C)(C1=NC(=CC=C1)N2C3=NC(=NC=C3C(=O)N2CC=C)NC4=CC=C(C=C4)N5CCN(CC5)C)O,C27H32N8O2,DB11740,,MK-1775,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
25913,11,4,28,uM,uM,-1.61275380440858,2.96684708912855,6.43046584469501,-2.12816616195527,0.0571866653447834,0.0437439398816446,51.881,35.101,70.436,63.958,67.197,-19.785,,23.706000000000003,15.316000000000004,doxorubicin,CHEMBL53463,AOJJSUZBOXZQNB-TZSSRYMLSA-N,CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O,C27H29NO11,DB00997,D03899,doxorubicin,915019-65-7,CHEMBL1879463,JOGKUKXHTYWRGZ-UHFFFAOYSA-N,CC(C)(C#N)C1=CC=C(C=C1)N2C3=C4C=C(C=CC4=NC=C3N(C2=O)C)C5=CC6=CC=CC=C6N=C5,C30H23N5O,DB11651,D10552,NVP-BEZ235,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
25917,11,5,28,uM,uM,-1.30307305996249,-6.11393403188008,-1.86417480358831,-2.79324107867984,0.0571866653447834,0.0036938532405762,51.881,52.363,60.716,68.26,64.488,-39.756,,12.366,12.125,doxorubicin,CHEMBL53463,AOJJSUZBOXZQNB-TZSSRYMLSA-N,CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O,C27H29NO11,DB00997,D03899,doxorubicin,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
25921,11,8,28,uM,uM,0.669440429482582,7.29322552780193,11.0162943885655,0.600419611500509,0.0571866653447834,0.118033389259186,51.881,43.276,68.451,70.752,69.6015,-25.5555,,22.023,17.7205,doxorubicin,CHEMBL53463,AOJJSUZBOXZQNB-TZSSRYMLSA-N,CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O,C27H29NO11,DB00997,D03899,doxorubicin,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
25925,11,10,28,uM,uM,0.616559754122896,-1.01410376495885,4.01750179382539,0.510214793131183,0.0571866653447834,0.0075883401911804,51.881,38.464,70.638,68.725,69.6815,-20.6635,,24.509,17.8005,doxorubicin,CHEMBL53463,AOJJSUZBOXZQNB-TZSSRYMLSA-N,CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O,C27H29NO11,DB00997,D03899,doxorubicin,Dinaciclib,CHEMBL2103840,PIMQWRZWLQKKBJ-SFHVURJKSA-N,CCC1=C2N=C(C=C(N2N=C1)NCC3=C[N+](=CC=C3)[O-])N4CCCCC4CCO,C21H28N6O2,DB12021,D09604,dinaciclib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
25929,11,12,28,uM,uM,2.34265878719253,1.96851199703966,6.21834648568967,1.83026235868899,0.0571866653447834,5.0,51.881,9.298,83.989,60.36,72.1745,10.9955,,41.585,20.293499999999995,doxorubicin,CHEMBL53463,AOJJSUZBOXZQNB-TZSSRYMLSA-N,CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O,C27H29NO11,DB00997,D03899,doxorubicin,Erlotinib,CHEMBL553,AAKJLRGGTJKAMG-UHFFFAOYSA-N,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,C22H23N3O4,DB00530,D07907,erlotinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
25933,11,36,28,uM,uM,-1.63688142071816,-3.07267924846798,2.880493450394,-2.94836631143999,0.0571866653447834,0.0344118931374301,51.881,79.99,64.428,85.449,74.9385,-56.9325,,9.003000000000014,-5.05149999999999,doxorubicin,CHEMBL53463,AOJJSUZBOXZQNB-TZSSRYMLSA-N,CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O,C27H29NO11,DB00997,D03899,doxorubicin,geldanamycin,CHEMBL278315,QTQAWLPCGQOSGP-KSRBKZBZSA-N,CC1CC(C(C(C=C(C(C(C=CC=C(C(=O)NC2=CC(=O)C(=C(C1)C2=O)OC)C)OC)OC(=O)N)C)C)O)OC,C29H40N2O9,DB02424,C11222,geldanamycin,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
25941,11,15,28,uM,uM,1.50847258695844,0.026663250075037,4.95652648568967,0.579488383811208,0.0571866653447834,4.18286321924403,51.881,10.617,81.844,57.332,69.588,7.08999999999999,,38.33899999999999,17.706999999999994,doxorubicin,CHEMBL53463,AOJJSUZBOXZQNB-TZSSRYMLSA-N,CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O,C27H29NO11,DB00997,D03899,doxorubicin,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
25945,11,16,28,uM,uM,1.25812433969642,4.35843456653146,8.25771577174799,0.365853761726363,0.0571866653447834,2.21500559399647,51.881,21.792,71.342,63.457,67.3995,-6.2735,,30.563,15.518500000000005,doxorubicin,CHEMBL53463,AOJJSUZBOXZQNB-TZSSRYMLSA-N,CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O,C27H29NO11,DB00997,D03899,doxorubicin,MK-2206,CHEMBL1079175,ULDXWLCXEDXJGE-UHFFFAOYSA-N,C1CC(C1)(C2=CC=C(C=C2)C3=C(C=C4C(=N3)C=CN5C4=NNC5=O)C6=CC=CC=C6)N,C25H21N5O,,,MK-2206,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
25965,11,26,28,uM,uM,-5.12534303791766,-0.701610271798079,2.98934167093057,-5.97547268092381,0.0571866653447834,0.0047899367025841,51.881,57.817,68.382,72.762,70.572,-39.126,,15.723,12.755000000000004,doxorubicin,CHEMBL53463,AOJJSUZBOXZQNB-TZSSRYMLSA-N,CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O,C27H29NO11,DB00997,D03899,doxorubicin,391210-10-9,CHEMBL507361,SUDAHWBOROXANE-SECBINFHSA-N,C1=CC(=C(C=C1I)F)NC2=C(C=CC(=C2F)F)C(=O)NOCC(CO)O,C16H14F3IN2O4,DB07101,,PD-0325901,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
25969,11,29,28,uM,uM,-5.83132201913649,-8.54597425431992,-0.516021677901186,-6.7870861951384,0.0571866653447834,5.63752169768596,51.881,60.964,62.506,70.6,66.553,-46.292,,10.130499999999998,5.588999999999999,doxorubicin,CHEMBL53463,AOJJSUZBOXZQNB-TZSSRYMLSA-N,CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O,C27H29NO11,DB00997,D03899,doxorubicin,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
25973,11,30,28,uM,uM,-0.349457091426558,-1.46584562040948,7.57199209469501,-0.754380169792582,0.0571866653447834,2.33877884349832,51.881,32.46,69.151,66.287,67.719,-16.622,,25.54849999999999,15.837999999999994,doxorubicin,CHEMBL53463,AOJJSUZBOXZQNB-TZSSRYMLSA-N,CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O,C27H29NO11,DB00997,D03899,doxorubicin,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
25977,11,31,28,uM,uM,3.71966793625608,-47.8049371922369,0.158489606941631,2.02462467384057,0.0571866653447834,28.1110621803845,51.881,-3.896,55.324,53.9,54.612,6.627,,30.6195,2.7310000000000016,doxorubicin,CHEMBL53463,AOJJSUZBOXZQNB-TZSSRYMLSA-N,CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O,C27H29NO11,DB00997,D03899,doxorubicin,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
25981,11,35,28,uM,uM,6.06683197053093,4.42367770214265,9.9548980304247,4.90808197726097,0.0571866653447834,1.76535402335707,51.881,34.787,90.286,87.124,88.705,2.03699999999999,,45.371,36.824,doxorubicin,CHEMBL53463,AOJJSUZBOXZQNB-TZSSRYMLSA-N,CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O,C27H29NO11,DB00997,D03899,doxorubicin,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
25985,12,2,28,uM,uM,-0.431548980088432,-25.8214310620754,-2.20317926805838,1.42856796404973,5.0,2.56897684420797,9.3,-4.166,9.055,42.897,25.976,20.842,,23.409,16.676,Erlotinib,CHEMBL553,AAKJLRGGTJKAMG-UHFFFAOYSA-N,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,C22H23N3O4,DB00530,D07907,erlotinib,Veliparib,CHEMBL506871,JNAHVYVRKWKWKQ-CYBMUJFWSA-N,CC1(CCCN1)C2=NC3=C(C=CC=C3N2)C(=O)N,C13H16N4O,DB07232,D09692,veliparib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
25989,12,4,28,uM,uM,11.51637948371,13.191629959424,16.0661606278797,10.8911864699154,5.0,0.0437439398816446,9.3,35.101,61.314,73.863,67.5885,23.1875,,45.388,32.4875,Erlotinib,CHEMBL553,AAKJLRGGTJKAMG-UHFFFAOYSA-N,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,C22H23N3O4,DB00530,D07907,erlotinib,915019-65-7,CHEMBL1879463,JOGKUKXHTYWRGZ-UHFFFAOYSA-N,CC(C)(C#N)C1=CC=C(C=C1)N2C3=C4C=C(C=CC4=NC=C3N(C2=O)C)C5=CC6=CC=CC=C6N=C5,C30H23N5O,DB11651,D10552,NVP-BEZ235,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
25993,12,5,28,uM,uM,-1.12040242342278,-2.88840239207082,0.871441130935119,0.275915602690214,5.0,0.0036938532405762,9.3,52.363,27.326,73.065,50.1955,-11.4675,,19.364000000000004,-2.167499999999997,Erlotinib,CHEMBL553,AAKJLRGGTJKAMG-UHFFFAOYSA-N,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,C22H23N3O4,DB00530,D07907,erlotinib,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
25997,12,8,28,uM,uM,7.95895228097499,11.6970886022025,13.9240816122039,7.87619481942743,5.0,0.118033389259186,9.3,43.276,51.119,75.967,63.543,10.967,,37.255,20.267,Erlotinib,CHEMBL553,AAKJLRGGTJKAMG-UHFFFAOYSA-N,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,C22H23N3O4,DB00530,D07907,erlotinib,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
26001,12,10,28,uM,uM,0.802837707129108,-5.30385661532075,-1.16201461906488,-1.51637346711106,5.0,0.0075883401911804,9.3,38.464,8.131,69.542,38.8365,-8.92749999999999,,14.954500000000005,0.3725000000000023,Erlotinib,CHEMBL553,AAKJLRGGTJKAMG-UHFFFAOYSA-N,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,C22H23N3O4,DB00530,D07907,erlotinib,Dinaciclib,CHEMBL2103840,PIMQWRZWLQKKBJ-SFHVURJKSA-N,CCC1=C2N=C(C=C(N2N=C1)NCC3=C[N+](=CC=C3)[O-])N4CCCCC4CCO,C21H28N6O2,DB12021,D09604,dinaciclib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
26005,12,36,28,uM,uM,2.65776589426971,0.904787912433349,3.82279397011659,1.3486585867504,5.0,0.0344118931374301,9.3,79.99,56.294,90.636,73.465,-15.825,,28.820000000000007,-6.524999999999992,Erlotinib,CHEMBL553,AAKJLRGGTJKAMG-UHFFFAOYSA-N,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,C22H23N3O4,DB00530,D07907,erlotinib,geldanamycin,CHEMBL278315,QTQAWLPCGQOSGP-KSRBKZBZSA-N,CC1CC(C(C(C=C(C(C(C=CC=C(C(=O)NC2=CC(=O)C(=C(C1)C2=O)OC)C)OC)OC(=O)N)C)C)O)OC,C29H40N2O9,DB02424,C11222,geldanamycin,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
26021,12,26,28,uM,uM,-1.25386459665373,-0.320776903224186,2.46154209511656,-2.0169213342809,5.0,0.0047899367025841,9.3,57.817,48.775,75.814,62.2945,-4.82250000000001,,28.736,4.477499999999999,Erlotinib,CHEMBL553,AAKJLRGGTJKAMG-UHFFFAOYSA-N,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,C22H23N3O4,DB00530,D07907,erlotinib,391210-10-9,CHEMBL507361,SUDAHWBOROXANE-SECBINFHSA-N,C1=CC(=C(C=C1I)F)NC2=C(C=CC(=C2F)F)C(=O)NOCC(CO)O,C16H14F3IN2O4,DB07101,,PD-0325901,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
26025,12,28,28,uM,uM,15.037400050764,11.5594797562403,17.0139839037912,13.8451368789601,5.0,0.005,9.3,10.812,70.738,63.115,66.9265,46.8145,,56.87050000000001,56.11450000000001,Erlotinib,CHEMBL553,AAKJLRGGTJKAMG-UHFFFAOYSA-N,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,C22H23N3O4,DB00530,D07907,erlotinib,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
26029,12,29,28,uM,uM,-1.47196668497127,-1.73321415030771,4.49228584511656,0.916964737568452,5.0,5.63752169768596,9.3,60.964,54.745,79.51,67.1275,-3.1365,,31.9955,6.163499999999999,Erlotinib,CHEMBL553,AAKJLRGGTJKAMG-UHFFFAOYSA-N,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,C22H23N3O4,DB00530,D07907,erlotinib,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
26037,13,2,28,uM,uM,7.0265916995066,-27.3699400251986,4.08417958194163,7.36847796474035,1.46662379502088,2.56897684420797,16.604,-4.166,24.251,57.498,40.8745,28.4365,,34.6555,24.2705,etoposide,CHEMBL44657,VJJPUSNTGOMMGY-MRVIYFEKSA-N,CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,C29H32O13,DB00773,D00125,etoposide,Veliparib,CHEMBL506871,JNAHVYVRKWKWKQ-CYBMUJFWSA-N,CC1(CCCN1)C2=NC3=C(C=CC=C3N2)C(=O)N,C13H16N4O,DB07232,D09692,veliparib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
26041,13,3,28,uM,uM,8.95581989798816,5.14770797006575,12.3510026315663,10.1388938921113,1.46662379502088,0.272102312999941,16.604,24.091,70.976,67.74,69.358,28.663,,49.01050000000001,45.267,etoposide,CHEMBL44657,VJJPUSNTGOMMGY-MRVIYFEKSA-N,CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,C29H32O13,DB00773,D00125,etoposide,MK-1775,CHEMBL1976040,BKWJAKQVGHWELA-UHFFFAOYSA-N,CC(C)(C1=NC(=CC=C1)N2C3=NC(=NC=C3C(=O)N2CC=C)NC4=CC=C(C=C4)N5CCN(CC5)C)O,C27H32N8O2,DB11740,,MK-1775,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
26045,13,4,28,uM,uM,2.65547583214704,5.56521242521749,8.3740523171434,3.12415453328896,1.46662379502088,0.0437439398816446,16.604,35.101,49.603,54.727,52.165,0.460000000000001,,26.3125,17.064,etoposide,CHEMBL44657,VJJPUSNTGOMMGY-MRVIYFEKSA-N,CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,C29H32O13,DB00773,D00125,etoposide,915019-65-7,CHEMBL1879463,JOGKUKXHTYWRGZ-UHFFFAOYSA-N,CC(C)(C#N)C1=CC=C(C=C1)N2C3=C4C=C(C=CC4=NC=C3N(C2=O)C)C5=CC6=CC=CC=C6N=C5,C30H23N5O,DB11651,D10552,NVP-BEZ235,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
26049,13,5,28,uM,uM,2.60290353979344,-1.12629225451359,2.75313046291689,2.43738058606658,1.46662379502088,0.0036938532405762,16.604,52.363,58.481,71.267,64.874,-4.093,,30.3905,12.510999999999996,etoposide,CHEMBL44657,VJJPUSNTGOMMGY-MRVIYFEKSA-N,CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,C29H32O13,DB00773,D00125,etoposide,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
26053,13,8,28,uM,uM,4.05399358887227,7.35013549694351,9.46139567646754,3.12535655287218,1.46662379502088,0.118033389259186,16.604,43.276,50.128,71.86,60.994,1.114,,31.054,17.717999999999996,etoposide,CHEMBL44657,VJJPUSNTGOMMGY-MRVIYFEKSA-N,CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,C29H32O13,DB00773,D00125,etoposide,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
26057,13,10,28,uM,uM,2.79580702454416,1.30546847050343,5.03790271843512,4.0534805302861,1.46662379502088,0.0075883401911804,16.604,38.464,50.272,60.249,55.2605,0.192500000000003,,27.7265,16.7965,etoposide,CHEMBL44657,VJJPUSNTGOMMGY-MRVIYFEKSA-N,CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,C29H32O13,DB00773,D00125,etoposide,Dinaciclib,CHEMBL2103840,PIMQWRZWLQKKBJ-SFHVURJKSA-N,CCC1=C2N=C(C=C(N2N=C1)NCC3=C[N+](=CC=C3)[O-])N4CCCCC4CCO,C21H28N6O2,DB12021,D09604,dinaciclib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
26061,13,12,28,uM,uM,9.66744880202483,9.21442819745417,12.5012781475156,10.1479194734053,1.46662379502088,5.0,16.604,9.298,63.561,65.796,64.6785,38.7765,,51.7275,48.0745,etoposide,CHEMBL44657,VJJPUSNTGOMMGY-MRVIYFEKSA-N,CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,C29H32O13,DB00773,D00125,etoposide,Erlotinib,CHEMBL553,AAKJLRGGTJKAMG-UHFFFAOYSA-N,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,C22H23N3O4,DB00530,D07907,erlotinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
26065,13,36,28,uM,uM,1.35692534471921,-1.77052970841885,2.34698209511659,-0.617829290696119,1.46662379502088,0.0344118931374301,16.604,79.99,53.127,89.151,71.139,-25.455,,22.842,-8.850999999999999,etoposide,CHEMBL44657,VJJPUSNTGOMMGY-MRVIYFEKSA-N,CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,C29H32O13,DB00773,D00125,etoposide,geldanamycin,CHEMBL278315,QTQAWLPCGQOSGP-KSRBKZBZSA-N,CC1CC(C(C(C=C(C(C(C=CC=C(C(=O)NC2=CC(=O)C(=C(C1)C2=O)OC)C)OC)OC(=O)N)C)C)O)OC,C29H40N2O9,DB02424,C11222,geldanamycin,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
26069,13,15,28,uM,uM,5.61834619068963,5.5367959054168,8.04622621001561,5.36028339826101,1.46662379502088,4.18286321924403,16.604,10.617,71.532,57.375,64.4535,37.2325,,50.843,47.849500000000006,etoposide,CHEMBL44657,VJJPUSNTGOMMGY-MRVIYFEKSA-N,CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,C29H32O13,DB00773,D00125,etoposide,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
26073,13,16,28,uM,uM,-0.588815143240334,3.44453872133226,5.59742822341631,1.1017618037548,1.46662379502088,2.21500559399647,16.604,21.792,53.701,60.823,57.262,18.866,,38.064,35.47,etoposide,CHEMBL44657,VJJPUSNTGOMMGY-MRVIYFEKSA-N,CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,C29H32O13,DB00773,D00125,etoposide,MK-2206,CHEMBL1079175,ULDXWLCXEDXJGE-UHFFFAOYSA-N,C1CC(C1)(C2=CC=C(C=C2)C3=C(C=C4C(=N3)C=CN5C4=NNC5=O)C6=CC=CC=C6)N,C25H21N5O,,,MK-2206,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
26093,13,26,28,uM,uM,-0.0291846252826196,2.06329806477854,5.59199536220385,0.355125585917869,1.46662379502088,0.0047899367025841,16.604,57.817,57.375,70.622,63.9985,-10.4225,,26.788000000000004,6.1815,etoposide,CHEMBL44657,VJJPUSNTGOMMGY-MRVIYFEKSA-N,CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,C29H32O13,DB00773,D00125,etoposide,391210-10-9,CHEMBL507361,SUDAHWBOROXANE-SECBINFHSA-N,C1=CC(=C(C=C1I)F)NC2=C(C=CC(=C2F)F)C(=O)NOCC(CO)O,C16H14F3IN2O4,DB07101,,PD-0325901,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
26097,13,29,28,uM,uM,-2.26133168091796,-5.27751758276032,0.340418752879716,-3.10590808557581,1.46662379502088,5.63752169768596,16.604,60.964,53.456,73.496,63.476,-14.092,,24.692,2.5120000000000005,etoposide,CHEMBL44657,VJJPUSNTGOMMGY-MRVIYFEKSA-N,CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,C29H32O13,DB00773,D00125,etoposide,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
26101,13,30,28,uM,uM,3.92270208791535,3.27247453607232,9.13288822341631,3.97809460020213,1.46662379502088,2.33877884349832,16.604,32.46,58.843,58.906,58.8745,9.8105,,34.3425,26.4145,etoposide,CHEMBL44657,VJJPUSNTGOMMGY-MRVIYFEKSA-N,CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,C29H32O13,DB00773,D00125,etoposide,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
26105,13,31,28,uM,uM,4.53950069436821,-47.0121302690948,3.24211708194162,6.30832607246416,1.46662379502088,28.1110621803845,16.604,-3.896,15.765,32.36,24.0625,11.3545,,17.7085,7.458500000000001,etoposide,CHEMBL44657,VJJPUSNTGOMMGY-MRVIYFEKSA-N,CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,C29H32O13,DB00773,D00125,etoposide,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
26109,13,35,28,uM,uM,6.34529633524003,5.86325096687017,10.1948002565663,7.4043732127614,1.46662379502088,1.76535402335707,16.604,34.787,79.211,69.253,74.232,22.841,,48.5365,39.445,etoposide,CHEMBL44657,VJJPUSNTGOMMGY-MRVIYFEKSA-N,CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,C29H32O13,DB00773,D00125,etoposide,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
26113,36,4,28,uM,uM,1.70617730666668,2.84826913835068,6.13958793462199,0.809039272673395,0.0344131146168697,0.0437439398816446,80.509,35.101,86.629,69.467,78.048,-37.562,,20.243,-2.4609999999999985,geldanamycin,CHEMBL278315,QTQAWLPCGQOSGP-KSRBKZBZSA-N,CC1CC(C(C(C=C(C(C(C=CC=C(C(=O)NC2=CC(=O)C(=C(C1)C2=O)OC)C)OC)OC(=O)N)C)C)O)OC,C29H40N2O9,DB02424,C11222,geldanamycin,915019-65-7,CHEMBL1879463,JOGKUKXHTYWRGZ-UHFFFAOYSA-N,CC(C)(C#N)C1=CC=C(C=C1)N2C3=C4C=C(C=CC4=NC=C3N(C2=O)C)C5=CC6=CC=CC=C6N=C5,C30H23N5O,DB11651,D10552,NVP-BEZ235,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
26117,36,10,28,uM,uM,1.14972491231479,-0.389231181114416,2.94817702174799,-0.0989917948061357,0.0344131146168697,0.0075883401911804,80.509,38.464,89.029,69.161,79.095,-39.878,,19.6085,-1.4140000000000017,geldanamycin,CHEMBL278315,QTQAWLPCGQOSGP-KSRBKZBZSA-N,CC1CC(C(C(C=C(C(C(C=CC=C(C(=O)NC2=CC(=O)C(=C(C1)C2=O)OC)C)OC)OC(=O)N)C)C)O)OC,C29H40N2O9,DB02424,C11222,geldanamycin,Dinaciclib,CHEMBL2103840,PIMQWRZWLQKKBJ-SFHVURJKSA-N,CCC1=C2N=C(C=C(N2N=C1)NCC3=C[N+](=CC=C3)[O-])N4CCCCC4CCO,C21H28N6O2,DB12021,D09604,dinaciclib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
26129,36,28,28,uM,uM,2.14180174662054,-3.68958956451269,2.48386927356366,0.134107754166846,0.0344131146168697,0.005,80.509,10.812,90.291,54.146,72.2185,-19.1025,,26.558000000000007,-8.290499999999994,geldanamycin,CHEMBL278315,QTQAWLPCGQOSGP-KSRBKZBZSA-N,CC1CC(C(C(C=C(C(C(C=CC=C(C(=O)NC2=CC(=O)C(=C(C1)C2=O)OC)C)OC)OC(=O)N)C)C)O)OC,C29H40N2O9,DB02424,C11222,geldanamycin,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
26133,36,29,28,uM,uM,-0.75667894773011,-1.98977991487567,2.95039819024714,-1.54250430004616,0.0344131146168697,5.63752169768596,80.509,60.964,83.831,65.93,74.8805,-66.5925,,4.143999999999991,-5.6285000000000025,geldanamycin,CHEMBL278315,QTQAWLPCGQOSGP-KSRBKZBZSA-N,CC1CC(C(C(C=C(C(C(C=CC=C(C(=O)NC2=CC(=O)C(=C(C1)C2=O)OC)C)OC)OC(=O)N)C)C)O)OC,C29H40N2O9,DB02424,C11222,geldanamycin,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
26141,14,2,28,uM,uM,12.5333952424845,-29.7127318644769,7.68784385694163,10.263067666795,0.0035412716570633,2.56897684420797,38.091,-4.166,46.418,59.149,52.7835,18.8585,,35.821,14.692499999999995,gemcitabine,CHEMBL888,SDUQYLNIPVEERB-QPPQHZFASA-N,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F,C9H11F2N3O4,DB00441,D02368,gemcitabine,Veliparib,CHEMBL506871,JNAHVYVRKWKWKQ-CYBMUJFWSA-N,CC1(CCCN1)C2=NC3=C(C=CC=C3N2)C(=O)N,C13H16N4O,DB07232,D09692,veliparib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
26145,14,3,28,uM,uM,29.1269379842829,23.6663967844871,32.7167520304247,28.6338882157489,0.0035412716570633,0.272102312999941,38.091,24.091,93.604,91.396,92.5,30.318,,61.409,54.409,gemcitabine,CHEMBL888,SDUQYLNIPVEERB-QPPQHZFASA-N,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F,C9H11F2N3O4,DB00441,D02368,gemcitabine,MK-1775,CHEMBL1976040,BKWJAKQVGHWELA-UHFFFAOYSA-N,CC(C)(C1=NC(=CC=C1)N2C3=NC(=NC=C3C(=O)N2CC=C)NC4=CC=C(C=C4)N5CCN(CC5)C)O,C27H32N8O2,DB11740,,MK-1775,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
26149,14,4,28,uM,uM,2.96132107433919,6.30695834043772,12.1084723450299,2.64354664013806,0.0035412716570633,0.0437439398816446,38.091,35.101,63.993,62.373,63.183,-10.009,,26.587,25.092,gemcitabine,CHEMBL888,SDUQYLNIPVEERB-QPPQHZFASA-N,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F,C9H11F2N3O4,DB00441,D02368,gemcitabine,915019-65-7,CHEMBL1879463,JOGKUKXHTYWRGZ-UHFFFAOYSA-N,CC(C)(C#N)C1=CC=C(C=C1)N2C3=C4C=C(C=CC4=NC=C3N(C2=O)C)C5=CC6=CC=CC=C6N=C5,C30H23N5O,DB11651,D10552,NVP-BEZ235,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
26153,14,5,28,uM,uM,5.83483078947356,0.890847216349325,7.14250232141168,6.20456455589736,0.0035412716570633,0.0036938532405762,38.091,52.363,74.971,76.297,75.634,-14.82,,30.407,23.271,gemcitabine,CHEMBL888,SDUQYLNIPVEERB-QPPQHZFASA-N,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F,C9H11F2N3O4,DB00441,D02368,gemcitabine,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
26157,14,8,28,uM,uM,5.56349986603676,12.9824404458632,16.6857897825299,5.47306272992095,0.0035412716570633,0.118033389259186,38.091,43.276,66.717,69.895,68.306,-13.061,,27.622499999999995,25.03,gemcitabine,CHEMBL888,SDUQYLNIPVEERB-QPPQHZFASA-N,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F,C9H11F2N3O4,DB00441,D02368,gemcitabine,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
26161,14,10,28,uM,uM,-0.591676876140224,-4.16867031130682,1.91730579382539,-1.36521224648172,0.0035412716570633,0.0075883401911804,38.091,38.464,59.294,58.464,58.879,-17.676,,20.601499999999994,20.415,gemcitabine,CHEMBL888,SDUQYLNIPVEERB-QPPQHZFASA-N,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F,C9H11F2N3O4,DB00441,D02368,gemcitabine,Dinaciclib,CHEMBL2103840,PIMQWRZWLQKKBJ-SFHVURJKSA-N,CCC1=C2N=C(C=C(N2N=C1)NCC3=C[N+](=CC=C3)[O-])N4CCCCC4CCO,C21H28N6O2,DB12021,D09604,dinaciclib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
26165,14,12,28,uM,uM,9.56695114136231,8.18159004371129,13.907802771748,9.32676253851361,0.0035412716570633,5.0,38.091,9.298,66.494,64.005,65.2495,17.8605,,41.55499999999999,27.1585,gemcitabine,CHEMBL888,SDUQYLNIPVEERB-QPPQHZFASA-N,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F,C9H11F2N3O4,DB00441,D02368,gemcitabine,Erlotinib,CHEMBL553,AAKJLRGGTJKAMG-UHFFFAOYSA-N,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,C22H23N3O4,DB00530,D07907,erlotinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
26169,14,36,28,uM,uM,-0.458732056224912,-0.901722113869467,3.61480173579245,-1.60268422413183,0.0035412716570633,0.0344118931374301,38.091,79.99,66.956,86.365,76.6605,-41.4205,,17.620000000000005,-3.329499999999996,gemcitabine,CHEMBL888,SDUQYLNIPVEERB-QPPQHZFASA-N,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F,C9H11F2N3O4,DB00441,D02368,gemcitabine,geldanamycin,CHEMBL278315,QTQAWLPCGQOSGP-KSRBKZBZSA-N,CC1CC(C(C(C=C(C(C(C=CC=C(C(=O)NC2=CC(=O)C(=C(C1)C2=O)OC)C)OC)OC(=O)N)C)C)O)OC,C29H40N2O9,DB02424,C11222,geldanamycin,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
26173,14,15,28,uM,uM,9.92524708221232,9.21085719932164,14.3385519421541,9.25608157733552,0.0035412716570633,4.18286321924403,38.091,10.617,81.995,61.729,71.862,23.154,,47.508,33.770999999999994,gemcitabine,CHEMBL888,SDUQYLNIPVEERB-QPPQHZFASA-N,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F,C9H11F2N3O4,DB00441,D02368,gemcitabine,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
26177,14,16,28,uM,uM,4.54789643097976,8.80345458038006,12.3734811016768,4.19875850811633,0.0035412716570633,2.21500559399647,38.091,21.792,64.335,57.232,60.7835,0.900499999999994,,30.841999999999995,22.692499999999995,gemcitabine,CHEMBL888,SDUQYLNIPVEERB-QPPQHZFASA-N,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F,C9H11F2N3O4,DB00441,D02368,gemcitabine,MK-2206,CHEMBL1079175,ULDXWLCXEDXJGE-UHFFFAOYSA-N,C1CC(C1)(C2=CC=C(C=C2)C3=C(C=C4C(=N3)C=CN5C4=NNC5=O)C6=CC=CC=C6)N,C25H21N5O,,,MK-2206,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
26197,14,26,28,uM,uM,-4.80755397024424,0.722117251397935,5.32619073166688,-4.07235570393527,0.0035412716570633,0.0047899367025841,38.091,57.817,60.718,68.165,64.4415,-31.4665,,16.487500000000004,6.624500000000005,gemcitabine,CHEMBL888,SDUQYLNIPVEERB-QPPQHZFASA-N,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F,C9H11F2N3O4,DB00441,D02368,gemcitabine,391210-10-9,CHEMBL507361,SUDAHWBOROXANE-SECBINFHSA-N,C1=CC(=C(C=C1I)F)NC2=C(C=CC(=C2F)F)C(=O)NOCC(CO)O,C16H14F3IN2O4,DB07101,,PD-0325901,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
26201,14,29,28,uM,uM,-3.77676047605476,-5.3110486922267,2.60347698166688,-3.70876582480499,0.0035412716570633,5.63752169768596,38.091,60.964,58.916,68.798,63.857,-35.198,,14.329499999999996,2.8930000000000007,gemcitabine,CHEMBL888,SDUQYLNIPVEERB-QPPQHZFASA-N,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F,C9H11F2N3O4,DB00441,D02368,gemcitabine,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
26205,14,30,28,uM,uM,10.3633492009358,9.52060698122002,19.4685849331412,10.4435309716434,0.0035412716570633,2.33877884349832,38.091,32.46,70.515,67.605,69.06,-1.491,,33.7845,30.969,gemcitabine,CHEMBL888,SDUQYLNIPVEERB-QPPQHZFASA-N,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F,C9H11F2N3O4,DB00441,D02368,gemcitabine,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
26209,14,31,28,uM,uM,12.1001463422404,-28.8533219549076,8.54734385694163,10.9515634125508,0.0035412716570633,28.1110621803845,38.091,-3.896,48.356,57.357,52.8565,18.6615,,35.759,14.765499999999996,gemcitabine,CHEMBL888,SDUQYLNIPVEERB-QPPQHZFASA-N,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F,C9H11F2N3O4,DB00441,D02368,gemcitabine,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
26313,15,2,28,uM,uM,7.37387191666185,-25.9251530283278,5.11478685694162,8.45456410399254,5.0,2.56897684420797,10.725,-4.166,4.616,92.336,48.476,41.917,,45.1965,37.751,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,Veliparib,CHEMBL506871,JNAHVYVRKWKWKQ-CYBMUJFWSA-N,CC1(CCCN1)C2=NC3=C(C=CC=C3N2)C(=O)N,C13H16N4O,DB07232,D09692,veliparib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
26317,15,4,28,uM,uM,6.77902577034573,11.0837715696938,13.2661783639675,8.00413850538442,5.0,0.0437439398816446,10.725,35.101,53.467,86.071,69.769,23.943,,46.85600000000001,34.668000000000006,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,915019-65-7,CHEMBL1879463,JOGKUKXHTYWRGZ-UHFFFAOYSA-N,CC(C)(C#N)C1=CC=C(C=C1)N2C3=C4C=C(C=CC4=NC=C3N(C2=O)C)C5=CC6=CC=CC=C6N=C5,C30H23N5O,DB11651,D10552,NVP-BEZ235,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
26321,15,5,28,uM,uM,2.83322832978447,-2.55741075380483,2.05916132141168,1.10945527281882,5.0,0.0036938532405762,10.725,52.363,54.897,91.706,73.3015,10.2135,,41.75750000000001,20.938500000000005,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
26325,15,8,28,uM,uM,8.88823847446169,12.3516729765636,13.8306906764675,8.18359261850608,5.0,0.118033389259186,10.725,43.276,46.355,93.409,69.882,15.881,,42.8815,26.606,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
26329,15,10,28,uM,uM,5.0957493206268,1.74193425250568,7.22479900591222,5.77361139172566,5.0,0.0075883401911804,10.725,38.464,69.223,86.242,77.7325,28.5435,,53.138000000000005,39.2685,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,Dinaciclib,CHEMBL2103840,PIMQWRZWLQKKBJ-SFHVURJKSA-N,CCC1=C2N=C(C=C(N2N=C1)NCC3=C[N+](=CC=C3)[O-])N4CCCCC4CCO,C21H28N6O2,DB12021,D09604,dinaciclib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
26333,15,12,28,uM,uM,4.15088388044471,4.36232965625612,8.69141563567537,5.72258180726204,5.0,5.0,10.725,9.298,54.919,92.33,73.6245,53.6015,,63.613,62.8995,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,Erlotinib,CHEMBL553,AAKJLRGGTJKAMG-UHFFFAOYSA-N,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,C22H23N3O4,DB00530,D07907,erlotinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
26337,15,36,28,uM,uM,1.56841713571981,-1.52137027159278,2.36269647011659,-0.270387336333497,5.0,0.0344118931374301,10.725,79.99,50.219,96.542,73.3805,-17.3345,,28.023000000000003,-6.609499999999997,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,geldanamycin,CHEMBL278315,QTQAWLPCGQOSGP-KSRBKZBZSA-N,CC1CC(C(C(C=C(C(C(C=CC=C(C(=O)NC2=CC(=O)C(=C(C1)C2=O)OC)C)OC)OC(=O)N)C)C)O)OC,C29H40N2O9,DB02424,C11222,geldanamycin,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
26341,15,16,28,uM,uM,9.73388669909799,14.8303988671108,16.0810131764675,11.4561048493464,5.0,2.21500559399647,10.725,21.792,59.271,93.275,76.273,43.756,,60.0145,54.481,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,MK-2206,CHEMBL1079175,ULDXWLCXEDXJGE-UHFFFAOYSA-N,C1CC(C1)(C2=CC=C(C=C2)C3=C(C=C4C(=N3)C=CN5C4=NNC5=O)C6=CC=CC=C6)N,C25H21N5O,,,MK-2206,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
26365,15,26,28,uM,uM,4.30364597979334,4.32187909077012,8.17948661220385,3.48477531937801,5.0,0.0047899367025841,10.725,57.817,57.982,96.13,77.056,8.514,,42.785,19.239,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,391210-10-9,CHEMBL507361,SUDAHWBOROXANE-SECBINFHSA-N,C1=CC(=C(C=C1I)F)NC2=C(C=CC(=C2F)F)C(=O)NOCC(CO)O,C16H14F3IN2O4,DB07101,,PD-0325901,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
26369,15,28,28,uM,uM,11.5279296149935,1.77184431993381,14.8788483231754,11.5546686651036,5.0,0.005,10.725,10.812,70.57,77.044,73.807,52.27,,63.0385,62.995000000000005,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
26373,15,29,28,uM,uM,2.35676002022113,-1.95417144448114,6.33332661220385,2.93667419161379,5.0,5.63752169768596,10.725,60.964,58.874,93.024,75.949,4.26000000000001,,40.1045,14.985,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
26381,23,2,28,uM,uM,2.01758960650081,-0.695677212052241,-0.18168089305839,3.97442926405774,232.787798280029,2.56897684420797,-0.982,-4.166,1.06,6.294,3.677,8.825,,6.251,4.659,metformin,CHEMBL1431,XZWYZXLIPXDOLR-UHFFFAOYSA-N,CN(C)C(=N)N=C(N)N,C4H11N5,DB00331,D04966,metformin,Veliparib,CHEMBL506871,JNAHVYVRKWKWKQ-CYBMUJFWSA-N,CC1(CCCN1)C2=NC3=C(C=CC=C3N2)C(=O)N,C13H16N4O,DB07232,D09692,veliparib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
26385,23,3,28,uM,uM,10.8106094035208,-8.17990086072418,13.4569574872039,14.0577959624468,232.787798280029,0.272102312999941,-0.982,24.091,67.664,44.108,55.886,32.777,,44.331500000000005,31.795,metformin,CHEMBL1431,XZWYZXLIPXDOLR-UHFFFAOYSA-N,CN(C)C(=N)N=C(N)N,C4H11N5,DB00331,D04966,metformin,MK-1775,CHEMBL1976040,BKWJAKQVGHWELA-UHFFFAOYSA-N,CC(C)(C1=NC(=CC=C1)N2C3=NC(=NC=C3C(=O)N2CC=C)NC4=CC=C(C=C4)N5CCN(CC5)C)O,C27H32N8O2,DB11740,,MK-1775,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
26389,23,4,28,uM,uM,5.86224548925619,-14.6007028529978,5.81941147011656,5.71517794862651,232.787798280029,0.0437439398816446,-0.982,35.101,40.485,52.231,46.358,12.239,,29.2985,11.256999999999998,metformin,CHEMBL1431,XZWYZXLIPXDOLR-UHFFFAOYSA-N,CN(C)C(=N)N=C(N)N,C4H11N5,DB00331,D04966,metformin,915019-65-7,CHEMBL1879463,JOGKUKXHTYWRGZ-UHFFFAOYSA-N,CC(C)(C#N)C1=CC=C(C=C1)N2C3=C4C=C(C=CC4=NC=C3N(C2=O)C)C5=CC6=CC=CC=C6N=C5,C30H23N5O,DB11651,D10552,NVP-BEZ235,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
26393,23,5,28,uM,uM,0.351655878329589,-8.53114316301644,-1.41948080029613,-0.820093893637047,232.787798280029,0.0036938532405762,-0.982,52.363,40.117,45.815,42.966,-8.41500000000001,,17.2755,-9.396999999999998,metformin,CHEMBL1431,XZWYZXLIPXDOLR-UHFFFAOYSA-N,CN(C)C(=N)N=C(N)N,C4H11N5,DB00331,D04966,metformin,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
26397,23,8,28,uM,uM,2.92676664042748,-24.0084849030027,2.6916464686263,2.53503597819253,232.787798280029,0.118033389259186,-0.982,43.276,40.667,48.734,44.7005,2.4065,,23.5535,1.4244999999999948,metformin,CHEMBL1431,XZWYZXLIPXDOLR-UHFFFAOYSA-N,CN(C)C(=N)N=C(N)N,C4H11N5,DB00331,D04966,metformin,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
26401,23,10,28,uM,uM,0.383065883635682,-26.1570783520842,-2.15868186908777,-0.303046085847623,232.787798280029,0.0075883401911804,-0.982,38.464,25.674,35.88,30.777,-6.705,,12.036,-7.686999999999998,metformin,CHEMBL1431,XZWYZXLIPXDOLR-UHFFFAOYSA-N,CN(C)C(=N)N=C(N)N,C4H11N5,DB00331,D04966,metformin,Dinaciclib,CHEMBL2103840,PIMQWRZWLQKKBJ-SFHVURJKSA-N,CCC1=C2N=C(C=C(N2N=C1)NCC3=C[N+](=CC=C3)[O-])N4CCCCC4CCO,C21H28N6O2,DB12021,D09604,dinaciclib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
26405,23,12,28,uM,uM,-4.62078730991392,-19.8943076547542,0.757002580953864,1.30233168333032,232.787798280029,5.0,-0.982,9.298,39.495,16.784,28.1395,19.8235,,23.9815,18.841500000000003,metformin,CHEMBL1431,XZWYZXLIPXDOLR-UHFFFAOYSA-N,CN(C)C(=N)N=C(N)N,C4H11N5,DB00331,D04966,metformin,Erlotinib,CHEMBL553,AAKJLRGGTJKAMG-UHFFFAOYSA-N,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,C22H23N3O4,DB00530,D07907,erlotinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
26409,23,36,28,uM,uM,-0.666105952275394,-24.0429842452969,-5.24936353137367,-5.32120801478214,232.787798280029,0.0344118931374301,-0.982,79.99,5.564,78.148,41.856,-37.152,,2.352000000000004,-38.13399999999999,metformin,CHEMBL1431,XZWYZXLIPXDOLR-UHFFFAOYSA-N,CN(C)C(=N)N=C(N)N,C4H11N5,DB00331,D04966,metformin,geldanamycin,CHEMBL278315,QTQAWLPCGQOSGP-KSRBKZBZSA-N,CC1CC(C(C(C=C(C(C(C=CC=C(C(=O)NC2=CC(=O)C(=C(C1)C2=O)OC)C)OC)OC(=O)N)C)C)O)OC,C29H40N2O9,DB02424,C11222,geldanamycin,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
26417,23,15,28,uM,uM,-1.54982422173639,-16.2782894511294,-1.34091879038244,-0.95958525914174,232.787798280029,4.18286321924403,-0.982,10.617,51.666,16.655,34.1605,24.5255,,29.343,23.5435,metformin,CHEMBL1431,XZWYZXLIPXDOLR-UHFFFAOYSA-N,CN(C)C(=N)N=C(N)N,C4H11N5,DB00331,D04966,metformin,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
26421,23,16,28,uM,uM,2.79062710382709,-21.3524897844234,3.43104628261656,3.23950235592023,232.787798280029,2.21500559399647,-0.982,21.792,40.453,28.3,34.3765,13.5665,,23.9715,12.584499999999998,metformin,CHEMBL1431,XZWYZXLIPXDOLR-UHFFFAOYSA-N,CN(C)C(=N)N=C(N)N,C4H11N5,DB00331,D04966,metformin,MK-2206,CHEMBL1079175,ULDXWLCXEDXJGE-UHFFFAOYSA-N,C1CC(C1)(C2=CC=C(C=C2)C3=C(C=C4C(=N3)C=CN5C4=NNC5=O)C6=CC=CC=C6)N,C25H21N5O,,,MK-2206,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
26441,23,26,28,uM,uM,-3.79631947499029,-44.4701607406163,-8.6026485313737,-8.72147477001381,232.787798280029,0.0047899367025841,-0.982,57.817,30.565,54.727,42.646,-14.189,,14.2285,-15.171,metformin,CHEMBL1431,XZWYZXLIPXDOLR-UHFFFAOYSA-N,CN(C)C(=N)N=C(N)N,C4H11N5,DB00331,D04966,metformin,391210-10-9,CHEMBL507361,SUDAHWBOROXANE-SECBINFHSA-N,C1=CC(=C(C=C1I)F)NC2=C(C=CC(=C2F)F)C(=O)NOCC(CO)O,C16H14F3IN2O4,DB07101,,PD-0325901,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
26445,23,29,28,uM,uM,-0.124576011505919,-33.8435204371973,0.853388968626302,0.742404021407349,232.787798280029,5.63752169768596,-0.982,60.964,48.033,65.178,56.6055,-3.3765,,26.6145,-4.358499999999999,metformin,CHEMBL1431,XZWYZXLIPXDOLR-UHFFFAOYSA-N,CN(C)C(=N)N=C(N)N,C4H11N5,DB00331,D04966,metformin,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
26449,23,30,28,uM,uM,8.57917003691566,-16.4181847450579,12.3859978451166,12.2853059488471,232.787798280029,2.33877884349832,-0.982,32.46,47.858,50.597,49.2275,17.7495,,33.4885,16.7675,metformin,CHEMBL1431,XZWYZXLIPXDOLR-UHFFFAOYSA-N,CN(C)C(=N)N=C(N)N,C4H11N5,DB00331,D04966,metformin,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
26453,23,31,28,uM,uM,1.90782807906806,-7.95164030020698,-4.70541834926673,-0.683801610014348,232.787798280029,28.1110621803845,-0.982,-3.896,-4.147,-3.981,-4.064,0.814,,-1.625,-3.082,metformin,CHEMBL1431,XZWYZXLIPXDOLR-UHFFFAOYSA-N,CN(C)C(=N)N=C(N)N,C4H11N5,DB00331,D04966,metformin,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
26457,23,35,28,uM,uM,0.522087802499599,-25.710699396736,0.174094282616561,0.335284276893055,232.787798280029,1.76535402335707,-0.982,34.787,73.215,40.783,56.999,23.194,,40.096500000000006,22.212000000000003,metformin,CHEMBL1431,XZWYZXLIPXDOLR-UHFFFAOYSA-N,CN(C)C(=N)N=C(N)N,C4H11N5,DB00331,D04966,metformin,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
26621,16,2,28,uM,uM,2.23652798349072,-15.2112561440178,1.53102460694162,4.75186661909236,2.21645036647099,2.56897684420797,21.792,-4.166,22.103,39.93,31.0165,13.3905,,22.2035,9.2245,MK-2206,CHEMBL1079175,ULDXWLCXEDXJGE-UHFFFAOYSA-N,C1CC(C1)(C2=CC=C(C=C2)C3=C(C=C4C(=N3)C=CN5C4=NNC5=O)C6=CC=CC=C6)N,C25H21N5O,,,MK-2206,Veliparib,CHEMBL506871,JNAHVYVRKWKWKQ-CYBMUJFWSA-N,CC1(CCCN1)C2=NC3=C(C=CC=C3N2)C(=O)N,C13H16N4O,DB07232,D09692,veliparib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
26625,16,4,28,uM,uM,1.84431979146789,8.38943357538919,10.3656292246851,1.09564964464275,2.21645036647099,0.0437439398816446,21.792,35.101,57.167,61.555,59.361,2.468,,30.9145,24.26,MK-2206,CHEMBL1079175,ULDXWLCXEDXJGE-UHFFFAOYSA-N,C1CC(C1)(C2=CC=C(C=C2)C3=C(C=C4C(=N3)C=CN5C4=NNC5=O)C6=CC=CC=C6)N,C25H21N5O,,,MK-2206,915019-65-7,CHEMBL1879463,JOGKUKXHTYWRGZ-UHFFFAOYSA-N,CC(C)(C#N)C1=CC=C(C=C1)N2C3=C4C=C(C=CC4=NC=C3N(C2=O)C)C5=CC6=CC=CC=C6N=C5,C30H23N5O,DB11651,D10552,NVP-BEZ235,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
26629,16,5,28,uM,uM,-1.58840665747579,-5.0631522012939,-2.37071980358831,-3.31859515802139,2.21645036647099,0.0036938532405762,21.792,52.363,35.689,67.779,51.734,-22.421,,14.6565,-0.6289999999999978,MK-2206,CHEMBL1079175,ULDXWLCXEDXJGE-UHFFFAOYSA-N,C1CC(C1)(C2=CC=C(C=C2)C3=C(C=C4C(=N3)C=CN5C4=NNC5=O)C6=CC=CC=C6)N,C25H21N5O,,,MK-2206,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
26633,16,8,28,uM,uM,12.9613208514447,22.1867854397358,23.5700468778797,12.7605676826544,2.21645036647099,0.118033389259186,21.792,43.276,66.761,79.647,73.204,8.136,,40.66999999999999,29.92799999999999,MK-2206,CHEMBL1079175,ULDXWLCXEDXJGE-UHFFFAOYSA-N,C1CC(C1)(C2=CC=C(C=C2)C3=C(C=C4C(=N3)C=CN5C4=NNC5=O)C6=CC=CC=C6)N,C25H21N5O,,,MK-2206,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
26637,16,10,28,uM,uM,-1.2881430417687,-1.27140188026047,0.914997696411686,-0.860126433196846,2.21645036647099,0.0075883401911804,21.792,38.464,43.02,66.618,54.819,-5.437,,24.691000000000003,16.355000000000004,MK-2206,CHEMBL1079175,ULDXWLCXEDXJGE-UHFFFAOYSA-N,C1CC(C1)(C2=CC=C(C=C2)C3=C(C=C4C(=N3)C=CN5C4=NNC5=O)C6=CC=CC=C6)N,C25H21N5O,,,MK-2206,Dinaciclib,CHEMBL2103840,PIMQWRZWLQKKBJ-SFHVURJKSA-N,CCC1=C2N=C(C=C(N2N=C1)NCC3=C[N+](=CC=C3)[O-])N4CCCCC4CCO,C21H28N6O2,DB12021,D09604,dinaciclib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
26641,16,12,28,uM,uM,16.2825480122217,19.2689964921365,21.5995029157124,15.9928171917465,2.21645036647099,5.0,21.792,9.298,67.611,65.274,66.4425,35.3525,,50.8975,44.6505,MK-2206,CHEMBL1079175,ULDXWLCXEDXJGE-UHFFFAOYSA-N,C1CC(C1)(C2=CC=C(C=C2)C3=C(C=C4C(=N3)C=CN5C4=NNC5=O)C6=CC=CC=C6)N,C25H21N5O,,,MK-2206,Erlotinib,CHEMBL553,AAKJLRGGTJKAMG-UHFFFAOYSA-N,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,C22H23N3O4,DB00530,D07907,erlotinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
26645,16,36,28,uM,uM,0.0766729907940836,-0.415095480445555,2.99314611079245,-1.6673590473021,2.21645036647099,0.0344118931374301,21.792,79.99,48.721,88.524,68.6225,-33.1595,,17.731500000000004,-11.367499999999993,MK-2206,CHEMBL1079175,ULDXWLCXEDXJGE-UHFFFAOYSA-N,C1CC(C1)(C2=CC=C(C=C2)C3=C(C=C4C(=N3)C=CN5C4=NNC5=O)C6=CC=CC=C6)N,C25H21N5O,,,MK-2206,geldanamycin,CHEMBL278315,QTQAWLPCGQOSGP-KSRBKZBZSA-N,CC1CC(C(C(C=C(C(C(C=CC=C(C(=O)NC2=CC(=O)C(=C(C1)C2=O)OC)C)OC)OC(=O)N)C)C)O)OC,C29H40N2O9,DB02424,C11222,geldanamycin,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
26661,16,26,28,uM,uM,2.25862630639618,2.5510793467724,9.25286486079242,1.09942943528306,2.21645036647099,0.0047899367025841,21.792,57.817,65.214,79.643,72.4285,-7.18050000000001,,32.623999999999995,14.6115,MK-2206,CHEMBL1079175,ULDXWLCXEDXJGE-UHFFFAOYSA-N,C1CC(C1)(C2=CC=C(C=C2)C3=C(C=C4C(=N3)C=CN5C4=NNC5=O)C6=CC=CC=C6)N,C25H21N5O,,,MK-2206,391210-10-9,CHEMBL507361,SUDAHWBOROXANE-SECBINFHSA-N,C1=CC(=C(C=C1I)F)NC2=C(C=CC(=C2F)F)C(=O)NOCC(CO)O,C16H14F3IN2O4,DB07101,,PD-0325901,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
26665,16,28,28,uM,uM,4.01578637162495,8.82211341238093,11.3983406628041,6.47756344925026,2.21645036647099,0.005,21.792,10.812,66.458,49.607,58.0325,25.4285,,41.7305,36.2405,MK-2206,CHEMBL1079175,ULDXWLCXEDXJGE-UHFFFAOYSA-N,C1CC(C1)(C2=CC=C(C=C2)C3=C(C=C4C(=N3)C=CN5C4=NNC5=O)C6=CC=CC=C6)N,C25H21N5O,,,MK-2206,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
26669,16,29,28,uM,uM,5.45635019934669,7.75978244363719,12.0051089333067,5.69033903847847,2.21645036647099,5.63752169768596,21.792,60.964,70.981,81.937,76.459,-6.297,,35.081,15.495000000000005,MK-2206,CHEMBL1079175,ULDXWLCXEDXJGE-UHFFFAOYSA-N,C1CC(C1)(C2=CC=C(C=C2)C3=C(C=C4C(=N3)C=CN5C4=NNC5=O)C6=CC=CC=C6)N,C25H21N5O,,,MK-2206,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
27217,26,2,28,uM,uM,0.0988805892415956,-40.1937196739758,-5.22163789305837,-3.4068198861242,0.0047902568642387,2.56897684420797,57.817,-4.166,53.721,40.83,47.2755,-6.3755,,20.450000000000003,-10.5415,391210-10-9,CHEMBL507361,SUDAHWBOROXANE-SECBINFHSA-N,C1=CC(=C(C=C1I)F)NC2=C(C=CC(=C2F)F)C(=O)NOCC(CO)O,C16H14F3IN2O4,DB07101,,PD-0325901,Veliparib,CHEMBL506871,JNAHVYVRKWKWKQ-CYBMUJFWSA-N,CC1(CCCN1)C2=NC3=C(C=CC=C3N2)C(=O)N,C13H16N4O,DB07232,D09692,veliparib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
27221,26,4,28,uM,uM,1.04824260615478,5.02597928266995,10.3121608881327,0.522782734541684,0.0047902568642387,0.0437439398816446,57.817,35.101,74.682,68.033,71.3575,-21.5605,,24.8985,13.540500000000002,391210-10-9,CHEMBL507361,SUDAHWBOROXANE-SECBINFHSA-N,C1=CC(=C(C=C1I)F)NC2=C(C=CC(=C2F)F)C(=O)NOCC(CO)O,C16H14F3IN2O4,DB07101,,PD-0325901,915019-65-7,CHEMBL1879463,JOGKUKXHTYWRGZ-UHFFFAOYSA-N,CC(C)(C#N)C1=CC=C(C=C1)N2C3=C4C=C(C=CC4=NC=C3N(C2=O)C)C5=CC6=CC=CC=C6N=C5,C30H23N5O,DB11651,D10552,NVP-BEZ235,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
27225,26,5,28,uM,uM,-2.69193184001549,-8.21843319495025,-5.29658230358831,-6.22281562791129,0.0047902568642387,0.0036938532405762,57.817,52.363,64.292,67.937,66.1145,-44.0655,,11.024500000000003,8.297500000000007,391210-10-9,CHEMBL507361,SUDAHWBOROXANE-SECBINFHSA-N,C1=CC(=C(C=C1I)F)NC2=C(C=CC(=C2F)F)C(=O)NOCC(CO)O,C16H14F3IN2O4,DB07101,,PD-0325901,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
27229,26,8,28,uM,uM,5.88126033857638,10.7959504731723,17.334402094695,5.56621608567325,0.0047902568642387,0.118033389259186,57.817,43.276,82.983,80.102,81.5425,-19.5505,,30.996,23.725500000000004,391210-10-9,CHEMBL507361,SUDAHWBOROXANE-SECBINFHSA-N,C1=CC(=C(C=C1I)F)NC2=C(C=CC(=C2F)F)C(=O)NOCC(CO)O,C16H14F3IN2O4,DB07101,,PD-0325901,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
27233,26,10,28,uM,uM,-2.68941874725253,-3.1951071108279,0.191236155424694,-3.8959979962321,0.0047902568642387,0.0075883401911804,57.817,38.464,58.395,59.148,58.7715,-37.5095,,10.631,0.954500000000003,391210-10-9,CHEMBL507361,SUDAHWBOROXANE-SECBINFHSA-N,C1=CC(=C(C=C1I)F)NC2=C(C=CC(=C2F)F)C(=O)NOCC(CO)O,C16H14F3IN2O4,DB07101,,PD-0325901,Dinaciclib,CHEMBL2103840,PIMQWRZWLQKKBJ-SFHVURJKSA-N,CCC1=C2N=C(C=C(N2N=C1)NCC3=C[N+](=CC=C3)[O-])N4CCCCC4CCO,C21H28N6O2,DB12021,D09604,dinaciclib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
27237,26,36,28,uM,uM,-1.28724142232337,1.79792838400501,4.46331018330672,-2.09683968167324,0.0047902568642387,0.0344118931374301,57.817,79.99,72.379,88.095,80.237,-57.57,,11.3335,0.2469999999999999,391210-10-9,CHEMBL507361,SUDAHWBOROXANE-SECBINFHSA-N,C1=CC(=C(C=C1I)F)NC2=C(C=CC(=C2F)F)C(=O)NOCC(CO)O,C16H14F3IN2O4,DB07101,,PD-0325901,geldanamycin,CHEMBL278315,QTQAWLPCGQOSGP-KSRBKZBZSA-N,CC1CC(C(C(C=C(C(C(C=CC=C(C(=O)NC2=CC(=O)C(=C(C1)C2=O)OC)C)OC)OC(=O)N)C)C)O)OC,C29H40N2O9,DB02424,C11222,geldanamycin,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
27253,26,28,28,uM,uM,-3.56616590680223,-5.76393560121037,-1.11220038931034,-5.70467823282969,0.0047902568642387,0.005,57.817,10.812,71.555,42.059,56.807,-11.822,,22.4925,-1.009999999999998,391210-10-9,CHEMBL507361,SUDAHWBOROXANE-SECBINFHSA-N,C1=CC(=C(C=C1I)F)NC2=C(C=CC(=C2F)F)C(=O)NOCC(CO)O,C16H14F3IN2O4,DB07101,,PD-0325901,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
27257,26,29,28,uM,uM,-3.28349643701537,-1.61416297884934,3.58409816021012,-3.56078865957641,0.0047902568642387,5.63752169768596,57.817,60.964,72.956,74.437,73.6965,-45.0845,,14.305999999999996,12.732500000000002,391210-10-9,CHEMBL507361,SUDAHWBOROXANE-SECBINFHSA-N,C1=CC(=C(C=C1I)F)NC2=C(C=CC(=C2F)F)C(=O)NOCC(CO)O,C16H14F3IN2O4,DB07101,,PD-0325901,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
27265,28,10,28,uM,uM,-2.12665824682048,-7.48930809661064,-1.09884990031489,-1.73584898980424,0.005,0.0075883401911804,10.961,38.464,46.822,61.642,54.232,4.807,,29.5195,15.768,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,Dinaciclib,CHEMBL2103840,PIMQWRZWLQKKBJ-SFHVURJKSA-N,CCC1=C2N=C(C=C(N2N=C1)NCC3=C[N+](=CC=C3)[O-])N4CCCCC4CCO,C21H28N6O2,DB12021,D09604,dinaciclib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
27273,28,29,28,uM,uM,-1.27406700070212,-6.59214500632011,3.27766161220385,-0.163411476510002,0.005,5.63752169768596,10.961,60.964,52.353,73.874,63.1135,-8.8115,,27.151000000000003,2.149500000000004,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
27277,29,10,28,uM,uM,-0.911225831141835,-6.23707563493501,0.671626747274682,-1.81909523708025,5.63768165117687,0.0075883401911804,60.964,38.464,67.91,63.251,65.5805,-33.8475,,15.866500000000002,4.616500000000002,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,Dinaciclib,CHEMBL2103840,PIMQWRZWLQKKBJ-SFHVURJKSA-N,CCC1=C2N=C(C=C(N2N=C1)NCC3=C[N+](=CC=C3)[O-])N4CCCCC4CCO,C21H28N6O2,DB12021,D09604,dinaciclib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
27285,30,2,28,uM,uM,18.8010580586616,-8.1827899368929,15.9972433569416,18.7681496962765,2.33851736233564,2.56897684420797,32.46,-4.166,49.789,60.669,55.229,26.935,,41.082,22.769,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,Veliparib,CHEMBL506871,JNAHVYVRKWKWKQ-CYBMUJFWSA-N,CC1(CCCN1)C2=NC3=C(C=CC=C3N2)C(=O)N,C13H16N4O,DB07232,D09692,veliparib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
27289,30,3,28,uM,uM,10.4625745789751,3.76808026081052,15.4950842804247,11.330448737003,2.33851736233564,0.272102312999941,32.46,24.091,69.874,65.757,67.8155,11.2645,,39.54,35.3555,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,MK-1775,CHEMBL1976040,BKWJAKQVGHWELA-UHFFFAOYSA-N,CC(C)(C1=NC(=CC=C1)N2C3=NC(=NC=C3C(=O)N2CC=C)NC4=CC=C(C=C4)N5CCN(CC5)C)O,C27H32N8O2,DB11740,,MK-1775,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
27293,30,4,28,uM,uM,15.4799019134776,20.2604538228131,25.2883879834306,15.4129778126188,2.33851736233564,0.0437439398816446,32.46,35.101,76.008,77.9,76.954,9.393,,43.17349999999999,41.853,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,915019-65-7,CHEMBL1879463,JOGKUKXHTYWRGZ-UHFFFAOYSA-N,CC(C)(C#N)C1=CC=C(C=C1)N2C3=C4C=C(C=CC4=NC=C3N(C2=O)C)C5=CC6=CC=CC=C6N=C5,C30H23N5O,DB11651,D10552,NVP-BEZ235,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
27297,30,5,28,uM,uM,4.90552201658387,0.687899941217626,7.05129582141169,6.11034603961646,2.33851736233564,0.0036938532405762,32.46,52.363,64.22,71.307,67.7635,-17.0595,,25.35199999999999,15.400499999999994,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
27301,30,8,28,uM,uM,15.5773024157651,23.4829027168924,27.3184188484163,15.660355118465,2.33851736233564,0.118033389259186,32.46,43.276,77.701,85.945,81.823,6.08699999999999,,43.95499999999999,38.54699999999999,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
27305,30,10,28,uM,uM,11.3294603743972,8.33950063979475,15.0848258214117,12.1949589930855,2.33851736233564,0.0075883401911804,32.46,38.464,81.199,75.572,78.3855,7.4615,,42.92349999999999,39.9215,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,Dinaciclib,CHEMBL2103840,PIMQWRZWLQKKBJ-SFHVURJKSA-N,CCC1=C2N=C(C=C(N2N=C1)NCC3=C[N+](=CC=C3)[O-])N4CCCCC4CCO,C21H28N6O2,DB12021,D09604,dinaciclib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
27309,30,12,28,uM,uM,15.7170683967564,15.6020836640827,21.616923146748,16.5008639669811,2.33851736233564,5.0,32.46,9.298,73.942,63.541,68.7415,26.9835,,47.8625,36.2815,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,Erlotinib,CHEMBL553,AAKJLRGGTJKAMG-UHFFFAOYSA-N,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,C22H23N3O4,DB00530,D07907,erlotinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
27313,30,36,28,uM,uM,4.56111872749191,3.08328062991419,9.23427798579245,4.18222416322101,2.33851736233564,0.0344118931374301,32.46,79.99,74.888,88.899,81.8935,-30.5565,,25.66850000000001,1.903500000000008,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,geldanamycin,CHEMBL278315,QTQAWLPCGQOSGP-KSRBKZBZSA-N,CC1CC(C(C(C=C(C(C(C=CC=C(C(=O)NC2=CC(=O)C(=C(C1)C2=O)OC)C)OC)OC(=O)N)C)C)O)OC,C29H40N2O9,DB02424,C11222,geldanamycin,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
27317,30,15,28,uM,uM,14.099434586949,14.4919546899859,20.3422253503041,15.1625982168228,2.33851736233564,4.18286321924403,32.46,10.617,80.509,60.585,70.547,27.47,,49.0085,38.087,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
27321,30,16,28,uM,uM,15.6460502557045,21.3314810627476,25.1191348516768,16.015021956257,2.33851736233564,2.21500559399647,32.46,21.792,75.212,69.684,72.448,18.196,,45.32199999999999,39.98799999999999,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,MK-2206,CHEMBL1079175,ULDXWLCXEDXJGE-UHFFFAOYSA-N,C1CC(C1)(C2=CC=C(C=C2)C3=C(C=C4C(=N3)C=CN5C4=NNC5=O)C6=CC=CC=C6)N,C25H21N5O,,,MK-2206,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
27345,30,26,28,uM,uM,4.43355247979621,7.57865279352206,13.9104175028797,4.63762894851087,2.33851736233564,0.0047899367025841,32.46,57.817,69.351,77.52,73.4355,-16.8415,,28.297000000000004,15.618500000000004,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,391210-10-9,CHEMBL507361,SUDAHWBOROXANE-SECBINFHSA-N,C1=CC(=C(C=C1I)F)NC2=C(C=CC(=C2F)F)C(=O)NOCC(CO)O,C16H14F3IN2O4,DB07101,,PD-0325901,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
27349,30,28,28,uM,uM,8.497935368894,4.69415906982223,13.1526121921541,8.16781766652829,2.33851736233564,0.005,32.46,10.812,68.165,57.397,62.781,19.509,,41.145,30.321,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
27353,30,29,28,uM,uM,2.88609019386619,-0.470309495928306,9.88783532539398,3.26697518387815,2.33851736233564,5.63752169768596,32.46,60.964,71.209,79.472,75.3405,-18.0835,,28.628500000000003,14.376500000000007,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
27357,30,31,28,uM,uM,18.7293289906661,-26.141689454612,16.2521183569416,18.8390264083119,2.33851736233564,28.1110621803845,32.46,-3.896,48.575,58.361,53.468,24.904,,39.18600000000001,21.008000000000003,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
27365,31,2,28,uM,uM,10.7506329888215,9.04130879753137,7.25998455305233,12.2727629478638,28.1241791687305,2.56897684420797,-3.897,-4.166,1.666,-4.848,-1.591,6.472,,2.4405,2.306,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,Veliparib,CHEMBL506871,JNAHVYVRKWKWKQ-CYBMUJFWSA-N,CC1(CCCN1)C2=NC3=C(C=CC=C3N2)C(=O)N,C13H16N4O,DB07232,D09692,veliparib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
27369,31,3,28,uM,uM,7.91380897025526,-62.9956603801272,6.00114646862632,8.76614082692262,28.1241791687305,0.272102312999941,-3.897,24.091,60.285,31.733,46.009,25.815,,35.912,21.918,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,MK-1775,CHEMBL1976040,BKWJAKQVGHWELA-UHFFFAOYSA-N,CC(C)(C1=NC(=CC=C1)N2C3=NC(=NC=C3C(=O)N2CC=C)NC4=CC=C(C=C4)N5CCN(CC5)C)O,C27H32N8O2,DB11740,,MK-1775,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
27373,31,4,28,uM,uM,5.32021564486988,-34.4260208840676,1.18117171862631,3.7058068490676,28.1241791687305,0.0437439398816446,-3.897,35.101,43.28,36.785,40.0325,8.8285,,24.4305,4.9315,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,915019-65-7,CHEMBL1879463,JOGKUKXHTYWRGZ-UHFFFAOYSA-N,CC(C)(C#N)C1=CC=C(C=C1)N2C3=C4C=C(C=CC4=NC=C3N(C2=O)C)C5=CC6=CC=CC=C6N=C5,C30H23N5O,DB11651,D10552,NVP-BEZ235,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
27377,31,5,28,uM,uM,5.02622736471019,-46.7124301178215,2.05516541862632,3.99807908437952,28.1241791687305,0.0036938532405762,-3.897,52.363,38.98,40.392,39.686,-8.78,,15.453,-12.677,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
27381,31,8,28,uM,uM,-1.05919236481687,-32.1091192440526,-6.7819160313737,-4.54881609119535,28.1241791687305,0.118033389259186,-3.897,43.276,26.096,33.613,29.8545,-9.5245,,10.165,-13.421500000000002,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
27385,31,10,28,uM,uM,0.803962544110452,-48.2654698336006,-2.37101938617507,0.765206342133808,28.1241791687305,0.0075883401911804,-3.897,38.464,14.196,35.924,25.06,-9.507,,7.776499999999999,-13.404,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,Dinaciclib,CHEMBL2103840,PIMQWRZWLQKKBJ-SFHVURJKSA-N,CCC1=C2N=C(C=C(N2N=C1)NCC3=C[N+](=CC=C3)[O-])N4CCCCC4CCO,C21H28N6O2,DB12021,D09604,dinaciclib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
27389,31,12,28,uM,uM,-0.319112261779827,-73.4949285810713,-7.57218990637368,-4.18154304685489,28.1241791687305,5.0,-3.897,9.298,44.587,5.405,24.996,19.595,,22.2955,15.698,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,Erlotinib,CHEMBL553,AAKJLRGGTJKAMG-UHFFFAOYSA-N,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,C22H23N3O4,DB00530,D07907,erlotinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
27393,31,36,28,uM,uM,2.17813018446605,-20.6345641104274,-1.84136353137367,-0.816937190856922,28.1241791687305,0.0344118931374301,-3.897,79.99,39.067,79.379,59.223,-16.87,,21.176500000000004,-20.767,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,geldanamycin,CHEMBL278315,QTQAWLPCGQOSGP-KSRBKZBZSA-N,CC1CC(C(C(C=C(C(C(C=CC=C(C(=O)NC2=CC(=O)C(=C(C1)C2=O)OC)C)OC)OC(=O)N)C)C)O)OC,C29H40N2O9,DB02424,C11222,geldanamycin,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
27397,31,15,28,uM,uM,6.21786476743775,-62.9120023141713,3.85258871862633,6.97064834106852,28.1241791687305,4.18286321924403,-3.897,10.617,29.301,11.165,20.233,13.513,,16.873,9.616,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
27401,31,16,28,uM,uM,3.08099740118046,-34.4347195075566,-1.09254853137369,1.91447150230342,28.1241791687305,2.21500559399647,-3.897,21.792,37.65,19.597,28.6235,10.7285,,19.676,6.831499999999998,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,MK-2206,CHEMBL1079175,ULDXWLCXEDXJGE-UHFFFAOYSA-N,C1CC(C1)(C2=CC=C(C=C2)C3=C(C=C4C(=N3)C=CN5C4=NNC5=O)C6=CC=CC=C6)N,C25H21N5O,,,MK-2206,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
27425,31,26,28,uM,uM,1.51166011605769,-37.2007425022585,-1.4233360313737,0.271000444196319,28.1241791687305,0.0047899367025841,-3.897,57.817,44.135,56.86,50.4975,-3.4225,,23.5375,-7.319499999999998,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,391210-10-9,CHEMBL507361,SUDAHWBOROXANE-SECBINFHSA-N,C1=CC(=C(C=C1I)F)NC2=C(C=CC(=C2F)F)C(=O)NOCC(CO)O,C16H14F3IN2O4,DB07101,,PD-0325901,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
27429,31,28,28,uM,uM,0.326437564824278,-88.082812192237,-2.84450378137368,0.471964559473755,28.1241791687305,0.005,-3.897,10.812,48.543,2.017,25.28,18.365,,21.8225,14.468000000000002,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
27433,31,29,28,uM,uM,-0.244229526821314,-36.2727665215717,-1.9724235313737,-0.389895577410399,28.1241791687305,5.63752169768596,-3.897,60.964,44.557,58.245,51.401,-5.666,,22.867500000000003,-9.562999999999995,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
27613,35,2,28,uM,uM,6.84728697700126,-33.620797768977,5.77478610694162,8.30421990725482,1.76624592313096,2.56897684420797,34.787,-4.166,42.187,77.293,59.74,29.119,,44.4295,24.953000000000003,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,Veliparib,CHEMBL506871,JNAHVYVRKWKWKQ-CYBMUJFWSA-N,CC1(CCCN1)C2=NC3=C(C=CC=C3N2)C(=O)N,C13H16N4O,DB07232,D09692,veliparib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
27617,35,3,28,uM,uM,1.94553537026095,-2.16598677230497,5.31372062227468,2.60944447834291,1.76624592313096,0.272102312999941,34.787,24.091,64.028,85.764,74.896,16.018,,45.457,40.109,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,MK-1775,CHEMBL1976040,BKWJAKQVGHWELA-UHFFFAOYSA-N,CC(C)(C1=NC(=CC=C1)N2C3=NC(=NC=C3C(=O)N2CC=C)NC4=CC=C(C=C4)N5CCN(CC5)C)O,C27H32N8O2,DB11740,,MK-1775,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
27621,35,4,28,uM,uM,7.01073067336136,9.84033163144117,13.4942611084306,7.56104148654919,1.76624592313096,0.0437439398816446,34.787,35.101,71.267,82.588,76.9275,7.03949999999999,,41.98349999999999,41.8265,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,915019-65-7,CHEMBL1879463,JOGKUKXHTYWRGZ-UHFFFAOYSA-N,CC(C)(C#N)C1=CC=C(C=C1)N2C3=C4C=C(C=CC4=NC=C3N(C2=O)C)C5=CC6=CC=CC=C6N=C5,C30H23N5O,DB11651,D10552,NVP-BEZ235,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
27625,35,5,28,uM,uM,1.67061201488785,-2.4580487001329,2.18527593779643,1.36252174728851,1.76624592313096,0.0036938532405762,34.787,52.363,80.182,89.258,84.72,-2.43000000000001,,41.145,32.357,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
27629,35,8,28,uM,uM,-1.85985432995482,2.20088594971596,5.2377125984163,-1.60555203808381,1.76624592313096,0.118033389259186,34.787,43.276,55.794,84.822,70.308,-7.75500000000001,,31.27650000000001,27.032000000000004,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
27633,35,10,28,uM,uM,-1.60283490686935,-6.11033781048235,-1.26003037293989,-2.63278237496532,1.76624592313096,0.0075883401911804,34.787,38.464,42.431,85.756,64.0935,-9.1575,,27.468000000000004,25.629500000000007,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,Dinaciclib,CHEMBL2103840,PIMQWRZWLQKKBJ-SFHVURJKSA-N,CCC1=C2N=C(C=C(N2N=C1)NCC3=C[N+](=CC=C3)[O-])N4CCCCC4CCO,C21H28N6O2,DB12021,D09604,dinaciclib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
27637,35,12,28,uM,uM,-1.4137231191705,-0.372928390505962,4.20986889674799,0.769263080369905,1.76624592313096,5.0,34.787,9.298,60.664,70.444,65.554,21.469,,43.5115,30.767000000000003,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,Erlotinib,CHEMBL553,AAKJLRGGTJKAMG-UHFFFAOYSA-N,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,C22H23N3O4,DB00530,D07907,erlotinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
27641,35,36,28,uM,uM,-0.451916795287584,-2.34794348135302,1.50162156714342,-1.7957264172127,1.76624592313096,0.0344118931374301,34.787,79.99,55.868,95.77,75.819,-38.958,,18.43050000000001,-4.170999999999992,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,geldanamycin,CHEMBL278315,QTQAWLPCGQOSGP-KSRBKZBZSA-N,CC1CC(C(C(C=C(C(C(C=CC=C(C(=O)NC2=CC(=O)C(=C(C1)C2=O)OC)C)OC)OC(=O)N)C)C)O)OC,C29H40N2O9,DB02424,C11222,geldanamycin,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
27645,35,14,28,uM,uM,3.6508232184784,2.81475765789723,9.50901648343058,4.21466350468281,1.76624592313096,0.0035408748294111,34.787,38.091,65.942,79.696,72.819,-0.0590000000000117,,36.38,34.728,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,gemcitabine,CHEMBL888,SDUQYLNIPVEERB-QPPQHZFASA-N,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F,C9H11F2N3O4,DB00441,D02368,gemcitabine,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
27649,35,15,28,uM,uM,6.53857348130061,5.79146286091452,10.3958621015789,7.2178717101752,1.76624592313096,4.18286321924403,34.787,10.617,85.733,79.309,82.521,37.117,,59.819,47.734,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
27653,35,16,28,uM,uM,6.20668014193739,9.14291012610573,12.2449925135655,6.44740559155575,1.76624592313096,2.21500559399647,34.787,21.792,65.902,87.465,76.6835,20.1045,,48.39399999999999,41.8965,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,MK-2206,CHEMBL1079175,ULDXWLCXEDXJGE-UHFFFAOYSA-N,C1CC(C1)(C2=CC=C(C=C2)C3=C(C=C4C(=N3)C=CN5C4=NNC5=O)C6=CC=CC=C6)N,C25H21N5O,,,MK-2206,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
27677,35,26,28,uM,uM,-2.08560425099196,-2.43950070266991,1.1189409421434,-4.43245172273717,1.76624592313096,0.0047899367025841,34.787,57.817,59.376,92.648,76.012,-16.592,,29.71,18.195,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,391210-10-9,CHEMBL507361,SUDAHWBOROXANE-SECBINFHSA-N,C1=CC(=C(C=C1I)F)NC2=C(C=CC(=C2F)F)C(=O)NOCC(CO)O,C16H14F3IN2O4,DB07101,,PD-0325901,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
27681,35,28,28,uM,uM,4.98713036949886,2.17493240138014,9.37914372821239,5.9466834208087,1.76624592313096,0.005,34.787,10.812,74.43,82.252,78.341,32.742,,55.5415,43.554,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
27685,35,29,28,uM,uM,-1.50146687045849,-5.09174437327233,3.05954263156631,-1.27022525073027,1.76624592313096,5.63752169768596,34.787,60.964,63.308,83.389,73.3485,-22.4025,,25.473,12.384500000000005,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
27689,35,30,28,uM,uM,3.60091387627851,1.76002325492784,9.66867947002988,3.96730236920962,1.76624592313096,2.33877884349832,34.787,32.46,67.093,85.713,76.403,9.15599999999999,,42.779500000000006,41.61600000000001,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
27693,35,31,28,uM,uM,0.869547031618675,-61.2712023444652,-2.65833889305838,-0.296868723334399,1.76624592313096,28.1110621803845,34.787,-3.896,35.265,72.04,53.6525,22.7615,,38.20700000000001,18.865500000000004,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
30433,8,36,33,uM,uM,-5.96673852556069,-1.00046562285498,1.23628256841221,-8.18201279337795,0.0573050722814169,0.130522148853204,24.122,40.464,54.846,27.555,41.2005,-23.3855,,8.907499999999999,0.7364999999999995,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,geldanamycin,CHEMBL278315,QTQAWLPCGQOSGP-KSRBKZBZSA-N,CC1CC(C(C(C=C(C(C(C=CC=C(C(=O)NC2=CC(=O)C(=C(C1)C2=O)OC)C)OC)OC(=O)N)C)C)O)OC,C29H40N2O9,DB02424,C11222,geldanamycin,LNCAP,C4863,No COSMIC ID,Prostate carcinoma
30453,8,29,33,uM,uM,-1.24989684351488,1.61616507603954,4.61760518330669,-2.97510250954078,0.0573050722814169,3.86320971337547,24.122,66.101,52.868,68.157,60.5125,-29.7105,,15.401000000000003,-5.588499999999996,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,LNCAP,C4863,No COSMIC ID,Prostate carcinoma
30737,36,29,33,uM,uM,-6.60343409635158,-4.76938742272095,-1.21383342460602,-9.77420431385575,0.130535933020579,3.86320971337547,40.464,66.101,46.172,69.379,57.7755,-48.7895,,4.493000000000002,-8.325499999999998,geldanamycin,CHEMBL278315,QTQAWLPCGQOSGP-KSRBKZBZSA-N,CC1CC(C(C(C=C(C(C(C=CC=C(C(=O)NC2=CC(=O)C(=C(C1)C2=O)OC)C)OC)OC(=O)N)C)C)O)OC,C29H40N2O9,DB02424,C11222,geldanamycin,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,LNCAP,C4863,No COSMIC ID,Prostate carcinoma
30929,15,8,33,uM,uM,3.77817583962281,14.0169731354076,14.624024700394,2.65619877825631,0.54348505655389,0.0572809570199721,17.683,24.122,27.45,42.898,35.174,-6.631,,14.2715,11.052,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,LNCAP,C4863,No COSMIC ID,Prostate carcinoma
30941,15,36,33,uM,uM,8.86735916639884,7.77290293410448,9.98423742632492,2.44933854665896,0.54348505655389,0.130522148853204,17.683,40.464,33.103,43.006,38.0545,-20.0925,,8.980999999999998,-2.4095000000000013,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,geldanamycin,CHEMBL278315,QTQAWLPCGQOSGP-KSRBKZBZSA-N,CC1CC(C(C(C=C(C(C(C=CC=C(C(=O)NC2=CC(=O)C(=C(C1)C2=O)OC)C)OC)OC(=O)N)C)C)O)OC,C29H40N2O9,DB02424,C11222,geldanamycin,LNCAP,C4863,No COSMIC ID,Prostate carcinoma
30945,15,16,33,uM,uM,-4.39842637511663,-4.90170935529699,0.923249595116554,-6.21154924912734,0.54348505655389,0.113948310213733,17.683,61.089,34.757,53.176,43.9665,-34.8055,,4.580500000000008,-17.122499999999995,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,MK-2206,CHEMBL1079175,ULDXWLCXEDXJGE-UHFFFAOYSA-N,C1CC(C1)(C2=CC=C(C=C2)C3=C(C=C4C(=N3)C=CN5C4=NNC5=O)C6=CC=CC=C6)N,C25H21N5O,,,MK-2206,LNCAP,C4863,No COSMIC ID,Prostate carcinoma
30965,15,26,33,uM,uM,27.5584946985856,32.7669836933088,32.9206746069416,27.2552513246104,0.54348505655389,0.013843527833231,17.683,6.873,45.473,56.115,50.794,26.238,,38.516,33.111,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,391210-10-9,CHEMBL507361,SUDAHWBOROXANE-SECBINFHSA-N,C1=CC(=C(C=C1I)F)NC2=C(C=CC(=C2F)F)C(=O)NOCC(CO)O,C16H14F3IN2O4,DB07101,,PD-0325901,LNCAP,C4863,No COSMIC ID,Prostate carcinoma
30973,15,29,33,uM,uM,-2.52440116446508,-6.35925533956338,-2.75669540488344,-9.09263069869121,0.54348505655389,3.86320971337547,17.683,66.101,19.724,67.138,43.431,-40.353,,1.5390000000000017,-22.67,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,LNCAP,C4863,No COSMIC ID,Prostate carcinoma
31165,16,8,33,uM,uM,4.74825486216577,8.02512231884566,13.0926530510067,4.39301353869379,0.113954370228904,0.0572809570199721,61.088,24.122,69.705,61.307,65.506,-19.704,,22.901,4.417999999999999,MK-2206,CHEMBL1079175,ULDXWLCXEDXJGE-UHFFFAOYSA-N,C1CC(C1)(C2=CC=C(C=C2)C3=C(C=C4C(=N3)C=CN5C4=NNC5=O)C6=CC=CC=C6)N,C25H21N5O,,,MK-2206,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,LNCAP,C4863,No COSMIC ID,Prostate carcinoma
31177,16,36,33,uM,uM,-0.237674300774816,5.57885039247706,8.22246584469501,-1.60455030187746,0.113954370228904,0.130522148853204,61.088,40.464,67.575,55.91,61.7425,-39.8095,,10.966500000000003,0.6544999999999987,MK-2206,CHEMBL1079175,ULDXWLCXEDXJGE-UHFFFAOYSA-N,C1CC(C1)(C2=CC=C(C=C2)C3=C(C=C4C(=N3)C=CN5C4=NNC5=O)C6=CC=CC=C6)N,C25H21N5O,,,MK-2206,geldanamycin,CHEMBL278315,QTQAWLPCGQOSGP-KSRBKZBZSA-N,CC1CC(C(C(C=C(C(C(C=CC=C(C(=O)NC2=CC(=O)C(=C(C1)C2=O)OC)C)OC)OC(=O)N)C)C)O)OC,C29H40N2O9,DB02424,C11222,geldanamycin,LNCAP,C4863,No COSMIC ID,Prostate carcinoma
31193,16,26,33,uM,uM,4.11309671247159,2.89175975965897,5.95142460694163,3.06787811234634,0.113954370228904,0.013843527833231,61.088,6.873,66.752,46.336,56.544,-11.417,,22.5635,-4.544000000000004,MK-2206,CHEMBL1079175,ULDXWLCXEDXJGE-UHFFFAOYSA-N,C1CC(C1)(C2=CC=C(C=C2)C3=C(C=C4C(=N3)C=CN5C4=NNC5=O)C6=CC=CC=C6)N,C25H21N5O,,,MK-2206,391210-10-9,CHEMBL507361,SUDAHWBOROXANE-SECBINFHSA-N,C1=CC(=C(C=C1I)F)NC2=C(C=CC(=C2F)F)C(=O)NOCC(CO)O,C16H14F3IN2O4,DB07101,,PD-0325901,LNCAP,C4863,No COSMIC ID,Prostate carcinoma
31201,16,29,33,uM,uM,-0.631051534428022,5.15335481462519,9.42798984968512,-0.505887539945918,0.113954370228904,3.86320971337547,61.088,66.101,71.222,75.883,73.5525,-53.6365,,9.957999999999998,7.451499999999996,MK-2206,CHEMBL1079175,ULDXWLCXEDXJGE-UHFFFAOYSA-N,C1CC(C1)(C2=CC=C(C=C2)C3=C(C=C4C(=N3)C=CN5C4=NNC5=O)C6=CC=CC=C6)N,C25H21N5O,,,MK-2206,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,LNCAP,C4863,No COSMIC ID,Prostate carcinoma
31713,26,8,33,uM,uM,-9.8524401244047,-14.6204232187415,-14.3301485313737,-19.585314867415,0.0139274529371978,0.0572809570199721,6.873,24.122,6.906,7.328,7.117,-23.878,,-8.380500000000001,-17.005,391210-10-9,CHEMBL507361,SUDAHWBOROXANE-SECBINFHSA-N,C1=CC(=C(C=C1I)F)NC2=C(C=CC(=C2F)F)C(=O)NOCC(CO)O,C16H14F3IN2O4,DB07101,,PD-0325901,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,LNCAP,C4863,No COSMIC ID,Prostate carcinoma
31721,26,36,33,uM,uM,4.39086019294394,3.72430820888689,5.55870218330669,1.89182686144436,0.0139274529371978,0.130522148853204,6.873,40.464,60.804,46.964,53.884,6.547,,30.2155,13.420000000000002,391210-10-9,CHEMBL507361,SUDAHWBOROXANE-SECBINFHSA-N,C1=CC(=C(C=C1I)F)NC2=C(C=CC(=C2F)F)C(=O)NOCC(CO)O,C16H14F3IN2O4,DB07101,,PD-0325901,geldanamycin,CHEMBL278315,QTQAWLPCGQOSGP-KSRBKZBZSA-N,CC1CC(C(C(C=C(C(C(C=CC=C(C(=O)NC2=CC(=O)C(=C(C1)C2=O)OC)C)OC)OC(=O)N)C)C)O)OC,C29H40N2O9,DB02424,C11222,geldanamycin,LNCAP,C4863,No COSMIC ID,Prostate carcinoma
31741,26,29,33,uM,uM,2.98899477579008,4.10416905615622,4.3407739686263,1.75945162454176,0.0139274529371978,3.86320971337547,6.873,66.101,56.282,70.808,63.545,-9.429,,27.058,-2.5559999999999974,391210-10-9,CHEMBL507361,SUDAHWBOROXANE-SECBINFHSA-N,C1=CC(=C(C=C1I)F)NC2=C(C=CC(=C2F)F)C(=O)NOCC(CO)O,C16H14F3IN2O4,DB07101,,PD-0325901,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,LNCAP,C4863,No COSMIC ID,Prostate carcinoma
89673,12,10,4,uM,uM,1.11321675853349,-2.29245207777736,2.58137232141168,1.97343444056322,5.0,0.0110887210319778,8.775,31.661,60.533,66.505,63.519,23.083,,43.301,31.858,Erlotinib,CHEMBL553,AAKJLRGGTJKAMG-UHFFFAOYSA-N,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,C22H23N3O4,DB00530,D07907,erlotinib,Dinaciclib,CHEMBL2103840,PIMQWRZWLQKKBJ-SFHVURJKSA-N,CCC1=C2N=C(C=C(N2N=C1)NCC3=C[N+](=CC=C3)[O-])N4CCCCC4CCO,C21H28N6O2,DB12021,D09604,dinaciclib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
89725,31,12,4,uM,uM,0.0475432521702651,-9.19609342430975,3.70586636396755,2.15329710179585,92.0820862226579,5.0,7.622,8.723,42.828,28.49,35.659,19.314,,27.4865,26.936,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,Erlotinib,CHEMBL553,AAKJLRGGTJKAMG-UHFFFAOYSA-N,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,C22H23N3O4,DB00530,D07907,erlotinib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
89733,35,12,4,uM,uM,-0.511132224730641,0.564273724502938,5.70594312064119,2.82151346983574,4.0,5.0,15.385,8.723,45.209,89.641,67.425,43.317,,55.371,52.04,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,Erlotinib,CHEMBL553,AAKJLRGGTJKAMG-UHFFFAOYSA-N,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,C22H23N3O4,DB00530,D07907,erlotinib,A375,C3802,Skin (Malignant melanoma),Amelanotic melanoma
132682,15,86,28,uM,uM,-0.428324540565462,-3.84770820769531,-3.05218822810535,-2.13524252585422,0.0962370538852604,2.49238167529758,-0.007,0.335,-1.352,-2.807,-2.0795,-2.4075,,-2.2435,-2.4145,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,methoxsalen,CHEMBL416,QXKHYNVANLEOEG-UHFFFAOYSA-N,COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,C12H8O4,DB00553,D00139,methoxsalen,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
132824,75,77,38,uM,uM,1.49241984003375,-5.11171634158583,-2.32979797542491,1.29315434115819,10.6932086884918,0.0596165988286443,-3.148,-0.546,-0.747,-1.028,-0.8875,2.8065,,0.9595,-0.3414999999999999,ifosfamide,CHEMBL1024,HOMGKSMUEGBAAB-UHFFFAOYSA-N,C1CN(P(=O)(OC1)NCCCl)CCCl,C7H15Cl2N2O2P,DB01181,D00343,ifosfamide,IMIQUIMOD,CHEMBL1282,DOUYETYNHWVLEO-UHFFFAOYSA-N,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N,C14H16N4,DB00724,D02500,imiquimod,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
133081,74,90,28,uM,uM,1.27564326058599,-4.52336201075408,-6.33141634625221,-3.27182775075518,1.42754821483657,0.0117946741736568,-0.472,-1.69,-2.217,-4.137,-3.177,-1.015,,-2.096,-2.705,hydroxyurea,CHEMBL467,VSNHCAURESNICA-UHFFFAOYSA-N,C(=O)(N)NO,CH4N2O2,DB01005,D00341,hydroxyurea,Nilotinib,CHEMBL255863,HHZIURLSWUIHRB-UHFFFAOYSA-N,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,C28H22F3N7O,DB04868,D08953,nilotinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
133430,100,78,38,uM,uM,-3.64958640748641,-6.49464213063752,-1.56925799825501,-4.50494613776845,0.0012830732054421,0.0203391763747341,25.903,26.291,33.886,46.313,40.0995,-12.0945,,14.002499999999998,13.8085,Romidepsin,CHEMBL343448,OHRURASPPZQGQM-GCCNXGTGSA-N,CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C,C24H36N4O6S2,,D06637,romidepsin,Ixabepilone,CHEMBL1201752,FABUFPQFXZVHFB-PVYNADRNSA-N,CC1CCCC2(C(O2)CC(NC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C,C27H42N2O5S,DB04845,D04645,ixabepilone,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
134087,43,35,38,uM,uM,-8.37615744919893,-1.70146934452968,0.162569913556384,-1.85955666436163,0.0607480543864306,0.176022954412325,5.36,16.408,20.952,19.627,20.2895,-1.4785,,9.4055,3.881499999999999,anastrozole,CHEMBL1399,YBBLVLTVTVSKRW-UHFFFAOYSA-N,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,C17H19N5,DB01217,D00960,anastrozole,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
134242,35,15,38,uM,uM,-5.47100775856624,-0.843976713401558,-0.0491070075254121,-3.16618427324256,1.0,3.0,14.126,4.271,19.881,28.456,24.1685,5.7715,,14.970000000000002,10.042500000000002,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
134444,96,85,28,uM,uM,-5.11925059120612,-4.95530877633811,-5.19555392520176,0.464742681169337,0.0002694964940544,2.0,-8.679,21.08,45.767,16.258,31.0125,18.6115,,24.812,9.9325,Pralatrexate,CHEMBL1201746,OGSBUKJUDHAQEA-WMCAAGNKSA-N,C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,C23H23N7O5,DB06813,D05589,pralatrexate,6-Mercaptopurine,CHEMBL1425,GLVAUDGFNGKCSF-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=CN2,C5H4N4S,DB01033,D04931,mercaptopurine,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
134692,35,29,38,uM,uM,-6.52020175777558,-51.5801500878241,-8.99577367419208,-7.79449951091741,1.0,3.23217375956692,19.184,-1.131,5.15,25.332,15.241,-2.812,,6.214499999999999,-3.9430000000000014,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
135062,86,78,38,uM,uM,0.675554013077635,-23.086626434842,-2.60109327359649,-2.06841027945858,0.206557764542352,0.0121596555881956,-2.64,35.749,19.436,33.2,26.318,-6.791,,9.7635,-9.431,methoxsalen,CHEMBL416,QXKHYNVANLEOEG-UHFFFAOYSA-N,COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,C12H8O4,DB00553,D00139,methoxsalen,Ixabepilone,CHEMBL1201752,FABUFPQFXZVHFB-PVYNADRNSA-N,CC1CCCC2(C(O2)CC(NC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C,C27H42N2O5S,DB04845,D04645,ixabepilone,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
135070,388,74,28,uM,uM,1.19265038043865,-2.98557514987554,-2.41733386958515,5.39639852636593,1.0,66.352712224773,-8.397,0.812,9.039,-11.073,-1.017,6.568,,2.7755,-1.829,raloxifene,CHEMBL81,GZUITABIAKMVPG-UHFFFAOYSA-N,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,C28H27NO4S,DB00481,D08465,raloxifene,hydroxyurea,CHEMBL467,VSNHCAURESNICA-UHFFFAOYSA-N,C(=O)(N)NO,CH4N2O2,DB01005,D00341,hydroxyurea,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
135175,80,86,28,uM,uM,1.55183082023,1.93043303356384,1.56228363062882,2.65956094950338,0.0128260710191966,2.49238167529758,-1.538,0.335,6.218,2.02,4.119,5.322,,4.7205,3.784,letrozole,CHEMBL1444,HPJKCIUCZWXJDR-UHFFFAOYSA-N,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,C17H11N5,DB01006,D00964,letrozole,methoxsalen,CHEMBL416,QXKHYNVANLEOEG-UHFFFAOYSA-N,COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,C12H8O4,DB00553,D00139,methoxsalen,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
135200,388,88,28,uM,uM,0.309786066053255,-28.2678606549395,-2.46922059186845,-0.890093547851801,0.024411737372345,0.14481097739648,-3.094,33.11,44.194,32.068,38.131,8.115,,23.123,5.021000000000001,raloxifene,CHEMBL81,GZUITABIAKMVPG-UHFFFAOYSA-N,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,C28H27NO4S,DB00481,D08465,raloxifene,mitoxantrone,CHEMBL58,KKZJGLLVHKMTCM-UHFFFAOYSA-N,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,C22H28N4O6,DB01204,D08224,mitoxantrone,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
135470,15,85,38,uM,uM,-2.66943212613062,-3.01001267037895,0.427669111111111,-2.86064870009506,3.0,0.258629758303853,13.903,26.013,34.777,42.139,38.458,-1.45800000000001,,18.5,12.444999999999997,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,6-Mercaptopurine,CHEMBL1425,GLVAUDGFNGKCSF-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=CN2,C5H4N4S,DB01033,D04931,mercaptopurine,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
135592,72,108,38,uM,uM,-2.04932214866124,2.36696874455822,3.26678215555556,-0.426151612838977,10.0,1.03364605094231,6.867,30.715,34.906,41.167,38.0365,0.454500000000003,,19.2455,7.321499999999997,Gefitinib,CHEMBL939,XGALLCVXEZPNRQ-UHFFFAOYSA-N,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,C22H24ClFN4O3,DB00317,D01977,gefitinib,6-Thioguanine,CHEMBL727,WYWHKKSPHMUBEB-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=C(N2)N,C5H5N5S,DB00352,D08603,thioguanine,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
135688,30,78,28,uM,uM,9.95236699307119,0.178573292922419,9.00876455555555,7.82802104918163,1.0,0.0049349515627974,4.199,77.504,74.384,84.451,79.4175,-2.28550000000001,,38.566,1.913499999999999,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,Ixabepilone,CHEMBL1201752,FABUFPQFXZVHFB-PVYNADRNSA-N,CC1CCCC2(C(O2)CC(NC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C,C27H42N2O5S,DB04845,D04645,ixabepilone,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
135817,80,75,38,uM,uM,-0.12639291947574,-1.38627571965591,-2.76891723333333,-2.77840537526792,0.0555780422137958,100.0,0.55,1.939,-0.104,-0.698,-0.401,-2.89,,-1.6455,-2.34,letrozole,CHEMBL1444,HPJKCIUCZWXJDR-UHFFFAOYSA-N,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,C17H11N5,DB01006,D00964,letrozole,ifosfamide,CHEMBL1024,HOMGKSMUEGBAAB-UHFFFAOYSA-N,C1CN(P(=O)(OC1)NCCCl)CCCl,C7H15Cl2N2O2P,DB01181,D00343,ifosfamide,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
135859,29,96,28,uM,uM,1.88138958867213,-2.89803294236912,-2.22554893333333,1.56436979574507,0.238232891514352,1.98792917293696e-05,-3.217,-0.119,-4.231,-2.296,-3.2635,0.0725000000000007,,-1.5955,-3.1445,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,Pralatrexate,CHEMBL1201746,OGSBUKJUDHAQEA-WMCAAGNKSA-N,C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,C23H23N7O5,DB06813,D05589,pralatrexate,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
136063,28,29,38,uM,uM,-2.83135075431321,-74.1583379142017,2.31978111111111,3.6683297790911,0.01,3.23203785210288,9.61,-1.131,7.68,20.829,14.2545,5.7755,,10.015,4.644500000000001,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
136422,77,5,28,uM,uM,-1.00009845960835,-21.6274282037677,-8.28098085555555,-3.32360125803523,6.36310075097759e-12,0.0550669336846505,-7.33,40.842,40.827,37.464,39.1455,5.6335,,22.3895,-1.6965000000000003,IMIQUIMOD,CHEMBL1282,DOUYETYNHWVLEO-UHFFFAOYSA-N,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N,C14H16N4,DB00724,D02500,imiquimod,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
136731,31,100,28,uM,uM,1.14299214089386,-69.8748747651419,-7.28555403333333,-2.13106753995959,16.3274762597665,0.0032561469459855,-9.611,18.556,74.384,7.201,40.7925,31.8475,,36.31999999999999,22.2365,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,Romidepsin,CHEMBL343448,OHRURASPPZQGQM-GCCNXGTGSA-N,CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C,C24H36N4O6S2,,D06637,romidepsin,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
137172,100,77,38,uM,uM,-0.54427297115348,-33.7820989629262,-4.98018827777778,-3.1681976502627,0.0011477132142162,0.0020538333057086,27.645,-2.222,27.353,19.598,23.4755,-1.9475,,10.764,-4.169499999999999,Romidepsin,CHEMBL343448,OHRURASPPZQGQM-GCCNXGTGSA-N,CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C,C24H36N4O6S2,,D06637,romidepsin,IMIQUIMOD,CHEMBL1282,DOUYETYNHWVLEO-UHFFFAOYSA-N,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N,C14H16N4,DB00724,D02500,imiquimod,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
137177,28,39,38,uM,uM,-6.19100097498204,-42.2496054420658,-3.67799666666667,-4.4875871669889,0.0097847183919996,10.0,10.811,0.696,14.123,22.828,18.4755,6.9685,,12.722,7.6645,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,allopurinol,CHEMBL1467,OFCNXPDARWKPPY-UHFFFAOYSA-N,C1=C2C(=NC=NC2=O)NN1; C1=NNC2=C1C(=O)NC=N2,C5H4N4O,DB00437,D00224,allopurinol,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
137730,43,5,28,uM,uM,0.95375152225453,-25.8305188892885,-1.22334282222222,2.66268834216963,0.0033765535308294,0.0444924565231995,-1.185,34.269,15.568,35.814,25.691,-7.393,,9.149,-8.578,anastrozole,CHEMBL1399,YBBLVLTVTVSKRW-UHFFFAOYSA-N,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,C17H19N5,DB01217,D00960,anastrozole,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
137853,8,29,38,uM,uM,-3.90789987266556,-8.26283359608158,-2.61910778888889,-1.28214859632223,0.1,3.23203785210288,7.39,-1.131,7.015,16.565,11.79,5.531,,8.660499999999999,4.4,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
137913,230,78,28,uM,uM,9.83843776535571,-8.72607655179485,8.91332177777778,8.0863721532388,0.400704304296647,0.0049349515627974,6.128,77.504,78.467,83.399,80.933,-2.69900000000001,,39.117,3.429000000000002,Imatinib,CHEMBL941,KTUFNOKKBVMGRW-UHFFFAOYSA-N,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,C29H31N7O,DB00619,D01441,imatinib,Ixabepilone,CHEMBL1201752,FABUFPQFXZVHFB-PVYNADRNSA-N,CC1CCCC2(C(O2)CC(NC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C,C27H42N2O5S,DB04845,D04645,ixabepilone,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
138755,230,78,38,uM,uM,2.67790976858633,-11.534798089746,1.83446016666667,1.92942502297,0.186462485838905,0.0203185246224506,-1.291,26.291,35.76,28.273,32.0165,7.0165,,19.5165,5.7255,Imatinib,CHEMBL941,KTUFNOKKBVMGRW-UHFFFAOYSA-N,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,C29H31N7O,DB00619,D01441,imatinib,Ixabepilone,CHEMBL1201752,FABUFPQFXZVHFB-PVYNADRNSA-N,CC1CCCC2(C(O2)CC(NC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C,C27H42N2O5S,DB04845,D04645,ixabepilone,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
138971,31,28,38,uM,uM,-3.73508259682277,-92.8299031333333,-2.6333318,0.541303993044109,20.0,0.01,-2.751,10.114,20.63,6.493,13.5615,6.1985,,9.88,3.4475,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
139619,8,86,38,uM,uM,-1.46744976971489,-2.09391600240561,-2.07999868888889,-2.65321302290138,0.0103310555714552,0.107786796112615,0.591,2.82,2.019,1.681,1.85,-1.561,,0.1445000000000003,-0.9699999999999998,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,methoxsalen,CHEMBL416,QXKHYNVANLEOEG-UHFFFAOYSA-N,COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,C12H8O4,DB00553,D00139,methoxsalen,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
139747,52,48,28,uM,uM,-1.23213417558745,-2.67491937359229,-2.54914058,-0.827163388051995,2.30629809904041,7.55099766413197,-1.932,2.11,0.337,1.164,0.7505,0.5725,,0.6615,-1.3595,celecoxib,CHEMBL118,RZEKVGVHFLEQIL-UHFFFAOYSA-N,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,C17H14F3N3O2S,DB00482,D00567,celecoxib,busulfan,CHEMBL820,COVZYZSDYWQREU-UHFFFAOYSA-N,CS(=O)(=O)OCCCCOS(=O)(=O)C,C6H14O6S2,DB01008,D00248,busulfan,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
139862,90,30,38,uM,uM,1.21163509748015,-3.79440150836379,-3.66555398888889,0.537547665353439,1.0,0.0097615238192383,-3.706,0.807,-5.038,-0.997,-3.0175,-0.1185,,-1.568,-3.8245,Nilotinib,CHEMBL255863,HHZIURLSWUIHRB-UHFFFAOYSA-N,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,C28H22F3N7O,DB04868,D08953,nilotinib,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
140100,388,40,28,uM,uM,8.04738331470049,0.435944171412909,-1.05690331333333,7.3776300281419,0.0245680781616445,0.787020214358145,-3.094,-9.583,-1.973,-4.135,-3.054,9.623,,3.2845,0.04,raloxifene,CHEMBL81,GZUITABIAKMVPG-UHFFFAOYSA-N,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,C28H27NO4S,DB00481,D08465,raloxifene,altretamine,CHEMBL1455,UUVWYPNAQBNQJQ-UHFFFAOYSA-N,CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C,C9H18N6,DB00488,D02841,altretamine,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
140265,85,5,38,uM,uM,-11.2227200629901,-8.07922291704843,-2.16787389111111,-2.30655991666726,0.354383080553578,0.157942847158906,12.622,6.879,40.808,34.916,37.862,18.361,,28.111500000000003,25.24,6-Mercaptopurine,CHEMBL1425,GLVAUDGFNGKCSF-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=CN2,C5H4N4S,DB01033,D04931,mercaptopurine,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
140803,388,75,28,uM,uM,1.90786154081932,-3.98470264340812,-3.7207763,0.483581315075296,0.011460426406139,31.7503671740097,-5.11,2.485,-2.167,-0.783,-1.475,1.15,,-0.1624999999999998,-3.96,raloxifene,CHEMBL81,GZUITABIAKMVPG-UHFFFAOYSA-N,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,C28H27NO4S,DB00481,D08465,raloxifene,ifosfamide,CHEMBL1024,HOMGKSMUEGBAAB-UHFFFAOYSA-N,C1CN(P(=O)(OC1)NCCCl)CCCl,C7H15Cl2N2O2P,DB01181,D00343,ifosfamide,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
140875,31,96,28,uM,uM,16.5557037612213,-5.77624823700533,5.83222222222222,8.43798825021529,20.0,5.64306248484113e-06,-6.611,78.49,68.454,76.463,72.4585,0.579499999999996,,36.519000000000005,-6.031499999999994,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,Pralatrexate,CHEMBL1201746,OGSBUKJUDHAQEA-WMCAAGNKSA-N,C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,C23H23N7O5,DB06813,D05589,pralatrexate,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
141037,90,30,7,uM,uM,2.07694041128091,-7.30839808428508,-7.79444311111111,-2.12708149326805,0.0087345804227806,1.0,-6.409,2.065,-7.795,-4.097,-5.946,-1.602,,-3.774,-8.011,Nilotinib,CHEMBL255863,HHZIURLSWUIHRB-UHFFFAOYSA-N,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,C28H22F3N7O,DB04868,D08953,nilotinib,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,A549,C3512,Lung (Carcinoma),Lung adenocarcinoma
141131,52,8,28,uM,uM,-2.20271086902131,-10.1670883822679,4.88473195666667,5.36854238861204,0.156312436048841,0.1,2.449,4.477,20.946,4.285,12.6155,5.6895,,9.1525,8.1385,celecoxib,CHEMBL118,RZEKVGVHFLEQIL-UHFFFAOYSA-N,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,C17H14F3N3O2S,DB00482,D00567,celecoxib,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
141308,74,29,28,uM,uM,0.357847656830923,-7.5436939549866,-2.87346366666667,0.283884467829006,2.56872634462717,17.3283871884441,5.209,-3.151,-0.032,0.309,0.1385,-1.9195,,-0.8904999999999998,-5.0705,hydroxyurea,CHEMBL467,VSNHCAURESNICA-UHFFFAOYSA-N,C(=O)(N)NO,CH4N2O2,DB01005,D00341,hydroxyurea,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
141359,28,74,28,uM,uM,-5.66324320142785,-22.4600020982457,-3.89497228444444,-1.8444000090242,0.0043756280290222,1.98131635465789,7.779,-0.61,10.774,31.013,20.8935,13.7245,,17.309,13.1145,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,hydroxyurea,CHEMBL467,VSNHCAURESNICA-UHFFFAOYSA-N,C(=O)(N)NO,CH4N2O2,DB01005,D00341,hydroxyurea,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
141412,80,77,38,uM,uM,2.83540053705441,0.395311048463529,-0.0531511555555557,3.60693975542489,0.4,0.0020538333057086,-2.482,-2.222,-0.063,-4.451,-2.257,2.447,,0.0950000000000002,-0.0350000000000001,letrozole,CHEMBL1444,HPJKCIUCZWXJDR-UHFFFAOYSA-N,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,C17H11N5,DB01006,D00964,letrozole,IMIQUIMOD,CHEMBL1282,DOUYETYNHWVLEO-UHFFFAOYSA-N,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N,C14H16N4,DB00724,D02500,imiquimod,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
141675,80,77,28,uM,uM,4.8885012143175,-2.50639954261973,-2.0633317,4.37139597321481,0.4,0.0088145103337468,-5.092,0.286,-5.474,-5.699,-5.5865,-0.7805,,-3.1835,-5.8725,letrozole,CHEMBL1444,HPJKCIUCZWXJDR-UHFFFAOYSA-N,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,C17H11N5,DB01006,D00964,letrozole,IMIQUIMOD,CHEMBL1282,DOUYETYNHWVLEO-UHFFFAOYSA-N,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N,C14H16N4,DB00724,D02500,imiquimod,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
141995,15,78,38,uM,uM,1.08829830866359,-7.77172178092365,0.884432936666669,0.351445649747778,0.29354659153425,0.0203185246224506,1.548,26.291,22.63,26.724,24.677,-3.162,,10.7575,-1.6140000000000008,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,Ixabepilone,CHEMBL1201752,FABUFPQFXZVHFB-PVYNADRNSA-N,CC1CCCC2(C(O2)CC(NC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C,C27H42N2O5S,DB04845,D04645,ixabepilone,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
142557,96,48,38,uM,uM,-2.0460930937205,7.01226709781641,2.25978188136347,0.159181653092698,0.0006,9.76277833497609,7.051,2.24,11.421,5.174,8.2975,-0.993500000000001,,3.6519999999999992,1.2464999999999993,Pralatrexate,CHEMBL1201746,OGSBUKJUDHAQEA-WMCAAGNKSA-N,C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,C23H23N7O5,DB06813,D05589,pralatrexate,busulfan,CHEMBL820,COVZYZSDYWQREU-UHFFFAOYSA-N,CS(=O)(=O)OCCCCOS(=O)(=O)C,C6H14O6S2,DB01008,D00248,busulfan,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
142826,388,85,38,uM,uM,-8.21170717348014,-3.01875307092336,-2.38679511671926,-6.12767719067409,0.171190531391502,0.253128636445136,12.108,8.344,11.96,10.041,11.0005,-9.4515,,0.7745000000000015,-1.1075,raloxifene,CHEMBL81,GZUITABIAKMVPG-UHFFFAOYSA-N,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,C28H27NO4S,DB00481,D08465,raloxifene,6-Mercaptopurine,CHEMBL1425,GLVAUDGFNGKCSF-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=CN2,C5H4N4S,DB01033,D04931,mercaptopurine,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
143199,80,48,38,uM,uM,-1.74171338338326,6.67324196121831,1.77113927262821,-0.310497656287458,0.4,9.76277833497609,7.187,2.24,7.242,8.499,7.8705,-1.5565,,3.157,0.6834999999999996,letrozole,CHEMBL1444,HPJKCIUCZWXJDR-UHFFFAOYSA-N,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,C17H11N5,DB01006,D00964,letrozole,busulfan,CHEMBL820,COVZYZSDYWQREU-UHFFFAOYSA-N,CS(=O)(=O)OCCCCOS(=O)(=O)C,C6H14O6S2,DB01008,D00248,busulfan,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
143335,230,107,28,uM,uM,-0.523974504734181,-2.32125597269341,-2.15112066260686,-2.38101328591119,0.175597419611961,0.587883665769743,1.763,1.922,0.029,-3.707,-1.839,-5.524,,-3.6815,-3.761,Imatinib,CHEMBL941,KTUFNOKKBVMGRW-UHFFFAOYSA-N,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,C29H31N7O,DB00619,D01441,imatinib,thalidomide,CHEMBL468,UEJJHQNACJXSKW-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,C13H10N2O4,DB01041,D00754,thalidomide,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
143373,74,78,38,uM,uM,1.54445174255655,-17.7677313660463,-0.701109480757336,-0.281666709981799,0.614563822390605,0.0114154409060072,-1.703,29.962,25.201,32.229,28.715,0.456,,14.5855,-1.247,hydroxyurea,CHEMBL467,VSNHCAURESNICA-UHFFFAOYSA-N,C(=O)(N)NO,CH4N2O2,DB01005,D00341,hydroxyurea,Ixabepilone,CHEMBL1201752,FABUFPQFXZVHFB-PVYNADRNSA-N,CC1CCCC2(C(O2)CC(NC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C,C27H42N2O5S,DB04845,D04645,ixabepilone,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
143432,52,107,28,uM,uM,0.0904497404797854,-4.11314883958441,-5.11336135647171,-2.41248705963653,0.161349120209825,0.587883665769743,-3.706,1.922,-4.642,-3.04,-3.841,-2.057,,-2.9490000000000003,-5.763,celecoxib,CHEMBL118,RZEKVGVHFLEQIL-UHFFFAOYSA-N,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,C17H14F3N3O2S,DB00482,D00567,celecoxib,thalidomide,CHEMBL468,UEJJHQNACJXSKW-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,C13H10N2O4,DB01041,D00754,thalidomide,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
143458,85,39,28,uM,uM,2.15086592155895,-10.7806100549408,2.5676055197943,3.97052529698323,0.400611801034161,5.30647327087452,18.296,-1.052,21.092,36.769,28.9305,11.6865,,20.3085,10.6345,6-Mercaptopurine,CHEMBL1425,GLVAUDGFNGKCSF-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=CN2,C5H4N4S,DB01033,D04931,mercaptopurine,allopurinol,CHEMBL1467,OFCNXPDARWKPPY-UHFFFAOYSA-N,C1=C2C(=NC=NC2=O)NN1; C1=NNC2=C1C(=O)NC=N2,C5H4N4O,DB00437,D00224,allopurinol,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
143652,80,90,38,uM,uM,0.722398923541331,-4.09796684874556,-4.70035792751654,-1.51088942435106,0.196579648765016,0.0336301677640424,-4.029,0.561,-4.168,-3.726,-3.947,-0.479,,-2.213,-4.508,letrozole,CHEMBL1444,HPJKCIUCZWXJDR-UHFFFAOYSA-N,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,C17H11N5,DB01006,D00964,letrozole,Nilotinib,CHEMBL255863,HHZIURLSWUIHRB-UHFFFAOYSA-N,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,C28H22F3N7O,DB04868,D08953,nilotinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
143835,388,74,38,uM,uM,-7.68629928265891,-1.56153533730915,-1.2112636190951,-5.9050787623417,0.171190531391502,100.0,12.108,7.037,21.747,18.678,20.2125,1.0675,,10.64,8.104499999999998,raloxifene,CHEMBL81,GZUITABIAKMVPG-UHFFFAOYSA-N,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,C28H27NO4S,DB00481,D08465,raloxifene,hydroxyurea,CHEMBL467,VSNHCAURESNICA-UHFFFAOYSA-N,C(=O)(N)NO,CH4N2O2,DB01005,D00341,hydroxyurea,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
143909,388,77,28,uM,uM,5.98671953413459,-2.12423426980857,-1.20310700752542,10.8615836199241,1.0,0.7,-4.051,-12.727,-0.949,-3.444,-2.1965,14.5815,,6.192499999999999,1.8545000000000005,raloxifene,CHEMBL81,GZUITABIAKMVPG-UHFFFAOYSA-N,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,C28H27NO4S,DB00481,D08465,raloxifene,IMIQUIMOD,CHEMBL1282,DOUYETYNHWVLEO-UHFFFAOYSA-N,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N,C14H16N4,DB00724,D02500,imiquimod,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
144018,388,80,28,uM,uM,2.11666273456926,-2.50286705760472,-4.74751252091541,-0.418198329539106,1.0,0.0951991816635956,-4.051,-2.579,-3.292,-3.402,-3.347,3.283,,-0.0319999999999995,-0.7679999999999998,raloxifene,CHEMBL81,GZUITABIAKMVPG-UHFFFAOYSA-N,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,C28H27NO4S,DB00481,D08465,raloxifene,letrozole,CHEMBL1444,HPJKCIUCZWXJDR-UHFFFAOYSA-N,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,C17H11N5,DB01006,D00964,letrozole,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
144653,388,116,38,uM,uM,-1.36310542739098,-2.70011506255825,0.308115214696806,2.05421228098284,0.018292512655514,1.52105826959341,8.679,-1.89,11.569,4.823,8.196,1.407,,4.801499999999999,-0.4830000000000005,raloxifene,CHEMBL81,GZUITABIAKMVPG-UHFFFAOYSA-N,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,C28H27NO4S,DB00481,D08465,raloxifene,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
144901,8,85,28,uM,uM,4.40952956778872,-3.20743923984391,-0.233444980696274,17.969264466303,0.1,0.967832303610972,-18.207,-6.453,23.222,1.344,12.283,36.943,,24.613,18.736,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,6-Mercaptopurine,CHEMBL1425,GLVAUDGFNGKCSF-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=CN2,C5H4N4S,DB01033,D04931,mercaptopurine,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
145091,80,35,28,uM,uM,3.95198935804471,-8.64353287601625,-7.3168056777607,7.97709623533673,0.34123313256245,0.144492266535655,-17.605,2.701,-10.722,1.163,-4.7795,10.1245,,2.6725000000000003,-7.480499999999999,letrozole,CHEMBL1444,HPJKCIUCZWXJDR-UHFFFAOYSA-N,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,C17H11N5,DB01006,D00964,letrozole,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
145105,230,48,28,uM,uM,-1.75786292525545,-3.64110105059722,-2.65716523563102,-0.643536409600616,1.71196426508742,7.55099759817741,0.648,2.11,3.454,7.824,5.639,2.881,,4.26,3.5290000000000004,Imatinib,CHEMBL941,KTUFNOKKBVMGRW-UHFFFAOYSA-N,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,C29H31N7O,DB00619,D01441,imatinib,busulfan,CHEMBL820,COVZYZSDYWQREU-UHFFFAOYSA-N,CS(=O)(=O)OCCCCOS(=O)(=O)C,C6H14O6S2,DB01008,D00248,busulfan,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
145466,29,85,28,uM,uM,-5.11925059120629,-47.7377103119758,-5.19555392520176,0.464742681169337,8.98321646588034,2.0,-8.679,21.08,45.784,16.258,31.021,18.62,,24.820500000000003,9.941000000000004,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,6-Mercaptopurine,CHEMBL1425,GLVAUDGFNGKCSF-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=CN2,C5H4N4S,DB01033,D04931,mercaptopurine,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
145495,388,230,28,uM,uM,6.51637583940274,-2.83874470354075,-2.53170235409528,8.00115551974047,0.0001210913448318,2.04611521814568,-8.257,-9.363,-7.554,-11.756,-9.655,7.965,,-0.8450000000000006,-1.3979999999999997,raloxifene,CHEMBL81,GZUITABIAKMVPG-UHFFFAOYSA-N,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,C28H27NO4S,DB00481,D08465,raloxifene,Imatinib,CHEMBL941,KTUFNOKKBVMGRW-UHFFFAOYSA-N,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,C29H31N7O,DB00619,D01441,imatinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
145583,90,30,28,uM,uM,6.49545160479648,-9.06499446316969,-7.91104970270452,3.21448128693905,0.0766120758057273,0.725465974035397,-10.583,-2.658,-8.759,-11.123,-9.941,3.3,,-3.320500000000001,-7.283000000000001,Nilotinib,CHEMBL255863,HHZIURLSWUIHRB-UHFFFAOYSA-N,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,C28H22F3N7O,DB04868,D08953,nilotinib,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
145762,230,85,28,uM,uM,-1.6263904402545,-17.6345811084415,1.35321052940015,5.88108580535112,0.145959279423367,0.274486589679313,-5.183,14.956,30.856,18.042,24.449,14.676,,19.5625,9.493000000000002,Imatinib,CHEMBL941,KTUFNOKKBVMGRW-UHFFFAOYSA-N,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,C29H31N7O,DB00619,D01441,imatinib,6-Mercaptopurine,CHEMBL1425,GLVAUDGFNGKCSF-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=CN2,C5H4N4S,DB01033,D04931,mercaptopurine,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
146382,31,100,38,uM,uM,1.26582329176747,-48.3649083244991,0.324446074798237,1.8711850612734,7.37933290675904,0.0014391938358074,-1.381,23.959,31.771,29.495,30.633,8.055,,19.344,6.674,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,Romidepsin,CHEMBL343448,OHRURASPPZQGQM-GCCNXGTGSA-N,CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C,C24H36N4O6S2,,D06637,romidepsin,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
146919,8,107,28,uM,uM,-4.08155738122978,-8.54151161876076,0.322049964238734,-1.04708996928468,0.0097650016877678,0.587883665769743,11.96,1.922,7.551,5.98,6.7655,-7.1165,,-0.1755000000000004,-5.194500000000001,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,thalidomide,CHEMBL468,UEJJHQNACJXSKW-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,C13H10N2O4,DB01041,D00754,thalidomide,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
147514,90,43,38,uM,uM,6.92105577858293,-4.09334038762072,-5.06888725853507,-0.0073932804890188,1.0,0.0912164999434249,-5.497,1.625,-2.667,-4.747,-3.707,0.165,,-1.771,-5.332,Nilotinib,CHEMBL255863,HHZIURLSWUIHRB-UHFFFAOYSA-N,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,C28H22F3N7O,DB04868,D08953,nilotinib,anastrozole,CHEMBL1399,YBBLVLTVTVSKRW-UHFFFAOYSA-N,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,C17H19N5,DB01217,D00960,anastrozole,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
147671,100,39,38,uM,uM,-1.86044456229631,-69.0321259090208,0.193099007535962,-2.50040359655428,0.01,10.0,35.283,3.455,31.924,72.008,51.966,13.228,,32.597,16.683,Romidepsin,CHEMBL343448,OHRURASPPZQGQM-GCCNXGTGSA-N,CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C,C24H36N4O6S2,,D06637,romidepsin,allopurinol,CHEMBL1467,OFCNXPDARWKPPY-UHFFFAOYSA-N,C1=C2C(=NC=NC2=O)NN1; C1=NNC2=C1C(=O)NC=N2,C5H4N4O,DB00437,D00224,allopurinol,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
148096,74,107,38,uM,uM,-1.22411902692346,-2.57111594957664,-2.03799589641431,-1.75092503432703,0.263719878181076,0.312134282934169,3.201,0.14,1.279,1.317,1.298,-2.043,,-0.3725,-1.903,hydroxyurea,CHEMBL467,VSNHCAURESNICA-UHFFFAOYSA-N,C(=O)(N)NO,CH4N2O2,DB01005,D00341,hydroxyurea,thalidomide,CHEMBL468,UEJJHQNACJXSKW-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,C13H10N2O4,DB01041,D00754,thalidomide,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
148716,28,5,38,uM,uM,-10.6783745705566,-6.68811413341067,1.03003399411685,0.716295746944125,0.0011967916298933,0.157942852211885,10.957,6.879,34.34,16.969,25.6545,7.8185,,16.7365,14.697499999999998,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
148916,90,15,38,uM,uM,0.628342865737372,-4.58161871173099,-3.45777614742397,3.61302532333441,1.0,3.0,-7.63,4.271,5.067,6.244,5.6555,9.0145,,7.335,1.3845,Nilotinib,CHEMBL255863,HHZIURLSWUIHRB-UHFFFAOYSA-N,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,C28H22F3N7O,DB04868,D08953,nilotinib,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
149885,388,30,28,uM,uM,4.15172627083787,-8.74026549380898,-5.90810948075731,1.84555993359756,0.0001210913448318,0.293608877795843,-8.257,-2.849,-5.139,-5.935,-5.537,5.569,,0.016,-2.688,raloxifene,CHEMBL81,GZUITABIAKMVPG-UHFFFAOYSA-N,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,C28H27NO4S,DB00481,D08465,raloxifene,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
149937,100,30,38,uM,uM,-0.878019780466382,-46.3672975313352,0.474226325807926,-0.0496700815926744,0.0019330152227597,0.0097628103283271,25.438,0.81,23.12,60.153,41.6365,15.3885,,28.5125,16.1985,Romidepsin,CHEMBL343448,OHRURASPPZQGQM-GCCNXGTGSA-N,CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C,C24H36N4O6S2,,D06637,romidepsin,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
150383,8,39,28,uM,uM,2.54679914235389,-14.1250909495236,1.67194432553292,3.14560006839831,0.0160618999590822,10.0,7.572,-1.317,3.039,16.131,9.585,3.33,,6.457500000000001,2.013000000000001,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,allopurinol,CHEMBL1467,OFCNXPDARWKPPY-UHFFFAOYSA-N,C1=C2C(=NC=NC2=O)NN1; C1=NNC2=C1C(=O)NC=N2,C5H4N4O,DB00437,D00224,allopurinol,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
150527,388,86,38,uM,uM,-7.42823017976228,-7.03491544163766,-3.95077367419207,-8.24640111965167,0.171190531391502,6.0,12.108,5.271,8.932,7.39,8.161,-9.218,,-0.5285000000000011,-3.947000000000001,raloxifene,CHEMBL81,GZUITABIAKMVPG-UHFFFAOYSA-N,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,C28H27NO4S,DB00481,D08465,raloxifene,methoxsalen,CHEMBL416,QXKHYNVANLEOEG-UHFFFAOYSA-N,COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,C12H8O4,DB00553,D00139,methoxsalen,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
150723,39,75,28,uM,uM,-1.84634421294084,2.79178671380302,-0.563861555789878,-2.32196871692345,0.515524267553202,2.73710599865836e-06,3.056,2.235,2.571,1.789,2.18,-3.111,,-0.4655,-0.8759999999999999,allopurinol,CHEMBL1467,OFCNXPDARWKPPY-UHFFFAOYSA-N,C1=C2C(=NC=NC2=O)NN1; C1=NNC2=C1C(=O)NC=N2,C5H4N4O,DB00437,D00224,allopurinol,ifosfamide,CHEMBL1024,HOMGKSMUEGBAAB-UHFFFAOYSA-N,C1CN(P(=O)(OC1)NCCCl)CCCl,C7H15Cl2N2O2P,DB01181,D00343,ifosfamide,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
150794,388,52,38,uM,uM,-2.37797239342449,4.17459509208992,5.81729755730056,5.83318801908553,0.0903119390827007,0.918895603107544,2.249,3.357,9.143,7.62,8.3815,2.7755,,5.578500000000001,5.024500000000001,raloxifene,CHEMBL81,GZUITABIAKMVPG-UHFFFAOYSA-N,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,C28H27NO4S,DB00481,D08465,raloxifene,celecoxib,CHEMBL118,RZEKVGVHFLEQIL-UHFFFAOYSA-N,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,C17H14F3N3O2S,DB00482,D00567,celecoxib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
150993,35,75,38,uM,uM,-1.70746158252,-6.53787739251485,-1.90943331850627,-0.260115376098087,0.453715452023561,100.0,-0.396,1.939,0.373,13.357,6.865,5.322,,6.093500000000001,4.926,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,ifosfamide,CHEMBL1024,HOMGKSMUEGBAAB-UHFFFAOYSA-N,C1CN(P(=O)(OC1)NCCCl)CCCl,C7H15Cl2N2O2P,DB01181,D00343,ifosfamide,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
151306,35,39,28,uM,uM,-6.96795832235132,-1.06329295239692,-2.12498887406182,-2.53315105679846,0.499610467840844,5.03320952824429e-13,8.215,1.321,4.606,39.357,21.9815,12.4455,,17.2135,13.7665,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,allopurinol,CHEMBL1467,OFCNXPDARWKPPY-UHFFFAOYSA-N,C1=C2C(=NC=NC2=O)NN1; C1=NNC2=C1C(=O)NC=N2,C5H4N4O,DB00437,D00224,allopurinol,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
151464,40,108,38,uM,uM,0.127222138899779,-24.821661679551,-1.082776147424,-0.656034801653402,38.9816803471719,1.03366265531186,-0.933,30.715,29.272,29.757,29.5145,-0.267500000000002,,14.623500000000002,-1.200499999999998,altretamine,CHEMBL1455,UUVWYPNAQBNQJQ-UHFFFAOYSA-N,CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C,C9H18N6,DB00488,D02841,altretamine,6-Thioguanine,CHEMBL727,WYWHKKSPHMUBEB-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=C(N2)N,C5H5N5S,DB00352,D08603,thioguanine,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
151525,31,8,38,uM,uM,5.3804447418545,-2.9352482264899,-2.28555392520176,4.57898603739591,16.7767822158723,0.0462823125036052,-8.243,0.322,-6.068,16.913,5.4225,13.3435,,9.383,5.1005,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
151681,90,86,28,uM,uM,-0.26930798765445,-1.49726220990346,-3.27669468980505,-1.93485385935326,0.0326248732738443,2.49238167529758,-1.698,0.335,0.33,-0.404,-0.037,1.326,,0.6445,-0.372,Nilotinib,CHEMBL255863,HHZIURLSWUIHRB-UHFFFAOYSA-N,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,C28H22F3N7O,DB04868,D08953,nilotinib,methoxsalen,CHEMBL416,QXKHYNVANLEOEG-UHFFFAOYSA-N,COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,C12H8O4,DB00553,D00139,methoxsalen,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
151765,31,90,38,uM,uM,0.391314478559357,0.479307672209719,-0.37146903862765,1.91782637664925,8.86604734350552,0.0336301677640424,-3.006,0.561,0.59,0.342,0.466,2.911,,1.6885,-0.095,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,Nilotinib,CHEMBL255863,HHZIURLSWUIHRB-UHFFFAOYSA-N,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,C28H22F3N7O,DB04868,D08953,nilotinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
152014,90,96,38,uM,uM,4.06014901680263,-17.6485324647419,-0.542220591868444,2.61490112854927,0.452884311793375,1.86748057980296e-05,-4.525,43.534,38.238,44.508,41.373,2.364,,21.8685,-2.1610000000000014,Nilotinib,CHEMBL255863,HHZIURLSWUIHRB-UHFFFAOYSA-N,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,C28H22F3N7O,DB04868,D08953,nilotinib,Pralatrexate,CHEMBL1201746,OGSBUKJUDHAQEA-WMCAAGNKSA-N,C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,C23H23N7O5,DB06813,D05589,pralatrexate,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
152498,15,86,38,uM,uM,4.89413578635852,-2.46639812070668,-2.37555392520175,-0.592396432152525,3.0,0.089053231514339,-1.21,2.82,0.274,0.235,0.2545,-1.3555,,-0.5505,-2.5655,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,methoxsalen,CHEMBL416,QXKHYNVANLEOEG-UHFFFAOYSA-N,COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,C12H8O4,DB00553,D00139,methoxsalen,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
152572,52,75,28,uM,uM,-2.22540149445129,3.64966050208112,3.33142284528494,1.80691546533157,0.0594470027313992,2.73710599865836e-06,2.625,2.235,3.569,5.161,4.365,-0.494999999999999,,1.9350000000000005,1.7400000000000002,celecoxib,CHEMBL118,RZEKVGVHFLEQIL-UHFFFAOYSA-N,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,C17H14F3N3O2S,DB00482,D00567,celecoxib,ifosfamide,CHEMBL1024,HOMGKSMUEGBAAB-UHFFFAOYSA-N,C1CN(P(=O)(OC1)NCCCl)CCCl,C7H15Cl2N2O2P,DB01181,D00343,ifosfamide,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
152638,230,75,38,uM,uM,2.02987308347392,-5.44358337155683,-6.13559978585479,-2.16897260355547,0.363571964976341,100.0,-4.387,1.939,-5.504,-1.235,-3.3695,-0.9215,,-2.1455,-5.3085,Imatinib,CHEMBL941,KTUFNOKKBVMGRW-UHFFFAOYSA-N,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,C29H31N7O,DB00619,D01441,imatinib,ifosfamide,CHEMBL1024,HOMGKSMUEGBAAB-UHFFFAOYSA-N,C1CN(P(=O)(OC1)NCCCl)CCCl,C7H15Cl2N2O2P,DB01181,D00343,ifosfamide,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
153557,90,78,38,uM,uM,2.42450527952949,1.01262736331019,3.21889554455394,1.74320411170592,1.0,0.0203391763747341,2.267,26.291,33.202,29.56,31.381,2.823,,17.102,5.09,Nilotinib,CHEMBL255863,HHZIURLSWUIHRB-UHFFFAOYSA-N,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,C28H22F3N7O,DB04868,D08953,nilotinib,Ixabepilone,CHEMBL1201752,FABUFPQFXZVHFB-PVYNADRNSA-N,CC1CCCC2(C(O2)CC(NC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C,C27H42N2O5S,DB04845,D04645,ixabepilone,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
153681,8,30,38,uM,uM,-0.803685173426901,-0.0539233891675752,1.04758931263344,1.81178614613543,0.0090534741954492,0.0097628103283271,0.076,0.81,1.34,2.462,1.901,1.015,,1.458,1.091,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
154139,29,85,38,uM,uM,1.1855711181729,-40.5549411959024,-6.88110948075733,-2.52368423968233,20.0,0.695984704897367,-6.196,27.669,45.504,16.746,31.125,9.652,,20.3885,3.4559999999999995,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,6-Mercaptopurine,CHEMBL1425,GLVAUDGFNGKCSF-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=CN2,C5H4N4S,DB01033,D04931,mercaptopurine,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
154157,96,39,38,uM,uM,0.0564721192977915,4.69903130994907,2.06533743691902,4.43132860383433,0.0006,10.0,1.74,-1.932,4.376,4.906,4.641,4.833,,4.737,2.901,Pralatrexate,CHEMBL1201746,OGSBUKJUDHAQEA-WMCAAGNKSA-N,C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,C23H23N7O5,DB06813,D05589,pralatrexate,allopurinol,CHEMBL1467,OFCNXPDARWKPPY-UHFFFAOYSA-N,C1=C2C(=NC=NC2=O)NN1; C1=NNC2=C1C(=O)NC=N2,C5H4N4O,DB00437,D00224,allopurinol,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
154362,28,78,38,uM,uM,-7.86977714994108,-5.52605903433271,-3.24902789998293,-7.80706719589973,0.001382644876657,0.0114154409060072,9.575,29.962,19.177,27.743,23.46,-16.077,,3.691500000000001,-6.501999999999999,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,Ixabepilone,CHEMBL1201752,FABUFPQFXZVHFB-PVYNADRNSA-N,CC1CCCC2(C(O2)CC(NC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C,C27H42N2O5S,DB04845,D04645,ixabepilone,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
155072,35,5,38,uM,uM,-8.24645037807748,-7.95076001916266,1.20974771118926,-0.441930544696688,1.0,0.3,-0.174,17.231,47.222,40.438,43.83,26.773,,35.3015,26.599,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
155271,230,74,38,uM,uM,1.93910239059711,-4.3064423538207,-5.77780580091617,-1.69193175588065,0.302458024468588,1.00270306168241,-3.538,0.167,-4.095,-3.269,-3.682,-0.311,,-1.9965,-3.849,Imatinib,CHEMBL941,KTUFNOKKBVMGRW-UHFFFAOYSA-N,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,C29H31N7O,DB00619,D01441,imatinib,hydroxyurea,CHEMBL467,VSNHCAURESNICA-UHFFFAOYSA-N,C(=O)(N)NO,CH4N2O2,DB01005,D00341,hydroxyurea,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
155392,230,90,28,uM,uM,3.4616320103442,4.07102245189618,3.09731926214601,7.69257170802347,0.0713462035134649,0.0117946741736568,-4.599,-1.69,1.206,0.768,0.987,7.276,,4.1315,2.677,Imatinib,CHEMBL941,KTUFNOKKBVMGRW-UHFFFAOYSA-N,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,C29H31N7O,DB00619,D01441,imatinib,Nilotinib,CHEMBL255863,HHZIURLSWUIHRB-UHFFFAOYSA-N,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,C28H22F3N7O,DB04868,D08953,nilotinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
155889,388,15,28,uM,uM,7.64652254691139,-3.07008190345826,-2.68381346520638,7.45342806328813,0.0001210913448318,2.0,-8.257,-9.435,-6.072,-10.881,-8.4765,9.2155,,0.3695000000000004,-0.2195,raloxifene,CHEMBL81,GZUITABIAKMVPG-UHFFFAOYSA-N,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,C28H27NO4S,DB00481,D08465,raloxifene,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
156156,388,108,28,uM,uM,1.74328381736069,-11.9041652710956,-0.3820932735965,1.15983620859895,0.024411737372345,1.28365692664823,-3.094,36.373,28.11,33.912,31.011,-2.268,,14.3715,-5.361999999999998,raloxifene,CHEMBL81,GZUITABIAKMVPG-UHFFFAOYSA-N,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,C28H27NO4S,DB00481,D08465,raloxifene,6-Thioguanine,CHEMBL727,WYWHKKSPHMUBEB-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=C(N2)N,C5H5N5S,DB00352,D08603,thioguanine,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
156206,96,78,38,uM,uM,-0.860791890625057,-4.17667589842776,-3.8368056777607,-2.23995035036451,1.3397683327006e-05,0.0203391763747341,-1.213,26.291,19.475,24.829,22.152,-2.926,,9.613,-4.138999999999999,Pralatrexate,CHEMBL1201746,OGSBUKJUDHAQEA-WMCAAGNKSA-N,C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,C23H23N7O5,DB06813,D05589,pralatrexate,Ixabepilone,CHEMBL1201752,FABUFPQFXZVHFB-PVYNADRNSA-N,CC1CCCC2(C(O2)CC(NC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C,C27H42N2O5S,DB04845,D04645,ixabepilone,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
156283,80,8,28,uM,uM,-0.77904425262686,-13.0549446436574,-8.15882748048229,-6.26549590920054,0.0124667911029347,0.1,-3.868,4.477,1.566,-2.018,-0.226,-0.835,,-0.5305000000000002,-4.703,letrozole,CHEMBL1444,HPJKCIUCZWXJDR-UHFFFAOYSA-N,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,C17H11N5,DB01006,D00964,letrozole,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
156418,31,48,38,uM,uM,2.07154804640965,-1.50417043202288,-1.23193430894082,3.36413956619896,20.0,20.4443291811165,-2.567,-1.708,-0.346,-1.566,-0.956,3.319,,1.1815000000000002,0.752,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,busulfan,CHEMBL820,COVZYZSDYWQREU-UHFFFAOYSA-N,CS(=O)(=O)OCCCCOS(=O)(=O)C,C6H14O6S2,DB01008,D00248,busulfan,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
157095,100,85,38,uM,uM,1.18557111814398,-7.05179797817787,-6.88110948075733,-2.52368423968233,0.01,0.695984704897367,-6.196,27.669,45.504,16.746,31.125,9.652,,20.3885,3.4559999999999995,Romidepsin,CHEMBL343448,OHRURASPPZQGQM-GCCNXGTGSA-N,CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C,C24H36N4O6S2,,D06637,romidepsin,6-Mercaptopurine,CHEMBL1425,GLVAUDGFNGKCSF-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=CN2,C5H4N4S,DB01033,D04931,mercaptopurine,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
157141,28,96,28,uM,uM,2.80555532501019,-12.0740186085285,-0.465553925201787,0.883222851122311,0.0014643208262997,5.64310095565242e-06,-4.563,78.522,34.63,68.405,51.5175,-22.4415,,14.537999999999997,-27.004500000000007,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,Pralatrexate,CHEMBL1201746,OGSBUKJUDHAQEA-WMCAAGNKSA-N,C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,C23H23N7O5,DB06813,D05589,pralatrexate,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
158172,39,107,28,uM,uM,-5.49950823064385,-8.58194451173685,-6.45355145196985,-7.97347182563342,10.0,0.587883665769743,9.705,1.922,5.398,7.59,6.494,-5.133,,0.6804999999999994,-3.2110000000000003,allopurinol,CHEMBL1467,OFCNXPDARWKPPY-UHFFFAOYSA-N,C1=C2C(=NC=NC2=O)NN1; C1=NNC2=C1C(=O)NC=N2,C5H4N4O,DB00437,D00224,allopurinol,thalidomide,CHEMBL468,UEJJHQNACJXSKW-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,C13H10N2O4,DB01041,D00754,thalidomide,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
158403,96,77,28,uM,uM,2.46139233052446,-2.78090887413159,-2.72888725853508,2.71200014539857,8.09226537362736e-05,0.0088144830043922,-6.947,0.286,-0.026,5.36,2.667,9.328,,5.9975000000000005,2.381,Pralatrexate,CHEMBL1201746,OGSBUKJUDHAQEA-WMCAAGNKSA-N,C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,C23H23N7O5,DB06813,D05589,pralatrexate,IMIQUIMOD,CHEMBL1282,DOUYETYNHWVLEO-UHFFFAOYSA-N,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N,C14H16N4,DB00724,D02500,imiquimod,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
158942,43,75,38,uM,uM,0.0013605100970566,-2.17964129224624,-2.42549010153536,-3.82634030641547,0.0012989591670321,100.0,2.571,1.939,-0.005,3.318,1.6565,-2.8535,,-0.5984999999999998,-0.9145,anastrozole,CHEMBL1399,YBBLVLTVTVSKRW-UHFFFAOYSA-N,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,C17H19N5,DB01217,D00960,anastrozole,ifosfamide,CHEMBL1024,HOMGKSMUEGBAAB-UHFFFAOYSA-N,C1CN(P(=O)(OC1)NCCCl)CCCl,C7H15Cl2N2O2P,DB01181,D00343,ifosfamide,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
159497,8,77,28,uM,uM,0.437584164711885,3.0242397266471,5.92285097152984,6.7883552451509,0.0425439934450091,0.0088144830043922,0.86,0.286,11.257,18.73,14.9935,13.8475,,14.4205,14.1335,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,IMIQUIMOD,CHEMBL1282,DOUYETYNHWVLEO-UHFFFAOYSA-N,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N,C14H16N4,DB00724,D02500,imiquimod,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
159787,86,78,28,uM,uM,3.55706024161303,-22.7944605476471,3.20668450418127,1.48592239216564,6.0,0.0051456902154446,3.055,73.025,39.417,79.861,59.639,-16.441,,21.599,-13.386000000000005,methoxsalen,CHEMBL416,QXKHYNVANLEOEG-UHFFFAOYSA-N,COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,C12H8O4,DB00553,D00139,methoxsalen,Ixabepilone,CHEMBL1201752,FABUFPQFXZVHFB-PVYNADRNSA-N,CC1CCCC2(C(O2)CC(NC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C,C27H42N2O5S,DB04845,D04645,ixabepilone,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
159829,85,5,28,uM,uM,-6.54211296114674,-22.3234006420205,-8.41691895547742,-5.7907920269514,0.613886760994948,0.0670668878318534,0.017,40.503,62.708,38.976,50.842,10.322,,30.582,10.339,6-Mercaptopurine,CHEMBL1425,GLVAUDGFNGKCSF-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=CN2,C5H4N4S,DB01033,D04931,mercaptopurine,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
160030,30,39,28,uM,uM,-3.04855432786647,-4.02609504714302,-4.9727666518396,-4.6883060911691,0.48564441761247,5.03320952824429e-13,2.475,1.321,5.444,16.312,10.878,7.082,,8.98,8.403,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,allopurinol,CHEMBL1467,OFCNXPDARWKPPY-UHFFFAOYSA-N,C1=C2C(=NC=NC2=O)NN1; C1=NNC2=C1C(=O)NC=N2,C5H4N4O,DB00437,D00224,allopurinol,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
160032,86,75,38,uM,uM,1.66374792723072,-1.37565479317951,-3.35120248042025,-0.617814703225362,4.39127135710944,47.8958350937766,-2.081,-0.592,-7.491,-4.923,-6.207,-3.534,,-4.8705,-5.615,methoxsalen,CHEMBL416,QXKHYNVANLEOEG-UHFFFAOYSA-N,COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,C12H8O4,DB00553,D00139,methoxsalen,ifosfamide,CHEMBL1024,HOMGKSMUEGBAAB-UHFFFAOYSA-N,C1CN(P(=O)(OC1)NCCCl)CCCl,C7H15Cl2N2O2P,DB01181,D00343,ifosfamide,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
160300,74,75,38,uM,uM,-2.36411280356215,-6.46026220832189,-5.56244034085876,-5.10309032573776,6.70597043088273,9.58563775493199,5.885,-0.464,0.45,-0.066,0.192,-5.229,,-2.5184999999999995,-5.693,hydroxyurea,CHEMBL467,VSNHCAURESNICA-UHFFFAOYSA-N,C(=O)(N)NO,CH4N2O2,DB01005,D00341,hydroxyurea,ifosfamide,CHEMBL1024,HOMGKSMUEGBAAB-UHFFFAOYSA-N,C1CN(P(=O)(OC1)NCCCl)CCCl,C7H15Cl2N2O2P,DB01181,D00343,ifosfamide,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
160795,388,101,28,uM,uM,6.69604285431354,-0.422341240528,-1.78242033333333,6.33914000770862,0.0001327104903001,0.216443921991295,-8.257,-4.918,-6.039,-6.658,-6.3485,6.8265,,0.2390000000000007,-1.4304999999999994,raloxifene,CHEMBL81,GZUITABIAKMVPG-UHFFFAOYSA-N,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,C28H27NO4S,DB00481,D08465,raloxifene,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
161030,90,78,28,uM,uM,4.2566002484965,-7.49136319882436,2.18652577777778,4.11648760826923,0.997239298910742,0.0049349515627974,-6.616,77.504,50.267,80.204,65.2355,-5.6525,,29.7915,-12.268500000000005,Nilotinib,CHEMBL255863,HHZIURLSWUIHRB-UHFFFAOYSA-N,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,C28H22F3N7O,DB04868,D08953,nilotinib,Ixabepilone,CHEMBL1201752,FABUFPQFXZVHFB-PVYNADRNSA-N,CC1CCCC2(C(O2)CC(NC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C,C27H42N2O5S,DB04845,D04645,ixabepilone,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
161078,230,15,7,uM,uM,1.33231272196602,-15.4819366616022,-8.37444281409064,0.905155251046782,0.103963413146861,0.483744839663606,-9.837,6.582,-7.957,-4.047,-6.002,-2.747,,-4.374499999999999,-12.584,Imatinib,CHEMBL941,KTUFNOKKBVMGRW-UHFFFAOYSA-N,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,C29H31N7O,DB00619,D01441,imatinib,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,A549,C3512,Lung (Carcinoma),Lung adenocarcinoma
161241,43,28,28,uM,uM,2.95847470236093,-28.8883918371853,-6.72444281409065,1.60136823426918,0.1,0.0016018065100563,-9.729,10.915,7.4,18.199,12.7995,11.6135,,12.2065,1.884500000000001,anastrozole,CHEMBL1399,YBBLVLTVTVSKRW-UHFFFAOYSA-N,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,C17H19N5,DB01217,D00960,anastrozole,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
161459,90,8,7,uM,uM,-0.0652237555366446,-23.3086289002086,-2.72111015444444,3.13258332364411,0.0474842976287694,0.1,-6.202,5.181,14.167,1.703,7.935,8.956,,8.4455,2.754,Nilotinib,CHEMBL255863,HHZIURLSWUIHRB-UHFFFAOYSA-N,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,C28H22F3N7O,DB04868,D08953,nilotinib,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,A549,C3512,Lung (Carcinoma),Lung adenocarcinoma
161510,28,77,28,uM,uM,-5.5413429161227,-12.5204925176079,-2.5549004,-2.41975046143334,0.0045018174796428,0.07,6.524,1.012,13.42,29.359,21.3895,13.8535,,17.6215,14.8655,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,IMIQUIMOD,CHEMBL1282,DOUYETYNHWVLEO-UHFFFAOYSA-N,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N,C14H16N4,DB00724,D02500,imiquimod,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
161574,35,74,38,uM,uM,-5.76012814158513,-11.6738466043254,0.705183511111111,1.14579981530033,0.363518192891702,1.00268810262577,10.228,0.167,17.205,15.201,16.203,5.808,,11.0055,5.975,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,hydroxyurea,CHEMBL467,VSNHCAURESNICA-UHFFFAOYSA-N,C(=O)(N)NO,CH4N2O2,DB01005,D00341,hydroxyurea,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
161860,100,75,28,uM,uM,-0.0531354921303953,-0.411476652567782,-0.536011600000002,0.460426942477976,0.0048533273409437,2.73710444642706e-06,19.341,2.235,31.381,64.956,48.1685,26.5925,,37.3805,28.8275,Romidepsin,CHEMBL343448,OHRURASPPZQGQM-GCCNXGTGSA-N,CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C,C24H36N4O6S2,,D06637,romidepsin,ifosfamide,CHEMBL1024,HOMGKSMUEGBAAB-UHFFFAOYSA-N,C1CN(P(=O)(OC1)NCCCl)CCCl,C7H15Cl2N2O2P,DB01181,D00343,ifosfamide,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
162055,388,8,28,uM,uM,-0.494909602474806,-21.5541034875418,-2.97710934444445,3.72539652201081,0.0001327104903001,0.0128305925809103,-8.257,14.885,8.673,14.311,11.492,4.864,,8.178,-3.392999999999999,raloxifene,CHEMBL81,GZUITABIAKMVPG-UHFFFAOYSA-N,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,C28H27NO4S,DB00481,D08465,raloxifene,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
162092,230,30,28,uM,uM,3.31328065419634,-10.8017632384976,-10.0882762888889,-0.631511230406347,2.61867266769017,0.7254659487299,-6.599,-2.658,-7.998,-11.88,-9.939,-0.682,,-5.3105,-7.281000000000001,Imatinib,CHEMBL941,KTUFNOKKBVMGRW-UHFFFAOYSA-N,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,C29H31N7O,DB00619,D01441,imatinib,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
162203,31,75,38,uM,uM,2.8519109548953,-1.76622542245857,-1.60580036666667,4.58267579774381,12.928221125124,9.5856372430147,-6.099,-0.464,-2.267,-2.079,-2.173,4.39,,1.1085000000000005,-1.709,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,ifosfamide,CHEMBL1024,HOMGKSMUEGBAAB-UHFFFAOYSA-N,C1CN(P(=O)(OC1)NCCCl)CCCl,C7H15Cl2N2O2P,DB01181,D00343,ifosfamide,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
162343,15,96,28,uM,uM,-2.69246994636873,-22.9040263481164,-11.2955558888889,-10.9408369272527,0.0927690738695125,5.64306248484113e-06,-3.131,78.49,10.612,73.626,42.119,-33.24,,4.439500000000002,-36.371,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,Pralatrexate,CHEMBL1201746,OGSBUKJUDHAQEA-WMCAAGNKSA-N,C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,C23H23N7O5,DB06813,D05589,pralatrexate,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
162396,43,5,38,uM,uM,-8.42112206624713,-6.95743787150361,-2.51327202222222,-2.23829038910465,0.0097809024942847,0.3,-0.159,17.231,44.214,9.003,26.6085,9.5365,,18.0725,9.377499999999998,anastrozole,CHEMBL1399,YBBLVLTVTVSKRW-UHFFFAOYSA-N,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,C17H19N5,DB01217,D00960,anastrozole,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
162431,96,86,28,uM,uM,1.44980823466544,-1.57966116311897,-1.27666510777778,2.35705416171677,0.0001,2.49238175155863,-3.668,0.335,2.559,1.5,2.0295,5.3625,,3.696,1.6945,Pralatrexate,CHEMBL1201746,OGSBUKJUDHAQEA-WMCAAGNKSA-N,C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,C23H23N7O5,DB06813,D05589,pralatrexate,methoxsalen,CHEMBL416,QXKHYNVANLEOEG-UHFFFAOYSA-N,COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,C12H8O4,DB00553,D00139,methoxsalen,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
162507,15,30,38,uM,uM,-1.32297015157686,-4.22735596999275,-1.97716607777778,-0.103498663772759,0.782922702044557,0.0097615238192383,0.854,0.807,0.725,3.904,2.3145,0.6535,,1.4839999999999998,1.4604999999999997,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
162606,43,96,28,uM,uM,-7.11976012784732,-45.6653626686986,-13.6434564666667,-12.0908974055892,0.1,0.0001017028993084,-1.879,17.451,8.955,-0.443,4.256,-11.316,,-3.53,-13.195,anastrozole,CHEMBL1399,YBBLVLTVTVSKRW-UHFFFAOYSA-N,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,C17H19N5,DB01217,D00960,anastrozole,Pralatrexate,CHEMBL1201746,OGSBUKJUDHAQEA-WMCAAGNKSA-N,C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,C23H23N7O5,DB06813,D05589,pralatrexate,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
162850,52,5,38,uM,uM,-6.34601549918352,-50.7205956805473,-1.54107690631111,-3.88173106936268,0.0657998090518911,0.3,5.0,17.231,45.177,10.295,27.736,5.505,,16.6205,10.505,celecoxib,CHEMBL118,RZEKVGVHFLEQIL-UHFFFAOYSA-N,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,C17H14F3N3O2S,DB00482,D00567,celecoxib,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
162899,80,39,38,uM,uM,5.69015901690406,1.70290710083617,-1.790218,0.523448906165283,0.381592249210736,10.0,4.846,-1.932,-0.346,1.729,0.6915,-2.2225,,-0.7655000000000001,-4.1545000000000005,letrozole,CHEMBL1444,HPJKCIUCZWXJDR-UHFFFAOYSA-N,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,C17H11N5,DB01006,D00964,letrozole,allopurinol,CHEMBL1467,OFCNXPDARWKPPY-UHFFFAOYSA-N,C1=C2C(=NC=NC2=O)NN1; C1=NNC2=C1C(=O)NC=N2,C5H4N4O,DB00437,D00224,allopurinol,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
163377,100,15,28,uM,uM,-3.47735691936169,-51.8335918269415,-2.13581611111111,-3.54159944253492,0.01,0.086008288783272,41.039,4.041,28.798,99.473,64.1355,19.0555,,41.5955,23.096499999999992,Romidepsin,CHEMBL343448,OHRURASPPZQGQM-GCCNXGTGSA-N,CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C,C24H36N4O6S2,,D06637,romidepsin,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
163684,388,40,38,uM,uM,-3.51502495799534,-12.1349353917453,-7.131885,-1.68254503900329,0.0735284306988261,75.0,10.629,-6.082,0.715,3.723,2.219,-2.328,,-0.0544999999999999,-8.41,raloxifene,CHEMBL81,GZUITABIAKMVPG-UHFFFAOYSA-N,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,C28H27NO4S,DB00481,D08465,raloxifene,altretamine,CHEMBL1455,UUVWYPNAQBNQJQ-UHFFFAOYSA-N,CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C,C9H18N6,DB00488,D02841,altretamine,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
163733,52,86,28,uM,uM,-0.436335473058443,1.23643112125381,1.80453885555556,1.87011363291011,0.722624702435094,2.49238175155863,0.725,0.335,6.37,0.096,3.233,2.173,,2.7030000000000003,2.508,celecoxib,CHEMBL118,RZEKVGVHFLEQIL-UHFFFAOYSA-N,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,C17H14F3N3O2S,DB00482,D00567,celecoxib,methoxsalen,CHEMBL416,QXKHYNVANLEOEG-UHFFFAOYSA-N,COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,C12H8O4,DB00553,D00139,methoxsalen,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
163763,29,107,28,uM,uM,3.61744176809369,7.7468325161024,7.73236455555556,6.13883038429254,20.0,0.587883741983402,3.917,1.922,10.431,11.258,10.8445,5.0055,,7.925000000000001,6.9275,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,thalidomide,CHEMBL468,UEJJHQNACJXSKW-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,C13H10N2O4,DB01041,D00754,thalidomide,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
163828,80,39,28,uM,uM,0.806584305977265,1.74376559356513,-4.46780458888889,-1.80580510857894,0.0332481829497516,10.0,1.872,-1.317,-0.309,-1.199,-0.754,-1.309,,-1.0315,-2.6260000000000003,letrozole,CHEMBL1444,HPJKCIUCZWXJDR-UHFFFAOYSA-N,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,C17H11N5,DB01006,D00964,letrozole,allopurinol,CHEMBL1467,OFCNXPDARWKPPY-UHFFFAOYSA-N,C1=C2C(=NC=NC2=O)NN1; C1=NNC2=C1C(=O)NC=N2,C5H4N4O,DB00437,D00224,allopurinol,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
163946,90,35,28,uM,uM,13.3756998458356,-15.114328273526,-7.02777538888889,13.1922252402543,0.0102071980902988,0.144492295349973,-23.94,2.701,-15.417,0.05,-7.6835,13.5555,,2.936,-10.3845,Nilotinib,CHEMBL255863,HHZIURLSWUIHRB-UHFFFAOYSA-N,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,C28H22F3N7O,DB04868,D08953,nilotinib,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
164395,53,108,38,uM,uM,-11.1060927662248,-5.437932703698,-3.34256894444444,-9.09878652298471,36.0206156402524,1.03364605094231,15.375,30.715,26.807,32.42,29.6135,-16.4765,,6.568499999999997,-1.1015000000000017,chlorambucil,CHEMBL515,JCKYGMPEJWAADB-UHFFFAOYSA-N,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,C14H19Cl2NO2,DB00291,D00266,chlorambucil,6-Thioguanine,CHEMBL727,WYWHKKSPHMUBEB-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=C(N2)N,C5H5N5S,DB00352,D08603,thioguanine,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
164431,52,28,38,uM,uM,-4.83033605712632,-78.4101642840879,1.59222377777778,1.35442241158544,0.612991974441215,0.01,0.266,10.114,29.798,14.097,21.9475,11.5675,,16.7575,11.8335,celecoxib,CHEMBL118,RZEKVGVHFLEQIL-UHFFFAOYSA-N,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,C17H14F3N3O2S,DB00482,D00567,celecoxib,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
164451,39,86,38,uM,uM,-1.38725821440692,0.110567639314151,0.255556877777778,1.1388909892943,0.771689137523472,0.107786796112615,-0.639,2.82,1.886,1.969,1.9275,-0.2535,,0.837,-0.8924999999999998,allopurinol,CHEMBL1467,OFCNXPDARWKPPY-UHFFFAOYSA-N,C1=C2C(=NC=NC2=O)NN1; C1=NNC2=C1C(=O)NC=N2,C5H4N4O,DB00437,D00224,allopurinol,methoxsalen,CHEMBL416,QXKHYNVANLEOEG-UHFFFAOYSA-N,COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,C12H8O4,DB00553,D00139,methoxsalen,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
165150,28,43,38,uM,uM,1.2905585204412,6.48417797751482,8.23647924444444,7.70449688255174,0.0008470904323459,0.0912903046862621,3.96,1.625,12.227,13.079,12.653,7.068,,9.8605,8.693000000000001,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,anastrozole,CHEMBL1399,YBBLVLTVTVSKRW-UHFFFAOYSA-N,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,C17H19N5,DB01217,D00960,anastrozole,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
165168,35,43,28,uM,uM,4.82067225432434,1.33629103802597,-1.01079944444444,-0.77306430180151,0.506831750304548,0.1,1.668,2.554,1.548,0.879,1.2135,-3.0085,,-0.8974999999999997,-1.3404999999999998,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,anastrozole,CHEMBL1399,YBBLVLTVTVSKRW-UHFFFAOYSA-N,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,C17H19N5,DB01217,D00960,anastrozole,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
165638,43,96,38,uM,uM,-0.767408730477969,-5.9482909919316,-4.69209135555556,-3.51943574291249,0.0497056254780888,4.18735762078171e-05,-0.298,2.806,-0.287,-2.925,-1.606,-4.114,,-2.8600000000000003,-4.412,anastrozole,CHEMBL1399,YBBLVLTVTVSKRW-UHFFFAOYSA-N,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,C17H19N5,DB01217,D00960,anastrozole,Pralatrexate,CHEMBL1201746,OGSBUKJUDHAQEA-WMCAAGNKSA-N,C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,C23H23N7O5,DB06813,D05589,pralatrexate,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
166004,30,48,38,uM,uM,-3.23828090882794,-0.564254503547787,-0.514297577777778,-1.7457487320738,0.0297623435963266,50.0,2.198,5.028,6.336,2.623,4.4795,-2.7465,,0.8665000000000003,-0.5484999999999998,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,busulfan,CHEMBL820,COVZYZSDYWQREU-UHFFFAOYSA-N,CS(=O)(=O)OCCCCOS(=O)(=O)C,C6H14O6S2,DB01008,D00248,busulfan,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
166639,75,5,38,uM,uM,-8.8092543640957,-17.1871757582356,-0.99631888888889,-3.03320294821357,30.0618921943594,0.083000891278258,4.058,10.544,26.515,19.24,22.8775,8.2755,,15.5765,12.3335,ifosfamide,CHEMBL1024,HOMGKSMUEGBAAB-UHFFFAOYSA-N,C1CN(P(=O)(OC1)NCCCl)CCCl,C7H15Cl2N2O2P,DB01181,D00343,ifosfamide,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
166657,80,5,28,uM,uM,1.36370500925444,-38.3409993498415,-1.47665993333334,1.91967024401534,0.4,0.0444924565231995,-2.518,34.269,47.614,30.857,39.2355,7.4845,,23.360000000000003,4.966500000000004,letrozole,CHEMBL1444,HPJKCIUCZWXJDR-UHFFFAOYSA-N,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,C17H11N5,DB01006,D00964,letrozole,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
167148,15,29,7,uM,uM,-0.45474856290885,-14.2140798025279,-6.90716722222222,-2.71299766883922,2.24394853179574,0.556430841969183,-2.339,-2.286,-3.178,0.933,-1.1225,3.5025,,1.19,1.1635,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,A549,C3512,Lung (Carcinoma),Lung adenocarcinoma
167501,8,74,38,uM,uM,-2.45199928891334,-14.4811053837663,1.09197937555556,0.9960198538002,0.0891269238921178,1.00268810262577,3.69,0.167,3.167,16.669,9.918,6.061,,7.9895,6.228,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,hydroxyurea,CHEMBL467,VSNHCAURESNICA-UHFFFAOYSA-N,C(=O)(N)NO,CH4N2O2,DB01005,D00341,hydroxyurea,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
167898,29,5,28,uM,uM,1.46916733403463,-63.7197943644665,-0.262215726666669,2.76285060826679,9.29718371523871,0.0444924565231995,-1.11,34.269,31.616,15.202,23.409,-9.75,,6.8295,-10.86,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
168303,75,78,28,uM,uM,4.4035489834331,-22.0702444132093,3.69001633333334,3.54140585656045,2.67777713286683,0.0051454589871745,-2.279,73.019,53.151,77.052,65.1015,-5.63850000000001,,29.7315,-7.917500000000004,ifosfamide,CHEMBL1024,HOMGKSMUEGBAAB-UHFFFAOYSA-N,C1CN(P(=O)(OC1)NCCCl)CCCl,C7H15Cl2N2O2P,DB01181,D00343,ifosfamide,Ixabepilone,CHEMBL1201752,FABUFPQFXZVHFB-PVYNADRNSA-N,CC1CCCC2(C(O2)CC(NC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C,C27H42N2O5S,DB04845,D04645,ixabepilone,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
168354,96,78,28,uM,uM,3.00828201627936,1.40919123804132,1.89208144444444,2.41385191652373,7.71304823934219e-05,0.0049349515627974,-2.545,77.504,54.686,78.294,66.49,-8.46900000000001,,29.0105,-11.01400000000001,Pralatrexate,CHEMBL1201746,OGSBUKJUDHAQEA-WMCAAGNKSA-N,C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,C23H23N7O5,DB06813,D05589,pralatrexate,Ixabepilone,CHEMBL1201752,FABUFPQFXZVHFB-PVYNADRNSA-N,CC1CCCC2(C(O2)CC(NC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C,C27H42N2O5S,DB04845,D04645,ixabepilone,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
169197,80,28,38,uM,uM,-3.60321818630496,-55.7755668082523,-5.22875775555555,-0.439470710712718,0.0139489862585618,0.01,-2.287,10.114,19.027,5.597,12.312,4.485,,8.398499999999999,2.1979999999999986,letrozole,CHEMBL1444,HPJKCIUCZWXJDR-UHFFFAOYSA-N,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,C17H11N5,DB01006,D00964,letrozole,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
169912,31,39,38,uM,uM,-1.53647311746182,1.27678445964733,0.2257243,-0.507960254554832,16.116214940483,10.0,3.294,0.696,4.73,4.822,4.776,0.786,,2.781,1.4819999999999998,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,allopurinol,CHEMBL1467,OFCNXPDARWKPPY-UHFFFAOYSA-N,C1=C2C(=NC=NC2=O)NN1; C1=NNC2=C1C(=O)NC=N2,C5H4N4O,DB00437,D00224,allopurinol,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
170110,88,108,28,uM,uM,-2.68080740225896,-1.9939379526726,2.21965255555555,-1.99695226907675,0.0631629573711623,0.776376318585053,27.297,45.766,53.088,52.811,52.9495,-20.1135,,16.418,7.183500000000002,mitoxantrone,CHEMBL58,KKZJGLLVHKMTCM-UHFFFAOYSA-N,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,C22H28N4O6,DB01204,D08224,mitoxantrone,6-Thioguanine,CHEMBL727,WYWHKKSPHMUBEB-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=C(N2)N,C5H5N5S,DB00352,D08603,thioguanine,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
171447,90,15,28,uM,uM,0.763212481677257,-12.4410336460737,-11.8800719666667,-7.33653226167255,0.112145582278235,0.086008288783272,-4.091,4.041,-9.292,-8.662,-8.977,-8.927,,-8.952,-13.018,Nilotinib,CHEMBL255863,HHZIURLSWUIHRB-UHFFFAOYSA-N,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,C28H22F3N7O,DB04868,D08953,nilotinib,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
171549,388,101,38,uM,uM,-4.45345975459445,-2.98776031348391,-2.16757222222222,-2.37311291315659,0.0182925923188435,4.88689390703771,8.679,-0.633,7.984,2.574,5.279,-2.767,,1.2560000000000002,-3.4000000000000004,raloxifene,CHEMBL81,GZUITABIAKMVPG-UHFFFAOYSA-N,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,C28H27NO4S,DB00481,D08465,raloxifene,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
171619,39,75,38,uM,uM,0.391155813073207,0.722112280487649,0.641723777777778,2.90586747624306,4.52287970688616,100.0,-2.678,1.939,8.014,9.161,8.5875,9.3265,,8.957,6.6485,allopurinol,CHEMBL1467,OFCNXPDARWKPPY-UHFFFAOYSA-N,C1=C2C(=NC=NC2=O)NN1; C1=NNC2=C1C(=O)NC=N2,C5H4N4O,DB00437,D00224,allopurinol,ifosfamide,CHEMBL1024,HOMGKSMUEGBAAB-UHFFFAOYSA-N,C1CN(P(=O)(OC1)NCCCl)CCCl,C7H15Cl2N2O2P,DB01181,D00343,ifosfamide,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
171802,90,48,38,uM,uM,-3.00319580986393,1.93207646282813,-2.80663657777778,-4.65008251391984,0.937170904441558,9.76277026404458,6.826,2.24,3.264,3.967,3.6155,-5.4505,,-0.9174999999999996,-3.2105,Nilotinib,CHEMBL255863,HHZIURLSWUIHRB-UHFFFAOYSA-N,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,C28H22F3N7O,DB04868,D08953,nilotinib,busulfan,CHEMBL820,COVZYZSDYWQREU-UHFFFAOYSA-N,CS(=O)(=O)OCCCCOS(=O)(=O)C,C6H14O6S2,DB01008,D00248,busulfan,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
172046,52,86,38,uM,uM,-1.88943291050395,-2.8485918779339,-3.33113946888889,-5.59827934184583,5.0,0.107786796112615,2.344,2.82,1.763,-4.671,-1.454,-6.618,,-4.036,-4.274,celecoxib,CHEMBL118,RZEKVGVHFLEQIL-UHFFFAOYSA-N,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,C17H14F3N3O2S,DB00482,D00567,celecoxib,methoxsalen,CHEMBL416,QXKHYNVANLEOEG-UHFFFAOYSA-N,COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,C12H8O4,DB00553,D00139,methoxsalen,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
172064,85,90,28,uM,uM,1.44143448206567,-2.1037410799044,3.34505600888889,8.88554327495575,0.692128789651385,0.0117945917851263,2.122,-1.69,0.55,7.208,3.879,3.447,,3.663,1.757,6-Mercaptopurine,CHEMBL1425,GLVAUDGFNGKCSF-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=CN2,C5H4N4S,DB01033,D04931,mercaptopurine,Nilotinib,CHEMBL255863,HHZIURLSWUIHRB-UHFFFAOYSA-N,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,C28H22F3N7O,DB04868,D08953,nilotinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
172386,86,75,28,uM,uM,-3.16461496708727,-44.2614273882782,1.14422472222222,3.45290176129554,6.0,9.19818281488408,18.448,-2.897,18.184,41.466,29.825,14.274,,22.0495,11.377,methoxsalen,CHEMBL416,QXKHYNVANLEOEG-UHFFFAOYSA-N,COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,C12H8O4,DB00553,D00139,methoxsalen,ifosfamide,CHEMBL1024,HOMGKSMUEGBAAB-UHFFFAOYSA-N,C1CN(P(=O)(OC1)NCCCl)CCCl,C7H15Cl2N2O2P,DB01181,D00343,ifosfamide,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
172730,96,107,38,uM,uM,0.144971209706864,-4.89894413427848,-4.89888756666667,-1.79491285230138,0.0001,2.69506480288668e-07,-3.167,2.732,-1.428,-0.778,-1.103,-0.668,,-0.8855000000000002,-3.835,Pralatrexate,CHEMBL1201746,OGSBUKJUDHAQEA-WMCAAGNKSA-N,C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,C23H23N7O5,DB06813,D05589,pralatrexate,thalidomide,CHEMBL468,UEJJHQNACJXSKW-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,C13H10N2O4,DB01041,D00754,thalidomide,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
173212,35,75,28,uM,uM,-7.4368068756866,-3.16303476488135,-3.2314538,-4.55697785467548,0.132813365066142,2.73710444642706e-06,14.2,2.235,5.329,5.908,5.6185,-10.8165,,-2.599,-8.581499999999998,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,ifosfamide,CHEMBL1024,HOMGKSMUEGBAAB-UHFFFAOYSA-N,C1CN(P(=O)(OC1)NCCCl)CCCl,C7H15Cl2N2O2P,DB01181,D00343,ifosfamide,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
173409,30,77,38,uM,uM,4.96416943509446,-6.56431351691991,-7.45777594444444,0.666853855042537,0.647223927181742,0.0020538333057086,-7.579,-2.222,-9.099,-6.627,-7.863,1.938,,-2.9625000000000004,-5.641,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,IMIQUIMOD,CHEMBL1282,DOUYETYNHWVLEO-UHFFFAOYSA-N,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N,C14H16N4,DB00724,D02500,imiquimod,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
173906,15,43,28,uM,uM,-1.57453960702524,-6.3796977103751,-7.10827762222222,-2.78843373297884,1.47533921685541,0.1,-3.209,2.554,-1.5,1.578,0.039,0.694,,0.3665000000000001,-2.515,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,anastrozole,CHEMBL1399,YBBLVLTVTVSKRW-UHFFFAOYSA-N,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,C17H19N5,DB01217,D00960,anastrozole,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
174077,31,30,38,uM,uM,1.6926276357774,-5.2987571146592,-5.16555397777778,-0.856539535731006,20.0,0.0097615238192383,-3.649,0.807,-5.246,-3.668,-4.457,-1.615,,-3.036,-5.264,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
174153,35,96,28,uM,uM,8.26497539093877,-5.19847045922755,6.41,6.65133580918164,0.299791429193112,5.64306248484113e-06,-1.248,78.49,63.213,80.318,71.7655,-5.47649999999999,,33.14450000000001,-6.724499999999992,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,Pralatrexate,CHEMBL1201746,OGSBUKJUDHAQEA-WMCAAGNKSA-N,C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,C23H23N7O5,DB06813,D05589,pralatrexate,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
174818,230,96,28,uM,uM,4.86794133097184,-13.6084704592276,-2.0,0.690803023349916,5.0,5.64306248484113e-06,-9.297,78.49,33.046,70.406,51.726,-17.467,,17.1295,-26.764,Imatinib,CHEMBL941,KTUFNOKKBVMGRW-UHFFFAOYSA-N,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,C29H31N7O,DB00619,D01441,imatinib,Pralatrexate,CHEMBL1201746,OGSBUKJUDHAQEA-WMCAAGNKSA-N,C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,C23H23N7O5,DB06813,D05589,pralatrexate,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
174870,35,74,28,uM,uM,-3.05508892382942,-14.2459954299912,2.00058211555556,2.89020681284183,0.496568263911327,1.98131635465789,8.474,-0.61,13.878,30.547,22.2125,14.3485,,18.2805,13.738499999999998,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,hydroxyurea,CHEMBL467,VSNHCAURESNICA-UHFFFAOYSA-N,C(=O)(N)NO,CH4N2O2,DB01005,D00341,hydroxyurea,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
174935,39,5,38,uM,uM,-9.53039493477966,-35.4859397674414,-2.31692007777778,-3.11998973376109,3.17194305645921,0.3,1.002,17.231,47.424,18.543,32.9835,14.7505,,23.867,15.752499999999998,allopurinol,CHEMBL1467,OFCNXPDARWKPPY-UHFFFAOYSA-N,C1=C2C(=NC=NC2=O)NN1; C1=NNC2=C1C(=O)NC=N2,C5H4N4O,DB00437,D00224,allopurinol,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
175171,90,35,7,uM,uM,1.55869781655068,-13.9805415335175,-9.61444321111111,-1.86221495994319,0.222174405862631,0.292734083615513,-7.569,3.034,-6.3,-7.112,-6.706,-2.171,,-4.4385,-9.74,Nilotinib,CHEMBL255863,HHZIURLSWUIHRB-UHFFFAOYSA-N,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,C28H22F3N7O,DB04868,D08953,nilotinib,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,A549,C3512,Lung (Carcinoma),Lung adenocarcinoma
175591,100,86,38,uM,uM,-0.0395883346569941,-3.37488567938629,-3.2938329,-1.46882139242634,0.0021211433528711,0.107786796112615,16.029,2.82,25.666,34.788,30.227,11.378,,20.8025,14.198,Romidepsin,CHEMBL343448,OHRURASPPZQGQM-GCCNXGTGSA-N,CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C,C24H36N4O6S2,,D06637,romidepsin,methoxsalen,CHEMBL416,QXKHYNVANLEOEG-UHFFFAOYSA-N,COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,C12H8O4,DB00553,D00139,methoxsalen,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
175910,31,78,28,uM,uM,0.497321194835127,-26.8416786951379,-0.972222222222225,-1.85961130909049,5.80614190160067,0.0059041832777556,2.444,66.783,36.698,67.881,52.2895,-16.9375,,17.675999999999995,-14.493500000000004,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,Ixabepilone,CHEMBL1201752,FABUFPQFXZVHFB-PVYNADRNSA-N,CC1CCCC2(C(O2)CC(NC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C,C27H42N2O5S,DB04845,D04645,ixabepilone,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
176198,74,90,38,uM,uM,-2.30093417531934,-1.00800945135026,-1.09034751111111,-1.98364526047736,9.53281089210229e-08,0.0336325681627958,4.103,0.561,3.677,3.083,3.38,-1.284,,1.048,-0.7229999999999999,hydroxyurea,CHEMBL467,VSNHCAURESNICA-UHFFFAOYSA-N,C(=O)(N)NO,CH4N2O2,DB01005,D00341,hydroxyurea,Nilotinib,CHEMBL255863,HHZIURLSWUIHRB-UHFFFAOYSA-N,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,C28H22F3N7O,DB04868,D08953,nilotinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
176706,230,74,28,uM,uM,-0.288577927831208,-4.6635157603053,-3.76608380666667,-0.584616599099178,2.26240562480486,1.98131635465789,-1.733,-0.61,0.988,1.733,1.3605,3.7035,,2.532,1.9705,Imatinib,CHEMBL941,KTUFNOKKBVMGRW-UHFFFAOYSA-N,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,C29H31N7O,DB00619,D01441,imatinib,hydroxyurea,CHEMBL467,VSNHCAURESNICA-UHFFFAOYSA-N,C(=O)(N)NO,CH4N2O2,DB01005,D00341,hydroxyurea,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
177280,30,77,28,uM,uM,0.0432609402671288,-5.82223587739773,-5.47383178888889,-2.54207646342677,0.466280884002159,0.0088145103337468,-2.952,0.286,-2.69,-2.23,-2.46,0.206,,-1.127,-2.746,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,IMIQUIMOD,CHEMBL1282,DOUYETYNHWVLEO-UHFFFAOYSA-N,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N,C14H16N4,DB00724,D02500,imiquimod,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
177453,108,8,28,uM,uM,-2.32676406079502,-3.62362457478683,0.140564888888889,-0.644917353704462,1.34021832818933,0.0478811819350707,31.67,17.234,54.81,36.332,45.571,-3.33300000000001,,21.119,13.900999999999996,6-Thioguanine,CHEMBL727,WYWHKKSPHMUBEB-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=C(N2)N,C5H5N5S,DB00352,D08603,thioguanine,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
177557,85,107,38,uM,uM,-6.0517862830032,-40.2341624487422,-6.079107,-5.86212611860593,2.0,0.31213319318303,28.698,0.14,24.328,56.12,40.224,11.386,,25.805,11.525999999999996,6-Mercaptopurine,CHEMBL1425,GLVAUDGFNGKCSF-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=CN2,C5H4N4S,DB01033,D04931,mercaptopurine,thalidomide,CHEMBL468,UEJJHQNACJXSKW-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,C13H10N2O4,DB01041,D00754,thalidomide,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
177797,388,85,28,uM,uM,3.12191223161676,-8.36406022191303,-3.35293933333333,5.57699052653368,1.0,0.820090820133949,-8.397,-4.802,11.468,-1.515,4.9765,18.1755,,11.576,9.7785,raloxifene,CHEMBL81,GZUITABIAKMVPG-UHFFFAOYSA-N,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,C28H27NO4S,DB00481,D08465,raloxifene,6-Mercaptopurine,CHEMBL1425,GLVAUDGFNGKCSF-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=CN2,C5H4N4S,DB01033,D04931,mercaptopurine,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
178604,388,53,28,uM,uM,-1.04596040399278,4.38662204257452,4.29718645777778,8.83674008711993,0.0245680781616445,54.9558578571309,-3.094,0.719,29.055,17.765,23.41,25.785,,24.5975,22.691,raloxifene,CHEMBL81,GZUITABIAKMVPG-UHFFFAOYSA-N,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,C28H27NO4S,DB00481,D08465,raloxifene,chlorambucil,CHEMBL515,JCKYGMPEJWAADB-UHFFFAOYSA-N,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,C14H19Cl2NO2,DB00291,D00266,chlorambucil,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
178665,48,86,38,uM,uM,-2.86243512599489,0.730628055669384,0.782833766666667,0.0893928202668667,7.37216215231049,0.107786796112615,3.086,2.82,5.617,10.21,7.9135,2.0075,,4.9605,4.827500000000001,busulfan,CHEMBL820,COVZYZSDYWQREU-UHFFFAOYSA-N,CS(=O)(=O)OCCCCOS(=O)(=O)C,C6H14O6S2,DB01008,D00248,busulfan,methoxsalen,CHEMBL416,QXKHYNVANLEOEG-UHFFFAOYSA-N,COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,C12H8O4,DB00553,D00139,methoxsalen,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
178791,28,75,28,uM,uM,0.619569096652988,-9.17381601833565,1.08613702222222,7.47019434691436,0.0053835881477344,100.0,-1.332,-5.124,4.677,30.865,17.771,24.227,,20.999,19.103,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,ifosfamide,CHEMBL1024,HOMGKSMUEGBAAB-UHFFFAOYSA-N,C1CN(P(=O)(OC1)NCCCl)CCCl,C7H15Cl2N2O2P,DB01181,D00343,ifosfamide,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
178824,28,86,38,uM,uM,-4.81364087151461,-69.1108255248863,-1.74577444444444,-3.13975812176223,0.01,6.0,9.585,1.566,7.518,18.145,12.8315,1.6805,,7.255999999999999,3.2465,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,methoxsalen,CHEMBL416,QXKHYNVANLEOEG-UHFFFAOYSA-N,COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,C12H8O4,DB00553,D00139,methoxsalen,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
178887,388,29,38,uM,uM,-5.37260223310722,-0.913500560478029,2.83327244444445,1.29850481060887,0.0182925923188435,1.52280262326198,8.679,16.866,16.994,13.342,15.168,-10.377,,2.3954999999999984,-1.6980000000000004,raloxifene,CHEMBL81,GZUITABIAKMVPG-UHFFFAOYSA-N,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,C28H27NO4S,DB00481,D08465,raloxifene,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
179608,28,35,28,uM,uM,1.72696347214607,-25.1339848458253,1.6809575,2.87521758103459,0.0013031646279368,0.144492295349973,29.932,2.701,19.461,7.608,13.5345,-19.0985,,-2.7819999999999983,-16.3975,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
179862,80,96,28,uM,uM,3.94310904475009,-10.504026014783,1.10444444444445,3.68772897244756,0.0577493687960728,5.64306248484113e-06,-8.899,78.49,51.623,78.052,64.8375,-4.75349999999999,,30.04200000000001,-13.65249999999999,letrozole,CHEMBL1444,HPJKCIUCZWXJDR-UHFFFAOYSA-N,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,C17H11N5,DB01006,D00964,letrozole,Pralatrexate,CHEMBL1201746,OGSBUKJUDHAQEA-WMCAAGNKSA-N,C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,C23H23N7O5,DB06813,D05589,pralatrexate,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
180883,85,90,38,uM,uM,-1.76078822749981,-2.89672317685014,-1.73352137777778,-2.19032054154193,0.177433492493151,0.0336325681627958,3.567,0.561,3.594,2.263,2.9285,-1.1995,,0.8645,-0.6385000000000001,6-Mercaptopurine,CHEMBL1425,GLVAUDGFNGKCSF-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=CN2,C5H4N4S,DB01033,D04931,mercaptopurine,Nilotinib,CHEMBL255863,HHZIURLSWUIHRB-UHFFFAOYSA-N,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,C28H22F3N7O,DB04868,D08953,nilotinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
181428,28,96,38,uM,uM,-3.55129609231375,-1.72263801359142,-1.29555122222222,-4.33918400665009,0.01,1.86748693003456e-05,10.261,43.534,30.126,35.248,32.687,-21.108,,5.789499999999997,-10.847,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,Pralatrexate,CHEMBL1201746,OGSBUKJUDHAQEA-WMCAAGNKSA-N,C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,C23H23N7O5,DB06813,D05589,pralatrexate,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
181444,80,230,38,uM,uM,4.97036911938893,-6.0919805643739,-7.32466615555556,1.91172132215936,0.175090299398795,3.36394247269348,-8.506,-2.051,-16.476,-10.322,-13.399,-2.842,,-8.1205,-11.348,letrozole,CHEMBL1444,HPJKCIUCZWXJDR-UHFFFAOYSA-N,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,C17H11N5,DB01006,D00964,letrozole,Imatinib,CHEMBL941,KTUFNOKKBVMGRW-UHFFFAOYSA-N,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,C29H31N7O,DB00619,D01441,imatinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
181702,30,86,28,uM,uM,-2.6586556836884,-3.39161327822264,-1.94164003333333,0.0681938933393099,0.538973861948993,2.49238175155863,4.647,0.335,11.612,16.475,14.0435,9.0615,,11.5525,9.3965,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,methoxsalen,CHEMBL416,QXKHYNVANLEOEG-UHFFFAOYSA-N,COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,C12H8O4,DB00553,D00139,methoxsalen,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
181987,8,30,28,uM,uM,3.28924864147652,2.63469423101345,3.22616804444444,12.0865093339314,0.0482742172073692,0.7254659487299,-6.483,-2.658,9.286,8.578,8.932,18.073,,13.5025,11.59,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
182148,29,48,28,uM,uM,1.19666080640283,-5.14426618841013,-4.03567855555556,1.40195251249735,20.0,3.7034900895783,-5.166,0.497,-4.394,0.429,-1.9825,2.6865,,0.3520000000000003,-2.4795,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,busulfan,CHEMBL820,COVZYZSDYWQREU-UHFFFAOYSA-N,CS(=O)(=O)OCCCCOS(=O)(=O)C,C6H14O6S2,DB01008,D00248,busulfan,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
182361,28,5,28,uM,uM,-1.45704126743899,-3.82068967318715,-1.40469911111111,-1.74235371147284,0.0019421479090801,0.0672032482713224,14.129,40.503,92.863,47.061,69.962,15.33,,42.646,29.459000000000003,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
182947,35,85,28,uM,uM,-10.4833122720925,-4.69396802167051,2.48544816666667,3.23275424081237,0.147120546229071,0.280210804959952,14.183,13.778,18.794,15.582,17.188,-10.773,,3.2075,3.004999999999999,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,6-Mercaptopurine,CHEMBL1425,GLVAUDGFNGKCSF-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=CN2,C5H4N4S,DB01033,D04931,mercaptopurine,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
183119,28,107,28,uM,uM,-5.02224324969396,-20.5403555624808,-0.820588928888889,-0.0484705488200392,0.0034439273152127,5.83307913893373,3.692,0.91,10.121,17.005,13.563,8.961,,11.262,9.871,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,thalidomide,CHEMBL468,UEJJHQNACJXSKW-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,C13H10N2O4,DB01041,D00754,thalidomide,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
183396,388,28,28,uM,uM,-6.71233566535302,-19.353898121323,-1.55801144444445,2.05959852958744,1.0,0.0054438254845205,-4.051,15.925,38.735,12.013,25.374,13.5,,19.437,9.448999999999998,raloxifene,CHEMBL81,GZUITABIAKMVPG-UHFFFAOYSA-N,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,C28H27NO4S,DB00481,D08465,raloxifene,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
183625,52,8,38,uM,uM,-0.528303125986972,0.321536832035041,0.472020911111111,1.7808412211743,0.437006081602928,0.0462823943752059,-0.842,0.322,5.32,3.005,4.1625,4.6825,,4.422499999999999,3.8405,celecoxib,CHEMBL118,RZEKVGVHFLEQIL-UHFFFAOYSA-N,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,C17H14F3N3O2S,DB00482,D00567,celecoxib,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
183631,96,85,38,uM,uM,1.18565335953929,-6.89100012894238,-6.88111038888889,-2.52368418753684,0.0006,0.695815622821477,-6.192,27.669,45.507,16.746,31.1265,9.6495,,20.388,3.4575,Pralatrexate,CHEMBL1201746,OGSBUKJUDHAQEA-WMCAAGNKSA-N,C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,C23H23N7O5,DB06813,D05589,pralatrexate,6-Mercaptopurine,CHEMBL1425,GLVAUDGFNGKCSF-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=CN2,C5H4N4S,DB01033,D04931,mercaptopurine,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
183736,52,30,38,uM,uM,0.0129575111808606,0.773510376421543,0.839928355555556,1.52197420070011,0.858679854644903,0.0097615238192383,-0.759,0.807,1.312,5.079,3.1955,3.1475,,3.1715,2.3885,celecoxib,CHEMBL118,RZEKVGVHFLEQIL-UHFFFAOYSA-N,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,C17H14F3N3O2S,DB00482,D00567,celecoxib,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
183851,90,5,38,uM,uM,-7.51978249050867,-6.76986570834366,-1.18130522222222,-4.10817496192529,1.0,0.3,5.566,17.231,45.571,16.027,30.799,8.002,,19.4005,13.567999999999998,Nilotinib,CHEMBL255863,HHZIURLSWUIHRB-UHFFFAOYSA-N,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,C28H22F3N7O,DB04868,D08953,nilotinib,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
183961,230,28,38,uM,uM,3.73016461480565,-77.101275495199,2.90111256666667,8.05105327191078,0.306486022420939,0.01,-5.706,10.114,33.665,7.562,20.6135,16.2055,,18.4095,10.499499999999998,Imatinib,CHEMBL941,KTUFNOKKBVMGRW-UHFFFAOYSA-N,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,C29H31N7O,DB00619,D01441,imatinib,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
184142,107,77,28,uM,uM,-3.13213737767975,0.589740085672188,-1.96814822222222,-6.62523469618043,10.0,0.07,8.184,4.465,7.289,4.825,6.057,-6.592,,-0.2674999999999992,-2.126999999999999,thalidomide,CHEMBL468,UEJJHQNACJXSKW-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,C13H10N2O4,DB01041,D00754,thalidomide,IMIQUIMOD,CHEMBL1282,DOUYETYNHWVLEO-UHFFFAOYSA-N,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N,C14H16N4,DB00724,D02500,imiquimod,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
185307,388,230,38,uM,uM,-3.51144758456759,0.319239999748079,0.597759777777778,2.1860044092956,0.0182925923188435,1.25439454009194,8.679,-1.451,10.088,5.037,7.5625,0.3345,,3.9485,-1.1165000000000005,raloxifene,CHEMBL81,GZUITABIAKMVPG-UHFFFAOYSA-N,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,C28H27NO4S,DB00481,D08465,raloxifene,Imatinib,CHEMBL941,KTUFNOKKBVMGRW-UHFFFAOYSA-N,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,C29H31N7O,DB00619,D01441,imatinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
185916,74,29,38,uM,uM,2.60580515348085,-3.0807914724001,-3.03021865555556,1.4832117202276,12.6803570635702,0.211657564482489,0.088,-5.245,1.709,-2.138,-0.2145,4.9425,,2.364,-0.3025,hydroxyurea,CHEMBL467,VSNHCAURESNICA-UHFFFAOYSA-N,C(=O)(N)NO,CH4N2O2,DB01005,D00341,hydroxyurea,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
186117,8,96,38,uM,uM,1.18884994701056,-11.0299555565039,0.054319511111111,0.592594123883825,0.0401500915339354,1.86748693003456e-05,-0.436,43.534,35.299,40.846,38.0725,-5.0255,,16.5235,-5.461500000000001,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,Pralatrexate,CHEMBL1201746,OGSBUKJUDHAQEA-WMCAAGNKSA-N,C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,C23H23N7O5,DB06813,D05589,pralatrexate,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
186140,43,35,28,uM,uM,9.37261974113002,-6.51973769698339,-4.77666511111111,13.545857377032,0.1,0.144492295349973,-16.082,2.701,-6.825,4.334,-1.2455,12.1355,,5.445,-3.9465,anastrozole,CHEMBL1399,YBBLVLTVTVSKRW-UHFFFAOYSA-N,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,C17H19N5,DB01217,D00960,anastrozole,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
186196,80,100,28,uM,uM,1.73302583710633,-74.9318443287433,-12.8588872666667,-5.55625970223356,0.4,0.0032561469459855,-9.466,18.556,83.191,26.839,55.015,45.925,,50.47,36.459,letrozole,CHEMBL1444,HPJKCIUCZWXJDR-UHFFFAOYSA-N,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,C17H11N5,DB01006,D00964,letrozole,Romidepsin,CHEMBL343448,OHRURASPPZQGQM-GCCNXGTGSA-N,CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C,C24H36N4O6S2,,D06637,romidepsin,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
186389,52,48,38,uM,uM,-2.50243554509704,4.85275604129844,-0.0699690000000002,-2.09591875058095,5.0,9.76277026404458,7.2,2.24,5.565,6.179,5.872,-3.568,,1.1519999999999992,-1.3280000000000003,celecoxib,CHEMBL118,RZEKVGVHFLEQIL-UHFFFAOYSA-N,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,C17H14F3N3O2S,DB00482,D00567,celecoxib,busulfan,CHEMBL820,COVZYZSDYWQREU-UHFFFAOYSA-N,CS(=O)(=O)OCCCCOS(=O)(=O)C,C6H14O6S2,DB01008,D00248,busulfan,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
186780,72,108,28,uM,uM,-3.31841925308107,-10.3200232103946,-4.98701328888889,-9.79727665750222,1.62873354360263,0.776376318585053,21.662,45.766,27.527,37.542,32.5345,-34.8935,,-1.179499999999997,-13.231499999999995,Gefitinib,CHEMBL939,XGALLCVXEZPNRQ-UHFFFAOYSA-N,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,C22H24ClFN4O3,DB00317,D01977,gefitinib,6-Thioguanine,CHEMBL727,WYWHKKSPHMUBEB-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=C(N2)N,C5H5N5S,DB00352,D08603,thioguanine,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
186788,48,77,28,uM,uM,-0.659996106527989,-6.98419813867641,-9.52163898888889,-5.16886464101137,49.7218831018132,0.0088145103337468,-2.409,0.286,-4.693,3.67,-0.5115,1.6115,,0.5499999999999999,-0.7974999999999999,busulfan,CHEMBL820,COVZYZSDYWQREU-UHFFFAOYSA-N,CS(=O)(=O)OCCCCOS(=O)(=O)C,C6H14O6S2,DB01008,D00248,busulfan,IMIQUIMOD,CHEMBL1282,DOUYETYNHWVLEO-UHFFFAOYSA-N,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N,C14H16N4,DB00724,D02500,imiquimod,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
186795,388,39,38,uM,uM,-6.99939975989495,-5.5936195028202,-1.12001733333333,-3.28076829763557,0.152484247829391,100.697052638337,12.108,0.508,12.176,9.129,10.6525,-1.9635,,4.3445,-1.455500000000001,raloxifene,CHEMBL81,GZUITABIAKMVPG-UHFFFAOYSA-N,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,C28H27NO4S,DB00481,D08465,raloxifene,allopurinol,CHEMBL1467,OFCNXPDARWKPPY-UHFFFAOYSA-N,C1=C2C(=NC=NC2=O)NN1; C1=NNC2=C1C(=O)NC=N2,C5H4N4O,DB00437,D00224,allopurinol,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
186922,74,48,28,uM,uM,-4.3554317138824,-5.13616611416973,-1.9568856,-1.35575822396647,20.0,16.6794907272345,8.801,-0.715,6.682,11.694,9.188,1.102,,5.1450000000000005,0.3870000000000004,hydroxyurea,CHEMBL467,VSNHCAURESNICA-UHFFFAOYSA-N,C(=O)(N)NO,CH4N2O2,DB01005,D00341,hydroxyurea,busulfan,CHEMBL820,COVZYZSDYWQREU-UHFFFAOYSA-N,CS(=O)(=O)OCCCCOS(=O)(=O)C,C6H14O6S2,DB01008,D00248,busulfan,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
186954,31,107,38,uM,uM,-0.311176902279425,0.266744696266704,-0.939287744444445,-0.304525240969485,0.69412484704248,0.31213319318303,0.257,0.14,0.215,-0.249,-0.017,-0.414,,-0.2155,-0.274,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,thalidomide,CHEMBL468,UEJJHQNACJXSKW-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,C13H10N2O4,DB01041,D00754,thalidomide,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
187013,80,35,38,uM,uM,-6.15812595616902,-12.6889868584342,-3.51222068444445,1.79309730978855,0.4,0.175934482588107,-6.983,16.408,7.702,12.939,10.3205,0.895499999999998,,5.607999999999999,-6.087500000000002,letrozole,CHEMBL1444,HPJKCIUCZWXJDR-UHFFFAOYSA-N,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,C17H11N5,DB01006,D00964,letrozole,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
187060,8,5,38,uM,uM,-9.27494619227983,-5.10790790325261,-3.14774377777778,-6.14487513318891,0.0026478075924542,0.3,7.669,17.231,45.044,10.903,27.9735,3.0735,,15.5235,10.7425,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
187216,31,43,38,uM,uM,0.372034683584912,-3.26423180587969,-5.04857718888889,-4.20106262068381,14.7563561273468,0.0912903046862621,0.472,1.625,-2.944,-6.599,-4.7715,-6.8685,,-5.819999999999999,-6.3965,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,anastrozole,CHEMBL1399,YBBLVLTVTVSKRW-UHFFFAOYSA-N,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,C17H19N5,DB01217,D00960,anastrozole,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
187253,74,77,38,uM,uM,0.382606797053673,-0.879146367185666,-0.935789150733333,0.0502520068375038,1.992962641748,0.0083877070873839,2.796,-0.958,1.038,1.192,1.115,-0.723,,0.196,-1.6809999999999998,hydroxyurea,CHEMBL467,VSNHCAURESNICA-UHFFFAOYSA-N,C(=O)(N)NO,CH4N2O2,DB01005,D00341,hydroxyurea,IMIQUIMOD,CHEMBL1282,DOUYETYNHWVLEO-UHFFFAOYSA-N,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N,C14H16N4,DB00724,D02500,imiquimod,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
187296,43,28,38,uM,uM,-4.32499903433373,-37.7013234336959,-3.10666513333333,-1.36615482448922,0.0384721613780146,0.01,-1.976,10.114,19.351,6.193,12.772,4.634,,8.703,2.6579999999999995,anastrozole,CHEMBL1399,YBBLVLTVTVSKRW-UHFFFAOYSA-N,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,C17H19N5,DB01217,D00960,anastrozole,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
187372,230,100,28,uM,uM,-0.826105404514373,-43.7620682678007,-4.32687642222222,-3.61750648192912,2.23235584219792,0.0032561469459855,1.713,18.556,49.848,21.481,35.6645,15.3955,,25.53,17.108499999999996,Imatinib,CHEMBL941,KTUFNOKKBVMGRW-UHFFFAOYSA-N,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,C29H31N7O,DB00619,D01441,imatinib,Romidepsin,CHEMBL343448,OHRURASPPZQGQM-GCCNXGTGSA-N,CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C,C24H36N4O6S2,,D06637,romidepsin,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
187381,100,8,38,uM,uM,-4.19138450110258,-44.2216770921317,-4.29577277777778,-4.88790433614678,0.01,0.0462823943752059,39.231,0.322,35.726,69.944,52.835,13.282,,33.058499999999995,13.604,Romidepsin,CHEMBL343448,OHRURASPPZQGQM-GCCNXGTGSA-N,CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C,C24H36N4O6S2,,D06637,romidepsin,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
188120,80,86,38,uM,uM,-0.805285718143359,-3.98930939106748,-3.95555427777778,-2.67733353423472,0.203051365488014,0.107786796112615,-0.443,2.82,0.204,-5.352,-2.574,-4.951,,-3.7625,-5.394,letrozole,CHEMBL1444,HPJKCIUCZWXJDR-UHFFFAOYSA-N,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,C17H11N5,DB01006,D00964,letrozole,methoxsalen,CHEMBL416,QXKHYNVANLEOEG-UHFFFAOYSA-N,COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,C12H8O4,DB00553,D00139,methoxsalen,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
188140,230,43,38,uM,uM,0.330158900497658,-3.3129379041754,-4.1302448,-1.19757038571493,0.607501029624528,0.0912903046862621,-2.947,1.625,-2.995,-1.927,-2.461,-1.139,,-1.7999999999999998,-4.086,Imatinib,CHEMBL941,KTUFNOKKBVMGRW-UHFFFAOYSA-N,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,C29H31N7O,DB00619,D01441,imatinib,anastrozole,CHEMBL1399,YBBLVLTVTVSKRW-UHFFFAOYSA-N,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,C17H19N5,DB01217,D00960,anastrozole,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
188306,15,74,28,uM,uM,2.67199816283011,-0.678163833937516,-0.487716462222222,4.67273535794833,0.0553594434331846,1.98131635465789,-6.417,-0.61,-1.098,-1.754,-1.426,5.601,,2.0875000000000004,-0.816,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,hydroxyurea,CHEMBL467,VSNHCAURESNICA-UHFFFAOYSA-N,C(=O)(N)NO,CH4N2O2,DB01005,D00341,hydroxyurea,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
188432,88,8,38,uM,uM,6.7496331297734,-2.56466097862826,2.89867088888889,8.18380725026671,0.21183580524177,0.0785633925702547,22.326,-6.568,30.664,43.503,37.0835,21.3255,,29.2045,14.7575,mitoxantrone,CHEMBL58,KKZJGLLVHKMTCM-UHFFFAOYSA-N,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,C22H28N4O6,DB01204,D08224,mitoxantrone,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
188457,28,39,28,uM,uM,-4.09938341065396,-13.7356947450777,-2.64275144444445,-0.831284727010912,0.0038904761309068,5.30647435409587,8.549,-1.052,5.561,28.292,16.9265,9.4295,,13.178,8.377500000000001,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,allopurinol,CHEMBL1467,OFCNXPDARWKPPY-UHFFFAOYSA-N,C1=C2C(=NC=NC2=O)NN1; C1=NNC2=C1C(=O)NC=N2,C5H4N4O,DB00437,D00224,allopurinol,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
188744,90,8,28,uM,uM,0.575643189378992,-14.8237599225031,-6.54104915555556,-4.54830094414567,0.0309764871988449,0.1,-4.346,4.477,0.987,-1.297,-0.155,-0.286,,-0.2205000000000001,-4.632000000000001,Nilotinib,CHEMBL255863,HHZIURLSWUIHRB-UHFFFAOYSA-N,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,C28H22F3N7O,DB04868,D08953,nilotinib,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
188971,388,77,38,uM,uM,0.679389259952019,-2.4413371592514,-0.459016888888889,6.60572270179417,0.0903119153931736,0.7,2.249,-8.043,3.816,2.072,2.944,8.738,,5.840999999999999,0.6949999999999998,raloxifene,CHEMBL81,GZUITABIAKMVPG-UHFFFAOYSA-N,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,C28H27NO4S,DB00481,D08465,raloxifene,IMIQUIMOD,CHEMBL1282,DOUYETYNHWVLEO-UHFFFAOYSA-N,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N,C14H16N4,DB00724,D02500,imiquimod,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
189462,48,39,28,uM,uM,-2.28673402518285,-2.09867577121686,-2.9279355,-3.30098093685694,26.2323223954721,2.6135402787803897e-13,2.017,1.273,-0.55,5.921,2.6855,-0.6045,,1.0405000000000002,0.6685000000000003,busulfan,CHEMBL820,COVZYZSDYWQREU-UHFFFAOYSA-N,CS(=O)(=O)OCCCCOS(=O)(=O)C,C6H14O6S2,DB01008,D00248,busulfan,allopurinol,CHEMBL1467,OFCNXPDARWKPPY-UHFFFAOYSA-N,C1=C2C(=NC=NC2=O)NN1; C1=NNC2=C1C(=O)NC=N2,C5H4N4O,DB00437,D00224,allopurinol,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
189502,8,30,7,uM,uM,-1.70542849844589,-4.59894744379007,4.26092133333333,3.81535689395576,0.0132472841320452,1.0,6.719,2.065,15.038,12.051,13.5445,4.7605,,9.1525,6.825499999999999,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,A549,C3512,Lung (Carcinoma),Lung adenocarcinoma
189676,100,5,38,uM,uM,-5.73676471160525,-3.90314588035631,0.975342000000001,-2.9304810170543,0.01,0.3,22.811,17.231,59.693,68.946,64.3195,24.2775,,44.2985,41.508500000000005,Romidepsin,CHEMBL343448,OHRURASPPZQGQM-GCCNXGTGSA-N,CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C,C24H36N4O6S2,,D06637,romidepsin,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
190024,230,77,38,uM,uM,5.35451850510998,-2.19098021879947,-3.08444272222222,4.08132108297032,0.272082696288394,0.0020538333057086,-7.043,-2.222,-4.004,-2.344,-3.174,6.091,,1.4585000000000004,-0.952,Imatinib,CHEMBL941,KTUFNOKKBVMGRW-UHFFFAOYSA-N,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,C29H31N7O,DB00619,D01441,imatinib,IMIQUIMOD,CHEMBL1282,DOUYETYNHWVLEO-UHFFFAOYSA-N,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N,C14H16N4,DB00724,D02500,imiquimod,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
190053,388,53,38,uM,uM,-3.13117264121687,1.1285780803953,1.81867122222222,-1.96558401838915,0.0735284306988261,9.30964351804981,10.629,21.203,29.634,27.393,28.5135,-3.3185,,12.5975,7.310500000000001,raloxifene,CHEMBL81,GZUITABIAKMVPG-UHFFFAOYSA-N,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,C28H27NO4S,DB00481,D08465,raloxifene,chlorambucil,CHEMBL515,JCKYGMPEJWAADB-UHFFFAOYSA-N,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,C14H19Cl2NO2,DB00291,D00266,chlorambucil,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
190213,29,107,38,uM,uM,0.691992508650779,-5.51006568137475,-5.50999870982222,-1.10475126845694,0.295021796543256,2.69506480288668e-07,-4.533,2.732,-4.194,-1.565,-2.8795,-1.0785,,-1.979,-5.6115,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,thalidomide,CHEMBL468,UEJJHQNACJXSKW-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,C13H10N2O4,DB01041,D00754,thalidomide,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
190350,15,77,38,uM,uM,0.571898035855152,-1.74707455834047,-2.04256991311111,-0.297525571997336,2.05502990435456,0.0020538333057086,0.701,-2.222,-1.275,-1.539,-1.407,0.114,,-0.6465000000000001,-2.108,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,IMIQUIMOD,CHEMBL1282,DOUYETYNHWVLEO-UHFFFAOYSA-N,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N,C14H16N4,DB00724,D02500,imiquimod,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
190791,90,75,28,uM,uM,-3.58347024681368,-2.45195967381656,1.63644883333333,-0.622931228690273,1.0,2.73710444642706e-06,6.231,2.235,5.785,10.238,8.0115,-0.454499999999999,,3.7785,1.7805,Nilotinib,CHEMBL255863,HHZIURLSWUIHRB-UHFFFAOYSA-N,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,C28H22F3N7O,DB04868,D08953,nilotinib,ifosfamide,CHEMBL1024,HOMGKSMUEGBAAB-UHFFFAOYSA-N,C1CN(P(=O)(OC1)NCCCl)CCCl,C7H15Cl2N2O2P,DB01181,D00343,ifosfamide,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
191038,52,75,38,uM,uM,0.265169155351699,-0.298913497738537,-2.51447284444444,-1.7272293165457,0.552326421692269,100.0,0.576,1.939,-0.758,0.341,-0.2085,-2.7235,,-1.466,-2.1475,celecoxib,CHEMBL118,RZEKVGVHFLEQIL-UHFFFAOYSA-N,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,C17H14F3N3O2S,DB00482,D00567,celecoxib,ifosfamide,CHEMBL1024,HOMGKSMUEGBAAB-UHFFFAOYSA-N,C1CN(P(=O)(OC1)NCCCl)CCCl,C7H15Cl2N2O2P,DB01181,D00343,ifosfamide,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
191068,388,96,28,uM,uM,2.09553151913924,-4.62075336367731,-4.62066533333333,2.79494981698862,0.0001327104903001,1.10068327987747e-11,-8.257,3.044,-4.735,1.344,-1.6955,3.5175,,0.9109999999999996,-4.7395,raloxifene,CHEMBL81,GZUITABIAKMVPG-UHFFFAOYSA-N,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,C28H27NO4S,DB00481,D08465,raloxifene,Pralatrexate,CHEMBL1201746,OGSBUKJUDHAQEA-WMCAAGNKSA-N,C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,C23H23N7O5,DB06813,D05589,pralatrexate,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
191503,31,230,38,uM,uM,1.51575514864336,0.775281823450276,-4.94305186666667,-0.468871929946037,6.64992925977644,3.36394247269348,2.07,-2.051,-4.549,-1.86,-3.2045,-3.2235,,-3.2139999999999995,-5.2745,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,Imatinib,CHEMBL941,KTUFNOKKBVMGRW-UHFFFAOYSA-N,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,C29H31N7O,DB00619,D01441,imatinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
191953,52,90,28,uM,uM,3.46163196229508,4.0710223175188,3.09731913333333,7.69257156870738,0.0713461780309911,0.0117945917851263,-4.599,-1.69,1.207,0.768,0.9875,7.2765,,4.132,2.6775,celecoxib,CHEMBL118,RZEKVGVHFLEQIL-UHFFFAOYSA-N,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,C17H14F3N3O2S,DB00482,D00567,celecoxib,Nilotinib,CHEMBL255863,HHZIURLSWUIHRB-UHFFFAOYSA-N,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,C28H22F3N7O,DB04868,D08953,nilotinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
192057,52,96,38,uM,uM,5.45114205622441,-18.4231370174066,-1.31888911111111,5.1160574074359,5.0,1.86748693003456e-05,-10.535,43.534,40.149,34.242,37.1955,4.1965,,20.696000000000005,-6.338499999999996,celecoxib,CHEMBL118,RZEKVGVHFLEQIL-UHFFFAOYSA-N,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,C17H14F3N3O2S,DB00482,D00567,celecoxib,Pralatrexate,CHEMBL1201746,OGSBUKJUDHAQEA-WMCAAGNKSA-N,C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,C23H23N7O5,DB06813,D05589,pralatrexate,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
192134,52,77,38,uM,uM,2.05700636942043,-3.30650361861019,-4.39973402222222,-0.422560391334256,2.48781511013744,0.0020538333057086,0.28,-2.222,-2.251,-5.345,-3.798,-1.856,,-2.827,-4.078,celecoxib,CHEMBL118,RZEKVGVHFLEQIL-UHFFFAOYSA-N,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,C17H14F3N3O2S,DB00482,D00567,celecoxib,IMIQUIMOD,CHEMBL1282,DOUYETYNHWVLEO-UHFFFAOYSA-N,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N,C14H16N4,DB00724,D02500,imiquimod,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
192174,15,75,38,uM,uM,-0.459716783771907,-2.41526702839933,-2.99135601111111,-1.97562339953472,0.929597869153922,100.0,-0.98,1.939,-0.443,-1.165,-0.804,-1.763,,-1.2835,-2.7430000000000003,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,ifosfamide,CHEMBL1024,HOMGKSMUEGBAAB-UHFFFAOYSA-N,C1CN(P(=O)(OC1)NCCCl)CCCl,C7H15Cl2N2O2P,DB01181,D00343,ifosfamide,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
192457,8,43,38,uM,uM,0.5032847673267,-1.96623290027576,-3.31302166666667,-0.922006894123815,0.0418171269245893,0.0912903046862621,-0.929,1.625,-3.528,-1.185,-2.3565,-3.0525,,-2.7045,-3.9815,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,anastrozole,CHEMBL1399,YBBLVLTVTVSKRW-UHFFFAOYSA-N,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,C17H19N5,DB01217,D00960,anastrozole,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
192538,230,35,28,uM,uM,7.24361007817876,-6.06679305242384,-0.171109,11.8491915424762,5.0,0.144492295349973,-13.519,2.701,7.446,6.601,7.0235,17.8415,,12.4325,4.3225,Imatinib,CHEMBL941,KTUFNOKKBVMGRW-UHFFFAOYSA-N,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,C29H31N7O,DB00619,D01441,imatinib,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
192613,107,75,38,uM,uM,4.14945242440595,-3.43439550558193,-3.818977,2.79989861420973,0.112966580642846,47.8958214849306,-7.647,-0.592,-3.787,-1.262,-2.5245,5.7145,,1.5950000000000002,-1.9325,thalidomide,CHEMBL468,UEJJHQNACJXSKW-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,C13H10N2O4,DB01041,D00754,thalidomide,ifosfamide,CHEMBL1024,HOMGKSMUEGBAAB-UHFFFAOYSA-N,C1CN(P(=O)(OC1)NCCCl)CCCl,C7H15Cl2N2O2P,DB01181,D00343,ifosfamide,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
192717,52,15,28,uM,uM,-0.883056135460842,-4.17197158725977,-4.11816313333333,-1.4939954292908,3.12316229349561,0.086008288783272,-3.677,4.041,-2.1,-1.067,-1.5835,-1.9475,,-1.7655,-5.6245,celecoxib,CHEMBL118,RZEKVGVHFLEQIL-UHFFFAOYSA-N,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,C17H14F3N3O2S,DB00482,D00567,celecoxib,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
192883,15,48,28,uM,uM,-1.19933902878081,-7.30409359183162,1.54758518777778,2.303998011595,3.0,7.55099766413197,1.514,2.11,5.455,5.477,5.466,1.842,,3.654,3.3560000000000003,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,busulfan,CHEMBL820,COVZYZSDYWQREU-UHFFFAOYSA-N,CS(=O)(=O)OCCCCOS(=O)(=O)C,C6H14O6S2,DB01008,D00248,busulfan,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
192942,8,86,28,uM,uM,-4.45577354297958,-25.1717038679162,0.209781888888888,-0.625484457058468,0.1,2.49238175155863,14.964,0.335,11.777,26.217,18.997,3.698,,11.3475,4.033,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,methoxsalen,CHEMBL416,QXKHYNVANLEOEG-UHFFFAOYSA-N,COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,C12H8O4,DB00553,D00139,methoxsalen,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
193113,30,75,28,uM,uM,-5.85482155256721,-3.5002855816049,-3.50021756333333,-5.62786752877884,5.51874320586853e-08,2.73710444642706e-06,11.171,2.235,9.619,2.735,6.177,-7.229,,-0.5259999999999998,-4.994,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,ifosfamide,CHEMBL1024,HOMGKSMUEGBAAB-UHFFFAOYSA-N,C1CN(P(=O)(OC1)NCCCl)CCCl,C7H15Cl2N2O2P,DB01181,D00343,ifosfamide,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
193624,52,90,38,uM,uM,0.0069283313162014,-0.507098049816235,-1.67782220888889,-1.06017268750837,0.156442197323562,0.0336325681627958,-0.991,0.561,0.429,0.452,0.4405,0.8705,,0.6555,-0.1205,celecoxib,CHEMBL118,RZEKVGVHFLEQIL-UHFFFAOYSA-N,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,C17H14F3N3O2S,DB00482,D00567,celecoxib,Nilotinib,CHEMBL255863,HHZIURLSWUIHRB-UHFFFAOYSA-N,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,C28H22F3N7O,DB04868,D08953,nilotinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
193791,52,74,28,uM,uM,1.4993810554,-4.48721484244412,-7.02860717333333,-4.56160972049384,0.780711235839792,1.98131635465789,1.152,-0.61,-4.433,-4.553,-4.493,-5.035,,-4.764,-5.6450000000000005,celecoxib,CHEMBL118,RZEKVGVHFLEQIL-UHFFFAOYSA-N,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,C17H14F3N3O2S,DB00482,D00567,celecoxib,hydroxyurea,CHEMBL467,VSNHCAURESNICA-UHFFFAOYSA-N,C(=O)(N)NO,CH4N2O2,DB01005,D00341,hydroxyurea,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
194991,8,78,28,uM,uM,-0.416731198571834,-0.184997122973768,0.226671444444443,-1.40686324422916,0.0004658607404311,0.0049349515627974,12.189,77.504,32.593,77.693,55.143,-34.55,,10.296499999999996,-22.361000000000004,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,Ixabepilone,CHEMBL1201752,FABUFPQFXZVHFB-PVYNADRNSA-N,CC1CCCC2(C(O2)CC(NC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C,C27H42N2O5S,DB04845,D04645,ixabepilone,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
195226,80,15,28,uM,uM,2.55391388173115,-11.1348257643435,-10.3377770222222,0.569731217084453,0.4,0.086008288783272,-11.179,4.041,-10.727,-6.82,-8.7735,-1.6355,,-5.2045,-12.8145,letrozole,CHEMBL1444,HPJKCIUCZWXJDR-UHFFFAOYSA-N,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,C17H11N5,DB01006,D00964,letrozole,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
195890,80,52,38,uM,uM,3.99005887704668,-3.20098882983593,-3.56999845555556,2.7903840748044,0.003758152383474,0.141640064518235,-7.07,-2.122,-7.068,-4.833,-5.9505,3.2415,,-1.3544999999999998,-3.8285,letrozole,CHEMBL1444,HPJKCIUCZWXJDR-UHFFFAOYSA-N,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,C17H11N5,DB01006,D00964,letrozole,celecoxib,CHEMBL118,RZEKVGVHFLEQIL-UHFFFAOYSA-N,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,C17H14F3N3O2S,DB00482,D00567,celecoxib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
195996,100,15,38,uM,uM,-3.06168614269806,-12.369795097186,-1.05012838888889,-2.89139351569048,0.0074412230488683,3.0,31.859,4.271,39.127,71.421,55.274,19.144,,37.209,23.415,Romidepsin,CHEMBL343448,OHRURASPPZQGQM-GCCNXGTGSA-N,CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C,C24H36N4O6S2,,D06637,romidepsin,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
196124,80,29,28,uM,uM,-0.699669240401477,3.25633147002519,-3.60763446666667,-3.49193062265499,0.158028733079378,0.622137048079663,7.251,1.38,5.942,1.531,3.7365,-4.8945,,-0.5790000000000002,-3.5145000000000004,letrozole,CHEMBL1444,HPJKCIUCZWXJDR-UHFFFAOYSA-N,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,C17H11N5,DB01006,D00964,letrozole,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
196269,29,5,38,uM,uM,-7.26962620754983,-33.8746454520367,-0.987429718888888,-3.94378521112383,15.4237904174687,0.3,7.12,17.231,48.983,11.092,30.0375,5.6865,,17.862000000000002,12.8065,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
196681,230,39,38,uM,uM,2.08091286046016,-1.30760381735615,-3.10440863333333,-0.327882400056939,1.84523396436855,10.0,-0.374,-1.932,-2.495,-5.93,-4.2125,-1.9065,,-3.0595000000000003,-3.8385,Imatinib,CHEMBL941,KTUFNOKKBVMGRW-UHFFFAOYSA-N,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,C29H31N7O,DB00619,D01441,imatinib,allopurinol,CHEMBL1467,OFCNXPDARWKPPY-UHFFFAOYSA-N,C1=C2C(=NC=NC2=O)NN1; C1=NNC2=C1C(=O)NC=N2,C5H4N4O,DB00437,D00224,allopurinol,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
196884,52,39,38,uM,uM,0.47346599835609,-2.23727632086868,-1.11799576666667,1.26006362280859,0.128807910276917,10.0,3.097,-1.932,2.246,1.093,1.6695,0.5045,,1.087,-1.4275,celecoxib,CHEMBL118,RZEKVGVHFLEQIL-UHFFFAOYSA-N,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,C17H14F3N3O2S,DB00482,D00567,celecoxib,allopurinol,CHEMBL1467,OFCNXPDARWKPPY-UHFFFAOYSA-N,C1=C2C(=NC=NC2=O)NN1; C1=NNC2=C1C(=O)NC=N2,C5H4N4O,DB00437,D00224,allopurinol,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
197474,31,85,28,uM,uM,-11.2933315533032,-28.6927539146836,-2.55888216666667,-5.50544087877811,0.261523838858346,2.0,4.891,21.08,49.88,20.796,35.338,9.367,,22.352500000000003,14.258000000000004,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,6-Mercaptopurine,CHEMBL1425,GLVAUDGFNGKCSF-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=CN2,C5H4N4S,DB01033,D04931,mercaptopurine,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
197675,100,35,28,uM,uM,0.50445463762606,-8.87650086146854,1.65209406666667,2.78432947085554,0.0005511892177054,0.144492295349973,68.982,2.701,67.504,85.485,76.4945,4.81150000000001,,40.653000000000006,7.512500000000003,Romidepsin,CHEMBL343448,OHRURASPPZQGQM-GCCNXGTGSA-N,CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C,C24H36N4O6S2,,D06637,romidepsin,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
197932,88,8,28,uM,uM,-1.85337951688314,4.48171047392536,6.29513666666667,1.2763582524711,0.5,0.0478811819350707,28.508,17.234,50.373,63.163,56.768,11.026,,33.897,28.26,mitoxantrone,CHEMBL58,KKZJGLLVHKMTCM-UHFFFAOYSA-N,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,C22H28N4O6,DB01204,D08224,mitoxantrone,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
198244,8,15,28,uM,uM,4.21040098241906,6.38508028472565,5.46239333333333,6.47529681419819,0.0028421494970061,0.086008288783272,3.674,4.041,4.83,2.69,3.76,-3.955,,-0.0975000000000001,-0.2810000000000006,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
198423,39,78,38,uM,uM,-1.1771440171584,-11.8426541726278,-2.9055671,-2.66865837732543,1.06577620474742,0.0203185246224506,0.425,26.291,7.863,24.045,15.954,-10.762,,2.596,-10.337,allopurinol,CHEMBL1467,OFCNXPDARWKPPY-UHFFFAOYSA-N,C1=C2C(=NC=NC2=O)NN1; C1=NNC2=C1C(=O)NC=N2,C5H4N4O,DB00437,D00224,allopurinol,Ixabepilone,CHEMBL1201752,FABUFPQFXZVHFB-PVYNADRNSA-N,CC1CCCC2(C(O2)CC(NC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C,C27H42N2O5S,DB04845,D04645,ixabepilone,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
198818,8,85,38,uM,uM,6.43583543317685,-2.97424330582283,-0.0022206666666667,11.5325803610098,0.1,0.324143735652072,-12.606,15.063,11.862,17.558,14.71,12.253,,13.4815,-0.3529999999999997,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,6-Mercaptopurine,CHEMBL1425,GLVAUDGFNGKCSF-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=CN2,C5H4N4S,DB01033,D04931,mercaptopurine,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
199402,388,116,28,uM,uM,5.34996472877806,-8.63006372870207,-0.416000333333333,4.45978288142497,0.0001327104903001,1.55693250977153,-8.257,37.123,55.86,34.671,45.2655,16.3995,,30.832500000000003,8.142500000000005,raloxifene,CHEMBL81,GZUITABIAKMVPG-UHFFFAOYSA-N,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,C28H27NO4S,DB00481,D08465,raloxifene,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
199445,52,100,28,uM,uM,0.828661238967479,-34.8260914967314,2.625634,0.60085974952263,0.0661800642095213,0.0032561469459855,13.805,18.556,96.292,41.02,68.656,36.295,,52.4755,50.10000000000001,celecoxib,CHEMBL118,RZEKVGVHFLEQIL-UHFFFAOYSA-N,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,C17H14F3N3O2S,DB00482,D00567,celecoxib,Romidepsin,CHEMBL343448,OHRURASPPZQGQM-GCCNXGTGSA-N,CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C,C24H36N4O6S2,,D06637,romidepsin,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
199693,35,8,7,uM,uM,-3.87487024955177,-4.52943876673286,1.13198588888889,-0.152137533654302,0.542715908224659,0.1,0.403,5.181,13.117,16.042,14.5795,8.9955,,11.7875,9.3985,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,A549,C3512,Lung (Carcinoma),Lung adenocarcinoma
200222,85,77,38,uM,uM,-6.57785024738025,-4.63398233395971,-2.45801275555555,-1.63957401532955,0.258422580461475,0.0083877070873839,15.721,-0.958,12.003,15.854,13.9285,-0.8345,,6.547,-1.7925000000000004,6-Mercaptopurine,CHEMBL1425,GLVAUDGFNGKCSF-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=CN2,C5H4N4S,DB01033,D04931,mercaptopurine,IMIQUIMOD,CHEMBL1282,DOUYETYNHWVLEO-UHFFFAOYSA-N,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N,C14H16N4,DB00724,D02500,imiquimod,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
200366,388,72,28,uM,uM,3.4602999269453,0.830936423390052,1.48570965111111,4.027858148924,0.0245680781616445,2.24683321093206,-3.094,20.255,10.335,22.741,16.538,-0.622999999999998,,7.957500000000001,-3.716999999999999,raloxifene,CHEMBL81,GZUITABIAKMVPG-UHFFFAOYSA-N,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,C28H27NO4S,DB00481,D08465,raloxifene,Gefitinib,CHEMBL939,XGALLCVXEZPNRQ-UHFFFAOYSA-N,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,C22H24ClFN4O3,DB00317,D01977,gefitinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
200376,90,86,38,uM,uM,1.28735003422212,-8.40165930296932,-8.34666533333333,-2.62111789251091,1.0,0.107786796112615,-6.636,2.82,-5.781,-8.492,-7.1365,-3.3205,,-5.2285,-9.9565,Nilotinib,CHEMBL255863,HHZIURLSWUIHRB-UHFFFAOYSA-N,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,C28H22F3N7O,DB04868,D08953,nilotinib,methoxsalen,CHEMBL416,QXKHYNVANLEOEG-UHFFFAOYSA-N,COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,C12H8O4,DB00553,D00139,methoxsalen,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
200602,35,48,38,uM,uM,-8.71384742843917,0.88273586610998,1.08616627777778,0.386836066145697,0.685520385716193,50.0,3.492,5.028,21.998,46.585,34.2915,25.7715,,30.0315,29.2635,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,busulfan,CHEMBL820,COVZYZSDYWQREU-UHFFFAOYSA-N,CS(=O)(=O)OCCCCOS(=O)(=O)C,C6H14O6S2,DB01008,D00248,busulfan,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
200608,388,31,28,uM,uM,5.79547137541747,-2.33526764124612,-1.41366244444444,7.25914389494059,1.0,0.257353613515055,-4.051,-8.364,-4.992,-3.582,-4.287,8.128,,1.9205000000000003,-0.2359999999999997,raloxifene,CHEMBL81,GZUITABIAKMVPG-UHFFFAOYSA-N,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,C28H27NO4S,DB00481,D08465,raloxifene,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
200716,85,75,28,uM,uM,-1.02768369535483,-18.4170343468306,4.21314414444444,9.9842707391002,0.26093036375581,100.0,12.059,-5.124,20.666,13.992,17.329,10.394,,13.8615,5.270000000000001,6-Mercaptopurine,CHEMBL1425,GLVAUDGFNGKCSF-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=CN2,C5H4N4S,DB01033,D04931,mercaptopurine,ifosfamide,CHEMBL1024,HOMGKSMUEGBAAB-UHFFFAOYSA-N,C1CN(P(=O)(OC1)NCCCl)CCCl,C7H15Cl2N2O2P,DB01181,D00343,ifosfamide,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
200821,230,107,38,uM,uM,-0.28818435615689,-5.86450798702554,-5.86444311111111,-3.79307051605903,0.656386706772963,2.69506480288668e-07,-2.254,2.732,-1.749,-6.666,-4.2075,-4.6855,,-4.4465,-6.9395,Imatinib,CHEMBL941,KTUFNOKKBVMGRW-UHFFFAOYSA-N,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,C29H31N7O,DB00619,D01441,imatinib,thalidomide,CHEMBL468,UEJJHQNACJXSKW-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,C13H10N2O4,DB01041,D00754,thalidomide,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
201062,90,43,28,uM,uM,1.96982995608164,-2.55197058642011,-7.47638277777778,-5.21096941425662,0.209572630603978,0.1,2.121,2.554,-3.128,0.652,-1.238,-5.913,,-3.5755,-3.792,Nilotinib,CHEMBL255863,HHZIURLSWUIHRB-UHFFFAOYSA-N,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,C28H22F3N7O,DB04868,D08953,nilotinib,anastrozole,CHEMBL1399,YBBLVLTVTVSKRW-UHFFFAOYSA-N,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,C17H19N5,DB01217,D00960,anastrozole,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
201134,388,31,38,uM,uM,2.24654853650554,-2.68564143145531,2.93989388888889,11.1732308074219,0.0903119153931736,21.62249876803,2.249,-7.985,5.567,2.008,3.7875,9.5235,,6.6555,1.5385,raloxifene,CHEMBL81,GZUITABIAKMVPG-UHFFFAOYSA-N,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,C28H27NO4S,DB00481,D08465,raloxifene,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
201547,79,8,38,uM,uM,2.99496897223586,-3.62093512297103,-3.79810665555556,2.94853435114719,30.0,0.0785633925702547,1.456,-6.568,-1.156,-2.181,-1.6685,3.4435,,0.8875,-3.1245000000000003,Lenalidomide,CHEMBL848,GOTYRUGSSMKFNF-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,C13H13N3O3,DB00480,D04687,lenalidomide,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
201678,35,107,28,uM,uM,-3.90841554165519,-10.4731264493006,-4.01383274444444,0.206241069966341,0.515051058008186,0.587883741983402,-0.063,1.922,-0.289,27.147,13.429,11.57,,12.4995,11.507,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,thalidomide,CHEMBL468,UEJJHQNACJXSKW-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,C13H10N2O4,DB01041,D00754,thalidomide,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
201722,100,107,28,uM,uM,-0.187367362222147,-33.2986802235693,-2.34830696666667,-0.596730510994773,0.0030531219722437,0.587883741983402,16.523,1.922,26.884,19.269,23.0765,4.6315,,13.854,6.5535,Romidepsin,CHEMBL343448,OHRURASPPZQGQM-GCCNXGTGSA-N,CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C,C24H36N4O6S2,,D06637,romidepsin,thalidomide,CHEMBL468,UEJJHQNACJXSKW-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,C13H10N2O4,DB01041,D00754,thalidomide,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
201793,388,78,28,uM,uM,1.01774797008232,-24.8034808265764,-6.36910955555556,0.717962753279665,0.0001327104903001,0.0010872027141041,-8.257,2.721,6.01,3.525,4.7675,10.3035,,7.5355,2.0465,raloxifene,CHEMBL81,GZUITABIAKMVPG-UHFFFAOYSA-N,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,C28H27NO4S,DB00481,D08465,raloxifene,Ixabepilone,CHEMBL1201752,FABUFPQFXZVHFB-PVYNADRNSA-N,CC1CCCC2(C(O2)CC(NC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C,C27H42N2O5S,DB04845,D04645,ixabepilone,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
202063,15,75,28,uM,uM,-1.50268533160567,-1.77364621206486,-1.88757885555556,-2.96292380019027,0.0899940294538204,2.73710444642706e-06,3.352,2.235,2.137,0.098,1.1175,-4.4695,,-1.676,-2.2345,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,ifosfamide,CHEMBL1024,HOMGKSMUEGBAAB-UHFFFAOYSA-N,C1CN(P(=O)(OC1)NCCCl)CCCl,C7H15Cl2N2O2P,DB01181,D00343,ifosfamide,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
202124,74,5,28,uM,uM,6.17624615679227,-43.9549542046737,2.78890461111111,3.2140872051979,2.37610768601691,0.0672032482713224,0.739,40.503,55.508,40.574,48.041,6.799,,27.42,7.537999999999997,hydroxyurea,CHEMBL467,VSNHCAURESNICA-UHFFFAOYSA-N,C(=O)(N)NO,CH4N2O2,DB01005,D00341,hydroxyurea,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
202386,53,108,28,uM,uM,7.4412433334513,-16.0373876769883,11.0557483333333,9.35769811416052,9.48714705942868,0.776376318585053,3.734,45.766,62.458,54.906,58.682,9.182,,33.932,12.916000000000004,chlorambucil,CHEMBL515,JCKYGMPEJWAADB-UHFFFAOYSA-N,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,C14H19Cl2NO2,DB00291,D00266,chlorambucil,6-Thioguanine,CHEMBL727,WYWHKKSPHMUBEB-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=C(N2)N,C5H5N5S,DB00352,D08603,thioguanine,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
202395,96,77,38,uM,uM,2.8317342564158,-3.42782585586629,-3.90448938888889,0.0767772883369816,4.88468558044259e-06,0.0020538333057086,-3.648,-2.222,-3.552,-6.07,-4.811,1.059,,-1.876,-2.589,Pralatrexate,CHEMBL1201746,OGSBUKJUDHAQEA-WMCAAGNKSA-N,C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,C23H23N7O5,DB06813,D05589,pralatrexate,IMIQUIMOD,CHEMBL1282,DOUYETYNHWVLEO-UHFFFAOYSA-N,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N,C14H16N4,DB00724,D02500,imiquimod,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
202613,52,77,28,uM,uM,2.64915436755981,-1.40039589441227,-0.834442788888889,2.70185818777101,5.0,0.0088145103337468,-3.541,0.286,-0.241,-1.371,-0.806,2.449,,0.8214999999999999,-1.092,celecoxib,CHEMBL118,RZEKVGVHFLEQIL-UHFFFAOYSA-N,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,C17H14F3N3O2S,DB00482,D00567,celecoxib,IMIQUIMOD,CHEMBL1282,DOUYETYNHWVLEO-UHFFFAOYSA-N,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N,C14H16N4,DB00724,D02500,imiquimod,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
202684,29,75,28,uM,uM,0.0763718838259012,12.5740758554931,3.16422777777778,1.04187265590878,20.0,2.73710444642706e-06,11.092,2.235,10.924,14.938,12.931,-0.395999999999999,,6.267499999999999,1.8389999999999984,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,ifosfamide,CHEMBL1024,HOMGKSMUEGBAAB-UHFFFAOYSA-N,C1CN(P(=O)(OC1)NCCCl)CCCl,C7H15Cl2N2O2P,DB01181,D00343,ifosfamide,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
202985,80,15,38,uM,uM,-1.30200100682199,2.44084236168912,2.79652745555556,3.57949991736831,0.0651799226455715,3.0,-0.723,4.271,16.049,5.532,10.7905,7.2425,,9.0165,6.5195,letrozole,CHEMBL1444,HPJKCIUCZWXJDR-UHFFFAOYSA-N,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,C17H11N5,DB01006,D00964,letrozole,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
203016,30,29,7,uM,uM,1.30746193268946,-4.90113174443317,-4.11573282888889,-1.6814040690348,0.103379172556706,0.556430841969183,-1.464,-2.286,-4.099,-4.966,-4.5325,-0.782500000000001,,-2.6575,-3.0685,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,A549,C3512,Lung (Carcinoma),Lung adenocarcinoma
203301,43,78,38,uM,uM,-8.73815051265112,-11.9494303018261,-5.71344255555555,-11.7654280507173,0.1,0.0203185246224506,19.532,26.291,21.745,25.811,23.778,-22.045,,0.8664999999999985,-2.5130000000000017,anastrozole,CHEMBL1399,YBBLVLTVTVSKRW-UHFFFAOYSA-N,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,C17H19N5,DB01217,D00960,anastrozole,Ixabepilone,CHEMBL1201752,FABUFPQFXZVHFB-PVYNADRNSA-N,CC1CCCC2(C(O2)CC(NC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C,C27H42N2O5S,DB04845,D04645,ixabepilone,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
203329,80,29,38,uM,uM,3.69028972297289,-8.82944025266934,-10.8700279555556,-4.32230772935175,0.0124384446811771,3.23203785210288,-7.778,-1.131,-9.925,-10.667,-10.296,-1.387,,-5.8415,-9.165,letrozole,CHEMBL1444,HPJKCIUCZWXJDR-UHFFFAOYSA-N,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,C17H11N5,DB01006,D00964,letrozole,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
203758,43,85,28,uM,uM,-9.83034141536883,-0.676389725447845,0.0744454444444435,-0.649951482420457,0.0494909528681203,2.0,0.596,21.08,49.824,18.706,34.265,12.589,,23.427,13.185000000000002,anastrozole,CHEMBL1399,YBBLVLTVTVSKRW-UHFFFAOYSA-N,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,C17H19N5,DB01217,D00960,anastrozole,6-Mercaptopurine,CHEMBL1425,GLVAUDGFNGKCSF-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=CN2,C5H4N4S,DB01033,D04931,mercaptopurine,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
203792,40,108,28,uM,uM,-0.76402416681669,-16.6925878292569,0.0239696666666678,-3.67671913251009,10.247490053348,0.776376318585053,16.189,45.766,47.484,47.912,47.698,-14.257,,16.7205,1.9320000000000024,altretamine,CHEMBL1455,UUVWYPNAQBNQJQ-UHFFFAOYSA-N,CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C,C9H18N6,DB00488,D02841,altretamine,6-Thioguanine,CHEMBL727,WYWHKKSPHMUBEB-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=C(N2)N,C5H5N5S,DB00352,D08603,thioguanine,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
204288,28,15,38,uM,uM,-6.15538696592164,-18.7964549563411,3.61317934555556,1.27926589347745,0.01,3.0,8.068,4.271,23.58,31.707,27.6435,15.3045,,21.474,19.5755,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
204517,74,39,38,uM,uM,-2.91805337497134,-3.94993448942021,-2.720218,-3.5963619512927,20.0,10.0,6.037,0.696,3.344,2.061,2.7025,-4.0305,,-0.6639999999999997,-3.3345,hydroxyurea,CHEMBL467,VSNHCAURESNICA-UHFFFAOYSA-N,C(=O)(N)NO,CH4N2O2,DB01005,D00341,hydroxyurea,allopurinol,CHEMBL1467,OFCNXPDARWKPPY-UHFFFAOYSA-N,C1=C2C(=NC=NC2=O)NN1; C1=NNC2=C1C(=O)NC=N2,C5H4N4O,DB00437,D00224,allopurinol,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
204531,388,56,28,uM,uM,1.83719322085635,-9.48360650718762,-5.83488866666667,1.58381196581855,0.0001327104903001,0.404474790457852,-8.257,0.465,-1.562,-5.117,-3.3395,4.4525,,0.5564999999999998,-3.8045,raloxifene,CHEMBL81,GZUITABIAKMVPG-UHFFFAOYSA-N,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,C28H27NO4S,DB00481,D08465,raloxifene,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
204582,90,39,38,uM,uM,1.41543172020975,1.07204791959448,-1.35234326666667,1.23081754788751,0.0790217190510949,10.0,0.881,-1.932,-1.764,-1.472,-1.618,-0.567,,-1.0925000000000002,-2.499,Nilotinib,CHEMBL255863,HHZIURLSWUIHRB-UHFFFAOYSA-N,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,C28H22F3N7O,DB04868,D08953,nilotinib,allopurinol,CHEMBL1467,OFCNXPDARWKPPY-UHFFFAOYSA-N,C1=C2C(=NC=NC2=O)NN1; C1=NNC2=C1C(=O)NC=N2,C5H4N4O,DB00437,D00224,allopurinol,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
204585,230,8,7,uM,uM,0.597713534745706,-36.5405661998609,0.948890444444444,8.21269194015522,4.04119334128291,0.1,-7.707,5.181,21.831,12.741,17.286,19.812,,18.549,12.105,Imatinib,CHEMBL941,KTUFNOKKBVMGRW-UHFFFAOYSA-N,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,C29H31N7O,DB00619,D01441,imatinib,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,A549,C3512,Lung (Carcinoma),Lung adenocarcinoma
204713,30,29,38,uM,uM,-0.433041514759328,-3.23469705069418,-2.73479206666667,-1.26517090317258,0.0877535175175971,3.23203785210288,3.51,-1.131,1.701,1.137,1.419,-0.96,,0.2295000000000002,-2.091,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
205392,28,74,38,uM,uM,-4.83264330380055,-43.2931668947728,-2.38799666666667,-2.5372311551998,0.01,1.00268810262577,11.012,0.167,8.992,21.001,14.9965,3.8175,,9.407,3.984499999999999,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,hydroxyurea,CHEMBL467,VSNHCAURESNICA-UHFFFAOYSA-N,C(=O)(N)NO,CH4N2O2,DB01005,D00341,hydroxyurea,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
205827,388,120,38,uM,uM,-4.54993291168447,0.939016767184743,1.75020515555556,0.314771941033552,0.0182925923188435,3.45153291335487,8.679,4.828,15.169,8.961,12.065,-1.442,,5.311499999999999,3.3859999999999992,raloxifene,CHEMBL81,GZUITABIAKMVPG-UHFFFAOYSA-N,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,C28H27NO4S,DB00481,D08465,raloxifene,Vismodegib,CHEMBL473417,BPQMGSKTAYIVFO-UHFFFAOYSA-N,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,C19H14Cl2N2O3S,DB08828,D09992,vismodegib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
205960,52,230,28,uM,uM,-0.781777345592187,0.706516242071484,1.17468612333333,1.89793682193195,0.142060439696195,2.20867564068689,1.4,0.942,9.264,5.196,7.23,4.888,,6.059000000000001,5.83,celecoxib,CHEMBL118,RZEKVGVHFLEQIL-UHFFFAOYSA-N,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,C17H14F3N3O2S,DB00482,D00567,celecoxib,Imatinib,CHEMBL941,KTUFNOKKBVMGRW-UHFFFAOYSA-N,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,C29H31N7O,DB00619,D01441,imatinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
206958,30,43,38,uM,uM,0.581778320564816,-1.27743054552164,-2.25333194444444,0.960932242131835,0.644562890760164,0.0912903046862621,-3.182,1.625,-4.466,1.231,-1.6175,-0.0605000000000002,,-0.839,-3.2425,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,anastrozole,CHEMBL1399,YBBLVLTVTVSKRW-UHFFFAOYSA-N,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,C17H19N5,DB01217,D00960,anastrozole,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
207029,52,230,38,uM,uM,2.55258072118599,-0.679425083286386,-0.564662621111111,2.53310357244295,4.49549180319288,3.36394247269348,0.331,-2.051,-2.259,-2.303,-2.281,-0.560999999999999,,-1.421,-2.612,celecoxib,CHEMBL118,RZEKVGVHFLEQIL-UHFFFAOYSA-N,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,C17H14F3N3O2S,DB00482,D00567,celecoxib,Imatinib,CHEMBL941,KTUFNOKKBVMGRW-UHFFFAOYSA-N,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,C29H31N7O,DB00619,D01441,imatinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
207473,8,5,28,uM,uM,-0.320503077875635,2.70144661730314,4.26449344444444,4.89048544770125,0.1,0.0444924565231995,8.313,34.269,21.466,38.045,29.7555,-12.8265,,8.464500000000001,-4.513499999999997,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
207526,85,86,28,uM,uM,-10.537551004751,-15.0622800434387,-0.801282711111111,-2.14052368179803,0.496639806255972,0.818787982245339,19.408,3.185,22.158,45.033,33.5955,11.0025,,22.299,14.1875,6-Mercaptopurine,CHEMBL1425,GLVAUDGFNGKCSF-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=CN2,C5H4N4S,DB01033,D04931,mercaptopurine,methoxsalen,CHEMBL416,QXKHYNVANLEOEG-UHFFFAOYSA-N,COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,C12H8O4,DB00553,D00139,methoxsalen,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
208150,388,29,28,uM,uM,-0.658357141956433,-6.48064065169549,-6.52266513333333,-0.403524228504781,0.0001327104903001,3.27938346125217,-8.257,10.191,20.536,7.039,13.7875,11.8535,,12.8205,3.596499999999999,raloxifene,CHEMBL81,GZUITABIAKMVPG-UHFFFAOYSA-N,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,C28H27NO4S,DB00481,D08465,raloxifene,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
208204,30,74,28,uM,uM,-0.0754177014787509,-3.78690867700201,0.234226519,0.817272446057376,0.108184550720613,1.98131635465789,2.96,-0.61,2.545,4.419,3.482,1.132,,2.3070000000000004,0.5220000000000002,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,hydroxyurea,CHEMBL467,VSNHCAURESNICA-UHFFFAOYSA-N,C(=O)(N)NO,CH4N2O2,DB01005,D00341,hydroxyurea,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
208254,75,77,28,uM,uM,1.05071937717771,-3.19593310811907,0.207279088888889,5.48314058665417,49.9704112391562,0.047131208469471,-4.479,-3.984,2.672,3.207,2.9395,11.4025,,7.171,6.9235,ifosfamide,CHEMBL1024,HOMGKSMUEGBAAB-UHFFFAOYSA-N,C1CN(P(=O)(OC1)NCCCl)CCCl,C7H15Cl2N2O2P,DB01181,D00343,ifosfamide,IMIQUIMOD,CHEMBL1282,DOUYETYNHWVLEO-UHFFFAOYSA-N,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N,C14H16N4,DB00724,D02500,imiquimod,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
208305,15,29,38,uM,uM,-1.06777404216762,-10.9423103600892,-5.5491069,-4.1346062350927,3.0,3.23203785210288,3.067,-1.131,-0.823,-6.901,-3.862,-5.798,,-4.83,-6.929,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
209123,90,15,7,uM,uM,-0.34362001877112,-11.0278790181733,-6.68110932222222,-0.952843172621069,1.0,0.483744845817817,-6.196,6.582,-6.279,-6.283,-6.281,-6.667,,-6.474,-12.863,Nilotinib,CHEMBL255863,HHZIURLSWUIHRB-UHFFFAOYSA-N,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,C28H22F3N7O,DB04868,D08953,nilotinib,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,A549,C3512,Lung (Carcinoma),Lung adenocarcinoma
209198,100,30,28,uM,uM,2.29843301996258,-32.1825933542414,2.37394491111111,7.13578662191777,0.0045932091062147,0.7254659487299,13.552,-2.658,16.341,90.618,53.4795,42.5855,,48.0325,39.9275,Romidepsin,CHEMBL343448,OHRURASPPZQGQM-GCCNXGTGSA-N,CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C,C24H36N4O6S2,,D06637,romidepsin,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
209855,8,75,28,uM,uM,-0.832063353449465,-53.3863457433887,1.88533811111111,-0.0903649677788431,0.1,2.73710444642706e-06,18.179,2.235,18.791,31.321,25.056,4.642,,14.849000000000002,6.877000000000002,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,ifosfamide,CHEMBL1024,HOMGKSMUEGBAAB-UHFFFAOYSA-N,C1CN(P(=O)(OC1)NCCCl)CCCl,C7H15Cl2N2O2P,DB01181,D00343,ifosfamide,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
210223,74,48,38,uM,uM,-2.19112184018985,-2.52024190742879,-5.07243891111111,-3.81802112125116,20.0,20.4443513442458,5.695,-1.708,3.21,1.373,2.2915,-1.6955,,0.298,-3.4035,hydroxyurea,CHEMBL467,VSNHCAURESNICA-UHFFFAOYSA-N,C(=O)(N)NO,CH4N2O2,DB01005,D00341,hydroxyurea,busulfan,CHEMBL820,COVZYZSDYWQREU-UHFFFAOYSA-N,CS(=O)(=O)OCCCCOS(=O)(=O)C,C6H14O6S2,DB01008,D00248,busulfan,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
210373,30,85,38,uM,uM,1.18565335953929,-18.8006628350506,-6.88111038888889,-2.52368418753684,1.0,0.695815622821477,-6.192,27.669,45.507,16.746,31.1265,9.6495,,20.388,3.4575,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,6-Mercaptopurine,CHEMBL1425,GLVAUDGFNGKCSF-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=CN2,C5H4N4S,DB01033,D04931,mercaptopurine,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
210630,43,77,28,uM,uM,5.09193841970309,-7.54865271975923,-7.17888642222222,5.25545931870515,0.0854604305971887,0.0088145103337468,-12.45,0.286,-5.351,-8.287,-6.819,5.345,,-0.7370000000000001,-7.105,anastrozole,CHEMBL1399,YBBLVLTVTVSKRW-UHFFFAOYSA-N,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,C17H19N5,DB01217,D00960,anastrozole,IMIQUIMOD,CHEMBL1282,DOUYETYNHWVLEO-UHFFFAOYSA-N,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N,C14H16N4,DB00724,D02500,imiquimod,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
211351,15,96,38,uM,uM,0.102807978415662,-7.28998791639397,-1.68556711111111,-1.07086673146046,0.355875618215742,1.86748693003456e-05,-0.165,43.534,28.035,43.984,36.0095,-7.3595,,14.325000000000005,-7.524499999999996,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,Pralatrexate,CHEMBL1201746,OGSBUKJUDHAQEA-WMCAAGNKSA-N,C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,C23H23N7O5,DB06813,D05589,pralatrexate,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
211393,388,52,28,uM,uM,0.314117755881454,-5.37685568061175,-5.3965128,-1.68282534345361,1.0,4.97096949791346,-4.051,1.035,-4.762,0.258,-2.252,0.764,,-0.7439999999999998,-3.287,raloxifene,CHEMBL81,GZUITABIAKMVPG-UHFFFAOYSA-N,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,C28H27NO4S,DB00481,D08465,raloxifene,celecoxib,CHEMBL118,RZEKVGVHFLEQIL-UHFFFAOYSA-N,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,C17H14F3N3O2S,DB00482,D00567,celecoxib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
211764,80,48,28,uM,uM,-1.78718167111719,-0.495971931565714,0.928636077777778,0.740695308072767,0.181363261750296,7.55099766413197,0.35,2.11,7.036,5.089,6.0625,3.6025,,4.8325,3.9525,letrozole,CHEMBL1444,HPJKCIUCZWXJDR-UHFFFAOYSA-N,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,C17H11N5,DB01006,D00964,letrozole,busulfan,CHEMBL820,COVZYZSDYWQREU-UHFFFAOYSA-N,CS(=O)(=O)OCCCCOS(=O)(=O)C,C6H14O6S2,DB01008,D00248,busulfan,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
211867,79,108,28,uM,uM,0.971324256210341,-13.2513679869032,1.42530355555556,-1.18444346791009,14.2462438857892,0.776376318585053,5.531,45.766,17.103,75.3,46.2015,-5.0955,,20.553000000000004,0.4355000000000046,Lenalidomide,CHEMBL848,GOTYRUGSSMKFNF-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,C13H13N3O3,DB00480,D04687,lenalidomide,6-Thioguanine,CHEMBL727,WYWHKKSPHMUBEB-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=C(N2)N,C5H5N5S,DB00352,D08603,thioguanine,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
212029,31,5,38,uM,uM,-7.0756453766548,-27.6208307415374,-4.42742982333333,-3.25910550543575,16.6798488368897,0.157942847158906,1.545,6.879,35.467,9.408,22.4375,14.0135,,18.2255,15.5585,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
212340,388,88,38,uM,uM,-3.0232212473948,0.11361899439584,3.36567177777778,-0.274506202738568,0.0735284306988261,0.0314236971513403,10.629,32.652,42.166,39.112,40.639,-2.642,,18.998500000000003,7.987000000000002,raloxifene,CHEMBL81,GZUITABIAKMVPG-UHFFFAOYSA-N,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,C28H27NO4S,DB00481,D08465,raloxifene,mitoxantrone,CHEMBL58,KKZJGLLVHKMTCM-UHFFFAOYSA-N,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,C22H28N4O6,DB01204,D08224,mitoxantrone,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
212375,28,8,28,uM,uM,-7.49019804721644,-1.15250189835812,-1.26938848888889,-0.656097831362151,0.0041832665081513,0.1,6.685,4.477,8.767,37.168,22.9675,11.8055,,17.3865,16.282500000000002,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
212574,31,74,38,uM,uM,0.902348890654386,1.25379615199139,0.0214662999999999,1.35938740852071,9.87618479402346,1.00268810262577,0.489,0.167,4.115,2.536,3.3255,2.6695,,2.9975,2.8365,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,hydroxyurea,CHEMBL467,VSNHCAURESNICA-UHFFFAOYSA-N,C(=O)(N)NO,CH4N2O2,DB01005,D00341,hydroxyurea,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
212766,43,86,38,uM,uM,-0.595463522361359,-4.56613826907228,-4.55222095555556,-3.41965494004151,0.0362529987438274,0.107786796112615,0.004,2.82,-1.469,-7.152,-4.3105,-7.1345,,-5.7225,-7.1305,anastrozole,CHEMBL1399,YBBLVLTVTVSKRW-UHFFFAOYSA-N,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,C17H19N5,DB01217,D00960,anastrozole,methoxsalen,CHEMBL416,QXKHYNVANLEOEG-UHFFFAOYSA-N,COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,C12H8O4,DB00553,D00139,methoxsalen,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
213065,107,77,38,uM,uM,3.87872081291689,-0.0817789209842747,-1.08888730222222,4.24250997004809,10.0,0.0048430170497354,-5.334,-1.053,-2.862,-3.266,-3.064,3.323,,0.1294999999999997,-2.011,thalidomide,CHEMBL468,UEJJHQNACJXSKW-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,C13H10N2O4,DB01041,D00754,thalidomide,IMIQUIMOD,CHEMBL1282,DOUYETYNHWVLEO-UHFFFAOYSA-N,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N,C14H16N4,DB00724,D02500,imiquimod,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
213527,43,86,28,uM,uM,2.61900803469574,-0.0198140696267251,0.08000152,4.52238334890011,0.1,2.49238175155863,-4.067,0.335,1.44,-1.735,-0.1475,3.5845,,1.7185,-0.4825,anastrozole,CHEMBL1399,YBBLVLTVTVSKRW-UHFFFAOYSA-N,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,C17H19N5,DB01217,D00960,anastrozole,methoxsalen,CHEMBL416,QXKHYNVANLEOEG-UHFFFAOYSA-N,COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,C12H8O4,DB00553,D00139,methoxsalen,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
213638,48,75,28,uM,uM,-3.4845396587172,-5.15015983281338,-4.45608346666667,-4.22194804622329,45.3457037562755,2.73710444642706e-06,5.501,2.235,2.759,11.313,7.036,-0.7,,3.168,1.5349999999999993,busulfan,CHEMBL820,COVZYZSDYWQREU-UHFFFAOYSA-N,CS(=O)(=O)OCCCCOS(=O)(=O)C,C6H14O6S2,DB01008,D00248,busulfan,ifosfamide,CHEMBL1024,HOMGKSMUEGBAAB-UHFFFAOYSA-N,C1CN(P(=O)(OC1)NCCCl)CCCl,C7H15Cl2N2O2P,DB01181,D00343,ifosfamide,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
214278,8,29,7,uM,uM,2.79993653596012,-16.2773384052155,1.74167666666667,20.8264987751262,0.057145503640152,0.556430841969183,-20.391,-2.286,15.602,39.826,27.714,50.391,,39.0525,30.0,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,A549,C3512,Lung (Carcinoma),Lung adenocarcinoma
215102,74,86,28,uM,uM,-5.04083567551113,-3.07838668533025,-3.93386141222222,-5.03708982870335,20.0,0.818787982245339,6.746,3.185,6.392,10.66,8.526,-1.405,,3.5605,1.7799999999999994,hydroxyurea,CHEMBL467,VSNHCAURESNICA-UHFFFAOYSA-N,C(=O)(N)NO,CH4N2O2,DB01005,D00341,hydroxyurea,methoxsalen,CHEMBL416,QXKHYNVANLEOEG-UHFFFAOYSA-N,COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,C12H8O4,DB00553,D00139,methoxsalen,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
215111,85,78,28,uM,uM,-2.63671974509889,-1.74331267276343,1.49763666666667,-1.64583938891675,2.0,0.0059041832777556,20.507,66.783,48.617,80.206,64.4115,-22.8785,,20.7665,-2.371499999999997,6-Mercaptopurine,CHEMBL1425,GLVAUDGFNGKCSF-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=CN2,C5H4N4S,DB01033,D04931,mercaptopurine,Ixabepilone,CHEMBL1201752,FABUFPQFXZVHFB-PVYNADRNSA-N,CC1CCCC2(C(O2)CC(NC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C,C27H42N2O5S,DB04845,D04645,ixabepilone,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
215262,8,107,38,uM,uM,-1.69358668855547,-1.12167121719608,-1.16673502222222,-2.05614292435694,0.0847857637136152,2.69506480288668e-07,0.502,2.732,2.844,0.706,1.775,-1.459,,0.1579999999999999,-0.9570000000000004,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,thalidomide,CHEMBL468,UEJJHQNACJXSKW-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,C13H10N2O4,DB01041,D00754,thalidomide,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
215331,80,31,28,uM,uM,5.28848280160341,-1.86448261928039,-1.9744429,7.33619509676349,0.4,1.08324699532232,-9.014,-2.377,-4.545,-1.404,-2.9745,8.4165,,2.720999999999999,-0.5975000000000001,letrozole,CHEMBL1444,HPJKCIUCZWXJDR-UHFFFAOYSA-N,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,C17H11N5,DB01006,D00964,letrozole,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
215605,30,74,38,uM,uM,-0.0958644410039594,-0.877824661843096,-0.794496522222222,0.0365986968541722,0.355862390163899,1.00268810262577,0.166,0.167,-0.211,1.062,0.4255,0.0925,,0.259,0.2584999999999999,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,hydroxyurea,CHEMBL467,VSNHCAURESNICA-UHFFFAOYSA-N,C(=O)(N)NO,CH4N2O2,DB01005,D00341,hydroxyurea,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
215884,15,30,28,uM,uM,5.16327253203205,0.614689289850461,1.22505744555556,16.0084041392381,1.09119152465535,0.7254659487299,-11.398,-2.658,2.404,3.56,2.982,17.038,,10.01,5.640000000000001,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
216120,230,8,28,uM,uM,3.30408374816603,-15.019839495228,0.9875857,2.62913140591957,0.148560481032036,0.1,-3.286,4.477,10.898,3.223,7.0605,5.8695,,6.465,2.5835,Imatinib,CHEMBL941,KTUFNOKKBVMGRW-UHFFFAOYSA-N,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,C29H31N7O,DB00619,D01441,imatinib,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
217016,100,5,28,uM,uM,0.325741622778723,-14.0783744849624,-1.26919928888889,0.289402855056806,0.0029061909355454,0.0444924565231995,17.134,34.269,32.415,82.562,57.4885,6.0855,,31.787000000000003,23.219500000000004,Romidepsin,CHEMBL343448,OHRURASPPZQGQM-GCCNXGTGSA-N,CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C,C24H36N4O6S2,,D06637,romidepsin,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
217114,74,43,38,uM,uM,-2.78996851894304,-2.73886223541546,-2.0411045,-3.36137622544537,0.735188350414047,0.0085031178321395,2.247,3.829,1.29,2.094,1.692,-4.384,,-1.3460000000000003,-2.1370000000000005,hydroxyurea,CHEMBL467,VSNHCAURESNICA-UHFFFAOYSA-N,C(=O)(N)NO,CH4N2O2,DB01005,D00341,hydroxyurea,anastrozole,CHEMBL1399,YBBLVLTVTVSKRW-UHFFFAOYSA-N,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,C17H19N5,DB01217,D00960,anastrozole,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
217148,80,74,38,uM,uM,4.75053985606582,-10.9987162329002,-11.2255538888889,-1.81159365597884,0.0047587273496985,1.00268810262577,-11.513,0.167,-12.369,-9.558,-10.9635,0.3825,,-5.2905,-11.1305,letrozole,CHEMBL1444,HPJKCIUCZWXJDR-UHFFFAOYSA-N,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,C17H11N5,DB01006,D00964,letrozole,hydroxyurea,CHEMBL467,VSNHCAURESNICA-UHFFFAOYSA-N,C(=O)(N)NO,CH4N2O2,DB01005,D00341,hydroxyurea,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
217225,107,78,38,uM,uM,-0.255642389709399,-23.6554703897602,-2.85111162222222,-2.42946670048173,7.61998695440087,0.0121596535240262,-0.868,35.749,16.1,30.864,23.482,-11.399,,6.041499999999999,-12.267000000000005,thalidomide,CHEMBL468,UEJJHQNACJXSKW-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,C13H10N2O4,DB01041,D00754,thalidomide,Ixabepilone,CHEMBL1201752,FABUFPQFXZVHFB-PVYNADRNSA-N,CC1CCCC2(C(O2)CC(NC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C,C27H42N2O5S,DB04845,D04645,ixabepilone,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
217247,31,96,38,uM,uM,2.08382743780864,-18.0931373507399,-0.996537666666666,0.845053492459411,20.0,1.86748693003456e-05,-2.516,43.534,33.629,28.516,31.0725,-9.9455,,10.5635,-12.461499999999996,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,Pralatrexate,CHEMBL1201746,OGSBUKJUDHAQEA-WMCAAGNKSA-N,C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,C23H23N7O5,DB06813,D05589,pralatrexate,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
217259,53,8,28,uM,uM,-8.80077004005477,-1.94282815546694,3.82596288888889,1.19859434894348,14.493469737573,0.0478811819350707,14.918,17.234,31.525,21.998,26.7615,-5.3905,,10.6855,9.5275,chlorambucil,CHEMBL515,JCKYGMPEJWAADB-UHFFFAOYSA-N,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,C14H19Cl2NO2,DB00291,D00266,chlorambucil,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
217289,80,96,38,uM,uM,5.18628965506724,-16.7598039840732,0.344443922222221,3.61759478079274,0.0394492909028113,1.86748693003456e-05,-4.89,43.534,21.465,46.603,34.034,-4.61,,14.712,-9.5,letrozole,CHEMBL1444,HPJKCIUCZWXJDR-UHFFFAOYSA-N,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,C17H11N5,DB01006,D00964,letrozole,Pralatrexate,CHEMBL1201746,OGSBUKJUDHAQEA-WMCAAGNKSA-N,C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,C23H23N7O5,DB06813,D05589,pralatrexate,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
217437,86,5,38,uM,uM,-10.064346480041,-8.61032639835211,-2.93323933333333,-6.81175200594478,6.0,0.083000891278258,9.347,10.544,23.958,19.375,21.6665,1.7755,,11.721,11.1225,methoxsalen,CHEMBL416,QXKHYNVANLEOEG-UHFFFAOYSA-N,COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,C12H8O4,DB00553,D00139,methoxsalen,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
217571,1,8,38,uM,uM,3.62170795121984,-0.522535487442155,-0.455106888888888,4.11976040026671,8.20038402033151,0.0785633925702547,33.193,-6.568,31.857,31.032,31.4445,4.8195,,18.132,-1.7484999999999964,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
217659,15,39,28,uM,uM,-0.350882228714004,0.22339475431705,1.3964488,2.68370089569109,0.48785522498398,10.0,2.232,-1.317,7.776,5.452,6.614,5.699,,6.156499999999999,4.382,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,allopurinol,CHEMBL1467,OFCNXPDARWKPPY-UHFFFAOYSA-N,C1=C2C(=NC=NC2=O)NN1; C1=NNC2=C1C(=O)NC=N2,C5H4N4O,DB00437,D00224,allopurinol,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
217759,80,75,28,uM,uM,-1.68393940625558,1.14659622791097,1.187823,-0.555354906079161,0.0220141596580025,2.73710444642706e-06,1.96,2.235,5.156,3.309,4.2325,0.0374999999999996,,2.135,1.9975,letrozole,CHEMBL1444,HPJKCIUCZWXJDR-UHFFFAOYSA-N,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,C17H11N5,DB01006,D00964,letrozole,ifosfamide,CHEMBL1024,HOMGKSMUEGBAAB-UHFFFAOYSA-N,C1CN(P(=O)(OC1)NCCCl)CCCl,C7H15Cl2N2O2P,DB01181,D00343,ifosfamide,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
217770,80,85,28,uM,uM,-0.682247114643747,-5.88617397644521,-1.85549462222222,-0.14900817245351,0.013154718872768,0.530786928015275,-4.444,19.92,37.6,21.959,29.7795,14.3035,,22.0415,9.859499999999995,letrozole,CHEMBL1444,HPJKCIUCZWXJDR-UHFFFAOYSA-N,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,C17H11N5,DB01006,D00964,letrozole,6-Mercaptopurine,CHEMBL1425,GLVAUDGFNGKCSF-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=CN2,C5H4N4S,DB01033,D04931,mercaptopurine,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
218264,35,96,38,uM,uM,3.03044997162948,-13.874248461851,2.46654177777778,2.70542645390386,1.0,1.86748693003456e-05,0.784,43.534,40.235,39.068,39.6515,-4.6665,,17.4925,-3.8825,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,Pralatrexate,CHEMBL1201746,OGSBUKJUDHAQEA-WMCAAGNKSA-N,C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,C23H23N7O5,DB06813,D05589,pralatrexate,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
218430,48,43,28,uM,uM,-0.799781362021962,-1.74137059460591,-2.87244027777778,-1.34172679790138,50.0,0.0032221619972192,4.014,-2.883,1.262,1.714,1.488,0.357,,0.9225,-2.526,busulfan,CHEMBL820,COVZYZSDYWQREU-UHFFFAOYSA-N,CS(=O)(=O)OCCCCOS(=O)(=O)C,C6H14O6S2,DB01008,D00248,busulfan,anastrozole,CHEMBL1399,YBBLVLTVTVSKRW-UHFFFAOYSA-N,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,C17H19N5,DB01217,D00960,anastrozole,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
218498,388,35,38,uM,uM,-2.08215617280302,-1.03839300976122,7.504116,8.43679211712189,0.0903119153931736,0.126535266373507,2.249,10.685,5.013,9.649,7.331,-5.603,,0.8639999999999999,-3.354,raloxifene,CHEMBL81,GZUITABIAKMVPG-UHFFFAOYSA-N,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,C28H27NO4S,DB00481,D08465,raloxifene,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
218512,31,86,28,uM,uM,-0.7342317849731,-3.37720172847063,-1.46520770111111,0.29234032078456,2.74301959325972,0.818787982245339,-0.254,3.185,1.77,1.404,1.587,-1.344,,0.1214999999999999,-1.598,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,methoxsalen,CHEMBL416,QXKHYNVANLEOEG-UHFFFAOYSA-N,COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,C12H8O4,DB00553,D00139,methoxsalen,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
219573,100,96,28,uM,uM,0.96163553447139,-10.7895777009845,0.818888888888891,-3.47216995614155,0.0009002754300795,5.64306248484113e-06,14.46,78.49,50.721,79.102,64.9115,-28.0385,,18.43650000000001,-13.578499999999991,Romidepsin,CHEMBL343448,OHRURASPPZQGQM-GCCNXGTGSA-N,CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C,C24H36N4O6S2,,D06637,romidepsin,Pralatrexate,CHEMBL1201746,OGSBUKJUDHAQEA-WMCAAGNKSA-N,C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,C23H23N7O5,DB06813,D05589,pralatrexate,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
219845,388,79,38,uM,uM,-4.73737001028374,-4.31301038661997,-0.0704399999999997,-3.07511130814107,0.0735284306988261,30.0,10.629,3.594,6.279,6.332,6.3055,-7.9175,,-0.8059999999999992,-4.323499999999999,raloxifene,CHEMBL81,GZUITABIAKMVPG-UHFFFAOYSA-N,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,C28H27NO4S,DB00481,D08465,raloxifene,Lenalidomide,CHEMBL848,GOTYRUGSSMKFNF-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,C13H13N3O3,DB00480,D04687,lenalidomide,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
219931,230,29,28,uM,uM,-0.294941863792859,-2.7619638975163,-3.34226165555556,-2.24208562321048,0.313267998536032,0.622137048079663,-0.104,1.38,-2.06,-0.633,-1.3465,-2.6225,,-1.9845,-2.7265,Imatinib,CHEMBL941,KTUFNOKKBVMGRW-UHFFFAOYSA-N,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,C29H31N7O,DB00619,D01441,imatinib,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
219981,52,31,28,uM,uM,4.89611811491489,3.3662753156007,3.47519757777778,8.89891395916597,3.70936230072069,1.08324699532232,-4.733,-2.377,-1.026,-0.616,-0.821,6.289,,2.734,1.5559999999999998,celecoxib,CHEMBL118,RZEKVGVHFLEQIL-UHFFFAOYSA-N,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,C17H14F3N3O2S,DB00482,D00567,celecoxib,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
220128,100,35,38,uM,uM,-0.911277046421983,-2.5772140627155,4.40542688888889,0.249094786099982,0.000272928405153,0.175934482588107,51.116,16.408,63.699,58.248,60.9735,-6.5505,,27.2115,9.857500000000002,Romidepsin,CHEMBL343448,OHRURASPPZQGQM-GCCNXGTGSA-N,CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C,C24H36N4O6S2,,D06637,romidepsin,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
220164,48,43,38,uM,uM,-3.58304717337886,-1.67627405892161,-1.99475488888889,-4.61618670002255,50.0,0.0085031178321395,4.916,3.829,3.867,10.681,7.274,-1.471,,2.9014999999999995,2.358,busulfan,CHEMBL820,COVZYZSDYWQREU-UHFFFAOYSA-N,CS(=O)(=O)OCCCCOS(=O)(=O)C,C6H14O6S2,DB01008,D00248,busulfan,anastrozole,CHEMBL1399,YBBLVLTVTVSKRW-UHFFFAOYSA-N,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,C17H19N5,DB01217,D00960,anastrozole,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
221472,15,85,28,uM,uM,-5.99643176415567,-7.40210415078325,-2.62441083333333,-5.9928383208019,0.366733168539842,0.530786928015275,20.944,19.92,39.97,27.651,33.8105,-7.05350000000001,,13.378499999999995,12.866499999999998,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,6-Mercaptopurine,CHEMBL1425,GLVAUDGFNGKCSF-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=CN2,C5H4N4S,DB01033,D04931,mercaptopurine,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
221601,388,115,38,uM,uM,-3.57069633100007,0.887235361992945,1.81071726666667,-0.188476236571067,0.0182925923188435,0.211995512023176,8.679,3.087,10.426,6.569,8.4975,-3.2685,,2.6145000000000005,-0.1814999999999997,raloxifene,CHEMBL81,GZUITABIAKMVPG-UHFFFAOYSA-N,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,C28H27NO4S,DB00481,D08465,raloxifene,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
221721,30,96,28,uM,uM,-1.48227347261778,-12.6118037925609,-1.00333333333333,-3.88492183817521,0.78519545830689,5.64306248484113e-06,9.927,78.49,46.267,69.315,57.791,-30.626,,13.582499999999996,-20.699,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,Pralatrexate,CHEMBL1201746,OGSBUKJUDHAQEA-WMCAAGNKSA-N,C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,C23H23N7O5,DB06813,D05589,pralatrexate,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
221767,230,35,7,uM,uM,0.100858505756612,-19.5997073318942,-10.9233321111111,-1.33505903726827,5.0,0.292734083615513,-10.278,3.034,-5.117,-8.454,-6.7855,0.4585,,-3.1634999999999995,-9.8195,Imatinib,CHEMBL941,KTUFNOKKBVMGRW-UHFFFAOYSA-N,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,C29H31N7O,DB00619,D01441,imatinib,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,A549,C3512,Lung (Carcinoma),Lung adenocarcinoma
221790,29,78,28,uM,uM,6.07327999107184,-26.1567154153087,2.43333311111111,4.37088571620284,15.5059311103282,0.0049349515627974,-6.256,77.504,50.924,56.092,53.508,-17.74,,17.884,-23.996,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,Ixabepilone,CHEMBL1201752,FABUFPQFXZVHFB-PVYNADRNSA-N,CC1CCCC2(C(O2)CC(NC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C,C27H42N2O5S,DB04845,D04645,ixabepilone,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
222447,30,39,38,uM,uM,-3.89061098344091,-6.39148605879861,-1.4849446,-3.50485957877758,1.0,10.0,3.41,3.455,5.433,10.133,7.783,0.917999999999999,,4.3505,4.328,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,allopurinol,CHEMBL1467,OFCNXPDARWKPPY-UHFFFAOYSA-N,C1=C2C(=NC=NC2=O)NN1; C1=NNC2=C1C(=O)NC=N2,C5H4N4O,DB00437,D00224,allopurinol,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
222649,388,43,38,uM,uM,-2.56472448318126,5.90473053028732,7.15859077777778,7.18377730539973,0.0903119153931736,0.3,2.249,2.753,5.052,10.743,7.8975,2.8955,,5.3965,5.1445,raloxifene,CHEMBL81,GZUITABIAKMVPG-UHFFFAOYSA-N,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,C28H27NO4S,DB00481,D08465,raloxifene,anastrozole,CHEMBL1399,YBBLVLTVTVSKRW-UHFFFAOYSA-N,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,C17H19N5,DB01217,D00960,anastrozole,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
222980,388,5,28,uM,uM,1.71962446993718,-11.5781805261327,-0.352133222222222,5.05958756142633,1.0,0.0028714708858365,-4.051,-1.736,13.185,-0.646,6.2695,12.0565,,9.163,8.0055,raloxifene,CHEMBL81,GZUITABIAKMVPG-UHFFFAOYSA-N,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,C28H27NO4S,DB00481,D08465,raloxifene,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
223074,85,75,38,uM,uM,0.61424754715417,-35.2863610888847,-1.00916647777778,-0.0732883954879449,0.257208229593487,9.5856372430147,24.223,-0.464,23.678,24.607,24.1425,0.383499999999998,,12.262999999999998,-0.0805000000000006,6-Mercaptopurine,CHEMBL1425,GLVAUDGFNGKCSF-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=CN2,C5H4N4S,DB01033,D04931,mercaptopurine,ifosfamide,CHEMBL1024,HOMGKSMUEGBAAB-UHFFFAOYSA-N,C1CN(P(=O)(OC1)NCCCl)CCCl,C7H15Cl2N2O2P,DB01181,D00343,ifosfamide,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
223201,74,43,28,uM,uM,5.0651605223076,0.821938384931643,-1.5742621,3.14751910284985,20.0,0.0032221619972192,-2.811,-2.883,-5.593,6.111,0.259,5.953,,3.106,3.07,hydroxyurea,CHEMBL467,VSNHCAURESNICA-UHFFFAOYSA-N,C(=O)(N)NO,CH4N2O2,DB01005,D00341,hydroxyurea,anastrozole,CHEMBL1399,YBBLVLTVTVSKRW-UHFFFAOYSA-N,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,C17H19N5,DB01217,D00960,anastrozole,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
223216,74,75,28,uM,uM,2.44839598164824,-0.678612519902665,1.70081311111111,7.11549977987639,8.96450954577211,100.0,-2.905,-5.124,-4.295,0.679,-1.808,6.221,,2.2065,1.0969999999999998,hydroxyurea,CHEMBL467,VSNHCAURESNICA-UHFFFAOYSA-N,C(=O)(N)NO,CH4N2O2,DB01005,D00341,hydroxyurea,ifosfamide,CHEMBL1024,HOMGKSMUEGBAAB-UHFFFAOYSA-N,C1CN(P(=O)(OC1)NCCCl)CCCl,C7H15Cl2N2O2P,DB01181,D00343,ifosfamide,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
223589,15,5,38,uM,uM,-9.96414432143299,-10.6857878153397,0.0830810555555568,-2.54008613694478,3.0,0.3,4.834,17.231,47.819,20.176,33.9975,11.9325,,22.965000000000003,16.7665,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
223834,74,77,28,uM,uM,-2.03743674552102,-3.11580829999821,-2.03638272222222,-2.46021362797619,2.50923936965234,0.07,4.888,1.012,5.344,1.769,3.5565,-2.3435,,0.6065,-1.3314999999999997,hydroxyurea,CHEMBL467,VSNHCAURESNICA-UHFFFAOYSA-N,C(=O)(N)NO,CH4N2O2,DB01005,D00341,hydroxyurea,IMIQUIMOD,CHEMBL1282,DOUYETYNHWVLEO-UHFFFAOYSA-N,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N,C14H16N4,DB00724,D02500,imiquimod,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
224285,388,72,38,uM,uM,-9.45734560828737,2.59995507880078,3.04320522222222,-3.21268692134446,0.0735284306988261,10.0,10.629,12.784,33.663,19.361,26.512,3.099,,14.8055,13.728,raloxifene,CHEMBL81,GZUITABIAKMVPG-UHFFFAOYSA-N,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,C28H27NO4S,DB00481,D08465,raloxifene,Gefitinib,CHEMBL939,XGALLCVXEZPNRQ-UHFFFAOYSA-N,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,C22H24ClFN4O3,DB00317,D01977,gefitinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
224607,388,80,38,uM,uM,-0.560167109206455,3.76589826965181,5.37625724444444,5.72726524471374,0.0903119153931736,2.26650683452673,2.249,2.417,11.091,10.231,10.661,5.995,,8.328,8.244,raloxifene,CHEMBL81,GZUITABIAKMVPG-UHFFFAOYSA-N,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,C28H27NO4S,DB00481,D08465,raloxifene,letrozole,CHEMBL1444,HPJKCIUCZWXJDR-UHFFFAOYSA-N,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,C17H11N5,DB01006,D00964,letrozole,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
225082,230,48,38,uM,uM,-0.545315480996692,-0.640026221257297,-1.4646133,-0.359382777085241,0.154362100514864,9.76277026404458,-1.792,2.24,-0.468,0.475,0.0034999999999999,-0.4445,,-0.2205000000000001,-2.2365000000000004,Imatinib,CHEMBL941,KTUFNOKKBVMGRW-UHFFFAOYSA-N,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,C29H31N7O,DB00619,D01441,imatinib,busulfan,CHEMBL820,COVZYZSDYWQREU-UHFFFAOYSA-N,CS(=O)(=O)OCCCCOS(=O)(=O)C,C6H14O6S2,DB01008,D00248,busulfan,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
225618,15,39,38,uM,uM,3.55426942629148,2.96605617803755,-2.17194078888889,5.98658877211131,1.00175633112161,10.0,0.175,-1.932,-6.536,0.041,-3.2475,-1.4905,,-2.369,-3.4225,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,allopurinol,CHEMBL1467,OFCNXPDARWKPPY-UHFFFAOYSA-N,C1=C2C(=NC=NC2=O)NN1; C1=NNC2=C1C(=O)NC=N2,C5H4N4O,DB00437,D00224,allopurinol,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
225638,48,107,28,uM,uM,-2.06730200407676,4.98385865462963,3.28662806666667,2.364766477166,1.40243614076105,0.587883741983402,2.782,1.922,6.242,1.765,4.0035,-0.7005,,1.6515,1.2214999999999998,busulfan,CHEMBL820,COVZYZSDYWQREU-UHFFFAOYSA-N,CS(=O)(=O)OCCCCOS(=O)(=O)C,C6H14O6S2,DB01008,D00248,busulfan,thalidomide,CHEMBL468,UEJJHQNACJXSKW-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,C13H10N2O4,DB01041,D00754,thalidomide,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
225994,388,86,28,uM,uM,3.74139597921638,-1.05213735226804,-2.25044311111111,5.36591680829291,1.0,0.191381241762108,-8.397,0.939,-2.484,-3.427,-2.9555,4.5025,,0.7735000000000003,-3.8945,raloxifene,CHEMBL81,GZUITABIAKMVPG-UHFFFAOYSA-N,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,C28H27NO4S,DB00481,D08465,raloxifene,methoxsalen,CHEMBL416,QXKHYNVANLEOEG-UHFFFAOYSA-N,COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,C12H8O4,DB00553,D00139,methoxsalen,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
226503,230,77,28,uM,uM,1.22301450750553,2.25872474684781,1.15058286666667,3.34943847024656,2.23782247739677,0.0088145103337468,-0.492,0.286,4.646,9.054,6.85,7.056,,6.952999999999999,6.564,Imatinib,CHEMBL941,KTUFNOKKBVMGRW-UHFFFAOYSA-N,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,C29H31N7O,DB00619,D01441,imatinib,IMIQUIMOD,CHEMBL1282,DOUYETYNHWVLEO-UHFFFAOYSA-N,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N,C14H16N4,DB00724,D02500,imiquimod,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
226988,15,78,28,uM,uM,5.84517324782894,-22.4211406666903,6.16888866666667,6.77946556496817,1.1734754873262,0.0049349515627974,-0.216,77.504,60.763,79.789,70.276,-7.01200000000001,,31.63199999999999,-7.228000000000009,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,Ixabepilone,CHEMBL1201752,FABUFPQFXZVHFB-PVYNADRNSA-N,CC1CCCC2(C(O2)CC(NC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C,C27H42N2O5S,DB04845,D04645,ixabepilone,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
227191,35,48,28,uM,uM,-2.52659650871956,-10.4222132643133,0.407277666666666,4.70567361297798,0.280677345494495,3.7034900895783,5.442,0.497,5.227,10.799,8.013,2.074,,5.0435,2.571,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,busulfan,CHEMBL820,COVZYZSDYWQREU-UHFFFAOYSA-N,CS(=O)(=O)OCCCCOS(=O)(=O)C,C6H14O6S2,DB01008,D00248,busulfan,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
227289,29,43,38,uM,uM,-0.85281051833752,-4.38836054712972,-6.02999863333333,-5.03999103769484,10.5066097280943,0.1,0.141,4.116,1.715,-2.894,-0.5895,-4.8465,,-2.718,-4.7055,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,anastrozole,CHEMBL1399,YBBLVLTVTVSKRW-UHFFFAOYSA-N,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,C17H19N5,DB01217,D00960,anastrozole,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
228312,90,96,28,uM,uM,9.77049329245433,-2.92624823700533,8.68222222222223,6.60702233473719,1.0,5.64306248484113e-06,7.093,78.49,71.886,82.819,77.3525,-8.23050000000001,,34.56100000000001,-1.1374999999999886,Nilotinib,CHEMBL255863,HHZIURLSWUIHRB-UHFFFAOYSA-N,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,C28H22F3N7O,DB04868,D08953,nilotinib,Pralatrexate,CHEMBL1201746,OGSBUKJUDHAQEA-WMCAAGNKSA-N,C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,C23H23N7O5,DB06813,D05589,pralatrexate,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
228438,31,74,28,uM,uM,-0.132366183207431,0.188803387410256,-0.707636284444444,0.0815378359790446,8.46604365239238,1.98131635465789,2.204,-0.61,0.789,4.016,2.4025,0.8085,,1.6054999999999997,0.1984999999999996,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,hydroxyurea,CHEMBL467,VSNHCAURESNICA-UHFFFAOYSA-N,C(=O)(N)NO,CH4N2O2,DB01005,D00341,hydroxyurea,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
228684,90,100,28,uM,uM,1.161667960914,-68.4137597117982,-5.84662202666667,-2.66435602902866,0.0264191176985232,0.0032561469459855,-6.427,18.556,12.73,16.967,14.8485,2.7195,,8.783999999999999,-3.707500000000002,Nilotinib,CHEMBL255863,HHZIURLSWUIHRB-UHFFFAOYSA-N,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,C28H22F3N7O,DB04868,D08953,nilotinib,Romidepsin,CHEMBL343448,OHRURASPPZQGQM-GCCNXGTGSA-N,CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C,C24H36N4O6S2,,D06637,romidepsin,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
228715,48,86,28,uM,uM,-2.7845532782042,-2.83001401018149,-3.79386271111111,-2.2398012192272,23.9189187002352,2.49238175155863,1.956,0.335,5.369,9.937,7.653,5.362,,6.507499999999999,5.696999999999999,busulfan,CHEMBL820,COVZYZSDYWQREU-UHFFFAOYSA-N,CS(=O)(=O)OCCCCOS(=O)(=O)C,C6H14O6S2,DB01008,D00248,busulfan,methoxsalen,CHEMBL416,QXKHYNVANLEOEG-UHFFFAOYSA-N,COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,C12H8O4,DB00553,D00139,methoxsalen,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
228730,31,78,38,uM,uM,1.72931673449477,-20.4098294013067,-3.34333388888889,-0.701761943169347,20.0,0.0114113983580218,-2.889,29.962,7.181,27.276,17.2285,-9.8445,,3.692,-12.7335,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,Ixabepilone,CHEMBL1201752,FABUFPQFXZVHFB-PVYNADRNSA-N,CC1CCCC2(C(O2)CC(NC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C,C27H42N2O5S,DB04845,D04645,ixabepilone,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
228757,96,86,38,uM,uM,1.382338656928,-8.57119029096664,-8.57110977777778,-2.73551025231929,1.52076837192187e-06,0.107786796112615,-7.785,2.82,-7.078,-3.571,-5.3245,-0.359500000000001,,-2.842,-8.144499999999999,Pralatrexate,CHEMBL1201746,OGSBUKJUDHAQEA-WMCAAGNKSA-N,C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,C23H23N7O5,DB06813,D05589,pralatrexate,methoxsalen,CHEMBL416,QXKHYNVANLEOEG-UHFFFAOYSA-N,COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,C12H8O4,DB00553,D00139,methoxsalen,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
228763,29,77,28,uM,uM,4.7791751992002,4.84847707060682,5.41444605555556,8.05329788451545,20.0,0.0088145103337468,-2.87,0.286,4.388,3.765,4.0765,6.6605,,5.3685,3.7905,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,IMIQUIMOD,CHEMBL1282,DOUYETYNHWVLEO-UHFFFAOYSA-N,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N,C14H16N4,DB00724,D02500,imiquimod,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
228897,90,77,28,uM,uM,4.91420046710834,-4.33354422039699,-3.7977767,6.47271809969641,1.0,0.0088145103337468,-10.411,0.286,-5.66,-4.836,-5.248,4.877,,-0.1855000000000002,-5.534,Nilotinib,CHEMBL255863,HHZIURLSWUIHRB-UHFFFAOYSA-N,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,C28H22F3N7O,DB04868,D08953,nilotinib,IMIQUIMOD,CHEMBL1282,DOUYETYNHWVLEO-UHFFFAOYSA-N,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N,C14H16N4,DB00724,D02500,imiquimod,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
228943,43,77,38,uM,uM,2.03938960313508,-1.03950385787602,-1.70092891444444,1.72891436100822,0.1,0.0020538333057086,-2.485,-2.222,-2.075,-4.879,-3.477,1.23,,-1.1235,-1.255,anastrozole,CHEMBL1399,YBBLVLTVTVSKRW-UHFFFAOYSA-N,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,C17H19N5,DB01217,D00960,anastrozole,IMIQUIMOD,CHEMBL1282,DOUYETYNHWVLEO-UHFFFAOYSA-N,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N,C14H16N4,DB00724,D02500,imiquimod,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
229225,28,15,28,uM,uM,-1.30116680374075,-17.0954136384017,-2.35716666666667,-0.123363419800326,0.0035745817859364,0.086008288783272,11.052,4.041,10.089,38.294,24.1915,9.0985,,16.645000000000003,13.139500000000002,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
229949,86,77,38,uM,uM,2.4530534973662,-0.20353978379283,-1.2844887,2.22872254812797,0.185322059380791,0.0048430170497354,-4.11,-1.053,-1.743,-3.848,-2.7955,2.3675,,-0.2139999999999999,-1.7425000000000002,methoxsalen,CHEMBL416,QXKHYNVANLEOEG-UHFFFAOYSA-N,COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,C12H8O4,DB00553,D00139,methoxsalen,IMIQUIMOD,CHEMBL1282,DOUYETYNHWVLEO-UHFFFAOYSA-N,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N,C14H16N4,DB00724,D02500,imiquimod,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
230311,52,5,28,uM,uM,0.710548189213054,-33.2113723543602,-2.90889835555556,-0.0055943171447819,7.78580679031542e-14,0.0444924565231995,0.259,34.269,-2.601,31.594,14.4965,-20.0315,,-2.7675,-19.7725,celecoxib,CHEMBL118,RZEKVGVHFLEQIL-UHFFFAOYSA-N,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,C17H14F3N3O2S,DB00482,D00567,celecoxib,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
230508,100,74,38,uM,uM,0.394885816396956,-45.8264296752248,1.79518317777778,1.86706096113366,0.0021272432135814,1.00268810262577,12.921,0.167,27.804,9.716,18.76,5.672,,12.216,5.839000000000002,Romidepsin,CHEMBL343448,OHRURASPPZQGQM-GCCNXGTGSA-N,CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C,C24H36N4O6S2,,D06637,romidepsin,hydroxyurea,CHEMBL467,VSNHCAURESNICA-UHFFFAOYSA-N,C(=O)(N)NO,CH4N2O2,DB01005,D00341,hydroxyurea,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
230821,8,96,28,uM,uM,5.39991026241666,-12.0918037924854,-0.483333333333334,-0.543049518340267,0.0090368469240224,5.64306248484113e-06,0.464,78.49,43.859,80.279,62.069,-16.885,,22.59200000000001,-16.420999999999992,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,Pralatrexate,CHEMBL1201746,OGSBUKJUDHAQEA-WMCAAGNKSA-N,C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,C23H23N7O5,DB06813,D05589,pralatrexate,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
230895,96,5,28,uM,uM,0.422059448700392,-2.86659049613129,-4.621061,-2.12423475938923,9.75219872573321e-06,0.0444924565231995,0.899,34.269,15.212,33.18,24.196,-10.972,,6.612000000000002,-10.072999999999997,Pralatrexate,CHEMBL1201746,OGSBUKJUDHAQEA-WMCAAGNKSA-N,C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,C23H23N7O5,DB06813,D05589,pralatrexate,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
230914,230,29,7,uM,uM,2.30147669482457,-4.19966543038415,-6.73447322222222,-3.04791680566857,0.159604849095167,0.556430841969183,-3.778,-2.286,-4.256,-5.985,-5.1205,0.9435,,-2.0885,-2.8345,Imatinib,CHEMBL941,KTUFNOKKBVMGRW-UHFFFAOYSA-N,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,C29H31N7O,DB00619,D01441,imatinib,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,A549,C3512,Lung (Carcinoma),Lung adenocarcinoma
231268,80,74,28,uM,uM,-1.29645243826274,2.97800842767233,-0.993551333333333,-0.4236033360254,0.4,1.98131635465789,5.064,-0.61,2.65,2.554,2.602,-1.852,,0.375,-2.462,letrozole,CHEMBL1444,HPJKCIUCZWXJDR-UHFFFAOYSA-N,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,C17H11N5,DB01006,D00964,letrozole,hydroxyurea,CHEMBL467,VSNHCAURESNICA-UHFFFAOYSA-N,C(=O)(N)NO,CH4N2O2,DB01005,D00341,hydroxyurea,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
231381,31,39,28,uM,uM,0.672490522974381,-2.13035014134167,-1.95654915555556,-0.0584674481236054,1.69990154302654,5.30647435409587,-0.438,-1.052,-0.927,-2.301,-1.614,-0.124,,-0.8690000000000001,-1.1760000000000002,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,allopurinol,CHEMBL1467,OFCNXPDARWKPPY-UHFFFAOYSA-N,C1=C2C(=NC=NC2=O)NN1; C1=NNC2=C1C(=O)NC=N2,C5H4N4O,DB00437,D00224,allopurinol,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
231385,90,8,38,uM,uM,0.0103037964743629,-2.75759573526817,-2.58716522222222,1.22881995714306,0.415380817105195,0.0462823943752059,-2.248,0.322,5.143,13.047,9.095,11.021,,10.058,8.773000000000001,Nilotinib,CHEMBL255863,HHZIURLSWUIHRB-UHFFFAOYSA-N,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,C28H22F3N7O,DB04868,D08953,nilotinib,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
231470,30,96,38,uM,uM,5.19840508329545,-15.4342483840732,1.66999952222222,5.26446191679274,1.0,1.86748693003456e-05,-5.562,43.534,48.639,45.937,47.288,9.316,,28.302,3.753999999999998,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,Pralatrexate,CHEMBL1201746,OGSBUKJUDHAQEA-WMCAAGNKSA-N,C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,C23H23N7O5,DB06813,D05589,pralatrexate,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
231509,35,107,38,uM,uM,-4.0088821249846,-6.0621602761107,-6.05605566666667,-4.2999300657998,0.473256095016369,2.69506480288668e-07,0.292,2.732,-0.498,18.615,9.0585,6.0345,,7.5465,6.3265,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,thalidomide,CHEMBL468,UEJJHQNACJXSKW-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,C13H10N2O4,DB01041,D00754,thalidomide,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
231660,31,75,28,uM,uM,2.74887360636335,-6.31104116506359,-5.00139337777778,0.269832526173156,10.0314287309612,100.0,-3.664,-5.124,-8.596,-5.332,-6.964,1.824,,-2.5700000000000003,-3.3000000000000003,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,ifosfamide,CHEMBL1024,HOMGKSMUEGBAAB-UHFFFAOYSA-N,C1CN(P(=O)(OC1)NCCCl)CCCl,C7H15Cl2N2O2P,DB01181,D00343,ifosfamide,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
231728,90,107,28,uM,uM,1.79244278455164,-0.980574412734288,-2.2989166,2.59283850774254,0.0775873771101157,0.587883741983402,-2.606,1.922,0.54,0.857,0.6985,1.3825,,1.0405,-1.2235,Nilotinib,CHEMBL255863,HHZIURLSWUIHRB-UHFFFAOYSA-N,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,C28H22F3N7O,DB04868,D08953,nilotinib,thalidomide,CHEMBL468,UEJJHQNACJXSKW-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,C13H10N2O4,DB01041,D00754,thalidomide,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
231948,80,90,28,uM,uM,3.46163196229588,4.06568479984926,3.09731913333333,7.69257156870738,0.0057076942424349,0.0117945917851263,-4.599,-1.69,1.207,0.786,0.9965,7.2855,,4.141,2.6865,letrozole,CHEMBL1444,HPJKCIUCZWXJDR-UHFFFAOYSA-N,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,C17H11N5,DB01006,D00964,letrozole,Nilotinib,CHEMBL255863,HHZIURLSWUIHRB-UHFFFAOYSA-N,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,C28H22F3N7O,DB04868,D08953,nilotinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
232200,8,75,38,uM,uM,0.396030635490176,1.58212621204407,0.196392077777778,-0.101669166534717,0.0031547423705976,100.0,-0.046,1.939,0.827,3.768,2.2975,0.4045,,1.351,0.3584999999999998,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,ifosfamide,CHEMBL1024,HOMGKSMUEGBAAB-UHFFFAOYSA-N,C1CN(P(=O)(OC1)NCCCl)CCCl,C7H15Cl2N2O2P,DB01181,D00343,ifosfamide,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
232542,230,90,7,uM,uM,2.36941278490186,-4.47948805405915,-5.74666503631286,-0.499301008553118,5.0,0.306035206235348,-4.715,-0.755,-6.17,-8.623,-7.3965,-1.9265,,-4.6615,-6.6415,Imatinib,CHEMBL941,KTUFNOKKBVMGRW-UHFFFAOYSA-N,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,C29H31N7O,DB00619,D01441,imatinib,Nilotinib,CHEMBL255863,HHZIURLSWUIHRB-UHFFFAOYSA-N,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,C28H22F3N7O,DB04868,D08953,nilotinib,A549,C3512,Lung (Carcinoma),Lung adenocarcinoma
232755,15,77,28,uM,uM,3.13851002236195,0.156172282449924,-0.148916912027266,3.15713556790107,0.171671469906518,0.0088144830043922,-2.623,0.286,-1.205,1.594,0.1945,2.5315,,1.363,-0.0914999999999999,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,IMIQUIMOD,CHEMBL1282,DOUYETYNHWVLEO-UHFFFAOYSA-N,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N,C14H16N4,DB00724,D02500,imiquimod,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
233046,39,86,28,uM,uM,-0.359489813268122,1.55736410104504,1.45536304479761,2.28112775244707,5.110659225579,2.49238167529758,-0.609,0.335,1.789,9.333,5.561,5.835,,5.698,5.226,allopurinol,CHEMBL1467,OFCNXPDARWKPPY-UHFFFAOYSA-N,C1=C2C(=NC=NC2=O)NN1; C1=NNC2=C1C(=O)NC=N2,C5H4N4O,DB00437,D00224,allopurinol,methoxsalen,CHEMBL416,QXKHYNVANLEOEG-UHFFFAOYSA-N,COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,C12H8O4,DB00553,D00139,methoxsalen,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
233052,90,29,38,uM,uM,1.9256529454375,1.78399621002139,-0.0313778006715398,3.25858877983473,0.0717533606322706,3.23217375956692,-1.926,-1.131,-0.904,-0.212,-0.558,2.499,,0.9705,0.573,Nilotinib,CHEMBL255863,HHZIURLSWUIHRB-UHFFFAOYSA-N,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,C28H22F3N7O,DB04868,D08953,nilotinib,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
233551,96,107,28,uM,uM,-0.0267463929993425,-1.17094194060297,-5.66113913424949,-1.74209524989857,4.40379507492952e-06,0.587883665769743,-4.398,1.922,2.528,1.148,1.838,4.314,,3.076,-0.0839999999999998,Pralatrexate,CHEMBL1201746,OGSBUKJUDHAQEA-WMCAAGNKSA-N,C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,C23H23N7O5,DB06813,D05589,pralatrexate,thalidomide,CHEMBL468,UEJJHQNACJXSKW-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,C13H10N2O4,DB01041,D00754,thalidomide,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
233779,80,31,38,uM,uM,5.49318453337713,-5.96862533231776,-6.8367108969659,0.980816228008111,0.0101645957807212,1.27528198439104,-7.21,-2.959,-9.161,-10.136,-9.6485,0.520500000000002,,-4.564,-6.689500000000001,letrozole,CHEMBL1444,HPJKCIUCZWXJDR-UHFFFAOYSA-N,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,C17H11N5,DB01006,D00964,letrozole,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
233868,52,85,38,uM,uM,-1.14341982617951,-33.7839494333473,-10.4466650363129,-5.96508995304263,5.0,0.695984704897367,-6.015,27.669,31.532,20.799,26.1655,4.5115,,15.338500000000002,-1.503499999999999,celecoxib,CHEMBL118,RZEKVGVHFLEQIL-UHFFFAOYSA-N,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,C17H14F3N3O2S,DB00482,D00567,celecoxib,6-Mercaptopurine,CHEMBL1425,GLVAUDGFNGKCSF-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=CN2,C5H4N4S,DB01033,D04931,mercaptopurine,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
233914,53,8,38,uM,uM,0.498190268327281,-0.338929719181158,0.411426868463994,6.14937718562241,10.0564078631981,0.0785633946652398,18.889,-6.568,21.359,18.23,19.7945,7.4735,,13.634,0.9055,chlorambucil,CHEMBL515,JCKYGMPEJWAADB-UHFFFAOYSA-N,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,C14H19Cl2NO2,DB00291,D00266,chlorambucil,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
234047,230,86,38,uM,uM,1.19707147532025,-7.18736863073218,-7.07555392520175,-1.62189401116417,0.270580570718811,0.089053231514339,-5.681,2.82,-3.884,-0.211,-2.0475,0.8135,,-0.6169999999999998,-4.8675,Imatinib,CHEMBL941,KTUFNOKKBVMGRW-UHFFFAOYSA-N,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,C29H31N7O,DB00619,D01441,imatinib,methoxsalen,CHEMBL416,QXKHYNVANLEOEG-UHFFFAOYSA-N,COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,C12H8O4,DB00553,D00139,methoxsalen,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
234162,388,78,38,uM,uM,-3.47483020970803,0.738317265736725,3.12116131238881,0.269295867651215,0.018292512655514,0.0003458583638209,8.679,7.476,11.116,9.452,10.284,-5.871,,2.2065,1.6050000000000004,raloxifene,CHEMBL81,GZUITABIAKMVPG-UHFFFAOYSA-N,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,C28H27NO4S,DB00481,D08465,raloxifene,Ixabepilone,CHEMBL1201752,FABUFPQFXZVHFB-PVYNADRNSA-N,CC1CCCC2(C(O2)CC(NC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C,C27H42N2O5S,DB04845,D04645,ixabepilone,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
234306,35,78,28,uM,uM,8.01019603815212,-12.6720852627586,5.61874987779485,6.87993414448601,0.146807692704996,0.0049933992099018,-0.477,77.487,56.878,76.083,66.4805,-10.5295,,27.97550000000001,-11.006499999999988,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,Ixabepilone,CHEMBL1201752,FABUFPQFXZVHFB-PVYNADRNSA-N,CC1CCCC2(C(O2)CC(NC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C,C27H42N2O5S,DB04845,D04645,ixabepilone,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
234466,39,107,38,uM,uM,-2.10670516067031,0.836302841416276,0.962894542421758,0.10347797885611,6.52522025268834,2.69507835556911e-07,1.147,2.736,2.431,9.215,5.823,1.94,,3.8815,3.087,allopurinol,CHEMBL1467,OFCNXPDARWKPPY-UHFFFAOYSA-N,C1=C2C(=NC=NC2=O)NN1; C1=NNC2=C1C(=O)NC=N2,C5H4N4O,DB00437,D00224,allopurinol,thalidomide,CHEMBL468,UEJJHQNACJXSKW-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,C13H10N2O4,DB01041,D00754,thalidomide,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
234665,8,77,38,uM,uM,2.92645057786056,-0.19333381268436,0.305167949267502,2.38492685843076,0.0511777952357877,0.0020545295081273,-1.373,-2.222,0.932,-2.752,-0.91,2.685,,0.8874999999999998,0.4629999999999999,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,IMIQUIMOD,CHEMBL1282,DOUYETYNHWVLEO-UHFFFAOYSA-N,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N,C14H16N4,DB00724,D02500,imiquimod,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
234723,29,39,38,uM,uM,-1.66922354983888,0.81321770169762,-1.7922502453606,-3.7469889171732,1.91175394675083,10.0,3.551,3.455,2.356,3.625,2.9905,-4.0155,,-0.5125000000000002,-0.5605000000000002,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,allopurinol,CHEMBL1467,OFCNXPDARWKPPY-UHFFFAOYSA-N,C1=C2C(=NC=NC2=O)NN1; C1=NNC2=C1C(=O)NC=N2,C5H4N4O,DB00437,D00224,allopurinol,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
235033,30,86,38,uM,uM,0.570584553980482,-7.88606619194318,-7.83110948075731,-3.66892264077118,0.0098550366058409,0.089053231514339,-4.922,2.82,-5.704,-3.136,-4.42,-2.318,,-3.369,-7.24,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,methoxsalen,CHEMBL416,QXKHYNVANLEOEG-UHFFFAOYSA-N,COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,C12H8O4,DB00553,D00139,methoxsalen,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
235045,230,39,28,uM,uM,1.02665656954152,0.230014335541385,0.290922645966771,3.9935010262692,0.0884447076345502,10.0,-2.162,-1.317,-1.546,1.116,-0.215,3.264,,1.5245,1.102,Imatinib,CHEMBL941,KTUFNOKKBVMGRW-UHFFFAOYSA-N,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,C29H31N7O,DB00619,D01441,imatinib,allopurinol,CHEMBL1467,OFCNXPDARWKPPY-UHFFFAOYSA-N,C1=C2C(=NC=NC2=O)NN1; C1=NNC2=C1C(=O)NC=N2,C5H4N4O,DB00437,D00224,allopurinol,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
235199,388,30,38,uM,uM,-1.45908890656081,1.9379434516404,4.28922632580791,3.69890575618838,0.018292512655514,0.0210697118552325,8.679,1.009,12.444,8.554,10.499,0.811,,5.655,1.8200000000000005,raloxifene,CHEMBL81,GZUITABIAKMVPG-UHFFFAOYSA-N,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,C28H27NO4S,DB00481,D08465,raloxifene,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
235225,388,56,38,uM,uM,-6.11783636269285,-0.983115841794377,0.864982661058519,-0.619460362780041,0.018292512655514,0.154857952435641,8.679,5.233,8.383,3.805,6.094,-7.818,,-0.8619999999999992,-2.585,raloxifene,CHEMBL81,GZUITABIAKMVPG-UHFFFAOYSA-N,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,C28H27NO4S,DB00481,D08465,raloxifene,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
235368,15,107,28,uM,uM,0.224190020243161,-2.8478250558907,-2.24777614742396,0.367224184926902,3.0,0.587883665769743,-2.247,1.922,-0.742,1.677,0.4675,0.7925,,0.63,-1.4545,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,thalidomide,CHEMBL468,UEJJHQNACJXSKW-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,C13H10N2O4,DB01041,D00754,thalidomide,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
235386,88,108,38,uM,uM,-10.6959950258829,-3.67821919668533,-1.78267838476807,-9.24233828833835,0.0527486408411434,1.03366265531186,24.508,30.715,31.625,36.341,33.983,-21.24,,6.3714999999999975,3.267999999999997,mitoxantrone,CHEMBL58,KKZJGLLVHKMTCM-UHFFFAOYSA-N,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,C22H28N4O6,DB01204,D08224,mitoxantrone,6-Thioguanine,CHEMBL727,WYWHKKSPHMUBEB-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=C(N2)N,C5H5N5S,DB00352,D08603,thioguanine,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
235674,15,74,38,uM,uM,-0.252738260430229,-1.02094344818364,0.535100557483135,2.13553789013963,1.58325340251745,1.00270306168241,-1.176,0.167,4.385,3.323,3.854,4.863,,4.3585,3.687,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,hydroxyurea,CHEMBL467,VSNHCAURESNICA-UHFFFAOYSA-N,C(=O)(N)NO,CH4N2O2,DB01005,D00341,hydroxyurea,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
235749,72,8,7,uM,uM,1.534817593552,9.73644250745126,11.4332724234999,3.60782579133104,3.46785227798922,0.1,23.925,19.551,63.661,56.803,60.232,16.756,,38.494,36.307,Gefitinib,CHEMBL939,XGALLCVXEZPNRQ-UHFFFAOYSA-N,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,C22H24ClFN4O3,DB00317,D01977,gefitinib,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,A549,C3512,Lung (Carcinoma),Lung adenocarcinoma
235937,80,43,38,uM,uM,1.40879529116024,-5.5259534610851,-6.31999836964619,-1.5510372218188,0.4,0.0912164999434249,-5.135,1.625,-6.516,-5.891,-6.2035,-2.6935,,-4.4485,-7.8285,letrozole,CHEMBL1444,HPJKCIUCZWXJDR-UHFFFAOYSA-N,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,C17H11N5,DB01006,D00964,letrozole,anastrozole,CHEMBL1399,YBBLVLTVTVSKRW-UHFFFAOYSA-N,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,C17H19N5,DB01217,D00960,anastrozole,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
236441,30,107,28,uM,uM,-3.8274106280469,-14.4946615637597,-5.90386155578986,-4.13390610433395,1.0,0.587883665769743,7.128,1.922,2.637,8.001,5.319,-3.731,,0.7939999999999996,-1.809,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,thalidomide,CHEMBL468,UEJJHQNACJXSKW-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,C13H10N2O4,DB01041,D00754,thalidomide,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
236626,230,15,28,uM,uM,-0.2816643150388,-7.97565638572059,-5.21383190229768,1.06391554927692,0.744324035843452,0.0860085158729254,-1.835,4.041,-5.114,-1.711,-3.4125,-5.6185,,-4.5155,-7.4535,Imatinib,CHEMBL941,KTUFNOKKBVMGRW-UHFFFAOYSA-N,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,C29H31N7O,DB00619,D01441,imatinib,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
236704,85,39,38,uM,uM,-7.53973019718379,-8.77174037220779,1.75652177241427,1.25917286470052,0.397478672781669,10.0,18.005,0.695,19.725,38.704,29.2145,10.5145,,19.8645,11.209500000000002,6-Mercaptopurine,CHEMBL1425,GLVAUDGFNGKCSF-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=CN2,C5H4N4S,DB01033,D04931,mercaptopurine,allopurinol,CHEMBL1467,OFCNXPDARWKPPY-UHFFFAOYSA-N,C1=C2C(=NC=NC2=O)NN1; C1=NNC2=C1C(=O)NC=N2,C5H4N4O,DB00437,D00224,allopurinol,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
236845,52,29,38,uM,uM,3.46052683299342,-1.64063952318337,-5.74339731363207,-0.401609397140126,4.38089170755131,3.23217375956692,-4.869,-1.131,-5.951,-6.123,-6.037,-0.0369999999999999,,-3.037,-4.906,celecoxib,CHEMBL118,RZEKVGVHFLEQIL-UHFFFAOYSA-N,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,C17H14F3N3O2S,DB00482,D00567,celecoxib,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
237041,35,78,38,uM,uM,-5.67148794994814,-4.81531905977488,0.757638766683741,-1.69284522973227,0.390155081713651,0.0203391763747341,-1.405,26.291,31.373,32.236,31.8045,6.9185,,19.3615,5.5135000000000005,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,Ixabepilone,CHEMBL1201752,FABUFPQFXZVHFB-PVYNADRNSA-N,CC1CCCC2(C(O2)CC(NC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C,C27H42N2O5S,DB04845,D04645,ixabepilone,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
237328,35,86,38,uM,uM,-3.35531870553145,-6.60906385582649,-6.59160968007546,-3.29798944924358,0.506435291660623,0.089053231514339,-1.582,2.82,3.684,24.076,13.88,12.642,,13.261,11.06,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,methoxsalen,CHEMBL416,QXKHYNVANLEOEG-UHFFFAOYSA-N,COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,C12H8O4,DB00553,D00139,methoxsalen,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
237521,48,39,38,uM,uM,-2.71487475575793,1.41163406784837,0.745056986591197,-1.08027872019974,23.1603223123021,10.0,2.162,3.455,4.457,8.233,6.345,0.728000000000001,,3.5365,2.89,busulfan,CHEMBL820,COVZYZSDYWQREU-UHFFFAOYSA-N,CS(=O)(=O)OCCCCOS(=O)(=O)C,C6H14O6S2,DB01008,D00248,busulfan,allopurinol,CHEMBL1467,OFCNXPDARWKPPY-UHFFFAOYSA-N,C1=C2C(=NC=NC2=O)NN1; C1=NNC2=C1C(=O)NC=N2,C5H4N4O,DB00437,D00224,allopurinol,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
237600,31,77,28,uM,uM,-0.639603308976275,-8.60787290558205,-5.58569685641066,-4.37624462873636,0.665337387906361,0.07,-1.296,1.012,-8.351,-0.704,-4.5275,-4.2435,,-4.3855,-5.5395,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,IMIQUIMOD,CHEMBL1282,DOUYETYNHWVLEO-UHFFFAOYSA-N,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N,C14H16N4,DB00724,D02500,imiquimod,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
237675,43,39,28,uM,uM,-2.21105689936822,-5.05190442909307,-6.77888957357549,-7.36082816083674,0.1,5.03320952824429e-13,1.622,1.321,-0.748,-1.841,-1.2945,-4.2375,,-2.766,-2.9165,anastrozole,CHEMBL1399,YBBLVLTVTVSKRW-UHFFFAOYSA-N,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,C17H19N5,DB01217,D00960,anastrozole,allopurinol,CHEMBL1467,OFCNXPDARWKPPY-UHFFFAOYSA-N,C1=C2C(=NC=NC2=O)NN1; C1=NNC2=C1C(=O)NC=N2,C5H4N4O,DB00437,D00224,allopurinol,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
237703,52,30,28,uM,uM,5.70488916115248,-1.22247735373781,0.380001630353817,9.89439812071306,0.0649711160009667,0.725465974035397,-9.148,-2.658,7.004,-1.095,2.9545,14.7605,,8.8575,5.6125,celecoxib,CHEMBL118,RZEKVGVHFLEQIL-UHFFFAOYSA-N,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,C17H14F3N3O2S,DB00482,D00567,celecoxib,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
237866,35,77,28,uM,uM,-3.66595643589535,-7.75479778911236,-6.13907735403322,-3.66418115042301,0.100118509790004,0.0088144830043922,6.167,0.286,3.255,-4.019,-0.382,-6.835,,-3.6085,-6.549,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,IMIQUIMOD,CHEMBL1282,DOUYETYNHWVLEO-UHFFFAOYSA-N,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N,C14H16N4,DB00724,D02500,imiquimod,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
237918,80,78,28,uM,uM,8.40267149421374,-27.6139504087767,-0.560980021159086,0.99617760681999,0.0490798279345654,0.0049933992099018,0.115,77.487,23.709,61.264,42.4865,-35.1155,,3.6855000000000047,-35.000499999999995,letrozole,CHEMBL1444,HPJKCIUCZWXJDR-UHFFFAOYSA-N,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,C17H11N5,DB01006,D00964,letrozole,Ixabepilone,CHEMBL1201752,FABUFPQFXZVHFB-PVYNADRNSA-N,CC1CCCC2(C(O2)CC(NC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C,C27H42N2O5S,DB04845,D04645,ixabepilone,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
238299,388,43,28,uM,uM,1.75980515701958,-3.30880987251921,-4.95955392520175,-1.29360234390431,1.0,0.010298916211081,-4.051,-0.637,-3.605,-5.833,-4.719,-0.0309999999999997,,-2.375,-4.082000000000001,raloxifene,CHEMBL81,GZUITABIAKMVPG-UHFFFAOYSA-N,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,C28H27NO4S,DB00481,D08465,raloxifene,anastrozole,CHEMBL1399,YBBLVLTVTVSKRW-UHFFFAOYSA-N,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,C17H19N5,DB01217,D00960,anastrozole,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
238336,78,5,38,uM,uM,6.15580478389433,-4.33587367691634,6.4420041035857,6.06361757856658,0.0060651580173283,0.028232026740825,36.905,0.49,41.542,45.072,43.307,5.912,,24.6095,6.402000000000001,Ixabepilone,CHEMBL1201752,FABUFPQFXZVHFB-PVYNADRNSA-N,CC1CCCC2(C(O2)CC(NC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C,C27H42N2O5S,DB04845,D04645,ixabepilone,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
238385,72,8,38,uM,uM,-0.342005401590181,-2.02061000972383,-2.49088478530319,4.00991177713461,8.59166072772443,0.0785633946652398,2.549,-6.568,4.425,13.903,9.164,13.183,,11.1735,6.615,Gefitinib,CHEMBL939,XGALLCVXEZPNRQ-UHFFFAOYSA-N,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,C22H24ClFN4O3,DB00317,D01977,gefitinib,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
239138,52,107,38,uM,uM,-1.51301111819501,-0.756729912382773,-0.772063768539076,-2.05500611517895,5.0,2.69507835556911e-07,1.545,2.736,2.572,-4.76,-1.094,-5.375,,-3.2345000000000006,-3.83,celecoxib,CHEMBL118,RZEKVGVHFLEQIL-UHFFFAOYSA-N,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,C17H14F3N3O2S,DB00482,D00567,celecoxib,thalidomide,CHEMBL468,UEJJHQNACJXSKW-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,C13H10N2O4,DB01041,D00754,thalidomide,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
239232,29,78,38,uM,uM,2.09088436956714,-15.1349865209547,3.3987660849557,3.24251815557486,10.9200230783626,0.0203391763747341,0.746,26.291,37.615,31.132,34.3735,7.3365,,20.855,8.0825,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,Ixabepilone,CHEMBL1201752,FABUFPQFXZVHFB-PVYNADRNSA-N,CC1CCCC2(C(O2)CC(NC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C,C27H42N2O5S,DB04845,D04645,ixabepilone,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
239680,90,29,28,uM,uM,-2.30362724622359,3.00515139600972,-2.10121595203092,-2.46358489210766,0.854207925658671,0.622137579745057,7.752,1.38,3.264,10.714,6.989,-2.143,,2.423,-0.7629999999999999,Nilotinib,CHEMBL255863,HHZIURLSWUIHRB-UHFFFAOYSA-N,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,C28H22F3N7O,DB04868,D08953,nilotinib,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
240196,74,85,38,uM,uM,1.13278670388696,-29.0205662287374,-1.00764668782576,1.73102728425865,20.0,0.233208781803712,-3.076,23.501,20.973,24.611,22.792,2.367,,12.5795,-0.7089999999999996,hydroxyurea,CHEMBL467,VSNHCAURESNICA-UHFFFAOYSA-N,C(=O)(N)NO,CH4N2O2,DB01005,D00341,hydroxyurea,6-Mercaptopurine,CHEMBL1425,GLVAUDGFNGKCSF-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=CN2,C5H4N4S,DB01033,D04931,mercaptopurine,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
240232,52,78,38,uM,uM,0.179168064955398,-4.30541427159492,-0.513456137266526,-0.985948739626223,2.38936893369271,0.0203391763747341,0.737,26.291,28.549,30.283,29.416,2.388,,15.902,3.125,celecoxib,CHEMBL118,RZEKVGVHFLEQIL-UHFFFAOYSA-N,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,C17H14F3N3O2S,DB00482,D00567,celecoxib,Ixabepilone,CHEMBL1201752,FABUFPQFXZVHFB-PVYNADRNSA-N,CC1CCCC2(C(O2)CC(NC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C,C27H42N2O5S,DB04845,D04645,ixabepilone,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
240360,230,43,28,uM,uM,5.72445978742612,-1.20051478013589,-3.21666503631287,6.82208541208678,5.0,0.1,-11.332,2.554,-6.295,7.14,0.4225,9.2005,,4.8115000000000006,-2.1315,Imatinib,CHEMBL941,KTUFNOKKBVMGRW-UHFFFAOYSA-N,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,C29H31N7O,DB00619,D01441,imatinib,anastrozole,CHEMBL1399,YBBLVLTVTVSKRW-UHFFFAOYSA-N,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,C17H19N5,DB01217,D00960,anastrozole,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
240640,28,48,28,uM,uM,-3.8952513113041,-86.3821259090208,1.39755965914126,1.97682247158518,0.01,16.6794883748937,7.905,-0.715,10.855,32.651,21.753,14.563,,18.158,13.848,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,busulfan,CHEMBL820,COVZYZSDYWQREU-UHFFFAOYSA-N,CS(=O)(=O)OCCCCOS(=O)(=O)C,C6H14O6S2,DB01008,D00248,busulfan,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
240764,52,28,28,uM,uM,-4.4894228694067,4.30617017729382,4.73898266105853,1.98472094828509,0.122231925694072,0.0016018065100563,12.663,10.915,23.097,26.167,24.632,1.054,,12.843000000000002,11.969,celecoxib,CHEMBL118,RZEKVGVHFLEQIL-UHFFFAOYSA-N,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,C17H14F3N3O2S,DB00482,D00567,celecoxib,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
240969,29,48,38,uM,uM,1.85557127732761,-7.69418366735083,-6.10555392520176,-0.953511420072684,0.632002578122768,50.0,-7.52,5.028,2.036,-2.709,-0.3365,2.1555,,0.9095,-5.3645,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,busulfan,CHEMBL820,COVZYZSDYWQREU-UHFFFAOYSA-N,CS(=O)(=O)OCCCCOS(=O)(=O)C,C6H14O6S2,DB01008,D00248,busulfan,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
241042,100,48,38,uM,uM,-1.57931135949227,-51.0093273071175,-0.23235090931378,-3.04199187693015,0.01,50.0,31.695,5.028,36.514,71.044,53.779,17.056,,35.417500000000004,22.084000000000003,Romidepsin,CHEMBL343448,OHRURASPPZQGQM-GCCNXGTGSA-N,CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C,C24H36N4O6S2,,D06637,romidepsin,busulfan,CHEMBL820,COVZYZSDYWQREU-UHFFFAOYSA-N,CS(=O)(=O)OCCCCOS(=O)(=O)C,C6H14O6S2,DB01008,D00248,busulfan,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
241556,100,43,28,uM,uM,-2.28938059985417,-16.2528568480703,1.08391622198791,0.742525089344446,0.0050288243476985,0.1,10.229,2.554,6.515,34.363,20.439,7.656,,14.0475,10.21,Romidepsin,CHEMBL343448,OHRURASPPZQGQM-GCCNXGTGSA-N,CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C,C24H36N4O6S2,,D06637,romidepsin,anastrozole,CHEMBL1399,YBBLVLTVTVSKRW-UHFFFAOYSA-N,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,C17H19N5,DB01217,D00960,anastrozole,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
242156,35,30,7,uM,uM,-2.66395915227883,0.543850243618078,1.36283476436899,0.948462859148415,0.16681763922955,1.0,3.82,2.065,4.431,4.873,4.652,-1.233,,1.7095000000000002,0.8320000000000003,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,A549,C3512,Lung (Carcinoma),Lung adenocarcinoma
242357,31,77,38,uM,uM,0.882784857699832,1.1938511577159,-1.46860680820725,1.15171106333904,8.18334864084318,0.0083877057479682,-0.193,-0.958,-1.316,0.7,-0.308,0.843,,0.2675,-0.1149999999999999,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,IMIQUIMOD,CHEMBL1282,DOUYETYNHWVLEO-UHFFFAOYSA-N,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N,C14H16N4,DB00724,D02500,imiquimod,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
242908,48,5,28,uM,uM,0.543675079624347,-34.6390423499397,-2.04579163720546,4.10748598764762,29.4591080239366,0.0444924568143905,-7.565,34.269,4.052,38.767,21.4095,-5.2945,,8.057500000000003,-12.859499999999995,busulfan,CHEMBL820,COVZYZSDYWQREU-UHFFFAOYSA-N,CS(=O)(=O)OCCCCOS(=O)(=O)C,C6H14O6S2,DB01008,D00248,busulfan,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
243037,43,90,38,uM,uM,0.451220525057597,-1.44774408742495,-2.0811094807573,-0.0061420236098595,0.0810905936146108,0.0336301677640424,-2.43,0.561,-0.335,0.403,0.034,1.903,,0.9685,-0.527,anastrozole,CHEMBL1399,YBBLVLTVTVSKRW-UHFFFAOYSA-N,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,C17H19N5,DB01217,D00960,anastrozole,Nilotinib,CHEMBL255863,HHZIURLSWUIHRB-UHFFFAOYSA-N,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,C28H22F3N7O,DB04868,D08953,nilotinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
244237,28,77,38,uM,uM,-3.71338208608557,-11.6819714082483,-0.762456548019583,0.0647451524781829,0.001291593495557,0.0083877057479682,12.783,-0.958,11.649,20.345,15.997,4.172,,10.0845,3.2140000000000004,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,IMIQUIMOD,CHEMBL1282,DOUYETYNHWVLEO-UHFFFAOYSA-N,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N,C14H16N4,DB00724,D02500,imiquimod,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
244501,15,48,38,uM,uM,-3.5978985385649,7.46000446811099,2.82644854803013,0.722156831777377,3.0,9.76277833497609,7.34,2.24,9.649,12.524,11.0865,1.5065,,6.296499999999999,3.7464999999999993,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,busulfan,CHEMBL820,COVZYZSDYWQREU-UHFFFAOYSA-N,CS(=O)(=O)OCCCCOS(=O)(=O)C,C6H14O6S2,DB01008,D00248,busulfan,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
244582,100,77,28,uM,uM,0.467351656830822,-48.4554785776095,-8.80830600023432,-4.52196739765264,0.0050970006166703,0.0088144830043922,14.652,0.286,25.681,75.077,50.379,35.441,,42.91,35.727,Romidepsin,CHEMBL343448,OHRURASPPZQGQM-GCCNXGTGSA-N,CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C,C24H36N4O6S2,,D06637,romidepsin,IMIQUIMOD,CHEMBL1282,DOUYETYNHWVLEO-UHFFFAOYSA-N,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N,C14H16N4,DB00724,D02500,imiquimod,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
244868,107,5,38,uM,uM,-10.0939752253353,-3.6635892102345,-3.61114679853973,-7.00802960982772,7.21498333355681e-06,0.0830008993235557,5.953,10.544,19.528,8.862,14.195,-2.302,,5.9465,3.651,thalidomide,CHEMBL468,UEJJHQNACJXSKW-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,C13H10N2O4,DB01041,D00754,thalidomide,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
245413,31,230,28,uM,uM,3.02079273096355,-0.531292795570113,1.57671186791242,5.90747926167423,1.9029983467568,2.20867560662903,-4.061,0.942,4.194,0.734,2.464,5.583,,4.0235,1.522,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,Imatinib,CHEMBL941,KTUFNOKKBVMGRW-UHFFFAOYSA-N,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,C29H31N7O,DB00619,D01441,imatinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
245688,80,100,38,uM,uM,0.790904231798001,-50.3203575351734,-1.63110948075732,-0.660789755755941,0.0031464878719855,0.0014391938358074,-1.435,23.959,14.751,9.473,12.112,-10.412,,0.8499999999999996,-11.847,letrozole,CHEMBL1444,HPJKCIUCZWXJDR-UHFFFAOYSA-N,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,C17H11N5,DB01006,D00964,letrozole,Romidepsin,CHEMBL343448,OHRURASPPZQGQM-GCCNXGTGSA-N,CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C,C24H36N4O6S2,,D06637,romidepsin,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
245842,43,107,28,uM,uM,0.963982105205538,2.07841020179843,2.10112894862577,3.54307078701039,0.0029146247463924,0.587883665769743,-1.899,1.922,3.502,5.232,4.367,4.344,,4.3555,2.4450000000000003,anastrozole,CHEMBL1399,YBBLVLTVTVSKRW-UHFFFAOYSA-N,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,C17H19N5,DB01217,D00960,anastrozole,thalidomide,CHEMBL468,UEJJHQNACJXSKW-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,C13H10N2O4,DB01041,D00754,thalidomide,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
246224,29,43,28,uM,uM,0.398975350761181,-9.20193962331758,-6.64780580091616,-4.04431615030285,0.672771982419552,0.1,-3.681,1.512,-8.75,-3.983,-6.3665,-4.1975,,-5.282,-7.878500000000001,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,anastrozole,CHEMBL1399,YBBLVLTVTVSKRW-UHFFFAOYSA-N,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,C17H19N5,DB01217,D00960,anastrozole,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
246481,35,39,38,uM,uM,-9.22731595180317,-21.1754388043775,-1.69483205073248,-4.741412275966,0.313224143958131,10.0,11.433,3.455,15.708,25.56,20.634,5.746,,13.19,9.201,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,allopurinol,CHEMBL1467,OFCNXPDARWKPPY-UHFFFAOYSA-N,C1=C2C(=NC=NC2=O)NN1; C1=NNC2=C1C(=O)NC=N2,C5H4N4O,DB00437,D00224,allopurinol,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
246779,74,85,28,uM,uM,-5.77696123488414,-9.6770538508875,1.19087502946122,2.64225462219977,12.0546370265363,0.274486589679313,-0.417,14.956,20.695,17.602,19.1485,4.6095,,11.878999999999998,4.192499999999999,hydroxyurea,CHEMBL467,VSNHCAURESNICA-UHFFFAOYSA-N,C(=O)(N)NO,CH4N2O2,DB01005,D00341,hydroxyurea,6-Mercaptopurine,CHEMBL1425,GLVAUDGFNGKCSF-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=CN2,C5H4N4S,DB01033,D04931,mercaptopurine,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
246961,107,75,28,uM,uM,-3.04437794949445,-5.80117617738067,0.505337436919037,3.10140769719577,0.937344267803769,8.19141110469415,7.428,-2.897,7.088,5.978,6.533,2.002,,4.2675,-0.8949999999999996,thalidomide,CHEMBL468,UEJJHQNACJXSKW-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,C13H10N2O4,DB01041,D00754,thalidomide,ifosfamide,CHEMBL1024,HOMGKSMUEGBAAB-UHFFFAOYSA-N,C1CN(P(=O)(OC1)NCCCl)CCCl,C7H15Cl2N2O2P,DB01181,D00343,ifosfamide,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
247718,43,85,38,uM,uM,-0.289488501525177,-2.47038039820636,-0.69666503631289,0.539633171973441,0.0033487189982452,0.695984704897367,-0.57,27.669,42.499,26.874,34.6865,7.5875,,21.137,7.017500000000002,anastrozole,CHEMBL1399,YBBLVLTVTVSKRW-UHFFFAOYSA-N,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,C17H19N5,DB01217,D00960,anastrozole,6-Mercaptopurine,CHEMBL1425,GLVAUDGFNGKCSF-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=CN2,C5H4N4S,DB01033,D04931,mercaptopurine,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
248499,52,15,38,uM,uM,-0.933714164667816,-5.2831534898643,-0.816632672549806,-0.442413473161407,0.172818744649894,3.0,1.151,4.271,10.947,2.115,6.531,1.109,,3.82,2.26,celecoxib,CHEMBL118,RZEKVGVHFLEQIL-UHFFFAOYSA-N,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,C17H14F3N3O2S,DB00482,D00567,celecoxib,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
249094,388,90,38,uM,uM,-4.03862899156425,-6.69028722392773,-4.28677367419208,-3.68099796456981,0.018292512655514,0.0321560470506014,8.679,0.434,2.998,3.31,3.154,-5.959,,-1.4025,-5.525,raloxifene,CHEMBL81,GZUITABIAKMVPG-UHFFFAOYSA-N,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,C28H27NO4S,DB00481,D08465,raloxifene,Nilotinib,CHEMBL255863,HHZIURLSWUIHRB-UHFFFAOYSA-N,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,C28H22F3N7O,DB04868,D08953,nilotinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
249146,31,43,28,uM,uM,1.02923368794913,-1.72691519978288,-4.16813570529432,-0.309037372914516,0.549608819300963,0.1,-5.968,2.554,-3.234,-0.639,-1.9365,1.4775,,-0.2295,-4.4905,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,anastrozole,CHEMBL1399,YBBLVLTVTVSKRW-UHFFFAOYSA-N,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,C17H19N5,DB01217,D00960,anastrozole,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
249301,29,86,28,uM,uM,-0.852783401403839,5.45890816193238,5.85789537083985,5.59288754009237,0.24554996845037,2.49238167529758,1.8,0.335,6.883,3.904,5.3935,3.2585,,4.3260000000000005,3.5935000000000006,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,methoxsalen,CHEMBL416,QXKHYNVANLEOEG-UHFFFAOYSA-N,COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,C12H8O4,DB00553,D00139,methoxsalen,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
249773,35,86,28,uM,uM,-6.61957673466302,-12.4671940330194,-0.591549902022674,-0.0955756621762578,0.413764131539873,2.49238167529758,5.382,0.335,14.985,21.804,18.3945,12.6775,,15.536,13.0125,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,methoxsalen,CHEMBL416,QXKHYNVANLEOEG-UHFFFAOYSA-N,COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,C12H8O4,DB00553,D00139,methoxsalen,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
250010,388,100,28,uM,uM,4.70835987097132,-74.2591339996898,-1.46973257653205,4.22904729982904,0.0001210913448318,0.01,-8.257,-3.164,91.978,9.575,50.7765,62.1975,,56.487,53.9405,raloxifene,CHEMBL81,GZUITABIAKMVPG-UHFFFAOYSA-N,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,C28H27NO4S,DB00481,D08465,raloxifene,Romidepsin,CHEMBL343448,OHRURASPPZQGQM-GCCNXGTGSA-N,CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C,C24H36N4O6S2,,D06637,romidepsin,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
250190,31,35,38,uM,uM,-7.52490006403397,-25.3862309849265,-1.10542446560352,-0.514445518435617,20.0,0.176022954412325,0.271,16.408,16.329,16.01,16.1695,-0.509500000000003,,7.829999999999998,-0.2385000000000019,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
250748,388,120,28,uM,uM,3.07191405946546,-4.76255196765668,-3.75577614742398,3.86942394951178,0.0001210913448318,11.5951846929507,-8.257,-1.96,2.372,-5.275,-1.4515,8.7655,,3.656999999999999,0.5085,raloxifene,CHEMBL81,GZUITABIAKMVPG-UHFFFAOYSA-N,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,C28H27NO4S,DB00481,D08465,raloxifene,Vismodegib,CHEMBL473417,BPQMGSKTAYIVFO-UHFFFAOYSA-N,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,C19H14Cl2N2O3S,DB08828,D09992,vismodegib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
251126,31,29,38,uM,uM,1.01389611524997,-1.77580516556567,-2.42798471456474,-0.883674448548982,20.0,3.23217375956692,1.522,-1.131,-3.804,-2.425,-3.1145,-3.5055,,-3.31,-4.6365,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
251659,29,77,38,uM,uM,2.34572676056042,2.04960316914331,1.61570815135963,3.83779431299128,8.84573666297455,0.0020545295081273,-0.705,-2.222,1.023,0.756,0.8895,3.8165,,2.353,1.5945,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,IMIQUIMOD,CHEMBL1282,DOUYETYNHWVLEO-UHFFFAOYSA-N,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N,C14H16N4,DB00724,D02500,imiquimod,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
251733,48,77,38,uM,uM,0.0871928449509177,-0.170856271769893,-1.13830600023432,1.75069155762257,29.9371833907711,0.0020545295081273,0.066,-2.222,2.444,8.557,5.5005,7.6565,,6.5785,5.4345,busulfan,CHEMBL820,COVZYZSDYWQREU-UHFFFAOYSA-N,CS(=O)(=O)OCCCCOS(=O)(=O)C,C6H14O6S2,DB01008,D00248,busulfan,IMIQUIMOD,CHEMBL1282,DOUYETYNHWVLEO-UHFFFAOYSA-N,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N,C14H16N4,DB00724,D02500,imiquimod,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
252184,1,108,38,uM,uM,-12.6988437675756,-2.90779642885009,-0.715060909833427,-10.2395529006289,5.59265862375072,1.03366265531186,33.409,30.715,40.216,33.066,36.641,-27.483,,4.579000000000001,3.232,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,6-Thioguanine,CHEMBL727,WYWHKKSPHMUBEB-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=C(N2)N,C5H5N5S,DB00352,D08603,thioguanine,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
252192,35,29,7,uM,uM,-5.06696038537207,-20.5133544128507,-5.02148251023831,-3.14450373251008,0.325247730696764,0.556492510256139,6.812,-2.286,2.36,3.867,3.1135,-1.4125,,0.8505000000000003,-3.6985,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,A549,C3512,Lung (Carcinoma),Lung adenocarcinoma
252335,52,43,28,uM,uM,0.571399791074374,0.785040775419683,-1.2311094807573,0.07138723215938,0.305340979460075,0.1,-1.421,2.554,-2.146,2.162,0.008,-1.125,,-0.5584999999999999,-2.546,celecoxib,CHEMBL118,RZEKVGVHFLEQIL-UHFFFAOYSA-N,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,C17H14F3N3O2S,DB00482,D00567,celecoxib,anastrozole,CHEMBL1399,YBBLVLTVTVSKRW-UHFFFAOYSA-N,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,C17H19N5,DB01217,D00960,anastrozole,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
252692,28,75,38,uM,uM,-2.13666929698425,-8.8232294162404,-1.11830600023432,0.116628765954707,0.0046714833169931,9.58563775493199,3.547,-0.464,6.24,15.671,10.9555,7.8725,,9.414,7.4085,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,ifosfamide,CHEMBL1024,HOMGKSMUEGBAAB-UHFFFAOYSA-N,C1CN(P(=O)(OC1)NCCCl)CCCl,C7H15Cl2N2O2P,DB01181,D00343,ifosfamide,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
252737,80,85,38,uM,uM,-1.10398171117534,-6.59578866211755,-0.486660011001616,-0.949225850106627,0.300166374735498,0.258973935345129,1.477,26.013,24.202,27.933,26.0675,-1.4225,,12.322499999999998,0.0544999999999973,letrozole,CHEMBL1444,HPJKCIUCZWXJDR-UHFFFAOYSA-N,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,C17H11N5,DB01006,D00964,letrozole,6-Mercaptopurine,CHEMBL1425,GLVAUDGFNGKCSF-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=CN2,C5H4N4S,DB01033,D04931,mercaptopurine,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
252876,88,8,7,uM,uM,0.812886580123551,4.62763504006589,7.35060551979426,2.33853861342798,0.0325221155811695,0.1,46.567,19.551,70.255,58.41,64.3325,-1.7855,,31.2735,17.765499999999996,mitoxantrone,CHEMBL58,KKZJGLLVHKMTCM-UHFFFAOYSA-N,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,C22H28N4O6,DB01204,D08224,mitoxantrone,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,A549,C3512,Lung (Carcinoma),Lung adenocarcinoma
253266,90,28,28,uM,uM,2.07277146588619,-34.6781781588112,-7.61555392520176,4.98224797613219,0.0124532336860987,0.0016018065100563,-18.286,10.915,9.458,11.086,10.272,17.643,,13.9575,-0.6429999999999989,Nilotinib,CHEMBL255863,HHZIURLSWUIHRB-UHFFFAOYSA-N,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,C28H22F3N7O,DB04868,D08953,nilotinib,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
254076,28,107,38,uM,uM,-3.94771281551413,-47.3300293493406,-1.7491070075254,-1.47935594929316,0.01,0.312134282934169,7.219,0.14,7.946,17.746,12.846,5.487,,9.1665,5.627,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,thalidomide,CHEMBL468,UEJJHQNACJXSKW-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,C13H10N2O4,DB01041,D00754,thalidomide,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
254094,100,86,28,uM,uM,-2.11639265432023,-65.6456578645972,-6.07799589641429,-6.67875818544741,0.0026403105755811,2.49238167529758,21.974,0.335,36.134,53.905,45.0195,22.7105,,33.865,23.0455,Romidepsin,CHEMBL343448,OHRURASPPZQGQM-GCCNXGTGSA-N,CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C,C24H36N4O6S2,,D06637,romidepsin,methoxsalen,CHEMBL416,QXKHYNVANLEOEG-UHFFFAOYSA-N,COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,C12H8O4,DB00553,D00139,methoxsalen,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
254115,8,15,38,uM,uM,-0.823514339520857,0.551406273784551,0.708749877794877,2.21821482756394,0.0114608253185496,3.0,-1.534,4.271,13.583,0.801,7.192,4.455,,5.8235,2.9210000000000003,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
254118,80,107,28,uM,uM,-2.263582464483,-3.36340647635461,-7.1930512526517,-6.75759314827075,0.210677490391456,0.587883665769743,7.51,1.922,-0.248,2.919,1.3355,-8.0965,,-3.3805000000000005,-6.1745,letrozole,CHEMBL1444,HPJKCIUCZWXJDR-UHFFFAOYSA-N,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,C17H11N5,DB01006,D00964,letrozole,thalidomide,CHEMBL468,UEJJHQNACJXSKW-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,C13H10N2O4,DB01041,D00754,thalidomide,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
254323,31,85,38,uM,uM,-4.66376209800456,-36.6716078625691,-3.20998216248538,-2.32511822270412,0.679688079570501,0.695984704897367,-2.274,27.669,41.258,27.054,34.156,8.761,,21.4585,6.486999999999998,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,6-Mercaptopurine,CHEMBL1425,GLVAUDGFNGKCSF-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=CN2,C5H4N4S,DB01033,D04931,mercaptopurine,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
254447,52,39,28,uM,uM,2.83315473024746,0.679689772661262,-2.24669468980505,1.90941767076036,0.164720874703716,10.0,-4.406,-1.317,-0.014,-1.022,-0.518,5.205,,2.3435,0.7989999999999999,celecoxib,CHEMBL118,RZEKVGVHFLEQIL-UHFFFAOYSA-N,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,C17H14F3N3O2S,DB00482,D00567,celecoxib,allopurinol,CHEMBL1467,OFCNXPDARWKPPY-UHFFFAOYSA-N,C1=C2C(=NC=NC2=O)NN1; C1=NNC2=C1C(=O)NC=N2,C5H4N4O,DB00437,D00224,allopurinol,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
255081,100,78,28,uM,uM,2.64319714170142,-5.32312926366368,3.78520265335027,2.08979090830662,0.01,0.0049933992099018,38.317,77.487,74.14,97.245,85.6925,-30.1115,,27.790499999999994,8.2055,Romidepsin,CHEMBL343448,OHRURASPPZQGQM-GCCNXGTGSA-N,CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C,C24H36N4O6S2,,D06637,romidepsin,Ixabepilone,CHEMBL1201752,FABUFPQFXZVHFB-PVYNADRNSA-N,CC1CCCC2(C(O2)CC(NC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C,C27H42N2O5S,DB04845,D04645,ixabepilone,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
255219,388,1,28,uM,uM,4.08061427226238,-0.28783606455619,1.05744607479822,2.25508110685414,0.024411737372345,5.37475384945868,-3.094,48.566,40.615,46.995,43.805,-1.667,,21.069,-4.761000000000003,raloxifene,CHEMBL81,GZUITABIAKMVPG-UHFFFAOYSA-N,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,C28H27NO4S,DB00481,D08465,raloxifene,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
255236,29,39,28,uM,uM,-4.20123796798753,-8.59451125061637,-5.63478619007945,-4.87613967659078,2.61661324931374,5.03320952824429e-13,5.979,1.321,3.956,4.832,4.394,-2.906,,0.7440000000000002,-1.585,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,allopurinol,CHEMBL1467,OFCNXPDARWKPPY-UHFFFAOYSA-N,C1=C2C(=NC=NC2=O)NN1; C1=NNC2=C1C(=O)NC=N2,C5H4N4O,DB00437,D00224,allopurinol,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
255736,85,48,38,uM,uM,-4.66210967316843,-20.0240664866699,-0.159077354033219,3.35650757454519,0.258360895262761,20.4443291811165,15.854,-1.708,20.749,21.543,21.146,7.0,,14.073,5.292000000000002,6-Mercaptopurine,CHEMBL1425,GLVAUDGFNGKCSF-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=CN2,C5H4N4S,DB01033,D04931,mercaptopurine,busulfan,CHEMBL820,COVZYZSDYWQREU-UHFFFAOYSA-N,CS(=O)(=O)OCCCCOS(=O)(=O)C,C6H14O6S2,DB01008,D00248,busulfan,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
255789,388,107,38,uM,uM,-5.45290656423631,1.80122084042724,2.23644854803015,-1.60169479463422,0.171190531391502,10.0,12.108,4.404,15.594,13.589,14.5915,-1.9205,,6.3355,2.4835,raloxifene,CHEMBL81,GZUITABIAKMVPG-UHFFFAOYSA-N,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,C28H27NO4S,DB00481,D08465,raloxifene,thalidomide,CHEMBL468,UEJJHQNACJXSKW-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,C13H10N2O4,DB01041,D00754,thalidomide,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
255883,107,78,28,uM,uM,2.10428117298766,-23.0224433807373,2.01321052940013,0.826093186206005,6.61234496104943,0.0051456902154446,3.875,73.025,56.881,78.974,67.9275,-8.9725,,29.477499999999992,-5.097500000000011,thalidomide,CHEMBL468,UEJJHQNACJXSKW-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,C13H10N2O4,DB01041,D00754,thalidomide,Ixabepilone,CHEMBL1201752,FABUFPQFXZVHFB-PVYNADRNSA-N,CC1CCCC2(C(O2)CC(NC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C,C27H42N2O5S,DB04845,D04645,ixabepilone,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
255996,48,75,38,uM,uM,-3.18191512503758,-0.7782284045526,-0.007966242922117,-1.50568630432141,1.90872321140485,100.0,5.195,1.939,7.136,0.583,3.8595,-3.2745,,0.2925,-1.3355,busulfan,CHEMBL820,COVZYZSDYWQREU-UHFFFAOYSA-N,CS(=O)(=O)OCCCCOS(=O)(=O)C,C6H14O6S2,DB01008,D00248,busulfan,ifosfamide,CHEMBL1024,HOMGKSMUEGBAAB-UHFFFAOYSA-N,C1CN(P(=O)(OC1)NCCCl)CCCl,C7H15Cl2N2O2P,DB01181,D00343,ifosfamide,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
256014,28,43,28,uM,uM,-1.96906957338273,3.78669264702848,1.76978188136346,-0.559274975607969,0.01,0.1,8.937,2.554,4.93,14.391,9.6605,-1.8305,,3.915000000000001,0.7235000000000014,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,anastrozole,CHEMBL1399,YBBLVLTVTVSKRW-UHFFFAOYSA-N,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,C17H19N5,DB01217,D00960,anastrozole,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
256549,78,5,28,uM,uM,8.98411777913739,-3.38973905921292,7.74978188136347,9.04756789733008,0.0027002279051011,0.0091479690062915,87.057,-3.963,86.879,73.994,80.4365,-2.65750000000001,,38.88949999999999,-6.620500000000007,Ixabepilone,CHEMBL1201752,FABUFPQFXZVHFB-PVYNADRNSA-N,CC1CCCC2(C(O2)CC(NC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C,C27H42N2O5S,DB04845,D04645,ixabepilone,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
256736,90,107,38,uM,uM,0.841175382930225,-6.86672718934825,-6.86666503631286,-2.15390297604722,0.0947281261742108,2.69507835556911e-07,-4.848,2.736,-3.954,-5.741,-4.8475,-2.7355,,-3.7915,-7.583500000000001,Nilotinib,CHEMBL255863,HHZIURLSWUIHRB-UHFFFAOYSA-N,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,C28H22F3N7O,DB04868,D08953,nilotinib,thalidomide,CHEMBL468,UEJJHQNACJXSKW-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,C13H10N2O4,DB01041,D00754,thalidomide,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
256819,43,100,38,uM,uM,0.29914771081628,-40.7848734049435,-0.924383036037873,-0.881546438534478,0.0107060292327388,0.0014391938358074,1.111,23.959,7.069,19.319,13.194,-11.876,,0.6590000000000007,-10.765,anastrozole,CHEMBL1399,YBBLVLTVTVSKRW-UHFFFAOYSA-N,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,C17H19N5,DB01217,D00960,anastrozole,Romidepsin,CHEMBL343448,OHRURASPPZQGQM-GCCNXGTGSA-N,CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C,C24H36N4O6S2,,D06637,romidepsin,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
256848,86,77,28,uM,uM,-6.25678822467106,-2.37220100464473,-6.77577367419207,-11.1917601597233,6.0,0.07,16.485,4.461,4.103,6.27,5.1865,-15.7595,,-5.286499999999999,-11.2985,methoxsalen,CHEMBL416,QXKHYNVANLEOEG-UHFFFAOYSA-N,COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,C12H8O4,DB00553,D00139,methoxsalen,IMIQUIMOD,CHEMBL1282,DOUYETYNHWVLEO-UHFFFAOYSA-N,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N,C14H16N4,DB00724,D02500,imiquimod,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
257074,230,90,38,uM,uM,1.37849186476127,-3.50373528733612,-4.77448867474367,-1.37744308850943,0.147652250156038,0.0336301677640424,-4.814,0.561,-1.53,-2.375,-1.9525,2.3005,,0.1740000000000001,-2.5135,Imatinib,CHEMBL941,KTUFNOKKBVMGRW-UHFFFAOYSA-N,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,C29H31N7O,DB00619,D01441,imatinib,Nilotinib,CHEMBL255863,HHZIURLSWUIHRB-UHFFFAOYSA-N,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,C28H22F3N7O,DB04868,D08953,nilotinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
257244,388,107,28,uM,uM,4.96472523147872,0.605579114462916,-1.1921094807573,6.42528697602872,1.0,0.843496987345885,-8.397,2.232,2.19,-3.319,-0.5645,5.6005,,2.518,-2.7965,raloxifene,CHEMBL81,GZUITABIAKMVPG-UHFFFAOYSA-N,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,C28H27NO4S,DB00481,D08465,raloxifene,thalidomide,CHEMBL468,UEJJHQNACJXSKW-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,C13H10N2O4,DB01041,D00754,thalidomide,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
257489,388,39,28,uM,uM,4.79090894091098,-3.02880438405741,-1.93248013187305,7.76640868157504,1.0,108.206339608835,-8.397,-6.912,-1.927,-4.382,-3.1545,12.1545,,4.5,3.7575,raloxifene,CHEMBL81,GZUITABIAKMVPG-UHFFFAOYSA-N,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,C28H27NO4S,DB00481,D08465,raloxifene,allopurinol,CHEMBL1467,OFCNXPDARWKPPY-UHFFFAOYSA-N,C1=C2C(=NC=NC2=O)NN1; C1=NNC2=C1C(=O)NC=N2,C5H4N4O,DB00437,D00224,allopurinol,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
257500,100,48,28,uM,uM,-0.0067182649223793,-43.2049914719858,-0.268130679983029,0.841084578521623,0.0020238722938011,3.7034904680665,32.545,0.497,35.123,62.079,48.601,15.559,,32.08,16.055999999999997,Romidepsin,CHEMBL343448,OHRURASPPZQGQM-GCCNXGTGSA-N,CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C,C24H36N4O6S2,,D06637,romidepsin,busulfan,CHEMBL820,COVZYZSDYWQREU-UHFFFAOYSA-N,CS(=O)(=O)OCCCCOS(=O)(=O)C,C6H14O6S2,DB01008,D00248,busulfan,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
257939,15,107,38,uM,uM,-1.25857652372822,-3.20672906057325,-3.20666503631286,-3.50153709356837,1.03006560595352,2.69507835556911e-07,0.278,2.736,-0.606,0.513,-0.0465,-3.0605,,-1.5535,-2.7825,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,thalidomide,CHEMBL468,UEJJHQNACJXSKW-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,C13H10N2O4,DB01041,D00754,thalidomide,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
258213,15,30,7,uM,uM,-1.72021843092347,-4.06711527855418,-1.19716523563101,0.954582430732999,0.763526136578667,1.0,3.444,2.065,-1.081,11.618,5.2685,-0.2405,,2.514,1.8245000000000005,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,A549,C3512,Lung (Carcinoma),Lung adenocarcinoma
258279,29,75,38,uM,uM,0.383243409570769,-5.29749034799001,-6.52225024536061,-4.43665554893768,2.6527674534623,100.0,-1.801,1.939,-3.874,-5.489,-4.6815,-4.8195,,-4.7505,-6.6205,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,ifosfamide,CHEMBL1024,HOMGKSMUEGBAAB-UHFFFAOYSA-N,C1CN(P(=O)(OC1)NCCCl)CCCl,C7H15Cl2N2O2P,DB01181,D00343,ifosfamide,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
258699,388,5,38,uM,uM,0.682335988873596,1.29786431289661,2.83478771396323,3.80896386157693,0.0903119390827007,0.0023530164408346,2.249,-0.1,6.017,5.741,5.879,3.73,,4.804499999999999,3.63,raloxifene,CHEMBL81,GZUITABIAKMVPG-UHFFFAOYSA-N,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,C28H27NO4S,DB00481,D08465,raloxifene,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
258884,388,108,38,uM,uM,-12.7037221296074,-8.30895098874528,-4.49843778877939,-8.63633305863564,0.0735901700282625,1.0402840741962,10.629,26.761,21.355,26.158,23.7565,-13.6335,,5.061499999999999,-3.0045,raloxifene,CHEMBL81,GZUITABIAKMVPG-UHFFFAOYSA-N,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,C28H27NO4S,DB00481,D08465,raloxifene,6-Thioguanine,CHEMBL727,WYWHKKSPHMUBEB-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=C(N2)N,C5H5N5S,DB00352,D08603,thioguanine,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
259014,15,43,38,uM,uM,-0.988137854837197,-1.1812550527908,-1.48827634674213,-1.61175479899993,0.364259420715187,0.0912164999434249,0.792,1.625,-0.189,-0.79,-0.4895,-2.9065,,-1.698,-2.1145,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,anastrozole,CHEMBL1399,YBBLVLTVTVSKRW-UHFFFAOYSA-N,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,C17H19N5,DB01217,D00960,anastrozole,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
259305,29,96,38,uM,uM,0.732415315982916,-6.13088903658046,-6.05052822245654,-3.01950764166858,9.1548770573407,0.0006,-0.188,-2.378,-5.803,-4.949,-5.376,-2.81,,-4.093,-5.188000000000001,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,Pralatrexate,CHEMBL1201746,OGSBUKJUDHAQEA-WMCAAGNKSA-N,C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,C23H23N7O5,DB06813,D05589,pralatrexate,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
259854,8,15,7,uM,uM,0.871194274496302,-0.0003532554302604,2.79641437785593,3.79776892358138,0.0162094323138322,0.483744839663606,2.651,6.582,4.144,12.451,8.2975,-0.935500000000001,,3.680999999999999,1.7154999999999996,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,A549,C3512,Lung (Carcinoma),Lung adenocarcinoma
259933,31,107,28,uM,uM,-0.622870221835282,-3.70222073125808,-2.41590084402923,-2.43969614654703,2.60541024407116,5.83307007506274,2.03,0.91,-3.562,-0.101,-1.8315,-4.7715,,-3.3015,-3.8615,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,thalidomide,CHEMBL468,UEJJHQNACJXSKW-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,C13H10N2O4,DB01041,D00754,thalidomide,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
260081,100,28,28,uM,uM,-1.34368556144718,-7.50570685231955,2.37542686846398,2.06649157261255,0.0002937142547132,0.0016018065100563,72.777,10.915,80.371,70.198,75.2845,-8.40750000000001,,33.43849999999999,2.507499999999993,Romidepsin,CHEMBL343448,OHRURASPPZQGQM-GCCNXGTGSA-N,CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C,C24H36N4O6S2,,D06637,romidepsin,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
260696,90,29,7,uM,uM,2.41124750810199,0.0305603438028661,-2.32336135647172,1.799156229014,0.0323591801357785,0.556492510256139,-4.349,-2.286,-5.404,-4.804,-5.104,1.531,,-1.7865000000000002,-2.818,Nilotinib,CHEMBL255863,HHZIURLSWUIHRB-UHFFFAOYSA-N,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,C28H22F3N7O,DB04868,D08953,nilotinib,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,A549,C3512,Lung (Carcinoma),Lung adenocarcinoma
261089,230,35,38,uM,uM,-7.72092254323715,-22.8238165824044,-4.57320224338129,-4.08365141428449,0.161389899811475,0.176022954412325,0.758,16.408,15.98,14.712,15.346,-1.82,,6.763,-1.0620000000000012,Imatinib,CHEMBL941,KTUFNOKKBVMGRW-UHFFFAOYSA-N,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,C29H31N7O,DB00619,D01441,imatinib,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
261126,100,29,28,uM,uM,-0.247649327885746,-65.4511484936346,-3.13486295730224,-3.31865395005443,0.0022663793620751,0.622137579745057,34.289,1.38,31.623,21.939,26.781,-8.88800000000001,,8.946499999999997,-7.508000000000003,Romidepsin,CHEMBL343448,OHRURASPPZQGQM-GCCNXGTGSA-N,CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C,C24H36N4O6S2,,D06637,romidepsin,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
261324,80,30,28,uM,uM,1.8201172252893,-5.27901809834832,-4.83105329610181,0.473736977212489,0.0148202167434104,0.725465974035397,-1.112,-2.658,-0.78,-5.384,-3.082,0.688,,-1.1969999999999998,-1.97,letrozole,CHEMBL1444,HPJKCIUCZWXJDR-UHFFFAOYSA-N,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,C17H11N5,DB01006,D00964,letrozole,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
261343,31,30,28,uM,uM,2.15606111084974,-10.3490389131132,-11.646694689805,-6.06987057123239,1.44155266697856,0.725465974035397,0.299,-2.658,-6.884,-7.51,-7.197,-4.838,,-6.0175,-7.496,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
261710,388,8,38,uM,uM,0.370155521920768,3.87112599342579,4.91320464624177,5.08974591916744,0.018292512655514,0.011490129261933,8.679,0.072,10.212,10.071,10.1415,1.3905,,5.766000000000001,1.4625000000000004,raloxifene,CHEMBL81,GZUITABIAKMVPG-UHFFFAOYSA-N,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,C28H27NO4S,DB00481,D08465,raloxifene,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
261923,39,78,28,uM,uM,2.06203615948801,-27.3034560340407,1.02000665566504,-0.128631416101189,10.0,0.0049933992099018,3.328,77.487,17.168,67.837,42.5025,-38.3125,,2.094999999999999,-34.9845,allopurinol,CHEMBL1467,OFCNXPDARWKPPY-UHFFFAOYSA-N,C1=C2C(=NC=NC2=O)NN1; C1=NNC2=C1C(=O)NC=N2,C5H4N4O,DB00437,D00224,allopurinol,Ixabepilone,CHEMBL1201752,FABUFPQFXZVHFB-PVYNADRNSA-N,CC1CCCC2(C(O2)CC(NC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C,C27H42N2O5S,DB04845,D04645,ixabepilone,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
262093,230,86,28,uM,uM,-0.504293490369381,-2.41812929847147,-3.8522502453606,-2.40338641442672,0.186979987232523,2.49238167529758,-1.383,0.335,6.298,-3.905,1.1965,2.2445,,1.7205,0.8614999999999999,Imatinib,CHEMBL941,KTUFNOKKBVMGRW-UHFFFAOYSA-N,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,C29H31N7O,DB00619,D01441,imatinib,methoxsalen,CHEMBL416,QXKHYNVANLEOEG-UHFFFAOYSA-N,COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,C12H8O4,DB00553,D00139,methoxsalen,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
262245,43,39,38,uM,uM,-3.662745302807,-69.6686422005377,-1.66052822245653,-4.75685111642141,0.1,10.0,4.643,3.455,6.269,9.231,7.75,-0.347999999999999,,3.701000000000001,3.107,anastrozole,CHEMBL1399,YBBLVLTVTVSKRW-UHFFFAOYSA-N,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,C17H19N5,DB01217,D00960,anastrozole,allopurinol,CHEMBL1467,OFCNXPDARWKPPY-UHFFFAOYSA-N,C1=C2C(=NC=NC2=O)NN1; C1=NNC2=C1C(=O)NC=N2,C5H4N4O,DB00437,D00224,allopurinol,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
262271,8,43,28,uM,uM,2.55590548963762,4.15754308418565,3.22058288865458,2.69401220898969,0.0735736677394924,0.1,6.157,2.554,4.258,17.754,11.006,2.295,,6.6505,4.849,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,anastrozole,CHEMBL1399,YBBLVLTVTVSKRW-UHFFFAOYSA-N,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,C17H19N5,DB01217,D00960,anastrozole,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
262495,30,43,28,uM,uM,-4.5317519092678,-2.66221097075036,-1.41574402069989,-2.68249960343731,0.100401152831044,0.1,10.22,2.554,9.186,3.235,6.2105,-6.5635,,-0.1765000000000007,-4.009500000000001,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,anastrozole,CHEMBL1399,YBBLVLTVTVSKRW-UHFFFAOYSA-N,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,C17H19N5,DB01217,D00960,anastrozole,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
262810,85,48,28,uM,uM,3.3247516854729,-40.0944845208898,4.80764909068622,5.35326015667631,2.0,16.6794883748937,21.693,-0.715,21.482,58.329,39.9055,18.9275,,29.416500000000003,18.2125,6-Mercaptopurine,CHEMBL1425,GLVAUDGFNGKCSF-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=CN2,C5H4N4S,DB01033,D04931,mercaptopurine,busulfan,CHEMBL820,COVZYZSDYWQREU-UHFFFAOYSA-N,CS(=O)(=O)OCCCCOS(=O)(=O)C,C6H14O6S2,DB01008,D00248,busulfan,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
262857,230,8,38,uM,uM,0.208929893585267,-4.10316198983122,-3.81650821298352,-1.41255608449406,0.175180441180045,0.0462823125036052,-0.939,0.322,3.456,-3.907,-0.2255,0.3915,,0.0829999999999999,-0.5475,Imatinib,CHEMBL941,KTUFNOKKBVMGRW-UHFFFAOYSA-N,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,C29H31N7O,DB00619,D01441,imatinib,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
262862,388,115,28,uM,uM,3.87944475008979,-6.93428649375509,-3.80144281409066,3.73611356629696,0.0001210913448318,0.867587714400043,-8.257,-1.055,1.376,-3.483,-1.0535,8.2585,,3.6025,0.0014999999999998,raloxifene,CHEMBL81,GZUITABIAKMVPG-UHFFFAOYSA-N,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,C28H27NO4S,DB00481,D08465,raloxifene,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
263131,8,39,38,uM,uM,-1.18334950348339,-3.66088557473869,-2.10244034085875,0.128043106203355,0.0009834640969437,10.0,9.336,-1.932,5.131,5.058,5.0945,-2.3095,,1.3925,-4.2415,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,allopurinol,CHEMBL1467,OFCNXPDARWKPPY-UHFFFAOYSA-N,C1=C2C(=NC=NC2=O)NN1; C1=NNC2=C1C(=O)NC=N2,C5H4N4O,DB00437,D00224,allopurinol,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
263388,388,48,38,uM,uM,-6.99018162513755,-5.28118380952939,-3.79957289449704,-5.98027219524057,0.171190531391502,13.4588343121566,12.108,4.416,6.983,12.802,9.8925,-6.6315,,1.6304999999999996,-2.2155000000000005,raloxifene,CHEMBL81,GZUITABIAKMVPG-UHFFFAOYSA-N,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,C28H27NO4S,DB00481,D08465,raloxifene,busulfan,CHEMBL820,COVZYZSDYWQREU-UHFFFAOYSA-N,CS(=O)(=O)OCCCCOS(=O)(=O)C,C6H14O6S2,DB01008,D00248,busulfan,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
263406,90,39,28,uM,uM,0.182153070190374,-3.04434452905222,-0.757171068230786,0.859056764381167,1.0,10.0,0.758,-1.317,2.356,-0.177,1.0895,1.6485,,1.3689999999999998,0.3314999999999999,Nilotinib,CHEMBL255863,HHZIURLSWUIHRB-UHFFFAOYSA-N,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,C28H22F3N7O,DB04868,D08953,nilotinib,allopurinol,CHEMBL1467,OFCNXPDARWKPPY-UHFFFAOYSA-N,C1=C2C(=NC=NC2=O)NN1; C1=NNC2=C1C(=O)NC=N2,C5H4N4O,DB00437,D00224,allopurinol,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
264109,75,78,38,uM,uM,1.27116912612199,-22.1028896020991,-1.06666503631289,-0.615491117849946,3.10021588927719,0.0121596555881956,-2.033,35.749,18.921,34.175,26.548,-7.168,,9.689999999999998,-9.201000000000004,ifosfamide,CHEMBL1024,HOMGKSMUEGBAAB-UHFFFAOYSA-N,C1CN(P(=O)(OC1)NCCCl)CCCl,C7H15Cl2N2O2P,DB01181,D00343,ifosfamide,Ixabepilone,CHEMBL1201752,FABUFPQFXZVHFB-PVYNADRNSA-N,CC1CCCC2(C(O2)CC(NC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C,C27H42N2O5S,DB04845,D04645,ixabepilone,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
264255,43,107,38,uM,uM,-0.110116644392198,-2.28894592070621,-2.28888725853508,-0.842255013769668,0.0430802174938516,2.69507835556911e-07,-1.125,2.736,1.6,-1.956,-0.178,-1.789,,-0.9835,-2.914,anastrozole,CHEMBL1399,YBBLVLTVTVSKRW-UHFFFAOYSA-N,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,C17H19N5,DB01217,D00960,anastrozole,thalidomide,CHEMBL468,UEJJHQNACJXSKW-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,C13H10N2O4,DB01041,D00754,thalidomide,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
265005,230,75,28,uM,uM,-3.15818789124218,-6.17260097589059,-2.55478619007944,-3.84352933923907,5.0,2.73710599865836e-06,4.109,2.235,2.831,5.278,4.0545,-2.2895,,0.8825000000000003,-0.0544999999999999,Imatinib,CHEMBL941,KTUFNOKKBVMGRW-UHFFFAOYSA-N,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,C29H31N7O,DB00619,D01441,imatinib,ifosfamide,CHEMBL1024,HOMGKSMUEGBAAB-UHFFFAOYSA-N,C1CN(P(=O)(OC1)NCCCl)CCCl,C7H15Cl2N2O2P,DB01181,D00343,ifosfamide,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
265349,8,78,38,uM,uM,0.767871155355963,-8.71827566890786,-0.469027899982938,-0.0034718271005595,0.0464058382133146,0.0203391763747341,-0.876,26.291,26.432,26.947,26.6895,1.2745,,13.982,0.3984999999999985,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,Ixabepilone,CHEMBL1201752,FABUFPQFXZVHFB-PVYNADRNSA-N,CC1CCCC2(C(O2)CC(NC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C,C27H42N2O5S,DB04845,D04645,ixabepilone,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
265700,230,85,38,uM,uM,3.33987940840226,-23.1250894314528,-0.484426606929834,2.0654941118033,0.157414204094494,0.233208781803712,-4.151,23.501,28.309,24.141,26.225,6.875,,16.55,2.724,Imatinib,CHEMBL941,KTUFNOKKBVMGRW-UHFFFAOYSA-N,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,C29H31N7O,DB00619,D01441,imatinib,6-Mercaptopurine,CHEMBL1425,GLVAUDGFNGKCSF-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=CN2,C5H4N4S,DB01033,D04931,mercaptopurine,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
265807,52,100,38,uM,uM,0.734054286859771,-49.9749083244991,-1.28555392520176,1.49285014989261,3.96319943461021,0.0014391938358074,-3.791,23.959,-1.605,12.049,5.222,-14.946,,-4.861999999999999,-18.737,celecoxib,CHEMBL118,RZEKVGVHFLEQIL-UHFFFAOYSA-N,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,C17H14F3N3O2S,DB00482,D00567,celecoxib,Romidepsin,CHEMBL343448,OHRURASPPZQGQM-GCCNXGTGSA-N,CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C,C24H36N4O6S2,,D06637,romidepsin,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
265904,52,31,38,uM,uM,2.35621745199726,0.0566710262922585,0.700844396271363,4.5701736029206,5.0,1.27528198439104,-1.325,-2.959,-1.088,0.111,-0.4885,3.7955,,1.6535,0.8365,celecoxib,CHEMBL118,RZEKVGVHFLEQIL-UHFFFAOYSA-N,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,C17H14F3N3O2S,DB00482,D00567,celecoxib,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
266452,230,28,28,uM,uM,0.0893413456916367,-22.2604004916236,-3.66463695520239,0.280524154508301,4.13647882593517,0.0016018065100563,-1.192,10.915,15.444,25.024,20.234,10.511,,15.372500000000002,9.319000000000004,Imatinib,CHEMBL941,KTUFNOKKBVMGRW-UHFFFAOYSA-N,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,C29H31N7O,DB00619,D01441,imatinib,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
266607,43,75,28,uM,uM,-3.7950420254519,-5.95118905802922,-3.81236711647461,-5.86514139192851,0.0079962172633138,2.73710599865836e-06,6.16,2.235,4.537,1.764,3.1505,-5.2445,,-1.0469999999999997,-3.0095,anastrozole,CHEMBL1399,YBBLVLTVTVSKRW-UHFFFAOYSA-N,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,C17H19N5,DB01217,D00960,anastrozole,ifosfamide,CHEMBL1024,HOMGKSMUEGBAAB-UHFFFAOYSA-N,C1CN(P(=O)(OC1)NCCCl)CCCl,C7H15Cl2N2O2P,DB01181,D00343,ifosfamide,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
266637,388,90,28,uM,uM,7.04940347872056,-3.19786893719288,-2.27945060153635,6.87494341349559,0.0001210913448318,0.8,-8.257,-7.822,-5.886,-9.781,-7.8335,8.2455,,0.2060000000000004,-0.0114999999999998,raloxifene,CHEMBL81,GZUITABIAKMVPG-UHFFFAOYSA-N,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,C28H27NO4S,DB00481,D08465,raloxifene,Nilotinib,CHEMBL255863,HHZIURLSWUIHRB-UHFFFAOYSA-N,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,C28H22F3N7O,DB04868,D08953,nilotinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
267350,107,86,38,uM,uM,-1.45166353961214,-0.673466462899355,-1.47226142721017,-1.44854698877767,0.86174021006879,0.564640534817585,3.436,0.49,2.505,2.442,2.4735,-1.4525,,0.5105,-0.9625,thalidomide,CHEMBL468,UEJJHQNACJXSKW-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,C13H10N2O4,DB01041,D00754,thalidomide,methoxsalen,CHEMBL416,QXKHYNVANLEOEG-UHFFFAOYSA-N,COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,C12H8O4,DB00553,D00139,methoxsalen,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
267435,230,5,28,uM,uM,5.46891050190512,-46.8938537228114,2.11000665566507,4.15521843701082,2.25509381441979,0.0444924568143905,0.538,34.269,17.131,21.144,19.1375,-15.6695,,1.7340000000000018,-15.1315,Imatinib,CHEMBL941,KTUFNOKKBVMGRW-UHFFFAOYSA-N,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,C29H31N7O,DB00619,D01441,imatinib,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
267578,72,8,28,uM,uM,4.1288345311791,6.03734694062163,11.8555176381965,7.97689511481822,3.99619933428471,0.0478811510156457,8.524,17.234,43.886,53.407,48.6465,22.8885,,35.7675,31.4125,Gefitinib,CHEMBL939,XGALLCVXEZPNRQ-UHFFFAOYSA-N,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,C22H24ClFN4O3,DB00317,D01977,gefitinib,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
267761,28,85,38,uM,uM,-3.02152602075816,-0.799152842883797,-0.206902748316571,-2.42517154570284,0.0028018874318542,0.695984704897367,3.388,27.669,50.577,31.223,40.9,9.843,,25.3715,13.230999999999998,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,6-Mercaptopurine,CHEMBL1425,GLVAUDGFNGKCSF-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=CN2,C5H4N4S,DB01033,D04931,mercaptopurine,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
267790,80,78,38,uM,uM,-0.644252628233263,-11.5753910830279,-0.104453995940234,-0.378188640574551,0.0128796985926969,0.0203391763747341,4.021,26.291,24.189,25.347,24.768,-5.544,,9.612,-1.5229999999999997,letrozole,CHEMBL1444,HPJKCIUCZWXJDR-UHFFFAOYSA-N,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,C17H11N5,DB01006,D00964,letrozole,Ixabepilone,CHEMBL1201752,FABUFPQFXZVHFB-PVYNADRNSA-N,CC1CCCC2(C(O2)CC(NC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C,C27H42N2O5S,DB04845,D04645,ixabepilone,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
268039,90,100,38,uM,uM,2.13109316539882,-50.7226860948111,-2.03333170297954,1.55550800042627,0.0073993886250272,0.0014391938358074,-5.249,23.959,14.791,25.914,20.3525,1.6425,,10.9975,-3.606500000000001,Nilotinib,CHEMBL255863,HHZIURLSWUIHRB-UHFFFAOYSA-N,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,C28H22F3N7O,DB04868,D08953,nilotinib,Romidepsin,CHEMBL343448,OHRURASPPZQGQM-GCCNXGTGSA-N,CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C,C24H36N4O6S2,,D06637,romidepsin,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
268343,230,100,38,uM,uM,2.44250793505701,-51.5849083244991,-2.89555392520176,1.05539531425809,0.209418604287167,0.0014391938358074,-5.489,23.959,10.106,19.827,14.9665,-3.5035,,5.7315000000000005,-8.9925,Imatinib,CHEMBL941,KTUFNOKKBVMGRW-UHFFFAOYSA-N,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,C29H31N7O,DB00619,D01441,imatinib,Romidepsin,CHEMBL343448,OHRURASPPZQGQM-GCCNXGTGSA-N,CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C,C24H36N4O6S2,,D06637,romidepsin,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
268798,28,48,38,uM,uM,-3.73715837588948,-14.4769757322602,2.38629526753947,3.98299827846722,0.0047662390099693,20.4443291811165,3.998,-1.708,11.393,16.941,14.167,11.877,,13.022,10.169,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,busulfan,CHEMBL820,COVZYZSDYWQREU-UHFFFAOYSA-N,CS(=O)(=O)OCCCCOS(=O)(=O)C,C6H14O6S2,DB01008,D00248,busulfan,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
268858,30,78,38,uM,uM,4.36630242352418,-16.8232192685157,-2.23110948075734,2.28471558151199,1.0,0.0203391763747341,-5.123,26.291,19.301,26.964,23.1325,1.9645,,12.5485,-3.1585,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,Ixabepilone,CHEMBL1201752,FABUFPQFXZVHFB-PVYNADRNSA-N,CC1CCCC2(C(O2)CC(NC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C,C27H42N2O5S,DB04845,D04645,ixabepilone,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
269046,35,77,38,uM,uM,-4.22076290194292,-6.51252112376623,-4.59796624292211,-2.66177710834347,0.169316815074149,0.0020545295081273,12.153,-2.222,-0.039,-4.165,-2.102,-12.033,,-7.067500000000001,-14.255,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,IMIQUIMOD,CHEMBL1282,DOUYETYNHWVLEO-UHFFFAOYSA-N,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N,C14H16N4,DB00724,D02500,imiquimod,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
269238,40,8,38,uM,uM,4.20225685327882,-5.05537454632502,-2.06435067227482,6.33845466141251,71.8922251036684,0.0785633946652398,-5.53,-6.568,-1.126,-0.408,-0.767,11.331,,5.281999999999999,4.763,altretamine,CHEMBL1455,UUVWYPNAQBNQJQ-UHFFFAOYSA-N,CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C,C9H18N6,DB00488,D02841,altretamine,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
269406,230,5,38,uM,uM,-8.15090919229344,-51.8405965419163,-0.318887258535097,-0.215169040339289,0.14464728079222,0.3,-0.87,17.231,50.01,20.748,35.379,19.018,,27.1985,18.148,Imatinib,CHEMBL941,KTUFNOKKBVMGRW-UHFFFAOYSA-N,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,C29H31N7O,DB00619,D01441,imatinib,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
269946,96,75,38,uM,uM,-1.33887595676409,-3.11331223652,-4.54052822245655,-5.2048617773214,3.59224059336958e-05,100.0,0.762,1.939,-0.359,-0.006,-0.1825,-2.8835,,-1.533,-2.1215,Pralatrexate,CHEMBL1201746,OGSBUKJUDHAQEA-WMCAAGNKSA-N,C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,C23H23N7O5,DB06813,D05589,pralatrexate,ifosfamide,CHEMBL1024,HOMGKSMUEGBAAB-UHFFFAOYSA-N,C1CN(P(=O)(OC1)NCCCl)CCCl,C7H15Cl2N2O2P,DB01181,D00343,ifosfamide,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
269973,80,28,28,uM,uM,-3.79012135821831,-36.7776162181885,-9.71555392520176,0.382129839358062,0.4,0.0016018065100563,-9.117,10.915,-1.151,12.63,5.7395,3.9415,,4.8405000000000005,-5.1755,letrozole,CHEMBL1444,HPJKCIUCZWXJDR-UHFFFAOYSA-N,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,C17H11N5,DB01006,D00964,letrozole,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
270506,8,48,28,uM,uM,-5.8573007941845,-11.0067121441787,-0.040128687091551,-1.52026518619567,0.0276833941225779,7.55099759817741,9.875,2.11,9.44,7.204,8.322,-3.663,,2.3294999999999995,-1.5530000000000008,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,busulfan,CHEMBL820,COVZYZSDYWQREU-UHFFFAOYSA-N,CS(=O)(=O)OCCCCOS(=O)(=O)C,C6H14O6S2,DB01008,D00248,busulfan,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
270589,39,5,28,uM,uM,1.01445468221391,-41.8983438145991,-0.3466600110016,2.43050558187479,5.86040202975691,0.0444924568143905,-1.369,34.269,4.655,15.935,10.295,-22.605,,-6.154999999999999,-23.974,allopurinol,CHEMBL1467,OFCNXPDARWKPPY-UHFFFAOYSA-N,C1=C2C(=NC=NC2=O)NN1; C1=NNC2=C1C(=O)NC=N2,C5H4N4O,DB00437,D00224,allopurinol,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
271467,35,85,38,uM,uM,-11.0538976634032,-1.61135547378941,2.83425193368649,-1.3869322297285,0.354463827435393,0.365066035876366,10.04,20.229,32.272,32.37,32.321,2.052,,17.1865,12.092,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,6-Mercaptopurine,CHEMBL1425,GLVAUDGFNGKCSF-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=CN2,C5H4N4S,DB01033,D04931,mercaptopurine,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
271603,35,43,38,uM,uM,-0.391765473964978,0.929705574261637,-1.50638458598503,-1.68982063763985,0.717891474107955,0.0912164999434249,3.769,1.625,-0.349,1.641,0.646,-4.748,,-2.051,-3.123,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,anastrozole,CHEMBL1399,YBBLVLTVTVSKRW-UHFFFAOYSA-N,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,C17H19N5,DB01217,D00960,anastrozole,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
271623,28,85,28,uM,uM,-9.28537199148404,-2.40043806569857,-2.01914117769962,-3.34754222055464,0.0027075776063784,2.0,8.796,21.08,52.491,27.104,39.7975,9.9215,,24.8595,18.7175,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,6-Mercaptopurine,CHEMBL1425,GLVAUDGFNGKCSF-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=CN2,C5H4N4S,DB01033,D04931,mercaptopurine,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
271963,100,39,28,uM,uM,0.996185434654201,0.857789095764902,-0.0805444296173779,1.10425956788262,0.0044843012746364,5.03320952824429e-13,12.826,1.321,-8.807,76.736,33.9645,19.8175,,26.891,21.1385,Romidepsin,CHEMBL343448,OHRURASPPZQGQM-GCCNXGTGSA-N,CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C,C24H36N4O6S2,,D06637,romidepsin,allopurinol,CHEMBL1467,OFCNXPDARWKPPY-UHFFFAOYSA-N,C1=C2C(=NC=NC2=O)NN1; C1=NNC2=C1C(=O)NC=N2,C5H4N4O,DB00437,D00224,allopurinol,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
271998,43,90,28,uM,uM,1.78148983369437,3.66293503344981,0.103071669084184,2.18853265774449,0.0108096066540133,0.0117946741736568,3.815,-1.69,4.316,2.178,3.247,1.122,,2.1845,-0.5680000000000001,anastrozole,CHEMBL1399,YBBLVLTVTVSKRW-UHFFFAOYSA-N,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,C17H19N5,DB01217,D00960,anastrozole,Nilotinib,CHEMBL255863,HHZIURLSWUIHRB-UHFFFAOYSA-N,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,C28H22F3N7O,DB04868,D08953,nilotinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
272257,388,96,38,uM,uM,-1.46537491363851,1.23543474731192,1.12273831047155,0.50841252166167,0.018292512655514,0.0003516400255781,8.679,1.956,9.968,9.656,9.812,-0.822999999999999,,4.4945,1.1329999999999991,raloxifene,CHEMBL81,GZUITABIAKMVPG-UHFFFAOYSA-N,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,C28H27NO4S,DB00481,D08465,raloxifene,Pralatrexate,CHEMBL1201746,OGSBUKJUDHAQEA-WMCAAGNKSA-N,C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,C23H23N7O5,DB06813,D05589,pralatrexate,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
272387,100,75,38,uM,uM,-0.598074908176599,-38.3232400096037,-2.12352179847766,-2.12165488639847,0.0017623352915097,100.0,19.045,1.939,21.767,18.375,20.071,-0.913000000000004,,9.579,1.0259999999999998,Romidepsin,CHEMBL343448,OHRURASPPZQGQM-GCCNXGTGSA-N,CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C,C24H36N4O6S2,,D06637,romidepsin,ifosfamide,CHEMBL1024,HOMGKSMUEGBAAB-UHFFFAOYSA-N,C1CN(P(=O)(OC1)NCCCl)CCCl,C7H15Cl2N2O2P,DB01181,D00343,ifosfamide,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
272410,85,107,28,uM,uM,-2.13981156110776,-17.70860187206,-1.09383190229767,1.87758591152826,0.920230544679306,5.83307007506274,3.557,0.91,17.402,48.448,32.925,28.458,,30.6915,29.368,6-Mercaptopurine,CHEMBL1425,GLVAUDGFNGKCSF-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=CN2,C5H4N4S,DB01033,D04931,mercaptopurine,thalidomide,CHEMBL468,UEJJHQNACJXSKW-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,C13H10N2O4,DB01041,D00754,thalidomide,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
272673,31,90,28,uM,uM,3.46163201034599,4.02547825663256,3.09731926214601,7.69257170802347,0.285384814033791,0.0117946741736568,-4.599,-1.69,1.206,0.782,0.994,7.283,,4.1385,2.684,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,Nilotinib,CHEMBL255863,HHZIURLSWUIHRB-UHFFFAOYSA-N,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,C28H22F3N7O,DB04868,D08953,nilotinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
273144,30,85,28,uM,uM,-5.11925059120589,-14.1415312452009,-5.19555392520176,0.464742681169337,0.44916082338194,2.0,-8.679,21.08,45.772,16.258,31.015,18.614,,24.8145,9.935000000000002,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,6-Mercaptopurine,CHEMBL1425,GLVAUDGFNGKCSF-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=CN2,C5H4N4S,DB01033,D04931,mercaptopurine,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
273523,388,1,38,uM,uM,-4.21624294221467,0.940551231619854,1.45811776677616,-3.76243567850709,0.0735901700282625,5.53572916372674,10.629,33.854,16.435,37.101,26.768,-17.715,,4.526500000000002,-7.085999999999999,raloxifene,CHEMBL81,GZUITABIAKMVPG-UHFFFAOYSA-N,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,C28H27NO4S,DB00481,D08465,raloxifene,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
273754,90,77,38,uM,uM,2.27049001808658,-0.0821412055245724,0.455321229758178,2.31771693142019,0.0299654217282811,0.0020545295081273,1.673,-2.222,1.629,1.758,1.6935,2.2425,,1.968,0.0204999999999999,Nilotinib,CHEMBL255863,HHZIURLSWUIHRB-UHFFFAOYSA-N,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,C28H22F3N7O,DB04868,D08953,nilotinib,IMIQUIMOD,CHEMBL1282,DOUYETYNHWVLEO-UHFFFAOYSA-N,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N,C14H16N4,DB00724,D02500,imiquimod,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
274276,35,30,38,uM,uM,-4.08265128144383,-6.68032200651017,-0.216884785303185,-0.844015467156175,1.0,0.0097628103283271,11.325,0.81,11.044,28.385,19.7145,7.5795,,13.647000000000002,8.389500000000002,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
274568,39,77,38,uM,uM,0.45079869609523,-3.33565062636243,-3.22927649517694,-1.12225367584561,4.74167180496984,0.0020545295081273,-0.864,-2.222,-2.033,1.234,-0.3995,2.6865,,1.1435,0.4644999999999999,allopurinol,CHEMBL1467,OFCNXPDARWKPPY-UHFFFAOYSA-N,C1=C2C(=NC=NC2=O)NN1; C1=NNC2=C1C(=O)NC=N2,C5H4N4O,DB00437,D00224,allopurinol,IMIQUIMOD,CHEMBL1282,DOUYETYNHWVLEO-UHFFFAOYSA-N,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N,C14H16N4,DB00724,D02500,imiquimod,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
274662,48,107,38,uM,uM,-3.3867620288099,0.787862618158429,1.49536709041122,-0.303654553326202,5.59785693329851,2.69507835556911e-07,5.962,2.736,7.697,4.327,6.012,-2.686,,1.6629999999999994,0.0499999999999998,busulfan,CHEMBL820,COVZYZSDYWQREU-UHFFFAOYSA-N,CS(=O)(=O)OCCCCOS(=O)(=O)C,C6H14O6S2,DB01008,D00248,busulfan,thalidomide,CHEMBL468,UEJJHQNACJXSKW-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,C13H10N2O4,DB01041,D00754,thalidomide,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
274756,52,35,28,uM,uM,4.03940694080086,-2.01159844368623,3.45530326674481,16.9812112609019,4.27224981849564,0.144492266535655,-15.327,2.701,4.757,0.496,2.6265,15.2525,,8.939499999999999,-0.0745,celecoxib,CHEMBL118,RZEKVGVHFLEQIL-UHFFFAOYSA-N,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,C17H14F3N3O2S,DB00482,D00567,celecoxib,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
274962,90,5,28,uM,uM,0.451661709219922,-49.7366226306993,-4.78661644010966,-2.16399103632057,0.0824748100526505,0.0444924568143905,-0.844,34.269,14.699,32.052,23.3755,-10.0495,,6.663,-10.8935,Nilotinib,CHEMBL255863,HHZIURLSWUIHRB-UHFFFAOYSA-N,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,C28H22F3N7O,DB04868,D08953,nilotinib,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
275089,52,35,38,uM,uM,-7.389002782499,-19.6971499157378,-1.42222059186843,-0.755080974856655,0.150532422867775,0.176022954412325,-1.533,16.408,21.116,17.664,19.39,4.515,,11.9525,2.982,celecoxib,CHEMBL118,RZEKVGVHFLEQIL-UHFFFAOYSA-N,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,C17H14F3N3O2S,DB00482,D00567,celecoxib,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
275102,79,8,28,uM,uM,-3.21779648836851,-18.9810261126371,3.98559174155731,2.32712476479641,12.0448043048582,0.0478811510156457,2.904,17.234,25.272,15.849,20.5605,0.422499999999996,,10.4915,3.3265,Lenalidomide,CHEMBL848,GOTYRUGSSMKFNF-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,C13H13N3O3,DB00480,D04687,lenalidomide,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
275179,80,107,38,uM,uM,-0.535151185225302,-0.66450346047961,-0.676508212983521,-1.5613962843125,0.0110381671121027,2.69507835556911e-07,1.23,2.736,3.144,4.658,3.901,-0.0649999999999999,,1.918,1.1649999999999996,letrozole,CHEMBL1444,HPJKCIUCZWXJDR-UHFFFAOYSA-N,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,C17H11N5,DB01006,D00964,letrozole,thalidomide,CHEMBL468,UEJJHQNACJXSKW-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,C13H10N2O4,DB01041,D00754,thalidomide,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
275315,80,30,38,uM,uM,-0.241670544529412,-1.88325673378689,-1.35827634674212,0.148086979675889,0.034686746919146,0.0097628103283271,-1.558,0.81,0.02,-0.03,-0.005,0.743,,0.369,-0.8150000000000001,letrozole,CHEMBL1444,HPJKCIUCZWXJDR-UHFFFAOYSA-N,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,C17H11N5,DB01006,D00964,letrozole,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
275899,80,52,28,uM,uM,10.7991626136074,-9.73695693545445,-7.84999836964619,14.6915272799574,0.4,2.66700269134641,-21.406,-3.362,-12.419,-15.609,-14.014,10.754,,-1.629999999999999,-10.652,letrozole,CHEMBL1444,HPJKCIUCZWXJDR-UHFFFAOYSA-N,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,C17H11N5,DB01006,D00964,letrozole,celecoxib,CHEMBL118,RZEKVGVHFLEQIL-UHFFFAOYSA-N,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,C17H14F3N3O2S,DB00482,D00567,celecoxib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
276711,74,39,28,uM,uM,-2.41422546307329,-5.28037064581514,-3.35466256308097,-2.34503194291781,20.0,5.30647327087452,3.667,-1.052,1.28,11.514,6.397,3.782,,5.0895,2.7300000000000004,hydroxyurea,CHEMBL467,VSNHCAURESNICA-UHFFFAOYSA-N,C(=O)(N)NO,CH4N2O2,DB01005,D00341,hydroxyurea,allopurinol,CHEMBL1467,OFCNXPDARWKPPY-UHFFFAOYSA-N,C1=C2C(=NC=NC2=O)NN1; C1=NNC2=C1C(=O)NC=N2,C5H4N4O,DB00437,D00224,allopurinol,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
277005,31,86,38,uM,uM,-0.629281809962128,0.754561810592645,-1.03422214181559,-0.595102733805716,11.9642277534219,6.0,2.342,1.566,-0.546,2.876,1.165,-2.743,,-0.7890000000000001,-1.177,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,methoxsalen,CHEMBL416,QXKHYNVANLEOEG-UHFFFAOYSA-N,COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,C12H8O4,DB00553,D00139,methoxsalen,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
277033,28,8,38,uM,uM,-5.66662704544824,-14.4163347749438,-5.03608377801209,-4.55978200711298,0.0063174037736273,0.0462823125036052,11.281,0.322,15.447,11.999,13.723,2.12,,7.921500000000001,2.442,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
277400,52,74,38,uM,uM,5.4977755399563,-6.93422013159847,-7.28444281409063,3.72019395232737,5.0,1.00270306168241,-9.737,0.167,-6.399,-7.751,-7.075,2.495,,-2.29,-7.242,celecoxib,CHEMBL118,RZEKVGVHFLEQIL-UHFFFAOYSA-N,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,C17H14F3N3O2S,DB00482,D00567,celecoxib,hydroxyurea,CHEMBL467,VSNHCAURESNICA-UHFFFAOYSA-N,C(=O)(N)NO,CH4N2O2,DB01005,D00341,hydroxyurea,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
278022,74,96,38,uM,uM,0.786080450049623,0.901495521572833,0.117021971732434,1.48659279504469,8.07496608849592,1.86495947222869e-05,0.698,-0.235,1.682,1.559,1.6205,1.1575,,1.389,0.9225,hydroxyurea,CHEMBL467,VSNHCAURESNICA-UHFFFAOYSA-N,C(=O)(N)NO,CH4N2O2,DB01005,D00341,hydroxyurea,Pralatrexate,CHEMBL1201746,OGSBUKJUDHAQEA-WMCAAGNKSA-N,C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,C23H23N7O5,DB06813,D05589,pralatrexate,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
278123,96,39,28,uM,uM,-0.346316116180571,-55.6481874192562,-2.09021811863652,-1.15997638032428,0.000182621996706,10.0,11.287,-1.317,21.537,56.074,38.8055,28.8355,,33.8205,27.518500000000003,Pralatrexate,CHEMBL1201746,OGSBUKJUDHAQEA-WMCAAGNKSA-N,C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,C23H23N7O5,DB06813,D05589,pralatrexate,allopurinol,CHEMBL1467,OFCNXPDARWKPPY-UHFFFAOYSA-N,C1=C2C(=NC=NC2=O)NN1; C1=NNC2=C1C(=O)NC=N2,C5H4N4O,DB00437,D00224,allopurinol,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
278449,43,78,28,uM,uM,4.54361977717521,-20.4471006891003,0.0866682970204327,2.64962352153757,0.0024306654869422,0.0049933992099018,-6.971,77.487,55.819,75.679,65.749,-4.767,,30.491,-11.738,anastrozole,CHEMBL1399,YBBLVLTVTVSKRW-UHFFFAOYSA-N,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,C17H19N5,DB01217,D00960,anastrozole,Ixabepilone,CHEMBL1201752,FABUFPQFXZVHFB-PVYNADRNSA-N,CC1CCCC2(C(O2)CC(NC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C,C27H42N2O5S,DB04845,D04645,ixabepilone,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
278601,100,74,28,uM,uM,-0.179725057790984,-63.2147234844541,-1.65355145196986,-1.26907402050023,0.0038779104997937,1.98131610867259,21.129,-0.61,28.486,44.512,36.499,15.98,,26.2395,15.37,Romidepsin,CHEMBL343448,OHRURASPPZQGQM-GCCNXGTGSA-N,CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C,C24H36N4O6S2,,D06637,romidepsin,hydroxyurea,CHEMBL467,VSNHCAURESNICA-UHFFFAOYSA-N,C(=O)(N)NO,CH4N2O2,DB01005,D00341,hydroxyurea,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
278742,85,78,38,uM,uM,-4.3503156282572,-3.74825801540957,-0.736789495879173,-2.84812490181796,0.214077510743976,0.0114154409060072,12.225,29.962,35.253,37.823,36.538,-5.649,,15.444499999999998,6.575999999999997,6-Mercaptopurine,CHEMBL1425,GLVAUDGFNGKCSF-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=CN2,C5H4N4S,DB01033,D04931,mercaptopurine,Ixabepilone,CHEMBL1201752,FABUFPQFXZVHFB-PVYNADRNSA-N,CC1CCCC2(C(O2)CC(NC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C,C27H42N2O5S,DB04845,D04645,ixabepilone,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
278761,74,5,38,uM,uM,-8.04818570287124,-28.0166546415643,-1.35003568742862,-1.01343921540128,20.0,0.157942852211885,2.181,6.879,36.755,6.77,21.7625,12.7025,,17.2325,14.8835,hydroxyurea,CHEMBL467,VSNHCAURESNICA-UHFFFAOYSA-N,C(=O)(N)NO,CH4N2O2,DB01005,D00341,hydroxyurea,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
278930,100,96,38,uM,uM,-3.65498217325861,-1.58874789934498,-0.905548899890497,-3.27256887958559,0.0079882206741283,1.86748057980296e-05,8.509,43.534,32.223,36.8,34.5115,-17.5315,,8.489999999999998,-9.0225,Romidepsin,CHEMBL343448,OHRURASPPZQGQM-GCCNXGTGSA-N,CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C,C24H36N4O6S2,,D06637,romidepsin,Pralatrexate,CHEMBL1201746,OGSBUKJUDHAQEA-WMCAAGNKSA-N,C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,C23H23N7O5,DB06813,D05589,pralatrexate,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
279208,28,30,28,uM,uM,-3.21783376680167,-28.2326679112922,-2.85790646486932,-0.490543710311278,0.0013076122557831,0.725465974035397,17.058,-2.658,10.806,-5.456,2.675,-11.725,,-4.525,-14.383,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
279267,388,79,28,uM,uM,2.57912390857775,-0.512887300366389,-2.13506807647097,1.26559286825113,0.024411737372345,0.868996491053726,-3.094,-2.321,-2.924,-1.886,-2.405,3.01,,0.3025000000000002,-0.0839999999999996,raloxifene,CHEMBL81,GZUITABIAKMVPG-UHFFFAOYSA-N,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,C28H27NO4S,DB00481,D08465,raloxifene,Lenalidomide,CHEMBL848,GOTYRUGSSMKFNF-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,C13H13N3O3,DB00480,D04687,lenalidomide,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
279359,85,86,38,uM,uM,0.25942738714346,-24.6015937030986,-0.440277896689302,-1.42006461184007,1.80159079515425,6.0,21.457,1.566,22.662,57.585,40.1235,17.1005,,28.612,18.6665,6-Mercaptopurine,CHEMBL1425,GLVAUDGFNGKCSF-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=CN2,C5H4N4S,DB01033,D04931,mercaptopurine,methoxsalen,CHEMBL416,QXKHYNVANLEOEG-UHFFFAOYSA-N,COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,C12H8O4,DB00553,D00139,methoxsalen,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
279361,388,100,38,uM,uM,-3.1341334406749,-14.8312708725623,1.16927242349992,-0.0811452190929093,0.018292512655514,0.0016747372971344,8.679,30.506,47.262,35.915,41.5885,2.40349999999999,,21.996,11.082500000000003,raloxifene,CHEMBL81,GZUITABIAKMVPG-UHFFFAOYSA-N,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,C28H27NO4S,DB00481,D08465,raloxifene,Romidepsin,CHEMBL343448,OHRURASPPZQGQM-GCCNXGTGSA-N,CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C,C24H36N4O6S2,,D06637,romidepsin,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
280363,52,43,38,uM,uM,-0.641386720707281,-3.44074102858114,-5.11447246758282,-5.28679579964773,0.32178001570124,0.0912164999434249,0.799,1.625,-3.193,-1.796,-2.4945,-4.9185,,-3.7065,-4.1195,celecoxib,CHEMBL118,RZEKVGVHFLEQIL-UHFFFAOYSA-N,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,C17H14F3N3O2S,DB00482,D00567,celecoxib,anastrozole,CHEMBL1399,YBBLVLTVTVSKRW-UHFFFAOYSA-N,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,C17H19N5,DB01217,D00960,anastrozole,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
280499,388,15,38,uM,uM,-2.0619320550155,-3.84379317870907,-2.83990646486933,0.113750769512306,0.018292512655514,0.709287380134443,8.679,-3.244,8.295,-0.576,3.8595,-1.5755,,1.142,-4.8195,raloxifene,CHEMBL81,GZUITABIAKMVPG-UHFFFAOYSA-N,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,C28H27NO4S,DB00481,D08465,raloxifene,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
280553,30,75,38,uM,uM,0.282074398111632,-1.08274632286937,-1.60555392520175,-0.403116720097437,0.465714807811373,100.0,-0.709,1.939,-0.847,-0.509,-0.678,-1.908,,-1.293,-2.617,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,ifosfamide,CHEMBL1024,HOMGKSMUEGBAAB-UHFFFAOYSA-N,C1CN(P(=O)(OC1)NCCCl)CCCl,C7H15Cl2N2O2P,DB01181,D00343,ifosfamide,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
280958,30,5,38,uM,uM,-9.05517327731415,-23.9166828005064,-5.9158078443663,-6.07743246406949,0.544880988966948,0.3,-0.607,17.231,44.647,14.168,29.4075,12.7835,,21.0955,12.176499999999995,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
281182,230,96,38,uM,uM,3.98080454860255,-17.8574213536308,-0.857646687825753,2.30337105150742,2.98042478074321,1.86748057980296e-05,-3.439,43.534,23.233,35.744,29.4885,-10.6065,,9.441,-14.0455,Imatinib,CHEMBL941,KTUFNOKKBVMGRW-UHFFFAOYSA-N,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,C29H31N7O,DB00619,D01441,imatinib,Pralatrexate,CHEMBL1201746,OGSBUKJUDHAQEA-WMCAAGNKSA-N,C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,C23H23N7O5,DB06813,D05589,pralatrexate,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
281369,74,86,38,uM,uM,-1.1075115096959,1.14656171185644,-2.29386155578988,-2.95772821726818,0.665244653739139,6.0,2.283,1.566,1.847,2.101,1.974,-1.875,,0.0494999999999998,-0.3089999999999999,hydroxyurea,CHEMBL467,VSNHCAURESNICA-UHFFFAOYSA-N,C(=O)(N)NO,CH4N2O2,DB01005,D00341,hydroxyurea,methoxsalen,CHEMBL416,QXKHYNVANLEOEG-UHFFFAOYSA-N,COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,C12H8O4,DB00553,D00139,methoxsalen,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
281426,77,78,38,uM,uM,0.15222953788828,-9.77727350609091,-0.693472344427371,-1.30693656254294,0.0351909692539787,0.0121596555881956,-0.035,35.749,19.963,33.709,26.836,-8.878,,8.978999999999996,-8.913000000000004,IMIQUIMOD,CHEMBL1282,DOUYETYNHWVLEO-UHFFFAOYSA-N,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N,C14H16N4,DB00724,D02500,imiquimod,Ixabepilone,CHEMBL1201752,FABUFPQFXZVHFB-PVYNADRNSA-N,CC1CCCC2(C(O2)CC(NC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C,C27H42N2O5S,DB04845,D04645,ixabepilone,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
282026,30,48,28,uM,uM,1.15692561709752,-0.601973992808803,-0.36777112211269,2.18166369573356,1.0,3.7034904680665,-2.049,0.497,0.635,4.278,2.4565,4.0085,,3.2325,1.9595,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,busulfan,CHEMBL820,COVZYZSDYWQREU-UHFFFAOYSA-N,CS(=O)(=O)OCCCCOS(=O)(=O)C,C6H14O6S2,DB01008,D00248,busulfan,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
282513,39,77,28,uM,uM,0.0149725525873686,-3.66303260813614,-4.4008528513219,-3.04048400320143,1.08324736273702,0.0088144830043922,0.735,0.286,-1.841,-3.156,-2.4985,-3.5195,,-3.009,-3.2335,allopurinol,CHEMBL1467,OFCNXPDARWKPPY-UHFFFAOYSA-N,C1=C2C(=NC=NC2=O)NN1; C1=NNC2=C1C(=O)NC=N2,C5H4N4O,DB00437,D00224,allopurinol,IMIQUIMOD,CHEMBL1282,DOUYETYNHWVLEO-UHFFFAOYSA-N,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N,C14H16N4,DB00724,D02500,imiquimod,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
282655,90,35,38,uM,uM,-2.56451498377011,-14.2050672171523,-2.60333170297954,2.32622089454573,0.0076355216915632,0.176022954412325,-5.83,16.408,5.173,15.59,10.3815,-0.196500000000002,,5.0925,-6.0265,Nilotinib,CHEMBL255863,HHZIURLSWUIHRB-UHFFFAOYSA-N,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,C28H22F3N7O,DB04868,D08953,nilotinib,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
283030,30,107,38,uM,uM,-0.58132008893829,-3.3322827449038,-3.33222059186841,-2.00535723032748,0.0305060079508691,2.69507835556911e-07,-2.048,2.736,-0.92,-0.368,-0.644,-1.332,,-0.988,-3.3800000000000003,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,thalidomide,CHEMBL468,UEJJHQNACJXSKW-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,C13H10N2O4,DB01041,D00754,thalidomide,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
283525,74,78,28,uM,uM,2.17167215753702,-23.6473028055433,2.22222385257599,0.414780530126051,7.92428641749396,0.0059043323746609,3.369,66.783,47.085,71.992,59.5385,-10.6135,,24.4625,-7.244500000000002,hydroxyurea,CHEMBL467,VSNHCAURESNICA-UHFFFAOYSA-N,C(=O)(N)NO,CH4N2O2,DB01005,D00341,hydroxyurea,Ixabepilone,CHEMBL1201752,FABUFPQFXZVHFB-PVYNADRNSA-N,CC1CCCC2(C(O2)CC(NC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C,C27H42N2O5S,DB04845,D04645,ixabepilone,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
283709,230,30,38,uM,uM,1.25998434290778,-5.97315887566507,-5.83999836964618,-2.5901119007089,0.268919560338717,0.0097628103283271,-3.259,0.81,-6.369,-6.111,-6.24,-3.791,,-5.0155,-7.050000000000001,Imatinib,CHEMBL941,KTUFNOKKBVMGRW-UHFFFAOYSA-N,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,C29H31N7O,DB00619,D01441,imatinib,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
284201,29,86,38,uM,uM,2.34167922634347,-9.28624173372199,-9.10333170297954,-1.29006308973514,0.230005445202516,0.089053231514339,-8.019,2.82,-7.494,-4.317,-5.9055,-0.7065,,-3.306,-8.7255,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,methoxsalen,CHEMBL416,QXKHYNVANLEOEG-UHFFFAOYSA-N,COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,C12H8O4,DB00553,D00139,methoxsalen,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
284271,388,48,28,uM,uM,3.11072253328999,-4.59888107609267,-3.42325790965085,6.53251935903391,1.0,43.2755523077319,-8.397,-5.2,7.867,-3.324,2.2715,15.8685,,9.07,7.471500000000001,raloxifene,CHEMBL81,GZUITABIAKMVPG-UHFFFAOYSA-N,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,C28H27NO4S,DB00481,D08465,raloxifene,busulfan,CHEMBL820,COVZYZSDYWQREU-UHFFFAOYSA-N,CS(=O)(=O)OCCCCOS(=O)(=O)C,C6H14O6S2,DB01008,D00248,busulfan,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
284835,100,43,38,uM,uM,-3.63256958041876,-12.3507584557515,0.815337436919038,-0.396290289369535,0.0020039969381474,0.0912164999434249,8.409,1.625,11.499,26.581,19.04,9.006,,14.023,10.630999999999998,Romidepsin,CHEMBL343448,OHRURASPPZQGQM-GCCNXGTGSA-N,CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C,C24H36N4O6S2,,D06637,romidepsin,anastrozole,CHEMBL1399,YBBLVLTVTVSKRW-UHFFFAOYSA-N,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,C17H19N5,DB01217,D00960,anastrozole,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
284902,80,8,38,uM,uM,0.251396124109828,-0.799132191633922,-0.689206813631472,4.12659615310941,0.0125350558580171,0.0462823125036052,-3.591,0.322,2.715,1.144,1.9295,5.1985,,3.564,1.6075,letrozole,CHEMBL1444,HPJKCIUCZWXJDR-UHFFFAOYSA-N,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,C17H11N5,DB01006,D00964,letrozole,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
285249,28,35,38,uM,uM,-6.13374118923309,1.05783079202845,3.12342710550297,-1.65268288192863,0.01,0.176022954412325,16.155,16.408,21.564,40.436,31.0,-1.563,,14.7185,14.592,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
285655,52,29,28,uM,uM,2.93599019159494,-7.48510044906462,-9.10780580091616,-0.875936553147748,0.394560229831408,0.622137579745057,-6.213,1.38,-6.219,-5.358,-5.7885,-0.9555,,-3.372,-7.1685,celecoxib,CHEMBL118,RZEKVGVHFLEQIL-UHFFFAOYSA-N,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,C17H14F3N3O2S,DB00482,D00567,celecoxib,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
285728,80,43,28,uM,uM,-1.88975822790163,0.261926627243863,-4.34749569709614,-5.47485088431475,0.144755568778298,0.1,4.793,2.554,1.736,3.769,2.7525,-4.5945,,-0.9209999999999998,-2.0405,letrozole,CHEMBL1444,HPJKCIUCZWXJDR-UHFFFAOYSA-N,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,C17H11N5,DB01006,D00964,letrozole,anastrozole,CHEMBL1399,YBBLVLTVTVSKRW-UHFFFAOYSA-N,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,C17H19N5,DB01217,D00960,anastrozole,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
285887,52,78,28,uM,uM,3.96488144211549,-28.7045659710397,-0.142204384707612,1.47031872068794,0.613143328332907,0.0049933992099018,-4.372,77.487,27.404,75.527,51.4655,-21.6495,,14.908,-26.0215,celecoxib,CHEMBL118,RZEKVGVHFLEQIL-UHFFFAOYSA-N,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,C17H14F3N3O2S,DB00482,D00567,celecoxib,Ixabepilone,CHEMBL1201752,FABUFPQFXZVHFB-PVYNADRNSA-N,CC1CCCC2(C(O2)CC(NC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C,C27H42N2O5S,DB04845,D04645,ixabepilone,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
286350,28,78,28,uM,uM,-2.32186624854956,-8.84279898453384,-1.76680567776071,-3.934679031591,0.004939950661398,0.0059043323746609,4.499,66.783,70.88,68.343,69.6115,-1.67049999999999,,33.97050000000001,2.8285000000000053,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,Ixabepilone,CHEMBL1201752,FABUFPQFXZVHFB-PVYNADRNSA-N,CC1CCCC2(C(O2)CC(NC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C,C27H42N2O5S,DB04845,D04645,ixabepilone,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
287099,48,5,38,uM,uM,-7.68330078768623,-18.532904133979,-0.625521561438716,-3.07957212055225,8.98330013790096,0.3,4.628,17.231,47.756,14.632,31.194,9.335,,20.2645,13.962999999999996,busulfan,CHEMBL820,COVZYZSDYWQREU-UHFFFAOYSA-N,CS(=O)(=O)OCCCCOS(=O)(=O)C,C6H14O6S2,DB01008,D00248,busulfan,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
287226,230,15,38,uM,uM,-0.372937152173801,-8.3402373388581,-3.46999836964619,0.880900552102358,3.9170396374763,3.0,-4.437,4.271,8.062,-3.131,2.4655,2.6315,,2.5485,-1.8055,Imatinib,CHEMBL941,KTUFNOKKBVMGRW-UHFFFAOYSA-N,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,C29H31N7O,DB00619,D01441,imatinib,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
287537,31,48,28,uM,uM,-1.02609583625007,-0.647952156398804,-3.52221788159754,-2.63106592322807,1.68066429727032,16.6794883748937,4.367,-0.715,2.238,0.842,1.54,-2.112,,-0.286,-2.827,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,busulfan,CHEMBL820,COVZYZSDYWQREU-UHFFFAOYSA-N,CS(=O)(=O)OCCCCOS(=O)(=O)C,C6H14O6S2,DB01008,D00248,busulfan,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
287611,90,28,38,uM,uM,-3.7687658896145,-60.4256548194132,-2.19207492510934,-2.65381467849965,0.491520058008665,0.01,1.509,10.114,23.429,11.053,17.241,5.618,,11.4295,7.126999999999999,Nilotinib,CHEMBL255863,HHZIURLSWUIHRB-UHFFFAOYSA-N,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,C28H22F3N7O,DB04868,D08953,nilotinib,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
287986,52,85,28,uM,uM,-1.00005236823235,-33.3997306769256,-3.91887105137425,-1.34591119437954,0.159594933633444,2.0,-5.253,21.08,52.062,15.407,33.7345,17.9075,,25.821,12.6545,celecoxib,CHEMBL118,RZEKVGVHFLEQIL-UHFFFAOYSA-N,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,C17H14F3N3O2S,DB00482,D00567,celecoxib,6-Mercaptopurine,CHEMBL1425,GLVAUDGFNGKCSF-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=CN2,C5H4N4S,DB01033,D04931,mercaptopurine,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
288233,90,75,38,uM,uM,0.510090010348848,-5.57941298953603,-6.15453224563561,-3.96830928625116,0.0907847348318701,100.0,-2.099,1.939,-4.812,-6.42,-5.616,-5.456,,-5.536,-7.555,Nilotinib,CHEMBL255863,HHZIURLSWUIHRB-UHFFFAOYSA-N,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,C28H22F3N7O,DB04868,D08953,nilotinib,ifosfamide,CHEMBL1024,HOMGKSMUEGBAAB-UHFFFAOYSA-N,C1CN(P(=O)(OC1)NCCCl)CCCl,C7H15Cl2N2O2P,DB01181,D00343,ifosfamide,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
288369,108,8,38,uM,uM,3.01308325172564,-1.44107824052253,-0.947440340858742,4.01695249984922,1.20129551167282,0.0785633946652398,28.045,-6.568,27.709,25.192,26.4505,4.97349999999999,,15.712,-1.5945,6-Thioguanine,CHEMBL727,WYWHKKSPHMUBEB-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=C(N2)N,C5H5N5S,DB00352,D08603,thioguanine,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
288529,43,100,28,uM,uM,-0.292965470317179,-46.5995467088593,-6.85338520264348,-6.36588673094561,0.0031496623908646,0.0032561471780651,-1.281,18.556,25.857,21.432,23.6445,6.3695,,15.007,5.0885,anastrozole,CHEMBL1399,YBBLVLTVTVSKRW-UHFFFAOYSA-N,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,C17H19N5,DB01217,D00960,anastrozole,Romidepsin,CHEMBL343448,OHRURASPPZQGQM-GCCNXGTGSA-N,CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C,C24H36N4O6S2,,D06637,romidepsin,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
288642,31,35,28,uM,uM,6.50243453838483,-18.8705794913189,-4.79875779893685,5.09197978504721,7.67980466585955,0.144492266535655,-9.17,2.701,-4.165,-12.429,-8.297,-1.828,,-5.062500000000001,-10.998,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
288978,100,8,28,uM,uM,-0.399424789259867,3.28622746827449,2.42956120908843,3.05688396533196,0.0038664446023858,0.1,20.403,4.477,25.797,15.672,20.7345,-4.1455,,8.294500000000001,0.3315000000000019,Romidepsin,CHEMBL343448,OHRURASPPZQGQM-GCCNXGTGSA-N,CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C,C24H36N4O6S2,,D06637,romidepsin,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
289207,107,86,28,uM,uM,3.12480398057129,-0.0755501566616893,-1.42688478530319,4.66830733952133,0.307811388035404,0.231123720650524,-0.187,-3.963,-0.231,-1.41,-0.8205,3.3295,,1.2545000000000002,-0.6335,thalidomide,CHEMBL468,UEJJHQNACJXSKW-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,C13H10N2O4,DB01041,D00754,thalidomide,methoxsalen,CHEMBL416,QXKHYNVANLEOEG-UHFFFAOYSA-N,COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,C12H8O4,DB00553,D00139,methoxsalen,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
289211,74,107,28,uM,uM,-0.717508366562922,-0.0800765784578558,0.901723653257864,2.06176428042212,6.72048326798093,5.83307007506274,-0.245,0.91,-0.541,0.613,0.036,-0.629,,-0.2965,-0.874,hydroxyurea,CHEMBL467,VSNHCAURESNICA-UHFFFAOYSA-N,C(=O)(N)NO,CH4N2O2,DB01005,D00341,hydroxyurea,thalidomide,CHEMBL468,UEJJHQNACJXSKW-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,C13H10N2O4,DB01041,D00754,thalidomide,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
289365,40,8,28,uM,uM,-3.71781869470979,-33.7575009615131,-3.5139167888718,0.962723124140386,26.3908002701868,0.0478811510156457,-5.571,17.234,33.726,12.706,23.216,11.553,,17.3845,5.981999999999999,altretamine,CHEMBL1455,UUVWYPNAQBNQJQ-UHFFFAOYSA-N,CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C,C9H18N6,DB00488,D02841,altretamine,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
289369,230,29,38,uM,uM,3.3024481892559,-1.09957005992713,-4.38811185912257,0.764922658938955,0.0718821245754673,3.23217375956692,-5.368,-1.131,-5.658,-3.487,-4.5725,1.9265,,-1.3229999999999995,-3.4415,Imatinib,CHEMBL941,KTUFNOKKBVMGRW-UHFFFAOYSA-N,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,C29H31N7O,DB00619,D01441,imatinib,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
289486,35,8,38,uM,uM,-5.73396236265514,-6.88109690985183,-5.65577367419207,-6.37331365316326,1.0,0.0462823125036052,20.013,0.322,21.629,35.001,28.315,7.98,,18.1475,8.302,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
289728,96,75,28,uM,uM,-2.31047228351719,-8.21306906274872,-10.3338615557899,-7.62291612364546,3.38764551871597e-05,2.73710599865836e-06,-1.031,2.235,-0.888,-2.424,-1.656,-2.86,,-2.258,-3.891,Pralatrexate,CHEMBL1201746,OGSBUKJUDHAQEA-WMCAAGNKSA-N,C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,C23H23N7O5,DB06813,D05589,pralatrexate,ifosfamide,CHEMBL1024,HOMGKSMUEGBAAB-UHFFFAOYSA-N,C1CN(P(=O)(OC1)NCCCl)CCCl,C7H15Cl2N2O2P,DB01181,D00343,ifosfamide,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
289861,388,28,38,uM,uM,-9.87590870085353,-14.3909992479247,2.5048793373931,2.78119468231945,0.0903119390827007,0.0036487771339743,2.249,17.537,16.078,21.927,19.0025,-0.7835,,9.109500000000002,1.4655000000000022,raloxifene,CHEMBL81,GZUITABIAKMVPG-UHFFFAOYSA-N,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,C28H27NO4S,DB00481,D08465,raloxifene,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
290335,8,48,38,uM,uM,-1.38972061671808,8.55620354180686,0.796448548030164,-1.23665018571289,0.1,9.76277833497609,8.555,2.24,10.741,12.503,11.622,0.827,,6.2245,3.067,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,busulfan,CHEMBL820,COVZYZSDYWQREU-UHFFFAOYSA-N,CS(=O)(=O)OCCCCOS(=O)(=O)C,C6H14O6S2,DB01008,D00248,busulfan,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
291207,388,75,38,uM,uM,-2.97655557026688,-13.3473136680416,-3.50021811863653,-1.95914512493141,0.614680699980221,13.4979673175241,12.789,-1.753,8.548,12.624,10.586,-0.449999999999999,,5.0680000000000005,-2.2029999999999994,raloxifene,CHEMBL81,GZUITABIAKMVPG-UHFFFAOYSA-N,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,C28H27NO4S,DB00481,D08465,raloxifene,ifosfamide,CHEMBL1024,HOMGKSMUEGBAAB-UHFFFAOYSA-N,C1CN(P(=O)(OC1)NCCCl)CCCl,C7H15Cl2N2O2P,DB01181,D00343,ifosfamide,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
292242,230,30,7,uM,uM,3.13680817347057,-7.5694689452362,-8.05555392520174,-0.23421635437399,5.0,1.0,-8.025,2.065,-6.108,-7.285,-6.6965,-0.736499999999999,,-3.7165,-8.7615,Imatinib,CHEMBL941,KTUFNOKKBVMGRW-UHFFFAOYSA-N,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,C29H31N7O,DB00619,D01441,imatinib,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,A549,C3512,Lung (Carcinoma),Lung adenocarcinoma
292377,28,86,28,uM,uM,-8.26284834201673,-23.6020300826973,-5.20015250798397,-6.7532918326589,0.003824223571406,0.818787969219374,9.225,3.185,11.337,18.32,14.8285,2.4185,,8.6235,5.6035,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,methoxsalen,CHEMBL416,QXKHYNVANLEOEG-UHFFFAOYSA-N,COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,C12H8O4,DB00553,D00139,methoxsalen,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
292615,1,108,28,uM,uM,-5.86192618098325,-14.2637727522738,-5.46967838476805,-10.0928881957398,11.0241842226184,0.776360765454622,32.057,45.766,48.822,51.037,49.9295,-27.8935,,11.017999999999994,4.163499999999999,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,6-Thioguanine,CHEMBL727,WYWHKKSPHMUBEB-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=C(N2)N,C5H5N5S,DB00352,D08603,thioguanine,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
293063,100,107,38,uM,uM,0.123906113196525,-2.14307391347849,-2.14272079118657,-1.41961374168988,0.0018997688945409,2.69507835556911e-07,25.868,2.736,18.931,52.869,35.9,7.296,,21.598,10.032,Romidepsin,CHEMBL343448,OHRURASPPZQGQM-GCCNXGTGSA-N,CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C,C24H36N4O6S2,,D06637,romidepsin,thalidomide,CHEMBL468,UEJJHQNACJXSKW-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,C13H10N2O4,DB01041,D00754,thalidomide,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
293222,388,35,28,uM,uM,0.116941552136581,-7.56945049076504,-3.36099836964621,0.0162074139263964,1.0,0.256641768384851,-4.051,4.479,5.11,1.198,3.154,2.726,,2.94,-1.3250000000000002,raloxifene,CHEMBL81,GZUITABIAKMVPG-UHFFFAOYSA-N,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,C28H27NO4S,DB00481,D08465,raloxifene,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
293573,35,15,7,uM,uM,-3.83344853423364,-2.09934439231176,-0.812474511032966,0.275404586609847,0.428366010954387,0.483744839663606,-1.098,6.582,2.828,6.55,4.689,-0.795,,1.947,-1.893,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,A549,C3512,Lung (Carcinoma),Lung adenocarcinoma
293964,79,108,38,uM,uM,0.857565560937801,-17.3012422790072,2.53701783751462,0.934571082818873,30.0,1.03366265531186,1.953,30.715,33.186,32.497,32.8415,0.173499999999997,,16.507500000000004,2.126500000000004,Lenalidomide,CHEMBL848,GOTYRUGSSMKFNF-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,C13H13N3O3,DB00480,D04687,lenalidomide,6-Thioguanine,CHEMBL727,WYWHKKSPHMUBEB-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=C(N2)N,C5H5N5S,DB00352,D08603,thioguanine,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
294014,28,30,38,uM,uM,-4.71800436722029,-73.2770078389602,-1.01910700752541,-1.65073740330364,0.01,0.0097628103283271,8.203,0.81,9.602,24.209,16.9055,7.8925,,12.399,8.7025,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
294054,85,77,28,uM,uM,-1.43784937065633,2.28843913596821,3.01521380992054,3.94261003512844,0.318276542326815,0.07,18.222,1.012,25.94,12.181,19.0605,-0.173500000000001,,9.4435,0.8384999999999998,6-Mercaptopurine,CHEMBL1425,GLVAUDGFNGKCSF-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=CN2,C5H4N4S,DB01033,D04931,mercaptopurine,IMIQUIMOD,CHEMBL1282,DOUYETYNHWVLEO-UHFFFAOYSA-N,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N,C14H16N4,DB00724,D02500,imiquimod,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
294414,100,85,28,uM,uM,-5.11924978322418,-5.04770474695964,-5.19555392520176,0.464742681169337,0.0044916082338194,2.0,-8.679,21.08,45.774,16.258,31.016,18.615,,24.8155,9.936,Romidepsin,CHEMBL343448,OHRURASPPZQGQM-GCCNXGTGSA-N,CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C,C24H36N4O6S2,,D06637,romidepsin,6-Mercaptopurine,CHEMBL1425,GLVAUDGFNGKCSF-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=CN2,C5H4N4S,DB01033,D04931,mercaptopurine,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
294763,80,5,38,uM,uM,-9.66302736349626,-13.3298885038205,-1.18979295011365,-4.2463391774448,0.4,0.3,5.13,17.231,48.56,7.406,27.983,5.622,,16.802500000000002,10.752,letrozole,CHEMBL1444,HPJKCIUCZWXJDR-UHFFFAOYSA-N,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,C17H11N5,DB01006,D00964,letrozole,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
295026,96,5,38,uM,uM,-7.39579633127325,-3.89056882359158,-4.3888872585351,0.0106948934805729,0.0001,0.3,-4.274,17.231,44.731,18.946,31.8385,18.8815,,25.36,14.607499999999998,Pralatrexate,CHEMBL1201746,OGSBUKJUDHAQEA-WMCAAGNKSA-N,C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,C23H23N7O5,DB06813,D05589,pralatrexate,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
295335,100,28,38,uM,uM,0.421928983461211,-3.04372827203533,0.903204646241773,-1.93433855469567,0.00014006510682,0.01,69.111,10.114,73.816,30.534,52.175,-27.05,,12.562499999999991,-16.936000000000007,Romidepsin,CHEMBL343448,OHRURASPPZQGQM-GCCNXGTGSA-N,CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C,C24H36N4O6S2,,D06637,romidepsin,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
295608,31,15,38,uM,uM,0.710010107120005,-15.4660814053476,-4.14775994026313,1.03703865196752,1.64957252285702,3.0,-5.069,4.271,12.141,-2.231,4.955,5.753,,5.354,0.6840000000000002,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
296056,80,230,28,uM,uM,-0.960776648119022,-10.6775270095823,-9.02774378366092,-7.82385293159321,0.0361332997217259,2.20867560662903,1.505,0.942,-6.083,-4.776,-5.4295,-7.8765,,-6.6530000000000005,-6.9345,letrozole,CHEMBL1444,HPJKCIUCZWXJDR-UHFFFAOYSA-N,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,C17H11N5,DB01006,D00964,letrozole,Imatinib,CHEMBL941,KTUFNOKKBVMGRW-UHFFFAOYSA-N,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,C29H31N7O,DB00619,D01441,imatinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
296071,100,29,38,uM,uM,0.800067562629364,-73.9810147979097,-0.934662563080962,0.141484530812452,0.01,3.23217375956692,31.551,-1.131,30.784,73.264,52.024,21.604,,36.814,20.473000000000003,Romidepsin,CHEMBL343448,OHRURASPPZQGQM-GCCNXGTGSA-N,CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C,C24H36N4O6S2,,D06637,romidepsin,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
296386,77,78,28,uM,uM,2.24599718264647,-17.2195138597356,0.148906726403499,-0.661500071049664,0.0022938366497193,0.0051456902154446,0.099,73.025,31.189,77.064,54.1265,-18.9975,,17.564499999999995,-18.89850000000001,IMIQUIMOD,CHEMBL1282,DOUYETYNHWVLEO-UHFFFAOYSA-N,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N,C14H16N4,DB00724,D02500,imiquimod,Ixabepilone,CHEMBL1201752,FABUFPQFXZVHFB-PVYNADRNSA-N,CC1CCCC2(C(O2)CC(NC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C,C27H42N2O5S,DB04845,D04645,ixabepilone,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
296840,8,74,28,uM,uM,-5.47341477277527,-68.3943379104697,-0.566884785303185,-0.0456089446789119,0.1,1.98131610867259,9.516,-0.61,6.082,30.653,18.3675,9.4615,,13.9145,8.8515,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,hydroxyurea,CHEMBL467,VSNHCAURESNICA-UHFFFAOYSA-N,C(=O)(N)NO,CH4N2O2,DB01005,D00341,hydroxyurea,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
297066,77,5,38,uM,uM,-4.76816224269974,-3.13691325023915,-1.19908139964685,-4.06130529388683,0.07,0.0830008993235557,3.924,10.544,15.577,9.758,12.6675,-1.8005,,5.4335,2.1235,IMIQUIMOD,CHEMBL1282,DOUYETYNHWVLEO-UHFFFAOYSA-N,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N,C14H16N4,DB00724,D02500,imiquimod,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
297565,90,48,28,uM,uM,-1.6939658925497,-1.37374513758014,2.03429193646045,0.784088637326556,1.0,7.55099759817741,3.566,2.11,10.141,7.374,8.7575,3.0815,,5.9195,5.1915,Nilotinib,CHEMBL255863,HHZIURLSWUIHRB-UHFFFAOYSA-N,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,C28H22F3N7O,DB04868,D08953,nilotinib,busulfan,CHEMBL820,COVZYZSDYWQREU-UHFFFAOYSA-N,CS(=O)(=O)OCCCCOS(=O)(=O)C,C6H14O6S2,DB01008,D00248,busulfan,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
298536,116,115,7,uM,uM,-0.807512686422347,-3.62979367128749,0.940525488967041,2.4611785645081,5.0,0.362846059169275,-2.354,10.313,12.085,8.616,10.3505,2.3915,,6.371,0.0374999999999996,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,A549,C3512,Lung (Carcinoma),Lung adenocarcinoma
298540,116,115,28,uM,uM,8.70281344447751,2.29118143325879,8.87098242401956,9.21245523160361,0.647196610526164,0.989961346082029,33.59,-1.287,48.611,53.274,50.9425,18.6395,,34.791,17.3525,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
298550,116,115,38,uM,uM,-1.92539276692559,-0.292213860623121,2.11187933739312,3.75911980748955,4.75243603628729,0.230579909168597,-1.244,4.436,7.267,9.681,8.474,5.282,,6.878,4.038,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
298720,120,115,38,uM,uM,-3.1680309903226,1.58264216160456,2.83901977952278,2.77997270315509,3.86072665158335,0.230579909168597,4.58,4.436,5.871,5.059,5.465,-3.551,,0.957,0.8849999999999998,Vismodegib,CHEMBL473417,BPQMGSKTAYIVFO-UHFFFAOYSA-N,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,C19H14Cl2N2O3S,DB08828,D09992,vismodegib,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
298726,120,115,28,uM,uM,5.45878595394901,3.82012245174491,7.44487833526091,10.7039525041648,13.2475908300401,0.989961346082029,-2.739,-1.287,22.813,33.193,28.003,32.029,,30.016,29.29,Vismodegib,CHEMBL473417,BPQMGSKTAYIVFO-UHFFFAOYSA-N,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,C19H14Cl2N2O3S,DB08828,D09992,vismodegib,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
298743,56,115,38,uM,uM,-1.53870324590748,2.31453616181759,4.57313089063389,4.68094279706058,0.134169130800938,0.230579909168597,4.756,4.436,9.339,10.808,10.0735,0.881499999999999,,5.477499999999999,5.317499999999999,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
298761,56,115,7,uM,uM,-2.46788574939234,4.77731478461163,6.25168430486315,4.90310209862269,0.497567802644297,0.362846059169275,4.613,10.313,9.382,39.229,24.3055,9.3795,,16.842499999999998,13.992499999999998,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,A549,C3512,Lung (Carcinoma),Lung adenocarcinoma
298765,56,115,28,uM,uM,-1.39896755518085,6.70416743617125,6.98088469908443,8.99556448869911,0.479317498262319,0.989961346082029,-0.542,-1.287,18.486,22.065,20.2755,22.1045,,21.19,20.817500000000003,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
298898,72,31,38,uM,uM,-1.339000160972,-8.15589292210371,-0.848995896414299,4.18562102212684,10.0,3.66108556338685,5.994,-5.471,9.347,11.594,10.4705,9.9475,,10.209,4.4765,Gefitinib,CHEMBL939,XGALLCVXEZPNRQ-UHFFFAOYSA-N,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,C22H24ClFN4O3,DB00317,D01977,gefitinib,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
298903,72,31,28,uM,uM,6.4399019346133,-5.07140272461997,6.77667077025237,10.3717863763721,4.63606799908028,0.241489425928935,10.57,-4.852,19.516,38.735,29.1255,23.4075,,26.2665,18.5555,Gefitinib,CHEMBL939,XGALLCVXEZPNRQ-UHFFFAOYSA-N,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,C22H24ClFN4O3,DB00317,D01977,gefitinib,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
298931,101,115,38,uM,uM,-1.59633378030599,-2.06985354231879,-0.798458303872112,0.053386379829875,4.38962339087133,0.230579909168597,-0.959,4.436,2.245,11.685,6.965,3.488,,5.2265,2.529,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
298941,101,115,28,uM,uM,1.9617213451348,-6.84366463134804,-0.867827480482318,4.54248658873837,0.171867099886755,0.989961346082029,-5.115,-1.287,4.269,0.931,2.6,9.002,,5.801,3.887,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
298945,101,115,7,uM,uM,-7.86568522302045,-1.08591032657441,0.694192155633709,-0.557721858272929,3.22123167658349,0.362846059169275,2.342,10.313,18.203,15.649,16.926,4.271,,10.598499999999998,6.612999999999998,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,A549,C3512,Lung (Carcinoma),Lung adenocarcinoma
299102,116,31,28,uM,uM,7.51197933913254,-26.6972578631699,3.49578188136348,6.48888051885656,0.647196610526164,0.241489425928935,33.59,-4.852,35.897,46.611,41.254,12.516,,26.885,7.663999999999994,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
299123,116,31,38,uM,uM,4.45045763677995,-4.16078015061733,-3.55623432579738,2.18659834201198,4.75243603628729,3.66108556338685,-1.244,-5.471,-4.642,-3.256,-3.949,2.766,,-0.5914999999999999,-2.705,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
299246,79,31,38,uM,uM,1.62938424558111,-0.88569479647446,-1.72632922974764,3.55319299940138,30.0,3.66108556338685,2.987,-5.471,0.306,0.598,0.452,2.936,,1.694,-2.535,Lenalidomide,CHEMBL848,GOTYRUGSSMKFNF-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,C13H13N3O3,DB00480,D04687,lenalidomide,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
299267,79,31,28,uM,uM,3.75870337607173,2.00836153587942,0.838115214696795,5.11054659877128,30.0,0.241489425928935,4.019,-4.852,2.625,6.327,4.476,5.309,,4.8925,0.4569999999999998,Lenalidomide,CHEMBL848,GOTYRUGSSMKFNF-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,C13H13N3O3,DB00480,D04687,lenalidomide,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
300169,72,78,38,uM,uM,-1.63301221341011,4.53552174344474,4.51584749201602,2.50438221480301,10.0,0.0003170996810811,5.994,2.629,9.71,23.359,16.5345,7.9115,,12.223000000000004,10.540500000000002,Gefitinib,CHEMBL939,XGALLCVXEZPNRQ-UHFFFAOYSA-N,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,C22H24ClFN4O3,DB00317,D01977,gefitinib,Ixabepilone,CHEMBL1201752,FABUFPQFXZVHFB-PVYNADRNSA-N,CC1CCCC2(C(O2)CC(NC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C,C27H42N2O5S,DB04845,D04645,ixabepilone,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
300191,72,78,28,uM,uM,-6.67249849060615,-1.9404233520651,0.763291936460453,0.586357218782164,4.63606799908028,0.0008670937706707,10.57,2.215,21.751,29.551,25.651,12.866,,19.2585,15.081,Gefitinib,CHEMBL939,XGALLCVXEZPNRQ-UHFFFAOYSA-N,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,C22H24ClFN4O3,DB00317,D01977,gefitinib,Ixabepilone,CHEMBL1201752,FABUFPQFXZVHFB-PVYNADRNSA-N,CC1CCCC2(C(O2)CC(NC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C,C27H42N2O5S,DB04845,D04645,ixabepilone,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
300268,101,31,38,uM,uM,2.2907022714503,-6.89308116390657,-4.79103045206229,0.982357000463415,4.38962339087133,3.66108556338685,-0.959,-5.471,-3.522,-2.277,-2.8995,3.5305,,0.3154999999999996,-1.9405,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
300274,101,31,28,uM,uM,5.04250227208928,-9.06075217475567,-10.2360280231384,-4.12245492400869,0.171867099886755,0.241489425928935,-5.115,-4.852,-8.846,-8.798,-8.822,1.145,,-3.838499999999999,-3.969999999999999,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
300347,115,31,28,uM,uM,1.00957219095084,-15.4700241944948,-8.45970473246052,-3.79000452122286,0.987963832062323,0.241489425928935,-1.287,-4.852,-3.593,2.025,-0.784,5.355,,2.2855,0.5029999999999999,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
300369,115,31,38,uM,uM,0.128943167313666,-15.6358811950646,-9.60734543690848,-4.1966159705928,0.230610312300154,3.66108556338685,4.437,-5.471,-5.1,-3.532,-4.316,-3.282,,-3.799,-8.753,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
300594,56,31,38,uM,uM,0.147833186177028,-18.5452897298296,-9.04917877024181,-3.54342509619476,0.134169130800938,3.66108556338685,4.756,-5.471,-8.013,-8.95,-8.4815,-7.7665,,-8.124,-13.2375,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
300620,56,31,28,uM,uM,0.537650541986301,-9.36466243720333,-1.73445868934588,2.67764648289652,0.479317498262319,0.241489425928935,-0.542,-4.852,2.241,9.292,5.7665,11.1605,,8.4635,6.3085,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
300729,120,31,28,uM,uM,1.28891862032844,-8.10711013929963,-4.20698887406183,1.11710852891773,13.2475908300401,0.241489425928935,-2.739,-4.852,-7.513,13.718,3.1025,10.6935,,6.898,5.8415,Vismodegib,CHEMBL473417,BPQMGSKTAYIVFO-UHFFFAOYSA-N,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,C19H14Cl2N2O3S,DB08828,D09992,vismodegib,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
300735,120,31,38,uM,uM,0.33705094913163,-8.5339785905976,-2.79006765913069,2.66135174323309,3.86072665158335,3.66108556338685,4.58,-5.471,2.408,6.389,4.3985,5.2895,,4.844,-0.1814999999999997,Vismodegib,CHEMBL473417,BPQMGSKTAYIVFO-UHFFFAOYSA-N,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,C19H14Cl2N2O3S,DB08828,D09992,vismodegib,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
301197,115,78,28,uM,uM,1.4359179428043,2.56152200791735,7.40102548896704,9.135488148965,0.987963832062323,0.0008670937706707,-1.287,2.215,5.82,12.917,9.3685,8.4405,,8.904499999999999,7.153499999999999,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,Ixabepilone,CHEMBL1201752,FABUFPQFXZVHFB-PVYNADRNSA-N,CC1CCCC2(C(O2)CC(NC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C,C27H42N2O5S,DB04845,D04645,ixabepilone,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
301219,115,78,38,uM,uM,-0.593164407940085,1.60525422654651,2.86595438062991,2.33645428041671,0.230610312300154,0.0003170996810811,4.437,2.629,1.995,8.183,5.089,-1.977,,1.556,0.6520000000000001,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,Ixabepilone,CHEMBL1201752,FABUFPQFXZVHFB-PVYNADRNSA-N,CC1CCCC2(C(O2)CC(NC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C,C27H42N2O5S,DB04845,D04645,ixabepilone,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
301287,56,78,38,uM,uM,2.70286924386507,6.3300811827543,7.75146422396723,8.15124314509252,0.134169130800938,0.0003170996810811,4.756,2.629,4.778,8.957,6.8675,-0.5175,,3.175,2.1114999999999995,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,Ixabepilone,CHEMBL1201752,FABUFPQFXZVHFB-PVYNADRNSA-N,CC1CCCC2(C(O2)CC(NC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C,C27H42N2O5S,DB04845,D04645,ixabepilone,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
301313,56,78,28,uM,uM,0.677821266630122,3.19570201793139,6.40111676464398,7.57775677141771,0.479317498262319,0.0008670937706707,-0.542,2.215,30.029,14.662,22.3455,20.6725,,21.509,20.1305,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,Ixabepilone,CHEMBL1201752,FABUFPQFXZVHFB-PVYNADRNSA-N,CC1CCCC2(C(O2)CC(NC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C,C27H42N2O5S,DB04845,D04645,ixabepilone,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
301352,120,78,28,uM,uM,2.76604029235344,4.59647807813691,9.43133476436898,12.1642323585501,13.2475908300401,0.0008670937706707,-2.739,2.215,6.707,14.544,10.6255,11.1495,,10.8875,8.4105,Vismodegib,CHEMBL473417,BPQMGSKTAYIVFO-UHFFFAOYSA-N,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,C19H14Cl2N2O3S,DB08828,D09992,vismodegib,Ixabepilone,CHEMBL1201752,FABUFPQFXZVHFB-PVYNADRNSA-N,CC1CCCC2(C(O2)CC(NC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C,C27H42N2O5S,DB04845,D04645,ixabepilone,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
301358,120,78,38,uM,uM,4.27101385806885,7.2490917093774,7.87579755730057,8.11274509563148,3.86072665158335,0.0003170996810811,4.58,2.629,5.526,17.305,11.4155,4.2065,,7.811,6.8355,Vismodegib,CHEMBL473417,BPQMGSKTAYIVFO-UHFFFAOYSA-N,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,C19H14Cl2N2O3S,DB08828,D09992,vismodegib,Ixabepilone,CHEMBL1201752,FABUFPQFXZVHFB-PVYNADRNSA-N,CC1CCCC2(C(O2)CC(NC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C,C27H42N2O5S,DB04845,D04645,ixabepilone,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
301596,101,78,38,uM,uM,3.90084952506423,6.94897858037334,7.9949699334115,8.68805763758404,4.38962339087133,0.0003170996810811,-0.959,2.629,3.932,15.721,9.8265,8.1565,,8.991499999999998,7.1975,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,Ixabepilone,CHEMBL1201752,FABUFPQFXZVHFB-PVYNADRNSA-N,CC1CCCC2(C(O2)CC(NC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C,C27H42N2O5S,DB04845,D04645,ixabepilone,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
301602,101,78,28,uM,uM,6.43021011854772,-4.28286840143587,5.20107339307019,10.2345699617347,0.171867099886755,0.0008670937706707,-5.115,2.215,15.554,5.754,10.654,13.554,,12.104,8.439,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,Ixabepilone,CHEMBL1201752,FABUFPQFXZVHFB-PVYNADRNSA-N,CC1CCCC2(C(O2)CC(NC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C,C27H42N2O5S,DB04845,D04645,ixabepilone,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
302066,1,5,38,uM,uM,1.28475274086597,0.35973487131527,0.364892992474593,0.621851977771028,4.93954994547436,0.0025947544914729,31.568,-0.608,30.864,7.704,19.284,-11.676,,3.804,-12.284000000000002,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
302486,40,5,38,uM,uM,1.31846869903023,-5.13153959120067,-4.07766720291847,-0.687292686838249,75.0,0.0025947544914729,-3.362,-0.608,-3.078,-0.591,-1.8345,2.1355,,0.1505,-1.2265,altretamine,CHEMBL1455,UUVWYPNAQBNQJQ-UHFFFAOYSA-N,CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C,C9H18N6,DB00488,D02841,altretamine,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
302496,40,5,28,uM,uM,2.50028219029914,-12.3648732471389,-7.30205609180736,-1.07597232046342,75.0,0.0022673877798144,-6.521,-2.49,-10.104,-9.825,-9.9645,-0.9535,,-5.459,-7.474499999999999,altretamine,CHEMBL1455,UUVWYPNAQBNQJQ-UHFFFAOYSA-N,CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C,C9H18N6,DB00488,D02841,altretamine,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
302544,53,5,38,uM,uM,-3.31670408698366,-5.40073684136214,-5.39910700752541,-5.09232503828982,20.7438362933702,0.0025947544914729,18.749,-0.608,15.126,36.517,25.8215,7.6805,,16.751,7.072500000000002,chlorambucil,CHEMBL515,JCKYGMPEJWAADB-UHFFFAOYSA-N,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,C14H19Cl2NO2,DB00291,D00266,chlorambucil,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
302554,53,5,28,uM,uM,-6.65833456980946,-8.70327978402081,-7.35929005153389,-5.72331379003442,13.0779438627311,0.0022673877798144,16.142,-2.49,3.517,-1.993,0.762,-12.89,,-6.064,-15.38,chlorambucil,CHEMBL515,JCKYGMPEJWAADB-UHFFFAOYSA-N,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,C14H19Cl2NO2,DB00291,D00266,chlorambucil,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
302575,108,5,38,uM,uM,-0.700596630349685,-3.70511139065809,-3.67744034085875,-3.40816996217133,1.45049066398121,0.0025947544914729,28.889,-0.608,24.715,47.396,36.0555,7.7745,,21.915000000000003,7.166500000000003,6-Thioguanine,CHEMBL727,WYWHKKSPHMUBEB-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=C(N2)N,C5H5N5S,DB00352,D08603,thioguanine,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
302585,108,5,28,uM,uM,-0.75074731627868,0.0828219284974624,1.07879955019204,3.04052141693069,1.31560298651524,0.0022673877798144,33.09,-2.49,37.333,37.015,37.174,6.574,,21.874,4.083999999999996,6-Thioguanine,CHEMBL727,WYWHKKSPHMUBEB-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=C(N2)N,C5H5N5S,DB00352,D08603,thioguanine,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
302716,116,78,28,uM,uM,2.12781424729642,3.52144709006635,3.61237131290843,3.20659271126664,0.647196610526164,0.0008670937706707,33.59,2.215,42.383,42.558,42.4705,6.66549999999999,,24.568,8.880499999999998,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,Ixabepilone,CHEMBL1201752,FABUFPQFXZVHFB-PVYNADRNSA-N,CC1CCCC2(C(O2)CC(NC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C,C27H42N2O5S,DB04845,D04645,ixabepilone,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
302737,116,78,38,uM,uM,1.53826511341621,3.64201853504511,7.05661274146492,8.34357487496594,4.75243603628729,0.0003170996810811,-1.244,2.629,4.253,7.321,5.787,4.402,,5.0945,3.158,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,Ixabepilone,CHEMBL1201752,FABUFPQFXZVHFB-PVYNADRNSA-N,CC1CCCC2(C(O2)CC(NC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C,C27H42N2O5S,DB04845,D04645,ixabepilone,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
302870,79,78,38,uM,uM,-0.499115013365965,5.18487586521797,6.1554369488403,4.54803516429978,30.0,0.0003170996810811,2.987,2.629,6.23,9.283,7.7565,2.1405,,4.9485,4.7695,Lenalidomide,CHEMBL848,GOTYRUGSSMKFNF-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,C13H13N3O3,DB00480,D04687,lenalidomide,Ixabepilone,CHEMBL1201752,FABUFPQFXZVHFB-PVYNADRNSA-N,CC1CCCC2(C(O2)CC(NC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C,C27H42N2O5S,DB04845,D04645,ixabepilone,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
302892,79,78,28,uM,uM,1.14762618173679,-3.01982722627649,0.965371549947401,0.978162668959156,30.0,0.0008670937706707,4.019,2.215,3.792,1.513,2.6525,-3.5815,,-0.4645000000000001,-1.3665000000000005,Lenalidomide,CHEMBL848,GOTYRUGSSMKFNF-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,C13H13N3O3,DB00480,D04687,lenalidomide,Ixabepilone,CHEMBL1201752,FABUFPQFXZVHFB-PVYNADRNSA-N,CC1CCCC2(C(O2)CC(NC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C,C27H42N2O5S,DB04845,D04645,ixabepilone,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
303109,72,52,28,uM,uM,6.43920115984785,7.66542041973791,8.70092472713772,9.16514792913739,4.63606799908028,10.0,10.57,-1.542,26.003,54.325,40.164,31.136,,35.65,29.594,Gefitinib,CHEMBL939,XGALLCVXEZPNRQ-UHFFFAOYSA-N,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,C22H24ClFN4O3,DB00317,D01977,gefitinib,celecoxib,CHEMBL118,RZEKVGVHFLEQIL-UHFFFAOYSA-N,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,C17H14F3N3O2S,DB00482,D00567,celecoxib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
303135,72,52,38,uM,uM,-3.8359320920609,-1.04550765371691,1.45729193646046,-0.599487057417019,10.0,1.10347460095095,5.994,3.194,8.567,18.544,13.5555,4.3675,,8.961500000000001,7.5615,Gefitinib,CHEMBL939,XGALLCVXEZPNRQ-UHFFFAOYSA-N,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,C22H24ClFN4O3,DB00317,D01977,gefitinib,celecoxib,CHEMBL118,RZEKVGVHFLEQIL-UHFFFAOYSA-N,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,C17H14F3N3O2S,DB00482,D00567,celecoxib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
303476,79,52,28,uM,uM,0.735967309299253,-2.55392721165401,2.85967100729133,3.2974204765366,30.0,10.0,4.019,-1.542,14.575,6.544,10.5595,8.0825,,9.321,6.5405,Lenalidomide,CHEMBL848,GOTYRUGSSMKFNF-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,C13H13N3O3,DB00480,D04687,lenalidomide,celecoxib,CHEMBL118,RZEKVGVHFLEQIL-UHFFFAOYSA-N,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,C17H14F3N3O2S,DB00482,D00567,celecoxib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
303486,79,52,38,uM,uM,-2.85906408662218,-3.17497447361498,-1.57084082893748,-2.99473902458692,30.0,1.10347460095095,2.987,3.194,3.584,3.364,3.474,-2.707,,0.3835000000000002,0.2800000000000002,Lenalidomide,CHEMBL848,GOTYRUGSSMKFNF-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,C13H13N3O3,DB00480,D04687,lenalidomide,celecoxib,CHEMBL118,RZEKVGVHFLEQIL-UHFFFAOYSA-N,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,C17H14F3N3O2S,DB00482,D00567,celecoxib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
303654,88,77,28,uM,uM,5.74530550508615,-9.55049893815121,1.09833743691903,3.01266963841233,0.186033682243995,0.7,29.019,-2.328,24.522,48.524,36.523,9.832,,23.1775,7.504000000000005,mitoxantrone,CHEMBL58,KKZJGLLVHKMTCM-UHFFFAOYSA-N,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,C22H28N4O6,DB01204,D08224,mitoxantrone,IMIQUIMOD,CHEMBL1282,DOUYETYNHWVLEO-UHFFFAOYSA-N,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N,C14H16N4,DB00724,D02500,imiquimod,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
303660,88,77,38,uM,uM,7.81702399821584,-10.6274170091338,4.54355965914125,6.24525364516356,0.0616476966214236,0.7,26.212,-2.317,28.114,44.992,36.553,12.658,,24.6055,10.340999999999998,mitoxantrone,CHEMBL58,KKZJGLLVHKMTCM-UHFFFAOYSA-N,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,C22H28N4O6,DB01204,D08224,mitoxantrone,IMIQUIMOD,CHEMBL1282,DOUYETYNHWVLEO-UHFFFAOYSA-N,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N,C14H16N4,DB00724,D02500,imiquimod,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
303736,116,52,38,uM,uM,0.0044698866794604,1.25765128495206,3.47954600405979,4.88251161524591,4.75243603628729,1.10347460095095,-1.244,3.194,3.372,7.264,5.318,3.368,,4.343,2.124,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,celecoxib,CHEMBL118,RZEKVGVHFLEQIL-UHFFFAOYSA-N,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,C17H14F3N3O2S,DB00482,D00567,celecoxib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
303746,116,52,28,uM,uM,11.9416056061806,3.5531489510266,14.6805935351307,15.3270183243996,0.647196610526164,10.0,33.59,-1.542,52.043,51.094,51.5685,19.5205,,35.5445,17.978499999999997,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,celecoxib,CHEMBL118,RZEKVGVHFLEQIL-UHFFFAOYSA-N,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,C17H14F3N3O2S,DB00482,D00567,celecoxib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
303827,56,52,28,uM,uM,-1.77454882718669,2.62563249439665,5.33528343131066,7.49209702760627,0.479317498262319,10.0,-0.542,-1.542,13.057,13.287,13.172,15.256,,14.214,13.714,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,celecoxib,CHEMBL118,RZEKVGVHFLEQIL-UHFFFAOYSA-N,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,C17H14F3N3O2S,DB00482,D00567,celecoxib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
303833,56,52,38,uM,uM,-1.18890879089235,2.20556236574524,5.09690866841169,5.40301944926139,0.134169130800938,1.10347460095095,4.756,3.194,14.439,10.5,12.4695,4.5195,,8.4945,7.7135,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,celecoxib,CHEMBL118,RZEKVGVHFLEQIL-UHFFFAOYSA-N,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,C17H14F3N3O2S,DB00482,D00567,celecoxib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
303878,120,52,38,uM,uM,0.387197020882111,7.12706229821176,9.4570197795228,9.59896597757812,3.86072665158335,1.10347460095095,4.58,3.194,15.086,17.677,16.3815,8.6075,,12.4945,11.8015,Vismodegib,CHEMBL473417,BPQMGSKTAYIVFO-UHFFFAOYSA-N,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,C19H14Cl2N2O3S,DB08828,D09992,vismodegib,celecoxib,CHEMBL118,RZEKVGVHFLEQIL-UHFFFAOYSA-N,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,C17H14F3N3O2S,DB00482,D00567,celecoxib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
303904,120,52,28,uM,uM,-1.09150355252119,-0.886836150297833,1.86032277970537,5.49903543973861,13.2475908300401,10.0,-2.739,-1.542,3.056,10.046,6.551,10.832,,8.6915,8.093,Vismodegib,CHEMBL473417,BPQMGSKTAYIVFO-UHFFFAOYSA-N,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,C19H14Cl2N2O3S,DB08828,D09992,vismodegib,celecoxib,CHEMBL118,RZEKVGVHFLEQIL-UHFFFAOYSA-N,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,C17H14F3N3O2S,DB00482,D00567,celecoxib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
304096,115,52,38,uM,uM,-1.11250732359083,5.15857978148209,6.89445438062991,6.25180364208557,0.230610312300154,1.10347460095095,4.437,3.194,11.459,11.676,11.5675,3.9365,,7.752000000000001,7.1305000000000005,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,celecoxib,CHEMBL118,RZEKVGVHFLEQIL-UHFFFAOYSA-N,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,C17H14F3N3O2S,DB00482,D00567,celecoxib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
304106,115,52,28,uM,uM,-0.277630320181053,1.54496613801711,4.91454500192759,7.62998356765355,0.987963832062323,10.0,-1.287,-1.542,12.439,13.37,12.9045,15.7335,,14.319,14.1915,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,celecoxib,CHEMBL118,RZEKVGVHFLEQIL-UHFFFAOYSA-N,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,C17H14F3N3O2S,DB00482,D00567,celecoxib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
304290,101,52,28,uM,uM,3.16556042414047,-9.30133197065934,-4.03306590986536,1.28439775264553,0.171867099886755,10.0,-5.115,-1.542,-6.041,-0.787,-3.414,3.243,,-0.0855000000000001,-1.872,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,celecoxib,CHEMBL118,RZEKVGVHFLEQIL-UHFFFAOYSA-N,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,C17H14F3N3O2S,DB00482,D00567,celecoxib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
304316,101,52,38,uM,uM,2.04201525954812,4.69195045226552,5.4050810445226,6.14800736536401,4.38962339087133,1.10347460095095,-0.959,3.194,8.499,14.086,11.2925,9.0575,,10.175,8.098500000000001,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,celecoxib,CHEMBL118,RZEKVGVHFLEQIL-UHFFFAOYSA-N,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,C17H14F3N3O2S,DB00482,D00567,celecoxib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
304482,88,52,38,uM,uM,1.08578265495822,-11.6241023959365,3.8468277420165,2.32821922890353,0.0616476966214236,1.10347460095095,26.212,3.194,30.997,36.625,33.811,4.405,,19.108,7.599,mitoxantrone,CHEMBL58,KKZJGLLVHKMTCM-UHFFFAOYSA-N,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,C22H28N4O6,DB01204,D08224,mitoxantrone,celecoxib,CHEMBL118,RZEKVGVHFLEQIL-UHFFFAOYSA-N,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,C17H14F3N3O2S,DB00482,D00567,celecoxib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
304488,88,52,28,uM,uM,10.4192745705617,-4.09393998450266,8.54903797957511,8.71894675278029,0.186033682243995,10.0,29.019,-1.542,45.53,52.865,49.1975,21.7205,,35.459,20.1785,mitoxantrone,CHEMBL58,KKZJGLLVHKMTCM-UHFFFAOYSA-N,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,C22H28N4O6,DB01204,D08224,mitoxantrone,celecoxib,CHEMBL118,RZEKVGVHFLEQIL-UHFFFAOYSA-N,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,C17H14F3N3O2S,DB00482,D00567,celecoxib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
307431,72,100,38,uM,uM,1.85081108646139,4.65700284526198,7.9253378223928,5.41617580378406,10.0,0.0011836233021096,5.994,21.417,17.599,46.312,31.9555,4.5445,,18.25,10.5385,Gefitinib,CHEMBL939,XGALLCVXEZPNRQ-UHFFFAOYSA-N,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,C22H24ClFN4O3,DB00317,D01977,gefitinib,Romidepsin,CHEMBL343448,OHRURASPPZQGQM-GCCNXGTGSA-N,CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C,C24H36N4O6S2,,D06637,romidepsin,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
307441,72,100,28,uM,uM,-1.51595419402859,-17.6585412675635,3.12742710550296,2.869799797682,4.63606799908028,0.0059496376741413,10.57,14.231,95.774,64.339,80.0565,55.2555,,67.656,65.8255,Gefitinib,CHEMBL939,XGALLCVXEZPNRQ-UHFFFAOYSA-N,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,C22H24ClFN4O3,DB00317,D01977,gefitinib,Romidepsin,CHEMBL343448,OHRURASPPZQGQM-GCCNXGTGSA-N,CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C,C24H36N4O6S2,,D06637,romidepsin,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
307899,120,100,28,uM,uM,-0.599861316289591,-47.1064951792331,-3.58958562214407,-1.25257945727233,13.2475908300401,0.0059496376741413,-2.739,14.231,93.062,36.23,64.646,53.154,,58.9,50.415,Vismodegib,CHEMBL473417,BPQMGSKTAYIVFO-UHFFFAOYSA-N,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,C19H14Cl2N2O3S,DB08828,D09992,vismodegib,Romidepsin,CHEMBL343448,OHRURASPPZQGQM-GCCNXGTGSA-N,CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C,C24H36N4O6S2,,D06637,romidepsin,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
307909,120,100,38,uM,uM,1.9490946833322,-20.6111855044262,5.43085882230037,4.89826104155698,3.86072665158335,0.0011836233021096,4.58,21.417,12.9,31.833,22.3665,-3.6305,,9.368,0.9494999999999968,Vismodegib,CHEMBL473417,BPQMGSKTAYIVFO-UHFFFAOYSA-N,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,C19H14Cl2N2O3S,DB08828,D09992,vismodegib,Romidepsin,CHEMBL343448,OHRURASPPZQGQM-GCCNXGTGSA-N,CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C,C24H36N4O6S2,,D06637,romidepsin,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
307951,56,100,28,uM,uM,-1.25197904470279,-45.0130321877025,-1.52658562214407,-0.357726182738003,0.479317498262319,0.0059496376741413,-0.542,14.231,86.248,37.143,61.6955,48.0065,,54.851,47.4645,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,Romidepsin,CHEMBL343448,OHRURASPPZQGQM-GCCNXGTGSA-N,CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C,C24H36N4O6S2,,D06637,romidepsin,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
307977,56,100,38,uM,uM,-0.805214452781522,-22.5056771493819,3.5511921556337,3.08697771324024,0.134169130800938,0.0011836233021096,4.756,21.417,17.774,34.693,26.2335,0.0604999999999976,,13.146999999999998,4.816499999999998,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,Romidepsin,CHEMBL343448,OHRURASPPZQGQM-GCCNXGTGSA-N,CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C,C24H36N4O6S2,,D06637,romidepsin,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
308161,115,100,28,uM,uM,-0.895898990340307,-43.9092892137984,-0.39536339992185,1.23780040286484,0.987963832062323,0.0059496376741413,-1.287,14.231,70.435,23.016,46.7255,33.7815,,40.2535,32.494499999999995,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,Romidepsin,CHEMBL343448,OHRURASPPZQGQM-GCCNXGTGSA-N,CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C,C24H36N4O6S2,,D06637,romidepsin,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
308187,115,100,38,uM,uM,1.16859849537747,-17.8227316775707,2.77221050412084,1.69588570661998,0.230610312300154,0.0011836233021096,4.437,21.417,6.42,32.348,19.384,-6.47,,6.456999999999999,-2.0330000000000013,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,Romidepsin,CHEMBL343448,OHRURASPPZQGQM-GCCNXGTGSA-N,CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C,C24H36N4O6S2,,D06637,romidepsin,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
308370,101,100,38,uM,uM,4.34441185365157,-32.1870993031405,2.18519432223931,2.53246422656509,4.38962339087133,0.0011836233021096,-0.959,21.417,19.053,31.928,25.4905,5.0325,,15.2615,4.073499999999999,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,Romidepsin,CHEMBL343448,OHRURASPPZQGQM-GCCNXGTGSA-N,CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C,C24H36N4O6S2,,D06637,romidepsin,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
308380,101,100,28,uM,uM,0.85855281323746,-73.0563823874765,-7.82733170297954,-4.36710065214319,0.171867099886755,0.0059496376741413,-5.115,14.231,90.253,9.939,50.096,40.98,,45.538,35.864999999999995,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,Romidepsin,CHEMBL343448,OHRURASPPZQGQM-GCCNXGTGSA-N,CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C,C24H36N4O6S2,,D06637,romidepsin,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
308484,53,52,38,uM,uM,-9.96187337495246,-4.11642204447175,-1.7622833690946,-3.43384908761476,20.7438362933702,1.10347460095095,18.749,3.194,18.54,37.685,28.1125,6.1695,,17.141000000000002,9.363500000000002,chlorambucil,CHEMBL515,JCKYGMPEJWAADB-UHFFFAOYSA-N,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,C14H19Cl2NO2,DB00291,D00266,chlorambucil,celecoxib,CHEMBL118,RZEKVGVHFLEQIL-UHFFFAOYSA-N,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,C17H14F3N3O2S,DB00482,D00567,celecoxib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
308506,53,52,28,uM,uM,-7.06886681711448,-10.0383478421053,-6.58440116264499,-5.51995827399579,13.0779438627311,10.0,16.142,-1.542,11.745,4.731,8.238,-6.362,,0.9379999999999996,-7.904,chlorambucil,CHEMBL515,JCKYGMPEJWAADB-UHFFFAOYSA-N,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,C14H19Cl2NO2,DB00291,D00266,chlorambucil,celecoxib,CHEMBL118,RZEKVGVHFLEQIL-UHFFFAOYSA-N,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,C17H14F3N3O2S,DB00482,D00567,celecoxib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
308572,108,52,38,uM,uM,0.0094239317548296,-11.1897191138038,1.02249440868318,-0.492143295940694,1.45049066398121,1.10347460095095,28.889,3.194,30.496,44.807,37.6515,5.5685,,21.61,8.7625,6-Thioguanine,CHEMBL727,WYWHKKSPHMUBEB-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=C(N2)N,C5H5N5S,DB00352,D08603,thioguanine,celecoxib,CHEMBL118,RZEKVGVHFLEQIL-UHFFFAOYSA-N,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,C17H14F3N3O2S,DB00482,D00567,celecoxib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
308593,108,52,28,uM,uM,-1.42053230672556,-14.9265992161133,-2.88063290958879,-1.2925173405373,1.31560298651524,10.0,33.09,-1.542,37.935,34.684,36.3095,4.7615,,20.5355,3.2194999999999965,6-Thioguanine,CHEMBL727,WYWHKKSPHMUBEB-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=C(N2)N,C5H5N5S,DB00352,D08603,thioguanine,celecoxib,CHEMBL118,RZEKVGVHFLEQIL-UHFFFAOYSA-N,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,C17H14F3N3O2S,DB00482,D00567,celecoxib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
309015,40,52,38,uM,uM,-0.384525713547231,-9.81403281420842,-5.71055392520174,-2.44834734282983,75.0,1.10347460095095,-3.362,3.194,-2.082,-1.082,-1.582,-1.414,,-1.498,-4.776,altretamine,CHEMBL1455,UUVWYPNAQBNQJQ-UHFFFAOYSA-N,CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C,C9H18N6,DB00488,D02841,altretamine,celecoxib,CHEMBL118,RZEKVGVHFLEQIL-UHFFFAOYSA-N,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,C17H14F3N3O2S,DB00482,D00567,celecoxib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
309037,40,52,28,uM,uM,2.06126464014199,-20.5753781390459,-8.44788725853507,-2.28457813126473,75.0,10.0,-6.521,-1.542,-7.71,-4.393,-6.0515,2.0115,,-2.02,-4.5095,altretamine,CHEMBL1455,UUVWYPNAQBNQJQ-UHFFFAOYSA-N,CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C,C9H18N6,DB00488,D02841,altretamine,celecoxib,CHEMBL118,RZEKVGVHFLEQIL-UHFFFAOYSA-N,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,C17H14F3N3O2S,DB00482,D00567,celecoxib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
309245,1,52,38,uM,uM,6.44357376997718,4.70889071066531,8.84955965914126,6.68617523066832,4.93954994547436,1.10347460095095,31.568,3.194,40.804,18.662,29.733,-5.029,,12.352,-1.8350000000000009,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,celecoxib,CHEMBL118,RZEKVGVHFLEQIL-UHFFFAOYSA-N,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,C17H14F3N3O2S,DB00482,D00567,celecoxib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
309271,1,52,28,uM,uM,1.12653864883108,-7.02153236038768,-4.99444034085874,-4.91577738014351,3.70539648442761,10.0,52.846,-1.542,48.172,16.845,32.5085,-18.7955,,6.8565000000000005,-20.3375,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,celecoxib,CHEMBL118,RZEKVGVHFLEQIL-UHFFFAOYSA-N,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,C17H14F3N3O2S,DB00482,D00567,celecoxib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
309608,79,100,38,uM,uM,2.4091174209835,-29.6535325612282,3.92022887788729,2.45371544772527,30.0,0.0011836233021096,2.987,21.417,8.805,18.237,13.521,-10.883,,1.318999999999999,-7.896000000000001,Lenalidomide,CHEMBL848,GOTYRUGSSMKFNF-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,C13H13N3O3,DB00480,D04687,lenalidomide,Romidepsin,CHEMBL343448,OHRURASPPZQGQM-GCCNXGTGSA-N,CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C,C24H36N4O6S2,,D06637,romidepsin,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
309634,79,100,28,uM,uM,0.834662352533734,-62.2536046096988,-0.0091284500526004,-0.17207028825211,30.0,0.0059496376741413,4.019,14.231,88.823,12.626,50.7245,32.4745,,41.5995,36.4935,Lenalidomide,CHEMBL848,GOTYRUGSSMKFNF-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,C13H13N3O3,DB00480,D04687,lenalidomide,Romidepsin,CHEMBL343448,OHRURASPPZQGQM-GCCNXGTGSA-N,CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C,C24H36N4O6S2,,D06637,romidepsin,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
309752,116,100,28,uM,uM,1.27884379294409,-0.132165699834728,0.796744231675455,0.588974070722052,0.647196610526164,0.0059496376741413,33.59,14.231,94.191,57.693,75.942,28.121,,52.0315,42.35199999999999,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,Romidepsin,CHEMBL343448,OHRURASPPZQGQM-GCCNXGTGSA-N,CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C,C24H36N4O6S2,,D06637,romidepsin,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
309778,116,100,38,uM,uM,3.28064210709633,-37.6934352300116,4.03922385257601,5.03437038478032,4.75243603628729,0.0011836233021096,-1.244,21.417,3.306,20.309,11.8075,-8.3655,,1.7209999999999983,-9.609500000000002,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,Romidepsin,CHEMBL343448,OHRURASPPZQGQM-GCCNXGTGSA-N,CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C,C24H36N4O6S2,,D06637,romidepsin,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
310447,1,28,38,uM,uM,-3.65655411132474,3.05473235177068,5.36229193646045,-1.40573794938734,4.93954994547436,0.0037555079071878,31.568,17.17,41.797,29.178,35.4875,-13.2505,,11.118499999999996,3.919499999999996,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
310456,1,28,28,uM,uM,-4.05279042670024,-1.77254871682435,-0.476906464869338,-4.6450084022332,3.70539648442761,0.0052251239534028,52.846,16.049,58.574,43.247,50.9105,-17.9845,,16.463,-1.9354999999999976,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
310503,40,28,38,uM,uM,-8.3161282297919,-14.9055804378103,-2.60956510705135,0.566479337114492,75.0,0.0037555079071878,-3.362,17.17,11.419,17.399,14.409,0.600999999999999,,7.505,-2.761000000000001,altretamine,CHEMBL1455,UUVWYPNAQBNQJQ-UHFFFAOYSA-N,CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C,C9H18N6,DB00488,D02841,altretamine,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
310508,40,28,28,uM,uM,-3.47905759197268,-35.9921883248632,-2.67977614742398,2.50879223553447,75.0,0.0052251239534028,-6.521,16.049,13.334,10.399,11.8665,2.3385,,7.102500000000001,-4.182499999999999,altretamine,CHEMBL1455,UUVWYPNAQBNQJQ-UHFFFAOYSA-N,CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C,C9H18N6,DB00488,D02841,altretamine,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
310761,88,116,7,uM,uM,5.93386399262161,-2.80571484720507,6.33120464624178,6.77881434800243,0.0309080476193319,5.0,46.022,-2.352,59.266,49.954,54.61,10.94,,32.775,8.588000000000001,mitoxantrone,CHEMBL58,KKZJGLLVHKMTCM-UHFFFAOYSA-N,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,C22H28N4O6,DB01204,D08224,mitoxantrone,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,A549,C3512,Lung (Carcinoma),Lung adenocarcinoma
310765,88,116,28,uM,uM,0.478478430989024,3.68300038618762,4.56550448905945,-0.292473867987993,0.186033682243995,0.647340538074254,29.019,33.591,47.162,56.869,52.0155,-10.5945,,20.710500000000003,18.4245,mitoxantrone,CHEMBL58,KKZJGLLVHKMTCM-UHFFFAOYSA-N,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,C22H28N4O6,DB01204,D08224,mitoxantrone,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
310775,88,116,38,uM,uM,0.587215406455215,-19.4894942264512,3.56489299247457,4.54270227854575,0.0616476966214236,4.79432171150704,26.212,-1.242,36.005,32.456,34.2305,9.26050000000001,,21.7455,8.0185,mitoxantrone,CHEMBL58,KKZJGLLVHKMTCM-UHFFFAOYSA-N,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,C22H28N4O6,DB01204,D08224,mitoxantrone,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
310888,108,28,38,uM,uM,-11.6965481226897,-6.29114173877101,-3.56252941220927,-7.75921791599636,1.45049066398121,0.0037555079071878,28.889,17.17,28.488,28.811,28.6495,-17.4095,,5.620000000000001,-0.2394999999999996,6-Thioguanine,CHEMBL727,WYWHKKSPHMUBEB-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=C(N2)N,C5H5N5S,DB00352,D08603,thioguanine,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
310894,108,28,28,uM,uM,-6.66538766733562,-6.38488877101657,-1.71865673048122,-1.84197477929364,1.31560298651524,0.0052251239534028,33.09,16.049,35.692,36.438,36.065,-13.074,,11.495499999999996,2.9749999999999943,6-Thioguanine,CHEMBL727,WYWHKKSPHMUBEB-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=C(N2)N,C5H5N5S,DB00352,D08603,thioguanine,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
310918,53,28,38,uM,uM,-14.724914127489,-7.11301719609731,-4.38306090983342,-8.34519138322597,20.7438362933702,0.0037555079071878,18.749,17.17,20.125,36.43,28.2775,-7.6415,,10.318,9.5285,chlorambucil,CHEMBL515,JCKYGMPEJWAADB-UHFFFAOYSA-N,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,C14H19Cl2NO2,DB00291,D00266,chlorambucil,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
310924,53,28,28,uM,uM,-9.19585184600484,-12.123980440756,-0.0134674203481756,-1.3264827754133,13.0779438627311,0.0052251239534028,16.142,16.049,39.47,20.84,30.155,-2.036,,14.0595,14.013000000000002,chlorambucil,CHEMBL515,JCKYGMPEJWAADB-UHFFFAOYSA-N,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,C14H19Cl2NO2,DB00291,D00266,chlorambucil,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
311164,88,15,28,uM,uM,18.924420561992,-7.94231865554597,13.8054485480301,17.892197900863,0.186033682243995,2.0,29.019,-5.891,51.844,61.153,56.4985,33.3705,,44.9345,27.4795,mitoxantrone,CHEMBL58,KKZJGLLVHKMTCM-UHFFFAOYSA-N,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,C22H28N4O6,DB01204,D08224,mitoxantrone,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
311168,88,15,7,uM,uM,6.06707873798688,-3.14161880653421,10.8292602017973,8.48742561408448,0.0309080476193319,0.345667582216306,46.022,8.249,61.348,57.581,59.4645,5.1935,,32.329,13.442500000000004,mitoxantrone,CHEMBL58,KKZJGLLVHKMTCM-UHFFFAOYSA-N,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,C22H28N4O6,DB01204,D08224,mitoxantrone,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,A549,C3512,Lung (Carcinoma),Lung adenocarcinoma
311188,88,15,38,uM,uM,9.02369828574077,-4.04133045717766,9.09770464624178,10.0722659901994,0.0616476966214236,0.318719508699081,26.212,-0.743,41.241,41.729,41.485,16.016,,28.7505,15.273,mitoxantrone,CHEMBL58,KKZJGLLVHKMTCM-UHFFFAOYSA-N,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,C22H28N4O6,DB01204,D08224,mitoxantrone,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
311259,72,88,38,uM,uM,6.74775471890591,10.7500230269387,11.5828955445539,7.84912434908381,10.0,0.0616241163046935,5.994,26.212,50.902,48.973,49.9375,17.7315,,33.8345,23.7255,Gefitinib,CHEMBL939,XGALLCVXEZPNRQ-UHFFFAOYSA-N,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,C22H24ClFN4O3,DB00317,D01977,gefitinib,mitoxantrone,CHEMBL58,KKZJGLLVHKMTCM-UHFFFAOYSA-N,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,C22H28N4O6,DB01204,D08224,mitoxantrone,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
311269,72,88,28,uM,uM,12.2897263381656,3.51862644965698,15.9910972516834,11.1662833012092,4.63606799908028,0.186079301414974,10.57,29.018,85.094,53.238,69.166,29.578,,49.372,40.148,Gefitinib,CHEMBL939,XGALLCVXEZPNRQ-UHFFFAOYSA-N,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,C22H24ClFN4O3,DB00317,D01977,gefitinib,mitoxantrone,CHEMBL58,KKZJGLLVHKMTCM-UHFFFAOYSA-N,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,C22H28N4O6,DB01204,D08224,mitoxantrone,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
311281,72,88,7,uM,uM,9.33326415455502,5.68479982656473,14.7948399889984,8.62361260805071,1.19272204952941,0.0309068635142965,22.807,46.021,66.18,68.358,67.269,-1.559,,32.855000000000004,21.248000000000005,Gefitinib,CHEMBL939,XGALLCVXEZPNRQ-UHFFFAOYSA-N,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,C22H24ClFN4O3,DB00317,D01977,gefitinib,mitoxantrone,CHEMBL58,KKZJGLLVHKMTCM-UHFFFAOYSA-N,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,C22H28N4O6,DB01204,D08224,mitoxantrone,A549,C3512,Lung (Carcinoma),Lung adenocarcinoma
311931,116,29,28,uM,uM,1.35620788493067,0.958396499346611,3.03787135227816,0.775944555706016,0.647196610526164,5.002041638138,33.59,8.418,61.254,49.995,55.6245,13.6165,,34.62049999999999,22.0345,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
311935,116,29,7,uM,uM,0.413960100894776,-2.88584801028377,-0.75388693494556,0.941785992933031,5.0,1.92472891821803,-2.354,24.143,41.073,33.281,37.177,15.388,,26.2825,13.034,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,A549,C3512,Lung (Carcinoma),Lung adenocarcinoma
311957,116,29,38,uM,uM,-3.84952757958637,-17.1102446188128,-2.67823046298646,-1.65172882276135,4.75243603628729,2.01775289851193,-1.244,24.125,16.832,21.935,19.3835,-3.4975,,7.943000000000001,-4.741499999999999,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
312141,79,29,38,uM,uM,-0.692339069648719,-17.8084008309607,1.06671143624539,-0.630023926366194,30.0,2.01775289851193,2.987,24.125,12.661,8.688,10.6745,-16.4375,,-2.881500000000001,-13.4505,Lenalidomide,CHEMBL848,GOTYRUGSSMKFNF-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,C13H13N3O3,DB00480,D04687,lenalidomide,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
312167,79,29,28,uM,uM,1.9216134026143,-5.62537048267244,0.847768451451749,1.36970919256966,30.0,5.002041638138,4.019,8.418,50.759,12.05,31.4045,18.9675,,25.186,22.9865,Lenalidomide,CHEMBL848,GOTYRUGSSMKFNF-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,C13H13N3O3,DB00480,D04687,lenalidomide,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
312348,115,29,28,uM,uM,-1.73463830041666,-3.85250883940554,-2.40329030222483,-0.524854727997191,0.987963832062323,5.002041638138,-1.287,8.418,37.891,25.165,31.528,24.397,,27.9625,23.11,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
312360,115,29,7,uM,uM,-4.37519670613779,-7.92760206779328,-0.0127275765000787,-1.22124126740866,0.362777838678078,1.92472891821803,10.315,24.143,39.511,13.341,26.426,-8.032,,9.197,2.2829999999999977,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,A549,C3512,Lung (Carcinoma),Lung adenocarcinoma
312374,115,29,38,uM,uM,-10.1156782064616,-14.9518214985388,-6.61496929625582,-7.50854533667487,0.230610312300154,2.01775289851193,4.437,24.125,5.754,7.465,6.6095,-21.9525,,-7.671500000000001,-17.5155,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
312631,120,29,28,uM,uM,-3.94968170850854,-4.23430460662834,-3.67217919111372,-0.986747684988164,13.2475908300401,5.002041638138,-2.739,8.418,57.069,25.146,41.1075,35.4285,,38.268,32.6895,Vismodegib,CHEMBL473417,BPQMGSKTAYIVFO-UHFFFAOYSA-N,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,C19H14Cl2N2O3S,DB08828,D09992,vismodegib,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
312641,120,29,38,uM,uM,-9.13119377819207,-13.3971045886415,-1.42559220288943,-1.67560424042383,3.86072665158335,2.01775289851193,4.58,24.125,15.504,26.151,20.8275,-7.8775,,6.475000000000001,-3.2974999999999994,Vismodegib,CHEMBL473417,BPQMGSKTAYIVFO-UHFFFAOYSA-N,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,C19H14Cl2N2O3S,DB08828,D09992,vismodegib,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
312686,56,29,38,uM,uM,-7.15768416492405,-8.10107481265347,-4.80070331400053,-4.98802638949432,0.134169130800938,2.01775289851193,4.756,24.125,25.4,20.19,22.795,-6.086,,8.354500000000002,-1.3299999999999983,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
312696,56,29,7,uM,uM,-5.31459523456624,-3.64336555641908,-2.90473225294251,-3.1767007508737,0.497567802644297,1.92472891821803,4.613,24.143,4.26,30.654,17.457,-11.299,,3.0790000000000006,-6.686,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,A549,C3512,Lung (Carcinoma),Lung adenocarcinoma
312708,56,29,28,uM,uM,-5.69731717431721,-5.08958366529353,-3.26620751115728,-1.96936244472161,0.479317498262319,5.002041638138,-0.542,8.418,52.274,21.161,36.7175,28.8415,,32.7795,28.2995,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
312886,115,88,28,uM,uM,21.4209871099925,4.61921510402385,20.0280810445226,19.8142230286142,0.987963832062323,0.186079301414974,-1.287,29.018,76.939,57.782,67.3605,39.6295,,53.495000000000005,38.3425,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,mitoxantrone,CHEMBL58,KKZJGLLVHKMTCM-UHFFFAOYSA-N,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,C22H28N4O6,DB01204,D08224,mitoxantrone,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
312898,115,88,7,uM,uM,6.25418933821527,-3.93211576241182,9.58497210001706,6.71217494095423,0.362777838678078,0.0309068635142965,10.315,46.021,48.994,65.445,57.2195,0.883499999999998,,29.0515,11.198499999999996,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,mitoxantrone,CHEMBL58,KKZJGLLVHKMTCM-UHFFFAOYSA-N,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,C22H28N4O6,DB01204,D08224,mitoxantrone,A549,C3512,Lung (Carcinoma),Lung adenocarcinoma
312912,115,88,38,uM,uM,7.03683815216842,-2.35328996861608,10.3844348929487,8.53895141191973,0.230610312300154,0.0616241163046935,4.437,26.212,50.069,33.815,41.942,11.293,,26.6175,15.73,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,mitoxantrone,CHEMBL58,KKZJGLLVHKMTCM-UHFFFAOYSA-N,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,C22H28N4O6,DB01204,D08224,mitoxantrone,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
313039,101,29,38,uM,uM,-4.99177578518067,-9.60153109645805,-3.08903664733387,-2.61124244859547,4.38962339087133,2.01775289851193,-0.959,24.125,17.173,21.914,19.5435,-3.6225,,7.9605000000000015,-4.581499999999998,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
313049,101,29,28,uM,uM,-2.89855965651423,-22.1585486638316,-6.94794828496397,-2.87202645556175,0.171867099886755,5.002041638138,-5.115,8.418,24.449,15.538,19.9935,16.6905,,18.342,11.575500000000002,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
313053,101,29,7,uM,uM,-3.18242139721319,-13.9643010194104,-2.93666471272333,-2.98857267033651,3.22123167658349,1.92472891821803,2.342,24.143,44.26,15.686,29.973,3.488,,16.7305,5.829999999999998,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,A549,C3512,Lung (Carcinoma),Lung adenocarcinoma
313089,56,88,38,uM,uM,2.11414627318514,-4.17546601471862,7.15324987779485,5.66321642520666,0.134169130800938,0.0616241163046935,4.756,26.212,51.22,32.464,41.842,10.874,,26.358,15.63,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,mitoxantrone,CHEMBL58,KKZJGLLVHKMTCM-UHFFFAOYSA-N,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,C22H28N4O6,DB01204,D08224,mitoxantrone,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
313107,56,88,7,uM,uM,3.35397565652822,-3.94329671269952,7.23213876668374,4.95364909631546,0.497567802644297,0.0309068635142965,4.613,46.021,53.485,66.737,60.111,9.477,,34.794,14.089999999999996,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,mitoxantrone,CHEMBL58,KKZJGLLVHKMTCM-UHFFFAOYSA-N,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,C22H28N4O6,DB01204,D08224,mitoxantrone,A549,C3512,Lung (Carcinoma),Lung adenocarcinoma
313111,56,88,28,uM,uM,21.775291155554,13.6041225081286,18.0403032667448,17.2867652619003,0.479317498262319,0.186079301414974,-0.542,29.018,77.844,51.64,64.742,36.266,,50.504000000000005,35.724000000000004,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,mitoxantrone,CHEMBL58,KKZJGLLVHKMTCM-UHFFFAOYSA-N,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,C22H28N4O6,DB01204,D08224,mitoxantrone,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
313218,120,88,28,uM,uM,17.6380648469871,-15.4230995079098,13.6069699334115,14.1562656829215,13.2475908300401,0.186079301414974,-2.739,29.018,74.415,48.043,61.229,34.95,,48.0895,32.211,Vismodegib,CHEMBL473417,BPQMGSKTAYIVFO-UHFFFAOYSA-N,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,C19H14Cl2N2O3S,DB08828,D09992,vismodegib,mitoxantrone,CHEMBL58,KKZJGLLVHKMTCM-UHFFFAOYSA-N,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,C22H28N4O6,DB01204,D08224,mitoxantrone,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
313228,120,88,38,uM,uM,12.3147728470668,-2.06839118767846,13.7259165444615,12.2888777090789,3.86072665158335,0.0616241163046935,4.58,26.212,52.542,38.957,45.7495,14.9575,,30.3535,19.5375,Vismodegib,CHEMBL473417,BPQMGSKTAYIVFO-UHFFFAOYSA-N,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,C19H14Cl2N2O3S,DB08828,D09992,vismodegib,mitoxantrone,CHEMBL58,KKZJGLLVHKMTCM-UHFFFAOYSA-N,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,C22H28N4O6,DB01204,D08224,mitoxantrone,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
313781,72,5,28,uM,uM,-1.87803114603415,0.938887093395556,0.805646949359935,1.90713179327204,4.63606799908028,0.0022673877798144,10.57,-2.49,21.525,41.705,31.615,23.535,,27.575,21.045,Gefitinib,CHEMBL939,XGALLCVXEZPNRQ-UHFFFAOYSA-N,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,C22H24ClFN4O3,DB00317,D01977,gefitinib,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
313787,72,5,38,uM,uM,-3.17566482700611,-0.482164702153908,-0.972884785303194,-0.625814634758759,10.0,0.0025947544914729,5.994,-0.608,2.203,14.027,8.115,2.729,,5.422000000000001,2.1210000000000004,Gefitinib,CHEMBL939,XGALLCVXEZPNRQ-UHFFFAOYSA-N,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,C22H24ClFN4O3,DB00317,D01977,gefitinib,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
313925,101,88,38,uM,uM,6.61722616499855,-9.01798516062436,6.34230543335041,6.53044921630929,4.38962339087133,0.0616241163046935,-0.959,26.212,47.618,34.124,40.871,15.618,,28.2445,14.659000000000002,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,mitoxantrone,CHEMBL58,KKZJGLLVHKMTCM-UHFFFAOYSA-N,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,C22H28N4O6,DB01204,D08224,mitoxantrone,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
313935,101,88,28,uM,uM,6.74834995062992,-22.6350080802784,0.702112741464879,4.51635465360618,0.171867099886755,0.186079301414974,-5.115,29.018,65.941,30.586,48.2635,24.3605,,36.312,19.2455,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,mitoxantrone,CHEMBL58,KKZJGLLVHKMTCM-UHFFFAOYSA-N,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,C22H28N4O6,DB01204,D08224,mitoxantrone,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
313939,101,88,7,uM,uM,-0.684655923928049,-14.0072503946682,1.0691943222393,-0.522602360580169,3.22123167658349,0.0309068635142965,2.342,46.021,33.183,49.521,41.352,-7.011,,17.170499999999997,-4.669000000000004,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,mitoxantrone,CHEMBL58,KKZJGLLVHKMTCM-UHFFFAOYSA-N,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,C22H28N4O6,DB01204,D08224,mitoxantrone,A549,C3512,Lung (Carcinoma),Lung adenocarcinoma
314064,116,88,28,uM,uM,6.50923441977459,10.6925463331177,11.5758432695188,6.71795431869365,0.647196610526164,0.186079301414974,33.59,29.018,73.307,46.552,59.9295,-2.6785,,28.625499999999995,26.3395,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,mitoxantrone,CHEMBL58,KKZJGLLVHKMTCM-UHFFFAOYSA-N,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,C22H28N4O6,DB01204,D08224,mitoxantrone,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
314068,116,88,7,uM,uM,6.64153812340259,-4.44210793826244,4.70930543335041,5.15702917331198,5.0,0.0309068635142965,-2.354,46.021,45.784,56.716,51.25,7.583,,29.4165,5.228999999999999,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,mitoxantrone,CHEMBL58,KKZJGLLVHKMTCM-UHFFFAOYSA-N,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,C22H28N4O6,DB01204,D08224,mitoxantrone,A549,C3512,Lung (Carcinoma),Lung adenocarcinoma
314090,116,88,38,uM,uM,11.0095674558773,-12.0501058158193,11.0004460747982,11.9780956967467,4.75243603628729,0.0616241163046935,-1.244,26.212,47.402,42.127,44.7645,19.7965,,32.2805,18.5525,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,mitoxantrone,CHEMBL58,KKZJGLLVHKMTCM-UHFFFAOYSA-N,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,C22H28N4O6,DB01204,D08224,mitoxantrone,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
314163,79,88,38,uM,uM,-0.618361942761166,-16.0704093337793,0.179228877887277,-1.73225089586387,30.0,0.0616241163046935,2.987,26.212,37.836,27.562,32.699,3.5,,18.0995,6.486999999999998,Lenalidomide,CHEMBL848,GOTYRUGSSMKFNF-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,C13H13N3O3,DB00480,D04687,lenalidomide,mitoxantrone,CHEMBL58,KKZJGLLVHKMTCM-UHFFFAOYSA-N,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,C22H28N4O6,DB01204,D08224,mitoxantrone,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
314173,79,88,28,uM,uM,-2.1568803080903,-37.2736321228959,-1.97709327359649,-5.25064335139162,30.0,0.186079301414974,4.019,29.018,62.975,18.347,40.661,7.624,,24.1425,11.643,Lenalidomide,CHEMBL848,GOTYRUGSSMKFNF-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,C13H13N3O3,DB00480,D04687,lenalidomide,mitoxantrone,CHEMBL58,KKZJGLLVHKMTCM-UHFFFAOYSA-N,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,C22H28N4O6,DB01204,D08224,mitoxantrone,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
315581,72,29,38,uM,uM,-3.00304130912449,1.39231623217731,2.70909377216963,0.417617872247722,10.0,2.01775289851193,5.994,24.125,37.569,26.732,32.1505,2.0315,,17.091,8.025500000000001,Gefitinib,CHEMBL939,XGALLCVXEZPNRQ-UHFFFAOYSA-N,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,C22H24ClFN4O3,DB00317,D01977,gefitinib,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
315591,72,29,28,uM,uM,5.5156073628981,8.15538989168542,7.65699067367398,6.27481778209577,4.63606799908028,5.002041638138,10.57,8.418,76.609,61.134,68.8715,49.8835,,59.3775,58.3015,Gefitinib,CHEMBL939,XGALLCVXEZPNRQ-UHFFFAOYSA-N,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,C22H24ClFN4O3,DB00317,D01977,gefitinib,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
315603,72,29,7,uM,uM,-0.603476364123276,-1.35160799744763,0.516982661058509,-2.06834421792065,1.19272204952941,1.92472891821803,22.807,24.143,22.649,43.267,32.958,-13.992,,9.482999999999995,8.814999999999998,Gefitinib,CHEMBL939,XGALLCVXEZPNRQ-UHFFFAOYSA-N,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,C22H24ClFN4O3,DB00317,D01977,gefitinib,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,A549,C3512,Lung (Carcinoma),Lung adenocarcinoma
315909,101,5,28,uM,uM,2.74099863755099,-9.65435672217135,-5.5937163693712,-0.0863854543309371,0.171867099886755,0.0022673877798144,-5.115,-2.49,-0.328,-5.759,-3.0435,4.5615,,0.7590000000000003,-0.5534999999999997,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
315915,101,5,38,uM,uM,-0.149515451955326,1.98412613077247,2.6907672241498,4.29766489913338,4.38962339087133,0.0025947544914729,-0.959,-0.608,1.745,7.416,4.5805,6.1475,,5.364,5.1885,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
316083,56,5,28,uM,uM,-1.03615083974212,2.41058524727241,4.57382914352888,7.33188154285203,0.479317498262319,0.0022673877798144,-0.542,-2.49,16.589,12.469,14.529,17.561,,16.045,15.071,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
316093,56,5,38,uM,uM,-1.56560276142012,-1.70891350317227,-1.195841745635,0.224967552475212,0.134169130800938,0.0025947544914729,4.756,-0.608,-2.043,-3.181,-2.612,-6.76,,-4.686,-7.368,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
316143,120,5,38,uM,uM,0.171939301347318,3.37430702341149,3.91026936547611,5.17542688079195,3.86072665158335,0.0025947544914729,4.58,-0.608,8.207,16.006,12.1065,8.1345,,10.1205,7.5265,Vismodegib,CHEMBL473417,BPQMGSKTAYIVFO-UHFFFAOYSA-N,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,C19H14Cl2N2O3S,DB08828,D09992,vismodegib,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
316149,120,5,28,uM,uM,4.11436117224996,1.67917555980366,4.2051561130387,8.29052927498438,13.2475908300401,0.0022673877798144,-2.739,-2.49,27.662,14.148,20.905,26.134,,23.5195,23.395000000000003,Vismodegib,CHEMBL473417,BPQMGSKTAYIVFO-UHFFFAOYSA-N,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,C19H14Cl2N2O3S,DB08828,D09992,vismodegib,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
316261,108,100,28,uM,uM,-0.362887702707864,-30.4604951618726,-3.73141045032761,-3.0002923542149,1.31560298651524,0.0059496376741413,33.09,14.231,87.816,47.2,67.508,20.187,,43.8475,34.41799999999999,6-Thioguanine,CHEMBL727,WYWHKKSPHMUBEB-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=C(N2)N,C5H5N5S,DB00352,D08603,thioguanine,Romidepsin,CHEMBL343448,OHRURASPPZQGQM-GCCNXGTGSA-N,CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C,C24H36N4O6S2,,D06637,romidepsin,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
316267,108,100,38,uM,uM,0.308405447151734,-1.69812403240886,3.66149464572214,-0.742251079184051,1.45049066398121,0.0011836233021096,28.889,21.417,44.0,56.861,50.4305,0.124499999999998,,25.277500000000003,21.541500000000003,6-Thioguanine,CHEMBL727,WYWHKKSPHMUBEB-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=C(N2)N,C5H5N5S,DB00352,D08603,thioguanine,Romidepsin,CHEMBL343448,OHRURASPPZQGQM-GCCNXGTGSA-N,CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C,C24H36N4O6S2,,D06637,romidepsin,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
316289,115,5,38,uM,uM,-1.76939796755099,0.994486526529258,1.3910337570779,2.42351977918828,0.230610312300154,0.0025947544914729,4.437,-0.608,8.331,1.349,4.84,1.011,,2.9254999999999995,0.4029999999999996,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
316310,115,5,28,uM,uM,1.60385531715816,-1.0894426865844,1.31104500192759,4.46495407623266,0.987963832062323,0.0022673877798144,-1.287,-2.49,10.044,12.489,11.2665,15.0435,,13.155,12.5535,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
316404,53,100,28,uM,uM,-4.57449928058698,-35.6392485010603,0.660016372490983,0.868363812837635,13.0779438627311,0.0059496376741413,16.142,14.231,76.968,25.318,51.143,20.77,,35.956500000000005,35.001000000000005,chlorambucil,CHEMBL515,JCKYGMPEJWAADB-UHFFFAOYSA-N,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,C14H19Cl2NO2,DB00291,D00266,chlorambucil,Romidepsin,CHEMBL343448,OHRURASPPZQGQM-GCCNXGTGSA-N,CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C,C24H36N4O6S2,,D06637,romidepsin,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
316410,53,100,38,uM,uM,5.51044939567117,1.89517229698398,6.22371686794435,2.75973331136409,20.7438362933702,0.0011836233021096,18.749,21.417,35.07,58.758,46.914,6.748,,26.831000000000003,25.497,chlorambucil,CHEMBL515,JCKYGMPEJWAADB-UHFFFAOYSA-N,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,C14H19Cl2NO2,DB00291,D00266,chlorambucil,Romidepsin,CHEMBL343448,OHRURASPPZQGQM-GCCNXGTGSA-N,CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C,C24H36N4O6S2,,D06637,romidepsin,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
316548,79,5,28,uM,uM,4.2229906999206,-0.71653991380557,-1.53390860619563,-0.37904519266208,30.0,0.0022673877798144,4.019,-2.49,0.492,3.707,2.0995,0.5705,,1.335,-1.9195,Lenalidomide,CHEMBL848,GOTYRUGSSMKFNF-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,C13H13N3O3,DB00480,D04687,lenalidomide,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
316569,79,5,38,uM,uM,-0.783912826287449,0.368122539313767,-0.469995896414312,-0.106042768595324,30.0,0.0025947544914729,2.987,-0.608,2.552,2.952,2.752,0.373,,1.5624999999999998,-0.2350000000000003,Lenalidomide,CHEMBL848,GOTYRUGSSMKFNF-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,C13H13N3O3,DB00480,D04687,lenalidomide,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
316747,88,28,28,uM,uM,-0.483113453106559,-5.32816645600436,5.38951415868266,2.84907617513505,0.186033682243995,0.0052251239534028,29.019,16.049,41.09,46.975,44.0325,-1.0355,,21.4985,15.0135,mitoxantrone,CHEMBL58,KKZJGLLVHKMTCM-UHFFFAOYSA-N,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,C22H28N4O6,DB01204,D08224,mitoxantrone,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
316771,88,28,38,uM,uM,-6.52759575141162,-0.622970301968338,2.05547058779072,-2.41935599115213,0.0616476966214236,0.0037555079071878,26.212,17.17,31.965,38.233,35.099,-8.28300000000001,,13.407999999999994,8.886999999999997,mitoxantrone,CHEMBL58,KKZJGLLVHKMTCM-UHFFFAOYSA-N,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,C22H28N4O6,DB01204,D08224,mitoxantrone,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
316806,116,5,38,uM,uM,0.920443637781222,-0.0580951467529413,0.723378509299764,2.33094144623751,4.75243603628729,0.0025947544914729,-1.244,-0.608,0.356,3.136,1.746,3.598,,2.672,2.354,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
316827,116,5,28,uM,uM,4.96776531434358,4.50477681258488,4.57576020179734,5.73175625520097,0.647196610526164,0.0022673877798144,33.59,-2.49,40.736,40.799,40.7675,9.6675,,25.2175,7.177499999999995,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
316874,40,100,28,uM,uM,1.41350510443895,-68.6520490541433,-3.42299836964621,0.717567323946547,75.0,0.0059496376741413,-6.521,14.231,68.029,8.903,38.466,30.756,,34.611000000000004,24.235,altretamine,CHEMBL1455,UUVWYPNAQBNQJQ-UHFFFAOYSA-N,CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C,C9H18N6,DB00488,D02841,altretamine,Romidepsin,CHEMBL343448,OHRURASPPZQGQM-GCCNXGTGSA-N,CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C,C24H36N4O6S2,,D06637,romidepsin,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
316880,40,100,38,uM,uM,3.17694038695231,-42.6458796744561,-0.913220591868432,1.62375975170458,75.0,0.0011836233021096,-3.362,21.417,-3.166,32.83,14.832,-3.223,,5.804500000000001,-6.585000000000001,altretamine,CHEMBL1455,UUVWYPNAQBNQJQ-UHFFFAOYSA-N,CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C,C9H18N6,DB00488,D02841,altretamine,Romidepsin,CHEMBL343448,OHRURASPPZQGQM-GCCNXGTGSA-N,CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C,C24H36N4O6S2,,D06637,romidepsin,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
317199,1,100,38,uM,uM,4.50946602598714,4.93234629969458,8.86453821661408,3.56761281631385,4.93954994547436,0.0011836233021096,31.568,21.417,42.317,31.887,37.102,-15.883,,10.609499999999995,5.533999999999995,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,Romidepsin,CHEMBL343448,OHRURASPPZQGQM-GCCNXGTGSA-N,CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C,C24H36N4O6S2,,D06637,romidepsin,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
317205,1,100,28,uM,uM,-0.0610477807007723,-4.27418718317869,-3.46757289449703,-3.93306336937667,3.70539648442761,0.0059496376741413,52.846,14.231,91.453,49.828,70.6405,3.5635,,37.102,17.794500000000006,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,Romidepsin,CHEMBL343448,OHRURASPPZQGQM-GCCNXGTGSA-N,CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C,C24H36N4O6S2,,D06637,romidepsin,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
318034,1,15,38,uM,uM,6.2666234067946,3.93118674740915,5.4140041035857,5.88465659863087,4.93954994547436,0.318719508699081,31.568,-0.743,36.219,28.137,32.178,1.35299999999999,,16.765499999999996,0.6099999999999959,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
318379,53,15,28,uM,uM,-4.91953018688746,-4.85297900169388,-3.4860223288531,1.2782355042442,13.0779438627311,2.0,16.142,-5.891,9.109,17.133,13.121,2.87,,7.995500000000001,-3.020999999999999,chlorambucil,CHEMBL515,JCKYGMPEJWAADB-UHFFFAOYSA-N,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,C14H19Cl2NO2,DB00291,D00266,chlorambucil,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
318389,53,15,38,uM,uM,3.52350355962476,1.77187494019509,2.27748242401956,3.3459136203478,20.7438362933702,0.318719508699081,18.749,-0.743,21.435,40.264,30.8495,12.8435,,21.8465,12.1005,chlorambucil,CHEMBL515,JCKYGMPEJWAADB-UHFFFAOYSA-N,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,C14H19Cl2NO2,DB00291,D00266,chlorambucil,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
318527,108,15,28,uM,uM,0.0112004900913098,-18.4797612030722,0.895426868464008,4.72245649143432,1.31560298651524,2.0,33.09,-5.891,39.469,16.762,28.1155,0.916499999999996,,14.515999999999998,-4.974500000000003,6-Thioguanine,CHEMBL727,WYWHKKSPHMUBEB-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=C(N2)N,C5H5N5S,DB00352,D08603,thioguanine,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
318537,108,15,38,uM,uM,1.22786168897832,-6.21429407250689,0.755371312908443,1.67565089868852,1.45049066398121,0.318719508699081,28.889,-0.743,32.306,38.624,35.465,7.319,,21.392000000000003,6.576000000000004,6-Thioguanine,CHEMBL727,WYWHKKSPHMUBEB-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=C(N2)N,C5H5N5S,DB00352,D08603,thioguanine,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
318732,40,15,28,uM,uM,6.63214904947828,0.929438325877773,1.86575193368649,8.81451528237352,75.0,2.0,-6.521,-5.891,0.544,6.781,3.6625,16.0745,,9.8685,9.5535,altretamine,CHEMBL1455,UUVWYPNAQBNQJQ-UHFFFAOYSA-N,CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C,C9H18N6,DB00488,D02841,altretamine,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
318742,40,15,38,uM,uM,1.88537473157767,-1.20872226851858,1.27239337794837,5.45086906846606,75.0,0.318719508699081,-3.362,-0.743,-2.021,5.241,1.61,5.715,,3.662500000000001,2.353,altretamine,CHEMBL1455,UUVWYPNAQBNQJQ-UHFFFAOYSA-N,CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C,C9H18N6,DB00488,D02841,altretamine,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
319531,79,56,28,uM,uM,-2.4662165429857,-3.88661242590199,-0.373017338941478,0.0285668590229184,30.0,0.492426793413144,4.019,-0.277,12.764,4.354,8.559,4.817,,6.687999999999999,4.539999999999999,Lenalidomide,CHEMBL848,GOTYRUGSSMKFNF-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,C13H13N3O3,DB00480,D04687,lenalidomide,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
319553,79,56,38,uM,uM,-3.46826985901948,-12.7788880768905,-7.74318400560815,-7.60675302761346,30.0,0.134148025266936,2.987,4.756,-2.221,-3.723,-2.972,-10.715,,-6.843500000000001,-7.728,Lenalidomide,CHEMBL848,GOTYRUGSSMKFNF-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,C13H13N3O3,DB00480,D04687,lenalidomide,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
319801,116,56,38,uM,uM,-1.72101059249703,-1.31374240385499,-1.14677112211271,0.735553863608264,4.75243603628729,0.134148025266936,-1.244,4.756,4.061,2.431,3.246,-0.266,,1.4899999999999998,-1.5100000000000002,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
319811,116,56,7,uM,uM,-1.62684827132953,-7.63342426309369,-1.03020871791881,1.51402285233701,5.0,0.496670532651513,-2.354,4.612,29.039,14.619,21.829,19.571,,20.7,17.217,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,A549,C3512,Lung (Carcinoma),Lung adenocarcinoma
319823,116,56,28,uM,uM,3.35660261184764,-1.83629344803771,3.23798242401954,2.98455484577484,0.647196610526164,0.492426793413144,33.59,-0.277,46.976,49.587,48.2815,14.9685,,31.625,14.691499999999998,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
319900,120,56,38,uM,uM,-3.20011231438071,-1.27867546144362,2.76550448905947,3.03234750094047,3.86072665158335,0.134148025266936,4.58,4.756,7.325,11.542,9.4335,0.0975000000000001,,4.7655,4.6775,Vismodegib,CHEMBL473417,BPQMGSKTAYIVFO-UHFFFAOYSA-N,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,C19H14Cl2N2O3S,DB08828,D09992,vismodegib,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
319906,120,56,28,uM,uM,3.963985445137,-2.696937624507,1.15901350430344,4.01175996805826,13.2475908300401,0.492426793413144,-2.739,-0.277,22.613,24.629,23.621,26.637,,25.129,23.898,Vismodegib,CHEMBL473417,BPQMGSKTAYIVFO-UHFFFAOYSA-N,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,C19H14Cl2N2O3S,DB08828,D09992,vismodegib,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
320275,115,56,38,uM,uM,-2.53197687776881,-0.619362370326819,1.63877242349992,1.7461646607257,0.230610312300154,0.134148025266936,4.437,4.756,2.842,2.012,2.427,-6.766,,-2.1695000000000007,-2.329,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
320293,115,56,7,uM,uM,-2.57523304375134,3.80879507850369,5.28335534278656,3.93421328664595,0.362777838678078,0.496670532651513,10.315,4.612,38.586,26.105,32.3455,17.4185,,24.882,22.030500000000004,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,A549,C3512,Lung (Carcinoma),Lung adenocarcinoma
320297,115,56,28,uM,uM,-1.53533985926118,1.92412957807397,2.23562461541454,4.25023356125098,0.987963832062323,0.492426793413144,-1.287,-0.277,17.978,17.457,17.7175,19.2815,,18.4995,17.994500000000002,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
320669,101,56,7,uM,uM,-2.78765666920651,-3.47346573383405,2.33111477207721,2.29998131844488,3.22123167658349,0.496670532651513,2.342,4.612,38.731,15.986,27.3585,20.4045,,23.8815,22.7465,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,A549,C3512,Lung (Carcinoma),Lung adenocarcinoma
320673,101,56,28,uM,uM,0.856853481624527,-8.74941987729088,-1.65884368764316,3.53913449624294,0.171867099886755,0.492426793413144,-5.115,-0.277,5.619,0.054,2.8365,8.2285,,5.532500000000001,3.1135,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
320679,101,56,38,uM,uM,-2.01193617999422,-5.49831611450075,-1.45127328871831,0.0300619456708159,4.38962339087133,0.134148025266936,-0.959,4.756,-0.567,7.868,3.6505,-0.1465,,1.752,-1.1055,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
321799,72,56,28,uM,uM,2.60607800741728,3.97356397611361,3.45795860312712,3.5510499366237,4.63606799908028,0.492426793413144,10.57,-0.277,17.236,34.039,25.6375,15.3445,,20.491,15.0675,Gefitinib,CHEMBL939,XGALLCVXEZPNRQ-UHFFFAOYSA-N,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,C22H24ClFN4O3,DB00317,D01977,gefitinib,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
321803,72,56,7,uM,uM,-6.99102872778478,1.60015016736918,2.02212526979377,-1.58738470459092,1.19272204952941,0.496670532651513,22.807,4.612,39.094,28.716,33.905,6.486,,20.195500000000003,11.098000000000004,Gefitinib,CHEMBL939,XGALLCVXEZPNRQ-UHFFFAOYSA-N,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,C22H24ClFN4O3,DB00317,D01977,gefitinib,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,A549,C3512,Lung (Carcinoma),Lung adenocarcinoma
321821,72,56,38,uM,uM,-3.35075038011368,-1.85650338925763,-1.42040622783037,-2.593261254888,10.0,0.134148025266936,5.994,4.756,7.247,15.65,11.4485,0.698499999999999,,6.073499999999999,5.4545,Gefitinib,CHEMBL939,XGALLCVXEZPNRQ-UHFFFAOYSA-N,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,C22H24ClFN4O3,DB00317,D01977,gefitinib,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
322338,88,100,28,uM,uM,2.66652426755816,-31.2894364167237,2.35076043883628,2.05532995465824,0.186033682243995,0.0059496376741413,29.019,14.231,95.401,56.368,75.8845,32.6345,,54.2595,46.8655,mitoxantrone,CHEMBL58,KKZJGLLVHKMTCM-UHFFFAOYSA-N,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,C22H28N4O6,DB01204,D08224,mitoxantrone,Romidepsin,CHEMBL343448,OHRURASPPZQGQM-GCCNXGTGSA-N,CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C,C24H36N4O6S2,,D06637,romidepsin,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
322360,88,100,38,uM,uM,-2.16930111806254,-0.126149835448492,4.73705020127768,0.58413791232684,0.0616476966214236,0.0011836233021096,26.212,21.417,41.009,46.445,43.727,-3.902,,19.912499999999994,17.514999999999997,mitoxantrone,CHEMBL58,KKZJGLLVHKMTCM-UHFFFAOYSA-N,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,C22H28N4O6,DB01204,D08224,mitoxantrone,Romidepsin,CHEMBL343448,OHRURASPPZQGQM-GCCNXGTGSA-N,CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C,C24H36N4O6S2,,D06637,romidepsin,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
322519,101,28,28,uM,uM,-6.44728593032215,-37.7542668616508,-4.64448216248537,-0.105850408333053,0.171867099886755,0.0052251239534028,-5.115,16.049,31.713,12.116,21.9145,10.9805,,16.4475,5.865500000000001,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
322529,101,28,38,uM,uM,-6.7239838938196,-21.5109081028492,1.09000665566505,2.42876223419722,4.38962339087133,0.0037555079071878,-0.959,17.17,4.104,14.909,9.5065,-6.7045,,1.4009999999999998,-7.663500000000001,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
322664,115,28,38,uM,uM,-9.22258021700188,-8.8499433317109,3.17422671128168,2.69684600980768,0.230610312300154,0.0037555079071878,4.437,17.17,17.113,21.456,19.2845,-2.3225,,8.481,2.1145,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
322690,115,28,28,uM,uM,-0.528789953962685,-2.84481855570409,2.17448614057233,3.99406535111943,0.987963832062323,0.0052251239534028,-1.287,16.049,28.312,16.686,22.499,7.737,,15.118,6.449999999999999,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
322868,88,56,38,uM,uM,-6.59737639730315,-13.33365339904,-2.00262868709156,-3.49272056856744,0.0616476966214236,0.134148025266936,26.212,4.756,23.556,28.892,26.224,-4.744,,10.74,0.0120000000000004,mitoxantrone,CHEMBL58,KKZJGLLVHKMTCM-UHFFFAOYSA-N,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,C22H28N4O6,DB01204,D08224,mitoxantrone,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
322890,88,56,7,uM,uM,1.65452680778559,-8.10220392794092,3.07514909068622,0.796569572818356,0.0309080476193319,0.496670532651513,46.022,4.612,58.813,41.949,50.381,-0.253,,25.064,4.359000000000002,mitoxantrone,CHEMBL58,KKZJGLLVHKMTCM-UHFFFAOYSA-N,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,C22H28N4O6,DB01204,D08224,mitoxantrone,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,A549,C3512,Lung (Carcinoma),Lung adenocarcinoma
322894,88,56,28,uM,uM,6.73372652995825,2.43152711103759,6.86962526979379,6.11593626026661,0.186033682243995,0.492426793413144,29.019,-0.277,42.784,48.279,45.5315,16.7895,,31.160500000000003,16.512500000000003,mitoxantrone,CHEMBL58,KKZJGLLVHKMTCM-UHFFFAOYSA-N,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,C22H28N4O6,DB01204,D08224,mitoxantrone,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
322932,56,28,28,uM,uM,-7.15999004864351,-11.1010886769033,-0.887162177607198,0.406285324961033,0.479317498262319,0.0052251239534028,-0.542,16.049,18.758,15.267,17.0125,1.5055,,9.259,0.9634999999999998,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
322954,56,28,38,uM,uM,-3.88745470722489,-14.2201826882097,2.49911560017057,2.51965213753906,0.134169130800938,0.0037555079071878,4.756,17.17,20.374,23.962,22.168,0.241999999999997,,11.204999999999998,4.9979999999999976,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
322995,120,28,38,uM,uM,2.08998311122398,-8.64735853196031,8.11889337794834,8.13299573252244,3.86072665158335,0.0037555079071878,4.58,17.17,29.414,35.884,32.649,10.899,,21.774,15.479,Vismodegib,CHEMBL473417,BPQMGSKTAYIVFO-UHFFFAOYSA-N,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,C19H14Cl2N2O3S,DB08828,D09992,vismodegib,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
323005,120,28,28,uM,uM,-0.121955135592826,-8.27456724374301,2.43331947390566,4.97764126487115,13.2475908300401,0.0052251239534028,-2.739,16.049,45.361,30.223,37.792,24.482,,31.137,21.743,Vismodegib,CHEMBL473417,BPQMGSKTAYIVFO-UHFFFAOYSA-N,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,C19H14Cl2N2O3S,DB08828,D09992,vismodegib,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
323134,116,28,38,uM,uM,1.60054087059551,-4.25294910541451,7.73261776677615,9.86992304241245,4.75243603628729,0.0037555079071878,-1.244,17.17,30.953,36.673,33.813,17.887,,25.85,16.643,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
323159,116,28,28,uM,uM,-0.163725375590878,1.87350866911367,4.65035947667963,2.2945003856433,0.647196610526164,0.0052251239534028,33.59,16.049,46.903,59.361,53.132,3.49299999999999,,28.3125,19.541999999999994,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
323225,88,29,28,uM,uM,8.29273446850524,-3.37847409669909,8.13276845145175,5.99037813951841,0.186033682243995,5.002041638138,29.019,8.418,68.336,68.571,68.4535,31.0165,,49.73500000000001,39.43450000000001,mitoxantrone,CHEMBL58,KKZJGLLVHKMTCM-UHFFFAOYSA-N,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,C22H28N4O6,DB01204,D08224,mitoxantrone,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
323237,88,29,7,uM,uM,5.57042841426991,2.89191425442074,8.8069586031271,5.07026284548457,0.0309080476193319,1.92472891821803,46.022,24.143,62.049,62.83,62.4395,-7.7255,,27.357000000000006,16.417500000000004,mitoxantrone,CHEMBL58,KKZJGLLVHKMTCM-UHFFFAOYSA-N,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,C22H28N4O6,DB01204,D08224,mitoxantrone,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,A549,C3512,Lung (Carcinoma),Lung adenocarcinoma
323247,88,29,38,uM,uM,1.71986598226979,2.81702291169639,5.1248246886828,0.991517242684502,0.0616476966214236,2.01775289851193,26.212,24.125,51.964,54.816,53.39,3.053,,28.2215,27.178,mitoxantrone,CHEMBL58,KKZJGLLVHKMTCM-UHFFFAOYSA-N,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,C22H28N4O6,DB01204,D08224,mitoxantrone,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
323291,79,28,28,uM,uM,-2.6478701655198,-15.8306163151745,3.33976043883628,3.1598294822247,30.0,0.0052251239534028,4.019,16.049,29.471,20.801,25.136,5.068,,15.102,9.087,Lenalidomide,CHEMBL848,GOTYRUGSSMKFNF-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,C13H13N3O3,DB00480,D04687,lenalidomide,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
323300,79,28,38,uM,uM,-9.68746544709623,-19.5760480246493,1.69256221122061,1.53019201091297,30.0,0.0037555079071878,2.987,17.17,17.734,21.747,19.7405,-0.416500000000003,,9.662,2.570499999999999,Lenalidomide,CHEMBL848,GOTYRUGSSMKFNF-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,C13H13N3O3,DB00480,D04687,lenalidomide,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
323646,72,28,28,uM,uM,8.90212298034489,1.22790068367551,12.0409684464644,9.55905235149214,4.63606799908028,0.0052251239534028,10.57,16.049,40.951,53.26,47.1055,20.4865,,33.796,31.0565,Gefitinib,CHEMBL939,XGALLCVXEZPNRQ-UHFFFAOYSA-N,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,C22H24ClFN4O3,DB00317,D01977,gefitinib,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
323656,72,28,38,uM,uM,6.46593880163536,10.3934896595375,12.2697822668372,10.3888413669717,10.0,0.0037555079071878,5.994,17.17,35.892,43.023,39.4575,16.2935,,27.8755,22.2875,Gefitinib,CHEMBL939,XGALLCVXEZPNRQ-UHFFFAOYSA-N,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,C22H24ClFN4O3,DB00317,D01977,gefitinib,7-Ethyl-10-hydroxycamptothecin,CHEMBL837,FJHBVJOVLFPMQE-QFIPXVFZSA-N,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O,C22H20N2O5,DB05482,C11173,SN-38,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
323872,115,15,28,uM,uM,0.842469389172105,-6.39128105705895,-2.46668638397339,3.08632382406961,0.987963832062323,2.0,-1.287,-5.891,2.978,9.349,6.1635,13.3415,,9.7525,7.4505,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
323884,115,15,7,uM,uM,-7.03025173058881,-3.00133611364706,-0.780352902205266,-3.10491041653235,0.362777838678078,0.345667582216306,10.315,8.249,11.741,14.026,12.8835,-5.6805,,3.6015,2.5685,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,A549,C3512,Lung (Carcinoma),Lung adenocarcinoma
323894,115,15,38,uM,uM,-0.411322401149955,-0.265461959142889,2.32102614334631,4.18357454949258,0.230610312300154,0.318719508699081,4.437,-0.743,10.638,4.773,7.7055,4.0115,,5.858499999999999,3.2684999999999995,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
324023,120,15,28,uM,uM,8.73981835690658,0.0233447047129346,0.712860666432353,6.69828735087688,13.2475908300401,2.0,-2.739,-5.891,6.94,2.663,4.8015,13.4315,,9.116499999999998,7.5405,Vismodegib,CHEMBL473417,BPQMGSKTAYIVFO-UHFFFAOYSA-N,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,C19H14Cl2N2O3S,DB08828,D09992,vismodegib,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
324045,120,15,38,uM,uM,-0.965439783488926,0.782909072636834,2.35585947667965,4.6672997902629,3.86072665158335,0.318719508699081,4.58,-0.743,5.578,8.719,7.1485,3.3115,,5.23,2.5685,Vismodegib,CHEMBL473417,BPQMGSKTAYIVFO-UHFFFAOYSA-N,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,C19H14Cl2N2O3S,DB08828,D09992,vismodegib,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
324142,56,15,38,uM,uM,-2.43734153266658,-2.04755162455672,1.18508169890186,3.60686663972395,0.134169130800938,0.318719508699081,4.756,-0.743,4.268,1.523,2.8955,-1.1175,,0.8890000000000002,-1.8605,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
324156,56,15,7,uM,uM,-6.55489807967534,2.77504795935684,3.03123986041871,2.29707866105108,0.497567802644297,0.345667582216306,4.613,8.249,23.092,30.762,26.927,14.065,,20.496,18.678,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,A549,C3512,Lung (Carcinoma),Lung adenocarcinoma
324168,56,15,28,uM,uM,0.473028093721093,-2.90193049892493,1.09675806047105,6.46806057374455,0.479317498262319,2.0,-0.542,-5.891,11.6,14.17,12.885,19.318,,16.1015,13.427,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
324324,101,15,38,uM,uM,0.944359654079993,1.85186365574723,3.40565917106253,5.9572223266599,4.38962339087133,0.318719508699081,-0.959,-0.743,3.561,10.775,7.168,8.87,,8.019,7.911,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
324330,101,15,28,uM,uM,4.84948924336478,-8.39829978580472,-7.54009342203126,-0.969184805382867,0.171867099886755,2.0,-5.115,-5.891,-10.86,-11.962,-11.411,-0.404999999999999,,-5.908,-6.295999999999999,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
324342,101,15,7,uM,uM,-6.38701350049376,-3.61636424434297,-2.87251385942767,-3.99288451806676,3.22123167658349,0.345667582216306,2.342,8.249,16.806,6.358,11.582,0.991,,6.2865,3.333,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,A549,C3512,Lung (Carcinoma),Lung adenocarcinoma
324705,116,15,38,uM,uM,1.08875079609628,-0.116051469269381,0.185716867944371,3.30046889181958,4.75243603628729,0.318719508699081,-1.244,-0.743,0.587,2.722,1.6545,3.6415,,2.648,2.3975,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
324719,116,15,7,uM,uM,-3.93346712167799,-4.22250978947034,-2.16851385942768,-0.465999206396849,5.0,0.345667582216306,-2.354,8.249,6.45,14.182,10.316,4.421,,7.368500000000001,2.067,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,A549,C3512,Lung (Carcinoma),Lung adenocarcinoma
324731,116,15,28,uM,uM,13.6632546568003,-4.14714685832258,10.8582263258079,14.5373715085935,0.647196610526164,2.0,33.59,-5.891,55.422,53.529,54.4755,26.7765,,40.62599999999999,20.8855,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
324790,1,85,28,uM,uM,-6.13038622247641,-3.37398901769538,-1.71901757598045,-6.4649001229745,3.70539648442761,0.343705490270365,52.846,17.466,57.2,44.818,51.009,-19.303,,15.853000000000002,-1.836999999999996,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,6-Mercaptopurine,CHEMBL1425,GLVAUDGFNGKCSF-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=CN2,C5H4N4S,DB01033,D04931,mercaptopurine,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
324812,1,85,38,uM,uM,-7.90534350458019,-3.80470805353802,-1.52615250798399,-8.88576640194987,4.93954994547436,0.268774665714487,31.568,19.202,36.535,28.249,32.392,-18.378,,7.0070000000000014,0.8240000000000016,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,6-Mercaptopurine,CHEMBL1425,GLVAUDGFNGKCSF-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=CN2,C5H4N4S,DB01033,D04931,mercaptopurine,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
324847,40,85,28,uM,uM,-5.57818519114294,-26.0113123689389,-10.7143317029795,-5.60015331854018,75.0,0.343705490270365,-6.521,17.466,3.563,4.712,4.1375,-6.8075,,-1.335,-13.328500000000002,altretamine,CHEMBL1455,UUVWYPNAQBNQJQ-UHFFFAOYSA-N,CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C,C9H18N6,DB00488,D02841,altretamine,6-Mercaptopurine,CHEMBL1425,GLVAUDGFNGKCSF-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=CN2,C5H4N4S,DB01033,D04931,mercaptopurine,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
324873,40,85,38,uM,uM,-8.86721104887092,-33.9877699797673,-4.45288725853509,-1.72903866655914,75.0,0.268774665714487,-3.362,19.202,10.227,16.852,13.5395,-2.3005,,5.6195,-5.662500000000001,altretamine,CHEMBL1455,UUVWYPNAQBNQJQ-UHFFFAOYSA-N,CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C,C9H18N6,DB00488,D02841,altretamine,6-Mercaptopurine,CHEMBL1425,GLVAUDGFNGKCSF-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=CN2,C5H4N4S,DB01033,D04931,mercaptopurine,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
324971,79,15,38,uM,uM,-1.36989470441403,2.30243538015056,2.78737154994741,4.27929640893119,30.0,0.318719508699081,2.987,-0.743,3.339,8.647,5.993,3.749,,4.871,3.006,Lenalidomide,CHEMBL848,GOTYRUGSSMKFNF-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,C13H13N3O3,DB00480,D04687,lenalidomide,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
324992,79,15,28,uM,uM,3.26170123419966,0.419838157898856,-0.749995896414318,4.50171721073042,30.0,2.0,4.019,-5.891,4.758,-4.239,0.2595,2.1315,,1.1955,-3.7595,Lenalidomide,CHEMBL848,GOTYRUGSSMKFNF-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,C13H13N3O3,DB00480,D04687,lenalidomide,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
325056,108,85,28,uM,uM,-6.62360105053297,-9.83684763427226,-1.36454561937012,-1.91754580781272,1.31560298651524,0.343705490270365,33.09,17.466,46.327,53.057,49.692,-0.864000000000004,,24.414,16.601999999999997,6-Thioguanine,CHEMBL727,WYWHKKSPHMUBEB-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=C(N2)N,C5H5N5S,DB00352,D08603,thioguanine,6-Mercaptopurine,CHEMBL1425,GLVAUDGFNGKCSF-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=CN2,C5H4N4S,DB01033,D04931,mercaptopurine,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
325082,108,85,38,uM,uM,-6.2702635210108,-6.89248795171341,-3.98630718998705,-8.98118016411445,1.45049066398121,0.268774665714487,28.889,19.202,33.149,36.149,34.649,-13.442,,10.6035,5.760000000000002,6-Thioguanine,CHEMBL727,WYWHKKSPHMUBEB-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=C(N2)N,C5H5N5S,DB00352,D08603,thioguanine,6-Mercaptopurine,CHEMBL1425,GLVAUDGFNGKCSF-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=CN2,C5H4N4S,DB01033,D04931,mercaptopurine,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
325143,53,85,28,uM,uM,-13.140397526338,-23.0991091288474,-11.0693464658997,-13.2360765454753,13.0779438627311,0.343705490270365,16.142,17.466,9.681,6.646,8.1635,-25.4445,,-8.640500000000001,-9.3025,chlorambucil,CHEMBL515,JCKYGMPEJWAADB-UHFFFAOYSA-N,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,C14H19Cl2NO2,DB00291,D00266,chlorambucil,6-Mercaptopurine,CHEMBL1425,GLVAUDGFNGKCSF-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=CN2,C5H4N4S,DB01033,D04931,mercaptopurine,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
325168,53,85,38,uM,uM,-10.2102281916842,-11.0147800426359,-8.28594979872231,-12.9312293735663,20.7438362933702,0.268774665714487,18.749,19.202,21.646,23.612,22.629,-15.322,,3.653500000000001,3.427,chlorambucil,CHEMBL515,JCKYGMPEJWAADB-UHFFFAOYSA-N,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,C14H19Cl2NO2,DB00291,D00266,chlorambucil,6-Mercaptopurine,CHEMBL1425,GLVAUDGFNGKCSF-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=CN2,C5H4N4S,DB01033,D04931,mercaptopurine,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
325394,72,15,38,uM,uM,-3.77132646443237,1.69886498790087,2.07118082534935,3.06048423721221,10.0,0.318719508699081,5.994,-0.743,8.118,22.713,15.4155,10.1645,,12.79,9.4215,Gefitinib,CHEMBL939,XGALLCVXEZPNRQ-UHFFFAOYSA-N,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,C22H24ClFN4O3,DB00317,D01977,gefitinib,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
325400,72,15,28,uM,uM,-1.01463649334126,3.02699343868781,2.4201152146968,6.83926535499787,4.63606799908028,2.0,10.57,-5.891,22.062,28.959,25.5105,20.8315,,23.171,14.9405,Gefitinib,CHEMBL939,XGALLCVXEZPNRQ-UHFFFAOYSA-N,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,C22H24ClFN4O3,DB00317,D01977,gefitinib,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
325404,72,15,7,uM,uM,-5.00225525549975,0.825776202265543,2.59979193646045,-1.74111567499144,1.19272204952941,0.345667582216306,22.807,8.249,26.684,25.393,26.0385,-5.0175,,10.5105,3.2315000000000005,Gefitinib,CHEMBL939,XGALLCVXEZPNRQ-UHFFFAOYSA-N,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,C22H24ClFN4O3,DB00317,D01977,gefitinib,Lapatinib,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,DB01259,D04024,lapatinib,A549,C3512,Lung (Carcinoma),Lung adenocarcinoma
325768,88,230,28,uM,uM,16.7092554912111,-7.00671229626336,16.0630041035857,16.4165141712489,0.186033682243995,3.10184621638237,29.019,-1.473,54.558,60.449,57.5035,29.9575,,43.730500000000006,28.484500000000004,mitoxantrone,CHEMBL58,KKZJGLLVHKMTCM-UHFFFAOYSA-N,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,C22H28N4O6,DB01204,D08224,mitoxantrone,Imatinib,CHEMBL941,KTUFNOKKBVMGRW-UHFFFAOYSA-N,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,C29H31N7O,DB00619,D01441,imatinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
325772,88,230,7,uM,uM,10.726704839481,-22.0264625906737,8.21244854803014,9.82026115898468,0.0309080476193319,0.0077012621661591,46.022,-3.445,47.293,54.192,50.7425,8.1655,,29.454,4.720500000000001,mitoxantrone,CHEMBL58,KKZJGLLVHKMTCM-UHFFFAOYSA-N,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,C22H28N4O6,DB01204,D08224,mitoxantrone,Imatinib,CHEMBL941,KTUFNOKKBVMGRW-UHFFFAOYSA-N,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,C29H31N7O,DB00619,D01441,imatinib,A549,C3512,Lung (Carcinoma),Lung adenocarcinoma
325794,88,230,38,uM,uM,12.4531164417921,-13.5897164486734,9.46467077025236,11.8664528718125,0.0616476966214236,0.287408466752974,26.212,-3.21,34.016,46.777,40.3965,17.3945,,28.89550000000001,14.184500000000003,mitoxantrone,CHEMBL58,KKZJGLLVHKMTCM-UHFFFAOYSA-N,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,C22H28N4O6,DB01204,D08224,mitoxantrone,Imatinib,CHEMBL941,KTUFNOKKBVMGRW-UHFFFAOYSA-N,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,C29H31N7O,DB00619,D01441,imatinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
327145,53,56,38,uM,uM,-6.31309971631485,-4.22201612443872,-3.3712636190951,-4.9233029117524,20.7438362933702,0.134148025266936,18.749,4.756,16.927,37.82,27.3735,3.8685,,15.621,8.624500000000001,chlorambucil,CHEMBL515,JCKYGMPEJWAADB-UHFFFAOYSA-N,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,C14H19Cl2NO2,DB00291,D00266,chlorambucil,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
327155,53,56,28,uM,uM,-8.03699739714922,-9.82621233137783,-5.57263959202807,-5.03365633611817,13.0779438627311,0.492426793413144,16.142,-0.277,18.576,-1.936,8.32,-7.545,,0.3875000000000002,-7.821999999999999,chlorambucil,CHEMBL515,JCKYGMPEJWAADB-UHFFFAOYSA-N,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,C14H19Cl2NO2,DB00291,D00266,chlorambucil,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
327232,108,56,38,uM,uM,-5.7881653560511,-8.11832485743412,-4.30862868709155,-5.73379590452278,1.45049066398121,0.134148025266936,28.889,4.756,25.606,42.89,34.248,0.603000000000009,,17.4255,5.358999999999998,6-Thioguanine,CHEMBL727,WYWHKKSPHMUBEB-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=C(N2)N,C5H5N5S,DB00352,D08603,thioguanine,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
327242,108,56,28,uM,uM,-2.37624216455845,-8.17492767596744,-0.16035513181101,0.495767153060131,1.31560298651524,0.492426793413144,33.09,-0.277,39.723,19.836,29.7795,-3.0335,,13.372999999999998,-3.3105000000000047,6-Thioguanine,CHEMBL727,WYWHKKSPHMUBEB-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=C(N2)N,C5H5N5S,DB00352,D08603,thioguanine,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
327504,53,29,28,uM,uM,-3.69179861543611,-8.97979769246776,-1.1365541834639,-1.71769886150058,13.0779438627311,5.002041638138,16.142,8.418,65.818,39.898,52.858,28.298,,40.578,36.716,chlorambucil,CHEMBL515,JCKYGMPEJWAADB-UHFFFAOYSA-N,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,C14H19Cl2NO2,DB00291,D00266,chlorambucil,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
327510,53,29,38,uM,uM,-4.2128104167053,-1.239915401477,0.834824688682786,-2.43188948409424,20.7438362933702,2.01775289851193,18.749,24.125,30.665,46.964,38.8145,-4.0595,,17.377500000000005,14.689500000000002,chlorambucil,CHEMBL515,JCKYGMPEJWAADB-UHFFFAOYSA-N,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,C14H19Cl2NO2,DB00291,D00266,chlorambucil,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
327650,108,29,28,uM,uM,1.61972779972354,-5.98682230944928,1.45073300565504,1.40898353779327,1.31560298651524,5.002041638138,33.09,8.418,62.483,50.231,56.357,14.849,,35.602999999999994,23.267,6-Thioguanine,CHEMBL727,WYWHKKSPHMUBEB-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=C(N2)N,C5H5N5S,DB00352,D08603,thioguanine,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
327656,108,29,38,uM,uM,-2.49221547344504,-1.93994444583493,0.498935799793896,-3.94388879356964,1.45049066398121,2.01775289851193,28.889,24.125,30.442,54.296,42.369,-10.645,,15.862000000000002,13.48,6-Thioguanine,CHEMBL727,WYWHKKSPHMUBEB-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=C(N2)N,C5H5N5S,DB00352,D08603,thioguanine,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
327676,40,56,38,uM,uM,-1.21671047642796,-14.5422992761233,-8.50763901109401,-5.13228419030081,75.0,0.134148025266936,-3.362,4.756,-5.95,-4.496,-5.223,-6.617,,-5.92,-9.979,altretamine,CHEMBL1455,UUVWYPNAQBNQJQ-UHFFFAOYSA-N,CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C,C9H18N6,DB00488,D02841,altretamine,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
327686,40,56,28,uM,uM,0.600183649689892,-18.2998933645667,-7.76516503631287,-1.7667055404451,75.0,0.492426793413144,-6.521,-0.277,-3.324,0.372,-1.476,5.322,,1.923,-1.1989999999999998,altretamine,CHEMBL1455,UUVWYPNAQBNQJQ-UHFFFAOYSA-N,CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C,C9H18N6,DB00488,D02841,altretamine,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
327742,40,29,28,uM,uM,4.52571193633816,-32.4672043923347,-2.60461495163064,2.27269579688412,75.0,5.002041638138,-6.521,8.418,45.775,16.77,31.2725,29.3755,,30.324,22.8545,altretamine,CHEMBL1455,UUVWYPNAQBNQJQ-UHFFFAOYSA-N,CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C,C9H18N6,DB00488,D02841,altretamine,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
327748,40,29,38,uM,uM,-3.55913607026054,-34.5498351572658,-5.46934157409757,-2.85242597461491,75.0,2.01775289851193,-3.362,24.125,11.888,12.263,12.0755,-8.6875,,1.6940000000000008,-12.0495,altretamine,CHEMBL1455,UUVWYPNAQBNQJQ-UHFFFAOYSA-N,CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C,C9H18N6,DB00488,D02841,altretamine,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
327854,1,56,38,uM,uM,-0.847324448856304,-1.49117416890692,-0.680850909313774,-3.07399701346932,4.93954994547436,0.134148025266936,31.568,4.756,31.199,2.945,17.072,-19.252,,-1.09,-14.496000000000002,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
327860,1,56,28,uM,uM,0.224653003167965,-2.07704871957201,-0.543218118636521,-1.72473742821275,3.70539648442761,0.492426793413144,52.846,-0.277,55.95,39.389,47.6695,-4.8995,,21.385,-5.176499999999997,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
328286,1,29,38,uM,uM,1.07353817356525,3.13748381215112,4.87209377216964,-0.0538171797964236,4.93954994547436,2.01775289851193,31.568,24.125,40.248,31.946,36.097,-19.596,,8.250500000000002,4.529,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,Sorafenib,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,DB00398,D08524,sorafenib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
330677,88,85,28,uM,uM,-7.39720092249766,-4.98697810688703,-0.140374730206218,-3.59584315449513,0.186033682243995,0.343705490270365,29.019,17.466,37.474,37.833,37.6535,-8.83150000000001,,14.411,8.634500000000003,mitoxantrone,CHEMBL58,KKZJGLLVHKMTCM-UHFFFAOYSA-N,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,C22H28N4O6,DB01204,D08224,mitoxantrone,6-Mercaptopurine,CHEMBL1425,GLVAUDGFNGKCSF-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=CN2,C5H4N4S,DB01033,D04931,mercaptopurine,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
330687,88,85,38,uM,uM,-6.24581443814332,-6.38928232082688,-3.27675163443149,-8.59182583927021,0.0616476966214236,0.268774665714487,26.212,19.202,31.957,34.225,33.091,-12.323,,10.384,6.879000000000001,mitoxantrone,CHEMBL58,KKZJGLLVHKMTCM-UHFFFAOYSA-N,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,C22H28N4O6,DB01204,D08224,mitoxantrone,6-Mercaptopurine,CHEMBL1425,GLVAUDGFNGKCSF-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=CN2,C5H4N4S,DB01033,D04931,mercaptopurine,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
332635,108,230,28,uM,uM,0.200126506315517,-11.2495379115208,1.87381153485566,3.56953391793133,1.31560298651524,3.10184621638237,33.09,-1.473,36.656,16.137,26.3965,-5.2205,,10.587999999999996,-6.693500000000004,6-Thioguanine,CHEMBL727,WYWHKKSPHMUBEB-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=C(N2)N,C5H5N5S,DB00352,D08603,thioguanine,Imatinib,CHEMBL941,KTUFNOKKBVMGRW-UHFFFAOYSA-N,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,C29H31N7O,DB00619,D01441,imatinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
332645,108,230,38,uM,uM,3.18030895164947,-11.5027139464113,0.517004103585701,2.83848765807938,1.45049066398121,0.287408466752974,28.889,-3.21,27.612,32.844,30.228,4.549,,17.3885,1.3390000000000022,6-Thioguanine,CHEMBL727,WYWHKKSPHMUBEB-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=C(N2)N,C5H5N5S,DB00352,D08603,thioguanine,Imatinib,CHEMBL941,KTUFNOKKBVMGRW-UHFFFAOYSA-N,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,C29H31N7O,DB00619,D01441,imatinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
332667,53,230,28,uM,uM,-3.19192930589805,-5.93756404087352,-2.80861577113564,-1.77546229729152,13.0779438627311,3.10184621638237,16.142,-1.473,20.519,5.677,13.098,-1.571,,5.763500000000001,-3.0439999999999987,chlorambucil,CHEMBL515,JCKYGMPEJWAADB-UHFFFAOYSA-N,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,C14H19Cl2NO2,DB00291,D00266,chlorambucil,Imatinib,CHEMBL941,KTUFNOKKBVMGRW-UHFFFAOYSA-N,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,C29H31N7O,DB00619,D01441,imatinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
332677,53,230,38,uM,uM,1.17095677696874,0.0587033865015107,1.65533743691904,4.30022284862754,20.7438362933702,0.287408466752974,18.749,-3.21,18.46,40.06,29.26,13.721,,21.490500000000004,10.511000000000005,chlorambucil,CHEMBL515,JCKYGMPEJWAADB-UHFFFAOYSA-N,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,C14H19Cl2NO2,DB00291,D00266,chlorambucil,Imatinib,CHEMBL941,KTUFNOKKBVMGRW-UHFFFAOYSA-N,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,C29H31N7O,DB00619,D01441,imatinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
332905,40,230,28,uM,uM,5.08063041095865,3.13286506018568,6.05755718590936,12.2398996516483,75.0,3.10184621638237,-6.521,-1.473,1.339,9.147,5.243,13.237,,9.24,6.716,altretamine,CHEMBL1455,UUVWYPNAQBNQJQ-UHFFFAOYSA-N,CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C,C9H18N6,DB00488,D02841,altretamine,Imatinib,CHEMBL941,KTUFNOKKBVMGRW-UHFFFAOYSA-N,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,C29H31N7O,DB00619,D01441,imatinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
332915,40,230,38,uM,uM,2.92933749761188,-1.46503418535195,-1.09148893706196,3.28095371119024,75.0,0.287408466752974,-3.362,-3.21,-4.675,-0.421,-2.548,4.024,,0.738,0.6619999999999999,altretamine,CHEMBL1455,UUVWYPNAQBNQJQ-UHFFFAOYSA-N,CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C,C9H18N6,DB00488,D02841,altretamine,Imatinib,CHEMBL941,KTUFNOKKBVMGRW-UHFFFAOYSA-N,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,C29H31N7O,DB00619,D01441,imatinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
332971,1,230,28,uM,uM,1.33845453137814,-6.1556649297861,-1.26810700752541,-1.04394493056378,3.70539648442761,3.10184621638237,52.846,-1.473,56.646,36.057,46.3515,-5.0215,,20.665000000000003,-6.494499999999995,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,Imatinib,CHEMBL941,KTUFNOKKBVMGRW-UHFFFAOYSA-N,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,C29H31N7O,DB00619,D01441,imatinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
332977,1,230,38,uM,uM,8.49116972549416,2.02896559918952,4.81911521469681,7.03445750913283,4.93954994547436,0.287408466752974,31.568,-3.21,34.437,23.669,29.053,0.694999999999997,,14.874,-2.515000000000001,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,Imatinib,CHEMBL941,KTUFNOKKBVMGRW-UHFFFAOYSA-N,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,C29H31N7O,DB00619,D01441,imatinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
333523,72,85,38,uM,uM,-6.02246864359188,-0.821547329665296,1.04278226683724,-1.85425639225743,10.0,0.268774665714487,5.994,19.202,22.174,25.391,23.7825,-1.4135,,11.184499999999998,4.580499999999997,Gefitinib,CHEMBL939,XGALLCVXEZPNRQ-UHFFFAOYSA-N,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,C22H24ClFN4O3,DB00317,D01977,gefitinib,6-Mercaptopurine,CHEMBL1425,GLVAUDGFNGKCSF-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=CN2,C5H4N4S,DB01033,D04931,mercaptopurine,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
333545,72,85,28,uM,uM,-6.16387412277351,-1.09443454917399,-0.468531553535552,-3.74992108924916,4.63606799908028,0.343705490270365,10.57,17.466,31.208,37.82,34.514,6.47799999999999,,20.496,17.048000000000002,Gefitinib,CHEMBL939,XGALLCVXEZPNRQ-UHFFFAOYSA-N,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,C22H24ClFN4O3,DB00317,D01977,gefitinib,6-Mercaptopurine,CHEMBL1425,GLVAUDGFNGKCSF-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=CN2,C5H4N4S,DB01033,D04931,mercaptopurine,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
334947,101,85,38,uM,uM,-8.88442374971435,-21.7700217873325,-10.5813612333162,-10.168563525032,4.38962339087133,0.268774665714487,-0.959,19.202,6.389,7.416,6.9025,-11.3405,,-2.219000000000001,-12.299500000000002,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,6-Mercaptopurine,CHEMBL1425,GLVAUDGFNGKCSF-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=CN2,C5H4N4S,DB01033,D04931,mercaptopurine,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
334969,101,85,28,uM,uM,-6.92901947339283,-45.1353085217002,-22.2106650363129,-17.9367951946299,0.171867099886755,0.343705490270365,-5.115,17.466,-3.148,-3.265,-3.2065,-15.5575,,-9.382,-20.6725,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,6-Mercaptopurine,CHEMBL1425,GLVAUDGFNGKCSF-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=CN2,C5H4N4S,DB01033,D04931,mercaptopurine,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
335052,115,85,28,uM,uM,-9.35488225401371,-22.8202076961075,-17.8951411776996,-16.6384659840663,0.987963832062323,0.343705490270365,-1.287,17.466,4.463,0.996,2.7295,-13.4495,,-5.360000000000001,-14.7365,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,6-Mercaptopurine,CHEMBL1425,GLVAUDGFNGKCSF-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=CN2,C5H4N4S,DB01033,D04931,mercaptopurine,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
335058,115,85,38,uM,uM,-7.61503230116568,-17.9535306327862,-5.66245616254581,-7.01247235608817,0.230610312300154,0.268774665714487,4.437,19.202,16.706,17.584,17.145,-6.494,,5.325499999999998,-2.057000000000002,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,6-Mercaptopurine,CHEMBL1425,GLVAUDGFNGKCSF-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=CN2,C5H4N4S,DB01033,D04931,mercaptopurine,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
335310,56,85,38,uM,uM,-6.17946695568099,-19.5306722506501,-9.24045616254582,-10.0092189272457,0.134169130800938,0.268774665714487,4.756,19.202,14.32,11.881,13.1005,-10.8575,,1.1214999999999993,-6.1015000000000015,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,6-Mercaptopurine,CHEMBL1425,GLVAUDGFNGKCSF-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=CN2,C5H4N4S,DB01033,D04931,mercaptopurine,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
335320,56,85,28,uM,uM,-9.63873288922914,-20.3368071663332,-15.5876805260943,-14.9168983641136,0.479317498262319,0.343705490270365,-0.542,17.466,10.613,11.905,11.259,-5.665,,2.7970000000000006,-6.207000000000001,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,6-Mercaptopurine,CHEMBL1425,GLVAUDGFNGKCSF-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=CN2,C5H4N4S,DB01033,D04931,mercaptopurine,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
335365,120,85,28,uM,uM,-7.90731707486137,-22.0873629917204,-15.7510300665885,-13.6541944942035,13.2475908300401,0.343705490270365,-2.739,17.466,9.985,12.003,10.994,-3.733,,3.6305,-6.472000000000001,Vismodegib,CHEMBL473417,BPQMGSKTAYIVFO-UHFFFAOYSA-N,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,C19H14Cl2N2O3S,DB08828,D09992,vismodegib,6-Mercaptopurine,CHEMBL1425,GLVAUDGFNGKCSF-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=CN2,C5H4N4S,DB01033,D04931,mercaptopurine,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
335387,120,85,38,uM,uM,-2.62705554905957,-18.1469111441135,-2.99201171810138,-3.83873471004007,3.86072665158335,0.268774665714487,4.58,19.202,23.355,16.369,19.862,-3.92,,7.9709999999999965,0.6599999999999966,Vismodegib,CHEMBL473417,BPQMGSKTAYIVFO-UHFFFAOYSA-N,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,C19H14Cl2N2O3S,DB08828,D09992,vismodegib,6-Mercaptopurine,CHEMBL1425,GLVAUDGFNGKCSF-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=CN2,C5H4N4S,DB01033,D04931,mercaptopurine,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
335405,116,85,28,uM,uM,-5.57856574889553,-9.68716521319542,-4.55802941220927,-7.5509730939869,0.647196610526164,0.343705490270365,33.59,17.466,40.611,46.116,43.3635,-7.6925,,17.8355,9.7735,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,6-Mercaptopurine,CHEMBL1425,GLVAUDGFNGKCSF-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=CN2,C5H4N4S,DB01033,D04931,mercaptopurine,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
335410,116,85,38,uM,uM,-7.51137041993514,-30.3167296472383,-9.63833170297954,-8.56988492237228,4.75243603628729,0.268774665714487,-1.244,19.202,2.011,9.318,5.6645,-12.2935,,-3.3145000000000007,-13.5375,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,6-Mercaptopurine,CHEMBL1425,GLVAUDGFNGKCSF-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=CN2,C5H4N4S,DB01033,D04931,mercaptopurine,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
335555,79,85,38,uM,uM,-3.59177121958037,-21.6164418257059,-0.383548899890497,-1.7892634149829,30.0,0.268774665714487,2.987,19.202,22.403,18.172,20.2875,-1.9015,,9.193,1.0854999999999997,Lenalidomide,CHEMBL848,GOTYRUGSSMKFNF-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,C13H13N3O3,DB00480,D04687,lenalidomide,6-Mercaptopurine,CHEMBL1425,GLVAUDGFNGKCSF-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=CN2,C5H4N4S,DB01033,D04931,mercaptopurine,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
335561,79,85,28,uM,uM,-7.89476940350584,-25.4865996710049,-0.224396384493051,-1.50528845296106,30.0,0.343705490270365,4.019,17.466,18.662,16.884,17.773,-3.712,,7.0305,0.3069999999999986,Lenalidomide,CHEMBL848,GOTYRUGSSMKFNF-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,C13H13N3O3,DB00480,D04687,lenalidomide,6-Mercaptopurine,CHEMBL1425,GLVAUDGFNGKCSF-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=CN2,C5H4N4S,DB01033,D04931,mercaptopurine,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
335726,72,107,28,uM,uM,-3.56702331803559,-11.4527468449988,-1.14332922974763,-1.54713397096198,4.63606799908028,9.17823955552302,10.57,0.501,12.801,43.275,28.038,16.967,,22.5025,17.468,Gefitinib,CHEMBL939,XGALLCVXEZPNRQ-UHFFFAOYSA-N,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,C22H24ClFN4O3,DB00317,D01977,gefitinib,thalidomide,CHEMBL468,UEJJHQNACJXSKW-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,C13H10N2O4,DB01041,D00754,thalidomide,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
335736,72,107,38,uM,uM,-0.916301649561757,0.132203753810749,3.55822632580792,4.11727755315912,10.0,0.305410012032212,5.994,-0.86,11.101,22.543,16.822,11.688,,14.255,10.828,Gefitinib,CHEMBL939,XGALLCVXEZPNRQ-UHFFFAOYSA-N,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,C22H24ClFN4O3,DB00317,D01977,gefitinib,thalidomide,CHEMBL468,UEJJHQNACJXSKW-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,C13H10N2O4,DB01041,D00754,thalidomide,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
337989,40,30,28,uM,uM,2.2552468155762,-5.41591429411149,-2.12627614742397,4.04801611858554,75.0,0.328052190693927,-6.521,-1.044,-0.655,-4.361,-2.508,5.057,,1.2744999999999995,-1.464,altretamine,CHEMBL1455,UUVWYPNAQBNQJQ-UHFFFAOYSA-N,CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C,C9H18N6,DB00488,D02841,altretamine,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
337999,40,30,38,uM,uM,1.15753674635186,-3.80703877885122,-3.30699836964619,0.0631515783296252,75.0,0.0449794155779465,-3.362,0.197,-2.948,-2.322,-2.635,0.53,,-1.0524999999999998,-2.832,altretamine,CHEMBL1455,UUVWYPNAQBNQJQ-UHFFFAOYSA-N,CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C,C9H18N6,DB00488,D02841,altretamine,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
338273,88,75,28,uM,uM,0.554808055610499,-35.8915308277277,-0.391218118636529,0.383744832529807,0.186033682243995,78.0766608828273,29.019,-1.231,28.99,26.15,27.57,-0.217999999999996,,13.676000000000002,-1.448999999999998,mitoxantrone,CHEMBL58,KKZJGLLVHKMTCM-UHFFFAOYSA-N,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,C22H28N4O6,DB01204,D08224,mitoxantrone,ifosfamide,CHEMBL1024,HOMGKSMUEGBAAB-UHFFFAOYSA-N,C1CN(P(=O)(OC1)NCCCl)CCCl,C7H15Cl2N2O2P,DB01181,D00343,ifosfamide,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
338299,88,75,38,uM,uM,-0.388113224851793,-32.9934438806289,-3.78932922974764,-3.65993599211177,0.0616476966214236,8.94103798313554,26.212,-0.162,22.974,31.891,27.4325,1.3825,,14.4075,1.2205000000000013,mitoxantrone,CHEMBL58,KKZJGLLVHKMTCM-UHFFFAOYSA-N,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,C22H28N4O6,DB01204,D08224,mitoxantrone,ifosfamide,CHEMBL1024,HOMGKSMUEGBAAB-UHFFFAOYSA-N,C1CN(P(=O)(OC1)NCCCl)CCCl,C7H15Cl2N2O2P,DB01181,D00343,ifosfamide,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
338558,108,86,28,uM,uM,-1.56702517851159,-13.5232707391395,0.0784782015223328,0.881922099774646,1.31560298651524,3.04733912633062,33.09,1.384,39.246,36.323,37.7845,3.3105,,20.5475,4.694499999999998,6-Thioguanine,CHEMBL727,WYWHKKSPHMUBEB-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=C(N2)N,C5H5N5S,DB00352,D08603,thioguanine,methoxsalen,CHEMBL416,QXKHYNVANLEOEG-UHFFFAOYSA-N,COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,C12H8O4,DB00553,D00139,methoxsalen,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
338564,108,86,38,uM,uM,-2.45567637826214,-17.0365144868313,-4.14877367419208,-4.39315247016928,1.45049066398121,0.207298887026913,28.889,0.121,23.51,19.863,21.6865,-7.3235,,7.1815,-7.202500000000001,6-Thioguanine,CHEMBL727,WYWHKKSPHMUBEB-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=C(N2)N,C5H5N5S,DB00352,D08603,thioguanine,methoxsalen,CHEMBL416,QXKHYNVANLEOEG-UHFFFAOYSA-N,COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,C12H8O4,DB00553,D00139,methoxsalen,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
338705,53,86,28,uM,uM,-1.3535112342809,-3.7393360018906,-0.483016496253337,-0.899656965233936,13.0779438627311,3.04733912633062,16.142,1.384,13.072,17.399,15.2355,-2.2905,,6.4725,-0.9064999999999994,chlorambucil,CHEMBL515,JCKYGMPEJWAADB-UHFFFAOYSA-N,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,C14H19Cl2NO2,DB00291,D00266,chlorambucil,methoxsalen,CHEMBL416,QXKHYNVANLEOEG-UHFFFAOYSA-N,COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,C12H8O4,DB00553,D00139,methoxsalen,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
338711,53,86,38,uM,uM,-9.32069350199338,-4.27142055069948,-2.38677367419207,-2.6651964573989,20.7438362933702,0.207298887026913,18.749,0.121,19.232,19.717,19.4745,0.604500000000002,,10.0395,0.7255000000000003,chlorambucil,CHEMBL515,JCKYGMPEJWAADB-UHFFFAOYSA-N,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,C14H19Cl2NO2,DB00291,D00266,chlorambucil,methoxsalen,CHEMBL416,QXKHYNVANLEOEG-UHFFFAOYSA-N,COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,C12H8O4,DB00553,D00139,methoxsalen,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
338825,40,86,28,uM,uM,1.26524616301263,-2.81763940828347,-1.15299836964619,4.87151916126941,75.0,3.04733912633062,-6.521,1.384,-2.714,2.104,-0.305,4.832,,2.2635,-1.6889999999999998,altretamine,CHEMBL1455,UUVWYPNAQBNQJQ-UHFFFAOYSA-N,CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C,C9H18N6,DB00488,D02841,altretamine,methoxsalen,CHEMBL416,QXKHYNVANLEOEG-UHFFFAOYSA-N,COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,C12H8O4,DB00553,D00139,methoxsalen,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
338831,40,86,38,uM,uM,1.13598028602369,-1.84364026881848,-2.18044281409063,1.17706208294158,75.0,0.207298887026913,-3.362,0.121,-2.874,3.083,0.1045,3.3455,,1.725,-0.0165,altretamine,CHEMBL1455,UUVWYPNAQBNQJQ-UHFFFAOYSA-N,CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C,C9H18N6,DB00488,D02841,altretamine,methoxsalen,CHEMBL416,QXKHYNVANLEOEG-UHFFFAOYSA-N,COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,C12H8O4,DB00553,D00139,methoxsalen,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
339034,108,30,28,uM,uM,-0.881738977453215,-6.34550803933944,0.266533757077886,1.91674355986854,1.31560298651524,0.328052190693927,33.09,-1.044,35.056,34.071,34.5635,2.51749999999999,,18.540499999999994,1.4734999999999945,6-Thioguanine,CHEMBL727,WYWHKKSPHMUBEB-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=C(N2)N,C5H5N5S,DB00352,D08603,thioguanine,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
339044,108,30,38,uM,uM,-0.383535942084063,-5.82500420298384,-2.16044034085875,-2.13643446367013,1.45049066398121,0.0449794155779465,28.889,0.197,26.506,45.952,36.229,7.143,,21.686,7.34,6-Thioguanine,CHEMBL727,WYWHKKSPHMUBEB-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=C(N2)N,C5H5N5S,DB00352,D08603,thioguanine,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
339243,1,86,28,uM,uM,-0.600669167906073,-7.13332599890764,-1.70555145196986,-2.68787180983159,3.70539648442761,3.04733912633062,52.846,1.384,51.441,38.681,45.061,-9.169,,17.946,-7.784999999999997,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,methoxsalen,CHEMBL416,QXKHYNVANLEOEG-UHFFFAOYSA-N,COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,C12H8O4,DB00553,D00139,methoxsalen,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
339253,1,86,38,uM,uM,5.67974224174562,2.54306003711606,5.65989299247459,5.42668751421751,4.93954994547436,0.207298887026913,31.568,0.121,36.855,30.329,33.592,1.903,,17.7475,2.0239999999999974,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,methoxsalen,CHEMBL416,QXKHYNVANLEOEG-UHFFFAOYSA-N,COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,C12H8O4,DB00553,D00139,methoxsalen,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
339600,53,30,28,uM,uM,-6.73790335783292,-4.8026971581786,-3.48883799335786,-2.64460041243854,13.0779438627311,0.328052190693927,16.142,-1.044,11.847,7.191,9.519,-5.579,,1.9700000000000009,-6.622999999999999,chlorambucil,CHEMBL515,JCKYGMPEJWAADB-UHFFFAOYSA-N,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,C14H19Cl2NO2,DB00291,D00266,chlorambucil,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
339610,53,30,38,uM,uM,0.31152614746051,-2.28178534532177,-2.04921811863654,-2.02186802423309,20.7438362933702,0.0449794155779465,18.749,0.197,16.635,38.774,27.7045,8.75850000000001,,18.2315,8.9555,chlorambucil,CHEMBL515,JCKYGMPEJWAADB-UHFFFAOYSA-N,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,C14H19Cl2NO2,DB00291,D00266,chlorambucil,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
340006,120,101,38,uM,uM,1.30221967052795,1.78076126751958,3.3468432695188,4.6481094816547,3.86072665158335,4.39125556033846,4.58,-0.959,11.853,8.33,10.0915,6.4705,,8.281,5.5115,Vismodegib,CHEMBL473417,BPQMGSKTAYIVFO-UHFFFAOYSA-N,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,C19H14Cl2N2O3S,DB08828,D09992,vismodegib,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
340032,120,101,28,uM,uM,1.93231010848505,-3.67856779711523,-2.21493331850626,3.68827256064357,13.2475908300401,0.172142546540428,-2.739,-5.115,-0.581,0.726,0.0725,7.9265,,3.9995,2.8115,Vismodegib,CHEMBL473417,BPQMGSKTAYIVFO-UHFFFAOYSA-N,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,C19H14Cl2N2O3S,DB08828,D09992,vismodegib,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
340131,56,101,7,uM,uM,0.544854715354934,0.832561349005905,2.80706120908842,2.77630701550079,0.497567802644297,3.2233263381149,4.613,2.343,16.502,32.062,24.282,17.326,,20.804,19.669,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,A549,C3512,Lung (Carcinoma),Lung adenocarcinoma
340135,56,101,28,uM,uM,1.09973576901036,-7.31085560991339,-0.222125356012547,4.97622878740011,0.479317498262319,0.172142546540428,-0.542,-5.115,2.054,8.655,5.3545,11.0115,,8.183,5.8965,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
340141,56,101,38,uM,uM,-2.68821453631628,-3.07003009437654,0.976954380629914,2.45838686444908,0.134169130800938,4.39125556033846,4.756,-0.959,7.655,3.546,5.6005,1.8035,,3.702,0.8445,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
340287,115,101,38,uM,uM,-1.73386167194875,1.07903728513393,2.2830535070774,3.13482205116215,0.230610312300154,4.39125556033846,4.437,-0.959,9.621,6.976,8.2985,4.8205,,6.559500000000001,3.8615,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
340297,115,101,28,uM,uM,1.4967926492039,-0.770610362814318,5.21608065904883,10.626805508003,0.987963832062323,0.172142546540428,-1.287,-5.115,4.687,5.601,5.144,11.546,,8.345,6.431,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
340301,115,101,7,uM,uM,-4.16444555302763,0.843984102769927,2.6247363809049,1.37271502680625,0.362777838678078,3.2233263381149,10.315,2.343,16.017,13.937,14.977,2.319,,8.648,4.662000000000001,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,A549,C3512,Lung (Carcinoma),Lung adenocarcinoma
340940,120,72,28,uM,uM,11.5575303819116,11.4241908656484,11.4786366000781,12.9927315455339,13.2475908300401,4.66068629069488,-2.739,10.571,71.018,48.005,59.5115,51.6795,,55.5955,48.9405,Vismodegib,CHEMBL473417,BPQMGSKTAYIVFO-UHFFFAOYSA-N,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,C19H14Cl2N2O3S,DB08828,D09992,vismodegib,Gefitinib,CHEMBL939,XGALLCVXEZPNRQ-UHFFFAOYSA-N,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,C22H24ClFN4O3,DB00317,D01977,gefitinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
340962,120,72,38,uM,uM,2.06912426654355,4.53692970345266,8.03541437785593,6.7566117244087,3.86072665158335,10.0,4.58,5.996,36.145,11.841,23.993,13.417,,18.705,17.997,Vismodegib,CHEMBL473417,BPQMGSKTAYIVFO-UHFFFAOYSA-N,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,C19H14Cl2N2O3S,DB08828,D09992,vismodegib,Gefitinib,CHEMBL939,XGALLCVXEZPNRQ-UHFFFAOYSA-N,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,C22H24ClFN4O3,DB00317,D01977,gefitinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
341022,56,72,7,uM,uM,6.71887640957848,14.2286229025663,14.6499143778559,11.0405317038303,0.497567802644297,1.19217998328566,4.613,22.807,43.375,52.124,47.7495,20.3295,,34.0395,24.9425,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,Gefitinib,CHEMBL939,XGALLCVXEZPNRQ-UHFFFAOYSA-N,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,C22H24ClFN4O3,DB00317,D01977,gefitinib,A549,C3512,Lung (Carcinoma),Lung adenocarcinoma
341034,56,72,28,uM,uM,13.6235740442515,14.7673640649207,15.4378588223004,15.5310879022905,0.479317498262319,4.66068629069488,-0.542,10.571,72.65,31.665,52.1575,42.1285,,47.143,41.5865,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,Gefitinib,CHEMBL939,XGALLCVXEZPNRQ-UHFFFAOYSA-N,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,C22H24ClFN4O3,DB00317,D01977,gefitinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
341040,56,72,38,uM,uM,-0.948639797299516,8.85844799000542,9.28900143103564,8.11674688498085,0.134169130800938,10.0,4.756,5.996,34.267,12.238,23.2525,12.5005,,17.8765,17.256500000000003,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,Gefitinib,CHEMBL939,XGALLCVXEZPNRQ-UHFFFAOYSA-N,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,C22H24ClFN4O3,DB00317,D01977,gefitinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
341326,115,72,7,uM,uM,2.81646134011069,5.77340825925912,7.44380326674479,2.63534035680238,0.362777838678078,1.19217998328566,10.315,22.807,30.694,32.174,31.434,-1.688,,14.873,8.627000000000002,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,Gefitinib,CHEMBL939,XGALLCVXEZPNRQ-UHFFFAOYSA-N,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,C22H24ClFN4O3,DB00317,D01977,gefitinib,A549,C3512,Lung (Carcinoma),Lung adenocarcinoma
341330,115,72,28,uM,uM,7.10305512254638,10.1596481870063,10.0068588223004,10.7058228356711,0.987963832062323,4.66068629069488,-1.287,10.571,62.646,35.76,49.203,39.919,,44.56100000000001,38.632000000000005,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,Gefitinib,CHEMBL939,XGALLCVXEZPNRQ-UHFFFAOYSA-N,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,C22H24ClFN4O3,DB00317,D01977,gefitinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
341336,115,72,38,uM,uM,4.11208128655796,10.4715868280024,11.0181921556337,8.78169618280504,0.230610312300154,10.0,4.437,5.996,32.489,20.829,26.659,16.226,,21.4425,20.663,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,Gefitinib,CHEMBL939,XGALLCVXEZPNRQ-UHFFFAOYSA-N,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,C22H24ClFN4O3,DB00317,D01977,gefitinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
341417,101,72,38,uM,uM,-1.70947769935767,5.46149749976551,7.04652548896703,7.01559967608347,4.38962339087133,10.0,-0.959,5.996,29.864,16.5,23.182,18.145,,20.6635,17.186,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,Gefitinib,CHEMBL939,XGALLCVXEZPNRQ-UHFFFAOYSA-N,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,C22H24ClFN4O3,DB00317,D01977,gefitinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
341427,101,72,7,uM,uM,3.21963114417979,2.72673781141782,7.8489143778559,4.57386701082353,3.22123167658349,1.19217998328566,2.342,22.807,31.182,36.163,33.6725,8.5235,,21.098,10.8655,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,Gefitinib,CHEMBL939,XGALLCVXEZPNRQ-UHFFFAOYSA-N,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,C22H24ClFN4O3,DB00317,D01977,gefitinib,A549,C3512,Lung (Carcinoma),Lung adenocarcinoma
341439,101,72,28,uM,uM,9.37076660845587,-7.65928432755708,2.64833496368713,6.77281201621865,0.171867099886755,4.66068629069488,-5.115,10.571,54.378,13.554,33.966,28.51,,31.238,23.395000000000003,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,Gefitinib,CHEMBL939,XGALLCVXEZPNRQ-UHFFFAOYSA-N,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,C22H24ClFN4O3,DB00317,D01977,gefitinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
341781,116,101,38,uM,uM,0.0596939785475483,1.26354981763111,1.45603399411686,3.46199035821138,4.75243603628729,4.39125556033846,-1.244,-0.959,4.897,-0.089,2.404,4.607,,3.5055,3.363,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
341791,116,101,28,uM,uM,3.84371598613479,-25.3921738155291,-0.658218118636533,2.77573554252681,0.647196610526164,0.172142546540428,33.59,-5.115,34.452,32.779,33.6155,5.1405,,19.378,0.0254999999999938,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
341803,116,101,7,uM,uM,2.18531992422322,-2.22990043372873,-0.862430940141028,1.59662570360842,5.0,3.2233263381149,-2.354,2.343,10.19,11.894,11.042,11.053,,11.0475,8.699,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,A549,C3512,Lung (Carcinoma),Lung adenocarcinoma
341846,72,230,38,uM,uM,0.751072444762067,-2.0351304396621,-0.122551451969849,2.86967387438084,10.0,0.287408466752974,5.994,-3.21,5.858,10.784,8.321,5.537,,6.929,2.327,Gefitinib,CHEMBL939,XGALLCVXEZPNRQ-UHFFFAOYSA-N,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,C22H24ClFN4O3,DB00317,D01977,gefitinib,Imatinib,CHEMBL941,KTUFNOKKBVMGRW-UHFFFAOYSA-N,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,C29H31N7O,DB00619,D01441,imatinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
341852,72,230,28,uM,uM,3.05479499509514,8.28235465719563,7.61053583824883,8.13260068093934,4.63606799908028,3.10184621638237,10.57,-1.473,42.666,34.724,38.695,29.598,,34.1465,28.125,Gefitinib,CHEMBL939,XGALLCVXEZPNRQ-UHFFFAOYSA-N,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,C22H24ClFN4O3,DB00317,D01977,gefitinib,Imatinib,CHEMBL941,KTUFNOKKBVMGRW-UHFFFAOYSA-N,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,C29H31N7O,DB00619,D01441,imatinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
341856,72,230,7,uM,uM,-2.20295364357878,-10.3142303073245,-3.19560700752541,-0.877467383980127,1.19272204952941,0.0077012621661591,22.807,-3.445,18.229,22.532,20.3805,1.0185,,10.699500000000002,-2.426499999999997,Gefitinib,CHEMBL939,XGALLCVXEZPNRQ-UHFFFAOYSA-N,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,C22H24ClFN4O3,DB00317,D01977,gefitinib,Imatinib,CHEMBL941,KTUFNOKKBVMGRW-UHFFFAOYSA-N,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,C29H31N7O,DB00619,D01441,imatinib,A549,C3512,Lung (Carcinoma),Lung adenocarcinoma
342431,79,230,38,uM,uM,1.25397341189472,0.391474229048166,-0.446773674192093,2.69100629609981,30.0,0.287408466752974,2.987,-3.21,0.138,0.44,0.289,0.512,,0.4004999999999999,-2.698,Lenalidomide,CHEMBL848,GOTYRUGSSMKFNF-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,C13H13N3O3,DB00480,D04687,lenalidomide,Imatinib,CHEMBL941,KTUFNOKKBVMGRW-UHFFFAOYSA-N,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,C29H31N7O,DB00619,D01441,imatinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
342453,79,230,28,uM,uM,4.84500978267273,6.43130723365692,5.24498028269326,5.72350753944967,30.0,3.10184621638237,4.019,-1.473,17.345,6.704,12.0245,9.4785,,10.7515,8.0055,Lenalidomide,CHEMBL848,GOTYRUGSSMKFNF-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,C13H13N3O3,DB00480,D04687,lenalidomide,Imatinib,CHEMBL941,KTUFNOKKBVMGRW-UHFFFAOYSA-N,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,C29H31N7O,DB00619,D01441,imatinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
342556,79,72,38,uM,uM,-3.86225497774212,-7.24351878486613,-0.0780103543098251,-3.11557154720079,30.0,10.0,2.987,5.996,13.374,3.339,8.3565,-0.6265,,3.865,2.3605,Lenalidomide,CHEMBL848,GOTYRUGSSMKFNF-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,C13H13N3O3,DB00480,D04687,lenalidomide,Gefitinib,CHEMBL939,XGALLCVXEZPNRQ-UHFFFAOYSA-N,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,C22H24ClFN4O3,DB00317,D01977,gefitinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
342562,79,72,28,uM,uM,15.3372099639988,6.17543022791672,15.9379938429081,13.1972697889986,30.0,4.66068629069488,4.019,10.571,62.443,32.667,47.555,32.965,,40.26,36.984,Lenalidomide,CHEMBL848,GOTYRUGSSMKFNF-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,C13H13N3O3,DB00480,D04687,lenalidomide,Gefitinib,CHEMBL939,XGALLCVXEZPNRQ-UHFFFAOYSA-N,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,C22H24ClFN4O3,DB00317,D01977,gefitinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
342636,116,230,38,uM,uM,2.11747237291893,0.982951738465168,1.38002510349327,4.88942459426599,4.75243603628729,0.287408466752974,-1.244,-3.21,-3.284,3.0,-0.142,4.312,,2.085,1.102,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,Imatinib,CHEMBL941,KTUFNOKKBVMGRW-UHFFFAOYSA-N,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,C29H31N7O,DB00619,D01441,imatinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
342650,116,230,7,uM,uM,1.49176531411498,-7.13202378916312,-3.35741711134542,1.00379197183669,5.0,0.0077012621661591,-2.354,-3.445,-7.021,4.7,-1.1605,4.6385,,1.7389999999999997,1.1935,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,Imatinib,CHEMBL941,KTUFNOKKBVMGRW-UHFFFAOYSA-N,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,C29H31N7O,DB00619,D01441,imatinib,A549,C3512,Lung (Carcinoma),Lung adenocarcinoma
342662,116,230,28,uM,uM,2.94207208803329,-6.78048755955942,1.88764909068623,2.55036689842383,0.647196610526164,3.10184621638237,33.59,-1.473,42.26,58.162,50.211,18.094,,34.1525,16.620999999999995,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,Imatinib,CHEMBL941,KTUFNOKKBVMGRW-UHFFFAOYSA-N,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,C29H31N7O,DB00619,D01441,imatinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
342850,120,230,28,uM,uM,7.46580793692457,1.62513152525349,2.40666809770233,6.14042723154058,13.2475908300401,3.10184621638237,-2.739,-1.473,33.037,34.066,33.5515,37.7635,,35.6575,35.0245,Vismodegib,CHEMBL473417,BPQMGSKTAYIVFO-UHFFFAOYSA-N,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,C19H14Cl2N2O3S,DB08828,D09992,vismodegib,Imatinib,CHEMBL941,KTUFNOKKBVMGRW-UHFFFAOYSA-N,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,C29H31N7O,DB00619,D01441,imatinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
342872,120,230,38,uM,uM,3.26499370747228,-0.516018133150142,3.15837678531375,6.48766852882041,3.86072665158335,0.287408466752974,4.58,-3.21,1.873,7.187,4.53,3.16,,3.845,-0.0499999999999998,Vismodegib,CHEMBL473417,BPQMGSKTAYIVFO-UHFFFAOYSA-N,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,C19H14Cl2N2O3S,DB08828,D09992,vismodegib,Imatinib,CHEMBL941,KTUFNOKKBVMGRW-UHFFFAOYSA-N,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,C29H31N7O,DB00619,D01441,imatinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
342934,116,72,7,uM,uM,4.26536970660483,0.0609110015492305,3.46139051924267,4.05016332249346,5.0,1.19217998328566,-2.354,22.807,27.4,29.847,28.6235,8.1705,,18.397,5.816500000000001,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,Gefitinib,CHEMBL939,XGALLCVXEZPNRQ-UHFFFAOYSA-N,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,C22H24ClFN4O3,DB00317,D01977,gefitinib,A549,C3512,Lung (Carcinoma),Lung adenocarcinoma
342946,116,72,28,uM,uM,14.3270284857582,17.8976681829949,18.863065491741,15.010308570195,0.647196610526164,4.66068629069488,33.59,10.571,74.572,61.576,68.074,23.913,,45.9935,34.483999999999995,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,Gefitinib,CHEMBL939,XGALLCVXEZPNRQ-UHFFFAOYSA-N,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,C22H24ClFN4O3,DB00317,D01977,gefitinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
342952,116,72,38,uM,uM,-1.07284734174965,4.62944621872008,6.53822385257601,7.75621371207648,4.75243603628729,10.0,-1.244,5.996,30.116,11.056,20.586,15.834,,18.21,14.589999999999998,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,Gefitinib,CHEMBL939,XGALLCVXEZPNRQ-UHFFFAOYSA-N,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,C22H24ClFN4O3,DB00317,D01977,gefitinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
343028,56,230,38,uM,uM,4.49592954493335,-5.99321447950814,2.95615456309152,6.34509897828146,0.134169130800938,0.287408466752974,4.756,-3.21,2.704,0.56,1.632,0.0859999999999999,,0.8589999999999998,-3.124000000000001,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,Imatinib,CHEMBL941,KTUFNOKKBVMGRW-UHFFFAOYSA-N,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,C29H31N7O,DB00619,D01441,imatinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
343042,56,230,7,uM,uM,-1.72122782071729,-18.0443139049047,-4.82225044467875,-1.75329774404871,0.497567802644297,0.0077012621661591,4.613,-3.445,-1.05,14.053,6.5015,5.3335,,5.9175,1.8885,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,Imatinib,CHEMBL941,KTUFNOKKBVMGRW-UHFFFAOYSA-N,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,C29H31N7O,DB00619,D01441,imatinib,A549,C3512,Lung (Carcinoma),Lung adenocarcinoma
343054,56,230,28,uM,uM,-1.58861522037407,-0.258684250487197,0.913878335260931,3.12388167274157,0.479317498262319,3.10184621638237,-0.542,-1.473,19.649,10.097,14.873,16.888,,15.8805,15.415,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,Imatinib,CHEMBL941,KTUFNOKKBVMGRW-UHFFFAOYSA-N,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,C29H31N7O,DB00619,D01441,imatinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
343231,115,230,28,uM,uM,-1.15597351284364,-7.45960544733989,-7.18356610918352,-4.38951176943338,0.987963832062323,3.10184621638237,-1.287,-1.473,1.898,8.406,5.152,7.912,,6.532,6.439,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,Imatinib,CHEMBL941,KTUFNOKKBVMGRW-UHFFFAOYSA-N,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,C29H31N7O,DB00619,D01441,imatinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
343243,115,230,7,uM,uM,-3.69539407114459,-18.3776064410726,-6.81844034085873,-4.12335830496548,0.362777838678078,0.0077012621661591,10.315,-3.445,7.44,7.144,7.292,0.422000000000001,,3.857,-3.023,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,Imatinib,CHEMBL941,KTUFNOKKBVMGRW-UHFFFAOYSA-N,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,C29H31N7O,DB00619,D01441,imatinib,A549,C3512,Lung (Carcinoma),Lung adenocarcinoma
343253,115,230,38,uM,uM,-0.875078695401575,-6.7347979330297,-1.30134543690848,1.99619054388342,0.230610312300154,0.287408466752974,4.437,-3.21,1.988,0.921,1.4545,0.2275,,0.8409999999999997,-2.9825000000000004,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,Imatinib,CHEMBL941,KTUFNOKKBVMGRW-UHFFFAOYSA-N,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,C29H31N7O,DB00619,D01441,imatinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
343272,101,230,38,uM,uM,1.20030776226535,2.01977891521608,3.59508065904883,7.17447118605075,4.38962339087133,0.287408466752974,-0.959,-3.21,0.725,9.993,5.359,9.528,,7.4435,6.318,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,Imatinib,CHEMBL941,KTUFNOKKBVMGRW-UHFFFAOYSA-N,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,C29H31N7O,DB00619,D01441,imatinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
343278,101,230,28,uM,uM,2.54116238199698,-13.642281563111,-12.0385103543098,-6.72525182444141,0.171867099886755,3.10184621638237,-5.115,-1.473,-10.991,-13.964,-12.4775,-5.8895,,-9.1835,-11.004499999999998,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,Imatinib,CHEMBL941,KTUFNOKKBVMGRW-UHFFFAOYSA-N,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,C29H31N7O,DB00619,D01441,imatinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
343290,101,230,7,uM,uM,-2.23003711067559,-10.1010297129669,-4.70748251023831,-1.73221533983323,3.22123167658349,0.0077012621661591,2.342,-3.445,3.039,14.616,8.8275,9.9305,,9.379,6.4855,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,Imatinib,CHEMBL941,KTUFNOKKBVMGRW-UHFFFAOYSA-N,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,C29H31N7O,DB00619,D01441,imatinib,A549,C3512,Lung (Carcinoma),Lung adenocarcinoma
343350,79,107,28,uM,uM,-1.8450348598378,-2.72590428724028,-3.89577367419209,-4.37565477911831,30.0,9.17823955552302,4.019,0.501,6.127,-1.83,2.1485,-2.3715,,-0.1115000000000003,-1.8705000000000005,Lenalidomide,CHEMBL848,GOTYRUGSSMKFNF-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,C13H13N3O3,DB00480,D04687,lenalidomide,thalidomide,CHEMBL468,UEJJHQNACJXSKW-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,C13H10N2O4,DB01041,D00754,thalidomide,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
343376,79,107,38,uM,uM,-0.956836651796391,2.23911773532375,1.40067077025235,1.98691664154478,30.0,0.305410012032212,2.987,-0.86,3.801,2.759,3.28,1.153,,2.2165,0.2929999999999997,Lenalidomide,CHEMBL848,GOTYRUGSSMKFNF-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,C13H13N3O3,DB00480,D04687,lenalidomide,thalidomide,CHEMBL468,UEJJHQNACJXSKW-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,C13H10N2O4,DB01041,D00754,thalidomide,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
344429,1,30,38,uM,uM,5.63503542632463,2.84893755605593,3.47433743691903,3.49724573405,4.93954994547436,0.0449794155779465,31.568,0.197,34.082,15.943,25.0125,-6.7525,,9.13,-6.555500000000002,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
344624,116,107,38,uM,uM,2.66349434246478,7.11589279661065,7.04582271670523,8.5135364952665,4.75243603628729,0.305410012032212,-1.244,-0.86,4.003,2.204,3.1035,5.2075,,4.1555,3.9635,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,thalidomide,CHEMBL468,UEJJHQNACJXSKW-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,C13H10N2O4,DB01041,D00754,thalidomide,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
344649,116,107,28,uM,uM,2.8673622602089,-19.366062704418,5.2748332144218,5.03170702430028,0.647196610526164,9.17823955552302,33.59,0.501,35.879,43.195,39.537,5.446,,22.4915,5.946999999999996,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,thalidomide,CHEMBL468,UEJJHQNACJXSKW-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,C13H10N2O4,DB01041,D00754,thalidomide,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
345128,53,75,38,uM,uM,-9.16026151982798,-18.7713958384153,-8.13821811863652,-7.99572797085228,20.7438362933702,8.94103798313554,18.749,-0.162,8.279,17.244,12.7615,-5.8255,,3.468,-5.987499999999999,chlorambucil,CHEMBL515,JCKYGMPEJWAADB-UHFFFAOYSA-N,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,C14H19Cl2NO2,DB00291,D00266,chlorambucil,ifosfamide,CHEMBL1024,HOMGKSMUEGBAAB-UHFFFAOYSA-N,C1CN(P(=O)(OC1)NCCCl)CCCl,C7H15Cl2N2O2P,DB01181,D00343,ifosfamide,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
345134,53,75,28,uM,uM,-6.64350817060381,-16.3495049866953,-2.89515934202758,-1.76669577063539,13.0779438627311,78.0766608828273,16.142,-1.231,14.187,6.944,10.5655,-4.3455,,3.1100000000000003,-5.576499999999999,chlorambucil,CHEMBL515,JCKYGMPEJWAADB-UHFFFAOYSA-N,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,C14H19Cl2NO2,DB00291,D00266,chlorambucil,ifosfamide,CHEMBL1024,HOMGKSMUEGBAAB-UHFFFAOYSA-N,C1CN(P(=O)(OC1)NCCCl)CCCl,C7H15Cl2N2O2P,DB01181,D00343,ifosfamide,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
345160,108,75,38,uM,uM,-0.989821482791196,-31.2608251075308,-4.64821811863653,-4.52315087251156,1.45049066398121,8.94103798313554,28.889,-0.162,24.332,44.874,34.603,5.876,,20.2395,5.714000000000002,6-Thioguanine,CHEMBL727,WYWHKKSPHMUBEB-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=C(N2)N,C5H5N5S,DB00352,D08603,thioguanine,ifosfamide,CHEMBL1024,HOMGKSMUEGBAAB-UHFFFAOYSA-N,C1CN(P(=O)(OC1)NCCCl)CCCl,C7H15Cl2N2O2P,DB01181,D00343,ifosfamide,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
345166,108,75,28,uM,uM,0.133388613300254,-44.2708324525092,0.14575597930011,2.03912471421222,1.31560298651524,78.0766608828273,33.09,-1.231,31.407,22.914,27.1605,-4.6985,,11.230999999999998,-5.929500000000004,6-Thioguanine,CHEMBL727,WYWHKKSPHMUBEB-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=C(N2)N,C5H5N5S,DB00352,D08603,thioguanine,ifosfamide,CHEMBL1024,HOMGKSMUEGBAAB-UHFFFAOYSA-N,C1CN(P(=O)(OC1)NCCCl)CCCl,C7H15Cl2N2O2P,DB01181,D00343,ifosfamide,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
345598,40,75,38,uM,uM,1.53738231075213,-8.65371344090917,-9.0272205918684,-5.65230909717847,75.0,8.94103798313554,-3.362,-0.162,-12.73,-9.149,-10.9395,-7.4155,,-9.1775,-10.7775,altretamine,CHEMBL1455,UUVWYPNAQBNQJQ-UHFFFAOYSA-N,CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C,C9H18N6,DB00488,D02841,altretamine,ifosfamide,CHEMBL1024,HOMGKSMUEGBAAB-UHFFFAOYSA-N,C1CN(P(=O)(OC1)NCCCl)CCCl,C7H15Cl2N2O2P,DB01181,D00343,ifosfamide,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
345604,40,75,28,uM,uM,3.89029714584365,-2.64162045085909,-2.17705392520175,4.04024794292921,75.0,78.0766608828273,-6.521,-1.231,-1.511,-3.341,-2.426,5.326,,1.4499999999999995,-1.195,altretamine,CHEMBL1455,UUVWYPNAQBNQJQ-UHFFFAOYSA-N,CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C,C9H18N6,DB00488,D02841,altretamine,ifosfamide,CHEMBL1024,HOMGKSMUEGBAAB-UHFFFAOYSA-N,C1CN(P(=O)(OC1)NCCCl)CCCl,C7H15Cl2N2O2P,DB01181,D00343,ifosfamide,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
345719,1,75,38,uM,uM,2.46713924980432,-9.79843134380397,0.307448548030142,0.426797556319675,4.93954994547436,8.94103798313554,31.568,-0.162,34.739,19.454,27.0965,-4.3095,,11.393499999999998,-4.4715000000000025,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,ifosfamide,CHEMBL1024,HOMGKSMUEGBAAB-UHFFFAOYSA-N,C1CN(P(=O)(OC1)NCCCl)CCCl,C7H15Cl2N2O2P,DB01181,D00343,ifosfamide,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
345729,1,75,28,uM,uM,3.76198352292504,-16.2548213394312,-0.21810700752541,0.273299944050434,3.70539648442761,78.0766608828273,52.846,-1.231,54.332,41.208,47.77,-3.845,,21.96250000000001,-5.075999999999993,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,ifosfamide,CHEMBL1024,HOMGKSMUEGBAAB-UHFFFAOYSA-N,C1CN(P(=O)(OC1)NCCCl)CCCl,C7H15Cl2N2O2P,DB01181,D00343,ifosfamide,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
346188,88,86,28,uM,uM,5.49722100702584,-19.6171441649344,3.45500410358569,1.90585653642556,0.186033682243995,3.04733912633062,29.019,1.384,30.729,60.284,45.5065,15.1035,,30.305000000000003,16.487500000000004,mitoxantrone,CHEMBL58,KKZJGLLVHKMTCM-UHFFFAOYSA-N,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,C22H28N4O6,DB01204,D08224,mitoxantrone,methoxsalen,CHEMBL416,QXKHYNVANLEOEG-UHFFFAOYSA-N,COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,C12H8O4,DB00553,D00139,methoxsalen,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
346209,88,86,38,uM,uM,9.23878634408871,-14.058694375164,9.68555965914125,9.43272796578606,0.0616476966214236,0.207298887026913,26.212,0.121,34.768,47.125,40.9465,14.6135,,27.78,14.7345,mitoxantrone,CHEMBL58,KKZJGLLVHKMTCM-UHFFFAOYSA-N,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,C22H28N4O6,DB01204,D08224,mitoxantrone,methoxsalen,CHEMBL416,QXKHYNVANLEOEG-UHFFFAOYSA-N,COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,C12H8O4,DB00553,D00139,methoxsalen,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
348155,72,86,38,uM,uM,-0.717806185935286,2.52654702516473,4.77844854803014,4.46346185724328,10.0,0.207298887026913,5.994,0.121,7.92,20.439,14.1795,8.0645,,11.122,8.185500000000001,Gefitinib,CHEMBL939,XGALLCVXEZPNRQ-UHFFFAOYSA-N,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,C22H24ClFN4O3,DB00317,D01977,gefitinib,methoxsalen,CHEMBL416,QXKHYNVANLEOEG-UHFFFAOYSA-N,COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,C12H8O4,DB00553,D00139,methoxsalen,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
348165,72,86,28,uM,uM,-6.89966984877033,-5.37964610296568,-0.855926954682757,-2.23414528721735,4.63606799908028,3.04733912633062,10.57,1.384,19.97,46.469,33.2195,21.2655,,27.2425,22.6495,Gefitinib,CHEMBL939,XGALLCVXEZPNRQ-UHFFFAOYSA-N,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,C22H24ClFN4O3,DB00317,D01977,gefitinib,methoxsalen,CHEMBL416,QXKHYNVANLEOEG-UHFFFAOYSA-N,COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,C12H8O4,DB00553,D00139,methoxsalen,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
348418,116,86,28,uM,uM,1.47976368325897,-7.28838441154882,1.72963288352538,1.04125429137825,0.647196610526164,3.04733912633062,33.59,1.384,35.98,45.977,40.9785,6.00449999999999,,23.491499999999995,7.388499999999993,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,methoxsalen,CHEMBL416,QXKHYNVANLEOEG-UHFFFAOYSA-N,COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,C12H8O4,DB00553,D00139,methoxsalen,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
348443,116,86,38,uM,uM,0.941433778147137,3.89342569911748,3.61233496368715,4.92933742435066,4.75243603628729,0.207298887026913,-1.244,0.121,4.998,7.269,6.1335,7.2565,,6.694999999999999,6.012499999999999,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,methoxsalen,CHEMBL416,QXKHYNVANLEOEG-UHFFFAOYSA-N,COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,C12H8O4,DB00553,D00139,methoxsalen,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
348500,79,86,38,uM,uM,2.72530260315448,7.61650766597548,6.7782263258079,6.44791733451781,30.0,0.207298887026913,2.987,0.121,7.357,10.814,9.0855,5.9775,,7.531499999999999,6.0985,Lenalidomide,CHEMBL848,GOTYRUGSSMKFNF-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,C13H13N3O3,DB00480,D04687,lenalidomide,methoxsalen,CHEMBL416,QXKHYNVANLEOEG-UHFFFAOYSA-N,COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,C12H8O4,DB00553,D00139,methoxsalen,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
348526,79,86,28,uM,uM,3.20816025423692,-1.93584211570364,-2.62077343715311,-4.42596378981814,30.0,3.04733912633062,4.019,1.384,3.088,-2.665,0.2115,-5.1915,,-2.49,-3.8075,Lenalidomide,CHEMBL848,GOTYRUGSSMKFNF-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,C13H13N3O3,DB00480,D04687,lenalidomide,methoxsalen,CHEMBL416,QXKHYNVANLEOEG-UHFFFAOYSA-N,COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,C12H8O4,DB00553,D00139,methoxsalen,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
348592,115,86,28,uM,uM,-1.40271643603384,1.50067262595405,1.39172365325787,3.25506456796548,0.987963832062323,3.04733912633062,-1.287,1.384,3.671,10.156,6.9135,6.8165,,6.865,5.5295000000000005,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,methoxsalen,CHEMBL416,QXKHYNVANLEOEG-UHFFFAOYSA-N,COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,C12H8O4,DB00553,D00139,methoxsalen,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
348618,115,86,38,uM,uM,-1.04497610850436,-1.07286005417067,3.87347820152233,4.45791564341253,0.230610312300154,0.207298887026913,4.437,0.121,5.11,9.607,7.3585,2.8005,,5.0795,2.9215,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,methoxsalen,CHEMBL416,QXKHYNVANLEOEG-UHFFFAOYSA-N,COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,C12H8O4,DB00553,D00139,methoxsalen,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
348738,56,86,38,uM,uM,-0.573589659030684,-7.61737465188108,0.589445875480104,1.60519133614391,0.134169130800938,0.207298887026913,4.756,0.121,1.933,-0.626,0.6535,-4.2235,,-1.7850000000000004,-4.1025,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,methoxsalen,CHEMBL416,QXKHYNVANLEOEG-UHFFFAOYSA-N,COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,C12H8O4,DB00553,D00139,methoxsalen,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
348760,56,86,28,uM,uM,-0.995808540478958,-2.85206346455554,-0.47349856896435,0.726540485140421,0.479317498262319,3.04733912633062,-0.542,1.384,2.503,8.518,5.5105,4.6685,,5.0895,4.1265,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,methoxsalen,CHEMBL416,QXKHYNVANLEOEG-UHFFFAOYSA-N,COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,C12H8O4,DB00553,D00139,methoxsalen,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
348803,120,86,28,uM,uM,1.06084596809286,3.69737556619166,3.93066809770232,6.8236838717172,13.2475908300401,3.04733912633062,-2.739,1.384,5.372,28.636,17.004,18.359,,17.6815,15.62,Vismodegib,CHEMBL473417,BPQMGSKTAYIVFO-UHFFFAOYSA-N,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,C19H14Cl2N2O3S,DB08828,D09992,vismodegib,methoxsalen,CHEMBL416,QXKHYNVANLEOEG-UHFFFAOYSA-N,COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,C12H8O4,DB00553,D00139,methoxsalen,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
348813,120,86,38,uM,uM,-1.04380942532321,1.85534855076245,4.99400143103565,5.87525999779397,3.86072665158335,0.207298887026913,4.58,0.121,9.269,11.003,10.136,5.435,,7.785499999999999,5.555999999999999,Vismodegib,CHEMBL473417,BPQMGSKTAYIVFO-UHFFFAOYSA-N,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,C19H14Cl2N2O3S,DB08828,D09992,vismodegib,methoxsalen,CHEMBL416,QXKHYNVANLEOEG-UHFFFAOYSA-N,COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,C12H8O4,DB00553,D00139,methoxsalen,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
349032,101,86,38,uM,uM,-0.110192835540282,1.48875408182193,2.43427920881343,3.80227139113543,4.38962339087133,0.207298887026913,-0.959,0.121,6.374,9.361,7.8675,8.7055,,8.2865,7.746499999999999,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,methoxsalen,CHEMBL416,QXKHYNVANLEOEG-UHFFFAOYSA-N,COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,C12H8O4,DB00553,D00139,methoxsalen,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
349042,101,86,28,uM,uM,8.11088700856367,-5.33690579788038,-4.58922059186842,0.445410946290789,0.171867099886755,3.04733912633062,-5.115,1.384,-9.324,1.164,-4.08,-0.349,,-2.2145,-5.464,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,methoxsalen,CHEMBL416,QXKHYNVANLEOEG-UHFFFAOYSA-N,COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,C12H8O4,DB00553,D00139,methoxsalen,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
351770,101,107,28,uM,uM,3.04438330683739,-2.72554465193584,-2.96466503631285,2.15146750143506,0.171867099886755,9.17823955552302,-5.115,0.501,-5.273,1.378,-1.9475,2.6665,,0.3594999999999999,-2.4485,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,thalidomide,CHEMBL468,UEJJHQNACJXSKW-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,C13H10N2O4,DB01041,D00754,thalidomide,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
351780,101,107,38,uM,uM,-0.0867514798599933,6.4092831667048,7.79850143103564,9.47975042038459,4.38962339087133,0.305410012032212,-0.959,-0.86,5.491,10.38,7.9355,9.7545,,8.845,8.7955,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,thalidomide,CHEMBL468,UEJJHQNACJXSKW-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,C13H10N2O4,DB01041,D00754,thalidomide,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
352003,40,77,38,uM,uM,2.45627062520662,-4.34609514893277,-4.26880237196099,-0.653483993236479,75.0,0.7,-3.362,-2.317,-8.731,-7.723,-8.227,-2.548,,-5.3875,-5.91,altretamine,CHEMBL1455,UUVWYPNAQBNQJQ-UHFFFAOYSA-N,CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C,C9H18N6,DB00488,D02841,altretamine,IMIQUIMOD,CHEMBL1282,DOUYETYNHWVLEO-UHFFFAOYSA-N,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N,C14H16N4,DB00724,D02500,imiquimod,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
352029,40,77,28,uM,uM,3.87079889793683,-4.82166580593396,-4.81438725853508,1.49742497992285,75.0,0.7,-6.521,-2.328,-9.751,-9.683,-9.717,-0.867999999999999,,-5.2925,-7.389000000000001,altretamine,CHEMBL1455,UUVWYPNAQBNQJQ-UHFFFAOYSA-N,CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C,C9H18N6,DB00488,D02841,altretamine,IMIQUIMOD,CHEMBL1282,DOUYETYNHWVLEO-UHFFFAOYSA-N,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N,C14H16N4,DB00724,D02500,imiquimod,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
352222,116,120,28,uM,uM,9.09634043894933,-1.07272439097957,11.0927046462418,12.0715371288844,0.647196610526164,13.2929931381835,33.59,-2.738,62.207,51.319,56.763,25.911,,41.337,23.172999999999995,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,Vismodegib,CHEMBL473417,BPQMGSKTAYIVFO-UHFFFAOYSA-N,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,C19H14Cl2N2O3S,DB08828,D09992,vismodegib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
352232,116,120,38,uM,uM,-1.73430813354571,-0.484106075296505,-0.297176218162436,1.39272550897186,4.75243603628729,3.86004632330607,-1.244,4.58,-1.022,9.702,4.34,1.004,,2.672,-0.2400000000000002,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,Vismodegib,CHEMBL473417,BPQMGSKTAYIVFO-UHFFFAOYSA-N,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,C19H14Cl2N2O3S,DB08828,D09992,vismodegib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
352592,101,120,38,uM,uM,0.128645882617162,1.2506184293146,2.81672671128169,4.11789514658996,4.38962339087133,3.86004632330607,-0.959,4.58,-0.164,7.944,3.89,0.269,,2.0795000000000003,-0.69,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,Vismodegib,CHEMBL473417,BPQMGSKTAYIVFO-UHFFFAOYSA-N,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,C19H14Cl2N2O3S,DB08828,D09992,vismodegib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
352618,101,120,28,uM,uM,2.00222253908474,-4.92160752542238,-3.4763950459808,2.42617397046365,0.171867099886755,13.2929931381835,-5.115,-2.738,-0.481,-1.569,-1.025,6.828,,2.9015,1.713,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,Vismodegib,CHEMBL473417,BPQMGSKTAYIVFO-UHFFFAOYSA-N,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,C19H14Cl2N2O3S,DB08828,D09992,vismodegib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
352663,115,120,38,uM,uM,-3.21260760104515,0.0858324818502543,1.3426613123888,1.28319403942263,0.230610312300154,3.86004632330607,4.437,4.58,9.049,8.252,8.6505,-0.366499999999998,,4.142,4.070499999999999,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,Vismodegib,CHEMBL473417,BPQMGSKTAYIVFO-UHFFFAOYSA-N,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,C19H14Cl2N2O3S,DB08828,D09992,vismodegib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
352669,115,120,28,uM,uM,4.93623184604024,1.67118579839408,5.29651986812694,8.55517283324945,0.987963832062323,13.2929931381835,-1.287,-2.738,30.445,16.367,23.406,27.431,,25.4185,24.693,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,Vismodegib,CHEMBL473417,BPQMGSKTAYIVFO-UHFFFAOYSA-N,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,C19H14Cl2N2O3S,DB08828,D09992,vismodegib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
352846,56,120,38,uM,uM,-3.11535884248511,-2.48322736258971,1.56217660285212,1.82912475132067,0.134169130800938,3.86004632330607,4.756,4.58,4.783,9.583,7.183,-2.153,,2.515,2.427,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,Vismodegib,CHEMBL473417,BPQMGSKTAYIVFO-UHFFFAOYSA-N,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,C19H14Cl2N2O3S,DB08828,D09992,vismodegib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
352852,56,120,28,uM,uM,0.0667553395635222,-1.40560475553643,2.34249581019554,5.19531122459106,0.479317498262319,13.2929931381835,-0.542,-2.738,22.776,15.892,19.334,22.614,,20.974,19.876,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,Vismodegib,CHEMBL473417,BPQMGSKTAYIVFO-UHFFFAOYSA-N,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,C19H14Cl2N2O3S,DB08828,D09992,vismodegib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
353440,120,107,38,uM,uM,6.03843732219006,4.84280587664335,8.62118207525742,9.91447954093203,3.86072665158335,0.305410012032212,4.58,-0.86,12.215,17.813,15.014,11.294,,13.154,10.434,Vismodegib,CHEMBL473417,BPQMGSKTAYIVFO-UHFFFAOYSA-N,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,C19H14Cl2N2O3S,DB08828,D09992,vismodegib,thalidomide,CHEMBL468,UEJJHQNACJXSKW-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,C13H10N2O4,DB01041,D00754,thalidomide,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
353450,120,107,28,uM,uM,0.601598135999713,3.41295039200269,3.57300143103565,6.98554087963924,13.2475908300401,9.17823955552302,-2.739,0.501,8.959,15.653,12.306,14.544,,13.425,11.805,Vismodegib,CHEMBL473417,BPQMGSKTAYIVFO-UHFFFAOYSA-N,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,C19H14Cl2N2O3S,DB08828,D09992,vismodegib,thalidomide,CHEMBL468,UEJJHQNACJXSKW-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,C13H10N2O4,DB01041,D00754,thalidomide,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
353609,56,107,38,uM,uM,-0.840442089115674,-7.71726927760684,1.31929318636853,2.79057932372642,0.134169130800938,0.305410012032212,4.756,-0.86,8.184,3.785,5.9845,2.0885,,4.036499999999999,1.2284999999999997,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,thalidomide,CHEMBL468,UEJJHQNACJXSKW-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,C13H10N2O4,DB01041,D00754,thalidomide,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
353632,56,107,28,uM,uM,1.6502820303453,-2.6629915528418,2.93827920881343,4.62683405417357,0.479317498262319,9.17823955552302,-0.542,0.501,0.666,14.287,7.4765,7.5175,,7.497,6.975499999999999,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,thalidomide,CHEMBL468,UEJJHQNACJXSKW-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,C13H10N2O4,DB01041,D00754,thalidomide,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
353829,53,77,38,uM,uM,-5.65012507373154,-6.08211867865509,-5.84955145196986,-3.97561559579918,20.7438362933702,0.7,18.749,-2.317,12.69,32.794,22.742,6.31,,14.526000000000002,3.993000000000002,chlorambucil,CHEMBL515,JCKYGMPEJWAADB-UHFFFAOYSA-N,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,C14H19Cl2NO2,DB00291,D00266,chlorambucil,IMIQUIMOD,CHEMBL1282,DOUYETYNHWVLEO-UHFFFAOYSA-N,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N,C14H16N4,DB00724,D02500,imiquimod,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
353855,53,77,28,uM,uM,-5.56844464711807,-0.648954814890401,-0.0576889955197685,2.17400455813376,13.0779438627311,0.7,16.142,-2.328,13.905,7.516,10.7105,-3.1035,,3.8035,-5.4315,chlorambucil,CHEMBL515,JCKYGMPEJWAADB-UHFFFAOYSA-N,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,C14H19Cl2NO2,DB00291,D00266,chlorambucil,IMIQUIMOD,CHEMBL1282,DOUYETYNHWVLEO-UHFFFAOYSA-N,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N,C14H16N4,DB00724,D02500,imiquimod,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
354401,115,107,38,uM,uM,-0.724010112941065,1.84263435050728,7.27358931263345,8.44953404488393,0.230610312300154,0.305410012032212,4.437,-0.86,8.564,6.105,7.3345,3.7575,,5.546,2.8975,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,thalidomide,CHEMBL468,UEJJHQNACJXSKW-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,C13H10N2O4,DB01041,D00754,thalidomide,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
354427,115,107,28,uM,uM,-1.26458846133653,-0.620095788339439,3.48105698659122,5.85026680088753,0.987963832062323,9.17823955552302,-1.287,0.501,8.315,12.515,10.415,11.201,,10.808,9.914,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,thalidomide,CHEMBL468,UEJJHQNACJXSKW-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,C13H10N2O4,DB01041,D00754,thalidomide,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
354631,108,77,38,uM,uM,1.75425502180373,-4.55522642520606,-0.890662563080977,0.754138853652654,1.45049066398121,0.7,28.889,-2.317,29.568,37.853,33.7105,7.1385,,20.4245,4.821500000000004,6-Thioguanine,CHEMBL727,WYWHKKSPHMUBEB-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=C(N2)N,C5H5N5S,DB00352,D08603,thioguanine,IMIQUIMOD,CHEMBL1282,DOUYETYNHWVLEO-UHFFFAOYSA-N,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N,C14H16N4,DB00724,D02500,imiquimod,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
354657,108,77,28,uM,uM,1.83936144065209,-7.09660532595636,0.189978201522332,2.61767042676141,1.31560298651524,0.7,33.09,-2.328,35.785,44.606,40.1955,9.43349999999999,,24.8145,7.105499999999999,6-Thioguanine,CHEMBL727,WYWHKKSPHMUBEB-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=C(N2)N,C5H5N5S,DB00352,D08603,thioguanine,IMIQUIMOD,CHEMBL1282,DOUYETYNHWVLEO-UHFFFAOYSA-N,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N,C14H16N4,DB00724,D02500,imiquimod,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
355733,72,75,28,uM,uM,1.61984656279566,-18.809577078353,2.60644854803014,3.44444406444244,4.63606799908028,78.0766608828273,10.57,-1.231,26.539,31.006,28.7725,19.4335,,24.103,18.2025,Gefitinib,CHEMBL939,XGALLCVXEZPNRQ-UHFFFAOYSA-N,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,C22H24ClFN4O3,DB00317,D01977,gefitinib,ifosfamide,CHEMBL1024,HOMGKSMUEGBAAB-UHFFFAOYSA-N,C1CN(P(=O)(OC1)NCCCl)CCCl,C7H15Cl2N2O2P,DB01181,D00343,ifosfamide,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
355743,72,75,38,uM,uM,-3.52539175946333,-18.7319599784029,-4.80466256308096,-4.64345987843231,10.0,8.94103798313554,5.994,-0.162,4.722,4.571,4.6465,-1.1855,,1.7304999999999997,-1.3475,Gefitinib,CHEMBL939,XGALLCVXEZPNRQ-UHFFFAOYSA-N,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,C22H24ClFN4O3,DB00317,D01977,gefitinib,ifosfamide,CHEMBL1024,HOMGKSMUEGBAAB-UHFFFAOYSA-N,C1CN(P(=O)(OC1)NCCCl)CCCl,C7H15Cl2N2O2P,DB01181,D00343,ifosfamide,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
355873,116,8,28,uM,uM,7.68939402464796,9.88351303489678,11.5278115348557,8.50481359132969,0.647196610526164,0.1,33.59,9.309,64.889,66.984,65.9365,23.0375,,44.487,32.34649999999999,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
355885,116,8,7,uM,uM,8.83518946248862,-5.64520935757713,10.7440810445226,11.9316995608435,5.0,0.1,-2.354,9.06,46.23,26.826,36.528,29.822,,33.175,27.468,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,A549,C3512,Lung (Carcinoma),Lung adenocarcinoma
355895,116,8,38,uM,uM,-0.0973766547865682,-1.92972685599841,1.93600163035381,3.23135320634782,4.75243603628729,0.1,-1.244,2.038,6.131,4.898,5.5145,4.7205,,5.1175,3.4765,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
356600,1,77,38,uM,uM,5.14316872054369,1.34249311161149,1.96789299247459,3.53749194026168,4.93954994547436,0.7,31.568,-2.317,34.035,20.976,27.5055,-1.7455,,12.88,-4.0625,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,IMIQUIMOD,CHEMBL1282,DOUYETYNHWVLEO-UHFFFAOYSA-N,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N,C14H16N4,DB00724,D02500,imiquimod,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
356622,1,77,28,uM,uM,2.53261682146423,-3.93143904448167,-2.80166256308098,-1.58777724117817,3.70539648442761,0.7,52.846,-2.328,54.21,27.089,40.6495,-9.86849999999999,,15.390500000000008,-12.196499999999991,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,IMIQUIMOD,CHEMBL1282,DOUYETYNHWVLEO-UHFFFAOYSA-N,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N,C14H16N4,DB00724,D02500,imiquimod,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
356722,56,75,28,uM,uM,-1.22359946016468,-10.7193951961917,-1.26627634674212,0.899441819855783,0.479317498262319,78.0766608828273,-0.542,-1.231,4.227,14.286,9.2565,11.0295,,10.143,9.7985,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,ifosfamide,CHEMBL1024,HOMGKSMUEGBAAB-UHFFFAOYSA-N,C1CN(P(=O)(OC1)NCCCl)CCCl,C7H15Cl2N2O2P,DB01181,D00343,ifosfamide,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
356744,56,75,38,uM,uM,-2.17594908812122,-7.67203655984932,0.985070964146316,2.27863001713497,0.134169130800938,8.94103798313554,4.756,-0.162,3.633,2.53,3.0815,-1.5125,,0.7845,-1.6745,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,ifosfamide,CHEMBL1024,HOMGKSMUEGBAAB-UHFFFAOYSA-N,C1CN(P(=O)(OC1)NCCCl)CCCl,C7H15Cl2N2O2P,DB01181,D00343,ifosfamide,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
356785,120,75,38,uM,uM,-1.24882056029157,-1.01337363849229,4.34095985303521,5.4554942343406,3.86072665158335,8.94103798313554,4.58,-0.162,4.764,8.854,6.809,2.391,,4.6,2.229,Vismodegib,CHEMBL473417,BPQMGSKTAYIVFO-UHFFFAOYSA-N,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,C19H14Cl2N2O3S,DB08828,D09992,vismodegib,ifosfamide,CHEMBL1024,HOMGKSMUEGBAAB-UHFFFAOYSA-N,C1CN(P(=O)(OC1)NCCCl)CCCl,C7H15Cl2N2O2P,DB01181,D00343,ifosfamide,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
356795,120,75,28,uM,uM,-0.0831878623829711,-2.52146513418843,0.910779208813436,4.83076927921034,13.2475908300401,78.0766608828273,-2.739,-1.231,3.746,9.576,6.661,10.631,,8.645999999999999,7.891999999999999,Vismodegib,CHEMBL473417,BPQMGSKTAYIVFO-UHFFFAOYSA-N,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,C19H14Cl2N2O3S,DB08828,D09992,vismodegib,ifosfamide,CHEMBL1024,HOMGKSMUEGBAAB-UHFFFAOYSA-N,C1CN(P(=O)(OC1)NCCCl)CCCl,C7H15Cl2N2O2P,DB01181,D00343,ifosfamide,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
356991,115,75,38,uM,uM,0.612629333631967,-4.42776060074531,1.09758931263345,2.0042890744036,0.230610312300154,8.94103798313554,4.437,-0.162,4.543,2.017,3.28,-0.995,,1.1424999999999996,-1.1570000000000005,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,ifosfamide,CHEMBL1024,HOMGKSMUEGBAAB-UHFFFAOYSA-N,C1CN(P(=O)(OC1)NCCCl)CCCl,C7H15Cl2N2O2P,DB01181,D00343,ifosfamide,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
357017,115,75,28,uM,uM,-0.343972046458407,-5.89285818442803,1.78339031992455,4.64671330018085,0.987963832062323,78.0766608828273,-1.287,-1.231,5.345,13.168,9.2565,11.7745,,10.5155,10.4875,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,ifosfamide,CHEMBL1024,HOMGKSMUEGBAAB-UHFFFAOYSA-N,C1CN(P(=O)(OC1)NCCCl)CCCl,C7H15Cl2N2O2P,DB01181,D00343,ifosfamide,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
357191,101,75,28,uM,uM,4.1366235074688,-1.72717404031226,-1.39827614742397,3.79746341295058,0.171867099886755,78.0766608828273,-5.115,-1.231,3.754,0.395,2.0745,8.4205,,5.2475000000000005,3.3055000000000003,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,ifosfamide,CHEMBL1024,HOMGKSMUEGBAAB-UHFFFAOYSA-N,C1CN(P(=O)(OC1)NCCCl)CCCl,C7H15Cl2N2O2P,DB01181,D00343,ifosfamide,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
357201,101,75,38,uM,uM,0.965420545782832,-0.290381715964925,0.965279208813424,2.5039385443487,4.38962339087133,8.94103798313554,-0.959,-0.162,-1.167,3.081,0.957,2.078,,1.5175,1.119,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,ifosfamide,CHEMBL1024,HOMGKSMUEGBAAB-UHFFFAOYSA-N,C1CN(P(=O)(OC1)NCCCl)CCCl,C7H15Cl2N2O2P,DB01181,D00343,ifosfamide,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
358446,79,75,28,uM,uM,0.902831870723033,4.86984433267194,3.66889299247457,4.6647659312861,30.0,78.0766608828273,4.019,-1.231,8.359,7.795,8.077,5.289,,6.683,4.058,Lenalidomide,CHEMBL848,GOTYRUGSSMKFNF-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,C13H13N3O3,DB00480,D04687,lenalidomide,ifosfamide,CHEMBL1024,HOMGKSMUEGBAAB-UHFFFAOYSA-N,C1CN(P(=O)(OC1)NCCCl)CCCl,C7H15Cl2N2O2P,DB01181,D00343,ifosfamide,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
358456,79,75,38,uM,uM,-0.397763182609655,-4.84931889875332,-5.76655145196987,-5.59750717893556,30.0,8.94103798313554,2.987,-0.162,-3.577,-6.121,-4.849,-7.674,,-6.2615,-7.836,Lenalidomide,CHEMBL848,GOTYRUGSSMKFNF-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,C13H13N3O3,DB00480,D04687,lenalidomide,ifosfamide,CHEMBL1024,HOMGKSMUEGBAAB-UHFFFAOYSA-N,C1CN(P(=O)(OC1)NCCCl)CCCl,C7H15Cl2N2O2P,DB01181,D00343,ifosfamide,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
358470,116,75,38,uM,uM,0.635965689557113,2.20003594788679,2.20477917109262,3.60394304978617,4.75243603628729,8.94103798313554,-1.244,-0.162,-0.75,8.151,3.7005,5.1065,,4.4035,3.8625,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,ifosfamide,CHEMBL1024,HOMGKSMUEGBAAB-UHFFFAOYSA-N,C1CN(P(=O)(OC1)NCCCl)CCCl,C7H15Cl2N2O2P,DB01181,D00343,ifosfamide,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
358496,116,75,28,uM,uM,4.8516606119096,-32.9143357884103,4.20922632580792,4.90689602914915,0.647196610526164,78.0766608828273,33.59,-1.231,38.148,40.278,39.213,6.854,,23.0335,5.6229999999999976,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,ifosfamide,CHEMBL1024,HOMGKSMUEGBAAB-UHFFFAOYSA-N,C1CN(P(=O)(OC1)NCCCl)CCCl,C7H15Cl2N2O2P,DB01181,D00343,ifosfamide,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
361232,120,8,28,uM,uM,4.61947949950265,-4.24729202062244,10.2230810445226,11.6604882577797,13.2475908300401,0.1,-2.739,9.309,47.219,34.217,40.718,34.148,,37.43300000000001,31.40900000000001,Vismodegib,CHEMBL473417,BPQMGSKTAYIVFO-UHFFFAOYSA-N,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,C19H14Cl2N2O3S,DB08828,D09992,vismodegib,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
361238,120,8,38,uM,uM,-2.15450405865496,3.43895446031656,3.78833476436898,4.18721580756891,3.86072665158335,0.1,4.58,2.038,15.857,6.815,11.336,4.718,,8.027000000000001,6.756,Vismodegib,CHEMBL473417,BPQMGSKTAYIVFO-UHFFFAOYSA-N,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,C19H14Cl2N2O3S,DB08828,D09992,vismodegib,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
361347,56,8,38,uM,uM,-1.63420047173686,-0.673623953324226,-0.201220791186571,0.336079145918847,0.134169130800938,0.1,4.756,2.038,9.649,-1.84,3.9045,-2.8895,,0.5074999999999998,-0.8515000000000001,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
361361,56,8,7,uM,uM,4.52914500683382,-5.27168378446019,14.4000014310356,13.2386158171803,0.497567802644297,0.1,4.613,9.06,56.068,43.241,49.6545,35.9815,,42.818,40.5945,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,A549,C3512,Lung (Carcinoma),Lung adenocarcinoma
361373,56,8,28,uM,uM,1.59228239194436,3.11761740541583,7.83374771118925,7.63511847675852,0.479317498262319,0.1,-0.542,9.309,40.709,32.256,36.4825,27.7155,,32.099000000000004,27.173500000000004,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
361859,115,8,28,uM,uM,-0.0935792220194757,-1.71255680685084,4.81174771118926,5.33927047902803,0.987963832062323,0.1,-1.287,9.309,36.747,23.767,30.257,22.235,,26.246,20.948,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
361863,115,8,7,uM,uM,14.5612529981147,-0.749204633381012,16.4216125421467,13.4528623951524,0.362777838678078,0.1,10.315,9.06,52.718,40.085,46.4015,27.0265,,36.714,36.0865,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,A549,C3512,Lung (Carcinoma),Lung adenocarcinoma
361881,115,8,38,uM,uM,-2.98583995527341,-3.41639370033971,-3.03510117492565,-3.43307888847919,0.230610312300154,0.1,4.437,2.038,5.07,-1.13,1.97,-4.505,,-1.2674999999999998,-2.4670000000000005,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
362302,1,116,28,uM,uM,-5.47241095484809,-1.82774992427255,0.645303921124053,-6.89178454313404,3.70539648442761,0.647340538074254,52.846,33.591,63.726,39.13,51.428,-35.009,,8.209499999999998,-1.4179999999999993,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
362324,1,116,38,uM,uM,5.79906940844693,1.67696559918951,4.4671152146968,5.36902145586609,4.93954994547436,4.79432171150704,31.568,-1.242,38.434,25.643,32.0385,1.7125,,16.8755,0.4704999999999977,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
362554,101,8,38,uM,uM,-0.686702058746202,1.16082155875121,1.60783476436898,2.43464690924369,4.38962339087133,0.1,-0.959,2.038,10.27,4.192,7.231,6.152,,6.6915,5.193,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
362560,101,8,28,uM,uM,-1.93408992025863,-48.5779128107963,-5.82310948075733,-1.13307890931334,0.171867099886755,0.1,-5.115,9.309,14.62,6.082,10.351,6.157,,8.254000000000001,1.0420000000000016,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
362564,101,8,7,uM,uM,6.19402672722884,-9.55122685812538,15.4599458754801,13.9318911380625,3.22123167658349,0.1,2.342,9.06,56.533,28.438,42.4855,31.0835,,36.7845,33.4255,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,Dasatinib,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,C22H26ClN7O2S,DB01254,D03658,dasatinib,A549,C3512,Lung (Carcinoma),Lung adenocarcinoma
362604,40,116,28,uM,uM,0.761090679323965,-38.8490463551152,-3.27455392520179,0.834405761300281,75.0,0.647340538074254,-6.521,33.591,21.453,35.164,28.3085,1.2385,,14.7735,-5.282500000000002,altretamine,CHEMBL1455,UUVWYPNAQBNQJQ-UHFFFAOYSA-N,CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C,C9H18N6,DB00488,D02841,altretamine,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
362630,40,116,38,uM,uM,1.71349270413616,-3.19351267177617,-2.83602789998289,0.66227237903461,75.0,4.79432171150704,-3.362,-1.242,-5.044,-3.564,-4.304,0.3,,-2.002,-3.0620000000000003,altretamine,CHEMBL1455,UUVWYPNAQBNQJQ-UHFFFAOYSA-N,CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C,C9H18N6,DB00488,D02841,altretamine,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
363233,108,116,28,uM,uM,-1.9098966082293,-4.92775334833058,0.475853112856098,-1.78631329575002,1.31560298651524,0.647340538074254,33.09,33.591,57.033,56.335,56.684,-9.99700000000001,,23.34349999999999,23.093,6-Thioguanine,CHEMBL727,WYWHKKSPHMUBEB-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=C(N2)N,C5H5N5S,DB00352,D08603,thioguanine,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
363259,108,116,38,uM,uM,0.0686041682653444,-13.2319361686335,-1.21221811863653,-0.267099835187368,1.45049066398121,4.79432171150704,28.889,-1.242,28.808,42.095,35.4515,7.8045,,21.628000000000004,6.562500000000004,6-Thioguanine,CHEMBL727,WYWHKKSPHMUBEB-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=C(N2)N,C5H5N5S,DB00352,D08603,thioguanine,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
363380,53,116,28,uM,uM,-5.14593269445309,-12.7139811465521,1.7010262158283,-1.33549606514509,13.0779438627311,0.647340538074254,16.142,33.591,40.729,40.155,40.442,-9.291,,15.575499999999998,6.850999999999999,chlorambucil,CHEMBL515,JCKYGMPEJWAADB-UHFFFAOYSA-N,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,C14H19Cl2NO2,DB00291,D00266,chlorambucil,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
363406,53,116,38,uM,uM,3.24367039148818,-0.17896328016516,1.41767077025237,2.49445184647191,20.7438362933702,4.79432171150704,18.749,-1.242,18.65,34.628,26.639,9.132,,17.8855,7.890000000000001,chlorambucil,CHEMBL515,JCKYGMPEJWAADB-UHFFFAOYSA-N,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,C14H19Cl2NO2,DB00291,D00266,chlorambucil,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
363974,56,53,38,uM,uM,0.141841809495446,0.270181380569736,1.12085882230036,-0.431049039449377,0.134169130800938,20.7378975640732,4.756,18.749,40.834,21.276,31.055,7.55,,19.3025,12.306,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,chlorambucil,CHEMBL515,JCKYGMPEJWAADB-UHFFFAOYSA-N,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,C14H19Cl2NO2,DB00291,D00266,chlorambucil,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
363984,56,53,28,uM,uM,-8.03704546645011,-7.07663422072281,-2.8083736251998,-2.2692988021367,0.479317498262319,13.0773575280054,-0.542,16.142,1.245,18.858,10.0515,-5.5485,,2.251500000000001,-6.090499999999999,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,chlorambucil,CHEMBL515,JCKYGMPEJWAADB-UHFFFAOYSA-N,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,C14H19Cl2NO2,DB00291,D00266,chlorambucil,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
364031,120,53,28,uM,uM,-7.33062702362975,-6.61379465688371,-2.60738983236064,-0.53766651155542,13.2475908300401,13.0773575280054,-2.739,16.142,13.323,20.341,16.832,3.429,,10.1305,0.6900000000000013,Vismodegib,CHEMBL473417,BPQMGSKTAYIVFO-UHFFFAOYSA-N,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,C19H14Cl2N2O3S,DB08828,D09992,vismodegib,chlorambucil,CHEMBL515,JCKYGMPEJWAADB-UHFFFAOYSA-N,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,C14H19Cl2NO2,DB00291,D00266,chlorambucil,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
364053,120,53,38,uM,uM,-0.626900567834899,-3.29193910288763,0.694747711189241,-0.910749888910428,3.86072665158335,20.7378975640732,4.58,18.749,41.449,19.557,30.503,7.174,,18.8385,11.754,Vismodegib,CHEMBL473417,BPQMGSKTAYIVFO-UHFFFAOYSA-N,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,C19H14Cl2N2O3S,DB08828,D09992,vismodegib,chlorambucil,CHEMBL515,JCKYGMPEJWAADB-UHFFFAOYSA-N,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,C14H19Cl2NO2,DB00291,D00266,chlorambucil,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
364183,115,53,28,uM,uM,-5.09783290360389,-1.10197770902712,1.95661016763935,3.15723842407498,0.987963832062323,13.0773575280054,-1.287,16.142,13.385,18.946,16.1655,1.3105,,8.738000000000001,0.023500000000002,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,chlorambucil,CHEMBL515,JCKYGMPEJWAADB-UHFFFAOYSA-N,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,C14H19Cl2NO2,DB00291,D00266,chlorambucil,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
364189,115,53,38,uM,uM,-1.47503285211829,1.86968451001258,2.57510155961531,0.492579138374803,0.230610312300154,20.7378975640732,4.437,18.749,34.776,20.991,27.8835,4.6975,,16.2905,9.134500000000005,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,chlorambucil,CHEMBL515,JCKYGMPEJWAADB-UHFFFAOYSA-N,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,C14H19Cl2NO2,DB00291,D00266,chlorambucil,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
364325,101,53,38,uM,uM,-0.945299271665035,-5.53101446126125,-3.19402789998292,-2.98619935945785,4.38962339087133,20.7378975640732,-0.959,18.749,35.293,14.746,25.0195,7.2295,,16.1245,6.270500000000002,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,chlorambucil,CHEMBL515,JCKYGMPEJWAADB-UHFFFAOYSA-N,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,C14H19Cl2NO2,DB00291,D00266,chlorambucil,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
364347,101,53,28,uM,uM,-2.0612454675613,-10.2748245726724,-4.86702480208501,-0.420453044724815,0.171867099886755,13.0773575280054,-5.115,16.142,-4.434,0.434,-2.0,-13.027,,-7.5135,-18.142,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,chlorambucil,CHEMBL515,JCKYGMPEJWAADB-UHFFFAOYSA-N,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,C14H19Cl2NO2,DB00291,D00266,chlorambucil,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
365696,79,53,38,uM,uM,-9.92088482164665,-3.61075697141275,-1.67032667766828,-3.70606124940878,30.0,20.7378975640732,2.987,18.749,29.62,18.04,23.83,2.094,,12.962,5.081,Lenalidomide,CHEMBL848,GOTYRUGSSMKFNF-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,C13H13N3O3,DB00480,D04687,lenalidomide,chlorambucil,CHEMBL515,JCKYGMPEJWAADB-UHFFFAOYSA-N,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,C14H19Cl2NO2,DB00291,D00266,chlorambucil,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
365702,79,53,28,uM,uM,40.421076063302,28.3654333968217,37.1365771830681,35.6428131724333,30.0,13.0773575280054,4.019,16.142,63.7,83.951,73.8255,53.6645,,63.745000000000005,57.68350000000001,Lenalidomide,CHEMBL848,GOTYRUGSSMKFNF-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,C13H13N3O3,DB00480,D04687,lenalidomide,chlorambucil,CHEMBL515,JCKYGMPEJWAADB-UHFFFAOYSA-N,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,C14H19Cl2NO2,DB00291,D00266,chlorambucil,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
365845,116,53,28,uM,uM,-7.07126118766931,-17.0899386078747,-2.67593592272401,-5.71242823500452,0.647196610526164,13.0773575280054,33.59,16.142,28.413,32.747,30.58,-19.152,,5.713999999999999,-3.010000000000005,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,chlorambucil,CHEMBL515,JCKYGMPEJWAADB-UHFFFAOYSA-N,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,C14H19Cl2NO2,DB00291,D00266,chlorambucil,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
365851,116,53,38,uM,uM,3.06941279314313,-0.0921827305434084,1.50455718590932,2.58116214320182,4.75243603628729,20.7378975640732,-1.244,18.749,40.648,21.391,31.0195,13.5145,,22.267000000000003,12.270500000000002,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,chlorambucil,CHEMBL515,JCKYGMPEJWAADB-UHFFFAOYSA-N,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,C14H19Cl2NO2,DB00291,D00266,chlorambucil,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
366212,72,53,38,uM,uM,-8.41986344840418,-1.28688438865069,-0.299995510940549,-4.36695356001667,10.0,20.7378975640732,5.994,18.749,25.338,28.3,26.819,2.076,,14.4475,8.07,Gefitinib,CHEMBL939,XGALLCVXEZPNRQ-UHFFFAOYSA-N,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,C22H24ClFN4O3,DB00317,D01977,gefitinib,chlorambucil,CHEMBL515,JCKYGMPEJWAADB-UHFFFAOYSA-N,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,C14H19Cl2NO2,DB00291,D00266,chlorambucil,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
366234,72,53,28,uM,uM,5.43406607344755,-2.7103094641055,1.74345082483859,-1.13036598058385,4.63606799908028,13.0773575280054,10.57,16.142,16.664,39.162,27.913,1.201,,14.557,11.771,Gefitinib,CHEMBL939,XGALLCVXEZPNRQ-UHFFFAOYSA-N,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,C22H24ClFN4O3,DB00317,D01977,gefitinib,chlorambucil,CHEMBL515,JCKYGMPEJWAADB-UHFFFAOYSA-N,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,C14H19Cl2NO2,DB00291,D00266,chlorambucil,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
368628,88,107,38,uM,uM,4.44294696743336,-20.0884550517445,5.45955965914125,5.9082956617019,0.0616476966214236,0.305410012032212,26.212,-0.86,30.649,50.502,40.5755,15.2235,,27.8995,14.363499999999998,mitoxantrone,CHEMBL58,KKZJGLLVHKMTCM-UHFFFAOYSA-N,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,C22H28N4O6,DB01204,D08224,mitoxantrone,thalidomide,CHEMBL468,UEJJHQNACJXSKW-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,C13H10N2O4,DB01041,D00754,thalidomide,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
368650,88,107,28,uM,uM,3.92833516989429,-20.759874135088,2.57978188136348,2.20635063045872,0.186033682243995,9.17823955552302,29.019,0.501,24.99,47.812,36.401,6.881,,21.641000000000005,7.382000000000005,mitoxantrone,CHEMBL58,KKZJGLLVHKMTCM-UHFFFAOYSA-N,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,C22H28N4O6,DB01204,D08224,mitoxantrone,thalidomide,CHEMBL468,UEJJHQNACJXSKW-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,C13H10N2O4,DB01041,D00754,thalidomide,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
369052,72,30,38,uM,uM,-0.734444457908172,1.35580392796407,1.3680041035857,1.39894595263134,10.0,0.0449794155779465,5.994,0.197,9.156,12.924,11.04,4.849,,7.9445,5.045999999999999,Gefitinib,CHEMBL939,XGALLCVXEZPNRQ-UHFFFAOYSA-N,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,C22H24ClFN4O3,DB00317,D01977,gefitinib,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
369058,72,30,28,uM,uM,2.13593242960247,3.34928903842755,2.7133136160266,3.08454682009877,4.63606799908028,0.328052190693927,10.57,-1.044,24.75,17.081,20.9155,11.3895,,16.152500000000003,10.3455,Gefitinib,CHEMBL939,XGALLCVXEZPNRQ-UHFFFAOYSA-N,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,C22H24ClFN4O3,DB00317,D01977,gefitinib,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
369070,72,30,7,uM,uM,2.22137270385089,-0.159246762893683,2.36683743691903,3.04510863134479,1.19272204952941,0.29572887941918,22.807,-1.113,25.501,25.44,25.4705,3.7765,,14.623500000000002,2.663500000000002,Gefitinib,CHEMBL939,XGALLCVXEZPNRQ-UHFFFAOYSA-N,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,C22H24ClFN4O3,DB00317,D01977,gefitinib,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,A549,C3512,Lung (Carcinoma),Lung adenocarcinoma
369457,72,48,38,uM,uM,5.19952839399406,-5.49662153081287,2.1607604388363,0.934092311536988,10.0,14.6683424827181,5.994,5.58,7.031,8.515,7.773,-3.801,,1.986,1.779,Gefitinib,CHEMBL939,XGALLCVXEZPNRQ-UHFFFAOYSA-N,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,C22H24ClFN4O3,DB00317,D01977,gefitinib,busulfan,CHEMBL820,COVZYZSDYWQREU-UHFFFAOYSA-N,CS(=O)(=O)OCCCCOS(=O)(=O)C,C6H14O6S2,DB01008,D00248,busulfan,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
369478,72,48,28,uM,uM,4.02492056037379,-4.15686299724869,5.19006971423823,6.98764000337349,4.63606799908028,41.9826965945651,10.57,-3.28,24.691,38.005,31.348,24.058,,27.703,20.778,Gefitinib,CHEMBL939,XGALLCVXEZPNRQ-UHFFFAOYSA-N,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,C22H24ClFN4O3,DB00317,D01977,gefitinib,busulfan,CHEMBL820,COVZYZSDYWQREU-UHFFFAOYSA-N,CS(=O)(=O)OCCCCOS(=O)(=O)C,C6H14O6S2,DB01008,D00248,busulfan,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
369746,72,116,38,uM,uM,-2.16783864758691,-4.11568599521765,-2.2031070075254,-0.984917518885895,10.0,4.79432171150704,5.994,-1.242,5.986,12.348,9.167,4.415,,6.791,3.173,Gefitinib,CHEMBL939,XGALLCVXEZPNRQ-UHFFFAOYSA-N,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,C22H24ClFN4O3,DB00317,D01977,gefitinib,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
369764,72,116,7,uM,uM,0.373939490102497,-3.19267551991861,0.199281881363477,0.78822272337095,1.19272204952941,5.0,22.807,-2.352,26.191,22.143,24.167,3.712,,13.939500000000002,1.360000000000003,Gefitinib,CHEMBL939,XGALLCVXEZPNRQ-UHFFFAOYSA-N,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,C22H24ClFN4O3,DB00317,D01977,gefitinib,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,A549,C3512,Lung (Carcinoma),Lung adenocarcinoma
369768,72,116,28,uM,uM,5.23270349304442,7.62454569364223,10.9472822668372,7.09444919725798,4.63606799908028,0.647340538074254,10.57,33.591,65.524,55.642,60.583,16.422,,38.5025,26.992,Gefitinib,CHEMBL939,XGALLCVXEZPNRQ-UHFFFAOYSA-N,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,C22H24ClFN4O3,DB00317,D01977,gefitinib,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
369994,101,30,38,uM,uM,0.147522831871264,1.08785799244068,1.42139031992453,2.91336393096792,4.38962339087133,0.0449794155779465,-0.959,0.197,-0.984,1.584,0.3,1.062,,0.681,0.1029999999999999,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
370000,101,30,28,uM,uM,7.91070655378467,-5.314534980506,-2.99851035430981,2.18863181194024,0.171867099886755,0.328052190693927,-5.115,-1.044,-3.691,-0.6,-2.1455,4.0135,,0.9340000000000002,-1.1015,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
370004,101,30,7,uM,uM,-3.06155463583326,-4.18605682612692,-4.42075044467876,-2.80511150784164,3.22123167658349,0.29572887941918,2.342,-1.113,-0.954,13.151,6.0985,4.8695,,5.484,3.7565,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,A549,C3512,Lung (Carcinoma),Lung adenocarcinoma
370279,120,30,28,uM,uM,-0.92012139862032,-5.08401409033273,-3.56977634674212,0.121098866533329,13.2475908300401,0.328052190693927,-2.739,-1.044,3.79,3.919,3.8545,7.6375,,5.746,4.8985,Vismodegib,CHEMBL473417,BPQMGSKTAYIVFO-UHFFFAOYSA-N,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,C19H14Cl2N2O3S,DB08828,D09992,vismodegib,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
370285,120,30,38,uM,uM,-1.47963570858615,3.79163503074302,4.26707533507835,5.32610342095981,3.86072665158335,0.0449794155779465,4.58,0.197,5.324,3.889,4.6065,-0.170500000000001,,2.2179999999999995,0.0264999999999995,Vismodegib,CHEMBL473417,BPQMGSKTAYIVFO-UHFFFAOYSA-N,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,C19H14Cl2N2O3S,DB08828,D09992,vismodegib,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
370330,56,30,38,uM,uM,-1.18046087766883,-5.02646873797394,-0.0110357760327652,1.20446729264307,0.134169130800938,0.0449794155779465,4.756,0.197,7.519,5.016,6.2675,1.3145,,3.791,1.5114999999999998,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
370352,56,30,7,uM,uM,-4.89222230326444,-3.8840950787478,-4.37591711134543,-2.50496363427935,0.497567802644297,0.29572887941918,4.613,-1.113,1.931,30.536,16.2335,12.7335,,14.4835,11.6205,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,A549,C3512,Lung (Carcinoma),Lung adenocarcinoma
370356,56,30,28,uM,uM,-1.60806291469694,-2.21373190758683,-0.909510553627963,1.1407795105121,0.479317498262319,0.328052190693927,-0.542,-1.044,6.102,9.083,7.5925,9.1785,,8.3855,8.134500000000001,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
370542,115,30,38,uM,uM,-2.38331990134349,-3.16402261761375,-0.325299576255433,0.49324584768948,0.230610312300154,0.0449794155779465,4.437,0.197,4.037,5.041,4.539,-0.0950000000000006,,2.2219999999999995,0.1019999999999994,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
370556,115,30,7,uM,uM,-3.2273365740767,-9.46048952882587,-3.27088478530319,-2.48232291741835,0.362777838678078,0.29572887941918,10.315,-1.113,6.708,27.518,17.113,7.911,,12.512,6.798,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,A549,C3512,Lung (Carcinoma),Lung adenocarcinoma
370568,115,30,28,uM,uM,-0.264992608427308,0.103126169508707,0.492612542146765,3.13284255028161,0.987963832062323,0.328052190693927,-1.287,-1.044,4.957,11.242,8.0995,10.4305,,9.265,9.1435,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
370935,56,48,38,uM,uM,-3.56923932298451,-7.05488351196634,-3.00378949587915,-2.80723669567349,0.134169130800938,14.6683424827181,4.756,5.58,-2.324,-2.549,-2.4365,-12.7725,,-7.6045,-8.0165,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,busulfan,CHEMBL820,COVZYZSDYWQREU-UHFFFAOYSA-N,CS(=O)(=O)OCCCCOS(=O)(=O)C,C6H14O6S2,DB01008,D00248,busulfan,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
370945,56,48,28,uM,uM,-2.4290615178914,-12.7287423776293,-7.33412845005258,-4.16418944760206,0.479317498262319,41.9826965945651,-0.542,-3.28,4.414,-0.983,1.7155,5.5375,,3.6265,2.2575000000000003,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,busulfan,CHEMBL820,COVZYZSDYWQREU-UHFFFAOYSA-N,CS(=O)(=O)OCCCCOS(=O)(=O)C,C6H14O6S2,DB01008,D00248,busulfan,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
370986,120,48,38,uM,uM,-3.6622172799373,-5.67723679292223,-3.12721773316276,-2.946842789579,3.86072665158335,14.6683424827181,4.58,5.58,6.629,8.241,7.435,-2.725,,2.3549999999999995,1.8549999999999995,Vismodegib,CHEMBL473417,BPQMGSKTAYIVFO-UHFFFAOYSA-N,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,C19H14Cl2N2O3S,DB08828,D09992,vismodegib,busulfan,CHEMBL820,COVZYZSDYWQREU-UHFFFAOYSA-N,CS(=O)(=O)OCCCCOS(=O)(=O)C,C6H14O6S2,DB01008,D00248,busulfan,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
371012,120,48,28,uM,uM,-1.08911836286821,-7.68479184131299,-6.27219251075795,-2.2296127921364,13.2475908300401,41.9826965945651,-2.739,-3.28,1.29,7.949,4.6195,10.6385,,7.629,7.3585,Vismodegib,CHEMBL473417,BPQMGSKTAYIVFO-UHFFFAOYSA-N,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,C19H14Cl2N2O3S,DB08828,D09992,vismodegib,busulfan,CHEMBL820,COVZYZSDYWQREU-UHFFFAOYSA-N,CS(=O)(=O)OCCCCOS(=O)(=O)C,C6H14O6S2,DB01008,D00248,busulfan,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
371321,115,48,28,uM,uM,-2.01196257158153,-12.0272031304791,-6.00779511671925,-2.47855839699923,0.987963832062323,41.9826965945651,-1.287,-3.28,11.641,-0.379,5.631,10.198,,7.9145,6.918,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,busulfan,CHEMBL820,COVZYZSDYWQREU-UHFFFAOYSA-N,CS(=O)(=O)OCCCCOS(=O)(=O)C,C6H14O6S2,DB01008,D00248,busulfan,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
371327,115,48,38,uM,uM,-4.34041927762803,-0.346940122615814,1.01160575683325,1.03560267881735,0.230610312300154,14.6683424827181,4.437,5.58,7.376,6.783,7.0795,-2.9375,,2.0710000000000006,1.4995000000000005,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,busulfan,CHEMBL820,COVZYZSDYWQREU-UHFFFAOYSA-N,CS(=O)(=O)OCCCCOS(=O)(=O)C,C6H14O6S2,DB01008,D00248,busulfan,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
371438,40,96,28,uM,uM,-2.34958143023124,-37.564823449174,-13.3993317029795,-8.01727138563207,75.0,0.0002366786209596,-6.521,7.951,-2.011,6.21,2.0995,0.6695,,1.3845,-5.8515,altretamine,CHEMBL1455,UUVWYPNAQBNQJQ-UHFFFAOYSA-N,CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C,C9H18N6,DB00488,D02841,altretamine,Pralatrexate,CHEMBL1201746,OGSBUKJUDHAQEA-WMCAAGNKSA-N,C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,C23H23N7O5,DB06813,D05589,pralatrexate,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
371448,40,96,38,uM,uM,1.65730525694586,-3.24932644734403,-4.17827614742397,-0.840508086123027,75.0,0.0006,-3.362,0.758,-5.868,-4.502,-5.185,-2.581,,-3.883,-5.943,altretamine,CHEMBL1455,UUVWYPNAQBNQJQ-UHFFFAOYSA-N,CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C,C9H18N6,DB00488,D02841,altretamine,Pralatrexate,CHEMBL1201746,OGSBUKJUDHAQEA-WMCAAGNKSA-N,C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,C23H23N7O5,DB06813,D05589,pralatrexate,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
371496,53,96,28,uM,uM,-11.0973071815804,-18.0910164344125,-12.1514173698059,-14.512799178903,13.0779438627311,0.0002366786209596,16.142,7.951,12.059,13.692,12.8755,-11.2175,,0.8290000000000006,-3.266499999999999,chlorambucil,CHEMBL515,JCKYGMPEJWAADB-UHFFFAOYSA-N,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,C14H19Cl2NO2,DB00291,D00266,chlorambucil,Pralatrexate,CHEMBL1201746,OGSBUKJUDHAQEA-WMCAAGNKSA-N,C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,C23H23N7O5,DB06813,D05589,pralatrexate,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
371506,53,96,38,uM,uM,1.58400667543422,1.37371443003969,1.36559900753596,0.618209256869824,20.7438362933702,0.0006,18.749,0.758,17.347,39.678,28.5125,9.0055,,18.759,9.7635,chlorambucil,CHEMBL515,JCKYGMPEJWAADB-UHFFFAOYSA-N,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,C14H19Cl2NO2,DB00291,D00266,chlorambucil,Pralatrexate,CHEMBL1201746,OGSBUKJUDHAQEA-WMCAAGNKSA-N,C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,C23H23N7O5,DB06813,D05589,pralatrexate,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
371755,101,48,38,uM,uM,-2.74254629168458,-9.08364609668335,-7.29977328871832,-5.93522859901533,4.38962339087133,14.6683424827181,-0.959,5.58,-5.376,-1.777,-3.5765,-8.1975,,-5.8870000000000005,-9.1565,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,busulfan,CHEMBL820,COVZYZSDYWQREU-UHFFFAOYSA-N,CS(=O)(=O)OCCCCOS(=O)(=O)C,C6H14O6S2,DB01008,D00248,busulfan,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
371777,101,48,28,uM,uM,1.55246102642611,-11.2699465675875,-10.4900039904863,-4.54138890311838,0.171867099886755,41.9826965945651,-5.115,-3.28,-4.193,-7.488,-5.8405,2.5545,,-1.6429999999999998,-2.5605,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,busulfan,CHEMBL820,COVZYZSDYWQREU-UHFFFAOYSA-N,CS(=O)(=O)OCCCCOS(=O)(=O)C,C6H14O6S2,DB01008,D00248,busulfan,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
371820,108,96,28,uM,uM,-4.36293105249468,-13.2159309248179,-6.80421228603677,-7.1971605849046,1.31560298651524,0.0002366786209596,33.09,7.951,33.596,21.21,27.403,-13.638,,6.882499999999997,-5.687000000000005,6-Thioguanine,CHEMBL727,WYWHKKSPHMUBEB-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=C(N2)N,C5H5N5S,DB00352,D08603,thioguanine,Pralatrexate,CHEMBL1201746,OGSBUKJUDHAQEA-WMCAAGNKSA-N,C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,C23H23N7O5,DB06813,D05589,pralatrexate,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
371830,108,96,38,uM,uM,-0.681166114496814,-2.13390690834117,-2.13066256308098,-2.793945500345,1.45049066398121,0.0006,28.889,0.758,27.567,48.189,37.878,8.231,,23.0545,8.989,6-Thioguanine,CHEMBL727,WYWHKKSPHMUBEB-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=C(N2)N,C5H5N5S,DB00352,D08603,thioguanine,Pralatrexate,CHEMBL1201746,OGSBUKJUDHAQEA-WMCAAGNKSA-N,C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,C23H23N7O5,DB06813,D05589,pralatrexate,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
372054,79,30,38,uM,uM,-0.80386273450942,0.401803934824905,-0.436329229747643,-0.403882236760792,30.0,0.0449794155779465,2.987,0.197,0.362,1.002,0.682,-2.502,,-0.91,-2.305,Lenalidomide,CHEMBL848,GOTYRUGSSMKFNF-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,C13H13N3O3,DB00480,D04687,lenalidomide,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
372076,79,30,28,uM,uM,-0.507857885725763,1.67409890724399,0.314781881363465,0.64434924805354,30.0,0.328052190693927,4.019,-1.044,6.543,7.626,7.0845,4.1095,,5.597,3.0655,Lenalidomide,CHEMBL848,GOTYRUGSSMKFNF-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,C13H13N3O3,DB00480,D04687,lenalidomide,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
372324,116,30,28,uM,uM,0.58128144417512,-9.03705040594575,-0.368795353758217,0.160663912583256,0.647196610526164,0.328052190693927,33.59,-1.044,35.429,39.033,37.231,4.685,,20.958,3.6409999999999982,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
372335,116,30,7,uM,uM,0.898959621007202,-2.96725157881655,-2.00328833140575,0.998715803828271,5.0,0.29572887941918,-2.354,-1.113,-0.369,2.817,1.224,4.691,,2.9575,2.337,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,A549,C3512,Lung (Carcinoma),Lung adenocarcinoma
372345,116,30,38,uM,uM,4.3643381582556,5.77588692227256,6.18754600405979,7.58029752529426,4.75243603628729,0.0449794155779465,-1.244,0.197,3.301,8.241,5.771,6.818,,6.2945,5.574,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
372753,1,96,28,uM,uM,-3.86092664596313,-3.59079400517301,-3.12212868709156,-7.17464969006639,3.70539648442761,0.0002366786209596,52.846,7.951,51.957,31.874,41.9155,-18.8815,,11.517000000000005,-10.930499999999997,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,Pralatrexate,CHEMBL1201746,OGSBUKJUDHAQEA-WMCAAGNKSA-N,C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,C23H23N7O5,DB06813,D05589,pralatrexate,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
372759,1,96,38,uM,uM,4.24419338871123,2.67657792963365,2.67722632580792,2.04426955070846,4.93954994547436,0.0006,31.568,0.758,33.182,10.448,21.815,-10.511,,5.652000000000001,-9.753,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,Pralatrexate,CHEMBL1201746,OGSBUKJUDHAQEA-WMCAAGNKSA-N,C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,C23H23N7O5,DB06813,D05589,pralatrexate,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
372839,79,48,38,uM,uM,-0.200312613132041,3.4122694477756,4.7708715499474,4.81561273325597,30.0,14.6683424827181,2.987,5.58,7.507,4.753,6.13,-2.437,,1.8465,0.5499999999999998,Lenalidomide,CHEMBL848,GOTYRUGSSMKFNF-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,C13H13N3O3,DB00480,D04687,lenalidomide,busulfan,CHEMBL820,COVZYZSDYWQREU-UHFFFAOYSA-N,CS(=O)(=O)OCCCCOS(=O)(=O)C,C6H14O6S2,DB01008,D00248,busulfan,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
372845,79,48,28,uM,uM,0.34408759091148,7.14671826226382,6.36864932772517,8.8280332007727,30.0,41.9826965945651,4.019,-3.28,15.576,11.972,13.774,13.035,,13.4045,9.755,Lenalidomide,CHEMBL848,GOTYRUGSSMKFNF-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,C13H13N3O3,DB00480,D04687,lenalidomide,busulfan,CHEMBL820,COVZYZSDYWQREU-UHFFFAOYSA-N,CS(=O)(=O)OCCCCOS(=O)(=O)C,C6H14O6S2,DB01008,D00248,busulfan,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
372862,116,48,28,uM,uM,0.674285926580506,-21.2827407302592,0.192649090686219,1.32391534863575,0.647196610526164,41.9826965945651,33.59,-3.28,38.902,49.571,44.2365,13.9265,,29.0815,10.646499999999996,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,busulfan,CHEMBL820,COVZYZSDYWQREU-UHFFFAOYSA-N,CS(=O)(=O)OCCCCOS(=O)(=O)C,C6H14O6S2,DB01008,D00248,busulfan,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
372883,116,48,38,uM,uM,-2.30793338303924,-3.94670531399027,-3.78238223322382,-2.03022187968898,4.75243603628729,14.6683424827181,-1.244,5.58,-4.126,6.383,1.1285,-3.2075,,-1.0395,-4.4515,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,busulfan,CHEMBL820,COVZYZSDYWQREU-UHFFFAOYSA-N,CS(=O)(=O)OCCCCOS(=O)(=O)C,C6H14O6S2,DB01008,D00248,busulfan,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
375907,1,107,28,uM,uM,0.214083128094131,-9.28232100634865,-2.20144034085874,-2.43823451579844,3.70539648442761,9.17823955552302,52.846,0.501,48.078,38.178,43.128,-10.219,,16.454500000000003,-9.717999999999996,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,thalidomide,CHEMBL468,UEJJHQNACJXSKW-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,C13H10N2O4,DB01041,D00754,thalidomide,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
375913,1,107,38,uM,uM,10.4357319113606,2.86244626622087,7.00311521469682,7.41701781013335,4.93954994547436,0.305410012032212,31.568,-0.86,38.137,23.448,30.7925,0.0844999999999985,,15.4385,-0.775500000000001,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,thalidomide,CHEMBL468,UEJJHQNACJXSKW-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,C13H10N2O4,DB01041,D00754,thalidomide,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
376344,40,107,38,uM,uM,1.7414500769468,-7.24417934932071,-7.62010948075731,-4.23065505447593,75.0,0.305410012032212,-3.362,-0.86,-5.341,-8.786,-7.0635,-2.8415,,-4.952500000000001,-6.2035,altretamine,CHEMBL1455,UUVWYPNAQBNQJQ-UHFFFAOYSA-N,CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C,C9H18N6,DB00488,D02841,altretamine,thalidomide,CHEMBL468,UEJJHQNACJXSKW-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,C13H10N2O4,DB01041,D00754,thalidomide,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
376350,40,107,28,uM,uM,2.11366337287561,0.835585162932795,0.512557185909369,6.63460006641368,75.0,9.17823955552302,-6.521,0.501,-0.576,7.476,3.45,9.47,,6.46,2.9490000000000003,altretamine,CHEMBL1455,UUVWYPNAQBNQJQ-UHFFFAOYSA-N,CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C,C9H18N6,DB00488,D02841,altretamine,thalidomide,CHEMBL468,UEJJHQNACJXSKW-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,C13H10N2O4,DB01041,D00754,thalidomide,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
376437,108,107,38,uM,uM,-6.36462642085488,-23.6788034433998,-8.29355145196985,-7.85981799647566,1.45049066398121,0.305410012032212,28.889,-0.86,20.878,36.948,28.913,0.884,,14.8985,0.0240000000000009,6-Thioguanine,CHEMBL727,WYWHKKSPHMUBEB-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=C(N2)N,C5H5N5S,DB00352,D08603,thioguanine,thalidomide,CHEMBL468,UEJJHQNACJXSKW-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,C13H10N2O4,DB01041,D00754,thalidomide,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
376443,108,107,28,uM,uM,1.08434413978734,-26.0931521998068,1.37292264596678,2.72773551047446,1.31560298651524,9.17823955552302,33.09,0.501,37.599,39.937,38.768,5.177,,21.9725,5.677999999999997,6-Thioguanine,CHEMBL727,WYWHKKSPHMUBEB-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=C(N2)N,C5H5N5S,DB00352,D08603,thioguanine,thalidomide,CHEMBL468,UEJJHQNACJXSKW-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,C13H10N2O4,DB01041,D00754,thalidomide,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
376584,53,107,38,uM,uM,-2.85380212953503,-6.90334630157905,-3.98277367419208,-3.48861756148306,20.7438362933702,0.305410012032212,18.749,-0.86,15.666,39.669,27.6675,9.7785,,18.723,8.918500000000002,chlorambucil,CHEMBL515,JCKYGMPEJWAADB-UHFFFAOYSA-N,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,C14H19Cl2NO2,DB00291,D00266,chlorambucil,thalidomide,CHEMBL468,UEJJHQNACJXSKW-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,C13H10N2O4,DB01041,D00754,thalidomide,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
376590,53,107,28,uM,uM,-6.84733204331121,-3.3787251502946,1.57811843575021,1.88386055428951,13.0779438627311,9.17823955552302,16.142,0.501,13.636,13.629,13.6325,-3.0105,,5.311,-2.509499999999999,chlorambucil,CHEMBL515,JCKYGMPEJWAADB-UHFFFAOYSA-N,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,C14H19Cl2NO2,DB00291,D00266,chlorambucil,thalidomide,CHEMBL468,UEJJHQNACJXSKW-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,C13H10N2O4,DB01041,D00754,thalidomide,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
376957,72,40,28,uM,uM,25.1222576182793,1.10666694798205,22.3842263258079,27.3198017428031,4.63606799908028,75.0,10.57,-6.514,43.317,58.65,50.9835,46.9275,,48.9555,40.4135,Gefitinib,CHEMBL939,XGALLCVXEZPNRQ-UHFFFAOYSA-N,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,C22H24ClFN4O3,DB00317,D01977,gefitinib,altretamine,CHEMBL1455,UUVWYPNAQBNQJQ-UHFFFAOYSA-N,CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C,C9H18N6,DB00488,D02841,altretamine,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
376979,72,40,38,uM,uM,-2.34244183199992,-14.429123548568,-2.29844034085874,0.806841559788884,10.0,75.0,5.994,-3.362,2.963,8.095,5.529,2.897,,4.213,-0.4649999999999998,Gefitinib,CHEMBL939,XGALLCVXEZPNRQ-UHFFFAOYSA-N,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,C22H24ClFN4O3,DB00317,D01977,gefitinib,altretamine,CHEMBL1455,UUVWYPNAQBNQJQ-UHFFFAOYSA-N,CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C,C9H18N6,DB00488,D02841,altretamine,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
377471,79,116,38,uM,uM,-0.0574339666783058,-0.119081326507387,-0.957329229747647,0.320118208388635,30.0,4.79432171150704,2.987,-1.242,3.689,4.202,3.9455,2.2005,,3.073,0.9585,Lenalidomide,CHEMBL848,GOTYRUGSSMKFNF-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,C13H13N3O3,DB00480,D04687,lenalidomide,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
377477,79,116,28,uM,uM,-2.99396450111524,-14.1819002794725,-3.15066001100161,-4.79815559423169,30.0,0.647340538074254,4.019,33.591,33.916,32.044,32.98,-4.63,,14.174999999999995,-0.6110000000000042,Lenalidomide,CHEMBL848,GOTYRUGSSMKFNF-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,C13H13N3O3,DB00480,D04687,lenalidomide,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
377617,88,96,28,uM,uM,-6.96013614583671,-19.3824912651916,-6.65981917465065,-9.59472731714256,0.186033682243995,0.0002366786209596,29.019,7.951,24.749,38.716,31.7325,-5.2375,,13.247500000000002,2.713500000000004,mitoxantrone,CHEMBL58,KKZJGLLVHKMTCM-UHFFFAOYSA-N,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,C22H28N4O6,DB01204,D08224,mitoxantrone,Pralatrexate,CHEMBL1201746,OGSBUKJUDHAQEA-WMCAAGNKSA-N,C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,C23H23N7O5,DB06813,D05589,pralatrexate,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
377643,88,96,38,uM,uM,-1.31586009106943,-3.8149993898643,-3.75310700752541,-4.43933245327854,0.0616476966214236,0.0006,26.212,0.758,21.18,29.806,25.493,-1.477,,12.008,-0.7190000000000012,mitoxantrone,CHEMBL58,KKZJGLLVHKMTCM-UHFFFAOYSA-N,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,C22H28N4O6,DB01204,D08224,mitoxantrone,Pralatrexate,CHEMBL1201746,OGSBUKJUDHAQEA-WMCAAGNKSA-N,C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,C23H23N7O5,DB06813,D05589,pralatrexate,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
378422,1,90,38,uM,uM,6.12086881816008,3.63526226851262,4.33800410358569,4.56186845804823,4.93954994547436,0.0909188015846464,31.568,-0.335,34.295,23.041,28.668,-2.565,,13.0515,-2.900000000000002,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,Nilotinib,CHEMBL255863,HHZIURLSWUIHRB-UHFFFAOYSA-N,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,C28H22F3N7O,DB04868,D08953,nilotinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
378448,1,90,28,uM,uM,2.07951792002517,-4.66760217729223,-3.39877367419208,-1.16004463101274,3.70539648442761,0.8,52.846,-5.329,54.999,30.798,42.8985,-4.6185,,19.14,-9.947499999999998,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,Nilotinib,CHEMBL255863,HHZIURLSWUIHRB-UHFFFAOYSA-N,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,C28H22F3N7O,DB04868,D08953,nilotinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
378481,40,90,28,uM,uM,4.52655962477751,-1.83107640041152,-1.07873474313765,5.81432234008826,75.0,0.8,-6.521,-5.329,-6.023,-7.637,-6.83,5.02,,-0.9050000000000002,-1.5010000000000003,altretamine,CHEMBL1455,UUVWYPNAQBNQJQ-UHFFFAOYSA-N,CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C,C9H18N6,DB00488,D02841,altretamine,Nilotinib,CHEMBL255863,HHZIURLSWUIHRB-UHFFFAOYSA-N,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,C28H22F3N7O,DB04868,D08953,nilotinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
378507,40,90,38,uM,uM,1.16502811998019,-4.31437225137513,-3.33969456664956,0.130795561216753,75.0,0.0909188015846464,-3.362,-0.335,-5.956,-5.462,-5.709,-2.012,,-3.8605,-5.374,altretamine,CHEMBL1455,UUVWYPNAQBNQJQ-UHFFFAOYSA-N,CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C,C9H18N6,DB00488,D02841,altretamine,Nilotinib,CHEMBL255863,HHZIURLSWUIHRB-UHFFFAOYSA-N,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,C28H22F3N7O,DB04868,D08953,nilotinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
378524,72,96,38,uM,uM,-3.69982705902797,-0.699499009589648,-1.19444034085874,-2.04936433959909,10.0,0.0006,5.994,0.758,6.912,17.011,11.9615,5.2095,,8.5855,5.967499999999999,Gefitinib,CHEMBL939,XGALLCVXEZPNRQ-UHFFFAOYSA-N,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,C22H24ClFN4O3,DB00317,D01977,gefitinib,Pralatrexate,CHEMBL1201746,OGSBUKJUDHAQEA-WMCAAGNKSA-N,C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,C23H23N7O5,DB06813,D05589,pralatrexate,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
378530,72,96,28,uM,uM,-7.59383520726488,-20.9250542723148,-10.1191708564711,-12.7095784741188,4.63606799908028,0.0002366786209596,10.57,7.951,19.111,39.697,29.404,10.883,,20.1435,18.834,Gefitinib,CHEMBL939,XGALLCVXEZPNRQ-UHFFFAOYSA-N,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,C22H24ClFN4O3,DB00317,D01977,gefitinib,Pralatrexate,CHEMBL1201746,OGSBUKJUDHAQEA-WMCAAGNKSA-N,C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,C23H23N7O5,DB06813,D05589,pralatrexate,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
378813,108,90,28,uM,uM,1.5092284818861,-12.003066281211,-3.28697822758573,0.198336549704606,1.31560298651524,0.8,33.09,-5.329,18.214,13.53,15.872,-11.889,,1.9914999999999985,-17.218000000000004,6-Thioguanine,CHEMBL727,WYWHKKSPHMUBEB-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=C(N2)N,C5H5N5S,DB00352,D08603,thioguanine,Nilotinib,CHEMBL255863,HHZIURLSWUIHRB-UHFFFAOYSA-N,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,C28H22F3N7O,DB04868,D08953,nilotinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
378839,108,90,38,uM,uM,1.58482320040862,-3.52011702049384,0.574115214696811,0.808705335883673,1.45049066398121,0.0909188015846464,28.889,-0.335,28.192,44.725,36.4585,7.9045,,22.1815,7.5695000000000014,6-Thioguanine,CHEMBL727,WYWHKKSPHMUBEB-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=C(N2)N,C5H5N5S,DB00352,D08603,thioguanine,Nilotinib,CHEMBL255863,HHZIURLSWUIHRB-UHFFFAOYSA-N,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,C28H22F3N7O,DB04868,D08953,nilotinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
378900,53,90,28,uM,uM,-5.48935957662775,-1.6155126328386,-0.973688995519761,3.14215051904706,13.0779438627311,0.8,16.142,-5.329,14.477,7.882,11.1795,0.366500000000002,,5.7730000000000015,-4.962499999999999,chlorambucil,CHEMBL515,JCKYGMPEJWAADB-UHFFFAOYSA-N,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,C14H19Cl2NO2,DB00291,D00266,chlorambucil,Nilotinib,CHEMBL255863,HHZIURLSWUIHRB-UHFFFAOYSA-N,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,C28H22F3N7O,DB04868,D08953,nilotinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
378926,53,90,38,uM,uM,2.78117871016104,1.53517044237922,1.79642686846401,2.13505234643183,20.7438362933702,0.0909188015846464,18.749,-0.335,18.659,40.687,29.673,11.259,,20.466,10.924,chlorambucil,CHEMBL515,JCKYGMPEJWAADB-UHFFFAOYSA-N,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,C14H19Cl2NO2,DB00291,D00266,chlorambucil,Nilotinib,CHEMBL255863,HHZIURLSWUIHRB-UHFFFAOYSA-N,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,C28H22F3N7O,DB04868,D08953,nilotinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
379172,101,96,38,uM,uM,-0.739421312760177,-1.62220646411423,-2.24149856896435,-1.06702091681806,4.38962339087133,0.0006,-0.959,0.758,-2.127,3.773,0.823,1.024,,0.9235,0.0649999999999999,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,Pralatrexate,CHEMBL1201746,OGSBUKJUDHAQEA-WMCAAGNKSA-N,C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,C23H23N7O5,DB06813,D05589,pralatrexate,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
379178,101,96,28,uM,uM,-4.28294152626407,-37.6890456713962,-13.5235539252018,-9.02581772061068,0.171867099886755,0.0002366786209596,-5.115,7.951,1.602,0.149,0.8755,-1.9605,,-0.5424999999999998,-7.0755,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,Pralatrexate,CHEMBL1201746,OGSBUKJUDHAQEA-WMCAAGNKSA-N,C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,C23H23N7O5,DB06813,D05589,pralatrexate,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
379287,120,96,28,uM,uM,-6.87142498066008,-25.4831376998377,-10.7151411776996,-8.54572613518427,13.2475908300401,0.0002366786209596,-2.739,7.951,4.272,9.967,7.1195,1.9075,,4.5135000000000005,-0.8314999999999992,Vismodegib,CHEMBL473417,BPQMGSKTAYIVFO-UHFFFAOYSA-N,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,C19H14Cl2N2O3S,DB08828,D09992,vismodegib,Pralatrexate,CHEMBL1201746,OGSBUKJUDHAQEA-WMCAAGNKSA-N,C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,C23H23N7O5,DB06813,D05589,pralatrexate,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
379309,120,96,38,uM,uM,-1.13369740492209,4.37407418136409,3.75477920881343,4.46354978011827,3.86072665158335,0.0006,4.58,0.758,8.649,5.067,6.858,1.52,,4.189,2.278,Vismodegib,CHEMBL473417,BPQMGSKTAYIVFO-UHFFFAOYSA-N,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,C19H14Cl2N2O3S,DB08828,D09992,vismodegib,Pralatrexate,CHEMBL1201746,OGSBUKJUDHAQEA-WMCAAGNKSA-N,C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,C23H23N7O5,DB06813,D05589,pralatrexate,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
379346,56,96,38,uM,uM,-2.64436474526501,1.91174757964095,1.42055698659121,2.26522045180153,0.134169130800938,0.0006,4.756,0.758,1.23,7.137,4.1835,-1.3305,,1.4265000000000003,-0.5724999999999998,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,Pralatrexate,CHEMBL1201746,OGSBUKJUDHAQEA-WMCAAGNKSA-N,C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,C23H23N7O5,DB06813,D05589,pralatrexate,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
379372,56,96,28,uM,uM,-7.38944962931884,-21.7150539964622,-9.69754205125212,-9.03482445953882,0.479317498262319,0.0002366786209596,-0.542,7.951,6.955,10.95,8.9525,1.5435,,5.248000000000001,1.001500000000001,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,Pralatrexate,CHEMBL1201746,OGSBUKJUDHAQEA-WMCAAGNKSA-N,C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,C23H23N7O5,DB06813,D05589,pralatrexate,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
379546,115,96,28,uM,uM,-4.25817542158401,-11.6997675790342,-0.914252288810736,0.377495536619563,0.987963832062323,0.0002366786209596,-1.287,7.951,13.58,16.268,14.924,8.26,,11.592,6.973,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,Pralatrexate,CHEMBL1201746,OGSBUKJUDHAQEA-WMCAAGNKSA-N,C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,C23H23N7O5,DB06813,D05589,pralatrexate,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
379568,115,96,38,uM,uM,-1.86193645363243,3.90100655287474,3.62064486818901,3.83967842157016,0.230610312300154,0.0006,4.437,0.758,8.274,11.048,9.661,4.466,,7.0635,5.223999999999999,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,Pralatrexate,CHEMBL1201746,OGSBUKJUDHAQEA-WMCAAGNKSA-N,C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,C23H23N7O5,DB06813,D05589,pralatrexate,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
380227,79,96,38,uM,uM,-1.58671225361436,0.488900226825396,-0.349218118636533,-1.24572927899122,30.0,0.0006,2.987,0.758,6.482,3.055,4.7685,1.0235,,2.8960000000000004,1.7815000000000003,Lenalidomide,CHEMBL848,GOTYRUGSSMKFNF-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,C13H13N3O3,DB00480,D04687,lenalidomide,Pralatrexate,CHEMBL1201746,OGSBUKJUDHAQEA-WMCAAGNKSA-N,C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,C23H23N7O5,DB06813,D05589,pralatrexate,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
380249,79,96,28,uM,uM,-7.53259180271214,-27.0907370036562,-13.8313506722748,-15.1043675767196,30.0,0.0002366786209596,4.019,7.951,1.483,-4.633,-1.575,-13.545,,-7.56,-9.526,Lenalidomide,CHEMBL848,GOTYRUGSSMKFNF-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,C13H13N3O3,DB00480,D04687,lenalidomide,Pralatrexate,CHEMBL1201746,OGSBUKJUDHAQEA-WMCAAGNKSA-N,C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,C23H23N7O5,DB06813,D05589,pralatrexate,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
380313,116,96,38,uM,uM,2.07096799093707,2.6593889972899,1.73161274146491,3.04087330389716,4.75243603628729,0.0006,-1.244,0.758,1.464,6.644,4.054,4.54,,4.297000000000001,3.2960000000000003,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,Pralatrexate,CHEMBL1201746,OGSBUKJUDHAQEA-WMCAAGNKSA-N,C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,C23H23N7O5,DB06813,D05589,pralatrexate,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
380338,116,96,28,uM,uM,-2.76020857814494,-2.7772824868517,-2.01500204847817,-4.90173380663435,0.647196610526164,0.0002366786209596,33.59,7.951,35.061,40.261,37.661,-3.88,,16.8905,4.070999999999998,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,Pralatrexate,CHEMBL1201746,OGSBUKJUDHAQEA-WMCAAGNKSA-N,C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,C23H23N7O5,DB06813,D05589,pralatrexate,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
380972,116,40,38,uM,uM,1.86674165556671,-3.21685254135138,-2.85768424264711,0.640601213007367,4.75243603628729,75.0,-1.244,-3.362,-2.915,-7.253,-5.084,-0.478,,-2.781,-3.84,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,altretamine,CHEMBL1455,UUVWYPNAQBNQJQ-UHFFFAOYSA-N,CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C,C9H18N6,DB00488,D02841,altretamine,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
380977,116,40,28,uM,uM,5.99042951649624,-31.5879778431692,3.98978188136347,8.09887479362093,0.647196610526164,75.0,33.59,-6.514,39.278,32.711,35.9945,8.9185,,22.4565,2.4044999999999987,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,altretamine,CHEMBL1455,UUVWYPNAQBNQJQ-UHFFFAOYSA-N,CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C,C9H18N6,DB00488,D02841,altretamine,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
381946,79,40,28,uM,uM,39.1211611357523,38.353476085027,37.1741152146968,43.0395475457579,30.0,75.0,4.019,-6.514,53.192,87.08,70.136,72.631,,71.3835,66.11699999999999,Lenalidomide,CHEMBL848,GOTYRUGSSMKFNF-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,C13H13N3O3,DB00480,D04687,lenalidomide,altretamine,CHEMBL1455,UUVWYPNAQBNQJQ-UHFFFAOYSA-N,CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C,C9H18N6,DB00488,D02841,altretamine,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
381952,79,40,38,uM,uM,2.27979515477966,0.188303193202766,-0.681884785303201,2.5744513148412,30.0,75.0,2.987,-3.362,3.515,-1.196,1.1595,1.5345,,1.347,-1.8275,Lenalidomide,CHEMBL848,GOTYRUGSSMKFNF-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,C13H13N3O3,DB00480,D04687,lenalidomide,altretamine,CHEMBL1455,UUVWYPNAQBNQJQ-UHFFFAOYSA-N,CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C,C9H18N6,DB00488,D02841,altretamine,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
382530,72,39,28,uM,uM,7.97501149226176,-4.64057553204304,5.83809139380438,8.17734872540465,4.63606799908028,96.1224495785589,10.57,-4.433,22.925,36.094,29.5095,23.3725,,26.441,18.9395,Gefitinib,CHEMBL939,XGALLCVXEZPNRQ-UHFFFAOYSA-N,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,C22H24ClFN4O3,DB00317,D01977,gefitinib,allopurinol,CHEMBL1467,OFCNXPDARWKPPY-UHFFFAOYSA-N,C1=C2C(=NC=NC2=O)NN1; C1=NNC2=C1C(=O)NC=N2,C5H4N4O,DB00437,D00224,allopurinol,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
382552,72,39,38,uM,uM,-5.17373072359429,-4.76550652018065,-0.166708063539549,-2.04005787703908,10.0,95.6248320718461,5.994,1.749,19.271,8.626,13.9485,6.2055,,10.076999999999998,7.954499999999999,Gefitinib,CHEMBL939,XGALLCVXEZPNRQ-UHFFFAOYSA-N,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,C22H24ClFN4O3,DB00317,D01977,gefitinib,allopurinol,CHEMBL1467,OFCNXPDARWKPPY-UHFFFAOYSA-N,C1=C2C(=NC=NC2=O)NN1; C1=NNC2=C1C(=O)NC=N2,C5H4N4O,DB00437,D00224,allopurinol,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
382740,1,48,28,uM,uM,-0.854918591749394,-19.0052657838757,-2.96855145196986,-3.21114677701852,3.70539648442761,41.9826965945651,52.846,-3.28,52.875,42.055,47.465,-2.10099999999999,,22.68200000000001,-5.380999999999993,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,busulfan,CHEMBL820,COVZYZSDYWQREU-UHFFFAOYSA-N,CS(=O)(=O)OCCCCOS(=O)(=O)C,C6H14O6S2,DB01008,D00248,busulfan,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
382760,1,48,38,uM,uM,-0.1213056560421,-3.84270448119901,2.97731575735289,0.249297315177881,4.93954994547436,14.6683424827181,31.568,5.58,34.697,25.036,29.8665,-7.2815,,11.292499999999997,-1.701500000000003,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,busulfan,CHEMBL820,COVZYZSDYWQREU-UHFFFAOYSA-N,CS(=O)(=O)OCCCCOS(=O)(=O)C,C6H14O6S2,DB01008,D00248,busulfan,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
383209,53,48,28,uM,uM,-6.65583333459086,-9.15552503863287,-4.1542900515339,-1.79858247255947,13.0779438627311,41.9826965945651,16.142,-3.28,7.278,1.187,4.2325,-8.6295,,-2.1985,-11.9095,chlorambucil,CHEMBL515,JCKYGMPEJWAADB-UHFFFAOYSA-N,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,C14H19Cl2NO2,DB00291,D00266,chlorambucil,busulfan,CHEMBL820,COVZYZSDYWQREU-UHFFFAOYSA-N,CS(=O)(=O)OCCCCOS(=O)(=O)C,C6H14O6S2,DB01008,D00248,busulfan,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
383234,53,48,38,uM,uM,-10.7441898462118,-10.0815863664918,-3.54970806353954,-5.30678566532742,20.7438362933702,14.6683424827181,18.749,5.58,19.334,34.723,27.0285,2.6995,,14.864,8.279500000000002,chlorambucil,CHEMBL515,JCKYGMPEJWAADB-UHFFFAOYSA-N,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,C14H19Cl2NO2,DB00291,D00266,chlorambucil,busulfan,CHEMBL820,COVZYZSDYWQREU-UHFFFAOYSA-N,CS(=O)(=O)OCCCCOS(=O)(=O)C,C6H14O6S2,DB01008,D00248,busulfan,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
383299,108,48,28,uM,uM,-0.713962369644643,-25.3220680053767,0.520315757352885,2.18233404147659,1.31560298651524,41.9826965945651,33.09,-3.28,41.123,25.841,33.482,3.672,,18.577,0.3919999999999959,6-Thioguanine,CHEMBL727,WYWHKKSPHMUBEB-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=C(N2)N,C5H5N5S,DB00352,D08603,thioguanine,busulfan,CHEMBL820,COVZYZSDYWQREU-UHFFFAOYSA-N,CS(=O)(=O)OCCCCOS(=O)(=O)C,C6H14O6S2,DB01008,D00248,busulfan,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
383324,108,48,38,uM,uM,-6.60814297621253,-22.3587691868357,-5.8724620204249,-7.66012199365337,1.45049066398121,14.6683424827181,28.889,5.58,24.033,38.452,31.2425,-3.2265,,14.008,2.3535000000000004,6-Thioguanine,CHEMBL727,WYWHKKSPHMUBEB-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=C(N2)N,C5H5N5S,DB00352,D08603,thioguanine,busulfan,CHEMBL820,COVZYZSDYWQREU-UHFFFAOYSA-N,CS(=O)(=O)OCCCCOS(=O)(=O)C,C6H14O6S2,DB01008,D00248,busulfan,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
383455,115,39,38,uM,uM,0.90044099487843,2.18242020108218,5.36786732745019,4.85251509524129,0.230610312300154,95.6248320718461,4.437,1.749,16.727,16.0,16.3635,10.1775,,13.270499999999998,11.926499999999995,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,allopurinol,CHEMBL1467,OFCNXPDARWKPPY-UHFFFAOYSA-N,C1=C2C(=NC=NC2=O)NN1; C1=NNC2=C1C(=O)NC=N2,C5H4N4O,DB00437,D00224,allopurinol,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
383461,115,39,28,uM,uM,-0.22667002269293,-6.08224464268698,0.892403047571577,5.31000668892083,0.987963832062323,96.1224495785589,-1.287,-4.433,9.411,12.878,11.1445,16.8645,,14.0045,12.4315,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,allopurinol,CHEMBL1467,OFCNXPDARWKPPY-UHFFFAOYSA-N,C1=C2C(=NC=NC2=O)NN1; C1=NNC2=C1C(=O)NC=N2,C5H4N4O,DB00437,D00224,allopurinol,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
383591,120,39,28,uM,uM,0.769572520030665,-5.58768136664735,-1.447883235356,3.52058578628366,13.2475908300401,96.1224495785589,-2.739,-4.433,9.989,15.071,12.53,19.702,,16.116,15.268999999999998,Vismodegib,CHEMBL473417,BPQMGSKTAYIVFO-UHFFFAOYSA-N,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,C19H14Cl2N2O3S,DB08828,D09992,vismodegib,allopurinol,CHEMBL1467,OFCNXPDARWKPPY-UHFFFAOYSA-N,C1=C2C(=NC=NC2=O)NN1; C1=NNC2=C1C(=O)NC=N2,C5H4N4O,DB00437,D00224,allopurinol,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
383617,120,39,38,uM,uM,-3.03807524576381,0.179945863844755,2.29371380992054,2.01287149267828,3.86072665158335,95.6248320718461,4.58,1.749,15.833,10.516,13.1745,6.8455,,10.01,8.5945,Vismodegib,CHEMBL473417,BPQMGSKTAYIVFO-UHFFFAOYSA-N,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,C19H14Cl2N2O3S,DB08828,D09992,vismodegib,allopurinol,CHEMBL1467,OFCNXPDARWKPPY-UHFFFAOYSA-N,C1=C2C(=NC=NC2=O)NN1; C1=NNC2=C1C(=O)NC=N2,C5H4N4O,DB00437,D00224,allopurinol,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
383658,56,39,28,uM,uM,-1.02185763540946,-7.05926505998115,-3.30293028576175,0.858174423595771,0.479317498262319,96.1224495785589,-0.542,-4.433,5.748,5.729,5.7385,10.7135,,8.225999999999999,6.2805,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,allopurinol,CHEMBL1467,OFCNXPDARWKPPY-UHFFFAOYSA-N,C1=C2C(=NC=NC2=O)NN1; C1=NNC2=C1C(=O)NC=N2,C5H4N4O,DB00437,D00224,allopurinol,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
383668,56,39,38,uM,uM,-2.38755093020578,-4.04873531384165,0.391158254364976,0.277473719917101,0.134169130800938,95.6248320718461,4.756,1.749,15.687,0.522,8.1045,1.5995,,4.851999999999999,3.3485,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,allopurinol,CHEMBL1467,OFCNXPDARWKPPY-UHFFFAOYSA-N,C1=C2C(=NC=NC2=O)NN1; C1=NNC2=C1C(=O)NC=N2,C5H4N4O,DB00437,D00224,allopurinol,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
383740,88,90,7,uM,uM,6.03126131792057,-16.6744131976969,5.43311521469681,6.10772430691136,0.0309080476193319,0.0222839338450436,46.022,-1.882,49.391,49.446,49.4185,5.27849999999999,,27.3485,3.396500000000003,mitoxantrone,CHEMBL58,KKZJGLLVHKMTCM-UHFFFAOYSA-N,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,C22H28N4O6,DB01204,D08224,mitoxantrone,Nilotinib,CHEMBL255863,HHZIURLSWUIHRB-UHFFFAOYSA-N,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,C28H22F3N7O,DB04868,D08953,nilotinib,A549,C3512,Lung (Carcinoma),Lung adenocarcinoma
383744,88,90,28,uM,uM,10.7100132677842,-3.16094854730659,7.51233743691903,11.0428777774666,0.186033682243995,0.8,29.019,-5.329,47.798,48.057,47.9275,24.2375,,36.0825,18.908500000000004,mitoxantrone,CHEMBL58,KKZJGLLVHKMTCM-UHFFFAOYSA-N,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,C22H28N4O6,DB01204,D08224,mitoxantrone,Nilotinib,CHEMBL255863,HHZIURLSWUIHRB-UHFFFAOYSA-N,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,C28H22F3N7O,DB04868,D08953,nilotinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
383754,88,90,38,uM,uM,0.788787208448183,-12.0032181673127,3.26587131290845,3.53770853850568,0.0616476966214236,0.0909188015846464,26.212,-0.335,23.958,35.797,29.8775,4.0005,,16.939,3.6655000000000015,mitoxantrone,CHEMBL58,KKZJGLLVHKMTCM-UHFFFAOYSA-N,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,C22H28N4O6,DB01204,D08224,mitoxantrone,Nilotinib,CHEMBL255863,HHZIURLSWUIHRB-UHFFFAOYSA-N,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,C28H22F3N7O,DB04868,D08953,nilotinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
383796,40,48,28,uM,uM,1.59491553855387,-6.09896761064648,-1.20630362186908,5.23361897186024,75.0,41.9826965945651,-6.521,-3.28,10.461,-3.955,3.253,13.054,,8.153500000000001,6.533,altretamine,CHEMBL1455,UUVWYPNAQBNQJQ-UHFFFAOYSA-N,CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C,C9H18N6,DB00488,D02841,altretamine,busulfan,CHEMBL820,COVZYZSDYWQREU-UHFFFAOYSA-N,CS(=O)(=O)OCCCCOS(=O)(=O)C,C6H14O6S2,DB01008,D00248,busulfan,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
383821,40,48,38,uM,uM,-0.413795798073695,-4.88633960111875,-2.44347234442735,0.863753215013052,75.0,14.6683424827181,-3.362,5.58,1.52,5.007,3.2635,1.0455,,2.1545,-2.3165,altretamine,CHEMBL1455,UUVWYPNAQBNQJQ-UHFFFAOYSA-N,CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C,C9H18N6,DB00488,D02841,altretamine,busulfan,CHEMBL820,COVZYZSDYWQREU-UHFFFAOYSA-N,CS(=O)(=O)OCCCCOS(=O)(=O)C,C6H14O6S2,DB01008,D00248,busulfan,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
383831,101,39,28,uM,uM,3.2078962307914,-8.4779546350709,-7.64939287937518,-1.48113385830942,0.171867099886755,96.1224495785589,-5.115,-4.433,-1.679,-5.377,-3.528,6.02,,1.246,0.9049999999999998,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,allopurinol,CHEMBL1467,OFCNXPDARWKPPY-UHFFFAOYSA-N,C1=C2C(=NC=NC2=O)NN1; C1=NNC2=C1C(=O)NC=N2,C5H4N4O,DB00437,D00224,allopurinol,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
383853,101,39,38,uM,uM,-2.52331165270682,-5.63869383842111,-4.31636339992185,-3.31896112092471,4.38962339087133,95.6248320718461,-0.959,1.749,5.785,-2.79,1.4975,0.7075,,1.1025,-0.2515,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,allopurinol,CHEMBL1467,OFCNXPDARWKPPY-UHFFFAOYSA-N,C1=C2C(=NC=NC2=O)NN1; C1=NNC2=C1C(=O)NC=N2,C5H4N4O,DB00437,D00224,allopurinol,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
384650,116,116,38,uM,uM,1.10660662014206,-1.69885180131383,-1.46444979872229,1.12839710737761,4.75243603628729,1.52105826959341,-1.244,-1.89,-3.21,-3.653,-3.4315,-0.2975,,-1.8645000000000005,-2.1875,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
384668,116,116,7,uM,uM,-1.70681714025247,-0.243997220387169,1.00445794874788,2.82101493119885,5.0,2.74180562059737,-2.354,2.365,9.894,13.007,11.4505,11.4395,,11.445,9.0855,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,A549,C3512,Lung (Carcinoma),Lung adenocarcinoma
384672,116,116,28,uM,uM,-3.94479417672517,-0.910096187599253,3.13893272634305,-3.38759046173016,0.647196610526164,1.55764970515166,33.59,37.123,55.789,44.736,50.2625,-20.4505,,14.906000000000006,13.139500000000004,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
385388,116,39,38,uM,uM,-0.999292717279138,-0.407974115646925,-0.293899268478035,0.981418960901632,4.75243603628729,95.6248320718461,-1.244,1.749,7.736,-3.492,2.122,1.617,,1.8695,0.3729999999999998,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,allopurinol,CHEMBL1467,OFCNXPDARWKPPY-UHFFFAOYSA-N,C1=C2C(=NC=NC2=O)NN1; C1=NNC2=C1C(=O)NC=N2,C5H4N4O,DB00437,D00224,allopurinol,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
385409,116,39,28,uM,uM,3.75401974988942,-11.9927039920499,3.54276020179734,5.74591100677803,0.647196610526164,96.1224495785589,33.59,-4.433,37.098,37.36,37.229,8.072,,22.6505,3.638999999999996,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,allopurinol,CHEMBL1467,OFCNXPDARWKPPY-UHFFFAOYSA-N,C1=C2C(=NC=NC2=O)NN1; C1=NNC2=C1C(=O)NC=N2,C5H4N4O,DB00437,D00224,allopurinol,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
385606,79,39,28,uM,uM,4.22442596499605,5.29658317007232,4.34311545173577,6.98818703113719,30.0,96.1224495785589,4.019,-4.433,10.516,6.508,8.512,8.926,,8.719000000000001,4.493,Lenalidomide,CHEMBL848,GOTYRUGSSMKFNF-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,C13H13N3O3,DB00480,D04687,lenalidomide,allopurinol,CHEMBL1467,OFCNXPDARWKPPY-UHFFFAOYSA-N,C1=C2C(=NC=NC2=O)NN1; C1=NNC2=C1C(=O)NC=N2,C5H4N4O,DB00437,D00224,allopurinol,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
385612,79,39,38,uM,uM,-1.70402413782102,2.58563563369771,2.02931599439185,1.35188662801324,30.0,95.6248320718461,2.987,1.749,11.431,7.059,9.245,4.509,,6.876999999999999,6.257999999999999,Lenalidomide,CHEMBL848,GOTYRUGSSMKFNF-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,C13H13N3O3,DB00480,D04687,lenalidomide,allopurinol,CHEMBL1467,OFCNXPDARWKPPY-UHFFFAOYSA-N,C1=C2C(=NC=NC2=O)NN1; C1=NNC2=C1C(=O)NC=N2,C5H4N4O,DB00437,D00224,allopurinol,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
386102,101,116,7,uM,uM,-4.64885488009149,-0.890663296438606,-1.40189944251685,-1.13166038047106,3.22123167658349,2.74180562059737,2.342,2.365,9.311,21.337,15.324,10.617,,12.9705,12.959,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,A549,C3512,Lung (Carcinoma),Lung adenocarcinoma
386106,101,116,28,uM,uM,0.901086971526642,-28.9269789373879,-4.287776147424,-1.01048098903985,0.171867099886755,1.55764970515166,-5.115,37.123,43.878,35.147,39.5125,7.50450000000001,,23.508500000000005,2.3895000000000053,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
386112,101,116,38,uM,uM,0.849351367437135,-1.27765870732497,-0.508420442424428,2.03530418249572,4.38962339087133,1.52105826959341,-0.959,-1.89,-0.681,1.062,0.1905,3.0395,,1.6149999999999998,1.1495,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
386312,115,116,38,uM,uM,-1.73269023462865,-6.25272180281819,-2.44795003576126,-0.282297533004951,0.230610312300154,1.52105826959341,4.437,-1.89,0.877,-2.177,-0.65,-3.197,,-1.9235,-5.087000000000001,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
386322,115,116,7,uM,uM,-5.87054767188569,-2.63823121009627,-0.980964841409739,-1.84273650115888,0.362777838678078,2.74180562059737,10.315,2.365,7.229,5.444,6.3365,-6.3435,,-0.0034999999999998,-3.9785,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,A549,C3512,Lung (Carcinoma),Lung adenocarcinoma
386333,115,116,28,uM,uM,4.67141278705206,-1.29627221428096,3.82252765557263,3.59655705930152,0.987963832062323,1.55764970515166,-1.287,37.123,65.963,51.288,58.6255,22.7895,,40.7075,21.502500000000005,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
386642,120,116,38,uM,uM,-0.996406059249614,-2.61533496654128,0.643637254457427,2.95730400859871,3.86072665158335,1.52105826959341,4.58,-1.89,3.975,2.028,3.0015,0.3115,,1.6565,-1.5785,Vismodegib,CHEMBL473417,BPQMGSKTAYIVFO-UHFFFAOYSA-N,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,C19H14Cl2N2O3S,DB08828,D09992,vismodegib,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
386648,120,116,28,uM,uM,7.7860991466947,-14.4770141579254,9.55691654446152,9.94208345638656,13.2475908300401,1.55764970515166,-2.739,37.123,63.72,66.292,65.006,30.622,,47.814,27.883000000000003,Vismodegib,CHEMBL473417,BPQMGSKTAYIVFO-UHFFFAOYSA-N,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,C19H14Cl2N2O3S,DB08828,D09992,vismodegib,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
386756,56,116,7,uM,uM,-3.53563934828007,-1.63070609162525,-0.235954998072414,0.288983493091227,0.497567802644297,2.74180562059737,4.613,2.365,10.925,31.988,21.4565,14.4785,,17.967499999999998,16.8435,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,A549,C3512,Lung (Carcinoma),Lung adenocarcinoma
386760,56,116,28,uM,uM,2.31869413003185,-4.10645323367856,2.51152765557263,1.72398099425423,0.479317498262319,1.55764970515166,-0.542,37.123,63.806,45.511,54.6585,18.0775,,36.368,17.5355,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
386770,56,116,38,uM,uM,-1.48630026334225,-10.3695240237205,-3.01802941220924,-0.596920830829133,0.134169130800938,1.52105826959341,4.756,-1.89,-3.318,-5.142,-4.23,-7.096,,-5.663,-8.986,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
387109,101,80,28,uM,uM,4.27955741673961,-0.666707627683224,-2.25956590986536,3.29694473456839,0.171867099886755,0.0869493513576087,-5.115,-2.943,-2.659,-3.021,-2.84,5.218,,1.189,0.1030000000000002,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,letrozole,CHEMBL1444,HPJKCIUCZWXJDR-UHFFFAOYSA-N,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,C17H11N5,DB01006,D00964,letrozole,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
387134,101,80,38,uM,uM,0.899175558294576,4.82378517974994,4.6899458754801,5.88958316924525,4.38962339087133,3.0,-0.959,0.884,3.185,10.672,6.9285,7.0035,,6.965999999999999,6.044499999999999,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,letrozole,CHEMBL1444,HPJKCIUCZWXJDR-UHFFFAOYSA-N,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,C17H11N5,DB01006,D00964,letrozole,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
387208,115,80,28,uM,uM,-0.114166880913262,-2.15742848138156,1.0683684919236,4.52356710068753,0.987963832062323,0.0869493513576087,-1.287,-2.943,1.71,13.787,7.7485,11.9785,,9.8635,9.0355,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,letrozole,CHEMBL1444,HPJKCIUCZWXJDR-UHFFFAOYSA-N,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,C17H11N5,DB01006,D00964,letrozole,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
387214,115,80,38,uM,uM,-0.125897925807425,-0.548718924426388,3.75970042374457,4.02624168041126,0.230610312300154,3.0,4.437,0.884,10.63,8.47,9.55,4.229,,6.8895,5.113,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,letrozole,CHEMBL1444,HPJKCIUCZWXJDR-UHFFFAOYSA-N,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,C17H11N5,DB01006,D00964,letrozole,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
387411,120,80,28,uM,uM,1.29370256873002,1.48534297990221,1.2701561130387,5.6608306349948,13.2475908300401,0.0869493513576087,-2.739,-2.943,1.818,9.43,5.624,11.306,,8.465,8.363,Vismodegib,CHEMBL473417,BPQMGSKTAYIVFO-UHFFFAOYSA-N,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,C19H14Cl2N2O3S,DB08828,D09992,vismodegib,letrozole,CHEMBL1444,HPJKCIUCZWXJDR-UHFFFAOYSA-N,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,C17H11N5,DB01006,D00964,letrozole,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
387433,120,80,38,uM,uM,3.10209116837981,5.59780878067499,7.05866809770232,7.78986456201491,3.86072665158335,3.0,4.58,0.884,12.66,6.226,9.443,3.979,,6.710999999999999,4.863,Vismodegib,CHEMBL473417,BPQMGSKTAYIVFO-UHFFFAOYSA-N,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,C19H14Cl2N2O3S,DB08828,D09992,vismodegib,letrozole,CHEMBL1444,HPJKCIUCZWXJDR-UHFFFAOYSA-N,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,C17H11N5,DB01006,D00964,letrozole,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
387474,56,80,38,uM,uM,-0.887987609592723,-2.54658642319653,4.61400143103565,5.48090798925373,0.134169130800938,3.0,4.756,0.884,5.322,2.846,4.084,-1.556,,1.2639999999999991,-0.6720000000000006,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,letrozole,CHEMBL1444,HPJKCIUCZWXJDR-UHFFFAOYSA-N,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,C17H11N5,DB01006,D00964,letrozole,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
387484,56,80,28,uM,uM,-0.565699236585829,0.802774083199308,4.61689017148974,7.59702712064025,0.479317498262319,0.0869493513576087,-0.542,-2.943,7.161,7.484,7.3225,10.8075,,9.065,7.8645,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,letrozole,CHEMBL1444,HPJKCIUCZWXJDR-UHFFFAOYSA-N,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,C17H11N5,DB01006,D00964,letrozole,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
387808,116,80,28,uM,uM,6.76851512333353,-8.36536105645142,8.61926567420263,10.0125542129892,0.647196610526164,0.0869493513576087,33.59,-2.943,41.777,46.437,44.107,13.46,,28.7835,10.516999999999996,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,letrozole,CHEMBL1444,HPJKCIUCZWXJDR-UHFFFAOYSA-N,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,C17H11N5,DB01006,D00964,letrozole,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
387814,116,80,38,uM,uM,2.46782496783303,3.17228611573422,2.86644607479825,4.17671319412714,4.75243603628729,3.0,-1.244,0.884,0.99,3.017,2.0035,2.3635,,2.1835,1.1195,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,letrozole,CHEMBL1444,HPJKCIUCZWXJDR-UHFFFAOYSA-N,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,C17H11N5,DB01006,D00964,letrozole,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
388008,79,80,38,uM,uM,-1.35703922209925,-2.42880679742223,-3.26699589641431,-4.08989272070568,30.0,3.0,2.987,0.884,-2.798,-2.667,-2.7325,-6.6035,,-4.668,-5.7195,Lenalidomide,CHEMBL848,GOTYRUGSSMKFNF-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,C13H13N3O3,DB00480,D04687,lenalidomide,letrozole,CHEMBL1444,HPJKCIUCZWXJDR-UHFFFAOYSA-N,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,C17H11N5,DB01006,D00964,letrozole,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
388014,79,80,28,uM,uM,0.911825278072525,2.67806326048006,1.5082263258079,3.4368317429039,30.0,0.0869493513576087,4.019,-2.943,5.959,2.354,4.1565,3.0805,,3.6185,0.1375000000000001,Lenalidomide,CHEMBL848,GOTYRUGSSMKFNF-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,C13H13N3O3,DB00480,D04687,lenalidomide,letrozole,CHEMBL1444,HPJKCIUCZWXJDR-UHFFFAOYSA-N,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,C17H11N5,DB01006,D00964,letrozole,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
388370,88,48,28,uM,uM,3.25392899463118,-25.9275320477168,3.04995860312711,3.88031316034973,0.186033682243995,41.9826965945651,29.019,-3.28,33.166,38.181,35.6735,9.9345,,22.804,6.654499999999999,mitoxantrone,CHEMBL58,KKZJGLLVHKMTCM-UHFFFAOYSA-N,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,C22H28N4O6,DB01204,D08224,mitoxantrone,busulfan,CHEMBL820,COVZYZSDYWQREU-UHFFFAOYSA-N,CS(=O)(=O)OCCCCOS(=O)(=O)C,C6H14O6S2,DB01008,D00248,busulfan,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
388379,88,48,38,uM,uM,-6.47658416205955,-17.4875279097727,-1.24901757598045,-3.12249775769802,0.0616476966214236,14.6683424827181,26.212,5.58,26.887,18.825,22.856,-8.936,,6.960000000000001,-3.355999999999998,mitoxantrone,CHEMBL58,KKZJGLLVHKMTCM-UHFFFAOYSA-N,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,C22H28N4O6,DB01204,D08224,mitoxantrone,busulfan,CHEMBL820,COVZYZSDYWQREU-UHFFFAOYSA-N,CS(=O)(=O)OCCCCOS(=O)(=O)C,C6H14O6S2,DB01008,D00248,busulfan,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
388482,72,80,38,uM,uM,-3.73664143049228,-3.08658183085521,-1.9381070075254,-2.722831475758,10.0,3.0,5.994,0.884,3.777,16.414,10.0955,3.2175,,6.656499999999999,4.1015,Gefitinib,CHEMBL939,XGALLCVXEZPNRQ-UHFFFAOYSA-N,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,C22H24ClFN4O3,DB00317,D01977,gefitinib,letrozole,CHEMBL1444,HPJKCIUCZWXJDR-UHFFFAOYSA-N,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,C17H11N5,DB01006,D00964,letrozole,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
388504,72,80,28,uM,uM,-8.83687437052303,-0.614807441872545,0.126004103585697,1.74886443994913,4.63606799908028,0.0869493513576087,10.57,-2.943,20.606,38.352,29.479,21.852,,25.6655,18.909,Gefitinib,CHEMBL939,XGALLCVXEZPNRQ-UHFFFAOYSA-N,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,C22H24ClFN4O3,DB00317,D01977,gefitinib,letrozole,CHEMBL1444,HPJKCIUCZWXJDR-UHFFFAOYSA-N,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,C17H11N5,DB01006,D00964,letrozole,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
389851,108,39,38,uM,uM,-6.3371095522508,-14.3492096131079,-2.27323979820268,-4.0827161488961,1.45049066398121,95.6248320718461,28.889,1.749,29.935,30.579,30.257,-0.381,,14.938000000000002,1.368000000000002,6-Thioguanine,CHEMBL727,WYWHKKSPHMUBEB-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=C(N2)N,C5H5N5S,DB00352,D08603,thioguanine,allopurinol,CHEMBL1467,OFCNXPDARWKPPY-UHFFFAOYSA-N,C1=C2C(=NC=NC2=O)NN1; C1=NNC2=C1C(=O)NC=N2,C5H4N4O,DB00437,D00224,allopurinol,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
389877,108,39,28,uM,uM,1.45806749291447,-29.6141619299767,3.28787131290844,6.0627024629522,1.31560298651524,96.1224495785589,33.09,-4.433,38.602,24.503,31.5525,2.89549999999999,,17.223999999999997,-1.537500000000005,6-Thioguanine,CHEMBL727,WYWHKKSPHMUBEB-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=C(N2)N,C5H5N5S,DB00352,D08603,thioguanine,allopurinol,CHEMBL1467,OFCNXPDARWKPPY-UHFFFAOYSA-N,C1=C2C(=NC=NC2=O)NN1; C1=NNC2=C1C(=O)NC=N2,C5H4N4O,DB00437,D00224,allopurinol,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
389883,53,39,38,uM,uM,-10.6871002674499,-6.96852488790234,-1.34570806353955,-3.48932303612571,20.7438362933702,95.6248320718461,18.749,1.749,19.367,16.392,17.8795,-2.6185,,7.630500000000001,-0.8694999999999986,chlorambucil,CHEMBL515,JCKYGMPEJWAADB-UHFFFAOYSA-N,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,C14H19Cl2NO2,DB00291,D00266,chlorambucil,allopurinol,CHEMBL1467,OFCNXPDARWKPPY-UHFFFAOYSA-N,C1=C2C(=NC=NC2=O)NN1; C1=NNC2=C1C(=O)NC=N2,C5H4N4O,DB00437,D00224,allopurinol,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
389909,53,39,28,uM,uM,-6.10199235312823,-13.0871366810526,-0.884401162645003,2.17768825586672,13.0779438627311,96.1224495785589,16.142,-4.433,15.719,10.444,13.0815,1.3725,,7.227,-3.0605,chlorambucil,CHEMBL515,JCKYGMPEJWAADB-UHFFFAOYSA-N,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,C14H19Cl2NO2,DB00291,D00266,chlorambucil,allopurinol,CHEMBL1467,OFCNXPDARWKPPY-UHFFFAOYSA-N,C1=C2C(=NC=NC2=O)NN1; C1=NNC2=C1C(=O)NC=N2,C5H4N4O,DB00437,D00224,allopurinol,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
389941,40,39,38,uM,uM,-0.60634797518464,-0.0545817736531099,1.05594607479823,4.27613537643699,75.0,95.6248320718461,-3.362,1.749,10.666,7.105,8.8855,10.4985,,9.692,7.1365,altretamine,CHEMBL1455,UUVWYPNAQBNQJQ-UHFFFAOYSA-N,CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C,C9H18N6,DB00488,D02841,altretamine,allopurinol,CHEMBL1467,OFCNXPDARWKPPY-UHFFFAOYSA-N,C1=C2C(=NC=NC2=O)NN1; C1=NNC2=C1C(=O)NC=N2,C5H4N4O,DB00437,D00224,allopurinol,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
389967,40,39,28,uM,uM,3.39306391854133,-0.531630653811844,1.06430748924206,7.7937381616692,75.0,96.1224495785589,-6.521,-4.433,0.986,-6.366,-2.69,8.264,,2.7870000000000004,1.743,altretamine,CHEMBL1455,UUVWYPNAQBNQJQ-UHFFFAOYSA-N,CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C,C9H18N6,DB00488,D02841,altretamine,allopurinol,CHEMBL1467,OFCNXPDARWKPPY-UHFFFAOYSA-N,C1=C2C(=NC=NC2=O)NN1; C1=NNC2=C1C(=O)NC=N2,C5H4N4O,DB00437,D00224,allopurinol,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
390235,1,39,38,uM,uM,-0.331283362417076,-7.18979935279864,0.519982424019543,-2.24806803117597,4.93954994547436,95.6248320718461,31.568,1.749,31.76,10.2,20.98,-12.337,,4.3215,-10.588,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,allopurinol,CHEMBL1467,OFCNXPDARWKPPY-UHFFFAOYSA-N,C1=C2C(=NC=NC2=O)NN1; C1=NNC2=C1C(=O)NC=N2,C5H4N4O,DB00437,D00224,allopurinol,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
390257,1,39,28,uM,uM,-3.06560099311689,-27.5526352122343,-8.68677367419208,-7.49342755943181,3.70539648442761,96.1224495785589,52.846,-4.433,38.431,30.45,34.4405,-13.9725,,10.234000000000002,-18.4055,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,allopurinol,CHEMBL1467,OFCNXPDARWKPPY-UHFFFAOYSA-N,C1=C2C(=NC=NC2=O)NN1; C1=NNC2=C1C(=O)NC=N2,C5H4N4O,DB00437,D00224,allopurinol,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
390358,101,40,28,uM,uM,5.38779644336827,-8.42267651719059,-7.69165114419243,-0.640689884799858,0.171867099886755,75.0,-5.115,-6.514,-8.136,-6.525,-7.3305,4.2985,,-1.5159999999999991,-2.2155,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,altretamine,CHEMBL1455,UUVWYPNAQBNQJQ-UHFFFAOYSA-N,CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C,C9H18N6,DB00488,D02841,altretamine,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
390380,101,40,38,uM,uM,0.809889890042266,-9.29914954495556,-6.55259695242844,-3.11334246187455,4.38962339087133,75.0,-0.959,-3.362,-9.784,-4.89,-7.337,-3.016,,-5.1765,-6.378,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,altretamine,CHEMBL1455,UUVWYPNAQBNQJQ-UHFFFAOYSA-N,CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C,C9H18N6,DB00488,D02841,altretamine,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
391095,72,90,38,uM,uM,-3.0289440361207,1.63957224759003,1.71233743691903,2.0147072299629,10.0,0.0909188015846464,5.994,-0.335,8.085,16.263,12.174,6.515,,9.3445,6.18,Gefitinib,CHEMBL939,XGALLCVXEZPNRQ-UHFFFAOYSA-N,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,C22H24ClFN4O3,DB00317,D01977,gefitinib,Nilotinib,CHEMBL255863,HHZIURLSWUIHRB-UHFFFAOYSA-N,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,C28H22F3N7O,DB04868,D08953,nilotinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
391113,72,90,7,uM,uM,1.33553982367268,-3.17560478342997,-0.419384785303191,0.553264674224326,1.19272204952941,0.0222839338450436,22.807,-1.882,22.224,23.604,22.914,1.989,,12.451500000000005,0.1070000000000028,Gefitinib,CHEMBL939,XGALLCVXEZPNRQ-UHFFFAOYSA-N,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,C22H24ClFN4O3,DB00317,D01977,gefitinib,Nilotinib,CHEMBL255863,HHZIURLSWUIHRB-UHFFFAOYSA-N,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,C28H22F3N7O,DB04868,D08953,nilotinib,A549,C3512,Lung (Carcinoma),Lung adenocarcinoma
391117,72,90,28,uM,uM,5.166656967511,3.54487925105518,2.75867077025237,6.57637195382372,4.63606799908028,0.8,10.57,-5.329,15.956,37.329,26.6425,21.4015,,24.022,16.072499999999998,Gefitinib,CHEMBL939,XGALLCVXEZPNRQ-UHFFFAOYSA-N,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,C22H24ClFN4O3,DB00317,D01977,gefitinib,Nilotinib,CHEMBL255863,HHZIURLSWUIHRB-UHFFFAOYSA-N,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,C28H22F3N7O,DB04868,D08953,nilotinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
391661,116,90,7,uM,uM,0.637617541681447,-3.04206541631216,-2.70006610918352,0.613121636430033,5.0,0.0222839338450436,-2.354,-1.882,-3.381,5.035,0.827,5.063,,2.945,2.709,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,Nilotinib,CHEMBL255863,HHZIURLSWUIHRB-UHFFFAOYSA-N,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,C28H22F3N7O,DB04868,D08953,nilotinib,A549,C3512,Lung (Carcinoma),Lung adenocarcinoma
391672,116,90,28,uM,uM,7.20481559924164,-5.01335554324126,4.9890041035857,8.16741544353042,0.647196610526164,0.8,33.59,-5.329,43.733,42.766,43.2495,14.9885,,29.119,9.659499999999994,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,Nilotinib,CHEMBL255863,HHZIURLSWUIHRB-UHFFFAOYSA-N,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,C28H22F3N7O,DB04868,D08953,nilotinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
391678,116,90,38,uM,uM,1.62776063345684,5.1911848514506,5.35595110010952,7.13202273179249,4.75243603628729,0.0909188015846464,-1.244,-0.335,4.512,4.954,4.733,6.312,,5.5225,5.068,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,Nilotinib,CHEMBL255863,HHZIURLSWUIHRB-UHFFFAOYSA-N,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,C28H22F3N7O,DB04868,D08953,nilotinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
391935,79,90,38,uM,uM,-1.06523536616547,-0.092304978489012,-0.930440340858753,-0.613361987206997,30.0,0.0909188015846464,2.987,-0.335,1.463,-1.081,0.191,-2.461,,-1.135,-2.7960000000000003,Lenalidomide,CHEMBL848,GOTYRUGSSMKFNF-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,C13H13N3O3,DB00480,D04687,lenalidomide,Nilotinib,CHEMBL255863,HHZIURLSWUIHRB-UHFFFAOYSA-N,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,C28H22F3N7O,DB04868,D08953,nilotinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
391941,79,90,28,uM,uM,4.14682054167111,1.04827957317354,-0.12155145196987,4.41540038455627,30.0,0.8,4.019,-5.329,4.921,-0.66,2.1305,3.4405,,2.7855,-1.8885,Lenalidomide,CHEMBL848,GOTYRUGSSMKFNF-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,C13H13N3O3,DB00480,D04687,lenalidomide,Nilotinib,CHEMBL255863,HHZIURLSWUIHRB-UHFFFAOYSA-N,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,C28H22F3N7O,DB04868,D08953,nilotinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
391996,115,40,38,uM,uM,-1.23457066988007,-10.0543813595423,-3.88846202042488,-0.604742588486307,0.230610312300154,75.0,4.437,-3.362,0.074,-2.234,-1.08,-2.155,,-1.6175000000000002,-5.517,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,altretamine,CHEMBL1455,UUVWYPNAQBNQJQ-UHFFFAOYSA-N,CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C,C9H18N6,DB00488,D02841,altretamine,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
392002,115,40,28,uM,uM,1.92377443432849,-7.08484730647919,1.00386917158217,7.0786986813193,0.987963832062323,75.0,-1.287,-6.514,4.585,12.083,8.334,16.135,,12.2345,9.621,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,altretamine,CHEMBL1455,UUVWYPNAQBNQJQ-UHFFFAOYSA-N,CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C,C9H18N6,DB00488,D02841,altretamine,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
392029,108,74,28,uM,uM,-1.6010323537838,-27.1037949618154,4.86523215840766,4.12502914091291,1.31560298651524,29.4525657262699,33.09,6.922,39.313,38.777,39.045,-0.966999999999999,,19.039,5.954999999999998,6-Thioguanine,CHEMBL727,WYWHKKSPHMUBEB-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=C(N2)N,C5H5N5S,DB00352,D08603,thioguanine,hydroxyurea,CHEMBL467,VSNHCAURESNICA-UHFFFAOYSA-N,C(=O)(N)NO,CH4N2O2,DB01005,D00341,hydroxyurea,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
392035,108,74,38,uM,uM,-15.6748179830592,-9.65853941091564,-7.02029957625546,-11.3208762366097,1.45049066398121,100.0,28.889,9.978,27.491,24.503,25.997,-12.87,,6.563500000000001,-2.8919999999999995,6-Thioguanine,CHEMBL727,WYWHKKSPHMUBEB-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=C(N2)N,C5H5N5S,DB00352,D08603,thioguanine,hydroxyurea,CHEMBL467,VSNHCAURESNICA-UHFFFAOYSA-N,C(=O)(N)NO,CH4N2O2,DB01005,D00341,hydroxyurea,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
392233,53,74,28,uM,uM,-4.37322350728601,-8.11633109120979,3.25973177646704,2.19307627027917,13.0779438627311,29.4525657262699,16.142,6.922,17.226,12.702,14.964,-8.1,,3.4320000000000004,-1.177999999999999,chlorambucil,CHEMBL515,JCKYGMPEJWAADB-UHFFFAOYSA-N,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,C14H19Cl2NO2,DB00291,D00266,chlorambucil,hydroxyurea,CHEMBL467,VSNHCAURESNICA-UHFFFAOYSA-N,C(=O)(N)NO,CH4N2O2,DB01005,D00341,hydroxyurea,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
392239,53,74,38,uM,uM,-11.983383227891,-2.75074184018025,-0.502878952703435,-5.00341017050594,20.7438362933702,100.0,18.749,9.978,25.67,42.576,34.123,5.39600000000001,,19.7595,15.374,chlorambucil,CHEMBL515,JCKYGMPEJWAADB-UHFFFAOYSA-N,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,C14H19Cl2NO2,DB00291,D00266,chlorambucil,hydroxyurea,CHEMBL467,VSNHCAURESNICA-UHFFFAOYSA-N,C(=O)(N)NO,CH4N2O2,DB01005,D00341,hydroxyurea,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
392523,40,74,28,uM,uM,-1.62089295490384,-4.62426881181624,-0.559887258535089,5.18142732240769,75.0,29.4525657262699,-6.521,6.922,3.516,12.052,7.784,7.383,,7.5835,0.8620000000000001,altretamine,CHEMBL1455,UUVWYPNAQBNQJQ-UHFFFAOYSA-N,CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C,C9H18N6,DB00488,D02841,altretamine,hydroxyurea,CHEMBL467,VSNHCAURESNICA-UHFFFAOYSA-N,C(=O)(N)NO,CH4N2O2,DB01005,D00341,hydroxyurea,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
392545,40,74,38,uM,uM,-3.66343992933687,-9.42794008902264,-5.16122059186843,-2.11341837238769,75.0,100.0,-3.362,9.978,13.457,2.333,7.895,1.279,,4.587,-2.083,altretamine,CHEMBL1455,UUVWYPNAQBNQJQ-UHFFFAOYSA-N,CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C,C9H18N6,DB00488,D02841,altretamine,hydroxyurea,CHEMBL467,VSNHCAURESNICA-UHFFFAOYSA-N,C(=O)(N)NO,CH4N2O2,DB01005,D00341,hydroxyurea,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
392768,1,74,28,uM,uM,-1.67981895012681,-21.6667464969738,0.679559659141258,-2.46768720424885,3.70539648442761,29.4525657262699,52.846,6.922,51.486,32.701,42.0935,-17.6745,,12.209500000000002,-10.752499999999998,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,hydroxyurea,CHEMBL467,VSNHCAURESNICA-UHFFFAOYSA-N,C(=O)(N)NO,CH4N2O2,DB01005,D00341,hydroxyurea,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
392778,1,74,38,uM,uM,0.84027567438811,6.41145730669165,8.38876020179733,2.61416932999936,4.93954994547436,100.0,31.568,9.978,42.958,31.281,37.1195,-4.4265,,16.346500000000002,5.551500000000001,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,hydroxyurea,CHEMBL467,VSNHCAURESNICA-UHFFFAOYSA-N,C(=O)(N)NO,CH4N2O2,DB01005,D00341,hydroxyurea,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
392980,56,40,28,uM,uM,1.11838830797834,-7.72575783953607,2.81494854803015,8.81360875127201,0.479317498262319,75.0,-0.542,-6.514,5.846,17.334,11.59,18.646,,15.118,12.132,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,altretamine,CHEMBL1455,UUVWYPNAQBNQJQ-UHFFFAOYSA-N,CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C,C9H18N6,DB00488,D02841,altretamine,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
392990,56,40,38,uM,uM,-1.19521310178463,-9.95034415557712,-3.91340646486932,-0.538078447421602,0.134169130800938,75.0,4.756,-3.362,-3.482,-4.595,-4.0385,-5.4325,,-4.7355,-8.7945,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,altretamine,CHEMBL1455,UUVWYPNAQBNQJQ-UHFFFAOYSA-N,CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C,C9H18N6,DB00488,D02841,altretamine,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
393120,101,90,38,uM,uM,5.41346230670503,5.0892970085176,5.67675820890584,7.36619976385504,4.38962339087133,0.0909188015846464,-0.959,-0.335,-2.93,6.249,1.6595,2.9535,,2.3065,1.9945,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,Nilotinib,CHEMBL255863,HHZIURLSWUIHRB-UHFFFAOYSA-N,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,C28H22F3N7O,DB04868,D08953,nilotinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
393129,101,90,7,uM,uM,-1.45646172222954,-3.09922178454897,-3.32892695468275,-1.37342023079544,3.22123167658349,0.0222839338450436,2.342,-1.882,0.807,1.332,1.0695,0.6095,,0.8394999999999998,-1.2725000000000002,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,Nilotinib,CHEMBL255863,HHZIURLSWUIHRB-UHFFFAOYSA-N,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,C28H22F3N7O,DB04868,D08953,nilotinib,A549,C3512,Lung (Carcinoma),Lung adenocarcinoma
393141,101,90,28,uM,uM,4.9813438306716,-3.45921445112858,-2.81620669974798,3.56042528955408,0.171867099886755,0.8,-5.115,-5.329,-4.632,-4.302,-4.467,5.977,,0.7549999999999999,0.6480000000000006,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,Nilotinib,CHEMBL255863,HHZIURLSWUIHRB-UHFFFAOYSA-N,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,C28H22F3N7O,DB04868,D08953,nilotinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
393151,120,40,38,uM,uM,-1.03775496024521,-6.34058157605621,-2.54518424264709,0.770785503117357,3.86072665158335,75.0,4.58,-3.362,1.46,-4.088,-1.314,-2.532,,-1.923,-5.894,Vismodegib,CHEMBL473417,BPQMGSKTAYIVFO-UHFFFAOYSA-N,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,C19H14Cl2N2O3S,DB08828,D09992,vismodegib,altretamine,CHEMBL1455,UUVWYPNAQBNQJQ-UHFFFAOYSA-N,CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C,C9H18N6,DB00488,D02841,altretamine,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
393173,120,40,28,uM,uM,2.61465040120407,-8.88761090899179,-4.3498713991272,2.15887549895989,13.2475908300401,75.0,-2.739,-6.514,2.108,6.942,4.525,13.778,,9.1515,7.264,Vismodegib,CHEMBL473417,BPQMGSKTAYIVFO-UHFFFAOYSA-N,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,C19H14Cl2N2O3S,DB08828,D09992,vismodegib,altretamine,CHEMBL1455,UUVWYPNAQBNQJQ-UHFFFAOYSA-N,CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C,C9H18N6,DB00488,D02841,altretamine,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
393383,115,90,7,uM,uM,-2.88389603187338,-9.13830015302732,-2.7889958964143,-1.65818821814993,0.362777838678078,0.0222839338450436,10.315,-1.882,5.01,9.505,7.2575,-1.1755,,3.0410000000000004,-3.057499999999999,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,Nilotinib,CHEMBL255863,HHZIURLSWUIHRB-UHFFFAOYSA-N,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,C28H22F3N7O,DB04868,D08953,nilotinib,A549,C3512,Lung (Carcinoma),Lung adenocarcinoma
393387,115,90,28,uM,uM,1.46530724864784,-0.748044093374838,0.875461934206137,5.90600687567323,0.987963832062323,0.8,-1.287,-5.329,1.874,9.231,5.5525,12.1685,,8.8605,6.8395,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,Nilotinib,CHEMBL255863,HHZIURLSWUIHRB-UHFFFAOYSA-N,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,C28H22F3N7O,DB04868,D08953,nilotinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
393393,115,90,38,uM,uM,-2.30901270027605,-1.12489404247296,1.75282774201652,2.78610203668771,0.230610312300154,0.0909188015846464,4.437,-0.335,5.545,6.309,5.927,1.825,,3.876,1.489999999999999,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,Nilotinib,CHEMBL255863,HHZIURLSWUIHRB-UHFFFAOYSA-N,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,C28H22F3N7O,DB04868,D08953,nilotinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
393498,56,90,7,uM,uM,-4.41613240389858,-9.46272875250635,-2.23959362134942,-0.137295676677599,0.497567802644297,0.0222839338450436,4.613,-1.882,2.194,28.452,15.323,12.592,,13.9575,10.71,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,Nilotinib,CHEMBL255863,HHZIURLSWUIHRB-UHFFFAOYSA-N,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,C28H22F3N7O,DB04868,D08953,nilotinib,A549,C3512,Lung (Carcinoma),Lung adenocarcinoma
393510,56,90,28,uM,uM,0.109971949007567,-3.90115861430332,-1.77996416175116,2.99628638395928,0.479317498262319,0.8,-0.542,-5.329,4.509,2.063,3.286,9.157,,6.2215,3.828,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,Nilotinib,CHEMBL255863,HHZIURLSWUIHRB-UHFFFAOYSA-N,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,C28H22F3N7O,DB04868,D08953,nilotinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
393516,56,90,38,uM,uM,-2.38207174026016,-2.72345459579188,2.2753432695188,3.76858178525242,0.134169130800938,0.0909188015846464,4.756,-0.335,6.379,5.504,5.9415,1.5205,,3.731,1.185499999999999,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,Nilotinib,CHEMBL255863,HHZIURLSWUIHRB-UHFFFAOYSA-N,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,C28H22F3N7O,DB04868,D08953,nilotinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
393591,120,90,28,uM,uM,0.848439742771213,-0.309652414933766,-0.0059486342488876,5.62384392164717,13.2475908300401,0.8,-2.739,-5.329,7.132,7.346,7.239,15.307,,11.273,9.978,Vismodegib,CHEMBL473417,BPQMGSKTAYIVFO-UHFFFAOYSA-N,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,C19H14Cl2N2O3S,DB08828,D09992,vismodegib,Nilotinib,CHEMBL255863,HHZIURLSWUIHRB-UHFFFAOYSA-N,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,C28H22F3N7O,DB04868,D08953,nilotinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
393612,120,90,38,uM,uM,1.19592974577084,5.37512331479616,6.33725820890586,7.68225804690249,3.86072665158335,0.0909188015846464,4.58,-0.335,9.7,6.818,8.259,4.014,,6.1365,3.679,Vismodegib,CHEMBL473417,BPQMGSKTAYIVFO-UHFFFAOYSA-N,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,C19H14Cl2N2O3S,DB08828,D09992,vismodegib,Nilotinib,CHEMBL255863,HHZIURLSWUIHRB-UHFFFAOYSA-N,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,C28H22F3N7O,DB04868,D08953,nilotinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
394185,40,53,28,uM,uM,3.68983729633073,-11.4706184118472,1.06264186458166,6.3834780174663,75.0,13.0773575280054,-6.521,16.142,11.276,48.457,29.8665,20.2455,,25.056,13.7245,altretamine,CHEMBL1455,UUVWYPNAQBNQJQ-UHFFFAOYSA-N,CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C,C9H18N6,DB00488,D02841,altretamine,chlorambucil,CHEMBL515,JCKYGMPEJWAADB-UHFFFAOYSA-N,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,C14H19Cl2NO2,DB00291,D00266,chlorambucil,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
394210,40,53,38,uM,uM,-8.4945259904881,-16.8703537019151,-7.32766503631288,-4.5830183676517,75.0,20.7378975640732,-3.362,18.749,27.132,14.588,20.86,5.473,,13.1665,2.1110000000000007,altretamine,CHEMBL1455,UUVWYPNAQBNQJQ-UHFFFAOYSA-N,CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C,C9H18N6,DB00488,D02841,altretamine,chlorambucil,CHEMBL515,JCKYGMPEJWAADB-UHFFFAOYSA-N,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,C14H19Cl2NO2,DB00291,D00266,chlorambucil,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
395253,1,53,28,uM,uM,-26.0725037259328,-66.1890436091872,-56.2340263867934,-60.5281182721024,3.70539648442761,13.0773575280054,52.846,16.142,-5.633,-4.391,-5.012,-74.0,,-39.506,-57.858,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,chlorambucil,CHEMBL515,JCKYGMPEJWAADB-UHFFFAOYSA-N,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,C14H19Cl2NO2,DB00291,D00266,chlorambucil,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
395275,1,53,38,uM,uM,-6.4613401984778,1.27363426046957,2.82958169890185,-5.73096509859799,4.93954994547436,20.7378975640732,31.568,18.749,40.378,21.574,30.976,-19.341,,5.817499999999999,-0.5920000000000023,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,chlorambucil,CHEMBL515,JCKYGMPEJWAADB-UHFFFAOYSA-N,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,C14H19Cl2NO2,DB00291,D00266,chlorambucil,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
395649,88,39,38,uM,uM,-0.857771903788923,-10.2351272237038,1.34309353513066,-0.53842243516297,0.0616476966214236,95.6248320718461,26.212,1.749,31.311,29.134,30.2225,2.2615,,16.242,4.0105,mitoxantrone,CHEMBL58,KKZJGLLVHKMTCM-UHFFFAOYSA-N,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,C22H28N4O6,DB01204,D08224,mitoxantrone,allopurinol,CHEMBL1467,OFCNXPDARWKPPY-UHFFFAOYSA-N,C1=C2C(=NC=NC2=O)NN1; C1=NNC2=C1C(=O)NC=N2,C5H4N4O,DB00437,D00224,allopurinol,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
395659,88,39,28,uM,uM,1.41794918085027,-31.2741974946741,4.20609353513066,6.108056493492,0.186033682243995,96.1224495785589,29.019,-4.433,30.506,36.036,33.271,8.685,,20.978,4.252000000000002,mitoxantrone,CHEMBL58,KKZJGLLVHKMTCM-UHFFFAOYSA-N,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,C22H28N4O6,DB01204,D08224,mitoxantrone,allopurinol,CHEMBL1467,OFCNXPDARWKPPY-UHFFFAOYSA-N,C1=C2C(=NC=NC2=O)NN1; C1=NNC2=C1C(=O)NC=N2,C5H4N4O,DB00437,D00224,allopurinol,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
396209,88,80,28,uM,uM,6.95350856790752,-24.3646937790488,-1.30155145196986,0.199240152480942,0.186033682243995,0.0869493513576087,29.019,-2.943,27.647,43.127,35.387,9.311,,22.349000000000004,6.368000000000002,mitoxantrone,CHEMBL58,KKZJGLLVHKMTCM-UHFFFAOYSA-N,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,C22H28N4O6,DB01204,D08224,mitoxantrone,letrozole,CHEMBL1444,HPJKCIUCZWXJDR-UHFFFAOYSA-N,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,C17H11N5,DB01006,D00964,letrozole,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
396219,88,80,38,uM,uM,0.334518835134358,-19.7478692231441,1.33722632580791,0.70734823278476,0.0616476966214236,3.0,26.212,0.884,30.876,24.393,27.6345,0.538500000000003,,14.0865,1.4224999999999994,mitoxantrone,CHEMBL58,KKZJGLLVHKMTCM-UHFFFAOYSA-N,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,C22H28N4O6,DB01204,D08224,mitoxantrone,letrozole,CHEMBL1444,HPJKCIUCZWXJDR-UHFFFAOYSA-N,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,C17H11N5,DB01006,D00964,letrozole,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
397029,88,74,28,uM,uM,-1.20705282510528,-18.1802633095736,4.45502614334629,1.44437159534162,0.186033682243995,29.4525657262699,29.019,6.922,30.737,62.196,46.4665,10.5255,,28.49600000000001,17.447500000000005,mitoxantrone,CHEMBL58,KKZJGLLVHKMTCM-UHFFFAOYSA-N,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,C22H28N4O6,DB01204,D08224,mitoxantrone,hydroxyurea,CHEMBL467,VSNHCAURESNICA-UHFFFAOYSA-N,C(=O)(N)NO,CH4N2O2,DB01005,D00341,hydroxyurea,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
397051,88,74,38,uM,uM,5.46687671437205,7.6665408661814,10.1867004237446,5.76197224379014,0.0616476966214236,100.0,26.212,9.978,42.528,49.411,45.9695,9.7795,,27.8745,19.7575,mitoxantrone,CHEMBL58,KKZJGLLVHKMTCM-UHFFFAOYSA-N,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,C22H28N4O6,DB01204,D08224,mitoxantrone,hydroxyurea,CHEMBL467,VSNHCAURESNICA-UHFFFAOYSA-N,C(=O)(N)NO,CH4N2O2,DB01005,D00341,hydroxyurea,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
398574,79,74,38,uM,uM,-5.67444487797763,1.45661481634731,3.14155718590935,0.110072968077457,30.0,100.0,2.987,9.978,21.395,13.827,17.611,4.646,,11.1285,7.633000000000001,Lenalidomide,CHEMBL848,GOTYRUGSSMKFNF-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,C13H13N3O3,DB00480,D04687,lenalidomide,hydroxyurea,CHEMBL467,VSNHCAURESNICA-UHFFFAOYSA-N,C(=O)(N)NO,CH4N2O2,DB01005,D00341,hydroxyurea,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
398600,79,74,28,uM,uM,-3.49518948649315,-2.22786341259177,-0.0272155665571482,-1.8292381531243,30.0,29.4525657262699,4.019,6.922,2.991,5.656,4.3235,-6.6175,,-1.1469999999999994,-2.5985,Lenalidomide,CHEMBL848,GOTYRUGSSMKFNF-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,C13H13N3O3,DB00480,D04687,lenalidomide,hydroxyurea,CHEMBL467,VSNHCAURESNICA-UHFFFAOYSA-N,C(=O)(N)NO,CH4N2O2,DB01005,D00341,hydroxyurea,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
398782,116,74,28,uM,uM,-2.70853132085323,-23.3895084757172,-2.14198178774818,-3.29633984183492,0.647196610526164,41.7002968547726,33.59,3.075,38.32,30.549,34.4345,-2.23050000000001,,16.101999999999997,0.8444999999999965,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,hydroxyurea,CHEMBL467,VSNHCAURESNICA-UHFFFAOYSA-N,C(=O)(N)NO,CH4N2O2,DB01005,D00341,hydroxyurea,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
398807,116,74,38,uM,uM,-3.18978085685841,0.0627744085966853,0.573775419815992,1.79071682161494,4.75243603628729,100.0,-1.244,8.663,20.449,5.991,13.22,5.801,,9.5105,4.557,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,hydroxyurea,CHEMBL467,VSNHCAURESNICA-UHFFFAOYSA-N,C(=O)(N)NO,CH4N2O2,DB01005,D00341,hydroxyurea,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
398937,120,74,28,uM,uM,-2.8896601603989,-3.44028860391463,-3.25348163135784,-0.760170135537131,13.2475908300401,41.7002968547726,-2.739,3.075,9.545,6.83,8.1875,7.8515,,8.0195,5.1125,Vismodegib,CHEMBL473417,BPQMGSKTAYIVFO-UHFFFAOYSA-N,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,C19H14Cl2N2O3S,DB08828,D09992,vismodegib,hydroxyurea,CHEMBL467,VSNHCAURESNICA-UHFFFAOYSA-N,C(=O)(N)NO,CH4N2O2,DB01005,D00341,hydroxyurea,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
398947,120,74,38,uM,uM,-4.43037720831472,3.70927588701424,4.6246339412011,3.70724963069374,3.86072665158335,100.0,4.58,8.663,26.015,13.405,19.71,6.467,,13.0885,11.047,Vismodegib,CHEMBL473417,BPQMGSKTAYIVFO-UHFFFAOYSA-N,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,C19H14Cl2N2O3S,DB08828,D09992,vismodegib,hydroxyurea,CHEMBL467,VSNHCAURESNICA-UHFFFAOYSA-N,C(=O)(N)NO,CH4N2O2,DB01005,D00341,hydroxyurea,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
398993,56,74,38,uM,uM,-4.76707771774635,-3.03145604211317,-2.14914383657668,-3.03842479916215,0.134169130800938,100.0,4.756,8.663,14.611,8.342,11.4765,-1.9425,,4.767,2.8134999999999994,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,hydroxyurea,CHEMBL467,VSNHCAURESNICA-UHFFFAOYSA-N,C(=O)(N)NO,CH4N2O2,DB01005,D00341,hydroxyurea,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
399014,56,74,28,uM,uM,-3.69839891775723,-10.0605597944298,-3.8483269493548,-2.92310718705687,0.479317498262319,41.7002968547726,-0.542,3.075,2.157,7.226,4.6915,2.1585,,3.4249999999999994,1.6164999999999994,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,hydroxyurea,CHEMBL467,VSNHCAURESNICA-UHFFFAOYSA-N,C(=O)(N)NO,CH4N2O2,DB01005,D00341,hydroxyurea,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
399141,115,74,28,uM,uM,-2.6878089733736,-3.8145130636817,1.00911749508965,2.60247257689022,0.987963832062323,41.7002968547726,-1.287,3.075,10.684,7.843,9.2635,7.4755,,8.3695,6.1885,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,hydroxyurea,CHEMBL467,VSNHCAURESNICA-UHFFFAOYSA-N,C(=O)(N)NO,CH4N2O2,DB01005,D00341,hydroxyurea,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
399167,115,74,38,uM,uM,-3.92361640425956,4.74612408088085,5.48420917468232,3.87932061739186,0.230610312300154,100.0,4.437,8.663,22.384,17.709,20.0465,6.9465,,13.4965,11.383500000000002,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,hydroxyurea,CHEMBL467,VSNHCAURESNICA-UHFFFAOYSA-N,C(=O)(N)NO,CH4N2O2,DB01005,D00341,hydroxyurea,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
399380,101,74,28,uM,uM,0.516251089867406,-4.35318869360576,-4.16668770146382,0.838365435757861,0.171867099886755,41.7002968547726,-5.115,3.075,9.56,3.884,6.722,8.762,,7.742000000000001,3.647,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,hydroxyurea,CHEMBL467,VSNHCAURESNICA-UHFFFAOYSA-N,C(=O)(N)NO,CH4N2O2,DB01005,D00341,hydroxyurea,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
399386,101,74,38,uM,uM,-4.28835217660267,-5.81000470682937,-5.41892161435447,-5.091276633001,4.38962339087133,100.0,-0.959,8.663,11.828,1.662,6.745,-0.959000000000001,,2.893,-1.918,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,hydroxyurea,CHEMBL467,VSNHCAURESNICA-UHFFFAOYSA-N,C(=O)(N)NO,CH4N2O2,DB01005,D00341,hydroxyurea,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
401542,40,80,28,uM,uM,3.46976251766307,-5.11985612120918,-6.45872275847403,-0.168378100452999,75.0,0.0869493513576087,-6.521,-2.943,-5.489,-1.254,-3.3715,6.0925,,1.3605,-0.4285000000000001,altretamine,CHEMBL1455,UUVWYPNAQBNQJQ-UHFFFAOYSA-N,CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C,C9H18N6,DB00488,D02841,altretamine,letrozole,CHEMBL1444,HPJKCIUCZWXJDR-UHFFFAOYSA-N,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,C17H11N5,DB01006,D00964,letrozole,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
401552,40,80,38,uM,uM,0.897076772670658,-0.50280925807567,-1.04577614742396,2.29455798327362,75.0,3.0,-3.362,0.884,2.764,0.386,1.575,4.053,,2.814,0.691,altretamine,CHEMBL1455,UUVWYPNAQBNQJQ-UHFFFAOYSA-N,CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C,C9H18N6,DB00488,D02841,altretamine,letrozole,CHEMBL1444,HPJKCIUCZWXJDR-UHFFFAOYSA-N,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,C17H11N5,DB01006,D00964,letrozole,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
401600,72,74,38,uM,uM,-6.05380019009843,6.45592469598238,8.21237502946122,3.37642204635847,10.0,100.0,5.994,9.978,28.685,27.64,28.1625,12.1905,,20.1765,18.1845,Gefitinib,CHEMBL939,XGALLCVXEZPNRQ-UHFFFAOYSA-N,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,C22H24ClFN4O3,DB00317,D01977,gefitinib,hydroxyurea,CHEMBL467,VSNHCAURESNICA-UHFFFAOYSA-N,C(=O)(N)NO,CH4N2O2,DB01005,D00341,hydroxyurea,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
401610,72,74,28,uM,uM,-6.57741976248756,-17.3321049319458,-2.86646401331638,-4.69488000607907,4.63606799908028,29.4525657262699,10.57,6.922,14.725,23.709,19.217,1.725,,10.470999999999998,8.646999999999998,Gefitinib,CHEMBL939,XGALLCVXEZPNRQ-UHFFFAOYSA-N,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,C22H24ClFN4O3,DB00317,D01977,gefitinib,hydroxyurea,CHEMBL467,VSNHCAURESNICA-UHFFFAOYSA-N,C(=O)(N)NO,CH4N2O2,DB01005,D00341,hydroxyurea,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
402011,53,80,28,uM,uM,-6.13557846701038,-10.4276816454116,-8.50344910446897,-6.48464908043678,13.0779438627311,0.0869493513576087,16.142,-2.943,9.016,2.366,5.691,-7.508,,-0.9085,-10.451,chlorambucil,CHEMBL515,JCKYGMPEJWAADB-UHFFFAOYSA-N,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,C14H19Cl2NO2,DB00291,D00266,chlorambucil,letrozole,CHEMBL1444,HPJKCIUCZWXJDR-UHFFFAOYSA-N,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,C17H11N5,DB01006,D00964,letrozole,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
402037,53,80,38,uM,uM,-5.8371928228867,-5.17508385143654,-4.19923432579737,-4.88374003040019,20.7438362933702,3.0,18.749,0.884,17.834,37.515,27.6745,8.0415,,17.857999999999997,8.9255,chlorambucil,CHEMBL515,JCKYGMPEJWAADB-UHFFFAOYSA-N,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,C14H19Cl2NO2,DB00291,D00266,chlorambucil,letrozole,CHEMBL1444,HPJKCIUCZWXJDR-UHFFFAOYSA-N,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,C17H11N5,DB01006,D00964,letrozole,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
402163,108,80,28,uM,uM,-0.581542537707349,-23.4577615339233,-2.75297822758572,-0.467765345281083,1.31560298651524,0.0869493513576087,33.09,-2.943,32.556,29.544,31.05,0.902999999999995,,15.9765,-2.0400000000000027,6-Thioguanine,CHEMBL727,WYWHKKSPHMUBEB-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=C(N2)N,C5H5N5S,DB00352,D08603,thioguanine,letrozole,CHEMBL1444,HPJKCIUCZWXJDR-UHFFFAOYSA-N,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,C17H11N5,DB01006,D00964,letrozole,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
402189,108,80,38,uM,uM,-0.0319664031785296,-9.36300653314446,0.264559659141247,-0.344259780948359,1.45049066398121,3.0,28.889,0.884,29.097,37.343,33.22,3.447,,18.3335,4.331,6-Thioguanine,CHEMBL727,WYWHKKSPHMUBEB-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=C(N2)N,C5H5N5S,DB00352,D08603,thioguanine,letrozole,CHEMBL1444,HPJKCIUCZWXJDR-UHFFFAOYSA-N,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,C17H11N5,DB01006,D00964,letrozole,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
402487,1,80,28,uM,uM,1.40971126253013,-9.48147540031901,-5.94366256308097,-4.99200490488732,3.70539648442761,0.0869493513576087,52.846,-2.943,47.045,1.701,24.373,-25.53,,-0.5784999999999982,-28.472999999999995,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,letrozole,CHEMBL1444,HPJKCIUCZWXJDR-UHFFFAOYSA-N,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,C17H11N5,DB01006,D00964,letrozole,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
402509,1,80,38,uM,uM,8.28159159262577,8.35914297232314,10.3510041035857,9.77002068343844,4.93954994547436,3.0,31.568,0.884,44.085,34.775,39.43,6.978,,23.204,7.861999999999998,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,letrozole,CHEMBL1444,HPJKCIUCZWXJDR-UHFFFAOYSA-N,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,C17H11N5,DB01006,D00964,letrozole,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
402947,1,35,38,uM,uM,8.58657072402713,12.855945509849,13.5672046462418,8.47125631593662,4.93954994547436,0.208496207352919,31.568,9.397,52.01,38.9,45.455,4.48999999999999,,24.9725,13.886999999999995,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
403240,40,35,28,uM,uM,-1.66696825830161,-11.091217455685,-1.91166503631287,3.82284020371225,75.0,0.262268148292762,-6.521,7.518,5.298,3.666,4.482,3.485,,3.9835,-3.036,altretamine,CHEMBL1455,UUVWYPNAQBNQJQ-UHFFFAOYSA-N,CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C,C9H18N6,DB00488,D02841,altretamine,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
403246,40,35,38,uM,uM,-3.86195040348373,-19.35089750241,-0.817776147423981,2.20731888466068,75.0,0.208496207352919,-3.362,9.397,22.553,9.223,15.888,9.853,,12.8705,6.491,altretamine,CHEMBL1455,UUVWYPNAQBNQJQ-UHFFFAOYSA-N,CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C,C9H18N6,DB00488,D02841,altretamine,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
403295,53,35,28,uM,uM,-8.12028068039148,-9.10207541895033,-3.69411140020362,-4.2916227213866,13.0779438627311,0.262268148292762,16.142,7.518,12.685,13.817,13.251,-10.409,,1.4209999999999994,-2.891,chlorambucil,CHEMBL515,JCKYGMPEJWAADB-UHFFFAOYSA-N,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,C14H19Cl2NO2,DB00291,D00266,chlorambucil,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
403301,53,35,38,uM,uM,-3.25172647709464,5.9786657423399,7.155847492016,3.5417243443202,20.7438362933702,0.208496207352919,18.749,9.397,40.758,38.601,39.6795,11.5335,,25.6065,20.9305,chlorambucil,CHEMBL515,JCKYGMPEJWAADB-UHFFFAOYSA-N,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,C14H19Cl2NO2,DB00291,D00266,chlorambucil,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
403383,108,35,28,uM,uM,-3.48561092918346,-8.15795230134141,-0.846101174925665,-0.580357013338073,1.31560298651524,0.262268148292762,33.09,7.518,33.215,37.286,35.2505,-5.3575,,14.9465,2.160499999999999,6-Thioguanine,CHEMBL727,WYWHKKSPHMUBEB-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=C(N2)N,C5H5N5S,DB00352,D08603,thioguanine,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
403389,108,35,38,uM,uM,-1.00718262245239,2.74986958000181,4.936847492016,1.08273099821648,1.45049066398121,0.208496207352919,28.889,9.397,33.587,43.333,38.46,0.173999999999999,,19.317,9.571000000000002,6-Thioguanine,CHEMBL727,WYWHKKSPHMUBEB-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=C(N2)N,C5H5N5S,DB00352,D08603,thioguanine,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
406017,72,43,38,uM,uM,-3.32483551673102,0.254031188185739,0.0431152146968114,-2.28554494407979,10.0,0.0115539149855814,5.994,2.525,6.178,13.56,9.869,1.35,,5.6095,3.875,Gefitinib,CHEMBL939,XGALLCVXEZPNRQ-UHFFFAOYSA-N,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,C22H24ClFN4O3,DB00317,D01977,gefitinib,anastrozole,CHEMBL1399,YBBLVLTVTVSKRW-UHFFFAOYSA-N,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,C17H19N5,DB01217,D00960,anastrozole,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
406039,72,43,28,uM,uM,-0.836197967583271,3.23934717793392,2.44689299247459,3.49466590560652,4.63606799908028,0.3,10.57,-1.356,20.024,35.75,27.887,18.673,,23.28,17.317,Gefitinib,CHEMBL939,XGALLCVXEZPNRQ-UHFFFAOYSA-N,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,C22H24ClFN4O3,DB00317,D01977,gefitinib,anastrozole,CHEMBL1399,YBBLVLTVTVSKRW-UHFFFAOYSA-N,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,C17H19N5,DB01217,D00960,anastrozole,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
406202,116,108,38,uM,uM,-0.370667647996184,-13.758739049964,-1.73966503631289,-0.794700981861353,4.75243603628729,1.45055431441366,-1.244,28.889,37.436,28.657,33.0465,5.4015,,19.224000000000004,4.157500000000002,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,6-Thioguanine,CHEMBL727,WYWHKKSPHMUBEB-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=C(N2)N,C5H5N5S,DB00352,D08603,thioguanine,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
406208,116,108,28,uM,uM,1.49559977350837,-1.20960783004245,4.19549464572213,1.93290598037074,0.647196610526164,1.31558516658958,33.59,33.09,55.17,45.951,50.5605,-16.1195,,17.220499999999994,16.970499999999994,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,6-Thioguanine,CHEMBL727,WYWHKKSPHMUBEB-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=C(N2)N,C5H5N5S,DB00352,D08603,thioguanine,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
406462,1,40,28,uM,uM,-19.1818843247431,-46.309179069718,-31.4549958964143,-28.5607368909222,3.70539648442761,75.0,52.846,-6.514,37.876,13.345,25.6105,-20.7215,,2.444500000000001,-27.2355,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,altretamine,CHEMBL1455,UUVWYPNAQBNQJQ-UHFFFAOYSA-N,CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C,C9H18N6,DB00488,D02841,altretamine,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
406484,1,40,38,uM,uM,3.04610786228827,-7.2517330918786,2.03644854803015,4.33549410120755,4.93954994547436,75.0,31.568,-3.362,32.593,30.082,31.3375,3.1315,,17.234499999999997,-0.2305000000000028,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,altretamine,CHEMBL1455,UUVWYPNAQBNQJQ-UHFFFAOYSA-N,CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C,C9H18N6,DB00488,D02841,altretamine,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
406761,101,108,28,uM,uM,3.80735038915048,-28.602185620242,-0.0022043847076008,3.75953495528327,0.171867099886755,1.31558516658958,-5.115,33.09,28.827,34.555,31.691,3.716,,17.7035,-1.3990000000000045,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,6-Thioguanine,CHEMBL727,WYWHKKSPHMUBEB-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=C(N2)N,C5H5N5S,DB00352,D08603,thioguanine,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
406783,101,108,38,uM,uM,-1.79537063726115,-16.0438488928424,-3.95325012220516,-3.79488429563215,4.38962339087133,1.45055431441366,-0.959,28.889,40.797,24.198,32.4975,4.5675,,18.5325,3.608500000000003,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,6-Thioguanine,CHEMBL727,WYWHKKSPHMUBEB-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=C(N2)N,C5H5N5S,DB00352,D08603,thioguanine,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
406854,88,35,38,uM,uM,-0.291587383061678,3.23581504413912,7.51362526979378,3.52324254528294,0.0616476966214236,0.208496207352919,26.212,9.397,45.809,36.24,41.0245,5.4155,,23.22,14.812500000000004,mitoxantrone,CHEMBL58,KKZJGLLVHKMTCM-UHFFFAOYSA-N,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,C22H28N4O6,DB01204,D08224,mitoxantrone,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
406868,88,35,7,uM,uM,4.0168566503726,-8.27228936324004,4.92864909068622,3.40683979443008,0.0309080476193319,0.445990451398277,46.022,2.715,62.324,47.442,54.883,6.146,,30.514500000000005,8.861000000000004,mitoxantrone,CHEMBL58,KKZJGLLVHKMTCM-UHFFFAOYSA-N,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,C22H28N4O6,DB01204,D08224,mitoxantrone,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,A549,C3512,Lung (Carcinoma),Lung adenocarcinoma
406880,88,35,28,uM,uM,4.04420406071917,0.804656717818792,8.02129193646045,6.66750384553508,0.186033682243995,0.262268148292762,29.019,7.518,33.698,44.829,39.2635,2.7265,,20.995,10.244500000000002,mitoxantrone,CHEMBL58,KKZJGLLVHKMTCM-UHFFFAOYSA-N,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,C22H28N4O6,DB01204,D08224,mitoxantrone,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
407071,56,108,28,uM,uM,3.01173602987289,-1.92909704952118,6.08328443344282,6.73927613302178,0.479317498262319,1.31558516658958,-0.542,33.09,46.774,46.089,46.4315,13.8835,,30.1575,13.341499999999996,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,6-Thioguanine,CHEMBL727,WYWHKKSPHMUBEB-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=C(N2)N,C5H5N5S,DB00352,D08603,thioguanine,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
407081,56,108,38,uM,uM,-2.86986535727374,-4.92784519825535,-1.11863901109403,-2.54374236451254,0.134169130800938,1.45055431441366,4.756,28.889,27.549,30.605,29.077,-4.568,,12.254500000000004,0.1880000000000024,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,6-Thioguanine,CHEMBL727,WYWHKKSPHMUBEB-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=C(N2)N,C5H5N5S,DB00352,D08603,thioguanine,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
407119,120,108,38,uM,uM,-0.852417155323496,-12.9381684897402,0.876027655572622,-0.502017080640272,3.86072665158335,1.45055431441366,4.58,28.889,35.541,32.991,34.266,0.796999999999997,,17.531499999999998,5.376999999999999,Vismodegib,CHEMBL473417,BPQMGSKTAYIVFO-UHFFFAOYSA-N,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,C19H14Cl2N2O3S,DB08828,D09992,vismodegib,6-Thioguanine,CHEMBL727,WYWHKKSPHMUBEB-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=C(N2)N,C5H5N5S,DB00352,D08603,thioguanine,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
407141,120,108,28,uM,uM,3.004917774611,-14.7122924276591,3.70021052940014,5.30782395737635,13.2475908300401,1.31558516658958,-2.739,33.09,40.279,44.347,42.313,11.962,,27.137500000000003,9.223,Vismodegib,CHEMBL473417,BPQMGSKTAYIVFO-UHFFFAOYSA-N,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,C19H14Cl2N2O3S,DB08828,D09992,vismodegib,6-Thioguanine,CHEMBL727,WYWHKKSPHMUBEB-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=C(N2)N,C5H5N5S,DB00352,D08603,thioguanine,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
407223,115,108,38,uM,uM,-2.4132281837332,-7.04420579865599,-0.446676218162465,-2.26041616668838,0.230610312300154,1.45055431441366,4.437,28.889,34.171,30.794,32.4825,-0.843499999999999,,15.8195,3.5935000000000024,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,6-Thioguanine,CHEMBL727,WYWHKKSPHMUBEB-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=C(N2)N,C5H5N5S,DB00352,D08603,thioguanine,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
407229,115,108,28,uM,uM,6.42251307737938,-3.24822659645858,6.76609941828903,7.85063476806908,0.987963832062323,1.31558516658958,-1.287,33.09,38.636,46.082,42.359,10.556,,26.4575,9.268999999999998,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,6-Thioguanine,CHEMBL727,WYWHKKSPHMUBEB-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=C(N2)N,C5H5N5S,DB00352,D08603,thioguanine,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
407994,101,43,38,uM,uM,0.516825728144489,2.60535527058835,2.63216314444789,3.2784510300946,4.38962339087133,0.0115539149855814,-0.959,2.525,3.521,8.816,6.1685,4.6025,,5.3855,3.6435,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,anastrozole,CHEMBL1399,YBBLVLTVTVSKRW-UHFFFAOYSA-N,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,C17H19N5,DB01217,D00960,anastrozole,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
408016,101,43,28,uM,uM,3.09942542056721,-6.51712782633359,-5.5070775870193,-0.297890007235296,0.171867099886755,0.3,-5.115,-1.356,-5.52,-4.813,-5.1665,1.3045,,-1.931,-3.8105,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,anastrozole,CHEMBL1399,YBBLVLTVTVSKRW-UHFFFAOYSA-N,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,C17H19N5,DB01217,D00960,anastrozole,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
408142,115,43,28,uM,uM,0.0744859058576149,1.10269715994133,1.38930047130543,4.33609402020059,0.987963832062323,0.3,-1.287,-1.356,2.219,12.985,7.602,10.245,,8.9235,8.889,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,anastrozole,CHEMBL1399,YBBLVLTVTVSKRW-UHFFFAOYSA-N,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,C17H19N5,DB01217,D00960,anastrozole,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
408148,115,43,38,uM,uM,-2.1658518521956,3.35550155872957,3.4747535026729,2.69643251955291,0.230610312300154,0.0115539149855814,4.437,2.525,11.33,11.0,11.165,4.203,,7.683999999999999,6.727999999999999,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,anastrozole,CHEMBL1399,YBBLVLTVTVSKRW-UHFFFAOYSA-N,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,C17H19N5,DB01217,D00960,anastrozole,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
408281,56,43,38,uM,uM,-0.50862709369135,1.33488962387033,1.52188536667012,1.89958772488342,0.134169130800938,0.0115539149855814,4.756,2.525,7.284,5.678,6.481,-0.800000000000001,,2.8405,1.7249999999999996,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,anastrozole,CHEMBL1399,YBBLVLTVTVSKRW-UHFFFAOYSA-N,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,C17H19N5,DB01217,D00960,anastrozole,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
408291,56,43,28,uM,uM,-0.354409306326908,3.16372402093885,3.44018936019432,5.68651475708114,0.479317498262319,0.3,-0.542,-1.356,6.982,17.758,12.37,14.268,,13.319,12.912,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,anastrozole,CHEMBL1399,YBBLVLTVTVSKRW-UHFFFAOYSA-N,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,C17H19N5,DB01217,D00960,anastrozole,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
408339,120,43,28,uM,uM,0.280118499668534,-1.14351055065916,-0.611643973139015,3.3940697631613,13.2475908300401,0.3,-2.739,-1.356,-0.071,12.122,6.0255,10.1205,,8.073,7.3815,Vismodegib,CHEMBL473417,BPQMGSKTAYIVFO-UHFFFAOYSA-N,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,C19H14Cl2N2O3S,DB08828,D09992,vismodegib,anastrozole,CHEMBL1399,YBBLVLTVTVSKRW-UHFFFAOYSA-N,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,C17H19N5,DB01217,D00960,anastrozole,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
408361,120,43,38,uM,uM,-0.325975484875836,1.71516241023014,1.86210758889234,2.10007943536843,3.86072665158335,0.0115539149855814,4.58,2.525,4.875,8.193,6.534,-0.571000000000001,,2.9815,1.954,Vismodegib,CHEMBL473417,BPQMGSKTAYIVFO-UHFFFAOYSA-N,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,C19H14Cl2N2O3S,DB08828,D09992,vismodegib,anastrozole,CHEMBL1399,YBBLVLTVTVSKRW-UHFFFAOYSA-N,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,C17H19N5,DB01217,D00960,anastrozole,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
408495,116,43,28,uM,uM,7.59373426986762,1.91572286647649,5.97722632580792,6.84954533367487,0.647196610526164,0.3,33.59,-1.356,39.472,50.985,45.2285,12.9945,,29.1115,11.638499999999992,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,anastrozole,CHEMBL1399,YBBLVLTVTVSKRW-UHFFFAOYSA-N,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,C17H19N5,DB01217,D00960,anastrozole,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
408501,116,43,38,uM,uM,0.498110038302962,-2.10142362864192,-1.23239468841671,0.0557346885933418,4.75243603628729,0.0115539149855814,-1.244,2.525,1.988,7.3,4.644,3.363,,4.0035,2.119,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,anastrozole,CHEMBL1399,YBBLVLTVTVSKRW-UHFFFAOYSA-N,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,C17H19N5,DB01217,D00960,anastrozole,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
408643,79,43,38,uM,uM,-2.45571006946294,-3.80845868544474,-4.23017901726329,-6.51470982768939,30.0,0.0115539149855814,2.987,2.525,-0.131,-3.379,-1.755,-7.267,,-4.511,-4.742,Lenalidomide,CHEMBL848,GOTYRUGSSMKFNF-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,C13H13N3O3,DB00480,D04687,lenalidomide,anastrozole,CHEMBL1399,YBBLVLTVTVSKRW-UHFFFAOYSA-N,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,C17H19N5,DB01217,D00960,anastrozole,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
408649,79,43,28,uM,uM,5.65938547531546,2.35661177003442,1.18678188136347,2.43195404490333,30.0,0.3,4.019,-1.356,6.204,0.98,3.592,0.928999999999999,,2.2605,-0.427,Lenalidomide,CHEMBL848,GOTYRUGSSMKFNF-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,C13H13N3O3,DB00480,D04687,lenalidomide,anastrozole,CHEMBL1399,YBBLVLTVTVSKRW-UHFFFAOYSA-N,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,C17H19N5,DB01217,D00960,anastrozole,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
409426,88,40,28,uM,uM,6.15266267414004,-31.2649752564743,4.23533743691903,8.79966745533492,0.186033682243995,75.0,29.019,-6.514,51.615,26.242,38.9285,16.4235,,27.676,9.9095,mitoxantrone,CHEMBL58,KKZJGLLVHKMTCM-UHFFFAOYSA-N,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,C22H28N4O6,DB01204,D08224,mitoxantrone,altretamine,CHEMBL1455,UUVWYPNAQBNQJQ-UHFFFAOYSA-N,CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C,C9H18N6,DB00488,D02841,altretamine,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
409436,88,40,38,uM,uM,1.86820602197167,-30.5989780893061,-1.53744034085876,0.955089357220536,0.0616476966214236,75.0,26.212,-3.362,27.179,40.221,33.7,10.85,,22.275,7.488000000000003,mitoxantrone,CHEMBL58,KKZJGLLVHKMTCM-UHFFFAOYSA-N,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,C22H28N4O6,DB01204,D08224,mitoxantrone,altretamine,CHEMBL1455,UUVWYPNAQBNQJQ-UHFFFAOYSA-N,CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C,C9H18N6,DB00488,D02841,altretamine,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
409602,116,388,38,uM,uM,7.62746925841275,4.77387160854895,7.93022385257599,9.12073492905137,4.75243603628729,0.0199876552638227,-1.244,9.85,13.483,21.334,17.4085,8.8025,,13.1055,7.5585,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,raloxifene,CHEMBL81,GZUITABIAKMVPG-UHFFFAOYSA-N,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,C28H27NO4S,DB00481,D08465,raloxifene,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
409608,116,388,28,uM,uM,8.56081342215265,-3.89664096344519,7.50789299247459,10.4874131616799,0.647196610526164,0.010486582322792,33.59,-5.189,39.046,36.974,38.01,9.60899999999999,,23.8095,4.419999999999995,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,raloxifene,CHEMBL81,GZUITABIAKMVPG-UHFFFAOYSA-N,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,C28H27NO4S,DB00481,D08465,raloxifene,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
409796,72,35,38,uM,uM,-4.62858150555415,4.47377204314883,5.09342710550297,2.65311421451795,10.0,0.208496207352919,5.994,9.397,28.254,26.271,27.2625,11.8715,,19.567,17.865499999999997,Gefitinib,CHEMBL939,XGALLCVXEZPNRQ-UHFFFAOYSA-N,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,C22H24ClFN4O3,DB00317,D01977,gefitinib,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
409806,72,35,28,uM,uM,0.996400247508341,5.4162891194034,7.37451415868268,6.6086864663366,4.63606799908028,0.262268148292762,10.57,7.518,35.089,57.08,46.0845,27.9965,,37.0405,35.5145,Gefitinib,CHEMBL939,XGALLCVXEZPNRQ-UHFFFAOYSA-N,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,C22H24ClFN4O3,DB00317,D01977,gefitinib,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
409818,72,35,7,uM,uM,2.71805638408661,8.02029452186626,9.02114909068622,6.13249343757638,1.19272204952941,0.445990451398277,22.807,2.715,41.471,34.926,38.1985,12.6765,,25.437500000000004,15.391500000000004,Gefitinib,CHEMBL939,XGALLCVXEZPNRQ-UHFFFAOYSA-N,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,C22H24ClFN4O3,DB00317,D01977,gefitinib,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,A549,C3512,Lung (Carcinoma),Lung adenocarcinoma
410211,115,388,28,uM,uM,5.2856853171229,5.10485098856133,7.90319177015994,12.6036169993783,0.987963832062323,0.010486582322792,-1.287,-5.189,6.833,14.492,10.6625,17.1385,,13.9005,11.9495,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,raloxifene,CHEMBL81,GZUITABIAKMVPG-UHFFFAOYSA-N,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,C28H27NO4S,DB00481,D08465,raloxifene,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
410221,115,388,38,uM,uM,6.58378173639345,12.8201925196694,13.7577477111892,10.7541907231132,0.230610312300154,0.0199876552638227,4.437,9.85,20.363,23.821,22.092,7.805,,14.9485,12.242,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,raloxifene,CHEMBL81,GZUITABIAKMVPG-UHFFFAOYSA-N,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,C28H27NO4S,DB00481,D08465,raloxifene,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
410413,120,388,28,uM,uM,4.32593140632967,5.43121171974947,5.73751112593817,11.1711104334078,13.2475908300401,0.010486582322792,-2.739,-5.189,3.106,12.859,7.9825,15.9105,,11.9465,10.7215,Vismodegib,CHEMBL473417,BPQMGSKTAYIVFO-UHFFFAOYSA-N,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,C19H14Cl2N2O3S,DB08828,D09992,vismodegib,raloxifene,CHEMBL81,GZUITABIAKMVPG-UHFFFAOYSA-N,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,C28H27NO4S,DB00481,D08465,raloxifene,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
410423,120,388,38,uM,uM,2.22637497939139,10.9333143648841,11.433334764369,9.49638975249469,3.86072665158335,0.0199876552638227,4.58,9.85,20.26,19.459,19.8595,5.4295,,12.6445,10.0095,Vismodegib,CHEMBL473417,BPQMGSKTAYIVFO-UHFFFAOYSA-N,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,C19H14Cl2N2O3S,DB08828,D09992,vismodegib,raloxifene,CHEMBL81,GZUITABIAKMVPG-UHFFFAOYSA-N,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,C28H27NO4S,DB00481,D08465,raloxifene,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
410592,56,388,38,uM,uM,5.6279839417451,10.1321928625797,10.777334764369,8.99784864640018,0.134169130800938,0.0199876552638227,4.756,9.85,18.621,17.465,18.043,3.437,,10.739999999999998,8.193,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,raloxifene,CHEMBL81,GZUITABIAKMVPG-UHFFFAOYSA-N,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,C28H27NO4S,DB00481,D08465,raloxifene,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
410598,56,388,28,uM,uM,4.27348314135798,4.04973547934812,7.82715242176524,12.3423795084977,0.479317498262319,0.010486582322792,-0.542,-5.189,10.195,18.691,14.443,20.174,,17.3085,14.985,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,raloxifene,CHEMBL81,GZUITABIAKMVPG-UHFFFAOYSA-N,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,C28H27NO4S,DB00481,D08465,raloxifene,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
410704,101,388,38,uM,uM,1.10128778013897,4.08667866086003,5.81758321112818,5.59852474305836,4.38962339087133,0.0199876552638227,-0.959,9.85,14.265,15.376,14.8205,5.9295,,10.375,4.9705,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,raloxifene,CHEMBL81,GZUITABIAKMVPG-UHFFFAOYSA-N,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,C28H27NO4S,DB00481,D08465,raloxifene,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
410729,101,388,28,uM,uM,6.36686511297292,1.63320396245723,0.165749754639399,6.27149953214802,0.171867099886755,0.010486582322792,-5.115,-5.189,-4.117,-0.425,-2.271,8.033,,2.881,2.8440000000000003,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,raloxifene,CHEMBL81,GZUITABIAKMVPG-UHFFFAOYSA-N,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,C28H27NO4S,DB00481,D08465,raloxifene,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
410980,79,35,38,uM,uM,-4.55111632817732,-5.35255736480296,2.15820488328074,0.754658580681379,30.0,0.208496207352919,2.987,9.397,9.788,10.064,9.926,-2.458,,3.734,0.5289999999999999,Lenalidomide,CHEMBL848,GOTYRUGSSMKFNF-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,C13H13N3O3,DB00480,D04687,lenalidomide,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
410990,79,35,28,uM,uM,1.69940331939876,-7.45038170071718,3.02820488328074,3.2136047415136,30.0,0.262268148292762,4.019,7.518,13.2,10.958,12.079,0.542000000000002,,6.310500000000001,4.561000000000001,Lenalidomide,CHEMBL848,GOTYRUGSSMKFNF-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,C13H13N3O3,DB00480,D04687,lenalidomide,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
411119,116,35,28,uM,uM,2.95532625947287,-1.93445644830382,6.55331575735289,4.72616526715442,0.647196610526164,0.262268148292762,33.59,7.518,47.657,44.88,46.2685,5.1605,,25.7145,12.6785,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
411123,116,35,7,uM,uM,-1.28142827067377,-5.70991078704141,-1.98665316236324,0.157146329504308,5.0,0.445990451398277,-2.354,2.715,8.63,10.65,9.64,9.279,,9.4595,6.925000000000001,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,A549,C3512,Lung (Carcinoma),Lung adenocarcinoma
411144,116,35,38,uM,uM,-4.39777295095811,-13.3135948594699,-0.626442814090653,0.560169781625317,4.75243603628729,0.208496207352919,-1.244,9.397,2.895,16.342,9.6185,1.4655,,5.541999999999999,0.2214999999999989,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
412767,101,35,38,uM,uM,-3.02947312835197,-1.62414573958141,1.16341437785593,1.87152374841009,4.38962339087133,0.208496207352919,-0.959,9.397,15.404,4.267,9.8355,1.3975,,5.616499999999999,0.4384999999999994,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
412777,101,35,28,uM,uM,-1.44178359529529,-14.2019473282002,-1.97409327359648,2.85549489984474,0.171867099886755,0.262268148292762,-5.115,7.518,2.844,2.501,2.6725,0.2695,,1.471,-4.8455,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
412781,101,35,7,uM,uM,-3.55845839408695,-1.03390638646057,0.339211668594246,0.263760128945497,3.22123167658349,0.445990451398277,2.342,2.715,15.138,9.548,12.343,7.286,,9.8145,9.628,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,A549,C3512,Lung (Carcinoma),Lung adenocarcinoma
412946,120,35,28,uM,uM,-4.29982896817959,-9.11850790951753,-3.14236339992185,-0.429340963617744,13.2475908300401,0.262268148292762,-2.739,7.518,2.559,8.235,5.397,0.618,,3.0075000000000003,-2.121,Vismodegib,CHEMBL473417,BPQMGSKTAYIVFO-UHFFFAOYSA-N,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,C19H14Cl2N2O3S,DB08828,D09992,vismodegib,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
412956,120,35,38,uM,uM,-3.00195247898352,-2.58076855011897,4.1780810445226,3.72353235506864,3.86072665158335,0.208496207352919,4.58,9.397,11.584,15.346,13.465,-0.512,,6.4765,4.068,Vismodegib,CHEMBL473417,BPQMGSKTAYIVFO-UHFFFAOYSA-N,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,C19H14Cl2N2O3S,DB08828,D09992,vismodegib,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
412997,56,35,38,uM,uM,-5.76980200489384,-2.49236093845166,1.97474771118927,1.55381036008524,0.134169130800938,0.208496207352919,4.756,9.397,26.564,17.565,22.0645,7.9115,,14.988,12.6675,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
413015,56,35,7,uM,uM,-6.0422900316462,-2.70620053074446,-1.12039944251687,-0.891609636381101,0.497567802644297,0.445990451398277,4.613,2.715,7.01,38.668,22.839,15.511,,19.175,18.226,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,A549,C3512,Lung (Carcinoma),Lung adenocarcinoma
413019,56,35,28,uM,uM,-2.3188568587902,-1.78381348584774,-0.283192510757953,0.873724160916598,0.479317498262319,0.262268148292762,-0.542,7.518,6.731,16.388,11.5595,4.5835,,8.0715,4.0415,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
413142,115,35,28,uM,uM,-3.39362160550113,-4.75760859061362,-2.72301385942767,-0.934354900702784,0.987963832062323,0.262268148292762,-1.287,7.518,5.559,13.562,9.5605,3.3295,,6.444999999999999,2.0424999999999995,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
413154,115,35,7,uM,uM,-4.17456468724655,1.92295639796524,3.37170182525692,2.24628249714657,0.362777838678078,0.445990451398277,10.315,2.715,17.499,12.508,15.0035,1.9735,,8.488500000000002,4.688500000000001,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,A549,C3512,Lung (Carcinoma),Lung adenocarcinoma
413168,115,35,38,uM,uM,-4.22316077898081,-5.06042031862063,-0.328410450327589,-1.20858844375724,0.230610312300154,0.208496207352919,4.437,9.397,8.237,8.016,8.1265,-5.7075,,1.2095000000000002,-1.2705000000000002,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,Vorinostat,CHEMBL98,WAEXFXRVDQXREF-UHFFFAOYSA-N,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,DB02546,D06320,vorinostat,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
414339,72,77,28,uM,uM,0.498196911415376,0.218787872519937,-0.569107466666666,1.50092900521131,4.6360573499979,0.7,10.57,-2.328,15.901,44.04,29.9705,21.7285,,25.8495,19.4005,Gefitinib,CHEMBL939,XGALLCVXEZPNRQ-UHFFFAOYSA-N,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,C22H24ClFN4O3,DB00317,D01977,gefitinib,IMIQUIMOD,CHEMBL1282,DOUYETYNHWVLEO-UHFFFAOYSA-N,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N,C14H16N4,DB00724,D02500,imiquimod,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
414361,72,77,38,uM,uM,-2.63979247914635,-2.33341018574277,-2.33188666666667,-0.2118562731198,10.0,0.7,5.994,-2.317,10.389,12.462,11.4255,7.7485,,9.587,5.4315,Gefitinib,CHEMBL939,XGALLCVXEZPNRQ-UHFFFAOYSA-N,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,C22H24ClFN4O3,DB00317,D01977,gefitinib,IMIQUIMOD,CHEMBL1282,DOUYETYNHWVLEO-UHFFFAOYSA-N,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N,C14H16N4,DB00724,D02500,imiquimod,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
416767,88,43,28,uM,uM,0.0994117400894728,-12.8787186084003,-2.24699533333333,-1.27803418641886,0.18603349028953,0.3,29.019,-1.356,23.307,44.157,33.732,6.069,,19.9005,4.713000000000001,mitoxantrone,CHEMBL58,KKZJGLLVHKMTCM-UHFFFAOYSA-N,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,C22H28N4O6,DB01204,D08224,mitoxantrone,anastrozole,CHEMBL1399,YBBLVLTVTVSKRW-UHFFFAOYSA-N,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,C17H19N5,DB01217,D00960,anastrozole,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
416777,88,43,38,uM,uM,-1.47110532504335,-6.4869371066568,-2.05880193333333,-3.63515143403132,0.0616016327000153,0.011557226187068,26.212,2.525,24.784,32.372,28.578,-0.158999999999999,,14.2095,2.366,mitoxantrone,CHEMBL58,KKZJGLLVHKMTCM-UHFFFAOYSA-N,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,C22H28N4O6,DB01204,D08224,mitoxantrone,anastrozole,CHEMBL1399,YBBLVLTVTVSKRW-UHFFFAOYSA-N,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,C17H19N5,DB01217,D00960,anastrozole,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
417334,1,31,38,uM,uM,7.86567831800544,-4.71865652868047,2.06422777777778,5.79168736760374,4.93955229646514,3.66101861219851,31.568,-5.471,33.356,22.012,27.684,1.587,,14.6355,-3.884,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
417566,40,31,28,uM,uM,5.84652885335899,2.28092122032822,2.41776532222222,8.93419226568806,75.0,0.238031687943589,-6.521,-4.85,-7.303,-0.455,-3.879,7.492,,1.8065,0.9709999999999996,altretamine,CHEMBL1455,UUVWYPNAQBNQJQ-UHFFFAOYSA-N,CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C,C9H18N6,DB00488,D02841,altretamine,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
417576,40,31,38,uM,uM,5.0710613375217,-5.38645150080691,-4.78366694444444,1.73638912727914,75.0,3.66101861219851,-3.362,-5.471,-8.739,-12.341,-10.54,-1.707,,-6.123499999999999,-7.177999999999999,altretamine,CHEMBL1455,UUVWYPNAQBNQJQ-UHFFFAOYSA-N,CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C,C9H18N6,DB00488,D02841,altretamine,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
417831,53,31,38,uM,uM,-3.83531063864861,-11.9096733778283,-5.69099505555555,-1.24080091197054,20.7445479067755,3.66101861219851,18.749,-5.471,14.029,33.449,23.739,10.461,,17.1,4.990000000000002,chlorambucil,CHEMBL515,JCKYGMPEJWAADB-UHFFFAOYSA-N,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,C14H19Cl2NO2,DB00291,D00266,chlorambucil,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
417837,53,31,28,uM,uM,-2.20598125186839,-9.74385856888883,0.608646655555556,4.48451786038126,13.0779434755627,0.238031687943589,16.142,-4.85,14.067,15.187,14.627,3.335,,8.981000000000002,-1.5149999999999988,chlorambucil,CHEMBL515,JCKYGMPEJWAADB-UHFFFAOYSA-N,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,C14H19Cl2NO2,DB00291,D00266,chlorambucil,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
418033,108,31,38,uM,uM,1.85386814519344,-25.2626440249588,-4.33644022222222,-0.430391034323875,1.45131581741944,3.66101861219851,28.889,-5.471,24.379,26.098,25.2385,1.8205,,13.5295,-3.650500000000001,6-Thioguanine,CHEMBL727,WYWHKKSPHMUBEB-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=C(N2)N,C5H5N5S,DB00352,D08603,thioguanine,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
418039,108,31,28,uM,uM,1.16284725587072,-41.6289080357374,-3.1010334,0.10797032265338,1.31560299364638,0.238031687943589,33.09,-4.85,30.428,30.987,30.7075,2.4675,,16.5875,-2.382500000000004,6-Thioguanine,CHEMBL727,WYWHKKSPHMUBEB-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=C(N2)N,C5H5N5S,DB00352,D08603,thioguanine,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
419011,88,53,38,uM,uM,-14.6500483916758,-3.80608052098641,-1.40486377777778,-7.59324111248249,0.0616016327000153,20.7385621197952,26.212,18.749,33.85,34.433,34.1415,-10.8195,,11.661,7.929500000000001,mitoxantrone,CHEMBL58,KKZJGLLVHKMTCM-UHFFFAOYSA-N,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,C22H28N4O6,DB01204,D08224,mitoxantrone,chlorambucil,CHEMBL515,JCKYGMPEJWAADB-UHFFFAOYSA-N,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,C14H19Cl2NO2,DB00291,D00266,chlorambucil,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
419021,88,53,28,uM,uM,5.39691614120734,-14.629178691801,3.66482914444444,0.444740187508336,0.18603349028953,13.0773576549536,29.019,16.142,35.223,60.818,48.0205,2.8595,,25.44,19.0015,mitoxantrone,CHEMBL58,KKZJGLLVHKMTCM-UHFFFAOYSA-N,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,C22H28N4O6,DB01204,D08224,mitoxantrone,chlorambucil,CHEMBL515,JCKYGMPEJWAADB-UHFFFAOYSA-N,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,C14H19Cl2NO2,DB00291,D00266,chlorambucil,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
419511,108,78,28,uM,uM,-1.78585169563465,-1.34182049426878,0.350089733333336,0.983600333462206,1.31560299364638,0.0008670937365112,33.09,2.215,40.669,21.301,30.985,-4.32000000000001,,13.332499999999996,-2.105000000000004,6-Thioguanine,CHEMBL727,WYWHKKSPHMUBEB-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=C(N2)N,C5H5N5S,DB00352,D08603,thioguanine,Ixabepilone,CHEMBL1201752,FABUFPQFXZVHFB-PVYNADRNSA-N,CC1CCCC2(C(O2)CC(NC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C,C27H42N2O5S,DB04845,D04645,ixabepilone,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
419521,108,78,38,uM,uM,-0.448737179343483,0.625554845491328,1.01366177777778,-0.357484195438257,1.45131581741944,0.0003170996753372,28.889,2.629,28.929,48.244,38.5865,7.0685,,22.8275,9.697500000000002,6-Thioguanine,CHEMBL727,WYWHKKSPHMUBEB-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=C(N2)N,C5H5N5S,DB00352,D08603,thioguanine,Ixabepilone,CHEMBL1201752,FABUFPQFXZVHFB-PVYNADRNSA-N,CC1CCCC2(C(O2)CC(NC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C,C27H42N2O5S,DB04845,D04645,ixabepilone,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
419608,116,77,38,uM,uM,2.11730062378054,-3.07522935445144,-2.82877801111111,-0.312748485413606,4.75243872110931,0.7,-1.244,-2.317,-3.174,-2.663,-2.9185,0.6425,,-1.138,-1.6745,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,IMIQUIMOD,CHEMBL1282,DOUYETYNHWVLEO-UHFFFAOYSA-N,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N,C14H16N4,DB00724,D02500,imiquimod,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
419614,116,77,28,uM,uM,5.47658137899169,-4.8924073018678,4.22567102222222,5.9490713614788,0.647141555789257,0.7,33.59,-2.328,40.28,58.945,49.6125,18.3505,,33.9815,16.022499999999994,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,IMIQUIMOD,CHEMBL1282,DOUYETYNHWVLEO-UHFFFAOYSA-N,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N,C14H16N4,DB00724,D02500,imiquimod,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
419662,53,78,28,uM,uM,-5.09908991413309,-5.75633672444211,-3.04673191111111,-2.79464059877317,13.0779434755627,0.0008670937365112,16.142,2.215,11.741,6.55,9.1455,-9.2115,,-0.0329999999999994,-6.996499999999999,chlorambucil,CHEMBL515,JCKYGMPEJWAADB-UHFFFAOYSA-N,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,C14H19Cl2NO2,DB00291,D00266,chlorambucil,Ixabepilone,CHEMBL1201752,FABUFPQFXZVHFB-PVYNADRNSA-N,CC1CCCC2(C(O2)CC(NC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C,C27H42N2O5S,DB04845,D04645,ixabepilone,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
419671,53,78,38,uM,uM,-3.69829804030351,-0.0110170577552781,0.282327888888888,-1.19041090654715,20.7445479067755,0.0003170996753372,18.749,2.629,18.891,39.827,29.359,7.981,,18.67,10.610000000000005,chlorambucil,CHEMBL515,JCKYGMPEJWAADB-UHFFFAOYSA-N,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,C14H19Cl2NO2,DB00291,D00266,chlorambucil,Ixabepilone,CHEMBL1201752,FABUFPQFXZVHFB-PVYNADRNSA-N,CC1CCCC2(C(O2)CC(NC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C,C27H42N2O5S,DB04845,D04645,ixabepilone,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
419726,40,78,28,uM,uM,1.21418175240735,-12.2398698436378,-2.73194366666667,3.26251642285689,75.0,0.0008670937365112,-6.521,2.215,-1.72,-4.983,-3.3515,0.9545,,-1.1985,-5.5665,altretamine,CHEMBL1455,UUVWYPNAQBNQJQ-UHFFFAOYSA-N,CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C,C9H18N6,DB00488,D02841,altretamine,Ixabepilone,CHEMBL1201752,FABUFPQFXZVHFB-PVYNADRNSA-N,CC1CCCC2(C(O2)CC(NC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C,C27H42N2O5S,DB04845,D04645,ixabepilone,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
419736,40,78,38,uM,uM,-0.198441975225254,-5.55253751912775,-2.13794322222222,1.14297835100643,75.0,0.0003170996753372,-3.362,2.629,-5.484,1.864,-1.81,-1.077,,-1.4435,-4.439,altretamine,CHEMBL1455,UUVWYPNAQBNQJQ-UHFFFAOYSA-N,CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C,C9H18N6,DB00488,D02841,altretamine,Ixabepilone,CHEMBL1201752,FABUFPQFXZVHFB-PVYNADRNSA-N,CC1CCCC2(C(O2)CC(NC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C,C27H42N2O5S,DB04845,D04645,ixabepilone,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
420007,1,78,28,uM,uM,-0.162523453492104,-3.21821772721024,-3.21266055555556,-4.42475382835685,3.70537747168014,0.0008670937365112,52.846,2.215,52.232,21.687,36.9595,-18.1015,,9.429000000000002,-15.886499999999998,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,Ixabepilone,CHEMBL1201752,FABUFPQFXZVHFB-PVYNADRNSA-N,CC1CCCC2(C(O2)CC(NC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C,C27H42N2O5S,DB04845,D04645,ixabepilone,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
420013,1,78,38,uM,uM,2.76836836848111,6.31589671018156,6.31900611111111,4.53467448789159,4.93955229646514,0.0003170996753372,31.568,2.629,35.78,26.812,31.296,-2.901,,14.197499999999998,-0.272000000000002,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,Ixabepilone,CHEMBL1201752,FABUFPQFXZVHFB-PVYNADRNSA-N,CC1CCCC2(C(O2)CC(NC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C,C27H42N2O5S,DB04845,D04645,ixabepilone,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
420615,88,30,28,uM,uM,11.1330448230779,-0.112500318857224,10.5363381111111,10.7927988040878,0.18603349028953,0.328052191594891,29.019,-1.044,41.183,51.839,46.511,18.536,,32.523500000000006,17.492000000000004,mitoxantrone,CHEMBL58,KKZJGLLVHKMTCM-UHFFFAOYSA-N,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,C22H28N4O6,DB01204,D08224,mitoxantrone,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
420627,88,30,7,uM,uM,4.84131192790267,-17.6802594732656,3.80211528888889,4.27254979598553,0.0309055857331494,0.295728840841155,46.022,-1.113,49.766,42.447,46.1065,1.1975,,23.652,0.0844999999999984,mitoxantrone,CHEMBL58,KKZJGLLVHKMTCM-UHFFFAOYSA-N,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,C22H28N4O6,DB01204,D08224,mitoxantrone,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,A549,C3512,Lung (Carcinoma),Lung adenocarcinoma
420641,88,30,38,uM,uM,2.94519722654772,-13.3798641271149,1.79089308888889,1.81572930037599,0.0616016327000153,0.0449794187025259,26.212,0.197,25.021,39.15,32.0855,5.6765,,18.881000000000004,5.873500000000004,mitoxantrone,CHEMBL58,KKZJGLLVHKMTCM-UHFFFAOYSA-N,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,C22H28N4O6,DB01204,D08224,mitoxantrone,Sunitinib,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,DB01268,D06402,sunitinib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
420919,79,77,28,uM,uM,0.938941284363916,0.483946904153707,-0.685883777777778,1.77414531158473,30.0,0.7,4.041,-2.328,5.021,-3.878,0.5715,-1.1415,,-0.2850000000000002,-3.4695000000000005,Lenalidomide,CHEMBL848,GOTYRUGSSMKFNF-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,C13H13N3O3,DB00480,D04687,lenalidomide,IMIQUIMOD,CHEMBL1282,DOUYETYNHWVLEO-UHFFFAOYSA-N,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N,C14H16N4,DB00724,D02500,imiquimod,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
420941,79,77,38,uM,uM,-0.167233834739419,-0.213640995383101,-1.05177413555556,1.17138364827306,30.0,0.7,2.988,-2.317,7.337,3.913,5.625,4.954,,5.2895,2.637,Lenalidomide,CHEMBL848,GOTYRUGSSMKFNF-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,C13H13N3O3,DB00480,D04687,lenalidomide,IMIQUIMOD,CHEMBL1282,DOUYETYNHWVLEO-UHFFFAOYSA-N,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N,C14H16N4,DB00724,D02500,imiquimod,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
420986,88,1,28,uM,uM,-15.3618231481378,-16.6859369932118,-15.8400323333333,-23.1743756693625,0.18603349028953,3.70475552916332,29.019,52.846,19.746,51.926,35.836,-46.029,,-5.096499999999999,-17.009999999999998,mitoxantrone,CHEMBL58,KKZJGLLVHKMTCM-UHFFFAOYSA-N,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,C22H28N4O6,DB01204,D08224,mitoxantrone,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
420992,88,1,38,uM,uM,-7.35930117875946,0.440600825836834,1.80385111111111,-7.67493625331804,0.0616016327000153,4.93634884876382,26.212,31.568,33.959,46.568,40.2635,-17.5165,,11.3735,8.6955,mitoxantrone,CHEMBL58,KKZJGLLVHKMTCM-UHFFFAOYSA-N,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,C22H28N4O6,DB01204,D08224,mitoxantrone,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
422618,1,43,28,uM,uM,1.77627485180891,-7.76128448807951,-7.23910555555555,-6.62468359472281,3.70537747168014,0.3,52.846,-1.356,47.648,-2.313,22.6675,-28.8225,,-3.077499999999997,-30.1785,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,anastrozole,CHEMBL1399,YBBLVLTVTVSKRW-UHFFFAOYSA-N,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,C17H19N5,DB01217,D00960,anastrozole,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
422640,1,43,38,uM,uM,8.36477048055783,8.22554393094215,8.51422777777778,6.7901664822762,4.93955229646514,0.011557226187068,31.568,2.525,40.413,31.638,36.0255,1.9325,,18.979,4.4575,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,anastrozole,CHEMBL1399,YBBLVLTVTVSKRW-UHFFFAOYSA-N,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,C17H19N5,DB01217,D00960,anastrozole,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
422739,40,43,28,uM,uM,2.83083326231439,-8.56743466759036,-7.88096655555556,-1.64757248965218,75.0,0.3,-6.521,-1.356,-10.539,-12.016,-11.2775,-3.4005,,-7.339,-9.9215,altretamine,CHEMBL1455,UUVWYPNAQBNQJQ-UHFFFAOYSA-N,CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C,C9H18N6,DB00488,D02841,altretamine,anastrozole,CHEMBL1399,YBBLVLTVTVSKRW-UHFFFAOYSA-N,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,C17H19N5,DB01217,D00960,anastrozole,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
422765,40,43,38,uM,uM,-0.0988554225853469,-6.54479274098646,-5.22550597777778,-1.94160869044222,75.0,0.011557226187068,-3.362,2.525,-2.807,-5.278,-4.0425,-3.2055,,-3.624000000000001,-6.567500000000001,altretamine,CHEMBL1455,UUVWYPNAQBNQJQ-UHFFFAOYSA-N,CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C,C9H18N6,DB00488,D02841,altretamine,anastrozole,CHEMBL1399,YBBLVLTVTVSKRW-UHFFFAOYSA-N,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,C17H19N5,DB01217,D00960,anastrozole,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
423147,53,43,28,uM,uM,-6.55894038539332,-8.19728472574918,-7.6497582,-6.38231241664289,13.0779434755627,0.3,16.142,-1.356,-2.803,-4.946,-3.8745,-18.6605,,-11.2675,-20.0165,chlorambucil,CHEMBL515,JCKYGMPEJWAADB-UHFFFAOYSA-N,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,C14H19Cl2NO2,DB00291,D00266,chlorambucil,anastrozole,CHEMBL1399,YBBLVLTVTVSKRW-UHFFFAOYSA-N,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,C17H19N5,DB01217,D00960,anastrozole,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
423157,53,43,38,uM,uM,-9.5505779230418,-2.08103130022522,-1.96035761111111,-3.59923242786244,20.7445479067755,0.011557226187068,18.749,2.525,19.25,39.681,29.4655,8.1915,,18.8285,10.7165,chlorambucil,CHEMBL515,JCKYGMPEJWAADB-UHFFFAOYSA-N,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,C14H19Cl2NO2,DB00291,D00266,chlorambucil,anastrozole,CHEMBL1399,YBBLVLTVTVSKRW-UHFFFAOYSA-N,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,C17H19N5,DB01217,D00960,anastrozole,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
423233,108,43,28,uM,uM,-0.483741743461047,-6.51930600711898,-3.28806686666667,-1.30372002634952,1.31560299364638,0.3,33.09,-1.356,34.352,36.997,35.6745,3.94049999999999,,19.8075,2.5844999999999985,6-Thioguanine,CHEMBL727,WYWHKKSPHMUBEB-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=C(N2)N,C5H5N5S,DB00352,D08603,thioguanine,anastrozole,CHEMBL1399,YBBLVLTVTVSKRW-UHFFFAOYSA-N,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,C17H19N5,DB01217,D00960,anastrozole,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
423243,108,43,38,uM,uM,-0.245406308921401,0.0918168938428799,0.886714333333333,-0.718548980764658,1.45131581741944,0.011557226187068,28.889,2.525,30.295,40.854,35.5745,4.1605,,19.8675,6.685500000000001,6-Thioguanine,CHEMBL727,WYWHKKSPHMUBEB-UHFFFAOYSA-N,C1=NC2=C(N1)C(=S)N=C(N2)N,C5H5N5S,DB00352,D08603,thioguanine,anastrozole,CHEMBL1399,YBBLVLTVTVSKRW-UHFFFAOYSA-N,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,C17H19N5,DB01217,D00960,anastrozole,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
423768,88,31,28,uM,uM,6.52386378767575,-32.3330837097877,3.16144866666667,6.48614568398115,0.18603349028953,0.238031687943589,29.019,-4.85,32.565,34.456,33.5105,9.3415,,21.426,4.491500000000002,mitoxantrone,CHEMBL58,KKZJGLLVHKMTCM-UHFFFAOYSA-N,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,C22H28N4O6,DB01204,D08224,mitoxantrone,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
423792,88,31,38,uM,uM,6.20462448864042,-25.8074825741161,2.33600425555555,6.37716104522057,0.0616016327000153,3.66101861219851,26.212,-5.471,27.813,45.39,36.6015,15.8605,,26.231,10.389500000000002,mitoxantrone,CHEMBL58,KKZJGLLVHKMTCM-UHFFFAOYSA-N,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,C22H28N4O6,DB01204,D08224,mitoxantrone,temozolomide,CHEMBL810,BPEGJWRSRHCHSN-UHFFFAOYSA-N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C6H6N6O2,DB00853,D06067,temozolomide,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
425199,101,77,28,uM,uM,3.99006526972734,-9.31232165661419,-11.4046271555556,-5.96377732233749,0.171868765665854,0.7,-5.115,-2.328,-17.705,-6.763,-12.234,-4.791,,-8.5125,-9.906,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,IMIQUIMOD,CHEMBL1282,DOUYETYNHWVLEO-UHFFFAOYSA-N,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N,C14H16N4,DB00724,D02500,imiquimod,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
425221,101,77,38,uM,uM,1.18432737440855,-4.32875994531855,-4.02534177777778,-1.53901383589361,4.38962377586057,0.7,-0.959,-2.317,-4.41,-1.139,-2.7745,0.5015,,-1.1365,-1.8155,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,IMIQUIMOD,CHEMBL1282,DOUYETYNHWVLEO-UHFFFAOYSA-N,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N,C14H16N4,DB00724,D02500,imiquimod,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
425529,115,79,28,uM,uM,-1.81517577465619,-3.60430807959055,-1.58405516666667,-0.546913617563134,0.987963146004799,30.0,-1.287,4.022,2.176,11.789,6.9825,4.2475,,5.615,2.9605,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,Lenalidomide,CHEMBL848,GOTYRUGSSMKFNF-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,C13H13N3O3,DB00480,D04687,lenalidomide,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
425551,115,79,38,uM,uM,-1.90574177457888,-0.413200241277164,3.86076844444444,2.7107671200902,0.230610346101871,30.0,4.437,2.982,7.612,8.793,8.2025,0.7835,,4.493,3.7655,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,Lenalidomide,CHEMBL848,GOTYRUGSSMKFNF-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,C13H13N3O3,DB00480,D04687,lenalidomide,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
425676,120,79,28,uM,uM,-2.56638111707694,-5.90894588444006,-4.68933422222222,-2.64481917987702,13.24738847718,30.0,-2.739,4.022,-0.648,3.859,1.6055,0.3225,,0.9639999999999996,-2.4165,Vismodegib,CHEMBL473417,BPQMGSKTAYIVFO-UHFFFAOYSA-N,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,C19H14Cl2N2O3S,DB08828,D09992,vismodegib,Lenalidomide,CHEMBL848,GOTYRUGSSMKFNF-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,C13H13N3O3,DB00480,D04687,lenalidomide,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
425682,120,79,38,uM,uM,1.17006272659828,5.56061343375733,5.92988988888889,5.9252028371051,3.86072710871984,30.0,4.58,2.982,7.963,8.674,8.3185,0.7565,,4.5375,3.7385,Vismodegib,CHEMBL473417,BPQMGSKTAYIVFO-UHFFFAOYSA-N,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,C19H14Cl2N2O3S,DB08828,D09992,vismodegib,Lenalidomide,CHEMBL848,GOTYRUGSSMKFNF-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,C13H13N3O3,DB00480,D04687,lenalidomide,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
425728,56,79,38,uM,uM,-1.17298047417511,-0.811481395773946,4.22533377777778,4.36235522066066,0.134169150105147,30.0,4.756,2.982,6.814,7.03,6.922,-0.816,,3.0529999999999995,2.1659999999999995,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,Lenalidomide,CHEMBL848,GOTYRUGSSMKFNF-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,C13H13N3O3,DB00480,D04687,lenalidomide,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
425753,56,79,28,uM,uM,0.227937379587049,-2.00536986743992,1.50450094444444,1.90668222197298,0.479317731304992,30.0,-0.542,4.022,1.19,26.478,13.834,10.354,,12.094,9.812,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,Lenalidomide,CHEMBL848,GOTYRUGSSMKFNF-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,C13H13N3O3,DB00480,D04687,lenalidomide,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
426087,101,79,38,uM,uM,0.486378399561395,2.35676940154279,1.80016873333333,2.17421733374973,4.38962377586057,30.0,-0.959,2.982,3.667,10.456,7.0615,5.0385,,6.05,4.0795,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,Lenalidomide,CHEMBL848,GOTYRUGSSMKFNF-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,C13H13N3O3,DB00480,D04687,lenalidomide,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
426093,101,79,28,uM,uM,1.07495435134706,-8.23260636126114,-9.40233252222222,-4.50081063577027,0.171868765665854,30.0,-5.115,4.022,-8.765,-4.465,-6.615,-5.522,,-6.0685,-10.637,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,Lenalidomide,CHEMBL848,GOTYRUGSSMKFNF-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,C13H13N3O3,DB00480,D04687,lenalidomide,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
426656,115,77,38,uM,uM,-1.30682021896967,-7.13186776115425,-3.88761316666667,-1.55151600040313,0.230610346101871,0.7,4.437,-2.317,-0.929,0.565,-0.182,-2.302,,-1.242,-4.619000000000001,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,IMIQUIMOD,CHEMBL1282,DOUYETYNHWVLEO-UHFFFAOYSA-N,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N,C14H16N4,DB00724,D02500,imiquimod,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
426662,115,77,28,uM,uM,0.0984143025657051,-11.1182454019119,-10.464423,-6.98839177287202,0.987963146004799,0.7,-1.287,-2.328,-10.882,-0.729,-5.8055,-2.1905,,-3.998,-4.5185,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,IMIQUIMOD,CHEMBL1282,DOUYETYNHWVLEO-UHFFFAOYSA-N,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N,C14H16N4,DB00724,D02500,imiquimod,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
426827,116,79,28,uM,uM,2.73092422905467,-6.60479205646421,4.42870055555556,2.7813372825617,0.647141555789257,30.0,33.59,4.022,38.129,27.709,32.919,-4.693,,14.112999999999996,-0.6710000000000065,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,Lenalidomide,CHEMBL848,GOTYRUGSSMKFNF-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,C13H13N3O3,DB00480,D04687,lenalidomide,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
426849,116,79,38,uM,uM,1.6849133203411,3.44497393211468,2.60677966666667,3.88401748908206,4.75243872110931,30.0,-1.244,2.982,3.349,4.175,3.762,2.024,,2.893,0.7799999999999998,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,Lenalidomide,CHEMBL848,GOTYRUGSSMKFNF-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,C13H13N3O3,DB00480,D04687,lenalidomide,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
427484,88,78,28,uM,uM,-0.859698949329601,1.49043998442463,3.27384744444444,2.25405429570887,0.18603349028953,0.0008670937365112,29.019,2.215,33.078,42.755,37.9165,6.6825,,22.2995,8.8975,mitoxantrone,CHEMBL58,KKZJGLLVHKMTCM-UHFFFAOYSA-N,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,C22H28N4O6,DB01204,D08224,mitoxantrone,Ixabepilone,CHEMBL1201752,FABUFPQFXZVHFB-PVYNADRNSA-N,CC1CCCC2(C(O2)CC(NC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C,C27H42N2O5S,DB04845,D04645,ixabepilone,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
427510,88,78,38,uM,uM,-1.11047746195935,-0.937686011255427,-0.432116044444444,-1.79349346320492,0.0616016327000153,0.0003170996753372,26.212,2.629,24.519,34.112,29.3155,0.474499999999999,,14.895,3.1035000000000004,mitoxantrone,CHEMBL58,KKZJGLLVHKMTCM-UHFFFAOYSA-N,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,C22H28N4O6,DB01204,D08224,mitoxantrone,Ixabepilone,CHEMBL1201752,FABUFPQFXZVHFB-PVYNADRNSA-N,CC1CCCC2(C(O2)CC(NC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C,C27H42N2O5S,DB04845,D04645,ixabepilone,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
428108,120,77,38,uM,uM,-1.11060288544679,-1.13203712392097,-0.553222911111111,1.82948137963266,3.86072710871984,0.7,4.58,-2.317,2.858,-1.249,0.8045,-1.4585,,-0.3269999999999999,-3.7755,Vismodegib,CHEMBL473417,BPQMGSKTAYIVFO-UHFFFAOYSA-N,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,C19H14Cl2N2O3S,DB08828,D09992,vismodegib,IMIQUIMOD,CHEMBL1282,DOUYETYNHWVLEO-UHFFFAOYSA-N,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N,C14H16N4,DB00724,D02500,imiquimod,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
428130,120,77,28,uM,uM,0.367760116802679,-7.23944583114484,-7.27022168888889,-2.84676906768591,13.24738847718,0.7,-2.739,-2.328,-0.827,4.846,2.0095,7.0765,,4.543,4.3375,Vismodegib,CHEMBL473417,BPQMGSKTAYIVFO-UHFFFAOYSA-N,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,C19H14Cl2N2O3S,DB08828,D09992,vismodegib,IMIQUIMOD,CHEMBL1282,DOUYETYNHWVLEO-UHFFFAOYSA-N,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N,C14H16N4,DB00724,D02500,imiquimod,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
428412,56,77,28,uM,uM,-0.356975109489145,-7.72930545897654,-4.33958633333333,-1.37514744528036,0.479317731304992,0.7,-0.542,-2.328,2.77,9.945,6.3575,9.2275,,7.7925,6.8995,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,IMIQUIMOD,CHEMBL1282,DOUYETYNHWVLEO-UHFFFAOYSA-N,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N,C14H16N4,DB00724,D02500,imiquimod,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
428422,56,77,38,uM,uM,-1.28900956603635,-9.50501443617994,-3.92344565555556,-1.4113730479229,0.134169150105147,0.7,4.756,-2.317,-0.362,-4.472,-2.417,-4.856,,-3.6365,-7.173,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,IMIQUIMOD,CHEMBL1282,DOUYETYNHWVLEO-UHFFFAOYSA-N,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N,C14H16N4,DB00724,D02500,imiquimod,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
429900,79,1,38,uM,uM,7.3033902008332,-2.70041498056433,4.08199944444445,1.79540494869275,30.0,4.93634884876382,2.988,31.568,27.437,34.445,30.941,-3.615,,13.662999999999997,-0.6270000000000024,Lenalidomide,CHEMBL848,GOTYRUGSSMKFNF-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,C13H13N3O3,DB00480,D04687,lenalidomide,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
429910,79,1,28,uM,uM,5.10389155543872,-10.9300981844908,0.221333000000001,-1.97871523051837,30.0,3.70475552916332,4.041,52.846,17.467,90.41,53.9385,-2.9485,,25.495,1.0925000000000011,Lenalidomide,CHEMBL848,GOTYRUGSSMKFNF-UHFFFAOYSA-N,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,C13H13N3O3,DB00480,D04687,lenalidomide,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
430056,116,1,28,uM,uM,-4.50982295658588,-0.31669314325751,2.15782,-5.37929773270261,0.647141555789257,3.70475552916332,33.59,52.846,54.38,64.575,59.4775,-26.9585,,16.259499999999996,6.631500000000003,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
430066,116,1,38,uM,uM,9.33497921342834,5.06885338771222,7.85899966666667,8.7607587449463,4.75243872110931,4.93634884876382,-1.244,31.568,33.146,44.904,39.025,8.701,,23.863,7.456999999999997,Vemurafenib,CHEMBL1229517,GPXBXXGIAQBQNI-UHFFFAOYSA-N,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,DB08881,D09996,vemurafenib,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
430308,101,1,38,uM,uM,3.65483580285075,0.731904198127395,4.87244411111111,4.66706500035941,4.38962377586057,4.93634884876382,-0.959,31.568,33.057,37.713,35.385,4.776,,20.0805,3.8169999999999966,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
430334,101,1,28,uM,uM,4.0206191842734,-12.4586348529199,-5.37766722222222,-2.95903785587392,0.171868765665854,3.70475552916332,-5.115,52.846,20.222,49.792,35.007,-12.724,,11.1415,-17.839,Ruxolitinib,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,DB08877,D09959,ruxolitinib,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
430432,120,1,28,uM,uM,1.20645458683667,-10.9269269286363,-0.487444777777778,-0.748881559688975,13.24738847718,3.70475552916332,-2.739,52.846,37.196,56.964,47.08,-3.027,,22.0265,-5.765999999999998,Vismodegib,CHEMBL473417,BPQMGSKTAYIVFO-UHFFFAOYSA-N,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,C19H14Cl2N2O3S,DB08828,D09992,vismodegib,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
430458,120,1,38,uM,uM,6.50213627051281,3.82440071407142,8.71524744444445,6.36138399162893,3.86072710871984,4.93634884876382,4.58,31.568,31.87,39.575,35.7225,-0.4255,,17.648499999999995,4.154499999999995,Vismodegib,CHEMBL473417,BPQMGSKTAYIVFO-UHFFFAOYSA-N,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,C19H14Cl2N2O3S,DB08828,D09992,vismodegib,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
430497,56,1,38,uM,uM,2.32569262655643,4.78000362002162,5.59024744444445,3.19717177918449,0.134169150105147,4.93634884876382,4.756,31.568,24.026,37.254,30.64,-5.684,,12.478000000000002,-0.9280000000000008,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
430503,56,1,28,uM,uM,-0.710102902151407,-4.51301708035903,-2.97911144444444,-4.16074032412231,0.479317731304992,3.70475552916332,-0.542,52.846,29.54,54.088,41.814,-10.49,,15.662000000000004,-11.031999999999996,Crizotinib,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,DB08865,D09731,crizotinib,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
430647,115,1,28,uM,uM,2.06582229671586,-1.15220500453519,1.50222222222222,0.835565389761023,0.987963146004799,3.70475552916332,-1.287,52.846,43.426,59.316,51.371,-0.187999999999995,,25.591500000000003,-1.4749999999999943,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
430657,115,1,38,uM,uM,2.00733420913078,4.86926320574968,6.34452555555556,3.42249953344991,0.230610346101871,4.93634884876382,4.437,31.568,32.111,36.994,34.5525,-1.45250000000001,,16.55,2.9845000000000006,Vandetanib,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,DB05294,D06407,vandetanib,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
431615,88,5,38,uM,uM,1.33921407334511,0.900086708048391,1.43211533333333,1.71069952952776,0.0616016327000153,0.0025938407477929,26.212,-0.608,26.954,23.002,24.978,-0.625999999999998,,12.176000000000002,-1.2339999999999982,mitoxantrone,CHEMBL58,KKZJGLLVHKMTCM-UHFFFAOYSA-N,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,C22H28N4O6,DB01204,D08224,mitoxantrone,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
431640,88,5,28,uM,uM,1.89459560603576,5.36017602224528,3.56622611111111,4.39546216433671,0.18603349028953,0.0022673877675779,29.019,-2.49,29.398,47.248,38.323,11.794,,25.0585,9.304000000000002,mitoxantrone,CHEMBL58,KKZJGLLVHKMTCM-UHFFFAOYSA-N,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,C22H28N4O6,DB01204,D08224,mitoxantrone,Bortezomib,CHEMBL325041,GXJABQQUPOEUTA-RDJZCZTQSA-N,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,DB00188,D03150,bortezomib,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
432386,72,1,38,uM,uM,0.799655844409609,5.41442190129765,6.21196966666667,1.21290892308325,10.0,4.93634884876382,5.994,31.568,29.698,43.541,36.6195,-0.942499999999995,,17.838500000000003,5.051500000000001,Gefitinib,CHEMBL939,XGALLCVXEZPNRQ-UHFFFAOYSA-N,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,C22H24ClFN4O3,DB00317,D01977,gefitinib,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,MCF7,C4194,Breast (Carcinoma),Invasive breast carcinoma of no special type
432396,72,1,28,uM,uM,-12.2191265934373,-10.7032119441304,-9.01758555555556,-14.7603920176279,4.6360573499979,3.70475552916332,10.57,52.846,23.649,65.246,44.4475,-18.9685,,12.7395,-8.398499999999999,Gefitinib,CHEMBL939,XGALLCVXEZPNRQ-UHFFFAOYSA-N,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,C22H24ClFN4O3,DB00317,D01977,gefitinib,5-Fluorouracil,CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,DB00544,D00584,fluorouracil,HT29,C4349,Large intestine; Colon (Carcinoma),Colon adenocarcinoma
